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Foreword 
 
The Community Epidemiology Work Group (CEWG) 
is a drug abuse surveillance network established in 
1976 by the National Institute on Drug Abuse (NIDA), 
National Institutes of Health (NIH). It is composed of 
researchers from 21 sentinel areas of the United States 
who meet semiannually to present and discuss quanti-
tative and qualitative data related to drug abuse. 
Through this program, the CEWG provides current 
descriptive and analytical information regarding the 
nature and patterns of drug abuse, emerging trends, 
characteristics of vulnerable populations, and social 
and health consequences to government officials and 
policymakers, community organizations, researchers 
and scientists, and the general public. 
 
The 53rd meeting of the CEWG, held in Miami, 
Florida, on December 10–13, 2002, provided a forum 
for presentation and discussion of drug abuse data in 
Canada, Central and Southwest Asia, Egypt, Israel, 
Mexico, Palestine, and Southern Africa. The meeting 
in Miami afforded the opportunity for presentation 
and discussion of drug abuse-related issues of special 
concern to the local community. A Broward County 
law enforcement official described drug diversion 
and associated problems identified in the re-
gion.Additional local reports focused on drug 
problems identified in toxicology reports, the toxi-
cology of substances abused alone and combination 
in South Florida, the club drug scene, drug preven-
tion and outreach efforts to high-risk populations, and 
drug abuse treatment methods and approaches cur-
rently being used in the region. In addition, members 
were provided an update on the Drug Abuse Warning 
Network. 
 
These wide-ranging research and other presentations 
pointed out unique and local aspects of drug abuse 
and social health consequences that have confronted 
and continue to concern the city of Miami. They also 
served to capture the diversity and community-based 
nature of drug abuse, its emergence in the commu-
nity, and its resolution by the community. They 
underscored, once again, the necessity of establishing 
effective networks of drug abuse surveillance at the 
local level in communities throughout the world. 
 
The December 2002 meeting of the CEWG was 
chaired by Nicholas Kozel, Division of Epidemio-
logy, Services and Prevention Resarch, NIDA.  
Shortly after the  meeting, Mr. Kozel retired from the 
Federal Government.  Mr. Kozel’s role in establish-
ing the Community Epidemiology Work Group in 
1976 and his tireless leadership in fostering its devel-
opment as a drug abuse surveillance system is greatly 
appreciated.   
 
Moira P. O’Brien 
Division of Epidemiology, Services and Prevention Research 
NIDA 
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Introduction 
 
At the 53rd meeting of the Community Epidemiology 
Work Group (CEWG), held in Miami, Florida, on De-
cember 10– 13, 2002, representatives from 21 CEWG 
areas presented data on drug abuse patterns and trends 
in the United States. Their papers are presented in this 
report. Also presented are international reports from 
Canada, Central Asia, Israel, Mexico, Palestine, and 
South Africa.  
 
CEWG DATA SOURCES 
 
To assess drug abuse patterns and trends, the 21 
CEWG members access and analyze data from various 
sources. As will be apparent in the CEWG papers, 
members derive drug indicator data from many local 
and State sources, including public health agencies, 
medical facilities, substance abuse treatment programs, 
criminal justice and correctional offices, law enforce-
ment agencies, surveys, and qualitative studies (e.g., 
focus groups, key informant surveys, ethnographic 
studies). In addition, national data sets that have in-
formation specific to CEWG sites are accessed and 
analyzed. The widely used national data sets are de-
scribed below. 
 
Drug Abuse Warning Network (DAWN) 
Emergency Department Data 
 
This voluntary national data collection system, man-
aged by the Office of Applied Studies (OAS), 
Substance Abuse and Mental Health Services Admini-
stration (SAMHSA), provides semiannual and annual 
estimates on substance use manifested in visits to hos-
pital emergency departments (EDs) in 21 metropolitan 
areas, including 20 CEWG areas. 
 
The data are gathered from a national representative 
sample of non-Federal hospitals in the 21 areas in 48 
States and the District of Columbia that have a 24-hour 
ED. Alaska and Hawaii are not included in the sample. 
With few exceptions, the geographic area boundaries 
correspond to the 1983 Office of Management and 
Budget definitions of Metropolitan Statistical Area and 
Primary Metropolitan Statistical Area. Periodic minor 
modifications are made to the ED sample to keep it 
current. Analyses show that such modifications have 
little impact on trends across time. Various statistical 
procedures are used to enhance precision in the 
sampling frame. By the end of 2001, 458 hospitals 
were included in the sample.  
 
ED data are reported for each “ episode”  (case or 
admission) that meets the criteria for “ drug abuser”  
that is taking one or more substances without proper 
medical supervision or for psychic effect, dependence, 
or suicide attempt or gesture. Each drug reported by a 
patient may be counted as a “ mention.”  Up to four 
drugs for each episode may be recorded. Some drugs 
are classified in a combined category, such as 
“ cocaine/crack,”  “ marijuana/hashish,”  and “ PCP/PCP 
combinations.”  
 
ED mention data are converted to rates per 100,000 
population when sample sizes permit. A probability 
value of less than .05 is used to determine statistical 
significance.  The 2001 DAWN estimates mark the 
first use of population data from the 2000 decennial 
census.  It is important to note that the population 
denominator used to calculate rates per 100,000 
population is considerably larger because the 2000 
census data are available.  (Prior periods used 
estimated yearly adjustments from the 1990 census.) 
Because of the larger denominator, there are many 
large decreases in the 2001 ED rates, making it 
important to verify rate reductions against total 
estimates for the same measure. It is possible to have 
an estimate (in mentions or episodes) increase from 
2000 to 2001 and have the corresponding rate decrease 
because of changes in the population denominator. 
 
Because an individual may be counted in more than 
one episode in a reporting period, and may mention 
more than one drug, the DAWN ED data cannot be 
used to estimate prevalence. 
 
DAWN Medical Examiner Data 
 
In 2000, 137 jurisdictions in 43 metropolitan areas 
submitted drug-related death data to DAWN, OAS, 
SAMHSA. The Mortality Data from the Drug Abuse 
Warning Network marked a major change in the pres-
entation of DAWN medical examiner data and 
replaced the previous DAWN Annual Medical Exam-
iner Data reports with a new title and design. The title 
change reflects the expansion of data collection on 
drug-related deaths to a variety of jurisdictions, 
including medical examiners, coroners, and other 
death investigation systems. Changes in format and 
content provide more information about metropolitan 
statistical areas represented in DAWN and their com-
ponent jurisdictions. The method by which drugs are 
coded was also changed to be consistent with DAWN 
ED terminology.  
 
A “ drug-related death”  may involve more than one 
drug “ mention.”  Excluded from the count are deaths 
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involving circumstances unrelated to the death, acci-
dental ingestion, adverse reactions to prescribed drugs, 
and consumption to conceal substances from law 
enforcement. Some deaths are caused by a drug over-
dose; in other cases, a drug may be considered a con-
tributory but not major cause of death. 
 
Jurisdictions do not represent a statistical sample. 
Counts of drug-related deaths do not represent the 
entire Nation, nor do they represent any metropolitan 
area in which there is less than full participation in this 
DAWN system. 
 
The Arrestee Drug Abuse Monitoring (ADAM) 
Program 
 
Managed by the National Institute of Justice (NIJ), the 
ADAM program is designed to gather drug use data 
quarterly from arrestees in 35 sites in the United 
States; 19 of these sites provide data relevant to the 
CEWG. Data are reported annually by NIJ. 
 
Beginning in 2000, the ADAM instrument for adult 
arrestees was revised and the adult male sample was 
based on probability sampling procedures. For these 
reasons, the 2000 (and beyond) data are not compara-
ble to data collected prior to 2000. In the 2001 analy-
ses, data on adult males, collected in all 35 sites, were 
typically weighted. Adult female data, collected in 
most sites, were unweighted and based on different 
data collection methods. Data on juvenile arrestees, 
collected at selected sites, continued to be based on the 
Drug Use Forecasting (DUF) model. 
 
Analyses and reporting of ADAM data focus on urin-
alysis results. Urinalysis confirms use of 10 drugs 
within a 2– 3 day period prior to arrest by using the 
Enzyme Multiplied Immunoassay Technology 
(EMIT). The urinalysis tests for use of cocaine, opiates 
(e.g., heroin), marijuana, phencyclidine, methadone, 
methaqualone (Quaalude), propoxyphene (Darvon), 
barbiturates (e.g., Seconal, Tuinal), benzodiazepines 
(e.g., Valium, Ativan), and amphetamines. Gas chro-
matography mass spectrometry (GC/MS) confirms use 
of illicit methamphetamine and amphetamines and 
distinguishes them from over-the-counter compounds. 
Self-report data on drug use are collected for particular 
drugs and time periods (past 30 days and past 12 
months). Self-report data also cover demographic 
characteristics and information related to the need for 
utilization of substance abuse treatment. 
 
As in other arrestee data sets, the rate and type of drug 
arrest may reflect changing law enforcement practices 
(e.g., “ crack-downs”  on specific population groups at a 
specific point in time) rather than prevalence of drug 
use among the sampled arrestees. 
 
The Domestic Monitor Program (DMP) 
 
Under the jurisdiction of the Drug Enforcement Ad-
ministration (DEA), the DMP reports on the sources, 
types, cost, and purity of retail-level heroin. The in-
formation is based on actual undercover heroin pur-
chases made by the DEA on streets in several cities, 
including 20 in CEWG areas. 
 
The heroin buys provide information on type of her-
oin (Asian, Mexican, Colombian, undetermined) and 
what diluents and adulterants are present in the drug. 
DMP reports indicate where the buy was made, the 
brand name (if any), purity level, and price per milli-
gram pure. 
 
By comparing DMP data over time, it is possible to 
assess changes in price per milligram pure and the 
sources of heroin purchased in an area. Price and 
purity for particular drugs can vary across years if 
there are only small numbers of buys made in a 
particular area. 
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Metropolitan Atlanta Drug Use Trends 
 
Tara McDonald1 and Claire E. Sterk2 
 
                                                           
1
  Tara McDonald is affiliated with the Department of Sociology at Georgia State University, Atlanta, Georgia. 
2
  Claire E. Sterk is affiliated with the Rollins School of Public Health at Emory University, Atlanta, Georgia. 
ABSTRACT 
 
The Metropolitan Atlanta area drug scene remains 
dominated by cocaine and marijuana. Leading indi-
cators suggest that cocaine use is on the rise again, 
with ethnographic reports suggesting this may be 
somewhat related to more recreational use among 
younger users, particularly of powder cocaine. 
Continuing a long-term trend, ethnographic data 
suggest that, regardless of other indicators, mari-
juana use is pervasive in and around Atlanta. The 
DEA considers it the ‘most widely abused drug’ in 
the State of Georgia. Indicators for marijuana have 
been rising, but they most likely do not capture the 
totality of its use. Some heroin indicators continued 
to increase, but use in Atlanta appears to remain 
well below the national rate. Heroin purity in At-
lanta remained fairly high, though it dropped some-
what in samples tested by the DEA in the first 
quarter of 2002, to 53 percent. Among other opiates, 
hydrocodone combinations (e.g., Vicodin) have the 
highest rate of emergency department (ED) men-
tions, although hydromorphone (Dilaudid) contin-
ues to be mentioned frequently in ethnographic 
reports. Methamphetamine rates continue to rise. 
Much of the methamphetamine found in Georgia is 
imported and distributed by Mexican nationals, but 
there continued to be a number of lab seizures, pri-
marily in the more rural parts of the State. The rate 
of methylenedioxymethamphetamine (MDMA or 
ecstasy) ED mentions increased in the metropolitan 
Atlanta area between 2000 and 2001, from 2 to 5. 
By comparison, the national rate is 2 per 100,000 
population. Ecstasy use is being widely reported in 
ethnographic reports by persons of various age 
groups and in a number of settings that do not nec-
essarily include clubs or parties. Atlanta remains 
one of the few places where indicators and ethno-
graphic data show extensive MDMA use in the 
African-American community. Reported AIDS 
cases in Georgia and Atlanta overall have been 
decreasing over the past few years, but the propor-
tion of cases directly related to injection drug use 
(approximately 18 percent both statewide and 
locally) has remained consistent. The same is true 
for cases among men who have sex with men and 
also inject drugs, which account for an additional 6 
percent. Injection-related AIDS cases again 
accounted for a greater percentage of female than 
male cases both statewide and in the metropolitan 
Atlanta area: 22.1 percent vs. 21.2 percent and 30.8 
percent vs. 22.1 percent, respectively. 
 
INTRODUCTION 
 
Area Description 
 
The city of Atlanta constitutes a very small area 
within the larger Atlanta metropolitan area. The city 
covers 131 square miles and had an estimated 
population of 416,474 in 2002 (U.S. Bureau of the 
Census). The Atlanta metropolitan area includes 
2,584 square miles and has an estimated population 
of 4,112,198. 
 
The 20 counties that make up the metropolitan area 
vary in geographic size, population size and growth, 
ethnic composition, and socioeconomic status. Fulton 
and DeKalb Counties, which include the city of 
Atlanta, have the largest total and minority 
populations. The total population in Fulton was 
816,006 in 2000, of which 49.1 percent were White, 
45.2 percent were African-American, 5.9 percent 
were Hispanic, and 3.5 percent were Asian. DeKalb 
County had a total population of 665,865; 55.3 
percent were African-American, 37.0 percent were 
White, 7.9 percent were Hispanic, and 4.6 percent 
were Asian. In Clayton County, located just south of 
Atlanta, the total population was 236,517; the 
majority were African-American (52.7 percent), 
followed by Whites (39.2 percent), Hispanics (7.5 
percent), and Asians (5.2 percent). The Hispanic 
population more than doubled in these three counties 
during the past 10 years. The African-American 
population increased by 180.9 percent in Clayton 
County, 56.7 percent in DeKalb County, and 12.2 
percent in Fulton County between 1990 and 2000. 
Gwinnett County, which has the fourth largest 
population in the metropolitan area (588,448), is 
located northeast of the city. The population in this 
county is 74.3 percent White, 13.9 percent African-
American, 10.9 percent Hispanic, and 7.9 percent 
Asian. The Asian population has increased 
dramatically (1990– 2000) in Gwinnett (318.5 per-
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cent), Fulton (201.3 percent), Clayton (114.4 per-
cent), and Cobb (139.3 percent) Counties. The 
majority of residents in the city of Atlanta are 
African-American (61.4 percent), followed by Whites 
(32.6 percent), Hispanics (4.5 percent), and Asians 
(1.9 percent). 
 
Data Sources 
 
Principal data sources for this report are described 
below.  
 
• Drug abuse treatment program data were 
provided by the Georgia Department of Human 
Resources (DHR). The data included the primary 
drugs of abuse among the approximately 4,331 
clients admitted to Atlanta’s public drug 
treatment programs between July 1, 2001, and 
December 31, 2001. Data for the nonmetro-
politan Atlanta counties of Georgia were also 
reported (n=8,147).  
 
• Emergency department (ED) drug mentions 
data were derived from the Drug Abuse Warn-
ing Network (DAWN), Office of Applied 
Studies, Substance Abuse and Mental Health 
Services Administration (SAMHSA). Data are 
presented on estimates of drug mentions among 
individuals admitted to participating metropoli-
tan Atlanta emergency departments between 
January 1994 and December 2001.  
 
• Heroin price, purity, and source data were 
obtained from the Drug Enforcement Admini-
stration (DEA), Domestic Monitor Program 
(DMP). The data are preliminary for 2002. 
 
• Atlanta High Intensity Drug Trafficking Area 
(HIDTA) 2003 Drug Threat Assessment data 
about the price and purity of drugs distributed in 
the metropolitan area, as well as information on 
trafficking trends, were provided by the Atlanta 
HIDTA Task Force, part of a coordinated effort 
of drug-related Federal, State, and local law 
enforcement agencies.  
 
• Ethnographic information was collected from 
local drug use researchers and is used for several 
purposes: (1) to corroborate the epidemiologic 
drug indicators; (2) to signal potential drug 
trends; and (3) to place the epidemiologic data in 
a social context. In addition, qualitative inter-
views were conducted with local treatment staff 
and clients, law enforcement officials, outreach 
workers, community health experts, and out-of-
treatment users. 
 
• Acquired immunodeficiency syndrome (AIDS) 
data were provided by the Georgia Department of 
Human Resources. The information represents 
AIDS cases in Georgia and an eight-county 
Atlanta metropolitan area from January 1981 
through the third quarter of 2002 (September 30). 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack  
 
Following an upward trend since 1997, the estimated 
rate per 100,000 population of ED cocaine mentions 
rose again significantly between 2000 and 2001, from 
221 to 244 (exhibit 1). The national rate also 
increased, and, continuing a long-term trend, the rate 
of cocaine mentions in Atlanta were more than three 
times the national rate (exhibit 2). Mentions remained 
higher among men than women, with a male-to-
female ratio of 2:1. Based on ED mentions, Atlanta’s 
cocaine users are generally an older population and 
are aging. The rate per 100,000 population among 
18– 25-year-olds fell significantly from 2000 (n=178) 
to 2001 (158), while it increased significantly among 
those age 35 and older, from 269 to 313. Mentions 
among those age 26– 34 increased from 345 to 386. 
African-Americans continued to account for the 
largest percentage of total ED cocaine mentions at 71 
percent, down slightly from 73 percent in 2000, with 
Whites representing 17 percent, down from 21 
percent. It is important to note that the percentage 
reported as unknown grew substantially from 4 
percent to 12 percent in the same time period. 
 
Among publicly funded treatment admissions in the 
metropolitan Atlanta area in the second half of 2001, 
the proportion of cocaine admissions continued to 
decline (exhibit 3). Cocaine accounted for 53 percent 
of total admissions in the second half of 2001, down 
from 57 percent in the first half of the year. African-
Americans remained the largest population among 
cocaine admissions (77 percent), down only slightly 
from 78 percent (exhibit 4). Admissions among 
Whites held steady at 21 percent, and Hispanics 
represented 1 percent. Cocaine was one of the few 
drugs for which treatment admissions were somewhat 
evenly split by gender, with a male-to-female ratio of 
1.5:1, consistent with the first half of 2001 (exhibit 
5). Traditionally, those in publicly funded treatment 
in Atlanta and the rest of Georgia have been an older 
population across all drugs, and that trend continued. 
Those age 35 and older accounted for the majority of 
cocaine admissions, at 79 percent, down from 82 
percent. Interestingly, they are most closely followed 
by those younger than 17, who represented just over 
7 percent of cocaine admissions. Those age 18– 25 
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and 26– 34 each accounted for approximately 5 per-
cent of cocaine admissions.  
  
Smoking remained the preferred route of administra-
tion among cocaine admissions in metropolitan 
Atlanta in the second half of 2001 at 62 percent, with 
those reporting oral as their preferred route (which 
may overlap with smoking) accounting for 22 per-
cent. Inhalation as a preferred route rose from 8 to 9 
percent, with injection continuing to be uncommon 
among treatment admissions (1 percent) (exhibit 6). 
Most cocaine users in treatment reported that they did 
not have a secondary drug of choice (55 percent). Of 
those reporting a secondary drug, alcohol was most 
common (29 percent), followed by marijuana (12 
percent). As a secondary drug of choice, cocaine was 
mentioned by 20 percent of other drug admissions. 
 
Cocaine treatment admissions in nonmetropolitan 
Atlanta experienced a considerable shift in the racial 
composition, with African-Americans still in the 
majority (57 percent) (exhibit 7). The proportion of 
Whites rose to 42 percent. The difference between 
male and female cocaine admissions was smaller than 
that in metropolitan Atlanta at 1.3:1. Smoking 
remained the preferred route of administration (68 
percent), followed by oral (12 percent) and inhalation 
(12 percent) (exhibit 8). The proportion who reported 
injection as the primary route of administration was 
higher in nonmetropolitan counties: 2 percent. 
  
According to the DEA, cocaine has historically been 
and remains “ readily available at both the wholesale 
and retail levels”  in the southeast, with Atlanta 
serving as the main transshipment and local distribu-
tion center, primarily for Mexican-based drug traf-
ficking. The southwest U.S. border and southern 
Florida continued to be the main source areas for 
cocaine seized in Georgia. In 2001, more than 965 
kilograms were seized in total. 
 
Heroin 
 
The rate per 100,000 population of heroin ED men-
tions in Atlanta continued to rise over the past few 
years, from 15 in 1999, to 17 in 2000, and to 23 in 
2001 (exhibit 1). The rate of heroin mentions in 
Atlanta remained lower than the national rate, but it 
increased significantly between 2000 and 2001, while 
the national rate declined (exhibit 9). The highest 
proportion of heroin mentions in 2001 occurred 
among African-Americans (53 percent), followed by 
Whites (32 percent), both reflecting decreases since 
2000 (55 percent and 34 percent, respectively). His-
panics accounted for just under 2 percent. The ratio 
of male-to-female mentions was rather high at 3.6:1. 
Much like cocaine, heroin users tended to be an older 
population. Rates continued to rise among those age 
26– 34, from 24 in 2000 to 38 in 2001, as well as 
among those 35 and older, from 18 to 28 during the 
same time period (exhibit 10). The rate of mentions 
among those age 18– 25 fell from 26 to 18 between 
2000 and 2001.  
 
Similar to ED mentions, the proportion of heroin 
treatment admissions was much smaller than those 
for cocaine, accounting for 7 percent of total admis-
sions in metropolitan Atlanta in the second half of 
2001 (exhibit 3). This is consistent with the first half 
of the year. Unlike cocaine admissions, the propor-
tions of African-American and White admissions 
were similar, at 49 percent and 47 percent, respec-
tively (exhibit 4). While Hispanics accounted for a 
very small percentage of total admissions in Atlanta 
(1.5 percent), they accounted for almost 3 percent of 
heroin admissions. Male heroin admissions outnum-
bered female admissions, with a ratio of 2:1 (exhibit 
5). 
 
The preferred route of administration for heroin 
treatment admissions remained injection, which rose 
from 57 percent in the first half of 2001 to 61 percent 
in the second half (exhibit 6). Those age 35 and older 
continued to account for the highest percentage of 
heroin admissions, increasing from 76 to 80 percent. 
Admissions for all other age categories declined. The 
majority of those entering publicly funded treatment 
with heroin as their primary drug of choice reported 
having no secondary drug (48 percent). Of those 
reporting a secondary drug, cocaine was the most 
frequently mentioned (32 percent), followed by alco-
hol (10 percent). Other opiates and benzodiazepines 
overall accounted for a very small portion of secon-
dary and tertiary drug choices, but among heroin 
users together they represented 5 percent of secon-
dary drugs and nearly 3 percent of tertiary drugs. 
Very few treatment admissions for other drugs 
reported heroin as a secondary or a tertiary drug of 
choice.  
 
The demographics of nonmetropolitan Atlanta heroin 
treatment admissions was fairly different from that of 
Atlanta admissions. Heroin admissions accounted for a 
smaller percentage of total admissions (2 percent), and 
Whites accounted for 81 percent of admissions (exhibit 
8). African-Americans accounted for 12 percent, 
followed by Hispanics at 7 percent, their highest 
representation across all drugs. The heroin treatment 
population in nonmetropolitan counties remained 
older, with those age 35 and older constituting the 
majority (84 percent), followed distantly by those 
younger than 17 and those age 18– 25, each at 7 per-
cent, and those age 26– 34 at 2 percent. Injection as a 
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primary route of administration accounted for 69 per-
cent of nonmetropolitan heroin admissions (exhibit 9). 
 
Other Opiates/Narcotics 
 
As a whole, the rate of narcotic analgesics/combina-
tions ED mentions per 100,000 population decreased 
in Atlanta, from 37 in 1999 and 2000 to 30 in 2001. 
Within this group of central nervous system agents, 
acetaminophen-hydrocodone (e.g., Vicodin, Lortab) 
had the highest rate of mentions per 100,000 
population: 5. Methadone’s rate of mentions has 
increased over the years, but it remained steady at 4, 
as did oxycodone mentions. Acetaminophen-oxy-
codone (e.g., Percocet) dropped from a rate of 2 
mentions in 2000 to 1 in 2001. Morphine historically 
has had a rate of 1 mention per 100,000 population, 
and that continued in 2001. 
 
While other opiates are not a primary drug of choice 
category for publicly funded treatment data in 
Georgia, some data are captured for secondary and 
tertiary drug choices. Other opiates accounted for less 
than 1 percent of the total of both secondary and 
tertiary choices in metropolitan Atlanta in the second 
half of 2001. Among primary heroin admissions, 
other opiates accounted for 2.8 percent of secondary 
drugs and 1.3 percent of tertiary drugs. In 
nonmetropolitan counties, other opiates accounted for 
almost 2 percent of secondary and just over 1 percent 
of tertiary drug choices in the second half of 2001. 
While other opiates remained more popular among 
heroin users, at 4.1 and 3.3 percent, methamphet-
amine users often identify other opiates as a second-
dary (3.7 percent) and tertiary (2.5 percent) choice.  
 
Marijuana 
 
Like all other major drugs, the rate of marijuana ED 
mentions in metropolitan Atlanta per 100,000 popu-
lation increased from 86 in 2000 to 96 2001, but not 
significantly (exhibit 1). African-Americans repre-
sented the largest percentage of total mentions at 56 
percent, followed by Whites at 28 percent and His-
panics at less than 1 percent. The ratio of male-to-
female mentions remained constant from 2000 to 
2001, at 2.3:1. Unlike mentions for cocaine and her-
oin, marijuana mentions were highest among those 
age 18– 25.  
 
Among treatment admissions in metropolitan Atlanta, 
those reporting marijuana as their primary drug of 
choice accounted for 17 percent in the second half of 
2001, up slightly from the first half of the year (16 
percent) (exhibit 3). African-Americans accounted 
for the majority of marijuana admissions (54 per-
cent), followed by Whites (42 percent) and Hispanics 
(2 percent) (exhibit 4). The ratio of male-to-female 
admissions in the second half of 2001 held steady 
from the first half of the year at 1.8:1 (exhibit 5). The 
highest proportion of marijuana admissions occurred 
among those age 35 and older (80 percent), consistent 
with the previous half-year. Among marijuana admis-
sions who named a secondary drug, alcohol was the 
most common (22 percent), followed by cocaine (14 
percent). Among those entering treatment for another 
drug, marijuana is often mentioned as a secondary 
(12 percent) and a tertiary (7 percent) drug choice.  
 
In nonmetropolitan Atlanta, marijuana accounted for 
a larger percentage of total treatment admissions (25 
percent). As with other drugs, African-Americans 
were less represented among marijuana treatment 
admissions outside metropolitan Atlanta, representing 
37 percent (exhibit 7). Whites accounted for the larg-
est proportion at 62 percent, and Hispanics consti-
tuted less than 1 percent. The gap between male and 
female admissions was larger (2:1) than in metro-
politan counties. Marijuana also accounted for a 
larger percentage of secondary and tertiary drug 
choices, at 19 percent and 9 percent, respectively.  
 
The DEA asserts that marijuana continued to be the 
most widely used drug in the State. Much of the 
marijuana found in Georgia is brought in along the 
same route as other imported drugs: from the U.S. 
southwest border and often by Mexican nationals. In 
2001, more than 5,200 kilograms of marijuana were 
seized throughout the State. There were other routes 
of marijuana distribution. In Arizona, for example, 
troopers in October 2002 stopped a man on his way 
back to Duluth, Georgia (located just northwest of 
Atlanta), where he lived, and found 100 pounds of 
marijuana with a potential street value of $73,000. 
Also in October 2002, authorities arrested two men 
just outside of Savannah, Georgia, and seized 400 
pounds of marijuana (with a potential street value of 
$770,000) that was determined to have come from 
“ out of State.”  While most marijuana is believed to 
come from outside the State, there is a significant 
amount of local growth. In July 2002, State and local 
officials found and destroyed approximately 1,600 
marijuana plants in rural portions of Oglethorpe and 
Wilkes Counties in northeast Georgia, approximately 
100 miles from Atlanta. The estimated street value of 
the plants was nearly $2 million, but no arrests were 
made in connection with the plants. 
 
Stimulants 
 
The rate of methamphetamine ED mentions per 
100,000 population in Atlanta continued its steady 
increase, from 3 in 1999, to 4 in 2000, and to 5 in 
2001 (exhibit 1). This local trend closely mirrors that 
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of the Nation (exhibit 11). The rate of amphetamine 
mentions per 100,000 population in metropolitan 
Atlanta in 2001 was twice that for methamphetamine, 
at 10 (exhibit 12). Whites accounted for the largest 
group for both methamphetamine (80 percent) and 
amphetamine (65 percent) mentions. The male-to-
female ratio of methamphetamine mentions narrowed 
from 2.5:1 in 2000 to 2:1 in 2001. The ratio was even 
smaller for amphetamines at 1.5:1. As mentioned 
previously, there were more overall mentions for 
amphetamine, and those mentions were spread over a 
wider range of users than those for methamphet-
amine. For amphetamine mentions, the rate of 
mentions among those younger than 17 was 4 per 
100,000 population. For methamphetamine mentions, 
the highest rate of mentions occurred among those 
age 18– 25 (30), and the rate for those younger than 
17 was zero.  
 
The proportion of clients in metropolitan Atlanta who 
sought treatment for primary methamphetamine 
abuse rose from 1.5 percent in 2000, to 1.6 percent in 
the first half of 2001, and to 2.4 percent in the second 
half of the year (exhibit 3). (Georgia DHR uses 
methamphetamine specifically and not stimulants in 
general as a category.) The vast majority of metham-
phetamine treatment admissions continued to be 
White, stable at 96 percent (exhibit 4). The propor-
tion of African-Americans dropped from 3 to 2 per-
cent, and the percentage of Hispanics was 2 percent. 
The ratio of male-to-female methamphetamine 
admissions also stayed relatively stable at 1.4:1, 
down slightly from 1.6:1 in the first half of the year 
(exhibit 5). 
 
The proportion of methamphetamine admissions in 
metropolitan Atlanta who reported injection fell from 
27 percent in 2000 to 17 percent in the first half of 
2001, and then rose to 29 percent in the second half 
of the year (exhibit 6). The increase in injection 
between the first and second halves of 2001 was 
accompanied by a slight rise in smoking, from 17 to 
19 percent, and decreases in those reporting oral, 
from 30 to 26 percent, and inhalation, from 31 to 23 
percent.  
 
The proportion of persons who entered publicly 
funded treatment in nonmetropolitan counties for 
methamphetamine use in the second half of 2001 was 
even larger than that in Atlanta, at 5 percent, con-
sistent with the first half of 2001. The ratio of male-
to-female admissions was smaller than in metro-
politan Atlanta counties, at 1.2:1. All methamphet-
amine admissions outside of Atlanta, with the 
exception of one individual, were White (exhibit 7). 
A greater number of these nonmetropolitan metham-
phetamine admissions reported smoking as their 
preferred route of administration (30 percent), 
followed by oral (24 percent), injection (21 percent), 
and inhalation (20 percent) (exhibit 8).  
 
Depressants  
 
Benzodiazepines accounted for the largest proportion 
of Atlanta psychotherapeutic agent ED mentions, 
with a rate of 32 mentions per 100,000 population. 
Within the benzodiazepines category, alprazolam, 
better known as Xanax, had the highest rate (9), 
which is steady from 2000 but down from a high of 
14 in 1998. The rate of mentions of both clonazepam 
(Klonopin) and diazepam (Valium) remained con-
stant, with 3 mentions each, and the rate of lorazepam 
(Ativan) mentions stayed at 2. 
 
While data on publicly funded treatment in Georgia 
do not capture depressants as a category for primary 
drug of choice, depressants do appear as secondary 
and tertiary drug choices, especially among heroin 
admissions in metropolitan Atlanta. In nonmetro-
politan counties, benzodiazepines remained a choice 
for some heroin users. An even greater portion of 
those reporting methamphetamine as their primary 
drug of choice, however, cited depressants as a sec-
ondary (3.7 percent) and tertiary (3.2 percent) choice.  
 
Ethnographers continually find that regardless of ED 
or treatment data, many individuals use various 
depressants as  part of a pattern of polydrug use. 
Xanax, Valium, and Dilaudid are mentioned most 
often. Most contacts report using depressants in their 
original pill form, but there are occasional reports of 
crushing the pills to either snort or inject them.  
 
Hallucinogens 
 
The rate of ED mentions per 100,000 population in 
metropolitan Atlanta for lysergic acid diethylamide 
(LSD) remained stable from 2000 to 2001 at 2 
(exhibit 12). Since 1994, mentions in this category 
have dropped by 73 percent. The ratio of male-to-
female mentions has generally been high, but the gap 
narrowed from 4:1 in 2000 to 3:1 in 2001. While the 
rate of LSD mentions has declined over the years, the 
rate has remained highest among those age 18– 25.  
 
Currently, LSD is mentioned most among those who 
are also regular users of methylenedioxymetham-
phetamine (MDMA). It remains fairly common to 
combine the two, a practice known as candyflipping. 
 
Club Drugs 
  
After a slow rise over the past few years, the rate of 
MDMA (ecstasy) ED mentions per 100,000 popula-
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tion in metropolitan Atlanta more than doubled 
between 2000 and 2001, from 2 to 5 (exhibit 12). 
While this rate is low compared with other drugs, it is 
more than double the national rate of 2 (exhibit 13). 
Unlike many other drugs, the racial composition of 
total MDMA mentions was evenly split between 
Whites and African-Americans, at 43 percent and 42 
percent, respectively. Hispanics accounted for 3 per-
cent. Much like methamphetamine, the rate of 
MDMA mentions per 100,000 population was high 
among younger users, with the highest rates reported 
among those age 18– 25 (17), followed by those 26–
34 (8).  
 
The rate of gamma hydroxybutyrate (GHB) mentions 
per 100,000 population fell significantly, from 5 in 
2000 to 2 in 2001. The ratio of male-to-female men-
tions was 3:1, and Whites continued to account for 
the majority of mentions at 74 percent. The rate of 
ketamine mentions has always been small. In 2001, 
the rate was 1 among those younger than 18. 
 
Currently, publicly funded treatment programs 
throughout Georgia do not report data on MDMA. It 
is possible that some individuals seeking treatment 
for primary MDMA abuse are being incorporated 
into the methamphetamine category, or that MDMA 
is a secondary or tertiary drug of choice that is con-
sidered an ‘other drug.’  An informal poll of some 
private and public treatment places in and around 
Atlanta, particularly in Atlanta’s northern suburbs, 
suggested that a number of young, primarily White 
clients have been seeking treatment for primary 
MDMA abuse. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
Georgia accounted for 3 percent of the Nation’s total 
AIDS cases and remained ninth among States, based 
on reported AIDS cases through December 2001. The 
Georgia DHR reported 25,485 cumulative adult and 
pediatric AIDS cases from 1981 through the third 
quarter 2002 (September 30), with 12,119 of those 
cases currently living with AIDS. Since the end of 
the second quarter of 2002, the percentage of cases 
among injection drug users (IDUs) and those who 
have male-to-male sexual contact and are also IDUs 
(MSM/IDUs) fell from 23 to 21.1 percent. The 
decline occurred among IDUs (from 17.7 to 15.9 per-
cent), while cases among MSM/IDUs rose slightly 
(from 5.5 to 5.9 percent). This drop in total cases 
ascribed to injection drug use has closed the gap 
some between male and female IDU cases. Females 
still outpace males among injection-related cases 22.1 
to 21.1 percent, even when factoring in MSM/IDU 
cases. 
 
An eight-county metropolitan Atlanta area accounts 
for 67 percent of the total cumulative Georgia AIDS 
cases. Consequently, this area bears 2 percent of the 
national total, ranking it 10th among selected metro-
politan areas in the number of cases. Many of the 
statewide trends are echoed in metropolitan Atlanta. 
Injection drug use is associated with 23 percent of all 
reported metropolitan adult and pediatric AIDS cases 
(17.4 percent IDU and 5.6 percent MSM/IDU), fall-
ing slightly since the second half of 2001. In the 
Atlanta-area cases related to injection drug use, the 
disparity between cases among women and men is 
even larger than statewide, at 30.8 percent vs. 22.1 
percent.  
 
REFERENCES 
 
Centers for Disease Control and Prevention (CDC). 
Basic Statistics— Ten States/Territories and Cit-
ies Reporting Highest Number of AIDS Cases. 
Data from the semiannual HIV/AIDS Surveil-
lance Report. Atlanta, GA: 2002. Retrieved 
November 23, 2002, from the World Wide Web: 
<http://www.cdc.gov/hiv/stats.htm>.  
 
For inquiries concerning this report, please contact Claire E. Sterk, Ph.D., Rollins School of Public Health at Emory University, 1518 Clifton 
Road, NE; Atlanta, GA 30322, Tel: (404) 727-9124, Fax: (404) 727-1369, E-mail: <csterk@sph.emory.edu>. 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Atlanta 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 11
Exhibit 1. Estimated Rate of ED Mentions Per 100,000 Population in Atlanta:  1994–2001   
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Exhibit 2. Rate of ED Cocaine Mentions Per 100,000 Population in the United States and Atlanta: 
 1994–2001 
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Exhibit 3. Primary Drug of Abuse Among Public Drug Treatment Admissions in Metropolitan  
 Atlanta by Percent and Half-Year:  1999–2001 
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Exhibit 4. Primary Drug Treatment Admissions in Metropolitan Atlanta by Race/Ethnicity and  
 Percent:  July–December 2001 
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Exhibit 5. Male-to-Female Ratio of Treatment Admissions in Metropolitan Atlanta by Half-Year:  
 2001 
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Exhibit 6. Route of Cocaine, Heroin, and Methamphetamine Administration Among Treatment 
Admissions in Metropolitan Atlanta by Percent:  July–December 2001 
 
SOURCE:  Department of Human Resources 
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Exhibit 7. Primary Drug Treatment Admissions in Nonmetropolitan Atlanta by Race/Ethnicity and 
Percent:  July–December 2001 
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Exhibit 8. Route of Cocaine, Heroin, and Methamphetamine Administration Among Treatment  
 Admissions in Nonmetropolitan Atlanta:  July–December 2001 
 
SOURCE:  Department of Human Resources 
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Exhibit 9. Rate of Heroin ED Mentions Per 100,000 Population in the United States and Atlanta:   
 1994–2001 
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Exhibit 10. Rate of Heroin ED Mentions Per 100,000 Population by Age and Percent in Atlanta: 
 1994–2001 
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Exhibit 11. Rate of Methamphetamine ED Mentions Per 100,000 Population in the United States  
  and Atlanta:  1994–2001 
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Exhibit 12. Estimated Rate of ED Mentions Per 100,000 Population for Selected Drugs in Atlanta: 
 1994–2001 
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Exhibit 13. Rate of MDMA ED Mentions Per 100,000 Population in the United States and Atlanta 
 1997–2001 
 
SOURCE:  DAWN, OAS, SAMHSA 
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ABSTRACT 
 
Heroin indicators, including treatment admission 
rates and rates of emergency department (ED) 
mentions, were mixed for the Baltimore metropoli-
tan area as a whole. The rate of heroin ED 
mentions fell significantly, as did heroin treatment 
admission rates for both intranasal and injection 
use in the city. However, treatment admission rates 
for both routes of administration increased in the 
suburban counties. In Baltimore City, the admission 
rate for intranasal heroin use was 39 percent higher 
than for injection. In the suburban counties, the 
rate for heroin injection was 24 percent higher than 
for inhalation. Admissions for intranasal heroin use 
were comprised predominantly of an aging Black 
population. Admissions for heroin injection were 
split into two distinct populations: an aging Black 
population and new White users. Cocaine treatment 
admission rates and ED mentions were stable. The 
population in treatment for smoked cocaine (crack) 
continued to age: in 2001, 66 percent were older 
than 35, compared with 44 percent in 1997. 
Marijuana treatment admission rates and rates of 
ED mentions increased. Nearly one-half of 
marijuana treatment admissions were younger than 
18, and 64 percent entered treatment as the result of 
a judicial process. Stimulants represented 
insignificant but apparently growing proportions of 
ED and treatment admissions. 
 
INTRODUCTION 
 
Area Description 
 
The Baltimore primary metropolitan statistical area 
(PMSA) was home to some 2.6 million persons in 
2001. It comprises Baltimore City and the suburban 
counties of Anne Arundel, Baltimore, Carroll, 
Harford, Howard, and Queen Anne’s. Baltimore City 
is the largest independent city in the United States. 
The city’s population declined by an estimated 14 
percent during the 1990s, falling from 735,000 in 
1990 to 633,000 in 1999. According to the 2000 
census, however, the population rose to 648,000 in 
2000. The population of the surrounding counties has 
grown steadily, from approximately 1.7 million in 
1990 to 1.9 million in 2001.  
 
The city and the suburban counties represent 
distinctly different socioeconomic groups. In 1999, 
median household income in the city was $30,000, 
and 23 percent of the population lived in poverty. In 
the suburban counties, however, median household 
income ranged from $50,000 to $74,000, and the 
poverty rate ranged from 4 to 7 percent. In 2000, the 
population composition of the city differed markedly 
from that of the surrounding counties: 31 percent 
White and 64 percent African-American versus 78 
percent White and 14 percent African-American, 
respectively. There were few persons of Hispanic or 
other ethnic origins in the area. 
 
The Baltimore area is a major node on the north-
south drug trafficking route. It has facilities for entry 
of drugs into the country by road, rail, air, and sea. 
Baltimore is located on Interstate 95, which continues 
north to Philadelphia, New York, and Boston, and 
south to Washington, DC, Richmond, and Florida. 
Frequent daily train service is available on this route. 
The area is served by three major airports (Baltimore-
Washington International Airport in Baltimore 
County and Reagan National and Dulles Airports in 
the vicinity of Washington, DC, approximately 50 
miles from the Baltimore City center). Baltimore is 
also a significant active seaport. The area has 
numerous colleges and universities and several 
military bases.  
 
Data Sources 
 
Data sources for this report are detailed below: 
 
• Population and demographic estimates for 
1990– 2001 and model-based income and poverty 
estimates for 1999 for Maryland counties were 
derived from the U.S. Bureau of the Census data 
(electronic access: <http://factfinder.census.gov> 
and <http://quickfacts.census.gov>) and Census 
2000 Summary File 3. 
 
• Emergency department (ED) drug mentions 
data were provided by the Drug Abuse Warning 
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Network (DAWN), Office of Applied Studies 
(OAS), Substance Abuse and Mental Health 
Services Administration (SAMHSA), for the 
Baltimore PMSA for 1997– 2001. 
 
• Drug treatment admissions data were provided 
by the Maryland Alcohol and Drug Abuse 
Administration, Department of Health and 
Mental Hygiene, for 1997– 2001. Data are 
presented for the PMSA as a whole, as well as 
separately for Baltimore City and the suburban 
counties. Included are those programs that 
receive both public and private funding. All 
clients are reported, regardless of individual 
source of funding. Significant omissions are the 
Baltimore City and Fort Howard Veterans’  
Administration Medical Centers, which do not 
report to the State data collection system. 
 
• Drug-related mortality data were provided by 
DAWN, OAS, SAMHSA, for the Baltimore 
PMSA for 2000. 
 
• Heroin price and purity data are preliminary 
for 2001 and were provided by the Drug En-
forcement Administration (DEA)’s Domestic 
Monitor Program (DMP). 
 
• Data on drug use prevalence among 12th-
grade students are from the Maryland State 
Department of Education’s 2001 Maryland 
Adolescent Survey; electronic access: <http:// 
www.msde.state.md.us>. 
 
• Acquired immunodeficiency syndrome 
(AIDS) and human immunodeficiency virus 
(HIV) data were provided by the Maryland 
Department of Health and Mental Hygiene, 
AIDS Administration, “ The Maryland 2001 
HIV/AIDS Annual Report”  (1999 demographic 
and risk category information for Baltimore); 
<http://www.dhmh.state.md.us/AIDS/epictr.htm
> (2001 data for Maryland and Baltimore).  
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Polydrug use in general appears to be the norm in the 
Baltimore PMSA. Three-quarters of drug-related 
treatment admissions in 2001 reported problems with 
at least one substance other than the primary drug of 
abuse. An average of 1.8 drugs was mentioned per 
ED visit in 2001. In 2000 (the latest year for which 
mortality data were available), multiple drugs were 
found in 91 percent of the 532 drug-involved deaths; 
the average number of drugs found was 3. 
In the second half of the 1990s, abuse of both heroin 
and cocaine emerged as the dominant pattern of drug 
abuse in the Baltimore PMSA. The cocaine and 
heroin ED rates and patterns have been similar since 
1995, probably because of the concurrent use of the 
two drugs. In the PMSA, cocaine was reported as the 
primary substance by 13 percent of drug-related 
treatment admissions, but was reported as a 
secondary substance by an additional 36 percent. 
Among 2001 treatment admissions for heroin 
injection, 61 percent also used cocaine, primarily by 
injection (51 percent), although 10 percent reported 
smoking cocaine. Secondary cocaine use was also 
reported by 48 percent of treatment admissions for 
heroin inhalation. Heroin inhalers, however, were 
more likely to report smoking cocaine (33 percent) 
than using it by other routes (15 percent).  
 
Heroin abuse indicators for the Baltimore metro-
politan area as a whole were mixed in 2001. 
However, heroin abuse in Baltimore is complex and 
dynamic. There appear to be different groups of 
heroin users (urban versus suburban, intranasal users 
versus injectors), and indicators for some of these 
groups increased in 2001. Heroin treatment 
admission rates for both intranasal and injection use 
fell in the city, but rates for both routes increased in 
the suburban counties. In Baltimore City, the 
admission rate for intranasal heroin use was 39 
percent higher than for injection. In the suburban 
counties, the rate for heroin injection was 24 percent 
higher than for inhalation. Admissions for intranasal 
heroin use were comprised predominantly of an aging 
African-American population. Admissions for heroin 
injection were split into two distinct populations: an 
aging Black population and new White users.  
 
Women outnumbered men among heroin and cocaine 
treatment admissions younger than 30. In 2001, 59 
percent of heroin inhalation admissions younger than 
30 were female, compared with 49 percent of 
admissions age 30 and older. Similarly, 52 percent of 
heroin injection admissions younger than 30 were 
female, compared with 38 percent of admissions age 
30 and older. Among cocaine treatment admissions 
younger than 30, 52 percent were female, compared 
with 46 percent of those aged 30 and older. 
 
Cocaine and Crack 
 
Cocaine indicators (treatment admission rates and 
rates of ED mentions) were stable between 2000 and 
2001. The rate of cocaine-related ED episodes (214 
per 100,000 for 2001) was similar to the rate reported 
in 2000 (exhibit 1). Cocaine remained highly 
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prevalent among treatment admissions, although the 
treatment admission rate for cocaine was stable at 
163 per 100,000 population age 12 and older (exhibit 
2). The treatment admission rate for primary cocaine 
use remained well below that for heroin use.  
 
According to the indicator data, cocaine use was 
generally associated with the use of alcohol and other 
drugs as well. Almost all (84 percent) cocaine-related 
ED episodes involved another drug in addition to 
cocaine (exhibit 1). While cocaine was reported as a 
primary substance by 13 percent of treatment 
admissions in 2001, it was reported as a secondary 
substance by an additional 36 percent (exhibit 2).  
 
Crack cocaine represented nearly 75 percent of the 
treatment admissions for primary cocaine use (exhibit 
2). The population in treatment for cocaine smoking 
has aged; 66 percent were age 35 or older in 2001 
(exhibit 3). The median age at admission to treatment 
was 37, compared with 34 in 1997. Nearly one-half 
(47 percent) of those in treatment for smoking 
cocaine were women, and two-thirds (66 percent) 
were African-American. Less than one-half (40 
percent) of the crack smokers were entering treatment 
for the first time, and 64 percent were likely to be 
referred through sources outside the criminal justice 
system. Daily crack use was reported by 37 percent, 
and use of other drugs was reported by more than 
two-thirds (69 percent). Alcohol was the most 
common secondary drug (used by 49 percent), 
followed by marijuana (26 percent) and opiates used 
intranasally (14 percent). Only 3 percent of crack 
smokers reported opiate injection. 
 
Heroin 
 
Heroin indicators were mixed for the Baltimore 
metropolitan area as a whole in 2001. The 2001 rate 
of heroin ED mentions (195 per 100,000 population) 
represented a significant decline from 227 per 
100,000 in 2000 (exhibit 1). Treatment admissions in 
the PMSA for primary heroin use remained stable in 
2001 at a rate of 647 admissions per 100,000 
population age 12 and older, compared to 651 per 
100,000 in 2000 (exhibit 2). 
 
In the indicator data, heroin use was frequently 
accompanied by the use of alcohol and other drugs. 
More than one-half (58 percent) of heroin-related ED 
episodes involved other drugs in addition to heroin 
(exhibit 1). Among treatment admissions in the 
PMSA, heroin was reported as a primary substance 
by 50 percent and as a secondary substance by 9 
percent (exhibit 2). 
 
Heroin use in the Baltimore metropolitan area is 
complex. There are several groups of heroin users 
that differ by urbanicity, route of administration, age, 
and race. Treatment admissions for some of these 
groups increased in 2001. The heroin treatment 
admission rate was 4½ times higher in Baltimore City 
than in the suburban counties (exhibit 2). While 
heroin treatment admission rates for both intranasal 
and injection use fell in the city in 2001, rates for 
both routes increased in the suburban counties. In 
Baltimore City, intranasal use was the preferred route 
of administration, and the admission rate for 
intranasal use was 39 percent higher than for 
injection. In the suburban counties, however, the 
admission rate for heroin injection was 24 percent 
higher than for inhalation. 
 
Exhibit 4 compares the number of treatment 
admissions in 2001 by urbanicity, age, and race for 
heroin injection and heroin inhalation. Baltimore City 
has a core of older African-American heroin users, 
both injectors and intranasal users. Inhalers as a 
group were slightly younger than injectors. White 
users entering treatment for heroin were younger, and 
they were predominantly injectors. In the suburban 
counties, heroin users entering treatment were 
predominantly young, White injectors.  
 
In the total PMSA, the proportion of White heroin 
injectors entering treatment increased from 42 
percent in 1997 to 49 percent in 2001 (exhibit 5). The 
proportion of admissions younger than 25 also 
increased, from 15 percent in 1997 to 21 percent in 
2001. In the suburban counties, admissions of those 
younger than 25 increased from 27 percent in 1997 to 
32 percent in 2001. The median age at admission for 
heroin injectors was 39 in Baltimore City and 32 in 
the suburban counties. Women accounted for 39 
percent of admissions in the total PMSA. In the 
PMSA, most persons reported daily use (75 percent), 
and relatively few had been referred through the 
criminal justice system (24 percent). The proportion 
receiving treatment for the first time declined 
slightly, from 39 percent in 1997 to 32 percent in 
2001. Use of other drugs was reported by 75 percent 
of heroin injectors entering treatment in the PMSA: 
51 percent used cocaine by routes other than 
smoking, 10 percent smoked cocaine, 27 percent had 
an alcohol problem, and 12 percent used marijuana.  
 
Among heroin intranasal users in the PMSA, most 
admissions were African-American (81 percent) and 
age 26 and older (91 percent) (exhibit 6). The median 
duration of use before first entering treatment was 10 
years. Nearly one-half of total PMSA admissions for 
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heroin intranasal use (48 percent) occurred among 
women. The proportion of intranasal users younger 
than 25 decreased from 21 percent in 1997 to 9 
percent in 2001. The median age at admission was 
35. Nearly three-quarters (71 percent) reported daily 
heroin use. Intranasal users were more likely than 
injectors to be referred through the criminal justice 
system (32 vs. 23 percent) and to be receiving 
treatment for the first time (38 vs. 32 percent). Heroin 
intranasal users were less likely than injectors to 
report use of other drugs (66 vs. 75 percent), and the 
drugs used were different. Cocaine smoking was 
much greater among heroin intranasal users (33 
percent), and 15 percent reported using cocaine by 
other routes. Alcohol use, at 27 percent, was similar 
in the two groups, but marijuana use was somewhat 
higher among heroin intranasal users than injectors 
(16 vs. 12 percent). 
 
Heroin purity remained low in 2001, at 24 percent, 
below the national metropolitan average of 35 
percent. Price also remained low, at $0.33 per 
milligram pure, compared with $1.05 per milligram 
pure as the national metropolitan average. 
Ethnographic research suggests that there are two 
grades of heroin sold in Baltimore. “ Raw dope,”  said 
to be of higher purity and preferred by inhalers, is 
sold in west Baltimore City. “ Scramble”  (heroin of 
lower purity, containing a higher proportion of 
adulterants and diluents) is preferred by injectors and 
is sold in east Baltimore City. 
 
Other Opiates/Narcotics 
 
Narcotic analgesics and narcotic analgesics/com-
binations have been mentioned with increasing 
frequency in drug-related ED episodes. In 2001, they 
were mentioned in 23 percent of these episodes at a 
rate of 114 per 100,000 population, compared with 
17 percent and 80 per 100,000 in 2000. Eighty-two 
percent of the narcotic analgesics/combinations 
mentions were in the “ not otherwise specified”  
category, with oxycodone/combinations accounting 
for 7.8 percent and methadone for 5.7 percent. 
 
Marijuana 
 
Indicators of marijuana use increased between 2000 
and 2001. The marijuana ED rate (78 per 100,000) 
increased significantly, and it did so among all age 
groups shown in exhibit 1 and for both males and 
females. The marijuana treatment admission rate in 
the PMSA rose from 199 per 100,000 population age 
12 and over in 2000 to 205 per 100,000 in 2001 
(exhibit 2). 
 
More often than not, marijuana use in the 2001 
indicator data sets was associated with the use of 
alcohol or other drugs. A majority (63 percent) of 
marijuana ED episodes involved multiple substances 
(exhibit 1). Among PMSA treatment admissions for 
primary marijuana use, 69 percent reported using 
additional substances: 59 percent reported alcohol 
use, 9 percent reported cocaine use, and 6 percent 
reported use of heroin or other opiates (exhibit 7). 
Some 11 percent of admissions used other 
substances, primarily hallucinogens and inhalants.  
 
Among 2001 treatment admissions, marijuana was 
more frequently reported as a secondary substance 
than as a primary substance, at 22 percent and 16 
percent, respectively, in the PMSA (exhibit 2).  
 
As shown in exhibit 2, the proportion of marijuana 
treatment admissions in 2001 was higher in the 
suburban counties (19 percent) than in Baltimore City 
(12 percent), but the admission rate was higher in the 
city (299 per 100,000 age 12 and over vs. 175 per 
100,000 in the counties).  
 
Persons entering treatment for marijuana use were 
young: 48 percent in the PMSA were younger than 
18, and the median age at admission to treatment was 
18 (exhibit 7). Marijuana admissions were primarily 
male (82 percent). The racial breakdown of 
marijuana admissions approached that of the 
underlying population more closely than for other 
illicit drugs (50 percent White and 48 percent 
African-American). A large proportion of marijuana 
treatment admissions (64 percent) represented 
referrals through the criminal justice system. 
Admission rates for criminal justice referrals were 80 
percent higher than those for other referrals in 2001. 
Admissions were likely to be experiencing their first 
treatment episode (71 percent), and more than one-
third (36 percent) reported daily marijuana use. 
 
Marijuana use in the past month was reported by 21 
to 29 percent of 12th-grade students in five of the six 
suburban counties, according to the 2001 Maryland 
Adolescent Survey. The proportion reporting past-
month use in Baltimore City, however, was only 14 
percent. 
 
Stimulants 
 
Stimulants were rarely mentioned as the primary 
substance of abuse by treatment admissions (exhibit 
2). ED mentions of amphetamines increased signifi-
cantly between 2000 and 2001, but the numbers 
remained low. Amphetamines were mentioned in 2 
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percent of drug-related ED episodes in 2001. 
Methamphetamine was reported in only six ED 
episodes in 2001. 
 
Amphetamine use in the past month was reported by 
about 5 to 10 percent of 12th-grade students in the 
suburban counties in the 2001 Maryland Adolescent 
Survey. Methamphetamine use in the past month was 
reported by 1 to 5 percent of 12th-grade students in 
the suburban counties. Use of any of the stimulant 
categories was lower in Baltimore City than in the 
suburban counties.  
 
Depressants 
 
Benzodiazepines were mentioned in 12 percent of 
drug-related ED episodes in 2001. This represented a 
significant increase in the rate of benzodiazepine ED 
mentions, from 45 per 100,000 in 2000 to 59 per 
100,000 in 2001. The specific benzodiazepines 
involved were generally not reported. 
 
Hallucinogens 
 
Lysergic acid diethylamide (LSD) use in the past 
month was reported by between 3 and 9 percent of 
12th-grade students in the suburban counties, as was 
use of other hallucinogens (mescaline, ‘shrooms), 
according to the 2001 Maryland Adolescent Survey. 
Reported use for any of the hallucinogen categories 
was lower in Baltimore City than in the counties.  
 
LSD mentions in drug-related ED episodes fell 
significantly from 49 mentions in 2000 to 29 in 2001. 
Phencyclidine (PCP) mentions remained stable, at 73 
in 2000 and 75 in 2001.  
 
Club Drugs 
 
The 2001 Maryland Adolescent Survey reported that 
“ designer drugs”  (including ecstasy) had been used in 
the past month by between 5 and 10 percent of 12th-
graders in the suburban counties. Use in the past 
month in Baltimore City, however, was only 2 
percent.  
 
ED mentions of methylenedioxymethamphetamine 
(MDMA or ecstasy) increased significantly between 
2000 and 2001, but the numbers remained low, 
increasing from 64 in 2000 to 75 in 2001. MDMA 
was mentioned in less than 1 percent of drug-related 
ED episodes in 2001.  
 
ED mentions of gamma hydroxybutyrate (GHB), 
flunitrazepam (Rohypnol), and ketamine remained 
low, at 7, 0, and 6, respectively, in 2001. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
The Baltimore metropolitan area had an AIDS 
incidence rate of 50.0 per 100,000 population in 
2001, an increase over the 37.8 per 100,000 reported 
in 2000. Improvements in reporting beginning in 
November 2000 led to an increase in the reported 
number of AIDS cases in Baltimore and Maryland, 
changing Baltimore’s AIDS incidence rank among 
major metropolitan areas from eighth to fifth. In the 
year ending December 31, 2000, the Baltimore 
metropolitan area accounted for 64 percent of 
Maryland’s incident HIV infections, 61 percent of its 
incident AIDS cases, and 63 percent of the 23,229 
persons in Maryland living with HIV or AIDS. In 
1998 (the latest year for which data by geographic 
region are available), Baltimore’s prevalent AIDS 
cases were about 70 percent male and 83 percent 
African-American. Sixty percent of cases were 
among injection drug users (IDUs), 21 percent were 
non-IDU men who had sex with men, and 16 percent 
involved heterosexual transmission.  
 
 
 
For inquiries concerning this report, please contact Leigh A. Henderson, Ph.D., Synectics for Management Decisions, Inc., 3001 Guilford 
Avenue, Baltimore, Maryland 21218-3926, Phone: 410-235-3096, Fax: 703-528-6421, E-mail: <leighh@smdi.com>. 
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ABSTRACT 
 
Heroin, cocaine, and marijuana continue to 
dominate as the major street drugs in Boston. Heroin 
treatment admissions and rates of emergency 
department (ED) mentions continued to increase 
through fiscal year 2002 and calendar year 2001, 
respectively. Although the number of cocaine 
treatment admissions has remained level, the rate of 
cocaine ED mentions increased between 2000 and 
2001. Marijuana indicators have remained relatively 
flat during the past year. Rates of ED mentions for 
amphetamines and MDMA are significantly higher 
than the 1999 rates. ED rates of barbiturates, 
benzodiazepines, and narcotic analgesics continue to 
increase annually. The drug arrest percentage of all 
arrests in the city of Boston was unchanged between 
2000 and 2001 but down 30 percent from 1997 (23.7 
to 16.7 percent). The drug class distribution for drug 
arrests has remained unchanged between 2000 and 
2001, with arrests for class B drugs (mainly 
cocaine/crack) accounting for the highest proportion 
(42 percent). The Drug Enforcement Agency reports 
that price, purity, and availability of all reported illicit 
drugs has remained unchanged across New England 
despite various successful interdiction efforts, 
including eradication of 1,853 marijuana plants 
between July and September 2002. In 2001, there 
were 166 new HIV cases in Boston. The primary 
transmission risks for these new cases included 11 
percent who were injection drug users (IDUs), 3 
percent who had sex with IDUs, and 33 percent with 
an unknown/undetermined transmission status. In 
2001, there were 145 new AIDS cases. Transmission 
risk included 23 percent who were IDUs, 1 percent 
who had sex with IDUs, and 31 percent for whom the 
risk behavior was unknown/undetermined. 
 
INTRODUCTION 
 
Area Description 
 
According to the 2000 U.S. census, Massachusetts 
ranks 13th in population (6,349,097 people). The 
746,914 people in the metropolitan Boston area 
represent 12 percent of the total Massachusetts 
population. In the city of Boston, 50 percent of 
residents are White non-Hispanic, 23 percent are 
Black non-Hispanic, 14 percent are Hispanic, and 8 
percent are Asian. 
 
Several characteristics influence drug trends in 
Boston and throughout Massachusetts: 
 
• Contiguity with five neighboring States linked 
by a network of State and interstate highways 
 
•  Proximity to Interstate 95, which connects 
Boston to all major cities on the east coast, 
particularly New York 
 
• A well-developed public transportation system 
that provides easy access to communities in 
eastern Massachusetts 
 
• A large population of college students in both the 
greater Boston area and western Massachusetts 
 
• Several seaport cities with major fishing 
industries (now in decline) and harbor areas 
 
• Two international airports (Boston and 
Springfield) and an expanding domestic travel 
airport (Worcester) 
 
• A struggling economy with increasing 
unemployment, declining State revenues, and 
social service cutbacks 
 
• A record number of homeless individuals 
seeking shelter 
 
Data Sources 
 
Data sources for this report include the following: 
 
• Emergency department (ED) drug mentions 
data for the Boston metropolitan statistical area 
from 1997 to 2001 were provided by the Drug 
Abuse Warning Network (DAWN), Office of 
Applied Studies, Substance Abuse and Mental 
Health Services Administration (SAMHSA). 
 
• Drug treatment admissions data  were provided 
by the Massachusetts Department of Public 
Health (DPH), Bureau of Substance Abuse 
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Services. These data represent State-funded 
substance abuse treatment admissions for fiscal 
year (FY) 1994 (starting July 1993) through FY 
2002 (ending June 30, 2002). 
 
•  Information on seized drug samples for 
January 1, 1993, through June 30, 2002, were 
provided by the DPH Drug Analysis Laboratory. 
 
•  Data on drug mentions in helpline calls from 
January through September 2002 were provided 
by the Massachusetts Substance Abuse 
Information and Education Helpline. 
 
•  Drug arrests, availability, price, purity, and 
distribution patterns data were provided by the 
Boston Police Department, Drug Control Unit 
and Office of Research and Evaluation, and the 
Drug Enforcement Administration (DEA). 
 
•  Self-reported drug use among Boston high 
school students, 2001, were derived from the 
Boston Youth Risk Behavior Survey (YRBS). 
 
•  Acquired immunodeficiency syndrome (AIDS) 
and human immunodeficiency virus (HIV) 
data by year between 1993 and 2001, and 
cumulative data through November 1, 2002, were 
provided by DPH, AIDS Surveillance Program. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
Cocaine/crack indicators were mixed, either increasing 
or remaining fairly stable in 2001.  According to 
DAWN, the number and rate of cocaine ED mentions 
increased, while the proportion of greater Boston 
substance abuse treatment admissions who reported 
current cocaine abuse decreased slightly in FY 2002. 
 
In 2001, there were 4,933 cocaine/crack ED mentions 
in greater Boston, up 20 percent from 2000 (exhibit 
1). Similarly, the rate of 138 cocaine/crack ED 
mentions per 100,000 population in 2001 was 28 
percent higher than the 2000 rate and 45 percent 
higher than the 1999 rate.  The 2001 rate marks a 
return to levels of cocaine/crack ED mentions in the 
mid-1990s (136 per 100,000 population in 1994). 
 
The 2001 cocaine/crack ED mention rate for males 
was more than 1½ times the rate for females (174 vs. 
103 per 100,000 population). Both male and female 
rates increased significantly from 2000 (32 and 21 
percent, respectively) and 1999 (51 and 35 percent, 
respectively). Similarly, all reported adult age group 
rates for cocaine/crack ED mentions increased 
significantly in 2001 from 2000 and 1999. The 
highest rate was seen among those age 26– 34 (317 
mentions per 100,000 population), reflecting a 50-
percent increase from 1999 to 2001 and a 29-percent 
increase from 2000 to 2001. From 1999 to 2001, the 
largest rate increase— 70 percent— was reported for 
those age 45– 54 (the 2001 rate was 112 mentions per 
100,000 population).  
 
In FY 2002, 2,230 treatment admissions (9 percent of 
all admissions) reported cocaine as their primary 
drug, and 6,141 mentions (24 percent of all mentions) 
of current cocaine use were made by those admitted 
to treatment (exhibit 2). The percent reporting 
cocaine as their primary drug did not change from FY 
2001 to FY 2002, but it decreased 25 percent from 
FY 2000 to FY 2002. The percent of mentions of 
current cocaine use decreased slightly (4 percent) 
from FY 2001 to FY 2002. 
 
The gender distribution of cocaine treatment 
admissions (63 percent male and 37 percent female) 
did not change from FY 2001 to FY 2002 (exhibit 
3a). However, the percentage of males increased 7 
percent and the percentage of females decreased 10 
percent from FY 2000. The percentage of females 
admitted for a primary cocaine/crack problem was 14 
percentage points higher than the proportion of 
females among total admissions for FY 2002 (exhibit 
4). 
 
The mean age of those admitted to cocaine treatment 
in FY 2002 was 36.7 years. The proportion of 
admissions age 40– 49 (29 percent in FY 2002) 
increased 16 percent from FY 2001. The racial 
distribution for cocaine admissions in FY 2002 (25 
percent White, 61 percent Black, and 11 percent 
Hispanic) was nearly identical to that in FY 2001. 
However, the proportion of Black cocaine admissions 
decreased slightly from FY 2000 to FY 2002. The 
proportion of homeless cocaine admissions increased 
from FY 2001 to FY 2002. 
 
The percentage of class B arrests (mainly cocaine and 
crack) among all drug arrests in the city of Boston 
did not change from 2000 to 2001 (42 percent) 
(exhibit 5). However, the proportion of class B 
arrests did decrease 12 percent since 1997. 
 
A comparison of seized drug lab submissions during 
the first halves of 2000– 2002 shows a 9-percent 
increase in the proportion of cocaine submissions 
from 2000 to 2002 (n=1,381) for greater Boston. 
 
YRBS data show that 3.6 percent of Boston high 
school students reported having used cocaine/crack at 
some point in their lives. 
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The DEA reports that a gram of cocaine costs 
between $50 and $90, and a vial of crack costs $20–
$50. Crack is reportedly “ more available in the inner 
cities”  of New England. 
 
Heroin 
 
Heroin indicators were up during this reporting 
period, including ED mentions and treatment 
admissions. 
 
In 2001, there were 4,358 heroin ED mentions, up 13 
percent from 2000 in greater Boston. Similarly, the 
heroin ED mentions rate of 122 per 100,000 
population for 2001 was 20 percent higher than the 
2000 rate and 59 percent higher than the 1999 rate 
(exhibit 1).   
 
The 2001 rates by gender show that the heroin ED 
rate for males was approximately 2½ times the 
female rate (173 vs. 73 per 100,000 population). Both 
male and female rates increased significantly from 
1999 (61 and 53 percent, respectively) and 1994 (74 
and 59 percent, respectively). Similarly, except for 
the 6– 17-year-old age group, rates for all reported 
age groups of heroin ED mentions increased 
significantly from 1999 to 2001. The highest rate by 
age group in 2001 (367 per 100,000 population) was 
seen among those age 26– 29; that rate increased 256 
percent from 1999 to 2001. Substantial rate increases 
of 166 and 236 percent from 1994 to 2001 were 
reported among two other age groups (those age 18–
25 and 45– 54, respectively).  
 
In FY 2002, there were 11,828 treatment admissions 
(46 percent of all admits) who reported heroin as 
their primary drug, and 10,746 mentions (42 percent 
of all mentions) of current heroin use among those 
admitted to State-funded treatment programs (exhibit 
2). The percent reporting heroin as their primary drug 
increased 10 percent from FY 2001, 24 percent from 
FY 2000, and 59 percent since 1996. The percent of 
mentions of current heroin use increased 8 percent 
from FY 2001, 20 percent from FY 2000, and 45 
percent from FY 1996. 
 
The gender distribution of heroin treatment 
admissions in FY 2002 (77 percent male and 23 
percent female) was similar to that in FY 2001 
(exhibit 3a). However, the male proportion increased 
12 percent and the female proportion decreased 26 
percent from FY 1997. 
 
The mean age of those admitted to heroin treatment 
in FY 2002 was 34.6 years. The percentage of 
admissions age 19– 29 (32 percent) increased 19 
percent from FY 2000. The racial distribution for 
heroin admissions in FY 2002 (53 percent White, 18 
percent Black, 25 percent Hispanic) reflected 
moderate changes, with Whites increasing 6 percent 
and Blacks decreasing 14 percent from FY 2001. 
There was a 21-percent increase in the percentage of 
heroin admissions who were homeless from FY 2001 
to FY 2002. Sixty-two percent of those in treatment 
for heroin as their primary drug of abuse reported 
needle use in the past year. 
 
The percentage of class A drug arrests (mainly heroin 
and other opiates) among all drug arrests (26 percent) 
in the city of Boston did not change from 2000 to 
2001 (exhibit 5). However, the proportion of class A 
arrests increased 16 percent from 1997 to 2001. 
 
A comparison of seized drug lab submissions during 
the first halves of 2000– 2002 shows a 25-percent 
decrease in the number of heroin submissions from 
2000 to 2002 (n=819 and 668, respectively) for 
greater Boston. 
 
YRBS data show that 1.5 percent of Boston high 
school students have used heroin at some point in 
their lives. 
 
The DEA reports that heroin is cheap, pure, and 
“ readily available throughout the New England area.”  
 
Marijuana 
 
Marijuana indicators were level for 2001, including ED 
mentions and FY 2001 treatment admissions, but the 
rate of ED mentions did increase from 1999 to 2001. 
 
In 2001, there were 3,423 marijuana ED mentions in 
greater Boston, up 75 percent from 1999 (exhibit 1). 
Similarly, the rate of 96 marijuana ED mentions per 
100,000 population for 2001 was 83 percent higher 
than the 1999 rate of 53 mentions per 100,000 
population, but not significantly greater than the rate 
of 78 reported in 2000.  
 
The 2001 marijuana ED mentions rate for males was 
nearly 2½ times the rate for females (136 vs. 58 
mentions per 100,000 population). In 2001, male ED 
rates increased significantly from 2000 (up 28 
percent) and 1999 (up 91 percent). Although the 
number of marijuana mentions among females has 
been increasing steadily, these increases have not 
tested significant. All three age group rates for 
marijuana ED mentions increased significantly from 
1999 to 2001. In 2001, the highest rate (246 
mentions) was reported among those age 18– 25, 
reflecting an increase of 84 percent from 1999. 
Substantial rate increases of 114 percent and 107 
percent occurred between 1999 and 2001 among the 
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two other age groups (those age 26– 34 and 35 and 
older, respectively).  
 
In FY 2002, 1,054 treatment admissions (4 percent of 
all admissions) reported marijuana as their primary 
drug, and there were 2,814 mentions (11 percent of all 
mentions) of current marijuana use among those 
admitted to treatment. The percentage reporting 
marijuana as their primary drug did not change from 
FY 2001. The percentage of mentions of current 
marijuana use decreased 15 percent from FY 2001 and 
FY 2000 and decreased 31 percent from FY 1996. 
 
The gender distribution of marijuana treatment 
admissions (77 percent male and 23 percent female) 
did not change between FYs 2001 and 2002 (exhibit 
3b). However, compared with FY 2000, the male 
proportion increased nearly 6 percent, while the 
female proportion decreased 15 percent.  
 
The mean age of marijuana admissions in FY 2002 
was 24.8 years. The proportion of admissions who 
were younger than 30 (74 percent) did not change 
from FY 2001 to FY 2002, nor did the racial/ethnic 
distribution for marijuana admissions (27 percent 
White, 48 percent Black, 20 percent Hispanic). 
However, from FY 1996 to FY 2001, there was a 23-
percent decrease in White marijuana admissions and 
a 23-percent increase in Black admissions.  
 
The proportion of class D arrests (mainly marijuana) 
among all drug arrests (29 percent) in Boston in 2001 
did not change from 2000 (exhibit 5).  
 
A comparison of drug lab submissions during the 
first halves of 2000– 2002 shows no significant 
change in the proportion of marijuana submissions 
(37 percent) for greater Boston. 
 
YRBS data show that 42 percent of Boston high 
school students reported having used marijuana in 
their lifetime, and 23 percent reported use within the 
past month. 
 
The DEA reports that highly potent marijuana is 
readily available throughout New England despite 
various successful interdiction efforts, including the 
eradication of 1,853 marijuana plants between July 
and September 2002. 
 
Narcotic Analgesics 
 
There were 2,902 narcotic analgesics/combinations 
(NA/C) ED mentions in 2001. The 2001 NA/C rate 
of 81 per 100,000 population is fourth highest among 
the 21 DAWN sites and represents a 53-percent 
increase since 2000, a 104-percent increase since 
1999, and a 145-percent increase since 1994. In 2001, 
Boston had the highest oxycodone/combinations ED 
rate (a subset of the NA/C category) of 27 per 
100,000 population among the 21 DAWN sites. The 
number of oxycodone/combinations ED mentions of 
948 increased nearly 59 percent from 2000, 222 
percent from 1999, and 229 percent from 1994.  
 
Drug lab submissions of oxycodone samples 
increased 57 percent between the first halves of 2000 
and 2001 (233 and 365 samples, respectively). There 
were 89 statewide OxyContin thefts from pharmacies 
during the first 10 months of 2002, compared with 
139 thefts during the same 10-month period in 2001. 
A new pharmacy regulation effective July 1, 2002, 
permits pharmacies to not stock OxyContin. Some 
pharmacies have displayed signs stating that limited 
quantities of OxyContin are on the premises in an 
effort to ward off thefts. 
 
MDMA  
 
There were 140 methylenedioxymethamphetamine 
(MDMA) (ecstasy) ED mentions in 2001 (up 61 
percent from 1999), producing a rate of 4 mentions 
per 100,000 population. Of these, 71 percent were 
among males, and 74 percent were among those 
younger than 26. YRBS data show that 7 percent of 
Boston high school students reported having used 
ecstasy at some point in their lives. The DEA reports 
that “ MDMA availability has remained high.”  
 
Other Drugs 
 
The rate of amphetamine ED mentions per 100,000 
population increased nearly 90 percent from 1999 to 
2001 (6 and 11, respectively). The 2001 rate is the 
highest amphetamine ED mentions rate that Boston 
experienced from 1994 to 2001.  
 
There were few ED mentions of methamphetamine 
(n=14) or ketamine (10) in 2001. Comparison of half-
year lab submissions (January through June) for ket-
amine show small but increasing numbers of 
submissions (7, 11, and 22 samples for 2000– 2002, 
respectively). 
 
There were 3,388 benzodiazepine ED mentions in 
2001, an increase of 16 percent from 2000 and 25 
percent from 1999. The benzodiazepine ED rate of 95 
mentions per 100,000 population is the highest 
among all 21 DAWN sites. 
 
There were 536 barbiturate ED mentions, yielding a 
rate of 15 mentions per 100,000 population, the 
highest barbiturates rate during the 8 years of DAWN 
reporting in the Boston area from 1994 to 2001. 
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There were few lysergic acid diethylamide (LSD) (33 
mentions) or phencyclidine (PCP) (23 mentions) ED 
mentions in Boston during 2001. However, the 
number of PCP mentions increased significantly from 
2000 to 2001 (109 percent) and also from 1999 to 
2001 (229 percent). 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
In 2001, there were 166 new HIV cases in Boston 
(exhibit 6). The primary risk factors included the 
following: 11 percent were injection drug users 
(IDUs), 3 percent had sex with an injection drug user, 
and 33 percent had an unknown/undetermined 
transmission status. In 2001, there were 145 new 
AIDS cases. By transmission risk this included 23 
percent who were IDUs, 1 percent who had sex with 
an IDU, and 31 percent for whom the risk behavior 
was unknown/undetermined. 
 
 
 
For inquiries concerning this report, please contact Daniel P. Dooley, Boston Public Health Commission, 1010 Massachusetts Avenue, Boston, 
MA 02118, Phone: 617-534-2360, Fax: 617-534-2422, E-mail: <Ddooley@bphc.org>. 
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Exhibit 4. Characteristics of Admissions1 to Greater Boston State-Funded Substance Abuse  
 Treatment Programs by Percent:  FY 1995–FY 2002 
 
Characteristic FY
2
 
1995 
FY 
1996 
FY 
1997 
FY 
1998 
FY 
1999 
FY 
2000 
FY 
2001 
FY 
2002 
Gender 
 Male 
 Female 
 
73 
27 
 
72 
28 
 
72 
28 
 
75 
25 
 
74 
26 
 
76 
24 
 
77 
23 
 
77 
23 
Race/Ethnicity 
 White 
 Black 
 Hispanic 
 Other 
 
44 
39 
13 
4 
 
45 
38 
14 
4 
 
47 
35 
14 
3 
 
47 
33 
15 
4 
 
48 
32 
16 
4 
 
48 
32 
16 
4 
 
48 
30 
18 
4 
 
49 
29 
18 
4 
Age at Admission 
 (Average age) 
 18 and younger 
 19–29 
 30–39 
 40–49 
 50 and older 
 
(34.2) 
2 
31 
42 
19 
6 
 
(34.6) 
2 
29 
42 
20 
6 
 
(35.1) 
3 
25 
43 
22 
7 
 
(35.5) 
3 
24 
42 
23 
8 
 
(36.5) 
2 
22 
41 
27 
9 
 
(36.7) 
2 
21 
40 
29 
9 
 
(36.5) 
2 
22 
38 
29 
9 
 
(36.5) 
2 
24 
37 
28 
10 
Marital Status 
 Married 
 Separated/divorced 
 Never married 
 
12 
22 
66 
 
11 
22 
68 
 
10 
22 
68 
 
10 
22 
68 
 
10 
21 
69 
 
10 
19 
71 
 
10 
18 
72 
 
10 
18 
72 
Annual Income 
 Less than $1,000 
 $1,000–$9,999 
 $10,000–$19,999 
 $20,000 and over 
 
55 
28 
10 
7 
 
56 
29 
9 
7 
 
59 
26 
9 
7 
 
58 
26 
9 
7 
 
58 
26 
8 
8 
 
62 
21 
9 
8 
 
64 
19 
8 
9 
 
70 
14 
7 
9 
Homeless 20 24 32 31 31 30 34 37 
Criminal Justice System 
Involvement 
 
25 
 
27 
 
26 
 
26 
 
28 
 
27 
 
26 
 
27 
Mental Health 
 No prior treatment 
 No treatment but has problem 
 Prior treatment (counseling or  
   hospitalization) 
 
78 
6 
 
16 
 
77 
5 
 
18 
 
79 
3 
 
18 
 
77 
3 
 
21 
 
76 
3 
 
21 
 
78 
3 
 
20 
 
78 
2 
 
19 
 
78 
2 
 
20 
Needle Use in Past Year 21 21 22 25 26 26 27 32 
Total (N) 23,282 24,363 25,470 26,505 24,653 24,478 25,269 25,586 
 
1 Excludes prisoners and out-of-State admissions. 
2 Fiscal years are from 7/1 to 6/30 for each time period. 
 
SOURCE:  Massachusetts Department of Public Health, Bureau of Substance Abuse Services 
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Patterns and Trends of Drug Abuse in Chicago 
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ABSTRACT 
 
Emergency department (ED) mentions stabilized at 
high levels and treatment admissions increased, 
indicating continued high levels of heroin use in 
Chicago during 2001. Between the second halves of 
2000 and 2001, heroin ED mentions did not change 
significantly, following the national trend. However, 
the rate of heroin ED mentions per 100,000 pop-
ulation in Chicago increased 142 percent from 1994 
to 2001 and 26 percent between 1999 and 2001. 
Indicators of cocaine use leveled off from previous 
increases, but some began to show a slight increase 
in 2001. Many cocaine indicators remained the 
highest for all substances except alcohol. Marijuana 
use, alone and in combination with other drugs, 
appeared to be increasing, especially among the 
youth in the Chicago metropolitan area. MDMA 
(ecstasy) ED mentions decreased significantly in 
2001 by 44 percent from the previous year and 
continued to remain highest among White youth. 
Methamphetamine indicators suggested continuing 
low levels of use in Chicago. The proportion of new 
AIDS cases attributed to injection drug use con-
tinued to increase, especially among women.  
 
INTRODUCTION 
 
Area Description 
 
The 2000 U.S. census estimated the population of 
Chicago at 2.9 million, Cook County (which includes 
Chicago) at 5.4 million, and the metropolitan sta-
tistical area (MSA) at slightly more than 8 million 
(ranking third in the Nation). The city population 
declined 4 percent between 1970 and 1980 and 
another 7 percent in the 1980s. Based on 2000 census 
data, the city population increased about 4 percent 
between 1990 and 2000. The number of Hispanics 
living in Chicago increased 38 percent during this 
period, while the number of Whites and African-
Americans declined by 14 and 2 percent, respec-
tively.  
 
According to the 2000 census, the Chicago pop-
ulation is 36 percent African-American, 31 percent 
White, 26 percent Hispanic, and 4 percent Asian-
American/Pacific Islander. In 2000, the median age 
of Chicagoans was 31.5, with 26 percent of the pop-
ulation younger than 18 and 10 percent 65 or older. 
 
Data Sources 
 
Most of this analysis highlights developments over 
the past few years, but in some instances a broader 
timeframe is used to reveal long-term trends. This 
paper is based on the most recent data available from 
the various sources detailed below. 
 
• Emergency department (ED) drug mentions 
data were provided by the Drug Abuse Warning 
Network (DAWN), Office of Applied Studies, 
Substance Abuse and Mental Health Services 
Administration (SAMHSA), for 1994 through 
2001; 2000 ED data were unavailable for meth-
amphetamine.  
 
• Treatment data were provided by the Illinois 
Office of Alcoholism and Substance Abuse 
(OASA) and include admissions data for the 
State of Illinois for fiscal years (FYs) 1999– 2002 
(July 1– June 30). 
 
• Drug-related mortality data were derived from 
the DAWN mortality system for 1998– 2000. The 
DAWN system covered 56 percent of the MSA 
jurisdictions and 92 percent of the MSA 
population in 2000. Data on pediatric toxicity 
were available from the Illinois Department of 
Public Health (IDPH) Adverse Pregnancy 
Outcome Reporting System (APORS) reports 
through 1999. Data on deaths related to accident-
al drug poisonings, based on the International 
Classification of Diseases, Ninth Revision (ICD-
9) codes on death certificates of Chicago res-
idents for 1980– 98, were also provided by IDPH 
and the Chicago Department of Public Health 
(CDPH); the report on deaths related to accident-
al drug poisonings has not been updated since 
the Chicago CEWG June 2000 report. 
 
• Arrestee drug testing data were provided by 
the Arrestee Drug Abuse Monitoring (ADAM) 
program, National Institute of Justice (NIJ), for 
1991 through 2001. Male and female arrestee 
urine toxicology results were from Treatment 
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Alternatives for Special Clients (TASC). The 
2000 data are based only on the first through 
third quarters, and 2001 data are based only on 
the fourth quarter. Female results were unavail-
able for 2001. Provisional unweighted data were 
obtained for males for the first three quarters of 
2002. 
 
• Heroin price and purity data were provided by 
the Drug Enforcement Administration (DEA), 
Domestic Monitor Program (DMP), for 1993 
through 2001; the data are preliminary and 
subject to updating. Price and purity data on drug 
samples analyzed from August 1989 to October 
2002 were provided by the Illinois State Police 
(ISP), Division of Forensic Science. Data on 
drug availability, demand, production, culti-
vation, and distribution for the State of Illinois 
were available from the Illinois Drug Threat 
Assessment, National Drug Intelligence Center, 
U.S. Department of Justice, in a report published 
in January 2001 (2001-SO382IL-001) and in the 
most recent update published in May 2002 
(2002-SO382IL-001). Ethnographic data on drug 
availability, price, and purity are from obser-
vations and interviews conducted by the Com-
munity Outreach Intervention Projects (COIP), 
School of Public Health, University of Illinois at 
Chicago (UIC). 
 
• Survey data on student and household 
populations were derived from several sources. 
OASA provided data from a statewide household 
survey to determine need for alcohol and other 
drug treatment services, funded by the Center for 
Substance Abuse, as well as data from Illinois 
Youth Surveys among junior and senior high 
school students (1990, 1993, 1995, 1997, 1998, 
and 2000). (The 2000 survey does not include 
figures for heroin or methamphetamine use.) 
Data on student drug use were also derived from 
the national Monitoring the Future (MTF) Study 
conducted by the Institute for Social Research, 
University of Michigan, through support from 
the National Institute on Drug Abuse (NIDA), 
and from the Chicago Youth Risk Behavior 
Survey (YRBS), as part of the Centers for 
Disease Control and Prevention (CDC) Youth 
Risk Behavior Surveillance System (1991–
2001). YRBS gathers data from a representative 
sample of Chicago public school students in 
grades 9– 12 and is conducted every other year to 
monitor changes in the prevalence of behaviors 
that contribute to the leading causes of death, 
disease, and injury among the Nation’s youth. 
 
• Acquired immunodeficiency syndrome (AIDS) 
and human immunodeficiency virus (HIV) 
data were derived from both agency sources and 
UIC studies. IDPH and CDPH surveys provided 
statistics on AIDS and HIV through November 
2001. CDC’s “ HIV/AIDS Surveillance Report,”  
December 2001, provided additional data on 
HIV and AIDS. The agency data are com-
plemented by UIC’s studies of injection drug 
users (IDUs) conducted by COIP at UIC’s 
School of Public Health. One is the NIDA-
funded “ AIDS Intervention Study,”  based on a 
panel of IDUs participating from 1988 to 1996. 
The second is the CDC-funded HIV Incidence 
Study (CIDUS I and II). The CIDUS data are 
from analyses of a 1994– 96 study of 794 IDUs, 
age 18– 50, in Chicago (Ouellet et al. 2000) and a 
1997– 99 study of 700 IDUs, age 18– 30, in 
Chicago and its suburbs (Thorpe et al. 2000; 
Bailey et al. 2001). 
 
Some of the sources traditionally used for this report 
have not been updated by their authors or were 
unavailable at the time this report was generated. 
Because some information has not changed— and to 
avoid redundancy— this report occasionally refers 
readers to a previous Chicago CEWG report for more 
information in a particular area. For a discussion of 
the limitations of survey data, the reader is referred to 
the December 2000 Chicago CEWG report. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
This report of drug abuse patterns and trends is 
organized by major pharmacologic categories. Read-
ers are reminded, however, that multidrug con-
sumption is the normative pattern among a broad 
range of substance abusers in Chicago. Various 
indicators suggest that drug combinations play a 
substantial role in drug use prevalence. The latest 
DAWN data show that 18 percent of all reported ED 
drug mentions in Chicago between July and Decem-
ber 2001 were alcohol-in-combination mentions, sim-
ilar to proportions in nationwide reports. 
 
In terms of public health impact, drug abuse causes 
significant morbidity and mortality. According to 
DAWN ED data, Chicago reports the highest ED 
drug mentions among the 21 DAWN metropolitan 
areas. A trend analysis of death certificates suggests 
that absolute drug-related mortality in Chicago 
increased more than 30 percent over the 10-year 
period from 1989 to 1998. The total annual number 
of deaths from accidental drug poisonings rose from 
256 in 1989 to a peak of 352 in 1993. In 1998, 344 
deaths were listed as overdoses on death certificates. 
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According to DAWN medical examiner (ME) data, 
drug-related mortality for Chicago’s greater six-
county region remained relatively stable from 1999 to 
2000. The total number of drug abuse-related deaths 
reported to DAWN ME sites in 2000 was 869, 
compared with 878 in 1999.  
 
While DAWN ME cases and CDPH death certificates 
differ in the information they provide, both indicators 
suggest that total drug-related deaths have increased 
slightly over the last few years. Evidence of an in-
crease is uniform across indicators. Drug-specific 
analyses later in this report provide more insight into 
factors that have shaped this overall drug mortality 
trend. 
 
Cocaine and Crack 
 
In this reporting period, the majority of quantitative 
cocaine indicators were mixed, but they suggested 
that use has increased slightly or remained stable and 
is comparable to levels in the mid-1990s.  
 
Cocaine ED mentions peaked at 14,373 in 1997 and 
remained relatively stable until 2001, when mentions 
increased to 16,202, a 21-percent increase from 1999. 
During 2001, mentions decreased slightly (4 percent) 
between the first and second halves, from 8,269 to 
7,933. 
 
In terms of rates per 100,000 population, mentions 
increased from 1999 (225) to 2000 (246) and 
continued to increase in 2001 (277), a 23-percent 
change from 1999. Rates of ED mentions decreased 
by nearly 6 percent between the first and second 
halves of 2001, from 142 to 134 per 100,000 
population (exhibit 1). Chicago had the most cocaine 
ED mentions among DAWN sites in 2001 and the 
highest rate per 100,000 population: 277. 
 
Cocaine ED mentions increased slightly across nearly 
every demographic group. Between 2000 and 2001, 
cocaine ED mentions increased significantly (13 
percent) among Whites. Slight but nonsignificant 
increases were reported for African-Americans and 
Hispanics during this period. Hispanics experienced a 
significant increase between 1999 (1,479) and 2001 
(1,976), a change of 34 percent. During 2001, ED 
mentions remained stable across racial/ethnic groups, 
except among African-Americans, for whom 
mentions decreased by nearly 10 percent between the 
first and second halves of the year. However, for the 
second half of 2001, African-Americans continued to 
report the highest number of cocaine ED mentions 
(4,516), followed by Whites and Hispanics 
(race/ethnicity was unknown for 1,330 of the 7,933 
cocaine ED mentions). In the second half of 2001, 
mentions decreased for all age categories except the 
20– 25 group, with the 30– 34 group experiencing the 
largest significant decrease (11 percent). Males 
continued to account for more cocaine ED mentions 
than females, with mentions increasing significantly 
for males between 2000 and 2001 by 11 percent. 
 
According to DAWN ME data, deaths associated 
with cocaine increased 9 percent, from 468 in 1998 to 
511 in 1999, but decreased 9 percent to 464 in 2000. 
Of the 869 total drug abuse deaths in 2000, 464 (53 
percent) had a mention of cocaine.   
 
State-supported drug treatment programs report that 
cocaine abuse remained the most frequent reason for 
entering treatment (excluding primary alcohol-only 
abuse) (exhibit 2). A total of 28,131 cocaine-related 
admissions to treatment were reported in Illinois in 
FY 2002, which decreased from 31,321 in 2001. 
Between 2001 and 2002, the proportion of cocaine-
related admissions slightly decreased across all 
demographic groups. The largest decrease was 
reported among African-Americans (13 percent), 
though they continued to make up the largest 
proportion of total admissions (64 percent). Cocaine-
related admissions decreased by 10 percent for both 
females and males between FY 2001 and 2002. 
 
According to the 2001 fourth quarter ADAM report, 
the weighted data for adult male arrestees showed 
that 41 percent tested cocaine-positive (exhibit 3). 
The provisional unweighted data for the first three 
quarters of 2002 suggested a stable trend or a slight 
increase in recent cocaine use by adult male arrestees.  
 
Based on analyses of drug seizures, the ISP crime labs 
indicate that cocaine purity remained relatively stable 
over the past decade until 2001. Across the State, the 
average purity of samples weighing 2−25 grams was 
60−70 percent during 1991−99. As of December 2001, 
the average purity of 2−25-gram samples increased to 
82 percent among Chicago seizures. There were too 
few exhibits reported by ISP in 2002 to make a 
reasonable comparison with earlier data.  
 
Cocaine prices and availability have historically been 
subject to wide variability. Ounce prices for powder 
cocaine were reported to be between $400 and $800, 
depending on the drug’s quality and the buyer’s 
relationship to the seller. Gram prices for powder and 
rock cocaine during this reporting period ranged from 
$50 to $150, with most reports around $75. Ounces 
of crack cocaine (“ rock” ) sell for about the same 
price as ounces of powdered cocaine, with reports 
ranging from $900– $1,600. Bags of crack cocaine—
the typical unit for street-level transactions— usually 
sell for $5, $10, or $20. Grams and fractions of 
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ounces are available— usually in off-street sales— and 
the typical buyers are said to be crack smokers who 
support their drug use through small-scale selling. 
Only one report was obtained for kilogram prices for 
rock cocaine: $19,000. In comparison, the Illinois 
Drug Threat Assessment, using DEA data, estimated 
kilogram prices in 2000 as ranging from $18,000 to 
$25,000. Compared with reports 5 and 10 years ago, 
current ounce prices are somewhat lower, gram 
prices are about the same or slightly higher, and bag 
prices are unchanged (unadjusted for inflation). 
 
The Illinois Youth Survey indicated that between 
1990 and 1993, the proportion of lifetime cocaine use 
among Chicago-area high school students decreased 
from 5 to 4 percent in the year prior to the survey. 
Results from the 1995 and 1997 surveys showed a 
slight rebound to 4 and 5 percent prevalence, respec-
tively. In 2000, cocaine use prevalence remained at 5 
percent. According to the MTF Study, cocaine and 
crack use decreased for all age groups (8th, 10th, and 
12th graders) in 2001. 
 
The 2001 Chicago YRBS of public school students in 
grades 9−12 showed a steady decline in levels of 
cocaine use since 1995, from 6 percent in 1995 to 4 
percent in 2001. The rates for the United States on 
the other hand have been increasing since 1995, 
reaching rates twice as high as Chicago in 2001. This 
finding parallels trends reported among young people 
age 12– 17 in the 2000 National Household Survey on 
Drug Abuse. Findings from the 1998 Illinois YRBS 
were discussed in the Chicago CEWG June 2000 
report. 
 
Heroin 
 
The rate of heroin/morphine ED mentions in Chicago 
increased significantly from 84 per 100,000 pop-
ulation in 1994 to 203 in 2001, an increase of 142 
percent. While there was a significant decrease of 10 
percent between the second halves of 2000 and 2001, 
the rates of heroin ED mentions remained high 
(exhibit 1), and Chicago ranked second in heroin ED 
rates in the contiguous United States. The number of 
heroin ED mentions increased from 4,640 in the first 
half of 1999 to 6,109 in the first half of 2000 and 
remained stable in the first half of 2001 (6,178). 
Between the first and second halves of 2001, the 
number of heroin ED mentions decreased 
significantly, a change of 7 percent. 
 
Within Chicago, heroin ED mentions were highest 
among African-Americans, followed by Whites and 
Hispanics. Between 2000 and 2001, heroin ED men-
tions remained relatively stable across all race/ethnic 
groups. Significant decreases were observed, how-
ever, between the first and second halves of 2001 for 
all race/ethnic categories except Whites. In the 
second half of 2001, rates of ED mentions for heroin 
were higher among males than among females (115 
vs. 79 per 100,000 population), but the rate declined 
significantly for women (10 percent) from the second 
half of 2000 and for men (8 percent) from the first 
half of 2001. Between the second halves of 2000 and 
2001, significant decreases in the number of ED 
mentions were observed in all age groups, except 
those age 35 and older (stable) and those age 26– 29 
(12-percent increase). The largest change in this 
reporting period was among 20– 25-year-olds, with a 
decrease of 43 percent. 
 
In  2000, 499 heroin deaths were reported by sentinel 
DAWN ME sites in the six-county Chicago area. 
This represents a 9-percent increase from the pre-
vious year, when 456 heroin deaths were recorded. 
Heroin-related deaths have increased more than 
twofold from the late 1980s, when less than 200 per 
year were reported. Of the 869 total drug abuse 
deaths in 2000, 499 (57 percent) had a mention of 
heroin, which makes it a factor in more deaths in the 
Chicago area than any other illicit drug.   
 
Health department death certificates also revealed a 
heroin mortality peak for the city of Chicago in 1993, 
with 143 certificates containing heroin-related ICD-9 
codes. While death certificate mentions of heroin 
declined to 92 in 1996, this number still exceeds 
annual heroin-related deaths noted during the 1980s. 
Heroin-associated death certificates increased to 128 
in 1997 and 130 in 1998, suggesting a relative rise in 
heroin-related overdose deaths in the past few years.  
 
The number of heroin admissions in State-supported 
treatment programs in FY 2002 was 21,909, a de-
crease of 10 percent from FY 2001 (exhibit 2). The 
proportion of heroin admissions who reported intra-
nasal “ snorting”  as their primary route of admin-
istration remained high and increased slightly, from 
68 to 70 percent between FYs 2001 and 2002. 
 
Between FY 2001 and 2002, heroin-related admis-
sions deceased 12 percent among African-Americans 
and 5 percent among Whites, and they increased by 
23 percent among Hispanics. Heroin-related admis-
sions decreased 11 percent for males, from 13,615 in 
2001 to 12,125 in 2002. Among females, heroin-
related admissions deceased 10 percent, from 10,848 
in 2001 to 9,784 in 2002.   
 
According to 2001 fourth quarter ADAM data, 22 
percent of adult male arrestees in Chicago tested pos-
itive for opiates (exhibit 3). The provisional un-
weighted data for the first three quarters of 2002 
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suggest that the percent of male arrestees positive for 
opiates remained relatively stable or increased 
slightly. Figures were not available for female 
arrestees. 
 
The DEA’s DMP makes street-level purchases of 
heroin in Chicago and analyzes them for content and 
purity. During the 1980s, Chicago’s heroin purity 
was among the lowest of any major metropolitan area 
(averaging 1−2 percent). Since then, the quality of 
street-level heroin has steadily increased, from an 
average purity of approximately 10 percent in 1991 
to 31 percent in 1997; however, it declined to 25 
percent in 1998 and 1999 (exhibit 4). In 2001, heroin 
purity in DMP samples averaged 19 percent. The 
price per pure milligram of heroin reached a low for 
the decade of $0.58 in 1998, but increased to $0.67 in 
1999. In 2000, the price per pure milligram decreased 
to $0.54, but it increased to $1.96 in 2001.  
 
DEA laboratory analyses confirmed that recent 
heroin exhibits in Chicago came predominantly from 
South America and Southwest Asia, but Southeast 
Asian and Mexican varieties were also available. 
Southwest Asian heroin, which became more 
available in recent years, tends to have the highest 
purity levels on average. It seems likely, therefore, 
that there may be an increase in purity during 2002. 
The DEA estimated that in the first half of 2001, 50 
percent of the heroin in Chicago was from South 
America. 
 
On the street, heroin commonly is sold in $10- and 
$20-units (bags), though $5 bags are also available. 
Prices for larger quantities vary greatly, depending on 
the type and quality of heroin, the buyer, and the area 
of the city where the heroin is sold. At outdoor drug 
markets, purchases of multibag quantities— versus 
grams and fractions of ounces— are the most 
common means of buying larger amounts of heroin. 
For example, buyers on the West Side can obtain 12 
$10-bags for $100 (sometimes called a “ jab” ). 
Sunday sales of two bags for the price of one were 
also reported. In sales conducted off the street, gram 
prices for white heroin generally were $125– $200, 
with some prices reported as low as $50 and as high 
as $300. There were reports of one-eighth of an 
ounce (“ eightballs” ) selling for $150– $200 and 
ounces selling for $1,500– $2,400. Prices for brown 
and black tar heroin were reported as somewhat 
lower than for white heroin: $60– $150 per gram and 
$1,400– $2,000 per ounce.  
 
Between 1991 and 1996, there was a large propor-
tional increase nationwide in heroin use among 
students in grades 8, 10, and 12, as reported in the 
MTF Study (Johnston et al. 2001). Heroin use in the 
MTF study peaked in 1996 among 8th graders, in 
1998 among 10th graders, and in 2000 among 12th 
graders. Student usage rates declined for all three 
groups in 2001. 
 
Among Illinois high school students, however, 
increases in heroin use have not yet been evidenced 
in periodic representative surveys. The Illinois Youth 
Survey indicates that heroin use among Chicago-area 
students is still relatively rare. Results from surveys 
conducted every 2 years between 1990 and 1997 
found that 1.3−1.5 percent of high school students 
reported past-year use. The youth subgroup reporting 
the highest level of use in 1990 was Hispanic males 
(3.1 percent), followed by African-American males 
(2.7 percent) and White males (2.4 percent). By 
1995, the youth subgroup reporting the highest preva-
lence of past-year heroin use had changed to White 
males (2.6 percent), followed by African-American 
males (1.8 percent) and Hispanic males (1.5 percent). 
According to YRBS, the percentage of students 
(grades 9– 12) in Chicago who reported at least one 
use of heroin in their lifetimes was 3.1 in 1999 and 
2.5 in 2001. 
 
APORS data indicate that opioid toxicity remained 
stable between 1995 and 1998 among infants who 
were tested for controlled substances. In 1995, 8 
percent tested positive for opiates, including heroin, 
averaging 44 infants per quarter-year. In 1998, 9 
percent of infants tested positive for opioids. Data 
from 1999 show a slight decline, with 7.1 percent 
testing positive.  
 
Other Opiates 
 
Hydromorphone (Dilaudid), the pharmaceutical 
opiate once preferred by many Chicago IDUs, is 
available, though in limited quantities (typical 
sources are said to be cancer patients). It sells for 
approximately $25 per tablet. Street sales of meth-
adone are more common, with the drug typically 
costing $1 per milligram.  
 
Abuse of codeine, in both pill (Tylenol 3s and 4s) and 
syrup form, has been declining over the past decade. 
Codeine ED mentions totaled 48 in 1999, a slight 
decrease from the 56 mentions in 1994, and increased 
to 79 in 2001, a statistically significant increase from 
1999. In 2000, 88 codeine-related deaths were 
reported from sentinel DAWN ME sites in the 6-
county Chicago area, a 15-percent decrease from the 
previous year. Codeine syrup is reported to sell for 
about $30 for 4 ounces. Codeine often is used by 
heroin users to moderate withdrawal symptoms or to 
help kick a drug habit.   
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Acetaminophen-codeine mentions increased signif-
icantly from 61 in 1999 to 100 in 2000, a 63.9-
percent increase. A nonsignificant decline to 85 
mentions was observed in 2001. Compared with 
1994, when 181 mentions were observed, mentions 
declined 53 percent by 2001.  
 
On the street, acetaminophen-codeine pills sell for 
$1−$4 each. There were 284 hydrocodone/com-
bination ED mentions reported in Chicago in 2000 
(the fourth highest among CEWG cities) and 339 in 
2001. Methadone mentions increased significantly 
between 1994 (103) and 2001 (355). Oxycodone and 
oxycodone/combinations ED mentions have in-
creased significantly from the previous years, but 
remain relatively low with 37 and 50 mentions, 
respectively, reported in 2001. Reports of OxyContin 
use remain uncommon. 
 
After large increases in treatment admissions related 
to the use of opioids, tranquilizers, and sedatives 
across all demographic groups between FYs 1999 
and 2000, admissions continued to increase in 2001, 
except for African-Americans, who reported a 6-
percent decrease. In FY 2002 treatment admissions 
remained stable among Whites and decreased 33 
percent among African-Americans and 31 percent 
among Hispanics. Whites continued to make up the 
largest proportion of all admissions (68 percent). 
After increasing 159 percent for males, from 313 in 
1999 to 810 in 2000, admissions increased only 7 
percent to 870 in 2001, and decreased by 8 percent to 
799 in 2002. Among females, after increasing 98 
percent from 1999 (446) to 2000 (883), admissions 
increased 30 percent to 1,149 in 2001 and decreased 
by 19 percent to 928 in 2002.   
 
Marijuana 
 
In the 1990s, marijuana indicators increased, closely 
corresponding with the rise in popularity of blunt 
smoking, especially common among African-Amer-
ican youth in the 14−24 age group. Blunt smokers cut 
cigars open with a razor, remove the tobacco, and 
replace it with marijuana. Cigars without tobacco are 
reportedly for sale at certain stores. Some blunt 
smokers add crack or phencyclidine (PCP) to the 
blunt before smoking it. 
 
The number of marijuana ED mentions remained 
relatively stable between the second halves of 2000 
and 2001 and changed significantly from 1994 to 
2001 by 133 percent. Marijuana ED mentions totaled 
2,482 in the second half of 2001. The rate of 
marijuana ED mentions per 100,000 was reported to 
be 89 for both 2000 and 2001. According to DAWN 
mortality data, marijuana was mentioned in 3 percent 
of total drug-related deaths reported in 2000.  
 
The number of marijuana ED mentions in Chicago 
have been higher among African-Americans and 
Whites than among Hispanics since 1994. In 2001, 
22 percent of all mentions were among Whites, 34 
percent were among African-Americans, and 15 
percent were among Hispanics. However, 29 percent 
of mentions were of unknown race/ethnicity. 
Between the first and second halves of 2001, 
marijuana mentions decreased for both Whites (16 
percent) and African-Americans (15 percent), and 
increased for Hispanics, though not significantly. For 
Whites, ED mentions also decreased significantly 
between the second halves of 2000 and 2001.  
 
Marijuana ED mentions remained relatively stable 
across all age groups in 2001, except for the 18– 25- 
year-olds. Between the second halves of 2000 and 
2001, mentions decreased by 40 percent in this age 
group. A significant decrease was also reported 
between the first and second halves of 2001 (22 
percent). This decrease was primarily driven by 18–
19-year-olds. Males continued to have more than 
twice as many mentions as females. 
 
In FY 2002, marijuana users represented 19 percent 
of all treatment admissions in Illinois and 28 percent 
of admissions when those for primary alcohol abuse 
are excluded; these proportions reflected a slight 
increase from FY 2001 (17 percent and 26 percent, 
respectively). Total marijuana admissions increased 
from  20,773 in FY 2000 to 25,626 in FY 2001, and 
to 26,371 in FY 2002 (exhibit 2).  
 
Between 2001 and 2002, marijuana-related treatment 
admissions remained stable among African-Amer-
icans and Whites, and increased 9 percent among 
Hispanics. Marijuana-related admissions increased 
nearly 4 percent for males, from 19,825 in 2001 to 
20,545 in 2002; among females, marijuana-related 
admissions remained stable in 2002 at 5,826.  
 
According to 2001 ADAM data, 50 percent of adult 
male arrestees tested positive for marijuana (exhibit 
3). The provisional unweighted data for adult males 
for the first three quarters of 2002 suggest a stable 
trend. Data for female arrestees was unavailable. 
 
APORS data also show increases in marijuana use. 
Among the 2,304 Illinois infants who tested positive 
for controlled substances in 1995, 103 (4.5 percent) 
tested positive for marijuana. Positive tests increased 
to 6.0 percent in 1996, 7.5 percent in 1997, and 8.0 
percent in 1998, evidencing a slow, continued up-
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ward trend. Data from 1999 show that 8.6 percent of 
all infants tested cannabis-positive. 
 
The 1995 Illinois Youth Survey reflected a dramatic 
increase in marijuana use among youth. In 1990, 17 
percent of students in the Chicago area reported 
marijuana use in the previous year, and use remained 
at approximately the same level in 1993. However, 
student reports of past-year marijuana use increased 
sharply to 28 percent in 1995 and to more than 30 
percent in 1997. This trend of increasing use 
continued with a 38-percent prevalence in 2000. 
According to the MTF Study, student usage remained 
stable in 2001. 
 
The 2001 Chicago YRBS showed that the proportion 
of high school respondents who reported ever using 
marijuana steadily increased since 1993. In 2001, the 
percentage of 9th– 12th graders who reported using 
marijuana at least once in their lifetime was nearly 
50. Similarly, the proportion of those who reported 
current marijuana use increased since 1993 and 
reached 29 percent in 2001. Ten percent of respon-
dents reported current use on school property. Similar 
trends were reported on the national level, although 
the ever-used proportion slightly decreased between 
1999 and 2001. Compared with the Chicago-area 
sample polled in the Illinois Youth Survey, the 
Chicago YRBS revealed higher concentrations of 
marijuana users within Chicago’s neighborhoods. 
 
In general, currently available marijuana is of high 
quality. The abundance and popularity of marijuana 
across the city has led to an increased array of 
varieties and prices. The price for a pound of mari-
juana is reported to range from $900 to $4,000, 
depending on the type and quality. Ounces typically 
sell for about $80−$200. On the street, marijuana is 
most often sold in bags for $5– $20 or as blunts.  
 
Stimulants 
 
Methamphetamine (“ speed” ) use in Chicago remains 
low, but it is more prevalent in many downstate 
counties. According to 2000 ADAM data, no male 
arrestees and only 0.3 percent of female arrestees in 
Chicago tested positive for methamphetamine. How-
ever, the most recent data from the ISP indicate that in 
October 2002, more methamphetamine was seized than 
cocaine or heroin in nearly 50 percent of Illinois 
counties. Even within Chicago, a low but stable prev-
alence of methamphetamine use has been reported in 
some areas of the city in the past 2 years, especially on 
the North Side, where young gay men, homeless youth, 
and “ ravers”  congregate. Of note, ethnographic data 
suggest that methamphetamine availability has in-
creased since June 2001 among at least some networks 
of gay White men on the North Side. However, the use 
of methamphetamine is not confined to these groups 
and seems more likely to occur among drug-using 
youth who travel beyond metropolitan Chicago to areas 
where methamphetamine is readily available. 
 
Until 1999, ED figures for methamphetamine had 
been slowly increasing during the 1990s in Chicago. 
In 1999, ED mentions numbered 22, down from a 
high of 31 in 1998. Data on methamphetamine ED 
mentions in Chicago were not available for 2000 and 
the first half of 2001. In the second half of 2001, 35 
mentions were reported, and the rate of mentions per 
100,000 population was 1 (exhibit 1). 
 
Methylphenidate (Ritalin) remained readily available 
in some South Side neighborhoods, where it could be 
purchased for injection, either alone or in combi-
nation with heroin. Pills, often referred to as “ beans”  
in these areas, are sold for $1.50 to $5.00 each, 
depending on the quantity being purchased. 
 
Amphetamine ED mentions have been increasing 
since 1994. Between the first halves of 2000 and 2001, 
mentions increased 55 percent, from 143 to 223.  
However, a nonsignificant decline to 185 ED mentions 
was observed in the second half of 2001.  
 
Stimulants accounted for nearly 4 percent of all State 
treatment admissions (excluding primary abuse of 
alcohol only) in FY 2001 and 2002, up from 2 percent 
in FY 2000. Total stimulant admissions dramatically 
increased from 1,270 in FY 2000 to 3,771 in FY 2001; 
however, admissions decreased 15 percent to 3,190 in 
2002 (exhibit 2). Between 2001 and 2002, stimulant/ 
methamphetamine-related treatment admissions in-
creased 28 percent among Whites and decreased 61 
percent among African-Americans and 42 percent 
among Hispanics. Admissions decreased 11 percent for 
males, from 2,092 in 2001 to 1,858 in 2002. Among 
females, stimulant-related admissions increased 7 
percent, from 1,679 in 2001 to 1,801 in 2002. 
 
Based on the 2000 National Household Survey on 
Drug Abuse, annual prevalence of overall stimulant 
use in the U.S. population during the previous year 
was estimated at 0.3 percent. The 1997 Illinois 
Youth Survey shows that 6 percent of all Chicago-
area students reported using stimulants in the 
previous year. The 2001 Chicago YRBS reported a 
decrease between 1999 and 2001 from 4.2 to 2.8 
percent. The national rates were almost four times 
higher in 2001. 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Chicago 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 49
Methamphetamine prices have not changed signif-
icantly, with bags selling for $20; however, many drug 
users still report that the drug is difficult to obtain.  
 
Depressants 
 
Three patterns of depressant-in-combination use have 
been common in Chicago and throughout Illinois: 
 
• Depressants are taken with narcotics to poten-
tiate the effect of opiates. Pharmaceutical 
depressants are frequently combined with heroin. 
 
• Depressants are taken with stimulants to mod-
erate the undesirable side effects of chronic 
stimulant abuse. Chronic cocaine and speed 
abusers often take depressants along with 
stimulants, or when concluding “ runs,”  to help 
induce sleep and to reduce the craving for more 
stimulants (especially in the case of cocaine). 
 
• Alcohol, also a central nervous system depres-
sant, is taken with pharmaceutical depressants 
(such as hypnotics or tranquilizers). The practice 
of mixing alcohol with other depressants may 
indicate illicit pharmaceutical depressant use. 
 
The number of barbiturate ED mentions increased 47 
percent between 1999 and 2001. ED mentions have 
remained relatively stable from 2000 to 2001, with 
243 mentions in the second half of 2001.  
 
ED mentions of benzodiazepines increased signif-
icantly between 1998 and 2000 (35 percent) and from 
1999 (1,911 mentions) to 2000 (2,564), a 34-percent 
increase, and continued to increase in 2001 (2,675) 
though not significantly. In 2001, alprazolam 
(Xanax) was mentioned most often (283), followed 
by clonazepam (Klonopin) (229), lorazepam (Ativan) 
(228), and diazepam (Valium) (180). Consistent with 
ED mentions, ethnographic reports indicate that 
alprazolam appears to be the benzodiazepine most 
readily available on the street, closely followed by 
clonazepam and lorazepam, with variations in differ-
ent areas of the city. 
 
Treatment admissions data for opioids, tranquilizers, 
and sedatives suggest that depressants are not the 
primary drugs of choice for most users. Treatment 
admissions in this category increased 19 percent from 
1,693 in FY 2000 to 2,019 in FY 2001 and decreased 
14 percent to 1,727 in FY 2002. Primary opioid, 
tranquilizer, and sedative users represented only 
about 1 percent of all treatment admissions. 
 
According to APORS, the proportion of infants test-
ing positive for depressants was less than 2 percent 
(n=22) in 1998 and about 1.3 percent in 1999. 
 
On the street, alprazolam typically sells for $2– $3 for 
0.5-milligram tablets and $5– $10 for 1-milligram 
tablets. 
 
Hallucinogens 
 
Following a nonsignificant increase in lysergic acid 
diethylamide (LSD) ED mentions from the first half 
of 2000 to the first half of 2001, a significant 
decrease occurred between the first and second 
halves of 2001, from 58 to 11 mentions. In 2001, ED 
mentions were 1 per 100,000 population, a 38-
percent decrease from the previous year. Although 
the decrease in 2001 is large, it is too soon to 
interpret the change as a downward trend in LSD use 
in Chicago.  
 
According to some accounts by White youth, hallu-
cinogenic mushrooms remain available. Reported 
prices were $10– $40 per bag and $200– $250 per 
ounce.  
 
Though not significant, recent ED mentions for PCP 
and its combinations increased from 429 in the first 
half of 2000 to 519 in the first half of 2001. The 
second half of 2001 experienced a significant decline 
in ED mentions to 355, a 32-percent change from the 
first half of the year. As with LSD, whether the sharp 
decline in PCP ED mentions will continue is difficult 
to conclude at this time.  
 
There was one report from a suburban injection drug 
user in his twenties who said the hallucinogen N,N-
dimethyltryptamine (DMT) was available in rock 
form. Typically this drug is smoked or injected and is 
said to produce a psychoactive state similar to LSD, 
though more intense and of shorter duration. 
 
Recent trends in hallucinogen treatment admissions 
have been uneven, but overall admissions have been 
relatively high compared with trends earlier in the 
decade. Admissions increased steadily from 85 in FY 
1992 to 550 in FY 1996. In FY 1997, treatment 
admissions dropped to 131, but rebounded to 455 in 
FY 1998 and to 401 in FY 1999. For FY 2000, treat-
ment admissions were up again, to 517; they in-
creased another 5 percent to 544 in FY 2001, but de-
creased 12 percent to 479 in FY 2002 (exhibit 2).  
 
According to the 2001 ADAM report, 5.1 percent of 
adult male arrestees tested positive for PCP.  
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In the 2001 Illinois Youth Survey, 6 percent of high 
school students reported “ any hallucinogen”  use in 
the past year. This category includes LSD and PCP.  
 
Ethnographic reports suggest that PCP use in 
Chicago has remained constant and that the drug can 
be found in all areas of the city. Users can easily 
identify drug-dealing locales in the city where PCP is 
readily available. The demographic characteristics of 
users vary widely and include suburban youth. PCP is 
typically smoked and is sold in various forms. “ Leaf”  
(also known as “ love leaf” ) is a moist, loose, tobacco-
like substance sprayed with PCP and wrapped in 
tinfoil. Some say the substance is marijuana, others 
say it looks and tastes like cigarette tobacco, but most 
often it is said to be parsley, which is frequently 
purchased in bags at neighborhood stores. On the 
West side, 2– 3 “ sticks”  about the size of toothpicks 
can be purchased for as little as $5– $10. Sherm sticks 
typically are cigarettes or small cigars dipped in PCP, 
drained, and dried. The cigarettes— most often 
Mores— are sold for about $20 each and are mainly 
available on the far South Side. “ Wicky sticks”  are 
said to be cigarettes dipped in PCP and embalming 
fluid. PCP was also said to be sold in sugar cubes, 
though prices were not given. Liquid PCP (“ water” ) 
was said to sell for $120 for a vial and $800– $1,000 
for a bottle (unit amounts were not verified).  
 
LSD hits typically cost $5– $10. LSD is available in 
the city and suburbs.  
 
Club Drugs 
 
In the Chicago area, methylenedioxymethamphet-
amine (MDMA or ecstasy) is the most prominently 
identified of the club drugs used. 
 
After a 46-percent increase in ED mentions for 
MDMA in Chicago from the first half to the second 
half of 2000, mentions decreased to 87 in the first 
half of 2001 and continued to decrease to 34 in the 
second half of 2001, a 61-percent decline. ED men-
tions per 100,000 population decreased by 42 percent 
between 2000 (4) to 2001 (2). Of all the CEWG sites, 
Chicago had the most MDMA ED mentions in 2000 
(215). The number of mentions increased 760 percent 
from 1998 (25 mentions) to 2000, and nearly 109 
percent from 1999 (103 mentions) to 2000. However, 
mentions decreased significantly to 121 in 2001.  
 
Illinois OASA began reporting treatment admission 
data related to club drugs for the first time in FY 
2002. During this period, there were 50 admissions, 
of which 68 percent were among males and 74 
percent were among Whites. 
 
Ecstasy, once limited to the rave scene, can be found 
in most mainstream dance clubs and at many house 
parties, according to ethnographic reports. Street 
reports suggest that ecstasy— or drugs sold as 
ecstasy— is widely available among high school and 
college students. It continued to be sold in pill or 
capsule form, and the price range remained un-
changed: $20– $40 per pill. Individuals with connec-
tions to suppliers or producers report prices as low as 
$12– $15 per pill. Ecstasy is usually sold at dance 
clubs, rave parties, house parties, or through indi-
vidual dealers; it is typically used in social settings. 
Along with other club drugs, it continues to be used 
predominantly by White youth, but there have been 
increasing reports of ecstasy use from low-income 
African-Americans in their twenties and thirties who 
have been involved in club scenes.  
 
Gamma hydroxybutyrate (GHB), a central nervous 
system depressant with hallucinogenic effects, is used 
infrequently in Chicago, mainly by young White 
males. Recent ED mentions for GHB decreased 42 
percent, from 88 in the first half of 2000 to 52 in the 
first half of 2001, and remained stable at 53 in the 
second half of 2001. ED mentions per 100,000 
population have remained at 1.0 since 1999. 
 
GHB is sold as a liquid, in amounts ranging from 
drops (from a dropper at raves or parties) to capfuls. 
Prices for a capful have been reported at $10– $25. 
Compared with other club drugs, overdoses are more 
frequent with GHB, especially when used in com-
bination with alcohol. GHB is not tracked in most 
quantitative indicators, but its use is perceived to be 
low compared with ecstasy. 
 
Ketamine, an animal tranquilizer, is another depres-
sant with hallucinogenic properties and is often 
referred to as “ Special K.”  Ketamine ED mentions in 
2001 were virtually unchanged from 1997 (from 16 
to 14). The rate of ED mentions per 100,000 pop-
ulation (0.3) also remained unchanged since 1997. 
Street reports indicate that ketamine is usually sold in 
$5– $30 bags of powder or in liquid form. The drug is 
somewhat available at rave parties or in clubs fre-
quented by younger adolescents.  
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
Through November 2001, 26,127 diagnosed AIDS 
cases were reported to the State. More than one-
quarter of adult AIDS cases occurred among IDUs, 
while an additional 6.5 percent involved male IDUs 
who had sex with other men. Within Illinois, 80 
percent of the cumulative AIDS cases reported to 
date originate in the Chicago metropolitan area.  
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The most recent report on AIDS cases in Chicago 
indicates that by December 2001, 22,703 AIDS cases 
were reported to CDC. While new drug therapies 
continue to reduce the incidence of AIDS cases by 
delaying the onset of AIDS, the decline appears to be 
leveling off. The proportion of cases among women 
tripled, from 7 percent in 1988 to 22 percent in 1997, 
and remained stable through 1999. African-Amer-
icans accounted for 68 percent of new AIDS cases in 
1999, although they constituted only 36 percent of 
the Chicago population. Of the remaining new cases, 
19 percent were among Whites and 12 percent were 
among Hispanics. 
 
Between 1988 and 1999, IDUs as a proportion of 
AIDS cases increased from 16 to 24 percent, while 
the proportion of cases among men who have sex 
with men (MSM) declined from 71 to 38 percent. In 
1999, 4 percent of cases occurred among homosexual 
or bisexual IDUs.  
 
AIDS mortality rates in Chicago declined 7 percent 
in 1999. Declines were smaller for women and 
people of color, and they were lowest for IDUs. 
 
Given the long latency between HIV infection and 
AIDS diagnosis, these figures do not reflect the full 
scope of the epidemic. Data from the authors’  AIDS 
intervention and CIDUS studies provide additional 
information on the extent of HIV infection among 
IDUs. It should be noted, however, that the studies 
are not directly comparable, because each had unique 
sampling and recruitment strategies.  
 
In the AIDS intervention study, 25 percent of the 850 
IDUs tested at baseline in 1998 were HIV-positive. 
The rate of new infections dropped (from about 9 to 2 
percent per person-year observed) over a 4-year time 
period (Wiebel et al. 1996). 
 
For the CIDUS I study, a cohort of 794 active 
injectors was recruited in 1994−96 from inner-city 
Chicago neighborhoods for longitudinal study. Race/ 
ethnicity and age stratification were incorporated into 
the sampling design. The HIV prevalence within this 
cohort was lower than expected— 18 percent. While 
the study did not evaluate a specific intervention, 
participants were exposed to a variety of HIV 
prevention activities, and a community-based organ-
ization had begun a needle exchange program that 
expanded during the study. The rate of new HIV 
infections among study participants was 1 percent per 
person-year observed (Ouellet et al. 2000). 
 
In an ongoing evaluation of needle exchange pro-
grams, 18 percent of the 683 needle exchange users 
who enrolled between 1996 and 1998 were HIV 
seropositive. Preliminary data indicate a rate of new 
HIV infections in this group of 1 percent per person-
year observed.  
 
While HIV seroprevalence was only 3 percent among 
the 700 young (age 18– 30) IDUs studied between 
1997 and 1999, the participants reported high levels 
of HIV risk practices (Thorpe et al. 2001). Of par-
ticular concern is the finding that young IDUs living 
in the suburbs reported the highest rates of needle 
sharing of any group observed during the 1990s. The 
prevalence and incidence of hepatitis C virus (HCV) 
among this sample was 27 percent (Thorpe et al. 
2000) and 10 percent per person-year observed 
(Thorpe et al. 2002). In this study, the sharing of 
paraphernalia other than needles— particularly 
cookers— was associated with new HCV infections.  
 
Together, these findings suggest that HIV prevalence 
and the rate of new HIV infections have declined 
among IDUs in Chicago since peaking in the late 
1980s. High rates of mortality among those infected 
early in the epidemic and the many HIV prevention 
activities taking place in Chicago almost certainly 
account for at least some of the observed reductions 
in infections. The findings also suggest that young 
IDUs, especially those in the suburbs, are engaging in 
high levels of HIV risk behavior and have avoided 
HIV infection only because they have yet to become 
integrated into social networks of older IDUs where 
infection is more common. Though the prevalence 
and incidence of HCV infection was high among 
young IDUs, the findings from these studies indicate 
that the time between the initiation of drug injection 
and subsequent infection with HCV is long enough 
for the majority of young IDUs to benefit from HCV 
prevention interventions that target young, new 
injectors. 
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Exhibit 1. Estimated Rate of ED Mentions Per 100,000 Population in Chicago  
     for Selected Drugs by Half Year:  1994–2001 
 
Year Cocaine Heroin/Morphine Marijuana Methamphetamine 
1994 
 1H 
 2H 
 
86 
105 
 
41 
44 
18 
22 
 
…
1
 
11 
1995 
 1H 
 2H 
 
106 
82 
 
40 
44 
27 
24 
 
28 
… 
1996 
 1H 
 2H 
 
100 
120 
 
46 
63 
29 
33 
 
0.0 
0.0 
1997 
 1H 
 2H 
 
122 
125 
 
68 
80 
35 
41 
 
0.0 
0.0 
1998 
 1H 
 2H 
 
117 
114 
 
77 
81 
 
44 
41 
 
0.0 
0.0 
1999 
 1H 
 2H 
 
104 
122 
 
78 
84 
38 
38 
 
0.0 
0.0 
2000 
 1H 
 2H 
 
122 
124 
 
102 
104 
42 
48 
 
… 
… 
2001 
 1H 
 2H 
142 
134 
106  
97 
47 
42 
 
… 
1 
 
1
 Dots (… ) indicate that an estimate with a relative standard of error greater than 50 percent has been suppressed. 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
Exhibit 2. Semiannual Illinois Treatment Admissions to Publicly Funded Programs by Primary 
Drug of Abuse:  FY 2000–FY 2002  
 
FY 2000 FY 2001 FY 2002 
Primary Drug Dec. 
1999 
June 
2000 Total 
Dec. 
2000 
June 
2001 Total 
Dec. 
2001 
June 
2002 Total 
Cocaine 18,531 12,937 31,468 16,967 14,354 31,321 14,581 13,550 28,131 
Heroin 11,733 8,121 19,854 13,745  10,718 24,463 10,747 11,162 21,909 
Cannabinoids 12,484 8,289 20,773 14,253  11,373 25,626 11,811 14,560 26,371 
Hallucinogens 290 227 517 323 221 544 237 242 479 
Stimulants 577 693 1,270 1,969 1,802 3,771 1,517 1,673 3,190 
 
SOURCE:  Illinois Office of Alcoholism and Substance Abuse 
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Exhibit 3. Percentage of ADAM Adult Male Arrestees Testing Positive in Chicago for Selected  
   Drugs by Year:  1991–2001 
    
Year Marijuana Cocaine Opiates 
1991 23 61 21 
1992 26 56 19 
1993 40 53 28 
1994 38 57 27 
1995 41 51 23 
1996 45 51 19 
1997 51 48 24 
1998 42 45 18 
1999 45 42 20 
20001,2 45 37 27 
20011,2 50 41 22 
 
1 Figures for 2000 and 2001 are based on a new method of data collection and cannot be compared with those from previous years;  
  data are weighted. 
2 Data for 2000 are for the first through third quarters; data for 2001 are for the fourth quarter only. 
 
SOURCE:  ADAM, NIJ 
 
 
 
 
Exhibit 4. Domestic Monitor Program Trends for Chicago— Heroin Purity (Percent) and Price Per  
    Milligram Pure:  1993–2001  
 
Trend 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Purity (%) 31.4 17.4 28.0 30.4 31.0 24.8 24.8 22.9 18.7 
Price per 
milligram pure $0.70 $1.90 $1.12 $0.84 $0.68 $0.58 $0.67 $0.54 $1.96 
 
SOURCE:  DMP, DEA  
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Patterns and Trends in Drug Abuse:  Denver And Colorado 
 
Bruce Mendelson1 
 
ABSTRACT 
 
Most amphetamine and methamphetamine in-
dicators have fluctuated in the past 6 years. 
However, in 2002, methamphetamine treatment 
admissions reached their highest level ever. 
Marijuana continues to be a major problem in 
Colorado, although most current indicators are 
stable or decreasing slightly. For example, clients 
whose primary drug was marijuana constituted the 
largest proportion of drug-related treatment admis-
sions in the first half of 2002, even though this 
percentage was down slightly from 2001. Also, 
marijuana emergency department (ED) mentions, 
which increased by 55 percent from 1995 to 2000, 
stabilized during 2001. Conversely, marijuana-
related hospital discharges climbed to their highest 
level in the 1995–2001 time period. Similar to 
marijuana, most cocaine indicators were stable or 
down slightly in the past 1½ years, with deaths, 
ADAM data, and treatment admissions remaining 
stable, while ED mentions and new users in 
treatment declined somewhat. The proportion of 
cocaine smokers entering treatment had been 
declining, but it increased slightly in the first half of 
2002. Curiously, this increase was attributable to 
Hispanic, rather than African-American, clients. A 
mixed pattern is also characteristic of heroin 
indicators, with hospital discharges and deaths 
increasing, ADAM data and ED mentions stable, 
and treatment admissions and new users in 
treatment down slightly. Also, heroin treatment 
client demographics have changed somewhat, with 
more White and younger users, but fewer 
Hispanics. Accompanying this has been a 
continuing small upward trend in the proportion of 
heroin smokers and inhalers. Finally, limited 
indicator data, a recent treatment study, data from 
the 2002 Colorado Youth Survey, and most 
anecdotal data point to an increasing club drug 
problem in Colorado, mostly among adolescents and 
young adults. 
 
INTRODUCTION 
 
Area Description 
 
Denver, the capital of Colorado, is located somewhat 
northeast of the State’s center. Covering only 111.32  
square miles, Denver is bordered by several large 
suburban counties: Arapahoe on the southeast, Adams 
on the northeast, Jefferson on the west, and Douglas on 
the south. This area constitutes the Denver primary 
metropolitan statistical area (PMSA). In recent years, 
Denver and the surrounding counties have experienced 
rapid population growth. According to the 1990 
census, the Denver PMSA population was 1,622,980. 
By the 2000 census, this had grown by 30 percent to 
2,109,282. In general, Colorado has been one of the 
top 5 fastest growing States in the Nation, with the 
population increasing from 3,294,394 in 1990 to 
4,324,920 in 2000, or by 31.3 percent. The Denver 
metropolitan area accounts for a large percentage of 
Colorado’s total population. 
 
Several considerations may influence drug use in 
Denver and Colorado: 
 
• Two major interstate highways intersect in Denver. 
 
• The area’s major international airport is nearly at 
the midpoint of the continental United States. 
 
• The remote rural areas are ideal for the undetected 
manufacture, cultivation, and transport of illicit 
drugs. 
 
• A young citizenry is drawn to the recreational 
lifestyle available in Colorado. 
 
• The large tourism industry draws millions of 
people to the State each year. 
 
• Several major universities and small colleges are 
in the area. 
 
• Colorado and the Denver metropolitan area, 
though prospering economically, have seen small 
increases in unemployment rates. Colorado’s un-
employment rate for September 2002 was 5.0 
percent, up from 3.9 in September 2001. Like-
wise, Denver’s unadjusted unemployment rate for 
September 2002 was 6.1 percent, compared with 
4.8 percent in September 2001. 
 
Data Sources 
 
Data presented in this report were collected and 
analyzed in October and November 2002. Although 
1
  The author is affiliated with the Alcohol and Drug Abuse Division, Colorado Department of Human Services. 
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these indicators reflect trends throughout Colorado, 
they are dominated by the Denver metropolitan area. 
 
• Qualitative and ethnographic data for this 
report are primarily from clinicians in treatment 
programs across the State, local researchers, and 
street outreach workers.  
 
• Drug-related emergency department (ED) 
mentions data for the Denver metropolitan area 
for 1994 through 2001 are provided by the Drug 
Abuse Warning Network (DAWN), Office of 
Applied Studies, Substance Abuse and Mental 
Health Services Administration (SAMHSA). 
 
• Hospital discharge data statewide for 1995–
2001 are available from the Colorado Hospital 
Association through the Colorado Department of 
Public Health and Environment (CDPHE), 
Health Statistics Section. Data included are 
diagnoses based on the International Classifi-
cation of Disease, Ninth Revision (ICD-9-CM) 
codes for inpatient clients at discharge from all 
acute care hospitals and some rehabilitation and 
psychiatric hospitals. These data do not include 
ED care.  
 
• Treatment data were provided by the Drug/ 
Alcohol Coordinated Data System (DACODS). 
Client reports are completed on clients at 
admission and discharge from all Colorado al-
cohol and drug treatment agencies receiving 
public monies. Annual figures are for 1996 
through the first half of 2002. DACODS data are 
collected and analyzed by the Alcohol and Drug 
Abuse Division (ADAD), Colorado Department 
of Human Services.  
 
• Availability, price, and distribution data are 
available from local Drug Enforcement Admin-
istration (DEA) Denver Division officials in their 
3rd quarter fiscal year (FY) 2002 report. Data 
from DEA’s Domestic Monitor Program (2001) 
are also reported. 
 
• Death statistics and communicable diseases 
data are from CDPHE for 1995– 2001. 
 
• Rocky Mountain Poison and Drug Center 
(RMPDC) data are presented for Colorado. The 
data represent the number of calls to the center 
regarding "street drugs" from 1994 through 2001. 
 
• Arrestee Drug Abuse Monitoring (ADAM) 
program data on arrestee urinalysis results are 
based on quarterly studies conducted under the 
auspices of the National Institute of Justice (NIJ). 
ADAM data in Colorado are collected and 
analyzed by the Division of Criminal Justice. In 
calendar year 2000, NIJ changed its procedures 
for covering adult male arrestees from conven-
ience to probability sampling. The female conven-
ience samples remain small and are not 
comparable to adult male data. Thus, no ADAM 
trend data are presented. Rather, 2001 and 2002 
(first two quarters) use percentages by drug type 
are indicated.  
 
• The Colorado Youth Survey (CYS) is an 
annual, statewide survey of 6th through 12th 
graders, with questions organized around risk and 
protective factors and drug use. The CYS was 
conducted in 1998, 2000, and 2002. The 2002 
sample included more than 26,000 students. 
 
• Acquired immunodeficiency syndrome (AIDS) 
data were provided by the CDPHE through 
September 30, 2002. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
Most cocaine indicators remained stable or declined 
in 2001 and the first half of 2002. Denver metro-
politan cocaine ED mentions per 100,000 population 
(exhibit 1), declined from 75 to 53 from 1995 to 1996 
and increased steadily to 87 in 1999. The rate 
declined slightly to 83 per 100,000 in 2000 and to 
only 69 per 100,000 for 2001. None of these changes 
was statistically significant. 
 
Also, statewide hospital discharge data (exhibit 2) 
showed that cocaine occurrences per 100,000 pop-
ulation increased from 55.3 in 1995 to 62.8 in 1998, 
but remained relatively stable through 2001 (63.2). 
 
In 1994 there were 71 calls to the RMPDC con-
cerning cocaine. The number dropped to 49 in 1995, 
remained at about that level through 1999, increased 
to 59 in 2000, and more than doubled to 127 in 2001.  
  
The proportion of cocaine treatment admissions has 
declined considerably over the past 6½ years (exhibit 
3). In 1996, primary cocaine abuse accounted for 
30.6 percent of all illicit drug abuse treatment 
admissions, compared with only 21.6 percent for the 
first half of 2002. 
 
Of the cocaine users entering treatment, the pro-
portion of “ new”  cocaine users, defined as those 
admitted to treatment within 3 years of initial cocaine 
use, remained relatively level from 1996, at 15.3 
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percent, to 2001, at 15.7 percent, but declined to 13.8 
percent during the first half of 2002 (exhibit 4).  
 
Treatment admissions data indicate that cocaine 
injecting has remained relatively stable, accounting 
for 11– 13 percent of admissions from 1996 through 
the first half of 2002. Smoking percentages declined 
steadily from 67.4 percent in 1996 to 57.9 percent in 
2001, but increased to 62.1 percent in the first half of 
2002 (the same proportion as in 1999). Conversely, 
inhalation steadily increased from 17.6 percent in 
1996 to 25.9 percent in 2001, but declined to 21.5 
percent in the first half of 2002.  
 
Curiously, a cross sectional analysis of route of drug 
administration by race/ethnicity reveals that the very 
recent increase in cocaine smoking is attributable to 
Hispanic rather than African-American clients. From 
1996 to 2001, the percentage of Hispanics who 
inhaled cocaine increased from 26.7 to 37.9 percent. 
However, in the first half of 2002, the percentage of 
Hispanics who inhaled dropped to only 27.2 percent. 
Conversely, the proportion of Hispanics smoking 
cocaine declined somewhat from 54.4 percent in 
1996 to 50.2 percent in 2001, but increased sharply to 
60.8 percent in the first half of 2002. On the other 
hand, the percentage of African-Americans smoking 
cocaine declined steadily from 89.5 percent in 1996 
to 78.5 percent in the first half of 2002, while the 
percentage inhaling cocaine increased from 6.1 
percent in 1996 to 12.8 percent in 2002. This 
occurrence may relate to the intertwining of crack 
and powder cocaine distribution networks (see 
discussion of cocaine trafficking below).  
 
In general, the race/ethnicity proportions for cocaine 
treatment admissions have been changing. Whites 
accounted for the largest percentage of cocaine 
admissions in the first half of 2002 (41.3 percent), a 
substantial decline from their proportion of total 
cocaine clients in 2001 (47.3 percent). Hispanic 
cocaine admissions increased dramatically from only 
17.5 percent in 1996 to a high of 28.8 percent in 
2000, but declined to 26.3 percent in 2001 and stayed 
at that level (26.4 percent) through the first half of 
2002. Conversely, African-American cocaine admis-
sions were nearly cut in half, dropping from 36.3 
percent in 1996 to only 19.7 percent in 2001; this 
proportion increased slightly to 22.7 percent in the 
first half of 2002.  
 
Likewise, there have been changes in the age cat-
egories of treatment admissions since 1996. In 1996, 
57 percent of cocaine admissions were younger than 
35; the proportion decreased to 45.2 percent in the 
first half of 2002. Conversely, cocaine admissions 
age 35 and older climbed steadily during the same 
time period, from 43.0 to 54.8 percent. Cocaine 
admissions remain predominantly male, with the 
proportion being relatively constant from 1996 (59.6 
percent) through the first half of 2002 (59.5 percent).  
 
Cocaine-involved deaths in the State climbed from 86 
in 1995 (23 per million) to a peak of 146 in 1999 (36 
per million). While cocaine-involved deaths declined 
to 116 in 2000 (27 per million), they increased again 
to 134 in 2001 (30.4 per million), the second highest 
number of deaths in the time period indicated.  
 
In recent ADAM data for samples of Denver 
arrestees, 35.4 percent of the adult males had 
cocaine-positive urine samples in 2000, as did 33.8 
percent in 2001. Among adult female arrestees, 46.5 
percent tested cocaine-positive in 2000, with 45.0 
percent testing positive in 2001. Provisional data for 
the first quarter of 2002 showed a substantial decline 
in positive cocaine urines for both males (27.1 
percent) and females (33.3 percent). However, these 
numbers substantially increased during the second 
quarter of 2002 to 33.7 percent of the weighted 
sample of males and 51.7 percent of the unweighted 
sample of females.  
 
The Denver Field Division of the DEA reports the 
substantial availability of cocaine hydrochloride 
(HCl) across the State in ounce, pound, and kilogram 
quantities. Mexican polydrug trafficking groups 
control the majority of cocaine distribution in the 
Denver metropolitan area through Hispanic, White, 
and African-American distributors. For the most part, 
cocaine is brought into Colorado in vehicles from the 
southwest border and southern California on 
interstate and local highway systems. Kilograms of 
cocaine are often sold in bricks covered in industrial 
tape. Smaller amounts of cocaine are usually 
packaged in zip-lock plastic bags with no special 
markings. The DEA also indicates that, despite 
declining use, crack cocaine availability remains 
stable in Colorado; suppliers continue to be street 
gangs in Los Angeles and Chicago. The crack is 
transported in passenger vehicles, commercial buses, 
or airlines from the aforementioned cities. Upper-
level crack organizations are primarily Mexican with 
gang affiliations and are intertwined with African-
Americans who control street-level distribution. 
 
The DEA reports current cocaine prices as follows: 
$17,000– $20,000 per kilogram (down from $20,000), 
and $500– $900 per ounce (down from $500– $1,100) 
in the Denver metropolitan area, with purity in the 30 
to 90 percent range; $15,000– $25,000 per kilogram, 
$500– $1,100 per ounce, and $100– $125 per gram (50 
percent purity) in Colorado Springs (south of Denver 
on the Front Range); and $21,000 per kilogram (60–
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70 percent purity) and $800– $1,000 per ounce (65–
85 percent purity) in Grand Junction (Western Slope 
of Colorado). Crack prices remain relatively stable at 
$900– $1,000 per ounce and $10– $20 per rock in 
Denver. 
 
Heroin 
 
For 2001 and the first half of 2002, most heroin 
indicators were mixed, with some increasing, some 
stable, and some declining.  
 
DAWN data show that the rate of heroin ED mentions 
per 100,000 population increased significantly from 
1994 (31) to 2001 (40) (exhibit 1). This rate declined 
slightly (3.9 percent) from 2000 to 2001.  
 
Conversely, hospital discharge data (exhibit 2) 
indicate that opiate (narcotic analgesics) occurrences 
per 100,000 population, dropped from 29.4 to 19.9 
from 1995 to 1996, and then climbed steadily to 50.8 
per 100,000 in 2001 (an overall increase of 73 
percent). 
 
Heroin-related calls to the RMPDC, which had been 
steady from 1994 (21 calls) to 1998 (22 calls), 
increased to 36 in 1999 but declined to only 12 in 
2000. However, in 2001, heroin-related calls in-
creased to the 1999 level of 36.  
 
Among Colorado treatment admissions (exhibit 3), 
the proportion and number of heroin admissions 
remained fairly stable from 1996 (15.1 percent) 
through 2000 (14.5 percent), with a slight decline to 
14.0 percent in 2001 and to 12.5 percent during the 
first half of 2002. Likewise, the proportion and 
number of new heroin users entering treatment, after 
increasing from 17.0 percent in 1996 to 18.7 percent 
in 2000, declined to 16.6 percent in 2001 and to 14.0 
percent in the first half of 2002 (exhibit 4).  
 
Like cocaine, there have also been some changes in 
the demographics of heroin users entering treatment. 
The proportion of female heroin admissions remained 
stable from 1996 (32.3 percent) through the first half 
of 2002 (31.6 percent). However, race/ethnicity pro-
portions changed during the same time period. 
Whites increased as a proportion of total admissions, 
from 57.6 percent in 1996 to 65.5 percent in the first 
half of 2002, while Hispanics decreased, from 29.4 
percent to 19.7 percent. Also, the 25-and-younger age 
group increased as a percentage of heroin admissions, 
from only 10.9 percent in 1996 to 16.9 percent in the 
first half of 2002.  
 
Accompanying the heroin client demographic 
realignments were small changes in route of 
administration, with heroin smoking and inhalation 
becoming more common. In 1996, only 5.9 percent 
of treatment admissions reportedly smoked or inhaled 
heroin, compared with 7.5 percent in 1997, 9.0 
percent in 1998, 8.5 percent in 1999, 10.2 percent in 
2000, 9.6 percent in 2001, and 12.1 percent in the 
first half of 2002.  
 
The heroin smoker, inhaler, and injector groups in 
treatment were distinctly different from one another 
demographically. The heroin smokers were much 
more likely to be White (78 percent) than inhalers (59 
percent) or injectors (62 percent). Also, smokers were 
younger than the other heroin users, with nearly 20 
percent being 25 or younger compared with 14 
percent of inhalers and 15 percent of injectors. 
Accordingly, more than three in five smokers abused 
heroin for 4 years or less, compared with only 41 
percent of inhalers and 31 percent of injectors. 
Gender differences were small, however, with 
females constituting 36 percent of the smokers, 32 
percent of inhalers, and 34 percent of injectors. 
Regarding educational levels, one-half of smokers 
had at least some college, compared with only 39 
percent of inhalers and 32 percent of injectors. Thus, 
not surprisingly, smokers were more likely to be 
employed full or part time (55 percent) than were 
inhalers (50 percent) or injectors (42 percent). 
Conversely, a much greater proportion of injectors 
had a prior arrest (48 percent) than did their smoking 
and inhaling counterparts (39 and 36 percent, 
respectively). Finally, smokers were somewhat more 
likely (78 percent) to live outside the city and county 
of Denver than inhalers (71 percent) or injectors (67 
percent). 
 
From 1990 through 1996, opiate-related deaths 
averaged 85 per year. However, this average in-
creased dramatically to 150 deaths per year from 
1996 through 2001, an increase of 76 percent. 
  
The 2000 ADAM data showed that 5.8 percent of 
females were opiate-positive, as were 3.4 percent of 
males. In 2001, 5.2 percent of males tested opiate-
positive. Only 2.4 percent of females tested positive 
for opiates in that year. Provisional data for the first 
two quarters of 2002 show a continuance of this 
seesaw pattern. In the first quarter of 2002, 1.9 
percent of females and 2.1 percent of males tested 
positives for opiates. However, in the second quarter, 
5.2 percent of females and 2.7 percent of males tested 
opiate-positive.  
 
The Denver DEA reports that heroin is widely avail-
able in the large metropolitan areas. In the Denver 
metropolitan area, the majority of heroin sales take 
place in the lower downtown area. Marketing is 
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controlled by Mexican nationals, who also control the 
street-level heroin market through small, autonomous 
distribution cells. Street-level heroin is usually 
packaged in balloons, plastic sandwich bags, or tin foil 
for gram and ounce quantities. Larger seizures have 
involved heroin wrapped in wax paper, further 
contained within foil paper and clear plastic wrap, and 
then flattened out to fit in hidden compartments. 
Street-level heroin is usually sold in grams priced at 
$100– $150, with ounces selling for $1,500– $3,000. 
The DMP buys reveal that the purity of Mexican 
heroin ranges from 8 to 64 percent (the average purity 
is around 18 percent). 
 
In Colorado Springs, quantities of heroin are selling 
for $1,800– $3,500 per ounce and $75– $300 per 
gram. The average purity is around 40 percent.  
 
Marijuana 
 
Most marijuana indicators were stable or decreasing 
for 2001 and the first half of 2002. 
 
From 1994 to 2001, the rate per 100,000 population 
of marijuana ED mentions increased significantly 
(92.5 percent) from 26 to 50 (exhibit 1). The 2001 
rate remained stable from 2000. However, marijuana 
hospital discharge occurrences per 100,000 pop-
ulation rose dramatically from 45.6 in 1995 to 62.5 in 
2001 (exhibit 2).  
 
Marijuana calls to the RMPDC were nearly non-
existent between 1994 and 1998, with only one or 
two per year. However, in 1999, 2000, and 2001, 
there were 47, 58, and 97 calls, respectively, related 
to the effects of marijuana use.  
 
The proportion of marijuana treatment admissions 
increased from 38.8 percent in 1996 to 43.7 percent in 
1999 (exhibit 3). However, after that time, the 
proportion declined slightly to 40.6 percent in 2001 
and to 39.1 percent in the first half of 2002. In general, 
marijuana users accounted for the largest proportion of 
all Colorado drug treatment clients since 1996. These 
increases may be partly related to users’ accounts of 
increased potency of marijuana and to a more casual 
attitude about marijuana use in society in general. 
 
The proportion of new users entering treatment for 
marijuana declined steadily from 1996 (35.8 percent) 
through 1999 (25.4 percent). This proportion climbed 
slightly to 29.9 percent in 2000, remained at that 
level (29.2 percent) during 2001, and dropped to 25.5 
percent in the first half of 2002 (exhibit 4).  
 
Data indicate only slight changes in the demographics 
of marijuana treatment clients. Race proportions re-
mained relatively stable from 1996 through the first 
half of 2001. Hispanics increased as a percentage of 
marijuana admissions, from 31.4 percent in 1995 to 
36.3 percent in 1999, but declined to only 26.1 percent 
through the first half of 2002. The proportion of 
Whites fluctuated only slightly from 1996 (57.3 
percent) through the first half of 2002 (53.8 percent). 
African-Americans constituted between 6.5 and 9.2 
percent of marijuana admissions between 1996 and 
2001, but rose to 10.7 percent in the first half of 2002, 
the highest proportion during the 6½-year time period. 
Male-to-female marijuana admission ratios remained 
at approximately 3 to 1 from 1996 to the first half of 
2002. There were also small changes in the marijuana 
age group proportions from 1996 through the first half 
of 2002. The proportion of those age 12– 17 decreased 
slightly from 41 percent in 1996 to 38.3 percent in 
2001, but dropped sharply to only 31.0 percent in the 
first half of 2002. Conversely, the proportion for the 
18– 25 age group, which fluctuated between 27 and 31 
percent from 1996 through 2001, increased to 33.2 
percent during the first half of 2002. Similarly, the 
proportion for the 26– 34 age group increased slightly, 
from 15.4 percent in 2001 to 17.9 percent in 2002, the 
highest percentage in the 6½-year time period. 
Likewise, the proportion of those age 35 and older, 
which increased from 12.4 percent in 1996 to 23.8 
percent in 1999 only to drop to 15.6 percent in 2001, 
increased to 18.0 percent in the first half of 2002.  
 
The 2000 ADAM data indicated that 40.9 percent of 
the adult male arrestee sample had marijuana-positive 
urine screens. Among females, 38.5 percent tested 
marijuana-positive. These percentages remained rel-
atively stable in 2001, with 40 percent of males and 
33 percent of females testing positive. In the first and 
second quarters of 2002, positive test proportions 
remained constant for males (41.5 and 38 percent, 
respectively) and females (33.3 and 31.3 percent, 
respectively).  
 
The Denver DEA reports that the most “ abundant 
supply of marijuana is Mexican grown and is 
trafficked into the area from the border areas of 
Texas, New Mexico, and Arizona by Mexican poly-
drug trafficking organizations. Vehicles with hidden 
compartments are used to transport shipments weigh-
ing from pound to multipound quantities.”  Mexican 
marijuana sells for $500– $800 per pound. The DEA 
also indicates that high tetrahydrocannabinol (THC), 
seedless marijuana from British Columbia, known as 
“ BC Bud”  or “ Triple A,”  continues to be increasingly 
available and popular in Colorado at prices of $600 
per ounce and $3,200– $4,000 per pound.  
 
Further, according to the DEA, locally grown mari-
juana is almost always grown indoors by independent 
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operators with grow equipment varying from basic to 
elaborate operations with sophisticated lighting and 
irrigation systems. Domestically grown marijuana 
prices range from $1,000 to $3,000 per pound and 
$200 to $300 per ounce. 
 
Stimulants 
 
While methamphetamine and other stimulant use in 
Denver and across Colorado has fluctuated from 
1996 through the first half of 2002, most indicators 
have increased during the last few years. 
  
Methamphetamine ED mentions per 100,000 pop-
ulation in Denver decreased from 9 in 1994 to only 5 
in 2001; this change was not significant (exhibit 1). 
Conversely, the rate of amphetamine ED mentions 
increased nearly 67 percent from 1994 to 2001, from 
13 to 21, but remained stable from 2000 to 2001. 
Amphetamine-related hospital discharge occurrences 
per 100,000 population also showed a fluctuating 
pattern from 1995 to 2001 (exhibit 2). However, 
overall amphetamine-related discharges increased 
during that time period, from 19.4 to 26.3 per 
100,000 population. 
  
Amphetamine-related calls (in the street drug cat-
egory) to the RMPDC decreased from 1994 (n=36) to 
1996 (16), but increased sharply in 1997 (38). While 
such calls dropped to only 11 in 1998, they 
rebounded sharply to 291, 269, and 581 in 1999, 
2000, and 2001, respectively.  
 
Methamphetamine treatment admissions have shown 
peaks and valleys over the past 6½ years (exhibit 3). 
Overall, they doubled from only 8.9 percent of illicit 
drug admissions in 1996 to 17.9 percent in the first 
half of 2002. Amphetamine admissions are typically 
only a fraction of those for methamphetamine. 
However, from 1996 to 2000, primary amphetamine 
admissions increased from 65 to 171, or from 0.5 
percent to 1.3 percent of all illicit drug treatment 
admissions, but declined slightly to 128 admissions 
(1.0 percent) during 2001 and to only 52 (1.0 percent) 
during the first half of 2002.  
  
In 1996, 25.8 percent of primary methamphetamine 
users entering treatment were new users (exhibit 4). 
This percentage rose to 30.5 in 1997. However, by 
the first half of 2002, the proportion of new users 
declined to only 18.6 percent.  
 
Injecting had been the most common route of 
administration for methamphetamine among primary 
methamphetamine admissions. However, the pro-
portion declined from 1996 (40.0 percent) to the first 
half of 2002 (30.6 percent), while smoking became 
increasingly common. In the first half of 2002, about 
52 percent of methamphetamine treatment admis-
sions smoked the drug, compared with only 22 
percent in 1996. 
 
Demographically, the methamphetamine smokers in 
treatment tend to be somewhat younger and more 
often Hispanic than their inhaling or injecting 
counterparts.  
 
Methamphetamine treatment admissions for the first 
half of 2002 remained predominately White (80.2 
percent), although the proportion of Hispanics 
increased from 6.9 percent in 1996 to 12.9 percent in 
the first half of 2002. Females accounted for slightly 
less than one-half of methamphetamine admissions in 
2001 and the first half of 2002 (45.9 and 47.3 
percent, respectively). In terms of age, from 1996 to 
the first half of 2002, those 25 and younger remained 
at about one-third of admissions, those age 26– 34 
declined from 40.0 to 32.1 percent of admissions, and 
those 35 and older have increased from about one-
fourth to one-third of methamphetamine admissions.  
 
Although amphetamine-related deaths in Colorado 
are far fewer than deaths involving opiates or 
cocaine, the number has increased sharply from only 
15 between 1994 and 1997 to 34 between 1998 and 
2001 (a 127-percent increase).  
 
According to ADAM data, only a small percentage of 
positive methamphetamine urine screens were 
reported in 2000. These involved 2.6 percent of the 
adult male arrestees. Among adult females, 5.3 
percent tested methamphetamine-positive. These 
figures changed only slightly in 2001 and the first 
quarter of 2002, with 3.4 and 4.3 percent of males, 
respectively, and 4.3 and 3.7 percent of females, 
respectively, testing positive for methamphetamine. 
However, in the second quarter of 2002, only 3.3 
percent of males had positive methamphetamine 
urines; 8.6 percent of females tested positive.  
 
The DEA describes widespread methamphetamine 
availability, with a majority of the drug originating in 
Mexico or in large-scale labs in California. The DEA, 
however, is making extensive lab seizures in the Rocky 
Mountain West (147 from April through June 2002). 
These labs, generally capable of manufacturing an 
ounce or less per “ cook,”  varied from being primitive to 
quite sophisticated. The ephedrine reduction method 
remains the primary means of manufacturing metham-
phetamine in the area. Most lab operators are able to 
get the precursor chemicals from legitimate businesses 
(e.g., discount stores, drug stores, and chemical supply 
companies). The average purity for methamphetamine 
is 8 to 12 percent. The DEA reports that Colorado 
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methamphetamine street prices are stable at $80– $110 
per gram and $700– $1,000 per ounce. 
  
Club Drugs 
 
Club drugs, a group of synthetic drugs commonly 
associated with all-night dance clubs called “ raves,”  
include methylenedioxymethamphetamine (MDMA, 
or ecstasy), gamma hydroxybutyrate (GHB), fluni-
trazepam (Rohypnol) (“ roofies” ), and ketamine 
(Special K).  
 
Information on use of these drugs in Colorado remains 
limited. While ADAD has added club drugs to an ex-
panded treatment client data set, the new information 
will not be available until early 2003. Also, hospital 
discharge and ADAM data have not routinely included 
separate breakout data for these drugs. However, there 
are currently two sources of institutional indicator data 
that include the club drugs— DAWN and the RMPDC. 
In addition, ADAD has worked with OMNI Research 
and Training, a Denver-based firm, to add club drug 
questions to the CYS. 
  
Additionally, in the summer of 2001, ADAD 
conducted a survey on club drug use among young 
adults and adolescents admitted to selected treatment 
programs across the State (N=782). Some results of 
this study are presented in this section along with 
DAWN, RMPDC, and CYS data. In addition, some 
anecdotal information on club drugs is presented 
from the DEA.  
 
MDMA 
 
The handful of MDMA-related calls to the RMPDC 
ranged from only 3 to 11 during the 1994 to 1999 
time period. MDMA ED mentions, however, jumped 
significantly from 2 in 1994, to 15 in 1999, to 57 in 
2000; they declined significantly to 42 in 2001. 
 
Exhibit 5 shows data from the 2002 CYS. As 
indicated, lifetime MDMA use was reported by 0.7 
percent of 6th graders, 1.1 percent of 7th graders, 3.0 
percent of 8th graders, 4.4 percent of 9th graders, 5.2 
percent of 10th graders, 10.8 percent of 11th graders, 
and 9.8 percent of 12th graders.  
 
In ADAD’s treatment survey sample of 782 clients, 
267 (34 percent) respondents reported lifetime use of 
ecstasy, with 4.5 percent having used it in the past 30 
days. The average age of the users was 17.3, and the 
average age of first use was 15.9.  
 
The above information does not come close to 
providing a complete view of MDMA prevalence in 
Colorado. The DEA reports that ecstasy has emerged 
as a popular drug in the Rocky Mountain region. It is 
readily obtainable by individuals at raves, nightclubs, 
strip clubs, and private parties. The traffickers are 
typically White and in their late teens or twenties and 
get their MDMA from Las Vegas, Nevada, and 
various cities in California and on the east coast that 
have source connections in Europe. The DEA places 
the one-tablet or capsule price at $15– $20, with 
larger quantities selling for $8– $12 per tablet.  
 
GHB 
 
During the 1994 to 1998 time period, the RMPDC 
reported only 1 to 6 calls about GHB. However, in 
1999, the number of GHB calls rose to 92. GHB ED 
mentions had also increased from 7 in 1997, to 13 in 
1998, to 71 in 1999. However, such mentions dropped 
significantly from 1999 to 2000 (N=43), and again 
from 2000 to 2001, when there were 16 mentions. 
 
In the 2001 CYS, lifetime GHB use was reported by 
0.4 percent of 6th graders, 0.6 percent of 7th graders, 
1.2 percent of 8th graders, 1.3 percent of 9th graders, 
1.5 percent of 10th graders, 1.4 percent of 11th 
graders, and 1.2 percent of 12th graders (exhibit 5).  
 
In ADAD’s treatment survey sample of 782 clients, 
73 (10.0 percent) respondents reported lifetime use of 
GHB, with 0.5 percent having used it in the past 30 
days. The average age of the users was 17.8, and the 
average age of first use was 16.1. 
 
The DEA reports that GHB is increasing in popu-
larity in Colorado and is readily available at raves, 
nightclubs, strip clubs, and private parties. The price 
is $5– $10 per dosage unit (i.e., one bottle capful). 
  
Rohypnol 
 
There does not appear to be widespread use of this 
drug among either the general population or those in 
the rave scene in Colorado. The number of calls 
received by RMPDC about this drug jumped from 1 
in 1994 and 1995 to 22 in 1998. However, such calls 
declined to only seven in 1999. Also, there were only 
two ED mentions from 1994 through 2001.  
 
In ADAD’s treatment survey sample of 782 clients, 
only 14 (2 percent) respondents reported lifetime use 
of Rohypnol, with 0.3 percent having used it in the 
past 30 days. The average age of the users was 19, 
and the average age of first use was 16. 
 
Ketamine 
 
The RMPDC did not report any ketamine calls from 
1994 to 1999. There were only three ketamine ED 
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mentions from 1994 to 1999. However, there were 12 
and 11 such mentions in 2000 and 2001, respectively. 
The increase from 1999 to 2001 was statistically 
significant. 
 
Interestingly, the CYS results indicated greater 
lifetime use of ketamine than GHB. As shown in 
exhibit 5, lifetime ketamine use was reported by 0.5 
percent of 6th graders, 1.0 percent of 7th graders, 1.7 
percent of 8th graders, 3.0 percent of 9th graders, 2.5 
percent of 10th graders, 4.8 percent of 11th graders, 
and 3.3 percent of 12th graders.  
 
In ADAD’s treatment survey, 139 (19 percent) client 
respondents reported lifetime use of ketamine, with 
2.2 percent having used it in the past 30 days. The 
average age of the users was 17, while the average 
age of first use was 15.6 years. 
Dextromethorphan (DXM) 
 
In ADAD’s treatment survey, 78 (11 percent) client 
respondents in 2001 reported lifetime use of DXM, 
with 2.2 percent having used it in the past 30 days. 
The average age of the users was 16, while the 
average age of first use was only 14.9. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
Of the 7,560 AIDS cases reported in Colorado 
through September 30, 2002, 9.0 percent were 
classified as injection drug users (IDUs), and 11.2 
percent were classified as homosexual or bisexual 
males and IDUs (exhibit 6). 
 
For inquiries concerning this report, please contact Bruce Mendelson, Colorado Department of Human Services, Alcohol and Drug Abuse 
Division, 4055 South Lowell Boulevard, Denver, Colorado 80236-3120, Phone: (303) 866-7497, Fax: (303) 866-7481, E-mail: 
<bruce.mendelson@state.co.us>. 
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Exhibit 1. Rates of DAWN ED Mentions Per 100,000 Population in the Denver Area for Selected 
Drugs:  1994–2001 
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SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
 
Exhibit 2. Colorado Hospital Discharge Mentions and Rates1 for Selected Drugs:  1995–2001 
 
Drug 1995 1996 1997 1998 1999 2000 2001 
Cocaine 
 (N) 
 Rate 
(2,070) 
55.3 
(2,255) 
59.0 
(2,245) 
57.7 
(2,492) 
62.8 
(2,517) 
62.3 
(2,732) 
63.2 
(2,787) 
63.2 
Marijuana 
 (N) 
 Rate 
(1,708) 
45.6 
(1,740) 
45.6 
(2,118) 
54.4 
(2,227) 
56.1 
(2,204) 
54.6 
(2,455) 
56.8 
(2,755) 
62.5 
Amphetamine 
 (N) 
 Rate 
(728) 
19.4 
(532) 
13.9 
(959) 
24.6 
(815) 
20.5 
(682) 
16.9 
(942) 
21.8 
(1,161) 
26.3 
Narcotic 
Analgesics 
 (N) 
 Rate 
(1,103) 
29.4 
(760) 
19.9 
(1,458) 
37.5 
(1,566) 
39.5 
(1,639) 
40.6 
(2,053) 
47.5 
(2,237) 
50.8 
Population 3,746,585 3,819,789 3,892,996 3,966,198 4,039,402 4,324,920 4,407,305 
 
1
 Per 100,000 population. 
 
SOURCES: Colorado Hospital Association and the Colorado Department of Public Health and Environment, Health Statistics 
Section 
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Exhibit 3. Treatment Admissions in Colorado by Primary Drug of Abuse and Percent: 
   1996–1H 20021 
 
Drug 1996 1997 1998 1999 2000 2001 2002 
Total Admissions (N) (12,991) (11,757) (14,301) (14,511) (13,109) (13,183) (6,529) 
Cocaine/crack 30.6 27.1 26.6 23.7 21.1 20.7 21.6 
Heroin 15.1 13.7 13.2 14.4 14.5 14.0 12.5 
Other opiates2 2.2 2.3 2.5 2.9 3.4 3.8 4.0 
Marijuana 38.8 37.9 39.8 43.7 42.5 40.6 39.1 
Methamphetamine 8.9 14.9 13.5 10.7 13.0 15.6 17.9 
Other stimulants 0.7 0.9 0.7 1.1 1.5 1.2 1.3 
Other drugs3 3.7 3.2 3.7 3.5 4.0 4.0 3.6 
 
1
 Excludes alcohol-only and alcohol-in-combination admissions. 
2 Includes a small percentage of nonprescription methadone admissions (0.1–0.3 percent per year). 
3 Includes hallucinogens, PCP, barbiturates, sedatives, tranquilizers, inhalants, and other drugs (each accounting for very small   
  percentages, usually less than 1 percent). 
 
SOURCE:  Drug/Alcohol Coordinated Data System 
 
 
 
Exhibit 4. Annual Number and Percentage of Cocaine, Heroin, Marijuana, and Methamphetamine 
 Users Entering Treatment in Colorado Within 3 Years of Initial Use:  1996–1H 2002 
 
Drug 1996 1997 1998 1999 2000 2001 2002 
Cocaine 
  (N) 
  Percent 
(599) 
15.3 
(433) 
14.0 
(587) 
15.8 
(516) 
15.5 
(447) 
16.5 
(418) 
15.7 
(193) 
13.8 
Heroin 
  (N) 
  Percent 
(328) 
17.0 
(262) 
16.6 
(362) 
19.6 
(356) 
17.6 
(352) 
18.7 
(301) 
16.6 
(113) 
14.0 
Marijuana 
  (N) 
  Percent 
(1,783) 
35.8 
(1,430) 
33.1 
(1,669) 
30.5 
(1,547) 
25.4 
(1,644) 
29.9 
(1,538) 
29.2 
(648) 
25.5 
Methamphetamine 
  (N) 
  Percent 
(296) 
25.8 
(514) 
30.5 
(517) 
27.3 
(312) 
20.5 
(347) 
20.5 
(406) 
20.0 
(217) 
18.6 
 
SOURCE:  Drug/Alcohol Coordinated Data System 
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Exhibit 5. Lifetime Use of Club Drugs Among 6th–12th Graders— Colorado Youth Survey:  2002  
 
MDMA Ketamine GHB Grade (N)1 (n Used) % Used (N)1 (n Used) % Used (N)1 (n Used) % Used 
6th 5,651 57 0.7 5,673 30 0.5 5,664 25 0.4 
7th 3,079 35 1.1 3,108 31 1.0 3,102 18 0.6 
8th 7,112 215 3.0 7,136 124 1.7 7,139 89 1.2 
9th 847 37 4.4 853 25 3.0 848 11 1.3 
10th 3,705 194 5.2 3,710 93 2.5 3,709 54 1.5 
11th 1,047 113 10.8 1,052 50 4.8 1,051 14 1.4 
12th 2,240 219 9.8 2,247 75 3.3 2,241 27 1.2 
 
1
 N=Total sample number. 
 
SOURCE:  Omni Research and Training 
 
 
 
Exhibit 6. Colorado Cumulative AIDS Cases by Demographic Category: Through September 30,  
 2002 
 
Category Number of Confirmed Cases Percent 
Total 7,560 100.0 
Gender 
 Male 
 Female 
 
6,999 
561 
 
92.6 
7.4 
Race/Ethnicity 
 White 
 African-American 
 Hispanic 
 Asian 
 Native American 
 
5,483 
852 
1,145 
30 
50 
 
72.5 
11.3 
15.1 
0.4 
0.7 
Exposure Category 
 Men/sex/men 
 Injection drug user (IDU) 
 MSM and IDU 
 Heterosexual contact 
 Other 
 Risk not identified 
 
5,138 
683 
843 
436 
184 
276 
 
68.0 
9.0 
11.2 
5.8 
2.3 
3.7 
 
SOURCE:  Colorado Department of Public Health and Environment 
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Drug Abuse Trends in Detroit/Wayne County and Michigan 
 
Richard F. Calkins1 
 
ABSTRACT 
 
Cocaine indicators continued to stabilize.  With 
increases in heroin ED mentions and heroin-
involved deaths, heroin indicators appeared to be 
increasing. Data on other opiates reflected increases 
in abuse, especially for hydrocodone. Marijuana 
continued to be the top illicit drug, but indicators 
remained stable. Indicators for methamphetamine 
and ecstasy showed increases, while indicators for 
abuse of GHB, ketamine, and Coricidin HBP showed 
some recent stabilizing or decreases. Twenty-nine 
percent of the cumulative AIDS cases in Michigan 
are among injection drug users. Hepatitis C cases 
showed a sharp increase in 2001. 
 
INTRODUCTION 
 
Area Description 
 
Detroit and surrounding Wayne County are located in 
the southeast corner of Michigan’s Lower Peninsula. 
In 2000, the Detroit/Wayne County population to-
taled 2.1 million residents and represented 21 percent 
of Michigan’s 9.9 million population.  
 
Currently, Michigan is the eighth most populous 
State in the Nation. The Detroit metropolitan area 
ranks 10th among the Nation’s major population 
centers. In 2000, the city of Detroit’s population was 
951,000. Michigan’s population increased by 6.9 
percent between 1990 and 2000. Population growth 
above the statewide average occurred among those 
age 10– 14 (12 percent), 15– 17 (8.5 percent), and 5– 9 
(7.6 percent). There was a net population loss among 
those younger than 5 (4.3 percent) by 2000 because 
of declining birth rates since the mid-1990s. The 
following factors contribute to probabilities of sub-
stance abuse in the State: 
 
• Michigan has a major international airport, with 
277,688 flights in 2000; 10 other large airports 
that also have international flights, with more than 
200,000 arrivals in 2000; and 235 public and 
private small airports. Long-term projections for 
the Detroit Metro airport forecast a 31-percent 
increase in flights during the next 10 years. 
The State has an international border of 700 miles 
with Ontario, Canada; land crossings at Detroit, Port 
Huron, and Sault Ste. Marie; and water crossings 
through three Great Lakes and the St. Lawrence 
Seaway, which connects to the Atlantic Ocean. 
Between Port Huron and Monroe, many places along 
the 85 miles of heavily developed waterway are less 
than one-half mile from Canada. Michigan has 
940,000 registered boats. In 2001, two major bridge 
crossings from Canada (Windsor Tunnel and 
Ambassador Bridge) had 7.9 million cars, 1.7 million 
trucks, and 93,000 buses cross into Detroit. Southeast 
Michigan, the busiest port on the northern U.S. 
border, had about 21 million vehicle crossings with 
Canada in 2000.  Detroit and Port Huron also have 
nearly 10,000 trains entering from Canada each year.  
The Foreign Mail Branch in Detroit processes 
250,000 foreign parcels and about 900,000 letter-
class pieces monthly. 
 
• Michigan’s numerous colleges and universities 
have many out-of-State or international students. 
 
• The State has a large population of skilled workers 
with relatively high income (especially in the 
automotive industry), as well as a large population 
with low or marginal employment skills. 
 
• There are chronic structural unemployment prob-
lems. Michigan has prospered in recent eco-
nomic periods, with low unemployment. As the 
national economy slowed in 2002, so did the 
Michigan economy. 
 
Data Sources 
 
Data for this report were drawn from the sources 
shown below. 
 
• Hospital emergency department (ED) drug 
mentions data through 2001 were obtained 
from the Drug Abuse Warning Network 
(DAWN), Office of Applied Studies, Substance 
Abuse and Mental Health Services Admin-
istration (SAMHSA).  
 
• Treatment admissions data were provided by 
the Division of Quality Management and Plan-
1
  The author is affiliated with the Office of Drug Control Policy, Michigan Department of Community Health, Lansing, Michigan. 
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ning, Michigan Department of Community 
Health (MDCH) for the State and Detroit/Wayne 
County, as reported by State and federally 
funded programs. Reporting practices, which 
changed on October 1, 1998, affect the capability 
to reliably track trends in client characteristics, 
drugs of abuse, and other data reported in 
admissions records. During fiscal year (FY) 
2001 and FY 2002, State reporting requirements 
were revised, which also challenged reporting 
continuity. The admissions volume reported has 
been declining over the past several years; it is 
difficult to identify whether changes in data 
reflect reporting practices or actual changes in 
the populations entering treatment, as all data is 
no longer reported. Software delays during FY 
2002 resulted in large volumes of unresolved 
errors in data submissions and an inability to 
produce data sets for analysis until yearend.  FY 
2002 data just recently became available for use 
in this report. 
 
• Drug-related mortality data were provided by 
the Wayne County Office of the Medical Exam-
iner (ME) and the MDCH. The Wayne County 
ME provided data on deaths with positive drug 
toxicology from 1995 through March 2002. 
These drug tests are routine when the decedent 
had a known drug use history, was younger than 
50, died of natural causes or homicide, was a 
motor vehicle accident victim, or there was no 
other clear cause of death. The MDCH provided 
statewide data on methamphetamines/stimulants. 
 
• Arrestee drug testing data were provided by 
the Arrestee Drug Abuse Monitoring (ADAM) 
program, National Institute of Justice (NIJ). The 
ADAM data are based on a sample of arrestees 
in Detroit/Wayne County, as collected by Mich-
igan State University. Data for 2000 are for adult 
arrestees and are based on a weighted sample for 
males and an unweighted sample for females. 
Data for 2001 are for the third and fourth 
quarters only and are limited to male arrestees. 
The ADAM sampling plan was revised in 1999 
and 2000, as directed by NIJ, in an effort to gain 
data that would be statistically representative of 
Wayne County arrestees. Earlier data were for 
city of Detroit arrestees only. Caution is 
suggested in making comparisons between 1999, 
2000, and 2001 findings.   The ADAM effort 
was discontinued at the end of 2001, and it is not 
clear if it will be resumed. 
• Drug price and purity data were provided by 
the Drug Enforcement Administration (DEA). 
Preliminary data on heroin purity in early 2001 
were from the DEA’s Domestic Monitor Pro-
gram (DMP). 
 
• Drug seizure data and trends were provided by 
the Michigan State Police and the U.S. Customs 
Service, as well as DEA and local police 
departments, for 2001 and 2002. 
 
• Drug distribution data, from the High Intensity 
Drug Trafficking Area, Investigative Support 
and Deconfliction Center, of Southeast Michigan 
(HIDTA– SEM), were derived from FY 2002 
Threat Assessment data. 
 
• Poison control case data were provided by the 
Children’s Hospital of Michigan Poison Control 
Center and represent contact data on cases of 
intentional abuse of substances through Sep-
tember 2002. This center is one of two in Mich-
igan; its catchment area is primarily eastern 
Michigan, although contacts can originate 
anywhere. 
 
• Drug-related infectious disease data were pro-
vided by the MDCH on the acquired immuno-
deficiency syndrome (AIDS) and human immuno-
deficiency virus (HIV) prevalence estimates as of 
July 1, 2002. Statewide data on hepatitis C trends 
were also provided by MDCH. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
Between 1994 and 1999, cocaine was the most 
frequent DAWN ED drug mention in Detroit metro-
politan counties (exhibits 1 and 2). The Detroit area 
rate of cocaine ED mentions per 100,000 population 
was 178 in 1999, 179 in 2000, and 186 in 2001. 
During 2000, the 7,870 cocaine mentions represented 
a slight but nonsignificant increase from 1999. Data 
for 2001 suggest there was a slight but nonsignificant 
decrease for the year compared with 2000. 
 
The typical cocaine ED case continued to be a male, 
age 35 or older, who went to the emergency depart-
ment seeking help for chronic effects or unexpected 
reaction and was treated and released in a multidrug-
involved episode.  There was a significant increase in 
cases among those age 45 and older between 1994 
and 2001. 
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Cocaine (including crack) has been the foremost 
primary illicit drug of abuse among admissions to 
State-funded treatment programs statewide since FY 
1986. During FY 2001, cocaine/crack remained the 
top illicit drug among statewide admissions, ac-
counting for 18 percent of total admissions. In FY 
2002, cocaine/crack accounted for 17 percent of 
statewide admissions. In Detroit/WayneCounty, co-
caine represented 28 percent of total admissions in 
FY 2001 and 26 percent in FY 2002.  It was 
exceeded only by heroin, which accounted for 34 
percent (FY 2001) and 29 percent (FY 2002) of total 
admissions.  
  
Cocaine (including crack) was involved (as either 
primary, secondary, or tertiary drug) in 35 percent of 
all treatment admissions statewide in FY 2002 and in 
52 percent of all admissions in Detroit/Wayne 
County. About one of every three cocaine-involved 
admissions statewide in FY 2002 was in Detroit/ 
Wayne County. 
 
The number of decedents with a positive drug 
toxicology for cocaine in Detroit/Wayne County 
were basically stable between 1995 and 1999, with 
plus or minus 1– 12-percent fluctuations year to year 
(exhibit 3). In 2000, there was a 16-percent increase 
in cocaine deaths over 1999. In 2001, cocaine deaths 
increased by less than 3 percent from 2000, to 406 
cases. In the first 9 months of 2002, 304 cocaine 
deaths were identified. At this rate, the yearend total 
will equal that of 2001. 
 
Prior to 2000, when ADAM began probability 
sampling of adult male arrestees, the proportion of 
males who tested positive for cocaine declined from a 
peak of 53 percent in 1987 to 27 percent in 1999. In 
2000, 24 percent of male arrestees (weighted Wayne 
County sample) tested cocaine-positive, while 42 
percent of female arrestees (unweighted Wayne 
County sample) tested cocaine-positive (exhibit 4). 
Weighted results for male arrestees in the third and 
fourth quarters of 2001 showed 22 percent were 
cocaine-positive. Among those who admitted to 
cocaine use in the month before their arrest, crack 
was used on about twice as many days (9.5 days) as 
cocaine powder (4.4 days). ADAM data collection 
ceased in 2002. 
 
Cocaine powder and crack availability, prices, and 
purity remained relatively stable. Ounce and kilo-
gram prices have been stable for at least the past 8 
years. The cost of crack rocks has now increased to 
as high as $50, with $10 the most common unit price 
in Detroit neighborhoods. Higher-priced units are 
more typical when sold to outsiders in Detroit, or 
when sold outside Detroit. Ounce amounts of cocaine 
and crack usually sold for the same price ($750–
$1,300) in 2001 in Detroit.  Small plastic bags (heat-
sealed or ziplock) or aluminum foil are now the most 
common packaging. 
 
Numerous organizations distribute cocaine in the 
metropolitan area and statewide, according to the FY 
2002 Threat Assessment by the HIDTA– SEM. The 
Detroit metropolitan area remains a source hub for 
other areas of Michigan and the larger Midwest. Gangs 
control a number of distribution points and are major 
suppliers to many markets, although it is reported that 
there is less organized street gang activity than in the 
past. 
 
The U.S. Customs Service in Detroit reported seizing 
161 kilograms of cocaine during the 6 months 
following September 2001, compared with 28 kilo-
grams in the previous 6 months. Michigan State Police 
have continued to make more large (multikilogram) 
seizures in the past several months in many urban areas 
outside Detroit, compared with earlier time periods. 
Some dealers reportedly have switched to selling 
marijuana because of the more severe criminal 
consequences for selling cocaine. 
 
Heroin 
 
ED mentions for heroin have trended gradually upward 
since 1994 (exhibits 1 and 2). In 1999, the Detroit 
metropolitan area rate of heroin mentions was 61.5 per 
100,000 population; in 2000, the rate was 75.8. In 
2001, the rate increased significantly to 93. The number 
of heroin ED mentions was 51 percent higher in 2001 
than in 1999. Heroin mentions increased significantly 
(by nearly 76 percent) between 1994 and 2001. 
 
The typical heroin ED case continued to be a male, 
age 45– 54, who sought help in an emergency 
department for chronic effects or unexpected reaction 
and was treated and released. Between 1994 and 
2001, there have been significant increases in females 
(more than doubling), in those age 20– 25, and in 
those older than 35. 
 
Heroin, as the primary drug among treatment admis-
sions in FY 2002, accounted for 29 percent of all 
admissions in Detroit/Wayne County and 12 percent of 
admissions statewide. The 4,138 admissions in 
Detroit/Wayne County involving heroin (as primary, 
secondary, or tertiary drug) accounted for 52 percent 
of the statewide total of 7,924 heroin-involved admis-
sions. One in three admissions in Detroit/Wayne 
County involved heroin, while heroin was involved in 
14 percent of all statewide admissions in FY 2002.  
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Heroin deaths have been steadily increasing in 
Detroit/Wayne County since 1992. In 1996, there 
were 240 heroin-present deaths; by 2000, the annual 
number had nearly doubled (exhibit 3). The 383 
deaths with heroin metabolites present in 1999 
represented a 24-percent increase from 1998, while in 
2000, heroin cases increased again, by 23 percent 
over the 1999 total. During 2001, the 465 heroin-
present deaths was a slight decrease from the 473 
deaths in 2000. During the first 9 months of 2002, 
381 heroin-present deaths were identified.  At the 
current rate, it is expected that heroin deaths could 
total more than 500 by the end of 2002.  There were 
at least two bodypacker fatalities in 2002. 
 
Since 1996, the Wayne County ME lab has tested 
decedents for 6-monoacetylmorphine (or 6-AM) to 
determine whether its presence parallels increases in 
heroin (morphine) positivity. Until nearly the end of 
2001, findings of 6-AM were at about one-half the 
level for heroin-present cases. Findings of this drug 
are most typical in decedents with more acute effects 
of heroin use. In late 2001 and the first 3 months of 
2002, there were roughly four heroin (morphine) 
cases for every one case of 6-AM.  In the 6 months 
from April through September 2002, there were 100 
findings of 6-AM and 269 findings of heroin 
(morphine); this is a ratio of about 37 percent of 6-
AM to heroin being present. 
 
Findings of heroin metabolites among urinalyses of city 
of Detroit adult arrestees were relatively stable from 
1995 to 1999, with 5– 9 percent of adult males and 9– 22 
percent of adult females testing opiate-positive (exhibit 
4). The female samples were relatively small, likely 
impacting year-to-year fluctuations. In 2000, 8 percent 
of a weighted sample of Wayne County adult male 
arrestees tested opiate-positive. Among adult females in 
2000, 24 percent of the unweighted Wayne County 
sample tested opiate-positive. Weighted results for 
male arrestees in the third and fourth quarters of 2001 
were stable, at 7 percent opiate-positive.  Just over 4 
percent of arrestees reported they used opiates in the 
month prior to their arrest, and the average number of 
days used was 11.8. 
 
Nearly all available heroin continued to be white in 
color. South America (Colombia) remains the 
dominant source, although in the past 3 years or so, 
heroin originating in both Southeast Asia and the 
Middle East has been identified. Heroin from these 
latter two sources was not very common between the 
mid-1990s and 2000.  Heroin originating in Mexico 
was available in some parts of Michigan outside the 
Detroit metropolitan area. 
 
Heroin street prices remained stable and relatively 
low in Detroit. Packets or “ hits”  available in Detroit 
are typically sold in $10-units, while outside the area 
individual units sometimes cost $15 or more. Price is 
also affected by whether the buyer is known to the 
seller, as well as whether the buyer and seller are of 
the same racial/ethnic origin. Bundles of 10 hits cost 
between $75 and $150. Packaging is often tinfoil; 
lottery papers; coin envelopes; balloons; fingers cut 
off from surgical gloves; or small plastic ziplock 
bags.  The practice of using brand names by dealers 
has reportedly declined greatly. 
 
According to the most recent information from the 
DEA, the average heroin price per pure milligram in 
the first half of 2001 was $0.95. Heroin purity, which 
had increased from the early 1990s to a peak of 
nearly 50 percent in 1999, was about 43 percent in 
the first half of 2001, with a range of 37– 72 percent 
per milligram pure. 
 
Other Opiates/Narcotic Analgesics 
 
In the Detroit area, indicators for opiates and 
narcotics other than heroin remained lower than those 
for cocaine and heroin, continuing a long-term trend 
since the early 1980s. Codeine and its prescription 
compounds (Schedule III and IV drugs) remained the 
most widely abused other opiates; codeine indicators 
were stable. However, there were further increases in  
hydrocodone (typically Vicodin, Lortab, or Lorcet) 
use, while indicators for carisoprodol (Soma) and 
oxycodone (OxyContin) appeared to be more stable. 
These drugs are available in myriad combinations 
that involve other drugs in the formulation of the pill 
or capsule. 
 
Other opiates, as primary drugs among treatment 
admissions in FY 2002, were reported for 284 cases 
in Detroit/Wayne County and 1,930 cases statewide.  
Other opiates (as primary, secondary, or tertiary 
drugs) were involved in 7 percent of statewide 
admissions and in 6 percent of Detroit/Wayne County 
admissions in FY 2002.  The other opiates-involved 
admissions in Detroit/Wayne County accounted for 
one of every five statewide other opiates-involved 
admissions during this time period.  
 
Toxicology findings from the Wayne County ME lab 
showed 225 cases of codeine positivity in the 12 
months between April 2001 and April 2002, compared 
with 121 cases from April through September 2002. 
 
Hydrocodone and hydrocodone/combinations began 
to appear in southeast Michigan hospital ED drug 
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mentions in 1994, with sharp and significant 
increases in 1998 (185 mentions), 1999 (238), 2000 
(371), and 2001 (483) (exhibit 1). There was a 443-
percent increase in hydrocodone mentions between 
1994 and 2001. This drug was identified by the 
Wayne County ME lab in 60 decedents in 2000, 80 in 
2001, and 66 in April– September, 2002. Information 
from the Children’s Hospital of Michigan Poison 
Control Center on intentional hydrocodone abuse 
cases for 2001 identified about 40 cases; about one-
half were female. In the first 9 months of 2002, 39 
cases of intentional hydrocodone abuse were reported 
to the poison control center. 
 
Carisoprodol was identified in 20 Wayne County 
decedents in 2000, 30 in 2001, and 15 in the 6 
months between April and September 2002. There 
were 21 cases of intentional carisoprodol abuse 
reported to the poison control center during the first 9 
months of 2002.  
 
The most recent revised southeast Michigan ED drug 
mentions data from DAWN show 21 oxycodone/ 
combinations mentions in 1996, 15 in 1997, 19 in 
1998, 17 in 1999, and 45 in both 2000 and 2001.  
Since about 2000, oxycodone (OxyContin) has been 
increasingly reported by law enforcement agencies in 
arrests, primarily in the western and northern lower 
Michigan areas, but more recently all over the State. 
It has been reported that it is not uncommon for 
persons in emergency departments to ask specifically 
for this drug for various ailments. Pharmacy break-
ins specifically related to this drug continued to be 
reported. Oxycodone was found in 10 decedents in 
Wayne County in 2000, 13 in 2001, and about this 
same number in 2002. It was involved in five 
intentional abuse cases reported to Children’s 
Hospital of Michigan Poison Control Center in the 3-
month period between July 1 and October 1, 2001; 
four of these cases involved female teens. Ten cases 
were reported to the poison control center in the first 
9 months of 2002. OxyContin pills sell for $0.50–
$1.50 per milligram. More than 50 arrests were made 
by Michigan State Police in the first 9 months of 
2002. Some oxycodone reportedly is being smuggled 
from Canada. 
 
Methadone was found in 35 decedents in Wayne 
County between April and September 2001, in 26 
decedents between October 2001 and March 2002, and 
in 36 decedents between April and September 2002. 
 
Marijuana 
 
Marijuana indicators either stabilized or increased. 
Mexican marijuana continued to be the dominant form 
available. 
Detroit metropolitan area ED marijuana data show a 
steady increasing trend since 1994, with some 
fluctuations in a few years (exhibits 1 and 2). In 1999, 
the case rate for marijuana mentions per 100,000 
population was 95; in 2000, the case rate was 99, while 
in 2001 the case rate was 121. Although this was an 
increase (paralleled by the number of marijuana 
mentions over this same time period), it was not sig-
nificant. However, there has been a significant increase 
in marijuana mentions among females since 1994.  
 
Treatment admissions during FY 2002 in Detroit/ 
Wayne County for marijuana as primary drug totaled 
1,105. For this same period statewide, there were 
8,834 marijuana admissions as primary drug.  
Marijuana was involved (as primary, secondary, or 
tertiary drug) in 40 percent of statewide admissions 
and in 31 percent of Detroit/Wayne County 
admissions in FY 2002.  The Detroit/Wayne County 
marijuana-involved admissions accounted for about  
one of every six (17 percent) statewide marijuana-
involved admissions in FY 2002. 
 
Marijuana-positive drug test findings among Detroit 
arrestees since 1995 were relatively stable, but 
showed a slight increase (exhibit 4). Between 1995 
and 1999, 42– 48 percent of the adult males arrested 
in Detroit were marijuana-positive, as were 16– 28 
percent of the adult females. In Wayne County in 
2000, one-half of the weighted sample of male 
arrestees and 24 percent of the unweighted sample of 
female arrestees were marijuana-positive. Weighted 
results for male arrestees in the third and fourth 
quarters of 2001 were stable, with 48 percent testing 
marijuana-positive. This same percentage of arrestees 
admitted use in the month before their arrest, and the 
average number of days used was 10.9. 
 
The majority of marijuana seized in Michigan orig-
inate in Mexico, with some of it passing through the 
United States and into Canada, where it is then 
repackaged into smaller amounts and brought back 
into the United States. The U.S. Customs Service 
seized about five times as much marijuana (1,782 
kilograms) in the 6 months after September 2001 
than in the previous 6 months (351 kilograms).  The 
U.S. Customs Service also reported sharp increases in 
seizures in hydoponically grown marijuana from 
Canada, which was being smuggled by Asian 
organized crime operations. 
 
Stimulants 
 
Indicator data showed increasing levels of meth-
amphetamine abuse in the State, mostly in the south-
western corner of lower Michigan. A Methamphet-
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amine Strategy has been developed to address the 
situation, and it is beginning to be implemented. 
 
Southeast Michigan DAWN ED drug mentions for 
methamphetamine declined to near zero from 1996 to 
2000 and remained at that level in 2001 (exhibit 1). 
Between 1992 and 1996, there were increases in 
amphetamine mentions, but they declined after 1996 
and then increased (nonsignificantly) in 2001. It is 
suspected that much of the reported amphetamine 
mentions may actually be methamphetamine. 
 
Methcathinone (“ cat” ), an easily manufactured 
stimulant, was identified in Michigan’s Upper Penin-
sula around 1990; an epidemic ensued until about 
1994, when no further labs were found. A trickle of 
reported admissions to treatment involving this drug 
continued; there were 9 primary methcathinone admis-
sions statewide in FY 2000, 4 in FY 2001, and 10 in 
FY 2002. Eight of the 10 cases in FY 2002 were 
admitted in southeast Michigan. 
 
In FY 2002, there were 280 primary methamphet-
amine admissions statewide, with 5 in Detroit/Wayne 
County. The 280 methamphetamine admissions in 
FY 2001 lived in 43 of the 83 counties in Michigan, 
mostly in rural areas, with more admissions in 
western and southern counties; 5 lived in Detroit/ 
Wayne County. Upper Peninsula residents accounted 
for 10 of the 280 methamphetamine admissions in 
FY 2002.  
 
Among primary drug methamphetamine admissions 
statewide in FY 2002, smoking was reported by 
almost one-half (43 percent), followed by inhalation 
(33 percent), oral (17 percent), and injection (eight 
percent) as the route of administration. 
 
Mortality data from the Wayne County ME lab show 
two methamphetamine-positive cases among dece-
dents between April and September 2001, one case 
between October 2001 and March 2002, and four 
cases between April and September 2002.  
 
A special analysis of statewide death certificate data 
conducted by MDCH Vital Statistics found 35 deaths 
in which involvement of amphetamines or stimulants 
was mentioned in both 1999 and 2000, compared 
with 20 in 1998 and 17 in 1997.  In 2001, there may 
have been 19 such deaths, but this is difficult to 
determine, as the coding structure available to report 
this drug is complex and covers a wide variety of 
other drugs as well. There were three reported 
methamphetamine overdoses during  2001. 
No methamphetamine has been found in drug testing 
of Detroit or Wayne County arrestee samples since 
the testing effort began. 
 
Michigan’s border with Canada has been the focus of 
efforts to stop the flow of large amounts of pseudo-
ephedrine and ephedrine into the United States. 
These imports are the necessary ingredients for 
making methamphetamine and have been destined 
for the Western United States and Mexico. Inten-
sified efforts by law enforcement after the September 
11, 2001, terrorist attacks resulted in the indictment 
of numerous individuals and seizures of millions of 
pseudoephedrine dosage units. One such seizure in 
June 2002 involved 21 million tablets. The U.S. 
Customs Service in Detroit reported seizures of more 
than 10,000 kilograms of pseudoephedrine in the 6 
months after September 2001, compared with 50 
kilograms in the previous 6 months. Multimillion 
tablet seizures are now commonplace. 
 
Michigan State Police reported seizing 40 metham-
phetamine labs in 2000 (all outside Detroit), 
compared with 14 labs in 1999. During 2001, 91 labs 
were seized by the Michigan State Police, and 120 
were seized by the State Police, DEA, and local 
departments combined. At least three labs have been 
found in the Upper Peninsula, where none were 
found in 2000. Environmental cleanups are an 
increasing problem. At least three labs exploded and 
burned in 2001, causing serious injuries. Most of the 
lab seizures have been in southwestern lower 
Michigan (particularly Allegan, Van Buren, and 
Barry Counties). Through October 2002, Michigan 
State Police had seized 172 labs; at this rate, the year-
end total will easily be double that of 2001.  At least 
three labs were seized in southeast Michigan to date 
in 2002. Some methamphetamine in pill form was 
reported in parts of Michigan in 2002. 
 
Michigan has a long history of high per capita 
distribution of methylphenidate (Ritalin). According 
to the DEA, Michigan ranks third per capita in 
distribution, with the amount of this drug distributed 
increasing by 45 percent since 1998. Consequently, 
distribution is 60 percent higher in Michigan than the 
national average for all States. Indicators show little 
evidence of intentional abuse, yet anecdotal reports 
of such cases continue.  There has been some recent 
efforts by the State legislature to reduce the emphasis 
of reliance on methylphenidate to deal with behavior 
difficulties in children. 
 
Khat, a plant grown in the Middle East that must be 
freshly harvested to produce its desired stimulant 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Detroit/Wayne County and Michigan 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 72
effects, continued to be seized in quantity at Mich-
igan airports. At least one smaller northern Lower 
Peninsula airport encountered several shipments. 
 
Depressants 
 
All indicators are relatively stable for depressants. 
 
Depressant treatment admissions in FY 2002 remained 
low in relation to those for alcohol, cocaine, heroin, and 
marijuana. Such admissions typically involved benzo-
diazepines or sedatives/hypnotics. Barbiturates or 
tranquilizers were reported less often. Depressants 
remained more often involved as secondary or tertiary 
drugs among treatment admissions. 
 
Hallucinogens 
 
Lysergic acid diethylamide (LSD) continued to be 
sporadically reported, and use remained relatively 
low. LSD is generally limited to high-school-age 
suburban and rural youth. Dose forms are primarily 
paper cutouts of various designs. Recently, however, 
there was a report of a liquid form (sold in breath 
drop bottles) and a geltab form.  
 
Hospital ED mentions for hallucinogens have been 
declining overall since about 1995 (exhibit 1). In 
2001 there was a slight but nonsignificant increase in 
PCP mentions. 
 
During FY 2002, there were 63 hallucinogen treat-
ment admissions as primary drug statewide, with 8 of 
these cases involving phencyclidine (PCP).  
 
Law enforcement sources noted more LSD activity 
recently in northern lower Michigan, and recent 
school survey data suggested that use may be higher 
in this area than in other parts of the State. 
 
Club Drugs 
 
This category of drugs includes ecstasy, gamma 
hydroxybutyrate (GHB), flunitrazepam (Rohypnol), 
and ketamine. Indicators increased for ecstasy, stabi-
lized for ketamine, and declined for GHB. There is 
still no information from any source or indicator data 
to suggest that flunitrazepam is being used in 
Michigan. 
 
The drug known as ecstasy is typically methylene-
dioxymethamphetamine (MDMA) or methylene-
dioxyamphetamine (MDA). Both drugs have been 
identified in lab testing of ecstasy samples, some-
times in combination. There have been many 
anecdotal reports of widespread and increasing use 
since about 1997, but these drugs rarely appear in 
traditional indicators identifying abuse. Ecstasy users 
are typically college students or young professionals, 
often in dance settings. Many urban and suburban 
areas outside Detroit are noted as having significant 
ecstasy use. 
 
Southeast Michigan ED drug mentions first began to 
reflect MDMA use in 1998, with six mentions 
reported (exhibit 1). MDMA mentions rose to 40 in 
1999 and 60 in 2000. The change between 1998 and 
2000 represented a 900-percent increase. Data for 
2001 show 111 MDMA mentions, a significant 
increase from 1999.  
 
During FY 2002, there were 158 ecstasy-involved (as 
primary, secondary, or tertiary drug) treatment ad-
missions statewide; 31 of these occurred in Detroit/ 
Wayne County. It was more common that ecstasy 
would be the tertiary or secondary drug than the 
primary drug involved among those seeking treatment. 
 
The Children’s Hospital of Michigan Poison Control 
Center received reports of 16 cases involving ecstasy 
in the 3-month period between July 1 and October 1, 
2001; cases were equally divided among males and 
females and ranged in age from 13 to 31. In the first 9 
months of 2002, there were 32 cases of intentional 
ecstasy abuse; half were younger than age 20. 
 
The Wayne County ME lab identified one MDMA/ 
MDA death in 1998, two in 1999, and three in 2000. 
Two cases were found among decedents between 
April and September 2001; one was a homicide 
victim. Three cases were found in the first 9 months 
of 2002, with homicide as the cause of death. 
Multiple drugs were found in all of these cases. 
 
Ecstasy, sold in various colored and often stamped 
pill forms, has been seized throughout Michigan. 
Sources remain Western Europe and Canada (where 
it is rumored that labs are operating in Quebec or 
Ontario).  More recently, there were reports that this 
drug is being made in Michigan. Wholesale prices 
can be as low as $10 per pill for quantities of 500 via 
Canada. Terms such as “ jars”  (usually 100 pills) and 
“ buckets”  (up to 1,000 pills) continued to be used in 
the distribution chain. U.S. Customs Service seizures 
at the airports and the border were 14,145 pills in 
1998, 42,000 in 1999, 131,000 in 2000, and almost 
400,000 in 2001. Projections for 2002 were that the 
U.S. Customs Service in Detroit would have seized 
1.2 million ecstasy pills by the end of the year.   
 
Since 1998, there have been several indicators of 
increasing ketamine use. Break-ins to veterinary 
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clinics have continued (but these may be slowing 
recently) in efforts to obtain this drug. The Children’s 
Hospital of Michigan Poison Control Center was 
consulted on three cases of hospitalization involving 
ketamine during the first 6 months of 2001. Five 
cases of intentional ketamine abuse were reported to 
the poison control center during the first 9 months of 
2002. There were 11 ketamine-involved treatment 
admissions statewide in FY 2002. 
 
GHB and GBL abuse began to be reported in about 
1997, with the number of ED mentions and poison 
control case reports peaking in about 1999. Use has 
been primarily at nightclubs (recent use appears to be 
more confined to gay scenes) and private parties. ED 
mentions of GHB totaled 45 in 1999, 22 in 2000, and 
31 in 2001 (exhibit 1). The Children’s Hospital of 
Michigan Poison Control Center GHB case reports 
totaled 100 in 1999, about 35 in 2000, and about one-
half that many in 2001. In the first 9 months of 2002, 
Children’s Hospital of Michigan Poison Control 
Center was notified of only seven cases of intentional 
GHB abuse. It is believed that GHB is now being 
underreported to this source.  During FY 2002 there 
were 4 admissions to treatment in Michigan involving 
GHB as the primary drug and 12 total cases in which 
GHB was involved. 
 
Other Drugs 
 
Nitrous oxide reportedly continued to be used at 
private parties and dance venues; most often it was 
combined with a variety of other drugs, primarily 
ecstasy. 
 
Inhalants continued to be reported as commonly 
used, mostly by teens and young adults. Paint, 
furniture polish, and cleaning products were the most 
common inhalants, and males and females were 
equally likely to be inhalant users. 
 
Intentional abuse of Coricidin HBP, the over-the-
counter cold and flu medicine, increased in case 
reports to Children’s Hospital of Michigan in 2000 
and 2001. These tablets contain dextromethorphan. 
Multiple tablets are taken for a dissociative effect; 
use of up to 40 pills at a time has been reported. 
During 2000, 44 Coricidin HBP cases were reported 
to the poison control center, while in the first 10 
months of 2001, at least 52 cases involved this drug. 
Most cases were teens, and nearly two of every three 
cases were male. About two of every three cases 
required hospitalization. In the first 9 months of 
2002, 54 intentional Coricidin abuse cases were 
reported to the poison control center.  
 
Abuse of cough syrup (also containing dextrometh-
orphan) continued to be noted. Shoplifting is report-
edly a common way of obtaining the substance. 
 
More than one in three (38 percent) male arrestees 
participating in the ADAM survey in the second half 
of 2001 in Detroit/Wayne County reported heavy use 
of a NIDA-5 drug (those tested for), and this same 
proportion was found to be at risk for drug 
dependence.  More than one in four male arrestees 
were found to be at risk for alcohol dependence.  
Slightly more than 8 percent reported that they had 
participated in a drug treatment program in the year 
before arrest. 
  
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
HIV/AIDS 
 
Michigan ranks 17th among all States, with an AIDS 
case rate of 113.9 per 100,000 population. As of July 
1, 2002, a cumulative total of 12,232 cases of AIDS 
had been reported in Michigan. Only 2 of Michigan’s 
83 counties have no reported AIDS cases.  
 
Injection drug users (IDUs) continued to account for 
29 percent of total AIDS cases; 22 percent have only 
this risk factor and 7 percent are IDUs who also have 
male-to-male sex as a risk factor.  
 
Of the 8,358 male cases currently living with AIDS 
or HIV, 14 percent are IDUs and 7 percent are in the 
dual risk group. 
 
Among the 2,442 females living with AIDS or 
HIV, 31 percent are IDUs, 40 percent were infected 
through heterosexual contact, and 26 percent have 
undetermined risk factors. 
 
Statewide, HIV prevalence is now estimated at a 
maximum of 3,260 IDUs and 1,090 IDUs who also 
engage in male-to-male sex. The total HIV 
prevalence estimate for Michigan increased from 
15,300 cases to 15,500 cases. 
 
Hepatitis C 
 
Hepatitis C cases reported to the MDCH communi-
cable disease surveillance system began to show 
increases in 1998, with 464 cases, compared with 362 
cases in the prior year. In 1999, total cases increased 
by 72 percent to 798. In 2000, cases again increased 
sharply to 2,754, a 245-percent increase from 1999. 
In 2001, there were a total of 4,594 cases, almost 
double that of the prior year. 
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Syphilis 
 
There has been a significant primary syphilis out-
break in Detroit, with increases in cases reported each  
year since 1997. About 500 new cases were expected 
during 2002. Inadequate outreach and followup have 
been cited as contributing to increased syphilis cases. 
 
 
For inquiries concerning this report, please contact Richard Calkins, Michigan Department of Community Health, Office of Drug Control Policy, 
Lewis Cass Building, 2nd Floor, 320 South Walnut Street, Lansing, Michigan 48913-2014, Phone: 517-335-5388, Fax: 517-373-2963, E-mail: 
<calkinsr@michigan.gov>. 
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Exhibit 1. Estimated Number of ED Drug Mentions in a Seven-County Area in Southeast  
 Michigan:  1994–20011  
 
Drug Mentions 1994 1995 1996 1997 1998 1999 2000 2001 
  Alcohol-in-combination 
  Cocaine 
  Heroin/morphine 
  PCP/PCP combinations 
  LSD 
  Amphetamine 
  Methamphetamine/speed 
  Marijuana/hashish  
  GHB 
  Ketamine 
  MDMA (ecstasy) 
  Rohypnol 
  Hydrocodone/combinations 
7,220 
8,268 
2,160 
26 
99 
305 
17 
2,955 
... 
- 
... 
- 
89 
8,379 
8,763 
2,390 
56 
143 
292 
15 
3,875 
        0 
        0 
        0 
        0 
    129 
9,087 
10,435 
3,188 
21 
57 
440 
... 
4,210 
... 
0 
0 
0 
165 
7,984 
8,093 
3,028 
19 
74 
359 
... 
3,742 
... 
... 
... 
0 
160 
7,992 
8,617 
2,879 
20 
27 
362 
0 
4,335 
11 
... 
6 
0 
185 
7,199 
7,699 
2,653 
24 
63 
178 
... 
4,100 
45 
... 
40 
0 
238 
8,447 
7,870 
3,328 
21 
35 
... 
... 
4,344 
22 
… 
60 
0 
371 
9,109 
7,730 
3,8702 
38 
15 
437 
... 
5,017 
31 
12 
111 
0 
483 
Drug Episodes 17,653 18,626 20,796 17,604 17,477 16,125 17,042 19,265 
Total Drug Mentions 31,633 34,152 38,952 32,487 32,582 30,207 32,740 37,164 
Total ED Visits (in 1,000s) 1,436   1,513 1,537 1,449 1,461 1,481 1,474 1,583 
Drug Episodes (rate/100,000) 432   451 498 417 409 374 388 463 
Drug Mentions (rate/100,000) 775   828 933 770 763 700 746 893 
 
1
 Dots (… ) indicate that an estimate with a relative standard error greater than 50 percent has been suppressed. 
2
 Heroin excludes a small, but unknown, number of morphine/combinations mentions, which have been moved to the narcotic  
  analgesics category during this time period. 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
Exhibit 2. Estimated Rates of ED Drug Mentions and Episodes by Age Group in a Seven-County  
 Area in Southeast Michigan:  1994–2001 
 
Rate1 1994 1995 1996 1997 1998 1999 2000 2001 
Total Drug Episodes 432 451 498 417 409 374 388 463 
Total Drug Mentions 775 828 933 770 763 700 746 893 
 Cocaine Mentions 203 212 250 192 202 178 179 186 
 Heroin Mentions 53 58 76 72 67 62 76 93 
 Marijuana Mentions 72 94 101 89 101 95 99 121 
Episodes by Age Group         
 6–17 130 132 130 97 87 87 90 119 
 18–25 610 616 586 558 532 448 445 512 
 26–34 772 770 842 656 645 554 557 692 
 35–44 400 440 514 439 437 414 440 821 
 45–54 352 399 492 463 496 519 5682 7362 
 55 and older 62 68 73 80 80 80 933 1323 
 
1
 All rates are per 100,000 population. 
2
 Represents a 109.1-percent increase from 1994 to 2000, and a 41.8-percent increase from 1999 to 2001. 
3
 Represents a 112.8-percent increase from 1994 to 2000, and a 63.8-percent increase from 1999 to 2001. 
 
SOURCE:  DAWN, OAS, SAMHSA 
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Exhibit 3. Detroit/Wayne County Positive Drug Toxicology Cases Involving Heroin or Cocaine as  
 an Independent Cause of Death:  1995–September 2002   
 
Month  1995 1996 1997 1998 1999 2000 2001 20021 
January Heroin 
Cocaine 
16 
31 
21 
36 
17 
29 
21 
32 
23 
21 
43 
39 
52 
50 
29 
25 
February Heroin 
Cocaine 
14 
23 
16 
29 
27 
33 
26 
27 
31 
20 
37 
27 
40 
36 
35 
28 
March Heroin 
Cocaine 
11 
28 
13 
15 
13 
29 
21 
27 
41 
33 
34 
38 
45 
39 
48 
32 
April Heroin 
Cocaine 
12 
25 
11 
33 
24 
29 
23 
35 
29 
34 
42 
24 
38 
32 
41 
37 
May Heroin 
Cocaine 
19 
36 
10 
19 
14 
22 
16 
32 
28 
33 
56 
46 
33 
27 
41 
29 
June Heroin 
Cocaine 
25 
31 
25 
32 
24 
30 
33 
38 
40 
32 
42 
32 
36 
30 
43 
38 
July Heroin 
Cocaine 
25 
27 
21 
32 
30 
26 
21 
32 
30 
25 
44 
36 
46 
42 
51 
33 
August Heroin 
Cocaine 
13 
14 
23 
29 
27 
28 
25 
25 
29 
31 
35 
36 
46 
36 
47 
44 
September Heroin 
Cocaine 
12 
16 
18 
25 
33 
22 
29 
37 
31 
21 
23 
24 
32 
24 
46 
38 
October Heroin 
Cocaine 
16 
29 
29 
34 
27 
32 
27 
33 
37 
35 
39 
26 
47 
42  
November Heroin 
Cocaine 
21 
29 
20 
28 
27 
28 
32 
32 
41 
32 
40 
35 
23 
22  
December Heroin 
Cocaine 
19 
28 
33 
37 
24 
36 
35 
35 
23 
25 
38 
33 
27 
26  
Total Heroin 
Cocaine 
203 
317 
240 
349 
287 
344 
309 
385 
383 
342 
473 
396 
465 
406  
 
1
 The 2002 data are for the first 9 months.  Annual projections are 508 cases for heroin and 405 cases for cocaine. 
 
SOURCE:  Wayne County Office of the Medical Examiner 
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Exhibit 4. Percentages of Adult Arrestees Testing Positive for Cocaine, Opiates, and Marijuana in  
  Detroit1:  1995–2001 
 
Drug/Year Males Positive Females Positive 
Cocaine 
 1995 
 1996 
 1997 
 1998 
 1999 
 20002 
 20013 
 
30 
27 
23 
28 
27 
24 
22 
 
61 
53 
48 
46 
46 
42 
N/A 
Opiates 
 1995 
 1996 
 1997 
 1998 
 1999 
 20002 
 20013 
 
6 
7 
5 
7 
9 
8 
7 
 
17 
18 
9 
22 
16 
24 
N/A 
Marijuana 
 1995 
 1996 
 1997 
 1998 
 1999 
 20002 
 20013 
 
42 
46 
44 
47 
48 
50 
48 
 
16 
19 
28 
22 
26 
24 
N/A 
 
1
 In year 2000, a revised sampling strategy was implemented to reflect a Detroit/Wayne County representative sample; earlier  
  samples were for city of Detroit arrestees only. 
2
 Results for 2000 are based on a weighted sample of male arrestees; the findings for the smaller sample of female arrestees are  
  unweighted. 
3
 Results for 2001 are for 3rd and 4th quarters only.  They are only for males and are weighted. 
 
SOURCE:  ADAM, NIJ 
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Illicit Drug Use in Honolulu and the State of Hawaii 
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ABSTRACT 
 
It is reported that the events surrounding September 
11, 2001, did not hurt Hawaii as much as had been 
anticipated. While that statement may be true, it is 
certainly also true that the events did not help. Be-
cause of these horrific events, it was initially noted 
that there was a sharp decline in drug availability, a 
concomitant increase in price, and a notable drop in 
drug use in Hawaii. However, by the beginning of 
2002, it was almost as though nothing had hap-
pened—supply was back, prices were down, and use 
was once again high. On reflection, the changes 
noted in patterns of reduced drug use, increasing 
unemployment, and decreasing tourism were al-
ready present before that fateful day, and, over time, 
the trends now experienced have emerged clearly as 
signs of the serious recession that began several 
years ago in Hawaii. The occurrences of September 
11, 2001, merely provided a convenient excuse to do 
what was already planned, namely, to adjust the 
economic and social circumstances of the State to a 
new paradigm, one far more austere. In the first 6 
months of 2002, some shifts occurred in drug use 
for the State. There was a slight increase in cocaine 
treatment admissions, and it was accompanied by a 
decline in deaths in which cocaine was detected 
through postmortem toxicological screens. Heroin 
treatment admissions were down, but deaths in 
which heroin was detected increased considerably. 
Marijuana use, as indicated by treatment admis-
sions, appeared to be slightly lower than in previous 
CEWG reporting periods, while methamphetamine 
indicators remained high. The continued presence 
of oxycodone among decedents remained a concern 
of the medical examiner as well as the police. 
 
INTRODUCTION 
 
This report presents current information on illicit drug 
use in the city and county of Honolulu (Oahu) and the 
neighboring island of Hawaii, based on data presented 
at the Honolulu Community Epidemiology Work 
Group (CEWG) meeting on October 25, 2002. Data 
were provided by most neighbor islands, excluding 
Kauai and the Kona-side of the island of Hawaii. 
Area Description 
 
The U.S. Census Bureau now reports that the State’s 
estimated 1.2 million population in 2000 was an un-
dercount of approximately 2.4 percent. The main 
components of the undercount are those without fixed 
addresses (homeless) and those who would be 
described as “ in transition.”  The undercount is not 
believed to materially change the demographics of 
the State as reported in recent CEWG reports.  
 
This report is for the period January– June 2002. The 
State legislature was in session throughout this period, 
but major legislation that may have had social 
consequences was not on the agenda since almost all 
members of both the senate and house were standing 
for reelection. In addition, term limits had been 
reached for the current Governor, so both the Governor 
and Lieutenant Governor were also up for reelection.  
 
The economy remained the greatest challenge to liv-
ing in Hawaii throughout the period, with tourism 
still much lower than in the past decade, unemploy-
ment still high, and other sectors of the economy 
weak. Because Hawaii’s economy is so dependent on 
tourism, the slow recovery of the mainland economy 
and the continued uncertainty in major Asian markets 
has meant that predictions for the future are tentative 
at best. 
 
Data Sources  
 
Data from the following sources are for January– June 
2002 but are reported as annual data, except as 
otherwise noted. 
 
• Quantitative and qualitative data were com-
piled from participants in the October 25, 2002, 
Honolulu CEWG meeting. The State of Hawaii 
Narcotics Enforcement Division and the Federal 
Drug Enforcement Agency (DEA), although 
invited, did not participate in this meeting. 
 
• Drug treatment admissions and demographic 
data were provided by the Hawaii State Depart-
ment of Health, Alcohol and Drug Abuse Divi-
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sion (ADAD). Previous data from ADAD are 
updated for this report whenever ADAD reviews 
its records. These data represent all the 
State-supported treatment facilities (95 percent of 
all facilities). About 5 percent of these programs 
and two large private treatment facilities do not 
provide data. During this CEWG reporting period, 
approximately 45 percent of the treatment 
admissions were paid for by ADAD; the 
remainder were covered by State health insurance 
agencies or by private insurance. 
 
• Drug-related death data were provided by the 
Honolulu City and County Medical Examiner 
(ME) Office. These data are based on toxicology 
screens performed by the ME Office on bodies 
brought to them for examination. The sorts of 
circumstances that would lead to the body being 
examined by the ME include unattended deaths, 
death by suspicious cause, and clear drug-
involved deaths. In short, while the ME data are 
consistent, they are not comprehensive and 
account for only about one-third of all deaths on 
Oahu. Data in some exhibits have been adjusted 
to fit the axes (multiplied by 10). 
 
• Law enforcement case data are usually pro-
vided by the Vice Divisions of the Honolulu, 
Maui, Kauai, and Hawaii Police Departments. 
These data are updated whenever possible to 
include cases that had occurred during a previous 
period but were under current investigation. In 
the current report, no data were received from 
the Kauai or East Hawaii Police Departments but 
recent data from all others are included.  
 
• Arrestee drug testing data were provided by 
the Arrestee Drug Abuse Monitoring (ADAM) 
program, National Institute of Justice. The 
ADAM program now reports data regularly to 
the CEWG. The latest report is based on data 
from the first two quarters of 2002; the second 
quarter data are preliminary. The ADAM pro-
gram collects data at the Central Receiving Unit 
of the Honolulu Police Department (HPD). Data 
on the results of the urine testing are presented. 
 
• Acquired immunodeficiency syndrome (AIDS) 
case data were reported by the Department of 
Health, Honolulu STD/AIDS Prevention Branch, 
AIDS Surveillance Program, for 1982 to 2001. 
 
Emergency department (ED) drug mentions data 
have not been available in Hawaii since 1994, 
because ADAD has canceled the Hawaii Emergency 
Department Episode Data (HEED) project. It is 
unlikely that HEED will be reinstated any time soon, 
given the State’s financial situation. Discussions with 
the Healthcare Association of Hawaii regarding 
inclusion in the Drug Abuse Warning Network 
(DAWN) have resulted in a briefing of all hospital 
chief executive officers and the sharing of DAWN 
information. However, with a possible nurse’s strike 
looming, no decisions were possible during this 
reporting period. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Indicators reflect the principal areas of activity with 
respect to substance abuse in the State of Hawaii. 
While much of the activity of participating agencies 
concerns alcohol and tobacco, crystal methamphet-
amine became more dominant about a year ago and 
remains so in terms of agency activity, including that 
of the ME Office. Police, treatment, and ME activity 
increased from previous CEWG reporting periods.  
 
Hawaiians and Whites remain the major user groups 
within the 17 identified ethnic groups (plus 2 other 
categories: “ other”  and “ unknown/blank” ) accessing 
ADAD facilities for substance abuse treatment. During 
January– June 2002, 42.8 percent and 23.9 percent of 
the admissions were Hawaiians and Whites, respec-
tively. All other groups had significantly lower rates. 
 
Methamphetamine remained the leading primary sub-
stance of abuse for those admitted to treatment (38.3 
percent of admissions). Alcohol, the primary sub-
stance for many years, accounted for 26.9 percent. 
However, it is important to note that almost all poly-
drug treatment admissions listed alcohol as a sub-
stance of abuse. Marijuana remained the third most 
frequently reported (20.4 percent) primary substance 
for treatment admissions. Those age 25– 34 and 35–
44 had the highest representation among treatment 
admission groups. While marijuana abuse accounted 
for the majority of treatment admissions among those 
younger than 18, the abuse of crystal methamphet-
amine still loomed as a major treatment category for 
this group. 
 
Price data for this period were not available at the 
time of the CEWG meeting. However, anecdotal 
reports from the HPD Narcotics/Vice Division sug-
gest that prices have been stable. The size of the drug 
supply makes for a relatively stable drug market, with 
only a few market adjustments caused by seizures of 
specific drugs or oversupply of others. 
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“ Ice”— the crystallized form of methamphetamine—
continues to dominate the Hawaiian drug market. 
Prices remained stable during the reporting period; 
this may indicate that still more ice is available on the 
street. It was easier to purchase larger quantities than 
in the past. The final police evidence of increased ice 
availability was the presence of clandestine labs, 
almost exclusively reprocessing labs that continued 
to be closed at a regular pace. 
 
Because of a lack of security forces at neighbor 
island airports, and thousands of miles of coastline 
with only a small Coast Guard presence in the State, 
shipping drugs to Hawaii is relatively safe and easy. 
From the neighbor islands, interisland flights con-
tinue to be used because of reduced security. The 
mainland supply chain is the major source of the 
material used for reprocessing to crystal metham-
phetamine. The purity of ice in Hawaii is reported to 
approach 100 percent, but no DEA price and purity 
reports have been received for several years. 
 
Marijuana remains a drug for which arrests result 
from circumstance, bad luck, or stupidity. The Big 
Island Police Department continues to partner with 
the Air National Guard for “ Operation Green Har-
vest.”  This program has been in operation for more 
than a decade, with the effort being to destroy the 
plants rather to seek interdiction directly. Close to 
100,000 plants are seized each half-year on the Hilo 
(east) side of the island, and about an additional 
30,000 plants are seized on the Kona (west) side of 
the island. Oahu efforts during this period have netted 
about 15,800 plants. Maui officials have seized 
nearly 7,000 pounds, compared with only 5,000 
pounds in the last CEWG reporting period. 
 
The Hawaii DEA continued its efforts to deal with 
crystal methamphetamine and, in particular, to break 
the supply route from California for the chemicals 
necessary to operate Hawaii’s ice labs. During this 
period, the HPD seized and closed several clandes-
tine methamphetamine laboratories and seized 12,000 
grams of the drug. 
 
In the following sections, the police activity data 
exhibits show all neighbor island data combined and 
are titled “ neighbor island.”  Because of inconsisten-
cies in reporting from these police departments, the 
data cannot be seen as very reliable. The Honolulu 
data represent reports from the HPD. To allow a 
direct comparison between ME data and treatment 
data, the ME data have been multiplied by 10. The 
stability of these data are assured. 
Cocaine and Crack 
 
Cocaine and crack treatment admissions somewhat 
stabilized in the first half of 2002.  There were 433 
admissions in 2001; in the first 6 months of 2002, 
there were 222 (exhibit 1). Thus, admissions for 
cocaine use, after being quite stable between 1996 
and 1999, began a decline in 2000 and have begun to 
stablize again. Again cocaine and crack ranked fourth 
among primary drugs of treatment admissions, after 
methamphetamine, alcohol, and marijuana. 
 
Between 1996 and 2001, the Honolulu ME consis-
tently reported between 22 and 32 deaths per year 
with cocaine-positive toxicology screens (exhibit 1). 
Data from January– June 2002 suggest a decline. 
Again, it should be pointed out that the number of 
deaths was 7 during that period and not 70. Data have 
been adjusted to allow for their presentation on the 
same axes. 
 
According to the HPD, cocaine prices remained sta-
ble during this period. With the apparent declining 
use of the drug, police arrests have declined slightly 
as well. The number of HPD cocaine cases has 
plummeted over the past 5 years. Neighbor island 
data are from all islands and showed a slight increase 
in cases in the first half of 2002 (exhibit 2).  
 
Heroin and Other Opiates 
 
Black tar heroin monopolizes the heroin market in 
Hawaii and is readily available in all areas of the 
State. “ China white”  is uncommon, but present. 
Seizure data show a 20-to-1 ratio for the amount of 
tar and powder seized. According to the HPD, heroin 
prices remained stable in Honolulu, at $50 per one-
quarter gram, $200 per gram, and $5,000 per ounce.  
 
Heroin treatment admissions continued the decline 
begun in 1999. In 1998, record levels of treatment 
admissions were recorded, with more than 500 indi-
vidual admissions that year (exhibit 3). In the first 
half of 2002, heroin ranked fifth among treatment 
admissions, at 3.2 percent. 
 
The Honolulu ME reported that deaths in which her-
oin was detected increased from previous periods. In 
the first 6 months of 2002, a total of 16 decedents had 
heroin in their systems. If this rate continues for the 
rest of the year, a total of 32 heroin-related deaths 
will occur, an increase of 28 percent. In 2001, there 
were 25 deaths with positive heroin toxicology 
screens.  
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Honolulu police reported only 17 heroin cases in 
2001. In the first half of 2002, a total of 25 cases 
were reported (exhibit 4). Neighbor Island police 
reported 13 heroin cases in the first half of 2002, 
about one-half the rate recorded over the previous 2 
years. 
 
Marijuana 
 
Marijuana treatment admissions tapered off during 
the first half of 2002. They remained high (exhibit 5), 
but if the rate continues for the balance of the year, 
the number of total marijuana admissions will be 
similar to that in 1999. There were 1,544 admissions 
for marijuana treatment in 2001. In examining these 
treatment data, it is important to remember that the 
number of persons in treatment for marijuana use is 
triple the number in 1992. It is also important to note 
that while marijuana is listed as the primary drug of 
use at admission, many of these clients also used 
other substances. 
 
Between 1996 and 2000, marijuana was found in 15–
25 deaths per year among specimens submitted for 
toxicology screening. In 2001, there were 36 such 
deaths and in the first half of 2002, there were 18. 
 
Honolulu police continue to monitor, but not to spe-
cifically report, case data for marijuana. As men-
tioned in previous CEWG reports, possession cases 
are steady at about 650 per year, although distribution 
cases have continued to increase. Law enforcement 
sources speculate that much of the Big Island’s 
marijuana is brought to Oahu for sale, and case data 
for the Big Island have increased substantially. The 
data on police cases are shown in exhibit 6. 
 
Methamphetamine 
 
On the basis of several indicators, Hawaii retains the 
title as the “ crystal methamphetamine”  capital of the 
United States. It remains the drug of choice in the 
island chain. California-based Mexican sources use 
Hawaii’s cultural diversity to facilitate smuggling 
and distribution to and within the islands. Analysis of 
confiscated methamphetamine reveals that the prod-
uct is still a high-quality d-methamphetamine hydro-
chloride in the 90– 100-percent purity range. 
 
Methamphetamine treatment admissions remained 
extremely high but stable during this 6-month CEWG 
reporting period, and still exceeded those for alcohol. 
A total of 1,312 admissions occurred during the first 
6 months of 2002, compared with 2,644 in 2001. 
Exhibit 7 shows the trend over the past decade. The 
rate of increase in demand for treatment space for 
methamphetamine abuse has been geometric and not 
linear. This situation has so far outstripped the treat-
ment system’s capacity that even people who might 
want treatment would not likely receive it in a timely 
manner.  
 
Between 1995 and 2000, the Oahu ME reported 
between 24 and 39 crystal methamphetamine cases 
per year (exhibit 7). In 2001, however, the number of 
such deaths increased to 54, and there were 32 in the 
first half of 2002. The numbers of decedents with 
methamphetamine present continuted to exceed the 
number found with alcohol present. 
 
Crystal methamphetamine prices have remained sta-
ble for larger quantities. It is sold in the islands as 
“ clear”  (a cleaner, white form) or “ wash”  (a 
brownish, less processed form). Prices and availabil-
ity for ice vary widely for these two categories. On 
Oahu, prices are as follows: $50 (wash) or $75 (clear) 
per one-tenth gram; $100– $200 (wash) or $600– $900 
(clear) per gram; $250– $400 (wash) or $1,000–
$2,000 (clear) per one-quarter ounce; and $2,200–
$3,000 (wash) per ounce. 
 
HPD methamphetamine case data show decreases 
again (exhibit 8). The annual number of cases peaked 
in 1995 and has subsequently declined annually. In 
the first half of 2002, there were 265 Honolulu cases 
and 269 from the neighbor islands. 
 
Weighted data for 2001, and unweighted data for the 
first and second quarters of 2002 show that the drug 
most frequently found in urines of adult male arres-
tees was amphetamines, which was almost entirely 
methamphetamine. The proportion of arrestees with 
positive toxicology screens for methamphetamine 
was nearly 50 percent, up from about 37 percent in 
2000. 
 
Depressants 
 
Barbiturates, sedatives, and sedatives/hypnotics are 
combined into this category. Few data were provided 
about these drugs in the islands. 
 
ADAD maintains three categories under this heading: 
benzodiazepines, other tranquilizers, and barbiturates. 
Treatment admissions for these drugs continued to 
have a minimal impact on the system. Annually, the 
numbers admitted to treatment for these drugs have 
been less than 10 since 1998 (exhibit 9). 
 
The number of ME mentions for depressants has 
remained stable for several years, at five or fewer. 
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The HPD has not reported depressant case data since 
1991. Neighbor island police report fewer than 20 
cases per year (exhibit 10) since 1997. 
 
Prices remained stable at $3– $20 per unit for barbitu-
rates and $2– $3 per pill for secobarbital (Seconal or 
“ reds” ). 
 
Hallucinogens 
 
Hallucinogen treatment admissions have decreased 
since 1997 and totaled three in the first half of 2002 
(exhibit 11). No hallucinogen ME mentions have 
been reported since the beginning of data collection. 
 
Prices for lysergic acid diethylamide (LSD) were $4–
$6 per “ hit”  and $225– $275 per 100 dosage-unit 
sheets (a “ page” ) in this reporting period. 
No hallucinogen case data were generated by the 
HPD for 2001 or the first half of 2002. Trends are 
shown in exhibit 12. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
As shown in exhibit 13, the rate of newly diagnosed 
cases of AIDS per 100,000 population varied consid-
erably by year from 1983 to 2001.  The highest rate 
(34.0) was in 1993, with subsequent declines there-
after. The rate rose from 9.0 per 100,000 population 
in 2000 to 10.5 in 2001. In 2001, nearly two-thirds of 
the AIDS cases involved men who have sex with men 
(MSM), 7 percent involved injection drug users 
(IDUs), and 1 percent involved MSM/IDUs (exhibit 
14). 
 
For inquiries concerning this report, please contact D. William Wood, Ph.D., University of Hawaii at Manoa, Department of Sociology, 265 N. 
Kalaheo Avenue, Honolulu, HI  96822, Phone: (250) 384-3748, Fax: (808) 956-3707, E-mail: <		
. 
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Exhibit 1. Cocaine Use Indicators in Hawaii:  1991–20021 
 
0
100
200
300
400
500
600
700
800
1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002
Oahu Deaths Treatment Admissions
1
 January–June 2002. 
2
 The number of deaths each year is multiplied by 10 to fit exhibit axes. 
 
SOURCES:  Honolulu City and County Medical Examiner Office and ADAD 
 
 
 
Exhibit 2. Cocaine Cases Reported by Police in Hawaii:  1991–20021 
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Exhibit 3. Heroin Use Indicators in Hawaii:  1991–20021 
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SOURCES:  Honolulu City and County Medical Examiner Office and ADAD 
 
 
 
Exhibit 4. Heroin Cases Reported by Police in Hawaii:  1991–20021 
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Exhibit 5. Marijuana Use Indicators in Hawaii:  1991–20021 
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Exhibit 6. Marijuana Cases Reported by Police in Hawaii:  1991–20021 
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Exhibit 7. Methamphetamine Use Indicators in Hawaii:  1991–20021 
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Exhibit 8. Methamphetamine Cases Reported by Police in Hawaii:  1991–20021 
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Exhibit 9. Barbiturate Use Indicators in Hawaii:  1991–20021 
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Exhibit 10. Barbiturate Cases Reported by Police in Hawaii:  1991–20021 
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Exhibit 11. Hallucinogen Use Indicators in Hawaii:  1992–20021 
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Exhibit 12. Hallucinogen Cases Reported by Police in Hawaii:  1991–20021 
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Exhibit 13. Rate of Newly Reported Cases1 of AIDS Per 100,000 Population Reported in Hawaii:   
 1982–2001 
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Exhibit 14. AIDS Cases1 by Risk Factor:  2001 
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Patterns and Trends in Drug Abuse:  Los Angeles County, 
California 
 
Beth Finnerty, M.P.H.1 
 
ABSTRACT 
 
Overall, patterns and trends in illicit drug use, 
purity, availability, and consequences in Los 
Angeles County remained relatively stable during 
the first half of 2002, compared with previous 
reporting periods. One exception is 
methamphetamine, whose presence is increasing 
both locally and regionally. The Los Angeles High 
Intensity Drug Trafficking Area (HIDTA) led all 
California HIDTAs in terms of clandestine 
laboratory seizures, with a total of 135 seizures 
made during the second quarter of 2002. Primary 
methamphetamine treatment admissions continued 
to climb as well. According to the California 
Department of Alcohol and Drug Programs’ First 
Annual Report to the Legislature, 
methamphetamine was the drug of choice for nearly 
one-half (48 percent) of all clients who received 
treatment under the Substance Abuse and Crime 
Prevention Act of 2000 (a.k.a. Proposition 36) from 
July 1 to December 31, 2001. Heroin and 
crack/cocaine, the principal illicit drugs of abuse in 
the county, continuously dominated many of the 
traditional substance abuse indicators. Although 
primary heroin treatment admissions continued to 
follow a declining trend that began in the late 
1990s, they still account for the highest proportion 
of all admissions (33 percent). Primary crack/ 
cocaine treatment admissions have remained 
relatively stable, at approximately 20 percent of all 
admissions. According to the Drug Abuse Warning 
Network, cocaine was mentioned much more fre-
quently during emergency department (ED) epi-
sodes than heroin, which has been the case for sev-
eral years. Marijuana, the most widely used illicit 
drug in Los Angeles County, was the primary drug 
for which 65 percent of youth (under the age of 18) 
entered treatment in the first half of 2002. Despite a 
recent significant decline in the number of MDMA 
(ecstasy) and GHB mentions recorded during drug-
related ED episodes, anecdotal evidence from a 
variety of local sources continues to lend support to 
the claim that the use of club drugs is spreading in 
Los Angeles County.  
INTRODUCTION 
 
Area Description 
 
Los Angeles County has the largest population 
(9,824,800 as of January 1, 2002) of any county in 
the Nation, and its population is exceeded in size by 
only 8 States. Approximately 29 percent of Califor-
nia’s residents live in Los Angeles County. Los 
Angeles County includes the islands of San Clemente 
and Santa Catalina. It is bordered on the east by 
Orange and San Bernardino Counties, on the north by 
Kern County, on the west by Ventura County, and on 
the south by the Pacific Ocean. Its coastline is 81 
miles long.  
 
The City of Los Angeles, with approximately 3.8 
million residents— an estimated 8,146 persons per 
square mile— is the largest city in California and the 
second largest city in the United States. Two of the 
busiest maritime ports in the world— Long Beach and 
Los Angeles— are located in Los Angeles County. 
The Port of Long Beach is the Nation’s busiest mari-
time cargo container facility, while the Port of Los 
Angeles ranks second, according to a report by the 
National Drug Intelligence Center (NDIC) in 2001. 
   
Los Angeles is also home to the world’s third busiest 
airport— Los Angeles International Airport. The air-
port handles over 1,000 cargo flights each day; 50 
percent of this activity is international in origin or 
destination (NDIC 2001 report).  
 
Residents of Los Angeles County primarily rely on 
automobiles for transportation, and the Los Angeles 
area has one of the most intricate highway systems in 
the world. Of these, Interstates 5, 10, and 15 connect 
the area to the rest of the Nation. Interstate 5 runs 
from the U.S.-Canada border to the U.S.-Mexico 
border and links Los Angeles to other key west coast 
cities, such as San Diego, Oakland, San Francisco, 
Sacramento, Portland, and Seattle. Interstate 10 
originates in Santa Monica, California, and runs 
across the United States to I-95 in Jacksonville, 
Florida. Interstate 15 originates in the area and runs 
1
 The author is affiliated with the University of California, Integrated Substance Abuse Programs, Los Angeles, California. 
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northeast through Las Vegas, Nevada, to the U.S.-
Canada border in Montana. In addition, State high-
ways 1 and 101 are extensively traveled roadways.   
 
California is one of the most active drug smuggling 
and production areas in the United States. The State’s 
proximity to the Pacific Ocean and Mexico contrib-
utes to the trafficking of large quantities of metham-
phetamine, cocaine, heroin, marijuana, and other 
dangerous drugs to markets within and outside Cali-
fornia. Los Angeles is a national-level transportation 
hub and distribution center for many illicit drugs. 
Because of this, all major drugs of abuse are readily 
available in the State, according to a report by NDIC 
in 2002.  
 
In August 2002, researchers from the State Univer-
sity of New York (SUNY) Downstate Medical Center 
in Brooklyn, New York, released a report entitled 
“ Healthy Cities, Healthy Suburbs: Progress in Meet-
ing Healthy People Goals for the Nation’s 100 Larg-
est Cities and Their Suburbs.”  The report focused on 
a set of seven infant health and infectious disease 
indicators and homicide goals, including the follow-
ing: low birth weight (5 percent of all live births); 
infant mortality (7 deaths per 1,000 live births); 
tuberculosis (3.5 cases per 100,000 population); the 
acquired immunodeficiency syndrome (AIDS) (43 
cases per 100,000 population); syphilis (4 cases per 
100,000 population); gonorrhea (100 cases per 
100,000 population); and homicide (7.2 homicides 
per 100,000 population). On average, cities met or 
made progress towards meeting these goals for infant 
mortality, AIDS, tuberculosis, syphilis, and homicide 
between 1990 and 1999 or 2000. The Los Ange-
les/Long Beach/Glendale metropolitan statistical area 
(MSA) met the goals for infant mortality, syphilis, 
and gonorrhea. The percentages and rates of the 
Healthy People goals for the three California CEWG 
cities (Los Angeles, San Diego, and San Francisco) 
and their suburbs are shown in exhibit 1.   
 
Data Sources 
 
This report describes drug abuse trends in Los 
Angeles County from 1995 to June 2002. Information 
was collected from the following sources: 
 
• Drug treatment data were derived from the 
California Department of Alcohol and Drug Pro-
grams (ADP), California Alcohol and Drug Data 
System (CADDS); and correspond to Los 
Angeles County alcohol and other drug (AOD) 
treatment and recovery program admissions from 
January 2000– June 2002. It should be noted that 
admissions for heroin treatment are dispropor-
tionately represented due to reporting require-
ments for facilities that use narcotic replacement 
therapy to treat heroin users. Both private and 
publicly funded narcotic treatment providers 
must report their admissions to the State, 
whereas for other drug types, only publicly 
funded providers must report. 
 
• Emergency department (ED) drug mentions 
data were accessed from the Substance Abuse 
and Mental Health Services Administration 
(SAMHSA), Office of Applied Studies (OAS), 
Drug Abuse Warning Network (DAWN) for 
1997– December 2001. 
 
• Drug availability, price, purity, and distribu-
tion data were derived from the Los Angeles 
Police Department (LAPD), the Los Angeles 
High Intensity Drug Trafficking Area (HIDTA), 
the Los Angeles County Regional Criminal 
Information Clearinghouse (LA CLEAR), the 
National Drug Intelligence Center, and the Drug 
Enforcement Administration (DEA).  
 
• Demographic and geographic data were pro-
vided by the United Way of Greater Los Ange-
les, Los Angeles County Online, and the Los 
Angeles County Department of Health Services, 
Public Health. 
 
• AIDS and human immunodeficiency virus 
(HIV) data (cumulative through June 2001) 
were provided by the Los Angeles County 
Department of Health Services, HIV Epidemio-
logy Program. 
 
• Healthy Cities data were compiled from a re-
port released by SUNY Downstate Medical 
Center entitled “ Healthy Cities, Healthy Sub-
urbs: Progress in Meeting Healthy People Goals 
for the Nation’s 100 Largest Cities and Their 
Suburbs,”  August 2002.  
 
• Adolescent substance use data were accessed 
from the Los Angeles County-level California 
Healthy Kids Survey (CHKS) data for the 2001–
2002 school year from WestEd. The CHKS is a 
modular survey that assesses the overall health of 
secondary school students (in grades 7, 9, and 
11). One module is comprised of questions on 
alcohol, drug, and tobacco use and attitudes 
associated with perceived use, harm, and avail-
ability.  
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DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
Cocaine/crack was second only to alcohol-in-combi-
nation as the most frequently mentioned substance of 
abuse in the Los Angeles-Long Beach metropolitan 
area in 2001, accounting for 22 percent of all DAWN 
ED drug mentions. Cocaine mentions increased sig-
nificantly (48 percent) from 1999 (6,768 mentions) to 
2001 (9,999 mentions) (exhibit 2). ED cocaine/crack 
mentions as a percentage of all ED drug episodes 
rose as well, from 34 percent in 1998 to 41 percent in 
2001. As shown in exhibit 3, ED cocaine/crack men-
tions totaled 5,123 in the second half of 2001, a non-
significant increase of 5 percent from the first half of 
2001, but a continuation of a rising trend that began 
in the first half of 1997.  
 
Of the 9,999 ED cocaine/crack mentions reported in 
2001, 69 percent occurred among males, 47 percent 
occurred among Blacks, and 58 percent occurred 
among individuals age 35 and older. Seventy-six per-
cent of the ED cocaine mentions represented multi-
drug episodes. In these cases, at least one other drug 
was mentioned during the episode. When asked about 
drug use motive, slightly more than one-half (52 per-
cent) reported cocaine dependence. Chronic effects 
(38 percent) was the most frequently reported reason 
for ED contact. An additional 9 percent of the 
cocaine mentions reported overdose as the reason for 
ED contact.  
 
After a significant increase of 47.5 percent in the rate 
of population-adjusted ED cocaine/crack mentions per 
100,000 population from 1999 to 2000, the rate 
remained relatively stable from 2000 to 2001 (at 105 
and 117 mentions, respectively) (exhibit 4). Between 
1994 and 2000, population-adjusted ED cocaine/crack 
mentions fluctuated between 56 and 79. In 2000, popu-
lation-adjusted cocaine mentions rose above 100 per 
100,000 population. In 2001, Los Angeles was one of 
14 CEWG cities in which the rate of cocaine/crack 
mentions surpassed 100. With regards to population-
adjusted rates of ED cocaine mentions in the six west-
ern CEWG sites (Denver, Los Angeles, Phoenix, San 
Diego, San Francisco, and Seattle), Los Angeles, San 
Francisco, and Seattle had 2001 ED cocaine rates that 
exceeded 100 per 100,000 population. Seattle led the 
group with 160 mentions per 100,000 population, fol-
lowed by San Francisco (158) and Los Angeles (117).  
 
Despite the fact that cocaine/crack continually ranks 
highest in terms of DAWN ED illicit drug mentions, 
only 20 percent of Los Angeles County treatment and 
recovery program admissions between January and 
June 2002 reported crack or powder cocaine as the 
primary drug of abuse (exhibit 5). As a percentage of 
the total, cocaine admissions have remained stable 
since July 1999. Alcohol has been the most com-
monly abused secondary drug among primary 
cocaine admissions (41 percent) for several reporting 
periods, followed by marijuana (20 percent). The 
preferred route of administration for approximately 
87 percent of the cocaine admissions was smoking; 
another 9 percent of the cocaine admissions reported 
inhalation as their preferred route of administration 
(exhibit 6). When asked whether they had used any 
drug intravenously in the year prior to admission, 5 
percent of all primary cocaine admissions reported 
that they had used needles to administer one or more 
drugs intravenously at least once during the specified 
time period (exhibit 7).     
 
Sixty-four percent of the primary cocaine admissions 
reported in the first half of 2002 were male. Blacks 
continued to constitute the largest percentage of 
cocaine admissions (at 57 percent), followed by His-
panics (21 percent) and Whites (15 percent). Com-
pared with other major illicit drug admissions, 
primary cocaine admissions included the largest pro-
portion of Blacks. The majority of cocaine admis-
sions were age 36 and older (60 percent). 
 
Nearly one-third of the primary cocaine/crack treat-
ment admissions were homeless at the time of admis-
sion (30 percent), and slightly more than one-quarter 
(27 percent) were referred by the court or criminal 
justice system. Thirty-seven percent did not have a 
history of prior treatment episodes. Forty-three per-
cent had graduated from high school.  At the time of 
admission, 14 percent were employed full- or part-
time (exhibit 7).     
 
According to CHKS data for the 2001– 2002 school 
year (exhibit 8), 8.0 percent of all Los Angeles 
County secondary school students who responded to 
the survey had ever used cocaine (crack or powder), 
and 3.9 percent were current cocaine users (defined 
as any use in the past 30 days). A breakdown of the 
data by grade level illustrated that among responding 
9th-graders, 5.5 percent had ever used cocaine and 
3.0 percent were current cocaine users. Rates of use 
were higher among 11th-graders; 8.4 percent had 
ever used cocaine and 3.3 percent used some form of 
cocaine within the past 30 days. Additional analyses 
will appear in future proceedings, including long-
term trends in self-reported drug use among secon-
dary school students in Los Angeles County.   
 
A total of 1,228 cocaine arrests were made within the 
city of Los Angeles in the first half of 2002. This 
represented a 48-percent decrease from the number of 
cocaine arrests made in the first half of 2001. Cocaine 
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arrests accounted for roughly 10 percent of all 
narcotics arrests made between January and June 2002.  
 
Citywide cocaine (includes crack and powder) seizures 
increased 6 percent, from 500 pounds seized in 
January– June 2001 to 534 pounds seized in January–
June 2002. The street value of the seized cocaine 
accounted for nearly 50 percent of the total street value 
of all drugs seized in the first half of 2002. 
 
Cocaine availability throughout Los Angeles County 
was high and stable. The wholesale price for 1 
kilogram of cocaine ranged from $14,000 to $17,000, 
which is similar to the multikilogram wholesale price 
reported in the June 2002 CEWG report. The current 
retail price of cocaine is $80 per gram and $500– $600 
per ounce (down from $600– $700). The purity of 
cocaine available in Los Angeles County continues to 
be high, but it decreased recently to approximately 78 
percent. Purity levels had been at 80– 85 percent for 
several reporting periods. Indications that cocaine 
popularity has peaked and even declined in many 
regions throughout the LA HIDTA continue to be 
reported. In those areas, another stimulant— metham-
phetamine— has supplanted cocaine in popularity.  
 
According to NDIC, Mexican drug trafficking 
organizations smuggle large quantities of cocaine 
into California, which are destined for drug markets 
in the State and throughout the Nation. The Los 
Angeles area serves as a significant transportation 
and distribution center. Most of the cocaine available 
in the State is smuggled through U.S.-Mexico land 
ports of entry in commercial and private vehicles. 
Mexican drug trafficking organizations dominate 
both the wholesale and retail distribution of pow-
dered cocaine. Street gangs dominate the retail level 
distribution of crack cocaine throughout California.   
 
According to the DEA, more than 100 individuals 
were arrested in November 2002 in connection with 
coordinated investigations in Los Angeles, California, 
Anchorage, Alaska, and Kansas City, Kansas. Sixteen 
subjects were named in Federal complaints or 
indictments in Operations “ Heavy Hitter,”  “ Once 
Again,”  and “ So-Cal Snow.”  The cases focused on 
targets in Los Angeles who were importing cocaine 
from Mexico and delivering it to the Los Angeles area 
for further distribution to cities nationwide.  
 
Heroin 
 
Heroin was the fourth most frequently mentioned 
major substance of abuse in the Los Angeles-Long 
Beach metropolitan area in 2001, accounting for 
approximately 6 percent of all DAWN ED drug 
mentions (exhibit 2). Heroin mentions steadily 
increased, but not significantly, from 1997 to 2000. 
Between 2000 and 2001, however, heroin mentions 
decreased significantly by 9 percent (from 3,177 
mentions to 2,878 mentions). Similarly, ED heroin 
mentions as a percentage of total ED drug episodes 
declined slightly, from 15 percent in 1998 to 12 per-
cent in 2001 (exhibit 2).  ED heroin mentions totaled 
1,372 in the second half of 2001 (exhibit 3), a slight 
decline from 1,506 mentions in the first half of 2001.  
 
Of the 2,878 ED heroin mentions reported in 2001, 
74 percent were made by males.  In terms of 
race/ethnicity, Hispanics continued to account for the 
highest proportion of mentions, at 41 percent, fol-
lowed by Whites (33 percent) and Blacks (16 
percent); race was unknown in 9 percent of the cases. 
Like ED cocaine mentions, the age category 
representing the highest percentage of heroin 
mentions was the 35-and-older category (72 percent), 
followed by those age 26– 34 (18 percent) and 18– 25 
(9 percent). Between 1994 and 1997, a greater 
percentage (approximately 60 percent) of heroin 
mentions were associated with single-drug episodes. 
Starting in 1998, the proportion of heroin mentions 
occurring during single-drug episodes decreased 
consistently, and in 2000 and 2001, approximately 
one-half of all heroin mentions were associated with 
multidrug episodes. 
 
In 2001, heroin dependence was reported as the drug 
use motive among the vast majority (85 percent) of 
these mentions. Chronic effects (45 percent) and 
overdose (28 percent) were the two most frequently 
reported reasons for ED contact.  In terms of patient 
disposition, roughly the same proportion were treated 
and released (45 percent) or admitted to the hospital 
(44 percent).  
 
The population-adjusted rate of heroin ED mentions 
in the Los Angeles-Long Beach metropolitan area in 
2001 remained stable at 34 mentions per 100,000 
population. This rate has fluctuated between 30 and 
37 mentions per 100,000 population since 1997 
(exhibit 4). For population-adjusted rates of ED 
heroin mentions in the six western CEWG cities, San 
Francisco continued to lead the group in 2001, with 
178 mentions per 100,000 population. Phoenix had 
the lowest number of population-adjusted mentions 
of heroin (27 per 100,000 population). Since 1997, 
Denver and Los Angeles have had similar rates of 
heroin mentions, fluctuating between 30 and 41 
mentions per 100,000 population (exhibit 4).  
 
The percentage of primary heroin treatment 
admissions to Los Angeles County treatment and 
recovery programs continued to decrease slightly 
overall, from nearly 36 percent of all admissions 
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(8,033 admissions) in July– December 2001 to 33 
percent (7,767 admissions) in January– June 2002 
(exhibit 5). In the first half of 2002, primary heroin 
admissions were predominantly male (72 percent), older 
than 35 (73 percent), and somewhat more likely to be 
Hispanic (44 percent) than White (37 percent) or Black 
(12 percent) (exhibit 6). Primary heroin admissions were 
most likely to report cocaine/crack as their secondary 
drug of abuse (23 percent). Alcohol was the second 
most frequently reported secondary drug of abuse (9 
percent). Eighty-eight percent of the primary heroin 
admissions injected heroin, 6 percent smoked the drug, 
and 4 percent snorted (inhaled) the drug. When asked 
whether they had used any drug intravenously in the 
year prior to admission, 90 percent of all primary heroin 
admissions reported that they had used needles to 
administer one or more drugs intravenously at least once 
during the specified time period (exhibit 7). Compared 
with other major types of illicit drug admissions, 
primary heroin admissions had the largest proportion of 
users age 36 and older (73 percent).  
 
Twelve percent of the primary heroin admissions 
were homeless at time of admission, and only 4 
percent were referred by the court or criminal justice 
system. Sixteen percent of the admissions indicated it 
was their first treatment episode. Forty-nine percent 
had graduated from high school, and, at the time of 
admission, 27 percent were employed full- or part-
time (exhibit 7). 
 
According to CHKS data for the 2001– 2002 school 
year, 4 percent of all Los Angeles County secondary 
school students who responded to the survey had ever 
used heroin (exhibit 8). A breakdown of the data by 
grade level showed that among responding 9th-
graders, 3.3 percent had ever used heroin.  Lifetime 
heroin use was slightly higher among 11th-graders: 
3.5 percent.  
 
A total of 4,254 heroin arrests were made within the 
city of Los Angeles in the first half of 2002. This 
represented a 21-percent increase from the number of 
heroin arrests made in the first half of 2001. Heroin 
arrests accounted for approximately 36 percent of all 
narcotics arrests made between January and June 2002. 
 
Continuing the major reversal of trends that was 
reported in December 2001, citywide seizures of black 
tar heroin decreased 95 percent, from 322 pounds 
seized in January−June 2001 to 17 pounds seized in 
January– June 2002. Similarly, seizures of other types 
of heroin decreased 72 percent, from 35 pounds seized 
in the first half of 2001 to 10 pounds seized in the first 
half of 2002. The street value of seized heroin 
accounted for 3 percent of the total street value of all 
drugs seized in the first half of 2002. 
According to NDIC, Mexican drug trafficking 
organizations and criminal groups dominate the 
wholesale and retail supply and distribution of 
Mexican black tar and brown powdered heroin in 
California. The wholesale price (per kilogram) of 
black tar heroin increased again in the second quarter 
of 2002, to approximately $19,200– $23,200 (up from 
$18,000– $22,000 in the latter part of 2001). The 
current retail value for a gram is $90– $100, and the 
retail value for a “ pedazo”  (Mexican ounce) is $700–
$800 (up from approximately $600– $700 in 2001). A 
regular ounce is 28.5 grams, whereas a pedazo is 25 
grams. According to the LA HIDTA, street samples 
of Mexican black tar heroin have a purity level of 
16– 18 percent. This purity level signifies a 
substantial decrease in purity from previous years, 
when purity levels for street samples of black tar 
averaged 30– 35 percent.  
 
Mexican brown heroin sells for a wholesale price of 
$24,000– $34,000 per kilogram and retail price of 
$35,000– $50,000 per kilogram. Mexican heroin 
continues to be the heroin of choice in the Los 
Angeles area. Southeast Asian heroin (i.e., China 
white), which is not often encountered on the streets 
of Los Angeles, has a wholesale price range of 
$35,000– $40,000 (for a 300– 350-gram unit) to 
$70,000– $80,000 (for a 700– 750-gram unit). The 
lack of China white on the streets is related, in part, 
to local users’  preference for black tar. Los Angeles 
is, however, a major transshipment center for the 
distribution of Southeast Asian heroin to east coast 
cities.  
 
The LA HIDTA continues to report that there are some 
indications that Colombian drug trafficking organ-
izations are expanding their heroin trafficking 
operations within the Los Angeles area. The wholesale 
price for a kilogram of Colombian heroin is $86,000–
$100,000. This type of heroin has a purity level of 94 
percent. The LA HIDTA also reports that the Los 
Angeles metropolitan area has one of the largest 
Middle Eastern populations in the United States. 
Because of this, it is believed that Southwest Asian 
opium trafficking activities may increase in the area.  
 
Other Opiates/Narcotics 
 
ED mentions of narcotic analgesics/combinations 
continued to increase steadily, but not significantly, 
from 1,978 mentions in 2000 to 2,135 mentions in 
2001. Of those in 2001, roughly three-quarters were 
mentions of a single formulation narcotic analgesic. 
The remaining one-quarter of mentions were for 
narcotic analgesics produced in combination. The 
vast majority of the 437 hydrocodone/combinations 
mentions were mentioned as an acetaminophen-
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hydrocodone combination (97 percent). Thirty-eight 
percent of the 52 oxycodone/combinations mentions 
were for an acetaminophen-oxycodone combination. 
Mentions of methadone have fluctuated over the 
years, from 175 mentions in 1997 to 137 mentions in 
2000. From 2000 to 2001, methadone mentions 
increased dramatically from 137 to 368 mentions; 
this increase was statistically significant. 
 
The population-adjusted rates for ED mentions of 
narcotic analgesics/combinations (25 per 100,000 
population), hydrocodone/combinations (5 per 
100,000 population), and oxycodone/combinations (1 
per 100,000 population) were consistently lower in 
the Los Angeles-Long Beach metropolitan area than 
in the coterminous United States (39, 9, and 7 per 
100,000 population, respectively). The population-
adjusted rate for mentions of methadone was 
identical in both Los Angeles and the coterminous 
United States (4 per 100,000 population).   
 
In January– June 2002, 431 (2 percent of all admis-
sions) Los Angeles County treatment and recovery 
program admissions reported other opiates/synthetics 
as their primary drug of choice. This number was 
nearly identical to the number of admissions for 
primary other opiates/synthetic abuse reported in the 
second half of 2001. Fifty-four percent of the other 
opiates/synthetics admissions were male, which was 
down slightly from 60 percent in the second half of 
2001. Seventy-three percent were White, and 76 
percent were age 36 and older.   
 
Marijuana 
 
Marijuana was the third most frequently mentioned 
major substance of abuse in the Los Angeles-Long 
Beach metropolitan area in 2001, accounting for 13 
percent of all ED drug mentions. The proportion of 
marijuana/hashish ED mentions among ED drug 
episodes remained stable at approximately 23 percent 
in 2001 (exhibit 2). ED marijuana mentions increased 
slightly (4 percent), from 2,814 mentions in the first 
half of 2001 to 2,915 mentions in the second half of 
2001 (exhibit 3). This change was not significant. 
 
Of the 5,729 ED marijuana mentions reported in 
2001, 67 percent occurred among males, 24 percent 
among Hispanics, and 20 percent among Whites. The 
vast majority of the ED marijuana mentions occurred 
during multidrug episodes; only about 15 percent 
occurred during an episode in which marijuana was 
the only drug mentioned. When asked about drug use 
motive, 32 percent of the mentions reported mari-
juana dependence. Thirty-seven percent were treated 
in the emergency department and released.  
 
In 2001, the Los Angeles population-adjusted rate of 
marijuana/hashish ED mentions was 67 per 100,000 
population. This rate has remained stable since 1999 
(exhibit 4). Prior to 1999, the population-adjusted 
rate had fluctuated between 25 and 40 per 100,000 
population. With regards to population-adjusted ED 
marijuana mentions in the six western CEWG sites, 
Seattle led the group in 2001 with 75 mentions per 
100,000 population. San Diego, San Francisco, and 
Phoenix had the lowest population-adjusted rates 
(44– 45 per 100,000 population) (exhibit 4).  
 
In terms of unadjusted ED mentions, the age group 
with the largest proportion of ED marijuana mentions 
was the 35-and-older group (38 percent), followed by 
those age 18– 25 (27 percent) and 26– 34 (22 percent). 
The age group with the highest rate of ED marijuana 
mentions was 18– 25-year-olds (119 per 100,000 
population), followed by those age 26– 34 (106 per 
100,000 population) and the 35-and-older group (51 per 
100,000 population). The population-adjusted rates 
more accurately reflect which group in Los Angeles 
County is accessing emergency department services for 
marijuana-related health problems and emergencies. 
 
The percentage of primary marijuana admissions 
among all Los Angeles County treatment and 
recovery program admissions increased 32 percent, 
from 9 percent of all admissions in July– December 
2001 to 11 percent of all admissions in January– June 
2002 (exhibit 5). This increase followed a 10-percent 
decrease in the total number of marijuana admissions 
from the first to second half of 2001. Males (74 
percent) and individuals younger than 18 (51 percent) 
constituted the majority of these admissions; 48 
percent were Hispanic (up from 43 percent in July-
December 2001), 25 percent were Black, and 18 
percent were White (exhibit 6). The proportion of 
young marijuana users was up again, after having 
declined from the first to second half of 2001. In 
July– December 2001, 47 percent of the primary 
marijuana admissions were among those younger 
than 18, compared with 51 percent in the first half of 
2002. Alcohol was identified as a secondary drug 
problem for 44 percent of the primary marijuana 
admissions in the first half of 2002. An additional 10 
percent reported either cocaine or methamphetamine 
as their secondary drug problem. Compared with 
other major illicit drug admissions, primary 
marijuana admissions had the largest proportion of 
males (74 percent) and users age 17 and younger (51 
percent). When asked whether they had used any 
drug intravenously in the year prior to admission, 
only 1 percent of all primary marijuana admissions 
answered affirmatively (exhibit 7). 
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Eight percent of the primary marijuana treatment 
admissions in the first half of 2002 were homeless at 
the time of admission, and two-fifths (40 percent) 
were referred to treatment by the court or criminal 
justice system. Seventy percent were entering 
treatment for the first time. Twenty-one percent had 
graduated from high school, and, at the time of 
admission, 13 percent were employed full- or part-
time (exhibit 7). Such characteristics reflect the fact 
that one-half of all primary marijuana admissions 
were younger than 18 at the time of admission.  
 
According to CHKS data for the 2001– 2002 school 
year, 22.9 percent of all Los Angeles County 
secondary school students who responded to the 
survey had ever used marijuana, and 12 percent had 
used marijuana in the past 30 days (exhibit 8).  A 
breakdown of the data by grade level illustrated that 
among responding 7th-graders, 7.8 percent had ever 
used marijuana, and 4.4 percent had used in the past 
30 days. Among 9th-graders, 22.2 percent had ever 
used marijuana, and 12.0 percent were current 
marijuana users. Rates of both lifetime and current 
marijuana use were highest among 11th-graders: 37.5 
percent had ever used marijuana and 18.0 percent 
used marijuana within the past 30 days. 
 
A total of 2,402 marijuana arrests were made within 
the city of Los Angeles in the first half of 2002. This 
represented a 13-percent decrease from the number of 
marijuana arrests made in the first half of 2001. Mari-
juana arrests accounted for roughly 20 percent of all 
narcotics arrests made between January and June 2002. 
 
Citywide marijuana seizures decreased 43 percent, 
from 8,012 pounds seized in January– June 2001 to 
4,539 pounds seized in January– June 2002. The street 
value of the seized marijuana accounted for approx-
imately 34 percent of the total street value of all 
drugs seized in the first half of 2002. 
 
Mexican low-grade marijuana was prevalent through-
out the Los Angeles HIDTA. The wholesale price of 
low-grade marijuana ranged from $300– $400 per 
pound to $60– $80 per ounce. The retail price for a 
gram of commercial grade marijuana was $10 per 
gram. All wholesale and retail prices remained stable 
from the second half of 2001. According to LA 
CLEAR, domestic midgrade outdoor and indoor 
growers continued to increase their share of the local 
marijuana market. The wholesale price of domestic 
midgrade marijuana ranged from $1,000 to $1,200 
per pound and from $200 to $250 per ounce. A gram 
of domestic midgrade marijuana sold for $25 on the 
street. Sinsemilla (high-grade) marijuana has a very 
high tetrahydrocannabinol (THC) content and is 
prized for its high potency. Wholesale prices of 
sinsemilla were as follows: $2,500– $6,000 per pound 
and $400– $600 per ounce. One-eighth ounce of 
sinsemilla has a retail price range of $60– $80. There 
were indications that “ BC Bud,”  a hybrid type of 
cannabis bud grown in Canadian British Columbia, 
continued to be smuggled into Southern California. A 
pound of BC Bud had a wholesale value of $6,000. 
Supposedly, a pound of BC Bud was being swapped 
straight across for a pound of cocaine. Demand for 
hashish, the compressed form of THC-rich resinous 
cannabis material, remained limited throughout the 
Los Angeles HIDTA; when it was available, it had a 
wholesale price of $8,000 per pound. 
 
Stimulants 
 
Methamphetamine was among the top five most 
frequently mentioned major substances of abuse in the 
DAWN Los Angeles-Long Beach metropolitan area in 
the year 2001, accounting for 3.4 percent of all ED drug 
mentions. ED mentions of amphetamines accounted for 
an additional 2.8 percent. Methamphetamine mentions 
have experienced numerous statistically significant 
increases over the past few years. From 1999 to 2001, 
there was a 67-percent increase. Following the same 
trend, methamphetamine mentions increased 
significantly from 2000 to 2001 (10 percent), from 
1,375 to 1,517 mentions (exhibit 2). Amphetamine 
mentions increased significantly (46 percent) from 1999 
(866 mentions) to 2001 (1,261 mentions). From 2000 to 
2001, amphetamine mentions continued to increase (18 
percent), but the increase was not statistically 
significant. The proportions of ED methamphetamine 
and amphetamine mentions among ED drug episodes 
have remained stable at approximately 6 percent and 5 
percent, respectively, since 1996. ED methamphetamine 
mentions remained relatively stable in 2001, increasing 
slightly (6 percent) from the first half to the second half 
of the year (exhibit 3). The number of ED amphetamine 
mentions totaled 630 in the first half of 2001 and 631 in 
the second half. 
 
In 2001, 73 percent of the ED methamphetamine 
mentions reported occurred among males, 46 percent 
occurred among Whites, and 39 percent occurred 
among Hispanics. A comparable proportion of 18–
25-year-olds, 26– 34-year-olds, and those age 35 and 
older mentioned methamphetamine during an ED 
drug episode (30, 32, and 29 percent, respectively).   
 
Approximately two-thirds (65 percent) of all ED 
methamphetamine mentions occurred during multi-
drug episodes. When asked about drug use motive, 58 
percent reported methamphetamine dependence, and 
another approximately 30 percent reported psychic 
effects. Chronic effects and unexpected reaction were 
reported as reasons for ED contact among 43 percent 
and 34 percent of the mentions, respectively.  
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Five of the six western CEWG sites continued to 
dominate for the rate of population-adjusted metham-
phetamine ED mentions in 2001. San Francisco led 
with 39 mentions per 100,000 population, followed 
by San Diego (27 mentions), Phoenix (21 mentions), 
and Los Angeles and Seattle (each with 18 mentions) 
(exhibit 4). Denver had just 5 mentions per 100,000 
population, which was nearly identical to the rate for 
the coterminous United States (6 mentions). 
 
Primary methamphetamine admissions to Los Angeles 
County treatment and recovery programs continued to 
increase. The 3,453 primary methamphetamine 
admissions that were reported in January– June 2002 
accounted for nearly 15 percent of all admissions 
(exhibit 5). Among those admissions, 58 percent were 
male (up slightly from 55 percent in the second half of 
2001) (exhibit 6). Nearly 67 percent of the admissions 
were age 18– 35. Whites (47 percent) were the 
predominant racial/ ethnic group among primary 
methamphetamine admissions, followed rather closely 
by Hispanics (37 percent). It is interesting to note that 
the decrease in the proportion of Whites was the same 
as the increase in the proportion of Hispanics entering 
treatment in the first half of 2002 (4 percent). 
Compared with other major illicit drug admissions, 
primary methamphetamine admissions had the largest 
proportion of females (42.2 percent), Whites (47.4 
percent), Asian/Pacific Islanders (3.9 percent), 18– 25-
year-olds (28.3 percent), and 26– 35-year-olds (38.3 
percent).  
 
On November 7, 2000, California voters approved 
the Substance Abuse and Crime Prevention Act 
(SACPA) of 2000 (a.k.a. Proposition 36), which 
mandates probation and community-based treatment 
instead of incarceration for nonviolent drug offenses.  
An observation made early on in the implementation 
process was that there was a high percentage of 
admissions for primary methamphetamine abuse. In 
Los Angeles County, primary methamphetamine 
abuse was reported by 32 percent of all SACPA-
referred treatment admissions from January to June 
2002. Among non-SACPA-referred clients admitted 
during the same 6-month period, only 12 percent 
reported primary methamphetamine abuse. The same 
pattern was seen at the State level. The California 
Department of Alcohol and Drug Program’s First 
Annual Report to the Legislature stated that from 
July through December 2001, 48 percent of the 
statewide SACPA treatment admissions reported 
methamphetamine abuse as their primary problem. 
The proportion of non-SACPA admissions identi-
fying methamphetamine as the primary drug of abuse 
was much lower (approximately 20 percent).  
 
The demographics for primary amphetamine 
admissions were roughly comparable to primary 
methamphetamine admissions in terms of age and 
race/ ethnicity, except that a slightly lower proportion 
of Whites reported amphetamine rather than 
methamphetamine as their primary problem. And 
unlike primary methamphetamine admissions, more 
females (52 percent) than males (48 percent) reported 
amphetamines as their primary problem.  
 
The greatest percentage of primary methamphetamine 
admissions reported smoking as their preferred route 
of administration (61 percent). Intranasal admin-
istration (snorting) and intravenous injection followed 
suit, at 24 and 10 percent, respectively.  When asked 
whether they had used any drug intravenously in the 
year prior to admission, 15 percent of all primary 
methamphetamine admissions reported that they had 
used needles to administer one or more drugs 
intravenously at least once during the specified time 
period (exhibit 7). The preferred routes of admin-
istration for other amphetamine admissions were 
smoking (53 percent), snorting (21 percent), and oral 
ingestion (11 percent). An interesting shift in the route 
of other amphetamine administration occurred 
between the fall of 2001 and the spring of 2002. From 
July to December 2001, 5 percent of primary other 
amphetamine admissions reported injection as their 
primary route of administration. But from January to 
June 2002, the proportion preferring to inject doubled 
to 10 percent (equal to the proportion of primary 
methamphetamine injectors during the same time 
period). Primary methamphetamine and other amphet-
amine admissions tended to most frequently report 
secondary alcohol or marijuana abuse. 
 
Approximately one-fifth of the primary meth-
amphetamine treatment admissions were homeless at 
time of admission (21 percent), and slightly more 
than one-quarter were referred by the court or 
criminal justice system (29 percent) (exhibit 7). 
Nearly one-half (47 percent) were entering treatment 
with a primary methamphetamine problem for the 
first time. Forty-two percent had graduated from high 
school, and, at the time of admission, 17 percent were 
employed full- or part-time. 
 
According to CHKS data for the 2001– 2002 school 
year, 8.3 percent of all Los Angeles County 
secondary school students who responded to the 
survey had ever used methamphetamine (including 
crystal, “ ice,”  speed, and other amphetamines), and 
4.1 percent had used methamphetamine in the past 30 
days (exhibit 8). A breakdown of the data by grade 
level illustrated that among responding 9th-graders, 
5.6 percent had ever used methamphetamine, and 2.9 
percent were current users of methamphetamine. 
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Among 11th-graders, 9.0 percent had ever used 
methamphetamine, and 3.7 percent had used the drug 
within the past 30 days. 
 
Sixty-five amphetamine arrests were made within the 
City of Los Angeles in the first half of 2002, which 
nearly matched the number of arrests made in the 
first half of 2001 (64). Amphetamine arrests 
accounted for less than 1 percent of all narcotics 
arrests made between January and June 2002. 
 
Citywide methamphetamine seizures decreased 80 
percent, from 192 pounds seized in January– June 
2001 to 39 pounds seized in January– June 2002. The 
street value of the seized methamphetamine ac-
counted for approximately 3 percent of the total street 
value of all drugs seized in the first half of 2002. 
 
The wholesale price per pound of methamphetamine 
ranged from $3,700−$5,000, which was the 
wholesale price level seen in late 2000 and early 
2001. The street value ranged from $450 to $550 per 
ounce (down from $500– $700), $100– $120 for one-
eighth ounce (“ eightball” ), and $60 for one-sixteenth 
ounce (“ teener” ). According to LA CLEAR, there are 
indications that the purity level of finished 
methamphetamine is once again increasing in 
potency. Mexican national methamphetamine traf-
fickers continue to cut the drug with methyl-
sulfonylmethane (MSM), but they are beginning to 
increase the purity to levels seen several years ago. 
The purity of methamphetamine available in the Los 
Angeles area has increased recently to approximately 
30– 35 percent. This development signals a reversal 
of a long-standing trend that saw a reduction in 
methamphetamine purity to a low of 15 to 20 percent.  
 
Ice, a potent form of methamphetamine, was not 
frequently encountered in the Los Angeles area. 
Anecdotal evidence from several local sources sug-
gests, however, that ice was smuggled from California 
to Hawaii by Asian organized criminal groups. A 
pound of ice that would sell for $22,000– $31,000 in 
Los Angeles sold for between $35,000 and $40,000 
(wholesale) in Hawaii. The retail price for an ounce of 
ice ranged from $600 to $800. A double case of 
pseudoephedrine (60-milligram tablets/17,000 tablets 
per case) sold for $2,800– $3,400 (up from $2,000–
$3,400). In addition, a 1,000-count bottle of 60-mil-
ligram tablets sold for $200.  
 
According to NDIC in its 2002 report, Mexican drug 
trafficking organizations and criminal groups 
continued to dominate the production and distribution 
of methamphetamine in California. The groups used 
established smuggling and distribution networks to 
supply methamphetamine to markets throughout the 
State. Local independent dealers, street gangs, and 
outlaw motorcycle gangs played a role in distributing 
the drug, as well. 
 
According to LA CLEAR, from April to June 2002 a 
total of 179 methamphetamine clandestine lab 
activities occurred throughout the LA HIDTA. 
Seventy-five percent of these activities were lab-
oratory seizures. With 135 methamphetamine lab 
seizures, the LA HIDTA led all California HIDTAs 
in clandestine lab seizures. Combined seizures in Los 
Angeles and San Bernardino Counties accounted for 
60 percent (30 percent in each county) of all lab 
seizures in the LA HIDTA from April to June 2002.  
 
The LA HIDTA reported the most dumpsites as 
well— a total of 33. Most of the dumpsites were 
reported in San Bernardino and Riverside Counties, 
with 16 and 13 dump sites reported, respectively. The 
location of a dumpsite is often indicative of a 
methamphetamine clandestine lab operation that is 
producing methamphetamine at a nearby location or a 
lab that operates in seclusion.   
 
The production of methamphetamine has major 
effects on the environment, as evidenced by the death 
of livestock, the contamination of streams, and the 
destruction of large trees and vegetation that results 
from the precursor chemicals used in manufacturing 
the drug. In its May 2002 Drug Threat Assessment 
Update, NDIC stated that in 2001, the California 
Department of Toxic Substances Control conducted 
more than 2,000 methamphetamine lab and dumpsite 
cleanups. The cleanups were estimated to cost 
California taxpayers close to $5.5 million, or $2,450 
per lab. These figures do not encompass building and 
environment remediation, which costs taxpayers even 
more money.  
 
According to the Associated Press (“ Number of Meth 
Raids Increasing in Missouri,”  November 5, 2002), 
Missouri has surpassed California to lead the Nation 
in methamphetamine-related law enforcement activ-
ity, with 2,130 raids on drug labs or discoveries of 
ingredient caches and methamphetamine-related 
dumps. A difference exists, however, in the yield of 
methamphetamine labs in California and Missouri. In 
California, most methamphetamine is made in so-
called “ superlabs,”  which can make as much as 10 
pounds of finished methamphetamine in an 8-hour 
period. Missouri labs tend to be much smaller (i.e., 
kitchen-, garage-, or automobile-based) and are 
capable of producing only a few ounces in the same 
8-hour period. 
 
On September 22, 2002, the Napa Valley Register 
reported that the newest thing to hit the underground 
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club scene in California is a “ sweet, colorful little pill 
that can keep someone dancing all night long.”  The 
pill is a new form of methamphetamine called “ ya ba,”  
which is Thai for “ crazy drug.”  The drug is sig-
nificantly more powerful and dangerous than ecstasy. 
In its pill form, ya ba is sometimes passed off at raves 
as ecstasy. So far, the drug has mostly appeared in 
Southeast Asian communities throughout California. 
In August 2002, 10 individuals in Sacramento were 
arrested for allegedly smuggling 75,000 pills from 
Thailand and Laos. In addition, the U.S. Customs 
Service seized 46 shipments of ya ba in Oakland, San 
Francisco, Los Angeles, and Honolulu. All shipments 
were destined for Sacramento addresses.  
 
Depressants  
 
Los Angeles ED mentions of psychotherapeutic 
agents, which include mentions of antidepressants, 
barbiturates, and benzodiazepines, decreased sig-
nificantly (17 percent), from 4,460 mentions in 2000 
to 3,694 mentions in 2001. All three individual sub-
groups showed signs of decline, but the only statisti-
cally significant decrease was seen among antide-
pressants (20 percent). Nonsignificant decreases were 
reported for benzodiazepines (from 2,113 to 1,823 
mentoins) and barbiturates (from 333 to 325 men-
tions) from 2000 to 2001. ED mentions of benzodia-
zepines primarily consisted of alprazolam (Xanax, 
with 263 mentions), clonazepam (Klonopin, with 261 
mentions), diazepam (Valium, with 267 mentions), 
and lorazepam (with 167 mentions). Frequently 
mentioned barbiturates included pentobarbital (31 
mentions) and phenobarbital (34 mentions). 
 
The rates per 100,000 population for ED mentions of 
antidepressants (n=9) and benzodiazepines (21) were 
consistently lower in the Los Angeles-Long Beach 
metropolitan area than in the coterminous United 
States (24 and 41 per 100,000 population, 
respectively). The population-adjusted rate for men-
tions of barbiturates, however, was identical for both 
Los Angeles and the coterminous United States (4 per 
100,000 population).   
 
In the first half of 2002, treatment and recovery pro-
gram admissions associated with primary barbiturate, 
benzodiazepine, or other sedative/ hypnotic abuse con-
tinued to comprise less than 1 percent of all admissions 
in Los Angeles County. 
 
Hallucinogens 
 
The proportion of ED hallucinogen mentions among 
ED drug episodes continued to remain low. ED men-
tions of phencyclidine (PCP) far outweigh ED lysergic 
acid diethylamide (LSD) mentions. The number of ED 
PCP mentions increased, though not significantly, 
from 2000 to 2001. ED mentions of miscellaneous 
hallucinogens remained stable at approximately 86 
mentions. Conversely, ED LSD mentions experienced 
a statistically significant decrease of 19 percent from 
2000 to 2001. The rate of PCP ED mentions per 
100,000 population has remained low and relatively 
stable since the mid 1990s. The population-adjusted 
rate of LSD mentions decreased significantly (18 per-
cent) from 2000 to 2001.  
 
Over the past several years, the proportion of primary 
PCP admissions has stabilized at approximately 1 
percent. The number of primary PCP admissions 
remained relatively stable from the second half of 
2001 (207) to the first half of 2002 (196). Alcohol 
(30 percent), marijuana (22 percent), and cocaine (14 
percent) were the secondary drugs used most 
frequently by primary PCP admissions. The vast 
majority (95 percent) of PCP admissions continued to 
smoke the drug. There were no notable changes from 
the previous reporting period in terms of user 
demographics. Other hallucinogens, such as LSD, 
peyote, and mescaline continued to account for 
approximately 0.1 percent of the total treatment 
admissions. 
 
According to CHKS data for the 2001– 2002 school 
year (exhibit 8), 7.9 percent of all Los Angeles 
County secondary school students who responded to 
the survey had ever used LSD or another psychedelic, 
and 3.3 percent had used LSD/other psychedelics in 
the past 30 days.  A breakdown of the data by grade 
level illustrated that among responding 9th-graders, 
5.3 percent had ever used LSD/other psychedelics, 
and 2.5 percent were current LSD/other psychedelics 
users. Among 11th-graders, 9.1 percent had ever used 
LSD/other psychedelics, and 3.1 percent had used the 
drug within the past 30 days.  
 
Ninety-one PCP arrests were made within the city of 
Los Angeles in the first half of 2002. This represented 
a 42-percent increase from the number of PCP arrests 
made in the first half of 2001. PCP arrests accounted 
for less than 1 percent of all narcotics arrests made 
between January and June 2002. 
 
Citywide PCP seizures increased substantially (by 
over 685 percent) from the first half of 2001 to the 
first half of 2002 (from 22 pounds seized in January–
June 2001 to 173 pounds seized in January– June 
2002). The street value of the PCP seized between 
January and June 2002 represented roughly 11 
percent of the total street value of all drugs seized 
during that time period.  
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The wholesale price range for a gallon of PCP remained 
at $6,500– $8,000; retail prices are $125– $175 per ounce 
and $20– $30 per sherm cigarette. Los Angeles-based 
Black street gangs continued to produce, supply, and 
distribute PCP in the Los Angeles area.   
 
A sheet of approximately 100 doses of LSD had a 
wholesale price range of $150– $200. Typically, a 
single dose sold on the streets for $5– $10. At the 
retail level, psilocybin mushrooms continued to run 
at about $20 per one-eighth ounce.  
 
Club Drugs 
 
Anecdotal evidence continued to circulate throughout 
the Los Angeles area regarding the use of club drugs, 
particularly ecstasy and gamma hydroxybutyrate 
(GHB). Currently, individual club drugs do not have 
separate entries under the “ primary drug”  section of the 
CADDS admission/discharge questionnaire. Instead, if 
an individual enters treatment for primary GHB, keta-
mine, or ecstasy abuse, his or her primary drug problem 
is most likely listed as methamphetamine, other 
amphetamines, other stimulants, or other tranquilizers.  
 
ED club drug mentions continued to represent a much 
smaller percentage of all mentions than mentions of 
other major substances of abuse. In 2001, 142 ED 
mentions for methylenedioxymethamphetamine 
(MDMA) were reported to the DAWN system in the 
Los Angeles area. This represented a statistically 
significant decrease of 20 percent from 2000. MDMA 
mentions were more likely to be male (53 percent) and 
White (35 percent) or Hispanic (29 percent). In addition, 
they were equally likely to be 18– 25-year-olds or 26–
34-year-olds (40 percent). Furthermore, two-thirds of all 
MDMA mentions were part of multidrug episodes. 
Nearly 50 percent involved a drug use motive of psychic 
effects. More than one-half (51 percent) visited the 
emergency department because of an unexpected 
reaction. Nearly 70 percent were treated and released. 
Twenty-five percent were admitted to the hospital.    
 
ED mentions of GHB experienced an even greater 
statistically significant decrease of 44 percent, from 
149 mentions in 2000 to 83 mentions in 2001. This 
decrease corresponds to half-year decreases that were 
noted in the June 2002 CEWG proceedings. 
Mentions of ketamine and flunitrazepam (Rohypnol) 
remained marginal.  
 
The general demographics of ED GHB mentions 
were quite different from those of ED MDMA men-
tions. In 2001, 9 out of 10 GHB mentions occurred 
among males, a shift 2000, when the proportion of 
male GHB mentions was 72 percent. In 2001, 71 
percent of the GHB mentions occurred among 
Whites, and an additional 14 percent occurred among 
Hispanics. In 2000, the racial/ethnic makeup of the 
GHB mentions was slightly different— 80 percent 
were White, and only 5 percent were Hispanic. In 
2001, 51 percent of the GHB mentions occurred 
among individuals age 26– 34, followed by 31 percent 
among 18– 25-year-olds and 16 percent among those 
aged 35 or older. Like ED MDMA mentions, 
approximately two-thirds of GHB mentions were part 
of a multidrug episode. Nearly 81 percent reported 
psychic effects as their drug use motive. Fifty-two 
percent visited the emergency department because of 
an unexpected reaction, and 41 percent visited for 
overdose. Most (77 percent) of the individuals were 
treated and released.  
 
According to CHKS data for the 2001– 2002 school 
year, 8.3 percent of all Los Angeles County secon-
dary school students who responded to the survey 
had ever used ecstasy (exhibit 8). Lifetime ecstasy 
use ranged from 2.6 percent among 7th-graders, to 
6.0 percent among 9th-graders and 9.6 percent among 
11th-graders. Students were not asked about past-
month ecstasy use.   
 
All wholesale and retail prices for club drugs have 
remained stable since the second half of 2001. In 
multiple quantities, MDMA had a wholesale price of 
$12 per pill or capsule. At the retail level, ecstasy 
usually sold for $25– $40 per pill. A standard dose of 
ecstasy is 60– 150 milligrams, which is equivalent to 
about 1– 2 pills. In Los Angeles, there is something 
known as a “ boat.”  A boat contains 1,000 MDMA 
pills and sells for $8,000. Rohypnol had a retail value 
of $6– $10 for a 1-milligram pill. The wholesale and 
retail prices of GHB were $65– $100 per 16-ounce 
bottle and $5– $20 per bottle capful, respectively. The 
vast majority of GHB users ingested the drug as a 
liquid, either in straight shots or mixed with a drink. 
Lastly, on the streets, ketamine sold for $60– $100 for 
a 10-milliliter vial or $20 for two-tenths grams of 
powder. In the party scene, ketamine is often taken 
with MDMA, which is known as “ kitty flipping.”   
 
According to an NDIC “ Information Bulletin”  
(August 2002), more than 57 individuals in southern 
California were arrested in connection with a 2-year 
investigation involving the production and distribu-
tion of methamphetamine, distribution of MDMA, 
and drug money laundering on August 8, 2002. 
Throughout the course of the investigation, 33 
pounds of methamphetamine, 8 pounds of crystal 
methamphetamine, 196 gallons of methamphetamine 
oil, and 100 pounds of pseudoephedrine were seized. 
Weapons, vehicles, money, and 30,000 MDMA tab-
lets were seized as well. 
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INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
A cumulative total of 44,308 adult/adolescent AIDS 
cases were reported in Los Angeles County through 
June 30, 2002. Of those cases, 415 were reported 
between April 1, 2002, and June 30, 2002. Approxi-
mately 16,663 Los Angeles County residents are 
currently living with advanced HIV disease. Los 
Angeles County cumulative cases represent approx-
imately 35 percent of the 125,848 cumulative cases in 
California and 6 percent of the 793,026 cumulative 
cases nationwide. Of the total cases reported in Los 
Angeles County, 49 percent occurred among Whites, 
29 percent among Hispanics, 20 percent among 
Blacks, 45 percent among 30– 39-year-olds, and 93 
percent among males. 
 
In 2001, 60 percent of males diagnosed with AIDS 
were exposed to the disease through male-to-male 
sexual contact. This proportion is down from 76 per-
cent in 1995 (exhibit 9). The proportion of males 
exposed through injection drug use, a combination of 
male-male sexual contact and injection drug use, het-
erosexual contact, blood transfusion, or hemo-
philia/coagulation disorder remained relatively stable 
between 1995 and 2001. The “ other or undetermined”  
exposure category accounted for 9 percent of all males 
diagnosed in 1995. The proportion of male cases with 
an exposure category of “ other or undetermined”  rose 
steadily over the years to eventually account for 21 
percent of all male cases diagnosed in 2001.  
 
The modal exposure category for females diagnosed 
with AIDS in 1995 was heterosexual contact (55 per-
cent). This exposure category has been associated 
with a lesser proportion of female AIDS cases since 
then, and in 2001, was associated with 28 percent of 
all newly diagnosed female AIDS cases. Female cases 
attributable to injection drug use remained relatively 
stable, ranging from 27 percent of all female cases in 
1995 to 20 percent of all female cases in 2001 (exhibit 
9). As was the case with males diagnosed with AIDS, 
the proportion of female cases with an exposure cate-
gory of “ other or undermined”  increased dramatically 
from 14 percent of all female cases in 1995 to 50 per-
cent of all female cases in 2001.  
 
In Los Angeles County, less than one-tenth (7 per-
cent) of the total cumulative AIDS cases involved 
injection drug use (alone) as the primary route of 
exposure. Among the 3,108 cases primarily attribut-
able to injection drug use, 74 percent occurred among 
males. Black males continued to be the modal group 
of male injection drug users (IDUs) (accounting for 
38 percent), followed by White males (31 percent) 
and Hispanic males (30 percent). For AIDS cases 
among female IDUs, Blacks continued to represent 
the majority (45 percent), followed by Whites (31 
percent) and Hispanics (22 percent). An additional 6 
percent of the total cumulative cases were attributable 
to a combination of male-to-male sexual contact and 
injection drug use. Fifty-three percent of the male-to-
male sexual contact and injection drug use cases oc-
curred among White males.  
 
The Supplement to the HIV/AIDS Surveillance 
(SHAS) Project is a U.S. Centers for Disease Control 
and Prevention-sponsored interview study designed 
to obtain supplemental descriptive information on 
persons diagnosed with AIDS. The project began in 
1990 and is conducted in Los Angeles County and 18 
other sites in the United States. The SHAS question-
naire includes information on demographics; sexual 
behaviors and sexually transmitted disease (STD) 
history; drug and alcohol use; reproductive/ 
gynecological history; HIV testing and medical 
therapy; and health and social services. In June 2002, 
the SHAS Project released an annual report through 
the HIV Epidemiology Program. Included in the 
report was a section on alcohol and drug use captured 
in interviews conducted from 1995 to 2000. Sixty 
percent of males and 41 percent of females reported 
ever using non-injection drugs. Of those, 74 percent 
of both males and females had used non-injection 
drugs in the prior 5 years. Additional information on 
non-injection drug use, such as type(s) of drugs used 
in the past 5 years is highlighted in exhibit 10. Fifteen 
percent of males and 14 percent of females had 
injected drugs in the prior 5 years (exhibit 11). Also, 
24 percent of males and 28 percent of females had 
injected drugs in the past year. Of those individuals, 
20 percent of males and 52 percent of females 
injected drugs several times a day. Finally, 30 percent 
of males and 57 percent of females had shared 
needles in the past year.  
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Exhibit 1. Healthy Cities, Healthy Suburbs: A Look at the Three California CEWG Areas 
 
Healthy People 2000/2010 
Objectives 
Healthy People 
Rate 
Los Angeles/Long 
Beach/Glendale, California 
San Diego, 
California 
San Francisco, 
California 
Low birth weight (percent of all 
live births), 1999 5.0 
City 6.7 
Suburb 6.4 
City 6.3 
Suburb 5.6 
City 6.8 
Suburb 5.7 
Infant mortality (deaths per 
1,000 live births), 1999 7.0 
City 6.0 
Suburb 4.8 
City 5.4 
Suburb 5.1 
City 3.8 
Suburb 3.5 
Tuberculosis (cases per 
100,000 population), 2000 3.5 
City 12.0 
Suburb 12.3 
City 13.8 
Suburb 3.7 
City 21.9 
Suburb 6.8 
AIDS (cases per 100,000 
population), 2000 43.0 
MSA 18.0 MSA 16.0 MSA 44.0 
Syphilis (cases per 100,000 
population), 2000 4.0 
City 1.5 City 1.0 City 7.1 
Gonorrhea (cases per 100,000 
population), 2000 100.0 
City 84.0 City 64.0 City 289.0 
Homicide (homicides per 
100,000 population), 1999 7.2 
City 10.9 
Suburb 8.1 
City 4.7 
Suburb 3.1 
City 8.2 
Suburb 2.1 
 
SOURCE:  SUNY Downstate Medical Center, Brooklyn, New York, August 2002 
 
 
 
Exhibit 2. Los Angeles-Long Beach Annual Estimated ED Mentions for Selected Drugs and 
Percentage of Mentions Per Drug in Total Drug Episodes: 1997–2001 
 
1997 1998 1999 2000 2001 Substance of 
Abuse Number Percent Number Percent Number Percent Number Percent Number Percent 
Alcohol-in-
Combination 4,650 (27) 6,129 (36) 8,195 (40) 10,993 (43) 10,907 (44) 
Cocaine 4,703 (27) 5,779 (34) 6,768 (33) 9,094 (36) 9,999 (41) 
Heroin 2,471 (14) 2,601 (15) 2,923 (14) 3,177 (13) 2,878 (12) 
Marijuana 2,084 (12) 3,422 (20) 5,472 (26) 5,846 (23) 5,729 (23) 
Methamphetamine 1,229 (7) 786 (5) 910 (4) 1,375 (5) 1,517 (6) 
Amphetamines 728 (4) 541 (3) 866 (4) 1,072 (4) 1,261 (5) 
PCP 696 (4) 605 (4) 731 (4) 823 (3) 990 (4) 
LSD 186 (1) 162 (<1) 229 (1) 217 (<1) 175 (<1) 
Total Drug 
Episodes 17,187 17,103 20,667 25,286 24,669 
Total Drug 
Mentions 29,684 29,805 36,945 45,015 44,670 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
Exhibit 3. Estimated Semiannual ED Mentions in Los Angeles-Long Beach:  
   January 1997 to December 2001 
 
Year 1H97 2H97 1H98 2H98 1H99 2H99 1H00 2H00 1H01 2H01 
Cocaine 2,295 2,408 2,629 3,150 3,183 3,586 4,622 4,472 4,876 5,123 
Heroin 1,324 1,147 1,214 1,387 1,431 1,491 1,791 1,386 1,506 1,372 
Marijuana 1,061 1,023 1,343 2,079 2,517 2,955 3,219 2,627 2,814 2,915 
Methamphetamine 596 633 418 368 414 496 682 693 737 780 
Amphetamines 337 391 272 268 410 456 532 540 630 631 
 
SOURCE:  DAWN, OAS, SAMHSA 
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Exhibit 4.  Population-Adjusted ED Rates Per 100,000 Population for Major Illicit Drug Mentions  
  Among Western U.S. CEWG Sites: 1997–2001 
 
Drug Mentions 1997 1998 1999 2000 2001 
Cocaine 
     Denver 
     Los Angeles 
     Phoenix 
     San Diego 
     San Francisco 
     Seattle 
 
69 
56 
66 
36 
126 
150 
 
73 
68 
73 
41 
116 
125 
 
87 
79 
91 
44 
120 
130 
 
83 
105 
85 
41 
126 
169 
 
69 
117 
62 
32 
158 
160 
Heroin 
     Denver 
     Los Angeles 
     Phoenix 
     San Diego 
     San Francisco 
     Seattle 
 
30 
30 
41 
39 
173 
152 
 
31 
31 
43 
41 
148 
126 
 
40 
34 
41 
44 
190 
127 
 
41 
37 
40 
42 
168 
126 
 
40 
34 
27 
29 
178 
90 
Marijuana 
     Denver 
     Los Angeles 
     Phoenix 
     San Diego 
     San Francisco 
     Seattle 
 
32 
25 
37 
41 
25 
87 
 
37 
40 
36 
47 
25 
49 
 
43 
64 
50 
38 
29 
42 
 
51 
67 
51 
39 
38 
72 
 
50 
67 
45 
44 
45 
75 
Methamphetamine 
     Denver 
     Los Angeles  
     Phoenix 
     San Diego 
     San Francisco  
     Seattle 
 
19 
15 
40 
41 
64 
25 
 
8 
9 
22 
30 
39 
14 
 
6 
11 
17 
24 
34 
18 
 
7 
16 
29 
31 
36 
27 
 
5 
18 
21 
27 
39 
18 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
 
Exhibit 5. Number of Treatment Admissions in Los Angeles County by Primary Illicit Drug of 
Abuse: January 2000–June 2002 
 
Drug 01/00–06/00 07/00–12/00 01/01–06/01 07/01–12/01 01/02–06/02 
Cocaine 4,609 4,342 4,349 4,354 4,655 
Heroin 12,333 10,642 9,527 8,033 7,767 
Marijuana 1,817 1,736 2,258 2,028 2,686 
Methamphetamine 2,181 1,959 2,403 3,015 3,453 
PCP 171 166 198 207 196 
Total Admissions 26,849 23,719 23,697 22,430 23,695 
 
SOURCE:  California Alcohol and Drug Data System (CADDS) 
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Exhibit 6. Characteristics of Treatment Admissions in Los Angeles County by Primary Illicit Drug  
 and Percent:  January–June 2002 
 
Characteristics Cocaine Heroin Marijuana Methamphet-
amine 
All 
Admissions 
Gender      
 Male 64.4 72.0 74.2 57.8 67.0 
 Female 35.6 28.0 25.8 42.2 33.0 
Race/Ethnicity      
 White/non-Hispanic 15.1 37.1 17.6 47.4 31.7 
 Black/non-Hispanic 57.4 12.1 25.2 3.8 24.2 
 Hispanic origin 20.9 44.5 48.5 37.1 35.9 
 American Indian <1.0 <1.0 <1.0 1.2 <1.0 
 Asian/Pacific Islander 1.5 <1.0 2.5 3.9 1.8 
 Other 4.6 4.8 5.6 6.6 5.5 
Age      
 17 and younger 1.1 <1.0 50.6 5.4 8.8 
 18–25 10.8 6.6 22.8 28.3 13.5 
 26–35 28.4 20.3 14.3 38.3 24.6 
 36 and older 59.7 73.0 12.3 28.0 53.1 
Route of Administration      
 Oral 2.3 1.2 2.6 4.0 21.0 
 Smoking 86.7 6.1 95.1 61.1 40.2 
 Inhalation 9.4 4.1 1.9 24.3 7.1 
 Injection <1.0 88.0 <1.0 9.6 30.6 
 Unknown/other <1.0 <1.0 <1.0 1.0 1.1 
Secondary Drug Alcohol Crack/ Cocaine Alcohol Marijuana Alcohol 
Total Admissions (N) (4,655) (7,767) (2,686) (3,453) (23,695) 
 
SOURCE:  California Alcohol and Drug Data System (CADDS) 
 
 
 
Exhibit 7: Additional Characteristics of Treatment Admissions in Los Angeles County by Primary  
 Illicit Drug of Abuse and Percent: January–June 2002 
 
Characteristics Cocaine Heroin Marijuana Methamphet-
amine 
All 
Admissions 
Percent Positive for 
IV Drug Use in Past 
Year 
5 90 1 15 34 
Percent Homeless 30 12 8 21 19 
Percent Employed 
Full- or Part-Time 14 27 13 17 19 
Percent Graduated 
from High School 43 49 21 42 42 
Percent Referred by 
Court/Criminal 
Justice System (Not 
Including SACPA1 
Referrals) 
27 4 40 29 19 
Percent First 
Treatment Episode 37 16 70 47 37 
Total Admissions 
(N) (4,655) (7,767) (2,686) (3,453) (23,695) 
 
1SACPA = Substance Abuse and Crime Prevention Act of 2000 (a.k.a., Proposition 36). 
 
SOURCE:  California Alcohol and Drug Data System (CADDS) 
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Exhibit 8. Drug Use Among Los Angeles County Secondary School Students by Percent: 
 2001–2002 School Year 
 
Usage Patterns Among 
Survey Respondents 7th Grade 9th Grade 11th Grade 
All 
Respondents1 
Cocaine (any form) 
     Lifetime 
     Past 30 days 
 
N/A2 
N/A 
 
5.5 
3.0 
 
8.4 
3.3 
 
8.0 
3.9 
Ecstasy 
     Lifetime 
     Past 30 days 
 
2.6 
N/A 
 
6.0 
N/A 
 
9.6 
N/A 
 
8.3 
N/A 
Heroin 
     Lifetime 
     Past 30 days 
 
N/A 
N/A 
 
3.3 
N/A 
 
3.5 
N/A 
 
4.0 
N/A 
Inhalants 
     Lifetime 
     Past 30 days 
 
10.0 
4.5 
 
12.9 
4.8 
 
15.5 
4.1 
 
13.2 
5.0 
LSD/Other Psychedelics  
     Lifetime 
     Past 30 days 
 
N/A 
N/A 
 
5.3 
2.5 
 
9.1 
3.1 
 
7.9 
3.3 
Marijuana 
     Lifetime 
     Past 30 days 
 
7.8 
4.4 
 
22.2 
12.0 
 
37.5 
18.0 
 
22.9 
12.0 
Methamphetamine 
     Lifetime 
     Past 30 days 
 
N/A 
N/A 
 
5.6 
2.9 
 
9.0 
3.7 
 
8.3 
4.1 
 
1All respondents include: responding 7th graders (when applicable), 9th graders, 11th graders, and a small sample of non-traditional  
 students (enrolled in continuation or alternative schooling programs).  
2
 N/A=Not applicable. 
 
SOURCE:  California Healthy Kids Survey, Los Angeles County Sample, WestEd
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Exhibit 9. Annual Adult/Adolescent AIDS Cases by Gender, Year of Diagnosis, and 
Exposure  Category: 1995–2001 
 
Adult/Adolescent  
Exposure Category1 
1995 
Number 
(%) 
1996 
Number 
(%) 
1997 
Number 
(%) 
1998 
Number 
(%) 
1999 
Number 
(%) 
2000 
Number 
(%) 
2001 
Number 
(%) 
Males 
Male-Male Sexual Contact 2,351 (76) 
1,807 
(74) 
1,195 
(66) 
1,041 
(63) 
911 
(63) 
722 
(61) 
597 
(60) 
Injection Drug User (IDU)  180 (6) 
163 
(7) 
129 
(7) 
101 
(6) 
78 
(5) 
81 
(7) 
75 
(8) 
Male-Male Sexual 
Contact/IDU 
197 
(6) 
144 
(6) 
104 
(6) 
91 
(6) 
69 
(5) 
62 
(5) 
55 
(6) 
Hemophilia or Coagulation 
Disorder 
12 
(<1) 
5 
(<1) 
10 
(<1) 
1 
(<1) 
2 
(<1) 
3 
(<1) 
5 
(<1) 
Heterosexual Contact 71 (2) 
47 
(2) 
61 
(3) 
59 
(4) 
45 
(3) 
44 
(4) 
51 
(5) 
Transfusion Recipient 15 (<1) 
14 
(<1) 
7 
(<1) 
3 
(<1) 
3 
(<1) 
4 
(<1) 
2 
(<1) 
Other/Undetermined 276 (9) 
264 
(11) 
319 
(17) 
344 
(21) 
339 
(23) 
266 
(23) 
214 
(21) 
Male Subtotal 3,102 2,444 1,825 1,640 1,447 1,182 999 
Females 
IDU 90 (27) 
71 
(26) 
69 
(26) 
40 
(20) 
38 
(19) 
30 
(15) 
30 
(20) 
Hemophilia or Coagulation 
Disorder 
0 
(0) 
0 
(0) 
0 
(0) 
1 
(0) 
0 
(0) 
0 
(0) 
0 
(0) 
Heterosexual Contact 187 (55) 
140 
(51) 
121 
(46) 
95 
(47) 
89 
(45) 
79 
(40) 
42 
(28) 
Transfusion Recipient 15 (4) 
9 
(3) 
7 
(3) 
3 
(1) 
3 
(2) 
0 
(0) 
3 
(2) 
Other/Undetermined 49 (14) 
57 
(20) 
66 
(25) 
63 
(32) 
68 
(34) 
89 
(45) 
74 
(50) 
Female Subtotal 341 277 263 202 198 198 149 
TOTAL 3,443 2,721 2,088 1,842 1,645 1,380 1,148 
 
1Exposure categories are ordered hierarchically. Cases with multiple exposure categories are included in the category listed first.  
 
SOURCE:  Los Angeles County Department of Health Services, HIV Epidemiology, Advanced HIV Disease (AIDS) Quarterly  
                  Surveillance Summary, Issued July 15, 2002 
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Exhibit 10. Non-Injection Drug Use— Supplement to HIV/AIDS Surveillance (SHAS) Project  
  Interviews: 1995–2000 
 
Males (n=1,312) Females (n=549) Non-Injection Drug Use Questions Number Percent Number Percent 
Ever used non-injection drugs 
     Yes 
     No 
 
782 
530 
 
60 
40 
 
224 
325 
 
41 
59 
Used non-injection drugs in past 5 years 
     Yes 
     No 
 
580 
202 
 
74 
26 
 
166 
58 
 
74 
26 
Non-injection drugs used in past 5 years 
     Heroin 
     Powder cocaine 
     Crack cocaine 
     Methamphetamine 
     Marijuana/hashish/THC 
     Amphetamines/speed (pills) 
     Nitrites (“poppers,” “rush,” “hardware”) 
 
45 
274 
189 
36 
446 
142 
67 
 
8 
47 
33 
6 
77 
24 
12 
 
28 
71 
98 
8 
113 
26 
1 
 
17 
43 
59 
5 
68 
16 
1 
 
SOURCE:  Supplement to HIV/AIDS Surveillance (SHAS) Project Los Angeles County, Annual Report, June 2002  
 
 
Exhibit 11. Injection Drug Use— Supplement to HIV/AIDS Surveillance (SHAS) Project  
  Interviews: 1995–2000 
 
Males (n=1,312) Females (n=549) Injection Drug Use Questions Number Percent Number Percent 
Used injection drugs (ever) 
     Yes 
     No 
 
194 
1,118 
 
15 
85 
 
75 
474 
 
14 
86 
Injection drugs used (ever) 
     Heroin 
     Cocaine 
     Heroin and cocaine (“speedball”) 
     PCP, ketamine, hallucinogens 
     Barbiturates 
     Stimulants/amphetamines/methamphetamine 
 
101 
29 
56 
11 
18 
83 
 
53 
15 
29 
6 
9 
43 
 
53 
4 
46 
3 
8 
15 
 
71 
5 
61 
4 
11 
20 
Injected drugs in the past year 
     Yes 
     No 
 
46 
148 
 
24 
76 
 
21 
54 
 
28 
72 
How often did you inject drugs in past year 
     Once a month or less 
     Once a week 
     Several times a week 
     Once a day 
     Several times a day 
 
18 
5 
7 
2 
8 
 
45 
13 
18 
5 
20 
 
4 
0 
3 
3 
11 
 
19 
0 
14 
14 
52 
Shared needles in past year 
     Yes 
     No 
 
14 
32 
 
30 
70 
 
12 
9 
 
57 
43 
How often did you share needles in past year 
     Sometimes (less than half the time) 
     Usually (more than half the time) 
     Every time 
     Don’t know/not sure 
 
6 
2 
6 
0 
 
43 
14 
43 
0 
 
7 
3 
1 
1 
 
58 
25 
8 
8 
 
SOURCE:  Supplement to HIV/AIDS Surveillance (SHAS) Project Los Angeles County, Annual Report, June 2002  
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Drug Abuse in Miami and South Florida 
 
James N. Hall,1 Joe Spillane, Pharm.D.,2 and Madeline Camejo, Pharm.D.3 
 
ABSTRACT 
 
Cocaine indicators remained stable at high levels, 
as the population abusing the drug continued to 
age. Cocaine remained the most frequently men-
tioned illicit substance in emergency department 
(ED) visits across the region. Many cocaine deaths 
also involved opioid abuse. Opioid abuse continued 
to diversify, with heroin, oxycodone, hydrocodone, 
and increasingly methadone diverted from medical 
pain management sources. Opioid abuse indicators 
appeared to be increasing; users remained pre-
dominantly White males older than 30 who also 
abuse benzodiazepines. Marijuana indicators con-
tinued to rise in Miami-Dade County, with DAWN 
ED mentions increasing 51 percent between 1999 
and 2001 and Broward County cocaine ED cases 
accounting for 51 percent of illicit drug cases in the 
first half of 2002. A 2002 statewide middle and high 
school survey revealed overall downward trends in 
the use of most substances. High school seniors in 
Florida were almost twice as likely to have tried 
ecstasy as cocaine and 10 times as likely to have 
tried ecstasy as crack cocaine. A relatively high per-
centage of ecstasy abusers were White. It is becom-
ing increasingly difficult to distinguish between 
ecstasy and other amphetamines, as use of 
amphetamines and methamphetamine increases 
and ecstasy pills become more adulterated with 
amphetamines or methamphetamine. GHB hospital 
episodes declined, but there were three deaths 
related to the use of this drug in Broward County 
during the first half of 2002. Indicators for three 
narcotic analgesics appeared to be increasing and 
bear watching in the future: methadone, hydro-
codone, and buprenorphine. Alprazolam (Xanax) 
remained popular among both younger and older 
drug abusers. 
 
INTRODUCTION 
 
Area Description 
 
Located in the extreme southern portion of the Florida 
peninsula, Miami-Dade County has a population of 
nearly 2.6 million; 56 percent are Hispanic, 21 percent 
are White, 21 percent are Black, and 2 percent are 
Asian/Pacific Islander. Miami is Dade County’s largest 
city, with 360,000 residents. More than 100,000 immi-
grants arrive in Florida each year; one-half establish 
residency in Miami-Dade County. 
 
Broward County, situated due north of Miami-Dade, is 
composed of Ft. Lauderdale, 28 other municipalities, 
and an unincorporated area. The county covers 1,197 
square miles, including 25 miles of coastline. Accord-
ing to the 2000 census, the population was 1,649,925. 
The population is roughly 63 percent White, 21 percent 
Black, and 17 percent Hispanic. Broward County is the 
second most populated county in Florida and accounts 
for approximately 10 percent of Florida’s population. 
Broward was the top growth county in Florida in the 
1990s, adding 367,000 more people. Palm Beach 
County (population 1,154,464) is located due north of 
Broward County and is the third most populated county 
in the State. Together, the 5.4 million people of these 3 
counties constitute one-third of the State’s 16.3 million 
population. 
 
Approximately 25 million tourists visit the area annu-
ally. The region is a hub of international transportation 
and the gateway to commerce between the Americas, 
accounting for sizable proportions of the Nation’s 
trade: 40 percent with Central America, 37 percent with 
the Caribbean region, and 17 percent with South 
America. South Florida’s airports and seaports remain 
among the busiest in the Nation for both cargo and 
international passenger traffic. These ports of entry 
make this region a major port of entry for illicit drugs. 
Smuggling by cruise ship passengers is an important 
trend in South Florida drug trafficking and has appar-
ently been growing since airline security increases after 
September 11, 2001. 
 
Several factors impact the potential for drug abuse 
problems in South Florida, including the following: 
 
• Proximity to the Caribbean and Latin America 
exposes South Florida to the entry and distribu-
tion of illicit foreign drugs destined for all 
regions of the United States. Haiti remains a 
major link with Colombian traffickers. 
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• South Florida is a designated High Intensity Drug 
Trafficking Area and a leading U.S. cocaine im-
portation center. It also became a gateway for 
Colombian heroin in the 1990s. Millions of meth-
ylenedioxymethamphetamine (MDMA, “ ecstasy,”  
or “ XTC” ) tablets originate in the Benelux coun-
tries and often— most recently— are flown to the 
Caribbean before entering the United States in 
South Florida. 
 
Extensive coastline and numerous private air and sea 
vessels make it difficult to pinpoint drug importation 
routes into Florida and throughout the Caribbean 
region. 
 
Data Sources 
 
This report describes current drug abuse trends in 
Miami and South Florida, using the data sources 
summarized below. 
 
• Drug treatment data on a sample of admissions 
were provided by Spectrum Programs, Inc., for 
1999 through June 2002. Data from the Broward 
Addiction Recovery Center (BARC) were not 
available for 2002. 
 
• Drug-related mortality data were provided by 
the Broward County Medical Examiner Depart-
ment in “ Drug Deaths 1999– June 2002,”  a review 
of all deaths in Broward County directly caused 
by or associated with drugs, and the Florida 
Department of Law Enforcement Medical Exam-
iners Commission, January– June 2002 “ Report of 
Drugs Identified in Deceased Persons by Florida 
Medical Examiners.”  
 
• Emergency department (ED) drug mentions 
data were derived from the Broward General 
Medical Center (BGMC) Emergency Department 
Drug Abuse Case Review, which is a review of all 
drug abuse cases presenting to the emergency 
department for the five semiannual periods from 
the first half of 2000 through the first half of 
2002; and from the Drug Abuse Warning 
Network (DAWN), Office of Applied Studies 
(OAS), Substance Abuse and Mental Health 
Services Administration (SAMHSA) for 1994 
through 2001. At the BGMC in the first half of 
2002, all ED charts were reviewed daily to 
identify illicit substance abuse-related ED cases. 
Drug abuse was identified in 3.5 percent (1,249) 
of the 36,621 charts reviewed, an average of 
approximately 7 drug abuse cases per day. 
 
• Drug analyses data were derived from reports 
of illicit substances analyzed from 1999 to June 
2002 by the Broward Sheriff’s Office (BSO) 
Crime Lab. 
 
• Heroin price and purity data, preliminary for 
2001, were obtained from the Drug Enforcement 
Administration (DEA)’s Domestic Monitor Pro-
gram (DMP). 
 
• Drug seizure information was available from 
the U.S. Customs Service. 
 
• School survey data were from two sources: the 
Florida Youth Surveys on Substance Abuse for 
2000 and 2002, which provide prevalence data 
on drug use among Florida students in grades 
6−12, and the 2001 Miami-Dade School Survey 
conducted by The Miami Coalition for A Safe 
and Drug-Free Community, which provides 
prevalence and risk-factor data on Miami-Dade 
public and parochial middle and high school stu-
dents.  
 
Other information on drug use patterns was derived 
from ethnographic research. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
Cocaine continued to be a major problem in South 
Florida, as indicated by ED visits, crime lab data, and 
drug treatment admissions. However, cocaine-related 
deaths decreased in the first half of 2002. Older 
patients continued to dominate among cocaine abus-
ers seeking emergency medical care and addiction 
treatment. 
 
Throughout Florida, there were 180 cocaine-caused 
fatalities in the first half of 2002. This represented an 
8-percent decrease from the last half of 2001. There 
were 13 cocaine-induced deaths in Miami-Dade 
County in first half of 2002, a 42-percent decrease 
from the 45 cocaine-induced deaths in all of 2001. In 
2000 there were 30 cocaine-induced deaths, in 1999 
there were 43, and in 1998 there were 39. The 59 
cocaine-related deaths in the first half of 2002 repre-
sent a 21-percent decrease from the previous semian-
nual period. There were 149 such cases during all of 
2001, 144 in 2000, 226 in 1999, and 246 in 1998. 
 
In Florida, a drug is considered to be a cause of death 
if the amount detected is considered to be a lethal dose 
by the local medical examiner. Mixtures of other drugs 
(unspecified) were detected in 26 of the 59 cocaine-
related deaths during the first half of 2002 in Miami-
Dade County. 
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In Broward County, 30 fatalities were attributed to 
cocaine use in the first half of 2002, compared with 
33 in the prior 6-month period. Opiates such as her-
oin, oxycodone, and methadone were involved in 17 
of the deaths in 2002. In an additional two deaths, 
both cocaine and heroin were considered the causes 
of death; six deaths involved cocaine and oxycodone; 
three others involved cocaine and methadone; and 
two involved cocaine, methadone, and oxycodone. 
Among cocaine decedents, there were 24 males and 6 
females. Twenty-five were White, four were Black 
(all four were positive for cocaine but not opioids), 
and one was Hispanic (cocaine and oxycodone). 
Among the 30 cocaine decedents, there were no teen-
agers; 17 percent were in their twenties, 50 percent 
were in their thirties, 27 percent were in their forties, 
and 7 percent were their fifties. In 2000, there were 
40 cocaine-caused deaths, and in 2001, there were 52. 
The recent increase in cocaine-deaths appears to be at 
least partly attributable to the opioid-cocaine 
combinations.  
 
Among the combined 243 cocaine-related deaths in 
both Broward and Miami-Dade Counties during 2001, 
fewer than 2 percent were younger than 18, 11 percent 
were 18– 25, 25 percent were 26– 34, 47 percent were 
35– 50, and 15 percent were older than 50. 
 
In Miami-Dade County in 2001, there were 4,641 
cocaine/crack ED mentions in the DAWN system 
(exhibit 1). Annual data reflect an insignificant 
increase in cocaine/crack ED mentions between 2001 
and 2000 and a significant 69-percent increase 
between 1994 and 2001. The number of ED cocaine 
mentions for those age 45– 54 rose nearly 185 percent 
between 1994 and 2001 and 37 percent between 1999 
and 2001.  
 
At BGMC in the first half of 2002, cocaine was 
clearly the most commonly involved illicit drug, 
accounting for 641 (51percent) drug abuse cases. Of 
the cocaine cases, males accounted for 70 percent, 
Whites for 52 percent, Blacks for 42 percent, and 
Hispanics/others for 7 percent. Eighty-three percent 
of the cocaine-using BGMC patients were age 30 or 
older, continuing a trend towards older cocaine ED 
patients. Only 3 percent were younger than 20; 14 
percent were in their twenties, 39 percent were in 
their thirties, 33 percent were in their forties, and 11 
percent were age 50 or older.  
 
The most common reasons for visiting the BGMC 
ED for cocaine use were as follows: depression/ 
suicidal (37 percent); chest pain/cardiac problems (10 
percent); psychosis/schizophrenia/hallucinations (8 
percent); dependence/seeking detoxification (7 per-
cent); trauma/accidents (7 percent); altered mental 
status (5 percent); and gastrointestinal complaints (5 
percent). 
 
Crack cocaine was mentioned in 29 percent of the 
BGMC ED cases in the first half of 2002. Cocaine 
was used in combination with alcohol in 43 percent 
of cocaine ED cases. This dangerous combination 
forms a cometabolite, cocaethylene, which can dra-
matically increase toxicity. Another common combi-
nation was cocaine and marijuana (24 percent of all 
cocaine cases). 
  
Among a sample of Spectrum Program treatment 
admissions in the first half of 2002, cocaine abuse 
accounted for 34 percent of the sample. Of the 602 
cocaine treatment clients in the first half of 2002, 55 
percent were White, 34 percent were Black, and 11 
percent were Hispanic/other. Among these same 
clients, 55 percent were age 35 or older, 29 percent 
were 26– 34, 11 percent were 18– 25, and 5 percent 
were younger than 18. 
 
Powder cocaine and crack are still reported as 
“ widely available”  throughout Florida. Cocaine 
remains the most commonly analyzed substance by 
the BSO Crime Lab, accounting for 83 percent of all 
items analyzed in the first half of 2002.  
 
In Miami, crack cocaine sells for $5– $20 per one-
tenth gram and is roughly 80 percent pure. Powder 
cocaine sells for $40– $60 per gram and is approxi-
mately 80 percent pure. The cocaine kilogram price 
range remains fairly stable at $18,000– $22,000, 
according to law enforcement officials. 
  
The 2002 Florida Youth Survey on Substance Abuse 
revealed that 3.2 percent of 8th graders, 5.1 percent 
of 10th graders, and 7.5 percent of the 12th graders 
surveyed statewide reported having ever used (life-
time) cocaine. These percentages were lower than 
those from the 2000 survey when 4.4 percent of 8th 
graders, 7.8 percent of 10th graders, and 8.7 percent 
of 12th graders reported having tried cocaine in their 
lifetime. In the 2001 Miami-Dade School Survey, 1.8 
percent of middle and high school students reported 
current (past-30-day) cocaine use. This percentage 
remained stable over the prior 6 years; however, the 
“ perceived risk of harm from cocaine use”  declined a 
full 10 percentage points from 1997 to 2001. 
 
Heroin 
 
Of all DAWN sites, Miami had the greatest increase 
in heroin ED mentions from 1994 to 2001, increasing 
significantly by 546 percent. Across the coterminous 
United States, DAWN heroin ED mentions rose 47 
percent over the same period. In Miami, the rate of 
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increase stabilized at nearly 15 percent between 2000 
and 2001. There has been an opiate epidemic in 
South Florida, with concentrations greatest in Palm 
Beach County, immediately north of Broward 
County. Older, White males continue to account for 
the majority of opiate-addicted treatment admissions 
and most narcotic-related deaths. Most DAWN ED 
heroin-related episodes were for chronic effects or 
because the patient was seeking detoxification.  
 
Throughout Florida, there were 120 heroin-involved 
deaths in the first half of 2002, representing a 10-
percent decline from the prior 6 months. 
 
In Miami-Dade County, heroin was detected in 14 
decedents during the first half of 2002, and it was 
considered the cause of death in all of those cases 
(exhibit 2). This represented the fewest annual num-
ber of deaths attributed to heroin in the county since 
1996, when there were 31 heroin-induced deaths. 
There were 51 heroin-related fatalities in Miami-
Dade County in 2001, including 32 heroin-induced 
deaths. Of the 14 heroin-induced decedents during 
the first half of 2002, other drugs were detected in 8 
cases. None of these decedents were younger than 18, 
7 percent were age 18– 25, 29 percent were 26– 34, 50 
percent were 35– 50, and 14 percent were older than 
50. 
 
In the first 6 months of 2002, heroin was considered a 
cause of 22 deaths in Broward County. In two of 
these deaths, the combination of heroin and cocaine 
was determined to be the cause; one death was 
caused by oxycodone and heroin. Heroin alone was 
involved in seven deaths, while heroin combined 
with alcohol and/or benzodiazepines in various com-
binations accounted for the remaining heroin-related 
deaths. Interestingly, there were no methadone/heroin 
combination deaths, although there were 18 metha-
done-induced deaths and 22 heroin-induced deaths. 
 
In the first half of 2002, Broward County heroin 
decedents remained predominately White (91 per-
cent) and male (86 percent), similar to the past sev-
eral years. Of the 22 heroin decedents in Broward 
County, none were younger than 18; 20 percent were 
age 20– 29, 23 percent were 30– 39, 36 percent were 
40– 49, and 18 percent were older than 50. 
  
From 1995 to 2000, Miami-Dade County recorded 
the greatest number of heroin-involved deaths of any 
county or medical examiner district in the State. By 
the first half of 2002, Miami-Dade County ranked 
sixth in the State for heroin-involved deaths, behind 
Palm Beach County, Broward County, Hillsboro 
County (Tampa), St. Petersburg, and Orlando.  
 
As noted earlier, in Miami-Dade County the number 
of DAWN heroin ED mentions increased signifi-
cantly from 258 in 1994 to 1,666 in 2001 (exhibit 1), 
the largest percentage increase (546 percent) in her-
oin ED mentions across the coterminous United 
States. Males accounted for 81 percent of the 2001 
heroin ED mentions. Among the heroin ED mentions, 
White non-Hispanics accounted for 61 percent, 
Blacks for 23 percent, and Hispanics for 15 percent. 
Of these racial/ethnic groups, the number of Hispanic 
mentions increased most significantly (1,055 percent) 
between 1994 and 2001, 1999 to 2001 (187 percent), 
and 2000 to 2001 (37 percent). One-third of the 
mentions in 2001 were age 26– 34, 34 percent were 
35– 44, one-fifth were older than 44, and 12 percent 
were 18– 25. Data on episode characteristics show 
that dependence accounted for 95 percent of the 
“ drug use motive”  for heroin; two-thirds of the men-
tions cited “ seeking detoxification”  as the reason for 
ED contact. 
 
Based on a daily review of all ED charts at BGMC 
for the first half of 2002, there were 65 heroin cases 
(5 percent of all illicit substance abuse cases), a slight 
decline from the second half of 2001 when there were 
70 cases (6 percent). However, the 159 cases in 2001 
represented a 15-percent increase from 2000, when 
there were 138 heroin cases. 
 
The BGMC heroin cases in the first half of 2002 
were predominantly older White males, with males 
accounting for 72 percent of the ED patients and 
Whites for 83 percent. Of the 65 heroin cases, 3 per-
cent were teenagers, 20 percent were in their twenties, 
40 percent were in their thirties, 23 percent were in 
their forties, and 14 percent were age 50 or older.  
 
Heroin was the sole drug of abuse (with or without 
alcohol) in 40 percent of the heroin BGMC ED cases. 
Cocaine was a coexposure in 48 percent of the cases, 
followed by benzodiazepine (26 percent) and mari-
juana (11 percent). Alcohol was involved in 52 per-
cent of cases. The most common reason for the 
patient to visit the BGMC ED was with-
drawal/seeking detoxification (40 percent of the 
cases). Depression accounted for 17 percent of the 
cases, followed by altered mental status (9 percent). 
Psychosis and chest pain each accounted for 3 per-
cent of the heroin ED cases. 
 
In the first half of 2002, 3 percent (n=60) of the 
Spectrum treatment sample reported heroin as their 
primary drug of abuse. One-half of these clients were 
older than 34, 20 percent were age 25– 34, 22 percent 
were 18– 24, and 8 percent were younger than 18. 
White non-Hispanics accounted for 66 percent of the 
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heroin treatment clients, Hispanics for 20 percent, 
and Blacks for 13 percent.  
 
During the first half of 2002, 102 heroin cases were 
analyzed by the BSO Crime Lab, compared with 71 
such cases during the first half of 2001.  
 
Colombian heroin is still reported as being widely 
available in South Florida. Heroin prices have 
remained steady at about $60,000−$65,000 per kilo-
gram over the past year after declining sharply sev-
eral years ago. Purity at the kilogram level is esti-
mated to range from 70 to 95 percent. According to 
the DMP, Miami’s heroin street purity is estimated at 
17– 23 percent. A $10 bag of heroin (roughly 20 per-
cent purity) weighing about one-tenth of a gram is the 
most common unit of street heroin. One street name 
given to heroin in the southeastern United States is 
“ bin laden murder one.”    
 
Current heroin use was reported by 1.1 percent of 
Miami-Dade middle and high school students in the 
2001 survey conducted by The Miami Coalition.  
 
Other Opiates 
 
Deaths from opiates other than heroin have been 
tracked in Florida since 2000. Methadone-related 
deaths increased 31 percent statewide between the 
second half of 2001 and the first half of 2002, rising 
from 194 to 254. Methadone was the cause of death in 
52 percent of the cases in the first half of 2002. The 
number of hydrocodone deaths rose 19-percent from 
209 in the second half of 2001 to 248 in the first half 
of 2002; it was the cause of death in 25 percent of 
those cases in 2002. The number of oxycodone deaths 
increased 7 percent from 249 in the second half of 
2001 to 267 in the first half of 2002; it was the cause 
of death in 42 percent of those cases in 2002.  
 
In the year 2000, Florida ranked fifth in the Nation 
behind West Virginia, Alaska, Delaware, and New 
Hampshire in the number of OxyContin prescriptions 
per 100,000 population. Since Florida is by far the 
most heavily populated of these five States, it is the 
largest market for OxyContin. A proposal to establish 
a prescription drug monitoring program in Florida to 
combat prescription drug abuse failed to pass the 
State legislature in 2002. 
 
Miami-Dade County reported seven oxycodone-related 
deaths during the first half of 2002; three were oxyco-
done-induced deaths (exhibit 2). Broward County 
recorded 33 oxycodone-related deaths; 22 were oxy-
codone-induced deaths. Only 1 of the 22 cases in 
Broward County involved only oxycodone. Benzodia-
zepine was present in 73 percent of these cases, and 
was at lethal levels in 64 percent of the cases. In Palm 
Beach County, there were 30 oxycodone-related and 12 
oxycodone-induced deaths.  
 
Miami-Dade County reported nine hydrocodone-
related deaths during the first half of 2002; four were 
hydrocodone-induced. Broward County recorded 14 
hydrocodone-related deaths; 6 were hydrocodone-
induced. In Palm Beach County, 5 of the 22 hydroco-
done-related deaths were hydrocodone-induced. 
 
Miami-Dade County reported five methadone-related 
deaths during the first half of 2002; three were con-
sidered methadone-induced. Broward County 
recorded 18 methadone-related deaths; 15 were con-
sidered methadone-induced. In Palm Beach County, 
there were 37 methadone-related deaths, with 24 
considered methadone-induced.  
 
The number of DAWN narcotic analgesics ED men-
tions in Miami-Dade County increased 254 percent 
between 1994 and 2001, rising from 86 to 304 (exhibit 
1). The number of ED mentions for narcotic analge-
sics/combinations also increased significantly (55 per-
cent), from 86 to 133 between 1994 and 2001, and 
again from 1999 to 2001 approximately 70 percent. 
 
A total of 36 oxycodone overdose ED cases were 
treated at BGMC in the first half of 2002. Males 
accounted for 55 percent of the cases, and 89 percent 
were White. The ages of these patients ranged from 
16 to 53. There was one teenager; 16 percent of the 
patients were in their twenties, 42 percent were in 
their thirties, 32 percent were in their forties, and 8 
percent were age 50 or older. The brand name prod-
uct, OxyContin, was specifically mentioned in 61 
percent of these cases. The route of administration 
was unclear upon reviewing most charts.  
 
In 34 percent of the oxycodone cases, the reason for 
visiting the BGMC ED was dependence/withdrawal. 
In 16 percent of the cases, the drug was used non-
medically. In 26 percent of cases, oxycodone was 
being used for other psychic effects (e.g., pain relief), 
and in 18 percent of cases, the oxycodone was taken 
in a suicidal gesture.  
 
Five percent of the oxycodone ED patients at BGMC 
presented with central nervous system depression, 
and 5 percent visited the emergency department 
because of convulsions. Naloxone was administered 
to 14 percent of these cases. Twenty-six percent 
required hospital admission, and 74 percent were 
treated and released from the emergency department. 
Co-ingestants included benzodiazepines (in 32 per-
cent of the cases), marijuana (16 percent), cocaine 
(39 percent), other opioids such as heroin or metha
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done (29 percent), and hydrocodone (2 percent). The 
benzodiazepine alprazolam was identified in 21 per-
cent of all cases. 
 
Diverted OxyContin is being sold in the same places 
that had traditionally sold crack cocaine, according to 
law enforcement in the Office of National Drug 
Control Policy’s April 2002 Pulse Check. 
 
The BSO Crime Lab analyzed 115 oxycodone cases 
in the first half of 2002 compared with 95 in the pre-
vious 6 months. There were also 88 hydrocodone 
crime lab cases in the first half of 2002 compared 
with 69 in the second half of 2001. 
 
Marijuana 
 
Cannabinoids were detected in 331 deaths statewide 
in the first half of 2002. If this trend continues for the 
rest of the year, the total deaths in 2002 will be 6 or 7 
percent lower than the 707 marijuana-related deaths 
for all of 2001. 
  
In Miami-Dade County, marijuana ED mentions 
reported by DAWN increased 171 percent from 1994 
to 2001 and nearly 51 percent from 1999 to 2001. In 
2001, there were 1,932 mentions (exhibit 1). In 2001, 
the rate of marijuana ED mentions per 100,000 
population across the coterminous United States was 
44; Miami ranked sixth in the DAWN system, with a 
rate of 94. A demographic profile of the Miami ED 
mentions from 2001 shows that 74 percent were 
male, 47 percent were Black, 37 percent were White, 
and 15 percent were Hispanic. Nine percent of the 
marijuana ED patients were age 12– 17, 27 percent 
were 18– 25, 24 percent were 26– 34, and 40 percent 
were age 35 and older. 
 
There were 461 BGMC marijuana ED cases in the 
first half of 2002, representing 37 percent of all drug 
ED mentions. Seventy-five percent of the patients 
were male. Whites accounted for 57 percent of 
marijuana ED cases, Blacks for 37 percent, and His-
panics/others for 5 percent. Twelve percent were 
teenagers, 32 percent were in their twenties, 28 per-
cent were in their thirties, 21 percent were in their 
forties, and 6 percent were age 50 or older.  
 
Marijuana was the only illicit drug (with or without 
alcohol) in 41 percent of the BGMC ED marijuana 
cases. More than one-third of the Broward County 
marijuana ED cases involved marijuana in combina-
tion with cocaine. Marijuana was also found in combi-
nation with MDMA or amphetamines in 26 additional 
cases. In 15 percent of the cases, alcohol was the only 
documented coingestant with marijuana. 
 
The most common reasons for BGMC marijuana ED 
visits in the second half of 2001were as follows: 
depression/suicidal (26 percent), trauma (13 percent), 
psychiatric-related (e.g., hallucinations, anxiety, 
bizarre behavior, delusions) (10 percent), chest pain 
(9 percent), and altered mental status (8 percent). 
Marijuana is still the most prevalent drug of abuse 
among young patients treated in the BGMC ED. 
Fifty-nine percent of all illicit substance abuse cases 
in the 12– 25 age group involved marijuana.  
 
In the first half of 2002, 970 treatment clients (54 
percent of the Spectrum sample) cited marijuana as 
their primary drug of abuse. Forty-eight percent were 
White, 38 percent were Black, and 14 percent were 
Hispanic/other. In contrast to cocaine and heroin 
patients, those seeking treatment for marijuana 
tended to be younger: 34 percent were age 17 or 
younger and 27 percent were 18– 25.  
 
Marijuana is still described as widely available 
throughout Florida, with local commercial, sinsemilla, 
and hydroponic grades available. One-quarter ounce of 
sinsemilla, with an estimated tetrahydrocannabinol 
(THC) content of 10– 18 percent, sells for $100– $120.  
 
The Miami-Dade School Survey showed a continuing 
downward trend in current (past-30-day) marijuana 
use among middle and high school students, from 
13.4 percent in 1995 to 9.4 percent in 2001. Yet, the 
perceived use of marijuana by friends and ease in 
obtaining the drug increased between 1999 and 2001. 
The 2002 Florida Youth Substance Abuse Survey 
reported decreases in lifetime marijuana use 
statewide since 2000, with decreases noted among 
8th graders (24.4 to 19.8 percent), 10th graders (38.6 
to 32.9 percent), and 12th graders (43.9 to 40.6 per-
cent). Students in Miami-Dade County recorded the 
lowest rate of current marijuana use in the State, at 
6.5 percent of all students in grades 6– 12. Ten per-
cent of the Broward County students reported current 
marijuana use, ranking the county fifth lowest among 
the 60 counties reporting. 
 
Gamma Hydroxybutyrate (GHB) 
 
The anesthetic GHB is a commonly abused substance 
in South Florida. Several compounds that are con-
verted by the body to GHB include gamma butyro-
lactone (GBL) and 1,4 butanediol (1,4 BD). Recently, 
most GHB abuse has involved 1,4 BD. These drugs 
have become popular in the techno-dance scene and 
at other parties. Commonly used with alcohol,  
they have been implicated in drug-facilitated rapes  
and other crimes. The drugs have a short duration  
of action and are not easily detectable 
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on routine hospital toxicology screens. GHB was 
declared a federally controlled Schedule I drug in 
March 2000.  
 
In Florida, GHB-related deaths increased from 23 in 
2000 to 28 in 2001. However, there were only eight 
GHB deaths in the second half of 2001, a 60-percent 
decrease from the previous 6 months. An additional 
eight GHB-related deaths were reported in the first 
half of 2002, one of which was considered to be 
caused by the drug. 
 
GHB-involved deaths in Miami-Dade County declined 
from three in 2000 to one in 2001. No GHB-involved 
deaths were reported in the first half of 2002. 
 
In Broward County, there were three GHB-caused 
fatalities in the first 6 months of 2002. The first involved 
a 30-year-old White male who was found with two 
empty medication bottles, one of an antidepressant 
(amitriptyline) and one of an antipsy-
chotic/anticonvulsant (gabapentin). He was pronounced 
dead at the scene. On autopsy, both medications, as 
measured in his blood, were found to be at a therapeutic 
level. No other drugs or alcohol were detected. Since a 
viable cause of death could not be found, a blood GHB 
level was assayed, and it came back at the highest level 
ever measured in Broward County (2,520 milligrams per 
deciliter). Given this information, the cause of death was 
recorded as “ acute drug toxicity-GHB,”  and the manner 
was ruled a suicide. There was no further clarifying his-
tory regarding a past or recent history of GHB abuse by 
this man. 
 
In the second death, a 33-year-old White male with a 
history of alcoholism, drug abuse, and depression 
was found unresponsive by his roommate. There was 
no history of GHB abuse, but his blood GHB level 
was extremely high, at 1,600 milligrams per deciliter, 
and he was also positive for benzodiazepines. His 
blood alcohol level was negative. This death, caused 
by GHB, was also considered to be a suicide.  
 
The third death involved a 21-year-old White male 
with a history of alcoholism but apparently no history 
of GHB abuse. He was found unresponsive and not 
breathing in bed by his mother with vomitus in and 
around his mouth. Attempts at resuscitation by staff 
of the Fire Rescue and the emergency department 
were unsuccessful. Initially, the medical examiner 
ruled that he had died of natural causes. However, the 
autopsy found a GHB blood level of 589 milligrams 
per deciliter. The case was reclassified as an acci-
dental GHB-caused drug death. No alcohol or other 
drugs were detected in the decedent at autopsy, and 
while there was no documented GHB abuse history, 
he was a user of multiple “ health foods.”   
From 1996 to June 2002 in Broward County, there 
was a total of 14 GHB-related deaths that involved 
GHB in some way (2 in 1996, 2 in 1997, 3 in 1998, 1 
in 1999, 3 in 2000, and 3 more in the first 6 months 
of 2002). In 12 of these cases, GHB was mentioned 
as one of the causes of death. In another case, a 
patient who was admitted to a hospital for GHB 
intoxication appeared to have recovered but subse-
quently succumbed because of other problems. In 
still another death, the patient was dead on arrival at 
the BGMC ED; the death was recorded as a multiple 
drug overdose that included a history of GHB use. 
However, the medical examiner found GHB to be a 
non-contributory cause of death.  
 
Ten of the 12 GHB-caused fatalities involved co-
ingestants, including alcohol, cocaine, marijuana, ben-
zodiazepines, opioids, carisoprodol (Soma), sertraline 
(Zoloft), gabapentin, amitriptyline, and methylenedi-
oxymethamphetamine (MDMA or ecstasy). Alcohol 
was detected in seven cases in quantities ranging from 
90 to 340 milligrams per deciliter (legally drunk in 
Florida is 80 milligrams per deciliter). Two fatalities 
involved no known or detected coingestants and no 
alcohol; these cases refute the commonly espoused 
misperception that GHB is only fatal when taken with 
another central nervous system depressant. Two of the 
12 cases were ruled suicides and had extremely high 
levels of GHB in their blood. 
 
In Miami-Dade County, DAWN ED mentions for 
GHB rose from zero in 1994 to 46 in 2000, before 
declining 28 percent to 33 in 2001 (exhibit 1).  
 
In the Broward County ED, there was a dramatic 
decrease in the number of GHB or GHB analog cases 
treated in the first 6 months of 2002, compared with 
39 in the last 6 months of 2001, 32 in the first 6 
months of 2001, and 77 in all of 2000.  
 
During the second half of 2001, the BGMC ED 
treated 39 people with GHB or GHB precursor over-
dose, compared with 32 in the first half of 2001 and 
77 in all of 2000. In most of the GHB overdose cases 
during the period from July 2001 to June 2002, the 
reason for the ED visit was decreased responsive-
ness/coma usually lasting less than 3 hours.  
 
The ages of the 16 GHB toxicity patients at BGMC 
in the first half of 2002 ranged from 19 to 35, with an 
average of 24.3 years. There were 2 teenagers (13 
percent); 11 (69 percent) were in their twenties, and 3 
(19 percent) were in their thirties. Twelve of these 
GHB overdose patients were men (75 percent); 14 
(88 percent) were White non-Hispanic, 1 (6 percent) 
was Native American, and race/ethnicity was 
unknown in 1 case. 
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Among the GHB BGMC patients in the first half of 
2002, a urine toxicology screen was amphetamine-
positive in two cases, cocaine-positive in two, and 
marijuana-positive in two. A urine toxicology screen 
was not obtained for every case. Alcohol was 
involved in 7 of the 16 cases, confirmed either by 
history or through a blood alcohol level test. In the 
GHB cases for which a blood alcohol level was 
obtained, the level ranged from zero to 212 milli-
grams per deciliter. 
 
The location of the incident requiring the ED visit 
was a local bar, nightclub, or the beach in four cases  
(25 percent). Ten cases (63 percent) presented to the 
ED between 11 p.m. and 6 a.m. Many patients were 
temporarily unresponsive, and two (13 percent) 
required intubation and mechanical ventilation. At 
least 4 (25 percent) of the 16 patients vomited. Most 
patients were treated and released from the ED after 
several hours. However, one patient required hospital 
admission.  
 
During the first half of 2002, six GHB, eight GBL, 
and six 1,4 BD cases were analyzed by the BSO 
Crime Lab. In the last half of 2001, there was one 
GHB, eight GBL, and three 1,4 BD cases analyzed by 
the BSO Crime Lab, compared with two GHB, five 
GBL, and four 1,4 BD cases in the first half of 2001. 
Only three GHB cases and one GBL case were 
analyzed by the crime lab in the second half of 2000, 
compared with 12 GHB-related cases and 1 GBL 
case during the first half of the year.  
 
MDMA 
 
MDMA, a methylated amphetamine, has become 
popular as a club drug and at techno-dance events 
such as raves and private parties. The psychoactive, 
synthetic, DEA Schedule I drug has gained the repu-
tation as a “ hug drug”  that can promote empathy, 
relaxation, and sexuality. Many indicators such as 
crime lab statistics and drug confiscations point to 
increased abuse of this drug. For the first time in 
2000, more teens said they had abused MDMA or 
ecstasy than cocaine.  
  
Ecstasy pills generally contain 75– 125 milligrams of 
MDMA, but they are often adulterated. Some ecstasy 
pills or tablets may contain no MDMA. Wholesale 
prices are approximately $8 per pill for 100 units, but 
retail prices in clubs and raves range from $10 to $50. 
According to local law enforcement sources, South 
Florida ecstasy prices began to drop in the first half 
of 2001, reflecting increased supply. In addition, 
giveaway deals are often brokered to establish future 
customers. 
 
The major sources of the designer logo-emblazoned 
pills are clandestine labs in Western Europe, especially 
the Netherlands and Belgium. There are unverified 
rumors of clandestine labs in South Florida attempting 
MDMA production, and more recently, evidence 
suggesting that Colombian drug trafficking 
organizations may be trying to enter ecstasy 
distribution. 
 
There were 52 methylated amphetamine-related deaths 
in the State of Florida during the first half of 2002; 8 
were considered to have been caused by the drug. Two 
deaths were in Miami-Dade County and one was 
considered to have been caused by the drug. There were 
five methylated amphetamine-related deaths in Broward 
County, but the drug was not considered the cause of 
death in these cases. Florida recorded 147 methylated 
amphetamine-related deaths statewide in 2001; in 37 of 
these cases, the drug was considered the cause of death.  
 
In Miami-Dade County, 184 MDMA ED mentions 
were reported by DAWN in 2001 (exhibit 1), a 75-
percent increase from 2000. A total of 105 MDMA 
mentions were reported in 2000, a significant 
increase from the 2 reported in 1994. 
 
In Broward County, it has become increasingly difficult 
to determine by chart review if MDMA or other types of 
amphetamines were involved with ED cases. This is 
because methamphetamine and other amphetamines have 
become increasingly popular. In addition, patients rarely 
say, and therefore it is rarely documented, which type of 
amphetamine was taken. Although the urine toxicology 
screen may be positive for amphetamines, this does not 
reliably distinguish between MDMA and other 
amphetamines. Since some patients use both, and many 
ecstasy pills are adulterated or substituted with other 
amphetamines, the picture becomes even less clear.  
 
At BGMC, ED cases involving ecstasy during the first 
half of 2002 can be divided into three major categories: 
(1) those in which ecstasy was mentioned in the medical 
record and the patient tested positive for amphetamines 
(there was only one of these cases); (2) those in which 
ecstasy was mentioned but the toxicology screen was 
either not obtained or negative for amphetamines (there 
were nine of these cases); and (3) cases for which 
ecstasy was not specifically mentioned but was 
suspected, based on circumstances and a positive urine 
screen for amphetamines. It has become increasingly 
difficult to determine a number in the last category 
because of the increasing use of methamphetamine and 
other amphetamines other than ecstasy.  
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There were 45 additional BGMC ED cases in which 
some type of amphetamine was either mentioned or 
analyzed by toxicology screening; 39 were amphet-
amine-positive.  
 
Adding only the first two categories mentioned 
above, there were only 10 ecstasy cases. If the third 
category is added, there were 55 cases. The actual 
number is probably somewhere in between.  
 
By adding all three of these types of cases, there were 
a total of 30 ED cases at BGMC in which ecstasy was 
involved in the last half of 2001. This was down from 
49 in the previous 6-month period.  
 
There are several reasons to believe that more and 
more of these amphetamine cases are methamphet-
amine or amphetamines other than ecstasy. First, with 
the increased airport security since September 11, 
2001, less ecstasy may be available. Secondly, as 
methamphetamine and other amphetamines become 
more popular and cheaper, they are more readily 
available adulterants or substitutes.  
 
The 10 ecstasy (MDMA) cases were all young, White 
non-Hispanic patients age 15– 27. Forty percent were 
in their teens, the others were in their twenties. Sixty-
percent also tested positive for marijuana; 30 percent 
had used cocaine, 20 percent had used alcohol, and 
only 1 had also used GHB.  
 
Sixty-percent were in the ED because of anxiety, 
agitation, confusion, paranoia, or bizarre behavior, 20 
percent for altered mental status/decreased respon-
siveness, and 10 percent for depression/suicidal 
ideation. 
 
In the first half of 2002, the BSO Crime Lab analyzed 
115 MDMA cases (only 1 was MDMA and 2 were 
methylenedioxyamphetamine [MDA]). In the last 
half of 2001, there were 121 MDMA cases; there 
were 132 in the first 6 months of 2001. MDMA was 
the fourth most common case analyzed, behind 
cocaine, marijuana, and alprazolam. 
 
According to the 2002 Florida Youth Substance 
Abuse Survey, lifetime ecstasy use among 12th grad-
ers was at an all time high (14.2 percent), and ecstasy 
was used more often than any other illicit drug except 
marijuana. Twice as many Florida 12th graders had 
used ecstasy in their lifetime as had used cocaine, and 
10 times as many seniors had used ecstasy as had 
used crack cocaine. The 2002 Florida Survey also 
showed that current (past-30-day) ecstasy use was 
reported by 1.4 percent of Miami-Dade County and 
1.3 percent of Broward County 6– 12th graders. 
MDMA current use was reported by 2.8 percent of 
Miami-Dade 7th– 12th graders in the 2001 survey 
conducted by the Miami Coalition. 
 
Other Stimulants 
 
Methamphetamine abuse is an emerging drug epi-
demic (in the “ outbreak”  stage) across the region and 
is linked to the techno-dance scene. The drug is being 
promoted to populations of men who have sex with 
men (MSM), who often combine it with sildenafil 
(Viagra) for high-risk sexual behavior known as 
“ Party and Play”  (PNP). Sources report the drug is 
being shipped by overnight delivery from California. 
Law enforcement sources confirm increased local traf-
ficking of methamphetamine. 
 
There was a significant increase in methamphetamine 
cases analyzed by the BSO Crime Lab in the first half 
of 2002. There were 41 cases from January to June 
2002, more than the total of 39 in 2001. There were 
30 cases in 2000. In addition, local law enforcement 
officials and ethnographers report a recent increase in 
crystal methamphetamine use, particularly among gay 
men, who refer to the drug as “ Tina.”   
 
Either d-methamphetamine or l-methamphetamine 
was identified in 16 of the 52 methylated 
amphetamine-related deaths in Florida in the first half 
of 2002. The drugs were detected in 44 of the 147 
methylated amphetamine-related deaths statewide in 
2001.  
 
Between the 2000 and 2001, the number of ampheta-
mine-related DAWN ED mentions in Miami-Dade 
County declined insignificantly from 83 to 64 (exhibit 
1). Over the same time period, there was an 80-percent 
increase in the number of methamphetamine-related 
ED mentions, from 15 to 27. It remains unclear how 
hospital staff classify amphetamine and methamphet-
amine cases. 
 
In the first half of 2002, there were 45 BGMC ED cases 
involving amphetamines, either as mentioned in the 
history or detected in a toxicology screen, more than 
the total for MDMA cases. This represents a 55-percent 
increase over the 29 cases in the previous 6-month 
period. Of the 45 cases, 84 percent were White and 78 
percent were male. Teenagers accounted for 13 percent 
of the cases; 29 percent were in their twenties, 40 
percent in their thirties, 13 percent in their forties, and 4 
percent in their fifties. Most cases were amphetamine-
positive on their toxicology screens (39, or 86 percent). 
In the majority of cases, the exact form of the 
amphetamine was not documented. However, a 
smokable form of methamphetamine was documented 
in two cases. Marijuana was a cointoxicant in 44 per-
cent of the cases, cocaine in 20 percent, and GHB in 
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one case (2 percent). Fifteen patients (33 percent) came 
to the ED for altered mental status, and 5 cases (11 
percent) were described as an overdose. Four of the 
patients reported gastrointestinal problems, four 
reported depression, and four others reported psychiat-
ric problems (9 percent each). Other common com-
plaints included chest pain (n=3), convulsions (n=3), 
and trauma (n=3 or 7 percent each). 
 
Local and national media has focused on the abuse of 
methylphenidate (Ritalin) by college students who 
use it either orally or crush it for intranasal use. Hot-
line calls and student personnel administrators at 
local universities confirm that methylphenidate abuse 
is a problem.  
 
Lysergic Acid Diethylamide (LSD) 
 
LSD, a synthetic hallucinogen popularized in the 
1960s in the United States, is usually abused orally in 
small tablets (“ microdots” ), thin squares of gelatin 
(“ windowpanes” ), or blotter paper. It is not easily 
detected by most hospital urine toxicology screens. 
The drug became popular again in the 1990s at lower 
doses as a stimulant and hallucinogen. However, in 
Miami-Dade County, LSD appears to be losing 
popularity among young people. 
 
There were 55 LSD DAWN ED mentions in Miami-
Dade County in 2001, the same number reported in 
2000 (exhibit 1).  
 
In 2001, the Miami-Dade School Survey found that 
only 1.7 percent of students in grades 7– 12 reported 
current LSD use, down from 3.8 percent in 1995. 
 
Benzodiazepines 
 
For a variety of reasons, it is more difficult to track 
benzodiazepine abuse than abuse of other substances. 
However, there are indicators that point to benzodia-
zepines in general and alprazolam (Xanax) in par-
ticular as substantial problems. Benzodiazepines 
were second only to alcohol in drug-related deaths 
throughout Florida. 
 
There were 734 benzodiazepine-related deaths in 
Florida during the first half of 2002; a benzodiazepine 
was identified as the cause of death in 150 (20 percent) 
of these cases. 
 
Benzodiazepines in general, and alprazolam (Xanax) 
in particular, are popular among opioid abusers. In 
Broward County, benzodiazepines were involved in 
16 of the 22 oxycodone deaths and alprazolam in 12 
in the first half of 2002. Among Broward County 
heroin-caused fatalities, benzodiazepines were in-
volved in 8 of the 22 deaths and alprazolam in 5 over 
the same time period. Benzodiazepines were also 
involved in 11 of the 16 Broward County methadone-
caused deaths and in 8 of the 11 hydrocodone-caused 
deaths. In addition, benzodiazepines were involved in 
17 of the 30 Broward cocaine-involved deaths in the 
first half of 2002. 
 
DAWN ED data reveal that alprazolam is the fifth most 
commonly mentioned drug across DAWN sites, 
ranking behind cocaine, alcohol-in-combination, mari-
juana, and heroin. In Miami-Dade County, DAWN 
benzodiazepine-related ED mentions totaled 1,075 in 
2001, representing a 43-percent increase over the num-
ber for 1999 (exhibit 1). Alprazolam accounted for 39 
percent of these mentions, clonazepam for 10 percent, 
diazepam for 8 percent, temazepam for 7 percent, and 
lorazepam for 6 percent. A non-specified benzodiaze-
pine accounted for 25 percent of these mentions. 
 
In Broward County, benzodiazepines were involved 
in 32 percent of the 38 oxycodone hospital ED cases 
in the first half of 2002; alprazolam was involved in 
21 percent of the oxycodone cases.  
 
The BSO crime lab analyzed 296 alprazolam cases in 
the first 6 months of 2002, 244 in the last 6 months of 
2001, and 258 in the first 6 months of 2001. The 
2001 cases are almost three times the numbers for 
ecstasy and oxycodone cases. The BSO Crime Lab 
analyzed more alprazolam cases in 2002 than any 
other drug except cocaine and marijuana.  
  
According to Broward High School substance abuse 
counselors, the most common drugs of abuse among 
high school students are alcohol, marijuana, and 
Xanax. Students refer to Xanax as “ Xany Bars”  or just 
“ bars.”  Alprazolam (Xanax) was added to the category 
of “ Depressants”  in the 2002 Florida Youth Abuse 
Survey. Lifetime use of “ Depressants”  increased from 
4.0 percent in 2001 to 5.1 percent in 2002 among 8th 
graders, from 8.7 to 10.3 percent among 10th graders, 
and from 8.9 to 12.7 percent among 12th graders. 
 
 
For inquiries concerning this report, please contact James N. Hall, Up Front Drug Information Center, 12360 SW 132nd Court, Suite 215, 
Miami, Florida 33186, Phone: (786) 242-8222, Fax: (786) 242-8759, E-mail: <upfrontin@aol.com>. 
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Exhibit 1. Number of ED Mentions for Selected Drugs in Miami-Dade County:  1994–2001 
 
Drug Category 1994 1995 1996 1997 1998 1999 2000 2001 
Cocaine 2,748 3,078 3,104 3,254 3,553 4,018 4,383 4,641 
Heroin 258 333 388 591 767 917 1,452 1,666 
Marijuana 713 966 1,011 1,024 1,113 1,283 1,768 1,932 
Amphetamines … 1 … … 28 64 53 83 64 
Methamphetamine 8 5 9 10 16 9 15 27 
MDMA 2 4 9 28 12 59 105 184 
LSD 74 83 54 63 54 50 55 55 
PCP 7 8 15 14 14 9 15 9 
GHB 0 0 … 2 10 29 46 33 
Benzodiazepine 700 742 769 715 761 750 963 1,075 
Narcotic Analgesics 86 117 120 139 190 197 242 304 
Narcotic 
Analgesics/Combinations 86 81 82 73 84 78 128 133 
 
1
 Dots (… ) indicate that an estimate with a relative standard error greater than 50 percent has been suppressed. 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
 
Exhibit 2. Number of Narcotic-Related Death Mentions in Three Florida Counties:  January–June  
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SOURCE:  Florida Medical Examiners Commission and Broward County Medical Examiner Department 
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Drug Abuse Trends in Minneapolis/St. Paul  
 
Carol L. Falkowski1 
 
ABSTRACT 
 
Law enforcement seizures of cocaine and most other 
illicit drugs increased in 2002. Hospital emergencies 
involving cocaine jumped 34 percent from 2000 to 
2001. The nonmedical use of prescription narcotic 
analgesics, particularly oxycodone, was identified as 
an emerging problem of expanding magnitude, as 
illustrated by hospital emergency department epi-
sodes, accidental deaths, and law enforcement 
activity. The continuing availability of high purity, 
low-cost heroin contributed to accidental overdose 
deaths and hospital emergencies. Methamphetamine-
related hospital emergencies more than doubled from 
2000 to 2001, although the growth in clandestine 
methamphetamine labs slowed somewhat. Hospital 
emergencies involving MDMA (‘ecstasy’) continued 
to increase, although less rapidly than in the past, and 
GHB hospital emergencies actually declined in 2001. 
More pills sold as ecstasy were found to contain 
substances other than MDMA. Roughly 4,000 annual 
admissions to addiction treatment programs cited 
marijuana as the primary substance problem; one-
half of the patients were younger than 18. 
 
INTRODUCTION 
 
This report was compiled using the most recent 
available data and information from multiple sources. 
It is produced twice annually as part of a nationwide 
drug abuse epidemiological surveillance network of 
the National Institute on Drug Abuse. 
 
Area Description 
 
The Minneapolis/St. Paul metropolitan area includes 
the City of Minneapolis (Hennepin County), the 
capital City of St. Paul (Ramsey County), and the 
surrounding counties of Anoka, Dakota, and Washing-
ton. Based on the 2000 census, the population is 
2,482,353, roughly one-half of the Minnesota State 
population. More than one-half (56 percent) of the 
Ramsey County population live in the City of St. Paul, 
and one-third (34.2 percent) of the Hennepin County 
population live in the City of Minneapolis. The 
remainder of the State is more sparsely populated and 
rural in character. 
 
In the five-county metropolitan area, 84 percent of the 
population is White. African-Americans constitute the 
largest minority group in Hennepin County, while 
Asians are the largest minority group in Ramsey, 
Anoka, Dakota, and Washington Counties. The total 
State population increased 9 percent from 1990 to 
1998, while the minority population increased 45 
percent. The Hmong population doubled over the past 
decade in St. Paul, reaching over 24,000, making it 
home to the largest Hmong population of any city in 
the United States. An estimated 40,000 Somalis also 
reside in the metropolitan area. 
 
The majority of Minnesota’s 600-mile northern 
international border with Canada is remote, undevel-
oped wilderness area. Duluth, the largest U.S. inland 
harbor, and other Lake Superior ports manage a high 
volume of foreign shipping, which also increases the 
opportunities for smuggling activity. Interstate High-
way 35 runs north-south from Duluth through Min-
neapolis/St. Paul to the Mexican border. Interstate 90, 
which runs east-west from Boston to Seattle, passes 
through southern Minnesota, and Interstate 94 con-
nects Minneapolis/St. Paul to Chicago. Minnesota 
borders Wisconsin to the east, Iowa to the south, and 
North Dakota and South Dakota to the west. 
 
According to the 1999 National Household Survey on 
Drug Abuse (of people age 12 and older), 6.1 percent 
of Minnesotans reported illicit drug use in the past 
month, compared with 6.4 percent nationally. How-
ever, Minnesota ranked 10th highest for past-month 
illicit drug use among young people age 12– 17 (11.6 
percent, compared with 9.9 percent nationally), and 
among those age 18– 25 (19.2 percent, compared with 
16.1 percent nationally). 
 
Data Sources 
 
• Mortality data on drug-related deaths are from 
the Hennepin County Medical Examiner and the 
Ramsey County Medical Examiner (through 
September 2002). Hennepin County cases in-
clude those in which drug toxicity was the 
immediate cause of death and those in which the 
recent use of a drug was listed as a significant 
condition contributing to the death. Ramsey 
1
  The author is affiliated with the Butler Center for Research, Hazelden Foundation, Center City, Minnesota. 
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County cases include those in which drug toxicity 
was the immediate cause of death and those in 
which drugs were present at the time of death. 
 
• Hospital emergency department (ED) drug 
mentions data are weighted estimates from the 
Drug Abuse Warning Network (DAWN), Office 
of Applied Studies, Substance Abuse and Mental 
Health Services Administration (SAMHSA), 
U.S. Public Health Service. These are weighted 
estimates of all drug abuse-related ED mentions 
in non-Federal, short-term general hospitals in 
the Minneapolis/St. Paul standard metropolitan 
statistical area (through 2001). A single, drug 
abuse-related ED episode can involve the 
“ mention”  of up to four drugs and alcohol-used-
in-combination.  
 
• Treatment data are from addiction treatment 
programs (residential, outpatient, extended care) 
in the five-county metropolitan area, as reported 
on the Drug and Alcohol Abuse Normative 
Evaluation System of the Minnesota Department 
of Human Services (through June 2002). 
 
• Poison center data are from the Hennepin 
Regional Poison Center, Toxic Exposure Sur-
veillance System (through September 2002).  
 
• Arrestee drug testing data are from the Arrest-
ee Drug Abuse Monitoring (ADAM) program of 
the National Institute of Justice (NIJ), U.S. 
Department of Justice, under the local direction 
of the Minneapolis Medical Research Foun-
dation (through 2001). During 2001, there were 
5,031 bookings of male arrestees in Hennepin 
County, from which a sample of 765 was drawn. 
 
• Drug-related law enforcement data and 
information are from various agencies, including 
the U.S. Drug Enforcement Administration 
(DEA), the Hennepin County Sheriff, the Wash-
ington County Sheriff, the Ramsey County 
Sheriff, the St. Paul Police Department, and the 
Minneapolis Police Department. Crime lab data 
on seizures and purity level are from the St. Paul 
Police Department, the Minneapolis Department 
of Health and Family Support, and the 
Minnesota Bureau of Criminal Apprehension 
(through September 2002). 
 
• Acquired immunodeficiency syndrome (AIDS) 
data are from the Minnesota Department of 
Health (through 2001). 
• Additional drug-related information is from 
interviews with program staff of treatment pro-
grams, poison control specialists, and school-
based “ chemical health”  specialists (November 
2002). 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack  
 
Indicators related to cocaine abuse either increased or 
remained stable in 2002. There were 22 cocaine-
related deaths in Hennepin County in 2002 (through 
September), compared with 37 in all of 2001. Three 
of these cases involved the simultaneous use of 
opiates, one involved the use of amphetamines, and 
one was a stillbirth in which the maternal use of 
cocaine during pregnancy was a significant con-
tributing condition. Ramsey County reported 7 deaths 
in 2002 (through September) and 11 in 2001. Five 
involved the simultaneous use of opiates. 
 
Cocaine-related ED mentions increased 31.4 percent 
from 2000 to 2001, after increasing a significant 35.7 
percent between 1999 and 2001. The numbers are 
shown in exhibit 1. The rate of cocaine-related 
hospital emergencies was 43 per 100,000 population 
in 2001, compared with 35 in 2000, a significant 
increase of nearly 23 percent. Very few (4.5 percent) 
cocaine mentions were made by those younger than 
18, and nearly one-half (46.4 percent) of them were 
made by those age 35 and older (exhibit 2).  
 
In the first half of 2002, 11.7 percent of the more than 
8,800 admissions to treatment programs were 
cocaine-related (exhibit 3). Most of the 1,030 
cocaine-related admissions were for crack cocaine. 
More than one-half (52.1 percent) were African-
American, and 59.6 percent were age 35 and older 
(exhibit 4).  
 
Roughly one-quarter (27.8 percent) of adult males 
arrested in Minneapolis in 2001 tested positive for 
cocaine (exhibit 5). 
 
Seizures and law enforcement cases involving 
cocaine increased in 2002. Gangs continued to play a 
significant role in the street-level, retail distribution 
of cocaine, especially crack. Cocaine prices were 
$100 per gram, $200 per “ eightball”  (one-eighth 
ounce), $700– $800 per ounce, and $22,000 per 
kilogram. The price of a rock of crack was $10– $20, 
higher in suburban and rural areas.  
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Heroin 
 
Heroin-related indicators remained at heightened 
levels in 2002. Opiate-related deaths, most from 
accidental heroin overdose, again surpassed those 
from cocaine in both cities, fueled by the steady 
supply of high-purity heroin at low prices. 
 
Hennepin County reported 46 opiate-related deaths in 
2002 (through September), compared with 58 in 
2001, and 41 in 2000. Most were accidental heroin 
overdoses, although a growing number (nine) 
involved nonmedical use of prescription oxycodone, 
three were accidental methadone overdose deaths, 
and two were fentanyl overdose deaths. Three 
involved the simultaneous use of cocaine, and one 
involved the use of amphetamines. The ages of the 
decedents ranged from 22 to 58, with an average age 
of 41.7. Most were male, and seven were female. 
 
Ramsey County reported 11 opiate-related deaths in 
2002 (through September); 5 also involved opiates 
and 1 involved oxycodone. Two were female. This 
compares with 19 opiate-related deaths in 2001 and 
17 in 2000. The age of decedents ranged from 23 to 
48, with an average age of 38.4.  
 
Heroin-related ED mentions rose 48 percent from 
228 in 2000 to 338 in 2001 (exhibit 1) and increased 
nearly 86 percent from 1999 to 2001. The rate of 
heroin-related ED mentions per 100,000 population 
was 13 in 2001, compared with 9 in 2000, an increase 
of 38.4 percent. None of the mentions involved 
persons younger than 18; 51 percent involved persons 
age 35 and older. 
 
Three percent of clients entering addiction treatment 
programs in 2002 reported heroin as the primary 
substance problem, a proportion basically unchanged 
from 2001 (exhibit 3). Most (82 percent) were age 26 
and older (exhibit 4). More than one-half (55 percent) 
reported injection as the primary route of 
administration, and 40 percent reported sniffing. In 
addition to abstinence-based treatment programs, 6 
methadone maintenance programs served roughly 
1,400 clients in the metropolitan area. Among Min-
neapolis male arrestees in 2001, 5.3 percent tested 
opiate-positive (exhibit 5). 
 
Law enforcement activity related to heroin increased 
in 2002. The St. Paul crime lab had 21 heroin cases in 
2002 (through September), compared with 11 during 
the same period in 2001. Purity levels remained high. 
For example, 14 of the 32 samples analyzed at the 
Minneapolis lab had purity levels of 70 percent or 
greater. 
 
The heroin seized by law enforcement officials in 
Hennepin County was typically white, off-white, or 
tan powder. The most commonly seized heroin in 
Ramsey County was dark-colored, Mexican “ black 
tar”  heroin. Since 2000, heroin prices have been at 
record low levels. Heroin sold for as little as $10 per 
dosage unit or “ paper,”  $50 per quarter gram, $350–
$400 per gram, and $900– $2,000 per ounce. 
 
Other Opiates/Narcotics 
 
Narcotic analgesics, medically prescribed for the 
treatment of pain, are sometimes used as heroin 
substitutes or are consumed by drug abusers and 
others seeking the predictable mood-altering, narcotic 
effects. DAWN collects data only on emergency 
department incidents involving the nonmedical use of 
these drugs.  
 
In 2001, there were 953 hospital ED mentions of 
narcotic analgesics and narcotic analgesic com-
binations (collectively called “ narcotic analgesics/ 
combinations” ), compared with 664 in 2000 and 461 
in 1996 (exhibit 6). This represents a doubling since 
1996 and a 43.5-percent increase from 2000 to 2001 
alone. The rate of narcotic analgesics/combinations 
per 100,000 population rose nearly 105 percent from 
18 in 1994 to 37 in 2001. 
 
Some of the incidents in this category involved 
narcotic analgesics and some “ narcotic analgesic 
combinations,”  which are narcotic analgesics com-
bined with other substances, such as acetaminophen 
or aspirin. There are significantly different trends for 
individual drugs, however, as discussed below and 
presented in exhibit 6. 
 
Hospital emergencies involving codeine/codeine 
combinations declined 28.4 percent from 2000 to 
2001. There were 96 mentions of codeine/codeine 
combinations in 2001, accounting for 10 percent of 
the total 953 narcotic analgesics/combinations that 
year. Most (86) involved codeine combined with 
acetaminophen. Propoxyphene/propoxyphene com-
binations (Darvon, Darvocet) declined nonsig-
nificantly from 99 in 1999 to 72 in 2001. Almost all 
(61) involved the propoxyphene-with-acetaminophen 
combination (Darvocet). 
 
In contrast, hospital ED mentions involving hydro-
codone/hydrocodone combinations more than doub-
led since 1997 and increased a significant 54 percent 
from 2000 to 2001 alone. The 188 mentions of 
hydrocodone/hydrocodone combinations in 2001 
represented 19.7 percent of the total narcotic anal-
gesics/combinations that year. Almost all (177 out of 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Minneapolis/St. Paul 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 122
188) were hydrocodone with acetaminophen 
(Vicodin). Hydrocodone-related calls to the Hen-
nepin Regional Poison Center grew from 5 in 2000 to 
16 in 2001 (through September). 
 
Methadone ED mentions more than doubled from 
2000 to 2001, rising from 60 to 122 (103 percent 
change), and accounting for 12.8 percent of the total 
narcotic analgesics/combinations in 2001. Morphine 
ED mentions increased significantly as well, with 45 in 
2001, compared with only 10 in 2000. Hydromor-
phone (Dilaudid), although a prescription painkiller 
popular among addicts, rarely appeared in hospital ED 
data, with 7 mentions in 2001 and 5 in 2000. 
 
Oxycodone (Percodan, Percocet, and the longer-
acting OxyContin) appears to be a significant and 
growing drug of abuse based on hospital, medical 
examiner, poison center, and law enforcement data. 
ED mentions of oxycodone/oxycodone combinations 
more than doubled from 2000 to 2001 (from 101 to 
222, a significant 120-percent increase) and increased 
372 percent from 1994 to 2001. Oxycodone 
accounted for 23.3 percent of the total narcotic 
analgesics/combinations ED mentions in 2001. The 
largest increase was in oxycodone-only mentions, 
which increased nearly fivefold from 2000 to 2001 
(from 15 to 72, or 380 percent). Oxycodone-with-
acetaminophen ED mentions increased 78 percent 
(from 80 in 2000 to 143 in 2001). ED mentions of 
oxycodone with aspirin remained stable and low, at 
seven in 2001. 
 
Nine accidental overdose deaths in Hennepin County 
were attributable to oxycodone in 2002 (through 
September), compared with three in 2001. The ages 
of the decedents ranged from 29 to 56, with an 
average age of 39.3. All were male, seven were 
White, one was African-American, and one was 
American Indian. In Ramsey County, there was one 
oxycodone death in 2002 and two in 2001. 
 
Law enforcement activity involving oxycodone 
escalated as well. The State crime lab reported 21 
cases in 2002 (through September), compared with 
18 in 2001. The St. Paul Police Department crime lab 
handled 14 oxycodone cases in 2002 (through 
September), compared with 4 during the same time 
period last year. The Hennepin Regional Poison 
Center received 7 calls regarding ingestion of 
oxycodone/combinations in 2001 compared with 17 
in 2002 (through September). 
 
In 2002, two deaths in Hennepin County and one in 
Ramsey County involved fentanyl, an extremely 
potent narcotic analgesic. There were eight fentanyl 
ED mentions in 2001. Earlier this year, the sale of 
fentanyl lollipops on the black market was reported. 
Within the Hmong community, opium smoking 
continued, as a steady stream of packages containing 
opium were shipped from Asia to residents of the 
Southeast Asian community in the Twin Cities. 
 
Marijuana 
 
Marijuana indicators continued upward trends. 
Hospital ED mentions increased 49.4 percent from 
2000 to 2001, and 92.0 percent from 1999 to 2001 
(exhibit 1). There were 46 marijuana ED mentions 
per 100,000 population in 2001, compared with 33 in 
2000 and 26 in 1999. The changes in rates were 
significant. In 2001, roughly one-third (30.8 percent) 
of the mentions were among those younger than 18, 
and few (17.2 percent) were made by patients older 
than 35 (exhibit 2).  
 
Marijuana was the primary substance problem 
reported by 22.7 percent of treatment admissions in 
the first half of 2002 (exhibit 4), compared with only 
8 percent in 1991. One-half were younger than 18 
and were entering treatment for the first time. The 
average age of first marijuana use among this group 
was 13.7 years.  
 
Among adult male arrestees in Minneapolis, 53.4 
percent tested marijuana-positive in 2001 (exhibit 5). 
 
Marijuana cigarettes, “ joints,”  are sometimes dipped 
into other psychoactive substances, such as phencyc-
lidine (PCP) and formaldehyde, to achieve additional, 
more pronounced effects or to enhance the effects of 
marijuana alone. 
 
Standard grade marijuana sold for $50 per quarter 
ounce, $150– $175 per ounce, and $600– $900 per 
pound. Higher potency “ BC bud”  from British Col-
umbia sold for $100 per quarter ounce and up to $400 
per ounce. Individual joints were typically $5.  
 
Other Stimulants 
 
The major stimulants of abuse other than cocaine are 
methamphetamine, also known as “ meth,”  “ crystal,”  
or “ crank,”  and amphetamine, known as “ speed,”  or 
“ crank.”  Most indicators rose again in 2002. 
 
Hennepin County reported seven methamphetamine-
related deaths in 2002 (through September), compared 
with eight in 2001. Included were the deaths of two 
Black males (age 21 and 25) with recent methylene-
dioxymethamphetamine (MDMA) use a significant 
contributing condition. Ramsey County reported three 
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methamphetamine-related deaths in the first 9 months 
of 2002, compared with two in 2001. All were White 
males. None involved MDMA. 
 
From 2000 to 2001, ED mentions of methamphet-
amine more than doubled (from 153 to 321, a change 
of nearly 110 percent); this was in the wake of a 187-
percent increase a year earlier (from 1999 to 2000) 
(exhibit 1). There were 321 methamphetamine and 
226 amphetamine-related ED mentions, for a com-
bined total of 547 in 2001. This compares with a 
combined total of 342 in 2000 and 213 in 1999. 
Nearly 67 percent of the methamphetamine mentions 
involved people between the ages of 18 and 34 
(exhibit 2). 
 
Admissions to addiction treatment programs for 
methamphetamine accounted for 4.7 percent of total 
admissions in 2001 and 5.2 percent in 2002 (exhibit 
3). Smoking was the most common route of 
administration among methamphetamine treatment 
admissions (38.6 percent), followed by sniffing (35.0 
percent), and injection (18.0 percent) (exhibit 4). 
 
Methamphetamine seizures increased in 2002. The 
State crime lab handled 883 cases in 2001 and 1,975 
in 2002 (through September). The St. Paul crime lab 
handled 365 cases in 2002 (through September), 
compared with 295 during the same time period in 
2001. Ramsey County reported one notable large 
case the summer of 2002 involving 28 pounds. Purity 
levels, as in years past, were still quite variable. 
Dimethylsulfone (DMSO), a fluffy, white substance 
used to treat arthritis in horses, was the most common 
cutting agent. 
 
The growth of makeshift, do-it-yourself methamphet-
amine labs continued. In 2002 (through November 8) 
there were 230 clandestine methamphetamine labs 
shut down in Minnesota by the DEA, compared with 
236 in 2001, and 138 in 2000.  
 
Volatile and toxic raw ingredients, combined with 
rudimentary lab conditions and inexperienced 
“ cookers,”  create hazardous conditions that can lead 
to serious injury and property damage. The severe, 
long-lasting environmental contamination of sur-
rounding areas continued to be taken seriously. For 
the first time, several apprehended methamphetamine 
lab operators were also charged in Federal court with 
violations of the Clean Water Act. 
 
Methamphetamine-related calls to the Hennepin 
Regional Poison Center rose sharply from 7 in 2000 
to 56 in 2001 (through September).  
 
In Minneapolis 2.4 percent of adult male arrestees 
tested positive for methamphetamine in 2001 (exhibit 
5). Prices were $90– $100 per gram, $600– $800 per 
ounce, and up to $10,000 per pound. Methamphet-
amine comes in white, tan, and various pastel colors. 
 
MDMA, a methamphetamine with mild hallucino-
genic properties, is also known as “ ecstasy,”  “ X,”  or 
“ e.”  MDMA abuse by young people in the 
metropolitan area continued to escalate and was no 
longer limited to raves or nightclub settings. MDMA 
comes in small pills of different colors with various 
logos imprinted on them, or in capsules that typically 
sell for $20 each.  
 
MDMA hospital ED mentions rose significantly from 
16 in 1999 to 77 in 2001 (exhibit 1). More females 
than males were represented in these mentions, and 
86 percent were age 25 or younger (exhibit 2).  
 
Law enforcement seizures of MDMA submitted to 
area crime labs revealed that the exact content of pills 
sold as ecstasy remained variable. Nearly 2,000 
ecstasy pills seized by Minneapolis police actually 
contained a combination of MDMA, methamphet-
amine, and ketamine. Methylenedioxyamphetamine 
(MDA), a chemical similar in effect to MDMA, was 
also being sold as ecstasy. 
 
Khat, a plant used for its stimulant effects in East 
Africa and the Middle East, first appeared several 
years ago within the growing Somali communities in 
the Twin Cities and Rochester, Minnesota. The active 
ingredients, cathinone and cathine, have been con-
trolled substances in the United States since 1993. A 
bundle, typically wrapped in banana leaves to 
preserve freshness, consists of 15 to 30 khat sticks 
and sells for $40. The active ingredients lose potency 
within 48 hours. The leaves are brewed in tea, 
chewed, or stuffed in the cheeks like chewing 
tobacco.  
 
Methylphenidate (Ritalin), a prescription drug used in 
the treatment of attention deficit hyperactive disorder, 
is also used as a drug of abuse by crushing and 
snorting the pills, which sell for $5 each. There were 
26 hospital ED episodes involving methylphenidate 
in 2001. 
 
Hallucinogens 
 
Lysergic acid diethylamide (LSD), a strong, synthet-
ically produced hallucinogen, is typically sold on 
saturated, tiny pieces of paper known as “ blotter 
acid,”  for $5– $10 per dosage unit. Hospital ED men-
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tions of LSD declined significantly, falling from 58 
in 2000 to 19 in 2001. This decrease is probably 
related in large part to the growing availability and 
popularity of MDMA.  
 
Ketamine, also known as “ Special K,”  “ Vitamin K,”  
or “ cat-killer,”  is a veterinary anesthetic that first 
appeared as a drug of abuse among young people in 
Minnesota in 1997. There were three ED mentions of 
ketamine in 2001 and one in 2000. In 2002, the 
Minneapolis crime lab reported four cases of 
ketamine (two cases involved a white powder, one a 
tan powder, and one a greenish powder), and one 
case involving a mixture of ketamine and meth-
amphetamine in a white powder. The State crime lab 
reported one ketamine case in 2001 and five in 2002 
(through September). Ketamine is snorted, injected, 
or swallowed in capsules or pills. People under the 
influence are said to be in the “ k-hole.”  
 
Incidents involving ingestion of alpha-methyl-
tryptamine (AMT), also known as “ Amtrack,”  or 
“ Amthrax,”  were reported by two law enforcement 
agencies. In both instances, it was a white granular 
powder purchased off the Internet that resulted in 
hallucinations and extreme, aggressive, and agitated 
behavior. Tryptamines are naturally occurring com-
pounds with structures and properties similar to LSD. 
AMT is sold as powder or in capsules (for $15 per 
pill). It can also be smoked or mixed with water and 
ingested. 
 
There were 47 hospital ED mentions involving psilo-
cybin mushrooms in 2001, compared with 36 in 2000 
and 25 in 1999. They sell for up to $200 per dried 
ounce.  
 
PCP, a dissociative anesthetic, is most often used in 
combination with marijuana. Joints dipped in 
formaldehyde or embalming fluid, which is often 
mixed with PCP, are known as “ wets,”  “ amp,”  “ wet 
sticks,”  or “ wet daddies.”  They are easily dis-
tinguished by their pungent, unpleasant, chemical 
odor. PCP can also be injected or snorted. In 
Minneapolis, 3.3 percent of male arrestees tested 
positive for PCP in 2001, compared with 1.8 percent 
in 2000. ED mentions of PCP rose insignificantly to 
24 in 2001 from 20 in 2000.  
 
Sedatives/Hypnotics 
 
Gamma hydroxybutyrate (GHB), also known as “ G,”  
“ Gamma,”  “ Liquid E,”  or “ Liquid X,”  is a highly 
concentrated liquid abused for its stupor-like, 
depressant effects and as a predatory drug-induced 
rape drug. It sells for $10 by the capful.  
 
After marked increases in prior years, GHB ED 
mentions declined in 2001 (exhibit 1). From 1999 to 
2000, ED mentions rose from 33 to 93, an increase of 
106 percent, but fell in 2001 to 68. Of the 2001 
mentions, nearly one-half (48.5 percent) were made 
by those age 18– 25. Two GHB-related deaths 
occurred in 1999. 
 
Gamma butyrolactone (GBL), known as furanone di-
hydro, and 1,4 butanediol (“ BD”  or “ 1,4 BD” ) are 
chemical cousins of GHB and, once ingested, convert 
into GHB. Despite recent State and Federal laws and 
regulatory actions targeting GHB, GBL, and 1,4 BD, 
as well as a recent nationwide, multicity law 
enforcement operation, it still may be possible to find 
recipes and purchase products containing these 
chemicals on the Internet, where they are sold as 
nutritional supplements, muscle-stimulating growth 
hormones, aphrodisiacs, or household cleaning sol-
vents. In November 2001, a Minnesota man was 
convicted in Federal court for distributing more than 
4,000 ounces of 1,4 butanediol in 1,041 separate 
spray bottles.  
 
Flunitrazepam (Rohypnol), a long-acting pharma-
ceutical benzodiazepine known on the street as 
“ roofies,”  or “ Roach pills,”  produces amnesia and is 
also used in drug-assisted rapes and assaults. There 
was one ED mention of flunitrazepam in 2001 and 
none in 2000. However, DAWN does not record 
cases unless the patient knowingly ingested the drugs 
and thereby excludes all drug-rape cases from its 
database. 
 
Other Drugs 
 
Alcohol remained the most prevalent drug of abuse 
and accounted for more than one-half of admissions 
to addiction treatment programs (exhibit 4). 
 
In Hennepin County, there were 64 alcohol-involved 
deaths reported in 2002 (through September), 
compared with 96 in 2001. This included 5 cases of 
alcohol poisoning and 59 cases in which acute 
alcohol intoxication was listed as a significant con-
tributing condition.  
 
Ramsey County reported 13 alcohol-related deaths in 
2002 (through September)— two from alcohol toxicity 
and 11 cases in which the blood-alcohol content level 
was over .10 percent. In comparison, there were 19 
alcohol-related deaths in Ramsey County in 2000.  
 
Because alcohol is reported by DAWN only when 
used in combination with other drugs, it is difficult to 
fully assess the relative contribution of alcohol versus 
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illegal drug abuse to the practice of emergency 
medicine. There were 2,238 ED mentions of alcohol-
in-combination in 2001, compared with 1,780 in 
2000, an increase of nearly 26 percent. 
 
This year in Hennepin County, a 38-year-old 
Hispanic male died because of intentional inhalation 
of gold paint and paint thinner fumes. 
 
School-based counselors and emergency medicine 
staff reported the intermittent abuse of dextro-
methorphan (DXM), a substance found in over-the-
counter cough medications and sold as a powder or in 
clear capsules for $5. Calls related to ingestions of 
cough/cold preparations, most of which contained 
DXM, grew from 68 in 2001 to 73 in 2002 (through 
September) according to the Hennepin Regional 
Poison Center. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
The rate of AIDS in Minnesota is 12th lowest in the 
Nation. Minnesota had 4 AIDS cases per 100,000 
population in 1999, compared with a high of 42.3 in 
New York and a low of 1.1 in North Dakota. Most 
(90 percent) AIDS patients resided in the Min-
neapolis/St. Paul metropolitan area at onset of the 
disease. 
 
Of the 1,489 males living with the human immuno-
deficiency virus (HIV) and AIDS in Minnesota in 
2001, the modes of exposure were as follows: 
homosexual contact (70.9 percent), injection drug use 
(6.4 percent), homosexual contact and injection drug 
use (7.3 percent), heterosexual contact (2.7 percent), 
other (2 percent), and unspecified (10.5 percent).  
 
HIV exposure associated with injection drug use is a 
much more prevalent risk factor for women. Of the 
HIV and AIDS cases among 283 women in 
Minnesota in 2001, 21.9 percent were attributable to 
injection drug use and 45 percent to heterosexual 
contact. 
 
Many addicts with a history of injection drug use 
contract the hepatitis C virus (HCV), a blood-borne 
liver disease, the symptoms of which may not appear 
for as long as 20 years after initial exposure. The 
estimated rate of HCV among methadone patients 
runs as high as 90 percent. In 2001, 31 cases of acute 
hepatitis C were reported in Minnesota; 35 percent 
were residents of the metropolitan area, and 55 
percent reported using needles to inject drugs. 
 
 
For inquiries concerning this report, please contact Carol L. Falkowski, Hazelden Foundation, Butler Center for Research, 15245 Pleasant 
Valley Road, Box 11, Center City, Minnesota 55012-0011, Phone: 651-213-4566, Fax: 651-213-4356, E-mail: <cfalkowski@hazelden.org>. 
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Exhibit 1.  Number1 of ED Mentions of Selected Drugs in Minneapolis/St. Paul:  1995–2001
1 One asterisk denotes a statistically significant (p<0.05) increase from 1999 to 2001 and/or 2000 to 2001; two asterisks denote a significant 
decrease for the two time periods.
2 Dots (…) indicate that an estimate with a relative standard error greater than 50 percent has been suppressed.
SOURCE:  DAWN, OAS, SAMHSA
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Exhibit 2. Characteristics of Cocaine, Heroin, Marijuana, Methamphetamine, and MDMA ED  
 Mentions in Minneapolis/St. Paul:  20011 
 
Characteristic Cocaine Heroin Marijuana Methamphet-
amine MDMA 
Gender 
 Male 
 Female 
 Unknown 
 
 63.0* 
 36.1* 
 0.9 
 
 65.7* 
 34.3* 
 0.0 
 
 63.5* 
 35.9* 
   …
2
 
 
61.4* 
38.6 
0.0 
 
48.0 
52.0* 
0.0 
Age Group 
 6–17 
 18–25 
 26–34 
 35 and older 
 Unknown 
 
 4.5 
 20.2* 
 28.9* 
 46.4* 
 0.0 
 
 0.0 
 18.8* 
 30.5* 
 50.9* 
 0.3 
 
 30.8* 
 35.2* 
 16.7* 
          17.2 
   … 
 
10.6 
38.6* 
28.0 
22.7* 
0.0 
 
20.8 
64.9 
9.1 
5.2 
0.0 
Race/Ethnicity 
 White 
 Black 
 Hispanic 
 Other 
 Unknown 
 
  45.8* 
 22.3 
             1.7 
             2.2 
           28.0* 
 
 34.9* 
 14.8* 
 1.5 
 1.2 
 47.6* 
 
  56.7* 
  10.1* 
  1.7 
   3.1* 
 28.4* 
 
… 
1.2 
… 
… 
35.2* 
 
55.8 
… 
0.0 
… 
35.0 
Concomitance 
 Multidrug 
 Single drug 
 Unknown 
 
 69.9 
 30.0 
   0.1 
 
 52.4* 
 47.6* 
 0.0 
 
 66.6* 
 33.4* 
 0.0 
 
71.7* 
28.3 
0.0 
 
92.2* 
7.8 
0.0 
 
1
 Asterisks denote a statistically significant (p< 0.05) increase from 2000 to 2001. 
2
 Dots (… ) indicate that an estimate with a relative standard error greater than 50 percent has been suppressed. 
 
SOURCE:  DAWN, OAS, SAMHSA 
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ABSTRACT 
 
This report presents the recent drug abuse indicators 
in Newark and the primary metropolitan statistical 
area (PMSA). The report also provides comparative 
data for the State. Treatment data for Newark City 
show that almost all admissions in 2001 (96.4 percent 
of 5,615 admissions) were illicit drug-related. Heroin 
accounted for 78.2 percent of primary treatment 
admissions in Newark, compared with 6.3 percent for 
crack/cocaine and 5.6 percent for marijuana. Heroin 
use as a primary, secondary, or tertiary drug was also 
very high, with heroin’s share increasing from 80.8 
percent of 4,985 admissions in 2000 to 82.6 percent 
of 5,556 admissions in 2001. Emergency department 
(ED) data in the Newark PMSA corroborate the very 
high prevalence of heroin use. Statewide, heroin also 
became the single most important drug of choice in 
2001, increasing from 26,570 admissions as a 
primary, secondary, or tertiary drug (48.9 percent of 
all admissions) in 2000 to 28,465 admissions (51.8 
percent) in 2001. Alcohol, cocaine/crack, and 
marijuana remain important secondary and tertiary 
drugs used by clients presenting for treatment in the 
Newark PMSA and the State. Consistent with the 
high prevalence of heroin and cocaine/crack use in 
the Newark PMSA, cocaine- and heroin-related 
deaths accounted for most ME deaths in 2000, with 
heroin-related deaths surpassing cocaine-related 
deaths in 2000. Heroin purity remained high in 2001 
(68.5 percent), compared with 72.2 percent in 2000, 
while its price remained at $0.33 per milligram pure. 
Most of the heroin sold in the Newark PMSA 
continued to be South American. Heroin injection 
continued to increase among 18–25-year-old primary 
heroin admissions, accounting for 36.5 percent of the 
group in Newark in 2001 and 53.4 percent in the 
State. More importantly, heroin injection as a mode 
of use has been rising in all regions of the State, 
including cities, suburbs, and rural areas. There was 
also a marked increase in the use of narcotics 
analgesics/combinations, other opiates/synthetics, 
benzodiazepines, ecstasy, and oxycodone between 
2000 and 2001 in the Newark PMSA.  
INTRODUCTION 
 
Area Description 
 
The population of Newark declined from 329,248 in 
1980 to 275,221 in 1990; it further declined to 
273,546 in 2000. Even with this sharp population 
decline, Newark remains the largest city in the State 
and houses diverse population groups. In 1990, 
Blacks accounted for 56 percent of the population, 
compared with 16 percent for Whites and 26 percent 
for Hispanics. By comparison, in 2000, Blacks 
accounted for 55 percent, Whites for 14 percent, and 
Hispanics for 29 percent. Only 4 percent reported 
multiple races. In 2000, about 5.0 percent of the 
population lived in group quarters, and 2.7 percent 
were institutionalized. More than one-half (51.9 
percent) of the families had underage children, and 
27.9 percent of Newark residents were younger than 
18. Although the recent introduction of multiple race 
categories makes data less comparable with previous 
years, the relative share of the population groups has 
not changed much. The 2000 census suggested a 
decrease in fertility, with only 7 percent of Newark 
residents being age 5 or younger, compared with 10 
percent in 1990. The average household size in 
Newark was 2.99, slightly larger than in 1990 (2.91). 
Statewide, the average household size increased from 
2.70 to 2.75 during the same time period. Newark 
residents had one of the lowest per capita incomes 
($13,009) in 1999, compared with $9,424 in 1989. 
Data Sources 
This report uses data from various sources, as 
indicated below. 
• Drug treatment data were obtained from the 
Alcohol and Drug Abuse Data System (ADADS), 
a statewide, episode-based data system operated 
by the Division of Addiction Services of the 
Department of Health and Senior Services. The 
data include demographic information, drug use 
history, and detailed information on the three most 
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abused drugs at the time of admission. ADADS 
has been operating since July 1, 1991, and 
contains more than 700,000 admission and 
discharge records. Treatment information 
obtained from ADADS includes all statistics for 
Newark City, the Newark primary metropolitan 
statistical area (PMSA), and the State. This report 
uses treatment data primarily from 2001. Also 
included are major drug treatment admissions in 
Newark and the Newark PMSA, excluding 
Newark City. In addition, data from the Client 
Oriented Data Program dating from 1985 to 1991 
are used to study trends in drug injection among 
Newark and statewide heroin treatment 
admissions. 
• Emergency department (ED) drug mentions 
data were obtained from the August 2002 issue 
of the “ Emergency Department Trends From the 
Drug Abuse Warning Network, Final Estimates 
1994– 2001.”  The Office of Applied Studies 
(OAS) of the Substance Abuse and Mental 
Health Services Administration (SAMHSA) 
compiled the Drug Abuse Warning Network 
(DAWN) data. The DAWN system collected 
data on ED cases in the Newark PMSA (i.e., in 
Essex, Morris, Somerset, and Union Counties). 
• Drug-related mortality data were obtained 
from the SAMHSA January 2002 report entitled 
“ Mortality Data From the Drug Abuse Warning 
Network 2000.”  The DAWN system compiled 
data for counties in the Newark PMSA. 
Additional mortality data were obtained from the 
State Medical Examiner (ME) office. The 
DAWN system covered 60 percent of PMSA 
jurisdictions and 88 percent of the PMSA 
population in 2000. 
• Heroin purity and price data were obtained 
from the Intelligence Division, Office of 
Domestic Intelligence, Domestic Strategic Unit, 
Drug Enforcement Administration (DEA). The 
Intelligence Division of DEA collects data every 
quarter for the Domestic Monitor Program 
(DMP) from 23 U.S. metropolitan areas on the 
purity, retail price, and origin of heroin by 
purchasing it through undercover operations.  
• Human immunodeficiency virus (HIV) and 
acquired immunodeficiency syndrome (AIDS) 
data were obtained from the statewide AIDS 
Registry maintained by the New Jersey Depart-
ment of Health and Senior Services, Division of 
AIDS Prevention and Control, HIV/AIDS 
Surveillance Program. Data compiled as of 
December 31, 2001, are used in this report. 
DRUG ABUSE PATTERNS AND TRENDS 
Drug abuse indicators for Newark (Newark City), the 
Newark PMSA, and the State are presented in this 
section. Since Newark City exhibits patterns of drug 
abuse that are usually unique from the rest of the 
PMSA, and because the State is diverse in its social, 
demographic, and economic composition, indicator 
data are presented for each geographic area to describe 
drug abuse variations. Summary trends are presented 
first, followed by details by drug type and region.  
Exhibit 1 summarizes general trends for selected 
indicators in the Newark PMSA between 2000 and 
2001. Treatment data show that drug-related 
admissions increased between 2000 and 2001, with 
the increases driven by heroin, “ other opiates and 
synthetics,”  and benzodiazepines. Injection drug use 
also increased in this time period. Trends suggested 
by ED data are not consistent with treatment data, 
except for cocaine, phencyclidine (PCP), and 
benzodiazepines. ED data further show that mari-
juana mentions increased between 2000 and 2001, as 
did mentions for narcotics analgesics/ combinations, 
oxycodone, ecstasy, and ketamine.  
In Newark City, alcohol-related treatment admissions 
were stable, with their share remaining at about 8 
percent (8.3 percent in 2000 and 8.7 percent in 2001) 
(exhibit 2). Unlike treatment data, which showed 
stability in alcohol-in-combination mentions, ED 
mentions in the Newark PMSA declined from 2,123 
to 2,015 between 2000 and 2001. ME alcohol-in-
combination mentions remained stable at 97 and 98 
in the same time period.  
Heroin was the most prevalent drug of abuse among 
treatment admissions in the Newark PMSA. Primary 
heroin treatment admissions accounted for 78.2 
percent of all treatment admissions in Newark City, 
compared with 48.2 percent in the State. Between 
2000 and 2001, primary heroin treatment admissions 
in the State increased by 8 percent. The rate of ED 
heroin mentions in the Newark PMSA declined from 
238 to 215 per 100,000 population. The number of 
heroin ED mentions also decreased significantly, 
from 4,399 in 2000 to 3,718 in 2001. Despite the 
decline in heroin ED mentions, the rise in heroin 
abuse in the Newark PMSA and the State is 
consistent with the increase in heroin-related deaths 
between 1999 and 2000. The number of heroin-
related deaths exceeded cocaine-related deaths in 
2000 for the first time since 1996. 
Most cocaine indicators continued to decline both in 
Newark and the PMSA. In Newark City, treatment 
admissions for primary abuse of cocaine/crack 
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accounted for only 6.3 percent of all treatment 
admissions in 2001, compared with 8.3 percent in 
2000. ED cocaine mentions also declined in the same 
time period. Contrary to the continued decline in 
cocaine abuse, recent ME data show that cocaine-
related deaths in the Newark PMSA increased from 
130 in 1999 to 137 in 2000 (a 5.4-percent rise). 
In 2001, primary marijuana use accounted for 5.6 
percent of all treatment admissions in Newark City 
(exhibit 2), the same as in 2000. Marijuana’s overall 
share as a primary, secondary, or tertiary drug, 
however, declined to 12.4 percent of treatment 
admissions in 2001, compared with 16.6 percent in 
2000 (exhibit 3). ED marijuana mentions were up in 
the Newark PMSA, from 539 in 2000 to 647 in 2001. 
The decline in marijuana abuse among treatment 
admissions is consistent with the 33.3-percent decline 
in marijuana-related ME death mentions in the 
Newark PMSA between 1999 and 2000. 
PCP and other hallucinogens were rarely reported in 
the Newark PMSA. Among treatment admissions, 
there were only 17 primary, secondary, or tertiary 
PCP admissions in 1999, compared with 34 in 2000 
and 45 in 2001. By comparison, there were 67 other 
hallucinogen mentions in 1999, 65 in 2000, and 59 in 
2001. Consistent with treatment data, ED PCP 
mentions totaled 39 in 2000 and 35 in 2001.  
Methamphetamine use was rare among treatment 
admissions in the Newark PMSA, with only 25 
admissions in 1999, 22 in 2000, and 20 in 2001. 
There were only six ED methamphetamine mentions 
in 2000, compared with none in 2001.  
Club drugs, such as methylenedioxymethamphet-
amine (MDMA or ecstasy), gamma hydroxybutyrate 
(GHB), and ketamine, were rarely reported by 
treatment populations in the Newark PMSA. While 
still rare, there were 49 ED MDMA mentions in 
2001, compared with 21 in 2000, a significant, 133-
percent increase. By comparison, 2001 treatment data 
show that there were 10 clients admitted with 
MDMA as their primary, secondary, or tertiary drug.  
Overall, substance abuse treatment admissions in the 
Newark PMSA increased by 3.7 percent, from 15,290 
in 2000 to 15,851 in 2001, with heroin admissions 
increasing the fastest (8.2 percent in the Newark 
PMSA and 14.4 percent in Newark city).  
Newark City continues to have the largest number of 
illicit drug abusers per capita compared with other 
parts of the State, yet needs assessment studies 
indicate that only a small percentage were in 
treatment. Estimates indicate that there were 16,839 
heroin abusers and 4,669 cocaine abusers in Newark 
City who needed treatment in 2000. However, only 
26.1 percent of those with a primary heroin problem 
and 7.6 percent of those with a primary cocaine 
problem received treatment in 2000.  
Statewide, the proportionate share of heroin treatment 
admissions as a primary, secondary, or tertiary drug 
grew from 48.1 percent (26,570 admissions) in 2000 
to 51.8 percent (28,465 admissions) in 2001. By 
comparison, primary, secondary, or tertiary alcohol 
treatment admissions declined from 52.2 percent 
(n=28,348) in 2000 to 49.2 percent (27,019) in 2001, 
while marijuana admissions declined from 27.4 
percent (14,868) to 26.0 percent (14,291) in 2001.  
The 2001 survey of middle school students suggested 
a substantial decrease among students in the use of 
alcohol, marijuana, inhalants, hallucinogens, cocaine, 
and heroin. The survey showed that 2.4 percent of 
students in grades 7 and 8 had used club drugs in 
their lifetime. Lifetime use of any illicit drug declined 
from 20.7 percent in 1999 to 15.6 percent in 2001.  
In 1999, 24.0 percent of primary heroin treatment ad-
missions in Newark injected the drug, compared with 
20.9 percent in 2001 (exhibit 2). Injection drug use is 
fast becoming popular among young heroin users in 
Newark and the State. In 2001, 36.5 percent of 18–
25-year-old treatment admissions in Newark City 
injected heroin, up from 26.1 percent in 1999 and 
28.9 percent in 2000 (exhibit 4). Statewide, heroin 
injection by 18– 25-year-old clients increased from 
49.5 percent in 2000 to 53.4 percent in 2001 (exhibit 
5). Heroin injection remains highest among Whites, 
followed by Hispanics and Blacks.  
During the period in which heroin injection in-
creased, its purity rose modestly, except for some 
year-to-year fluctuations. The most recent data show 
that heroin purity in the Newark PMSA declined to 
68.5 percent in 2001 from 72.2 percent in 2000. 
Heroin purity remained high in the Newark PMSA, 
second only to Philadelphia among the 21 DAWN 
cities. 
The State AIDS Registry data show that 38 percent of 
people living with HIV/AIDS reported injection as a 
mode of transmission, compared with 44 percent in 
Newark. HIV/AIDS cases were predominantly Black 
(57 percent) or Hispanic (20 percent). 
In 2000, the total number of drug-related deaths in 
the Newark PMSA was 250. Seventy-five percent of 
the decedents were male, with Blacks and Whites 
accounting for 45 and 43 percent of the ME drug-
related deaths, respectively. Most of the decedents 
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(90 percent) were older than 25, with 67.6 percent 
being age 35 or older. 
Arrests for the sale and manufacture of drugs in the 
Newark PMSA increased from 5,353 in 2000 to 
9,414 in 2001. By comparison, arrests for drug 
possession and use declined from 12,382 in 2000 to 
8,115 in 2001. In 2001, most of the arrests for sale 
and manufacture (64.5 percent) and for possession 
and sale (76.3 percent) were made in Essex County, 
where Newark is located. Statewide, arrest patterns 
were similar to patterns in the Newark PMSA. 
Statewide, drug abuse violation arrests dropped from 
57,806 in 2000 to 55,451 in 2001, a 4-percent 
decline. More than one-half (53.2 percent) of the 
arrests in the State involved opium or cocaine and 
their derivatives (morphine, heroin). 
The section below presents details of trends in 
indicators by drug type and demographic 
characteristics. A more indepth look at patterns of 
drug abuse, drug-related arrests, and other indicators 
is also presented. 
Cocaine and Crack  
Primary cocaine/crack treatment admissions in 
Newark accounted for 6.3 percent of treatment 
admissions (4.4 percent for crack cocaine and 1.9 
percent for powder cocaine) in 2001 (exhibit 2). In 
2000, 5.6 percent were primary crack abusers and 2.7 
percent were powder cocaine abusers, for a total of 
8.3 percent. Despite cocaine’s small proportion as a 
primary drug among treatment admissions, it 
remained popular as a secondary drug for alcohol-in-
combination and primary heroin clients in Newark. 
Consistent with the decline in Newark, the proportion 
of cocaine abuse as a primary, secondary, or tertiary 
drug in the rest of the Newark PMSA decreased to 
36.6 percent in 2001, from 38.9 percent in 2000 
(exhibit 3). It may be safe to attribute most of the 
recent decline in cocaine abuse to the reduced use of 
the drug by Newark PMSA residents. 
In 2001, males accounted for 68.9 percent of powder 
cocaine admissions and 48.6 percent of crack cocaine 
admissions in Newark (exhibit 2). The majority (89.6 
percent) of powder cocaine admissions in Newark 
were older than 25. By comparison, 59.8 percent of 
crack cocaine and 58.5 percent of powder cocaine 
admissions were age 35 or older. 
More than two-thirds (70.1 percent) of cocaine/crack 
admissions in 2001 in Newark smoked the drug, 
while 24.7 percent used it intranasally. Reversing the 
long-term trend, cocaine injection among cocaine/ 
crack treatment admissions increased from about 2.0 
percent in 1999 to 4.9 percent in 2000, but fell to 3.7 
percent in 2001.  
Cocaine/crack use varies by race/ethnicity in Newark. 
In 2001, 85.9 percent of crack admissions were 
Black, 10.0 percent were Hispanic, and 4.0 percent 
were White. By comparison, 58.5 percent of powder 
cocaine admissions were Black, 30.2 percent were 
Hispanic, and 11.3 percent were White. 
Cocaine as a primary, secondary, or tertiary drug 
among treatment admissions in the Newark PMSA 
decreased only slightly from 39.9 percent (n=6,083) in 
2000 to 38.4 percent (6,047) in 2001. Excluding 
Newark City, cocaine treatment admissions as a 
primary, secondary, or tertiary drug dropped from 38.9 
percent in 2000 to 36.6 percent in 2001 (exhibit 3). 
After declining from 246 to 201 per 100,000 
population between 1994 and 1997, the rate of ED 
cocaine mentions in the Newark PMSA increased to 
208 per 100,000 population in 1998. However, the 
rate declined significantly between 1999 (172 
mentions) and 2000 (147). In 2001, cocaine mentions 
per 100,000 population inched up to 152, although 
the rate reflected a significant decline since 1999. 
Cocaine prices have been remarkably stable over the 
years; the drug sold for $5– $30 per bag in the 
Newark PMSA in the first quarter of 2001. Price 
reports obtained from a survey of clients in 
methadone clinics also estimated the median price of 
cocaine at $5 to $35 per bag. 
Cocaine-related deaths increased to 137 in 2000, up 
from 130 in 1999. The increase in cocaine-related 
deaths in the Newark PMSA was consistent with the 
marginal increase in cocaine treatment mentions and 
the increase in ED cocaine mentions per 100,000 
population. ME data for 2001 were not available to 
report. 
Heroin 
In Newark City, there were 4,389 primary heroin 
admissions in 2001 (exhibit 2), compared with 3,826 
in 2000, suggesting a substantial increase in the 
number of primary heroin admissions. The proportion 
of primary heroin admissions also increased to 78.2 
percent, from 76.9 percent in 2000.  
In 2001, males accounted for 60.0 percent of heroin 
admissions. The racial/ethnic distribution of heroin 
admissions in Newark reflects the population 
distribution of the city, with Blacks accounting for 
71.0 percent, Hispanics for 19.9 percent, and Whites 
for 7.0 percent of heroin treatment admissions. 
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Almost two-thirds (63.5 percent) of primary heroin 
admissions were older than 35, with only 5.3 percent 
age 25 or younger.  
Heroin abuse as a primary, secondary, or tertiary 
drug as a proportion of total drug use was higher in 
Newark City (82.6 percent) compared with the rest of 
the Newark PMSA (62.5 percent) in 2001 (exhibit 3). 
Heroin use has continued to rise in the rest of the 
Newark PMSA, growing from 60.2 percent (6,169 
mentions) in 2000 to 62.5 percent (6,375 mentions) 
in 2001. Early indications for 2002 suggest a further 
increase in the proportion of heroin mentions, both in 
the Newark PMSA and the State. The continued rise 
of heroin mentions beyond Newark City and its 
PMSA is consistent with the spread of heroin to 
suburban and rural areas of the State.  
In the early 1980s, intranasal use of heroin in Newark 
was less common than injecting. In 1992, intranasal 
use surpassed injecting and has remained at elevated 
levels (78.2 percent in 2001) since. Heroin smoking 
in Newark remains rare, with 0.6 percent of primary 
heroin treatment admissions reporting this route of 
administration (exhibit 2).  
In 2001, 20.9 percent of Newark’s primary heroin 
admissions injected the drug. While heroin injection 
in Newark City appeared stable in recent years, 
heroin injection by 18– 25-year-old clients has 
continued to rise, reaching a high of 36.5 percent in 
2001, compared with the low of 11.8 percent in 1993 
(exhibit 4). 
Statewide, 59.6 percent of primary heroin treatment 
admissions used the drug intranasally, and 39.6 
percent injected it. Consistent with Newark, heroin 
injection among 18– 25-year-olds continued to 
increase. This pattern of injection is consistent with 
patterns in major urban areas, suburban areas, and 
rural areas of the State (exhibit 6). There was also a 
less dramatic but continued rise in statewide heroin 
injection by 26– 34-year-old clients (exhibit 5). Older 
heroin users (35 or older) injected heroin less 
frequently compared with younger heroin users, 
suggesting a change in the culture of drug use in all 
areas of the State. 
Following the increase that started in 1990, ED 
heroin mentions surpassed cocaine mentions in 1993. 
Between 1994 and 1998, the rate of ED heroin 
mentions per 100,000 population rose from 262 to 
282, but declined to 238 in 2000 and further declined 
to 215 in 2001, a significant decrease of nearly 10 
percent. Among Newark PMSA treatment admis-
sions, the proportion of heroin mentions surpassed 
that of cocaine mentions in 1994 after a lag of 1 year 
from the crossover in Newark (exhibit 3). This 
upward trend in the proportion of heroin admissions 
in the Newark PMSA has continued, with no 
indication of a decline in sight. 
Although heroin purity is still very high, it has 
fluctuated in recent years. In 2001, heroin purity was 
estimated at 68.5 percent. In 2000, heroin was 72.2 
percent pure, compared with 67.5 percent in 1999. 
The price per milligram of heroin has continued to 
fall. In 2001, the average price of a milligram of 
heroin was $0.33. The Newark PMSA has the second 
highest heroin purity (after Philadelphia) coupled 
with the lowest price (with Baltimore) among the 21 
DAWN cities. Most of the heroin sold in the Newark 
PMSA is South American. 
In 2000, ME data showed 179 heroin-related deaths 
in the Newark PMSA, up from 128 in 1999 and 107 
in 1998. Consistent with the ever-increasing 
percentage of heroin admissions among treatment 
admissions in the Newark PMSA, heroin-related 
deaths exceeded cocaine-related deaths in 2000, 
accounting for 28.6 percent of all ME drug mentions 
in the PMSA. 
Opiates Other than Heroin 
There were 241 primary, secondary, or tertiary “ other 
opiates or synthetics”  drug abuse mentions among 
treatment admissions in 2001 in the Newark PMSA, 
of which 21 were in Newark. The corresponding 
numbers in 2000 were 183 and 29, respectively. 
Statewide, 1,739 “ other opiates or synthetics”  drug 
mentions were reported in 2001, compared with 
1,291 in 2000.  
Consistent with the increase in reported “ other 
opiates or synthetics”  drug abuse, ED narcotic 
analgesics/combinations mentions increased from a 
low of 332 in 1996 to a high of 739 in 2001.  Most of 
the increase was driven by the rise in narcotics 
analgesics.  
In 2000, there were 4 oxycodone overdose deaths in 
New Jersey and a total of 57 oxycodone mentions 
reported among State ME cases. There were no 
updates of mortality data for 2001 to report.  
Marijuana  
The prevalence of primary marijuana use among 
treatment admissions in Newark stayed the same as 
in 2000, accounting only for 5.6 percent of all admis-
sions (exhibit 2). 
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As expected, primary marijuana users were younger, 
with 21.8 percent being younger than 18. Only 15.1 
percent of 2001 primary marijuana treatment admis-
sions were age 35 or older. A substantial proportion 
(42.6 percent) of primary marijuana treatment admis-
sions in Newark also abused alcohol as a secondary 
drug (36.3 percent) or tertiary drug (6.3 percent).  
There were 29 ED marijuana mentions per 100,000 
population in 2000 and 37 in 2001. Primary, secondary, 
or tertiary marijuana use among treatment admissions 
declined from 22.1 percent in 2000 to 19.4 percent in 
2001 in the Newark PMSA (excluding Newark City) 
and from 16.6 to 12.4 percent in Newark during the 
same time period (exhibit 3). ME marijuana deaths 
declined by 33.3 percent (from 21 to 14) between 1999 
and 2000 in the Newark PMSA. ME data for 2001 
were not available to report. 
Marijuana-related arrests in New Jersey declined 
from 24,422 in 2000 to 22,449 in 2001. 
Prices of marijuana were stable in the Newark PMSA. 
According to the DEA, marijuana sold for $5– $10 per 
bag and $2– $5 per joint in the first quarter of 2001. 
Stimulants 
MDMA use is still rare in Newark City. In the 
Newark PMSA, there were 38 ED MDMA mentions 
in 1999. In 2001, there were 49 ED MDMA mentions 
in the Newark PMSA, a significant increase from the 
21 reported in 2000. Among treatment admissions, 
there were 95 MDMA mentions as a primary, 
secondary, or tertiary drug in New Jersey in 2001. In 
the Newark PMSA, there were only 10 MDMA 
admissions in 2001. 
In 2001, only one primary methamphetamine treat-
ment admission was reported in Newark City. 
Methamphetamine use as a primary, secondary, or 
tertiary drug was reported 4 times in Newark and 20 
times in the Newark PMSA. Methamphetamine use 
was also rare in the State, with its use as a primary, 
secondary, or tertiary drug reported 190 times in 
2000 and 170 times in 2001. 
Depressants 
Benzodiazepines remain the fifth most abused drugs 
in Newark after alcohol, heroin, cocaine, and 
marijuana. In 2001, 1.0 percent of treatment admis-
sions reported benzodiazepines as a primary, second-
ary, or tertiary drug of abuse, compared with 0.7 
percent in 2000. Statewide, benzodiazepine abuse 
accounted for 2.7 percent of primary, secondary, or 
tertiary drug use; benzodiazepines were the sixth 
most abused drugs. In contrast to the low proportion 
of treatment admissions, benzodiazepines in the 
Newark PMSA accounted for 5.6 percent of ME 
cases in 2000, compared with 9.1 percent in 1999.  
Use of GHB and ketamine (“ Special K” ) remained 
rare. According to the 2001 DAWN data, GHB ED 
mentions were too few for valid estimates, and only 5 
mentions were reported in 2000. There were 12 
ketamine ED mentions in 2001, compared with 9 in 
2000. Statewide data also showed that there were 
only 7 GHB and 20 ketamine use treatment admis-
sions as a primary, secondary, or tertiary drug. 
Hallucinogens 
In the Newark PMSA, PCP abuse as a primary, 
secondary, or tertiary drug increased from 34 
mentions in 2000 to 45 in 2001. Only 35 ED PCP 
mentions were reported in 2001 in the Newark 
PMSA. Statewide, PCP use as a primary, secondary, 
or tertiary drug rose from 338 in 2000 to 383 in 2001.  
Lysergic acid diethylamide (LSD) use remained low 
in the Newark PMSA, with 20 ED mentions in 1999 
and only 10 in each of the 2000 and 2001 reporting 
periods. 
Alcohol 
In Newark City, primary alcohol abuse among 
treatment admissions declined from 26.0 percent to 
8.7 percent between 1992 and 2000. In 2001, alcohol-
only admissions accounted for 3.6 percent, while 
alcohol-in-combination admissions accounted for 5.1 
percent of total Newark City primary treatment 
admissions (exhibit 2).  
Alcohol continued to be an important concomitant drug 
among crack/cocaine, heroin, and marijuana treatment 
clients. In 2001, 36.6 percent of crack admissions and 
36.3 percent of marijuana admissions reported alcohol 
as their secondary drug. 
Alcohol abuse as a primary, secondary, or tertiary drug 
continued to decline in the Newark PMSA. In the 
Newark PMSA, excluding Newark City, alcohol as a 
primary, secondary, or tertiary drug fell from 47.3 
percent in 2000 to 44.9 percent in 2001. The drop in 
alcohol use mentions in Newark City was less marked 
(from 28.3 percent to 27.3 percent). Statewide, alcohol 
abuse as a primary, secondary, or tertiary drug declined 
from 52.2 percent in 2000 to 49.2 percent in 2001.  
As in previous years, large proportions of alcohol-
only treatment admissions (84.0 percent) and alcohol-
in-combination admissions (89.9 percent) were older 
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than 25 in 2001 (exhibit 2). In the Newark PMSA, 
alcohol-in-combination ME cases in 2000 were stable 
(98 in 2000 vs. 97 in 1999), while their proportionate 
share declined from 18.1 percent to 15.7 percent in 
the same time period. 
Tobacco 
Cigarettes are the most commonly used substances by 
treatment populations in New Jersey. In 2001, 82.0 
percent of treatment admissions in Newark reported 
smoking cigarettes, compared with 77.2 percent in 
the State.  
Cigarette smoking in Newark continued to vary by 
gender, race/ethnicity, and type of drug abused. 
Exhibit 7 shows the proportions of admissions who 
reported smoking by selected drug type. Overall, 79.8 
percent of male clients and 86.4 percent of female 
clients smoked cigarettes in 2001. Among male treat-
ment admissions in Newark in 2001, heroin admis-
sions smoked the most (85.1 percent), followed by 
admissions for alcohol-in-combination (79.4 percent), 
cocaine (74.0 percent), crack (68.6 percent), alcohol-
only (56.7 percent), and marijuana (51.9 percent). For 
females, the corresponding percentages were 86.2, 
79.6, 74.5, 76.3, 61.1 and 54.1 percent, respectively.  
Females also smoked cigarettes at a higher proportion 
than males within each racial/ethnic group. Statewide, 
75.7 percent of male and 81.8 percent of female 
treatment admissions smoked cigarettes. As in Newark 
City, cigarette smoking prevalence was the highest for 
heroin abusers and was increasing among heroin and 
powder cocaine users. Overall, smoking appears to 
have remained common among treatment admissions. 
The recent effort to curb smoking has not translated 
itself in these special population groups.  
Smoking has become increasingly less popular in the 
general public, with only 20 percent of adults and 38 
percent of high school students in 1998 smoking cig-
arettes in the 30 days prior to the survey date. Among 
middle school students, only 7.2 percent of students 
in grades 7 and 8 in 2001 smoked cigarettes in the 30 
days prior to the survey. 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
The drug-abusing population in Newark and the rest of 
the State and those living with HIV/AIDS exhibit 
similar characteristics. There were 5,809 people living 
with HIV/AIDS in Newark as of December 31, 2001. 
Of these, 5,367 were adults/adolescents and 2,432 
(41.8 percent) were females; 43.5 percent of the 
adult/adolescent cases were either injection drug users 
(IDUs) or IDUs who also engage in male-to-male sex 
(IDU/MSMs) (exhibit 8). Only 8 percent were younger 
than 20, and 19 percent were older than 49. Sixty-six 
percent of the cases were in the 30– 49 age group. 
The population living with HIV/AIDS in Newark was 
overwhelmingly Black (80 percent), followed by 
Hispanics (16 percent). In Newark, the AIDS Registry 
data suggest that for every 1,000 Black residents, there 
are about 28 people living with HIV/AIDS. The rates 
for Hispanics and Whites are also alarmingly high, at 
10.9 and 4.7 per 1,000, respectively. 
Statewide, the number of people living with HIV/ 
AIDS as of December 31, 2001, was 30,536, of which 
28,856 were adults; 35.4 percent of the adult cases 
were females. IDUs, including those who engage in 
male-to-male sex, accounted for 38.3 percent of 
statewide adult cases (exhibit 9).  
Only 5 percent of statewide cases were younger than 
20, and 19 percent were older than 49. The race/ 
ethnicity distribution of people living with HIV/ 
AIDS statewide is also skewed towards Blacks, who 
accounted for 57 percent of all cases, and Hispanics, 
who accounted for 20 percent. 
A large and growing proportion of females in New 
Jersey (37 percent as of December 31, 2001) were 
infected through heterosexual contact, compared with 
10 percent for males. In Newark, the corresponding 
percentages, respectively, were 37 and 13. 
The continued increase in heroin injection by young 
adults (age 25 or younger), the rise in heroin abuse, 
and the sharp increase in heroin-related deaths suggest 
a possible increase in the prevalence of infectious 
diseases. However, no data are yet available to docu-
ment any rise in the prevalence of infectious diseases. 
 
 
 
 
 
 
For inquiries concerning this report, please contact Abate Mammo, Ph.D., Department of Health and Senior Services, Division of Addiction 
Services, Research and Information Systems, 120 South Stockton Street, 3rd Floor, P.O. Box 362, Trenton, New Jersey 08625-0362, Phone: (609) 
292-8930, Fax: (609) 292-1045, E-mail: <abate.mammo@doh.state.nj.us>. 
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Exhibit 1.  Trends in Selected Indicators in the Newark PMSA:  2000–2001 
 
Drug Use Mentions Treatment Data ED Mentions 
Alcohol-in-Combination Stable Decreased 
Heroin Increased Decreased 
Other Opiates and 
Synthetics Increased (N/A) 
Narcotics 
Analgesics/Combinations (N/A) Increased 
Cocaine Nonsignificant decrease Decreased 
Marijuana Decreased Increased 
PCP Increased Increased 
Methamphetamine Nonsignificant decrease Decreased 
Benzodiazepines Increased Increased 
Oxycodone (N/A) Increased 
Ecstasy (MDMA) (N/A) Increased 
Ketamine (N/A) Increased 
Total  Increased Decreased 
Other Trends   
 Heroin purity Decreased slightly, but second highest among DAWN cities 
 Heroin price Stable  
 Injection Increased 
 
 Drug-related deaths Increased (Driven by heroin, cocaine, narcotic analgesics, and 
antidepressants) 
        
SOURCES: Division of Addiction Services, State Department of Health and Senior Services; DAWN, OAS, SAMHSA; 
 Drug Enforcement Administration, Domestic Monitor Program 
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Exhibit 2. Demographic Characteristics of Treatment Admissions in Newark City by Primary 
Drug at Admission by Percent1:  2001 
 
Demographic Characteristic Alcohol-Only 
Alcohol-in-
Combination Crack Cocaine Heroin Marijuana 
Gender       
Male  
Female 
82.5 
17.5 
68.5 
31.5 
48.6 
51.4 
68.9 
31.1 
60.0 
40.0 
83.6 
16.4 
Race/Ethnicity 
White 
Black 
Hispanic 
Other 
 
15.0 
52.0 
31.0 
2.0 
 
7.3 
74.1 
18.2 
0.4 
 
4.0 
85.9 
10.0 
0.0 
 
11.3 
58.5 
30.2 
0.0 
 
7.0 
71.0 
19.9 
2.1 
 
4.7 
71.9 
22.4 
1.0 
Age at Admission 
17 and younger 
18–25 
26–34 
35 and older 
 
1.0 
14.5 
20.0 
64.0 
 
1.8 
 8.0 
27.3 
62.6 
 
0.0 
3.6 
35.7 
59.8 
 
0.9 
8.5 
31.1 
58.5 
 
0.2 
5.1 
31.1 
63.5 
 
21.8 
38.5 
24.6 
15.1 
Route of Administration 
Smoking 
Inhaling 
Injecting 
All other/multiple 
  
– 
– 
– 
100 
 
– 
– 
– 
100 
 
100 
– 
– 
– 
 
– 
82.8 
12.3 
0.9 
 
0.6 
78.2 
20.9 
0.3 
 
97.5 
– 
– 
2.5 
Most Frequently Reported Secondary Drug 
 
 
Most Frequently Reported Tertiary Drug 
– 
 
 
– 
Cocaine/Crack 
51.8 
 
Cocaine/Crack 
19.6 
Alcohol 
36.6 
 
Alcohol 
10.0 
Heroin 
34.9 
 
Alcohol 
17.9 
Cocaine/Crack 
36.8 
 
Alcohol 
8.3 
Alcohol 
36.3 
 
Alcohol 
6.3 
Total (N=5,615) 
Percentage of Total 
(200) 
3.6 
(286) 
5.1 
(249) 
4.4 
(106) 
1.9 
(4,389) 
78.2 
(317) 
5.6 
 
1Percentages may not add to 100 due to rounding.  
 
SOURCE:  Alcohol and Drug Abuse Data System, Research and Information Systems, Division of Addiction Services, State  
  Department of Health and Senior Services  
 
 
 
Exhibit 3. Primary, Secondary, or Tertiary Treatment Admissions in Newark City and the Newark 
PMSA Excluding Newark City (PMSA) by Major Drug Type and by Percent: 1992–2001 
 
Year 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Alcohol 
(PMSA) 73.1 67.1 62.0 58.7 56.4 53.3 49.8 48.1 47.3 44.9 
Alcohol 
(City) 56.9 48.5 40.3 34.3 31.5 29.6 27.9 30.4 28.3 27.3 
Heroin 
(PMSA) 30.5 40.4 44.9 50.9 52.0 53.9 58.0 59.9 60.2 62.5 
Heroin 
(City) 54.0 66.8 70.4 79.0 78.6 78.6 80.5 80.4 80.8 82.6 
Cocaine 
(PMSA) 49.0 45.6 42.9 44.3 44.4 41.1 41.6 40.7 38.9 36.6 
Cocaine 
(City) 65.7 57.0 53.5 52.8 52.8 47.4 45.7 47.6 42.2 41.7 
Marijuana 
(PMSA) 21.5 21.4 21.3 22.5 21.8 23.1 22.3 20.4 22.1 19.4 
Marijuana 
(City) 12.4 12.6 15.0 12.7 15.5 16.5 14.5 14.2 16.6 12.4 
 
SOURCE:  Alcohol and Drug Abuse Data System, Research and Information Systems, Division of Addiction Services, State   
  Department of Health and Senior Services  
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Exhibit 4. Heroin Injectors Among Treatment Admissions by Age Group in Newark  
 City: 1985–2001 
0
10
20
30
40
50
60
70
80
90
100
18–25 78.0 73.7 48.8 42.9 29.9 37.5 26.4 15.7 11.8 11.9 14.8 17.8 18.5 21.4 26.1 28.9 36.5
26–34 89.9 88.4 76.5 62.8 57.1 57.1 43.4 28.4 19.4 21.1 15.8 15.2 15.0 16.3 18.7 17.7 18.5
35+ 92.1 89.9 84.7 80.6 75.7 80.8 61.2 58.4 43.0 42.2 29.2 29.6 26.7 27.7 26.6 24.4 20.8
1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
  
 
Exhibit 5. Heroin Injection Among Treatment Admissions by Age Group in New  
  Jersey: 1985–2001 
 
0
10
20
30
40
50
60
70
80
90
100
Under 18 72.7 35.7 40.9 10.0 8.3 9.7 24.0 21.5 18.2 22.2 20.1 29.4 26.9 27.3 23.3 25.7 31.7
18–25 88.3 80.3 69.4 55.5 48.3 46.4 30.7 25.6 21.9 25.1 26.1 35.7 40.3 44.0 47.1 49.5 53.4
26–34 93.8 91.3 84.0 75.1 68.0 63.5 46.0 38.0 30.6 31.2 27.7 28.5 30.9 30.6 31.5 32.8 36.0
35+ 94.7 92.9 89.8 85.7 81.5 81.6 63.5 56.8 49.6 50.2 41.7 41.2 39.6 38.0 36.7 34.9 35.1
1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
 
SOURCE:  Client Oriented Data Program and Alcohol and Drug Abuse Data System 
SOURCE:  Client Oriented Data Program and Alcohol and Drug Abuse Data System 
Percent 
Percent 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Newark and the PMSA 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 142
Exhibit 6.  Trends in Heroin Injection for 18–25-Year-Olds for Regions of New Jersey:  1992–2001 
 
0
10
20
30
40
50
60
70
80
90
100
Major Cities/Urban Centers 22.4 18.0 19.8 21.7 26.6 31.5 36.2 39.7 44.6 45.2
Suburbs 38.4 33.2 36.1 36.5 47.4 47.3 49.9 53.2 54.4 54.4
Rural Areas 48.5 48.0 46.6 39.4 46.4 44.3 45.9 52.6 52.2 51.1
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
 
 
 
 
SOURCE:  Client Oriented Data Program and Alcohol and Drug Abuse Data System 
Percent 
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Exhibit 7. Trends in Cigarette Smoking by Treatment Clients by Major Drug Types:   New Jersey,  
1992–2001 
 
40
50
60
70
80
90
100
Alcohol-Only 61.6 63.6 64.0 63.5 61.3 63.0 62.7 63.4 62.2 63.5
Alcohol-in-Combination 74.9 76.3 75.2 75.0 76.0 74.9 74.9 75.3 73.6 74.3
Heroin 83.4 84.4 84.4 84.8 84.5 84.8 85.2 85.4 85.3 86.4
Crack 79.16 79.45 78.96 79.18 78.87 76.72 77.29 78.18 77.97 76.87
Powder Cocaine 67.63 68.6 70.18 68.38 69.8 67.8 68.07 68.73 70.64 71.01
Marijuana 60.9 65.71 66.48 68.34 70.06 68.82 67.48 66.93 65.66 66.4
1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
 
 
 
 
    
 
SOURCE:  Client Oriented Data Program and Alcohol and Drug Abuse Data System 
 
Percent 
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Exhibit 8. Adult/Adolescent and Pediatric Cases Living With HIV/AIDS in Newark by Exposure  
  Category and Gender as of December 31, 2001 
 
Males Females Total 
Exposure Category 
N (%) N (%) N (%) 
Adult/Adolescent 
   Men/sex/men (MSM) 
   Injection drug user (IDU) 
   IDU/MSM 
   Hemophiliac 
   Heterosexual contact 
   Transfusion with blood/ 
      products 
   Risk not specified/other 
 
480 
1,344 
160 
 13 
415 
 
 9 
743 
 
(15) 
(42) 
(5) 
(<1) 
(13) 
 
(<1) 
    (23) 
 
0 
832 
  0 
  0 
807 
 
 16 
548 
     
(0)     
(38) 
    (0) 
   (0) 
   (37) 
 
    (1) 
   (25) 
 
480 
2,176 
 160 
  13 
 1,222 
 
  25 
1,291 
 
(9) 
(41) 
 (3) 
 (<1) 
(23) 
 
 (<1) 
(24) 
Total 3,164   (100) 2,203   (100) 5,367 (100) 
Pediatric 
   Hemophiliac 
   Parent at risk/has AIDS/HIV 
   Transfusion with blood/ 
      products 
   Risk not specified/other 
 
0 
212 
 
 0 
 1 
 
(0) 
(99) 
 
 (0) 
(<1) 
 
0 
224 
 
 0 
 5 
 
(0) 
(98) 
 
 (0) 
(2) 
 
0 
436 
 
 0 
6 
  
 (0) 
 (99) 
 
  (0) 
  (<1) 
Total 213 (100) 229 (100) 442 (100) 
 
SOURCE:  New Jersey Department of Health and Senior Services, Division of AIDS Prevention and Control 
             
     
 
Exhibit 9. Adult/Adolescent and Pediatric Cases Living With HIV/AIDs in New Jersey by Exposure 
Category and Gender as of December 31, 2001 
 
Males Females Total 
Exposure Category 
N (%) N (%) N (%) 
Adult/Adolescent 
Men/sex/men (MSM) 
Injection drug user (IDU) 
IDU/MSM 
Hemophiliac 
Heterosexual contact 
Transfusion with blood/ 
    products 
Risk not specified/other 
 
4,957 
6,676 
826 
67 
1,836 
 
94 
4,180 
 
(27) 
(36) 
(4) 
(<1) 
(10) 
 
(1) 
(22) 
 
0 
3,561 
  0 
  1 
3,750 
 
 141 
2,767 
   
(0) 
(35) 
(0) 
(<1) 
(37) 
 
(1) 
(27) 
 
4,957 
10,237 
 826 
  68 
 5,586 
 
  235 
6,947 
 
(17) 
(35) 
(3) 
(<1) 
(19) 
 
(1) 
(24) 
Total 18,636 (100) 10,220 (100) 28,856 (100) 
Pediatric 
Hemophiliac 
Parent at risk/has AIDS/HIV 
Transfusion with blood/ 
    products 
Risk not specified/other 
 
7 
809 
 
3 
10 
 
(1) 
(98) 
 
(<1) 
(1) 
 
0 
833 
 
6 
12 
 
(0) 
(98) 
 
(1) 
(1) 
 
7 
1,642 
 
9 
22 
 
(<1) 
(98) 
 
(1) 
(1) 
Total 829 (100) 851 (100) 1,680 (100) 
 
SOURCE:  New Jersey Department of Health and Senior Services, Division of AIDS Prevention and Control 
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Overview of Drug Abuse Indicators in New Orleans 
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ABSTRACT 
 
Crack cocaine remains a serious problem in the New 
Orleans area, but treatment admissions trended down, 
emergency department (ED) mentions dropped, and 
fewer adult female arrestees tested cocaine-positive. 
Heroin abuse was up despite mixed indicators. The 
number of ED mentions for narcotic analgesics/ com-
binations rose. Marijuana indicators, such as treat-
ment admissions and the proportion of male adult 
arrestees testing marijuana-positive, were stable, but 
ED mentions declined. AIDS and HIV cases 
increased in Louisiana. Injection drug users 
accounted for 18 percent of adult AIDS cases and 17 
percent of HIV cases statewide through November 
2002. 
 
INTRODUCTION 
 
Area Description 
 
Located in southern Louisiana, New Orleans covers 
366 square miles, of which 164 are water. Jefferson 
Parish borders the city on the west. About one-half of 
the metropolitan area’s 1.2 million inhabitants live in 
Orleans Parish, the largest of Louisiana’s 64 parishes. 
 
New Orleans is serviced by several deep-water ports 
located at the confluence of the Nation’s two principal 
waterways: the Gulf Intracoastal Waterway and the 
Mississippi River. Barge lines and more than 100 
steamship lines service the ports, with more than 4,000 
ships calling annually. 
 
New Orleans has two airports: the New Orleans Inter-
national Airport, which serves all cargo airlines, and 
the New Orleans Lakefront Airport, which serves gen-
eral aviation and corporate and private aircraft. 
Domestic and international trade is served directly by 
the Public Belt Railroad and trunk line railroads; other 
rail companies maintain offline offices in New 
Orleans. 
 
Data Sources 
 
Information for this report was collected from the fol-
lowing sources: 
• Emergency department (ED) drug mentions 
data were derived from the Drug Abuse Warning 
Network (DAWN), Office of Applied Studies 
(OAS), Substance Abuse and Mental Health 
Services Administration (SAMHSA), for 1994 
through 2001. 
 
• Drug-related homicide and suicide data were 
derived by the Orleans Parish Coroner’s Office for 
1999, 2000, and 2001. 
 
• Drug treatment data were provided by the Lou-
isiana State Office for Addictive Disorders and by 
not-for-profit treatment facilities for Orleans 
Parish for fiscal years 1991– 2001. 
 
• Arrestee drug testing data came from the Arres-
tee Drug Abuse Monitoring (ADAM) Program, 
National Institute of Justice (NIJ), for 2000, 2001, 
and the first three quarters of 2002. 
 
• Drug arrest data were provided by the New 
Orleans Police Department (NOPD) for 2000, 
2001, and the first half of 2002. 
 
• Drug price, purity, and seizure information 
was provided by the New Orleans Division of the 
Drug Enforcement Administration (DEA) for 
2000– 2001. Data for 2001 were also derived from 
the DEA’s Domestic Monitor Program (DMP). 
 
• Acquired immunodeficiency syndrome (AIDS) 
and human immunodeficiency virus (HIV) 
data were provided by the Louisiana State Health 
Department and represent new and cumulative 
cases through May 2002. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
Cocaine abuse remains at high levels, despite indica-
tors declining in 2001. 
 
Rates of cocaine/crack ED mentions per 100,000 
population declined significantly from 164 in 1994 to 
123 in 2001, with a continuing decline from 1999 to 
2001 (exhibit 1). In 2001, cocaine ED rates were 
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approximately 2.7 times higher among males (183 per 
100,000) than females (68), and were highest among 
those age 26– 29 (289 per 100,000). Significant 
declines by gender and all age groups were reported 
from 2000 to 2001. 
 
In 1991, primary cocaine treatment admissions 
accounted for 57.6 percent of all admissions, but they 
declined over the subsequent 11-year period to 32.5 
percent in 2001 (exhibit 2). Between 2000 and 2001, 
the decline in the proportion of cocaine admissions 
was slight— from 34.4 to 32.5 percent, respectively. 
 
Cocaine/crack arrests totaled 2,464 for the first half of 
2002, up from 1,751 in the same period in 2001. 
Cocaine/crack distribution arrests totaled 691 in the 
first half of 2002, compared with 474 in 2001. Posses-
sion arrests totaled 1,773 in 2002, up from 1,277 in the 
first half of 2001. Of the 691 distribution arrests, 3.6 
percent (n=25) were White males, 82.9 percent (573) 
were Black males, 0.8 percent (6) were White females, 
and 11.9 percent (82) were Black females. Of the 
1,773 possession arrests, 12.2 percent (216) were 
White males and 66.9 percent (1,186) were Black 
males. 
 
New Orleans ADAM data for the first three quarters of 
2002 show that 41.0 percent of adult male arrestees 
tested positive for cocaine, compared with 37.2 percent 
in 2001 and 34.8 percent in 2000. In the first three 
quarters of 2002, 41.9 percent of adult female arrestees 
tested positive for cocaine, compared with 31.0 percent 
in 2001 and. 41.0 percent in 2000. 
 
The price and purity of powder cocaine remained sta-
ble over the last year, averaging $80– $150 per gram, 
$800– $1,200 per ounce, and $20,000– $28,000 per 
kilogram. 
 
Heroin 
 
Heroin indicators are mixed. According to the DEA, 
NOPD, and the Coroner’s Office, heroin distribution 
and deaths increased in the first half of 2002. ED rates 
of heroin mentions declined, however, from 2000. 
 
Heroin ED rates increased significantly from 1994 to 
2001, climbing from 17 to 46 per 100,000 population 
(exhibit 1). However, significant declines were 
reported in heroin ED rates from 1999 to 2001 and 
from 2000 to 2001. In 2001, heroin ED rates continued 
to be higher among males than females (82 vs. 13 per 
100,000 population, respectively). The rates among 
age groups were highest among those age 26– 29 and 
those age 20– 25 (160 and 138 per 100,000, respec-
tively). However, heroin ED rates declined signifi-
cantly from 2000 to 2001 for both males and females 
and for all age categories. 
 
Despite decreases in ED rates, the proportion of pri-
mary heroin treatment admissions rose in 2001 to 14.8 
percent of all admissions— the largest percentage since 
1991 (2.6 percent) (exhibit 2). The admissions 
increased slightly from 11.2 percent in 2001 to 14.8 
percent in 2001. 
 
Among adult male arrestees in the ADAM program in 
the first three quarters of 2002, 17.5 percent tested 
positive for opiates, compared with 15.5 percent dur-
ing the same period in 2001, and 15.5 percent in 2000. 
The percentage of female arrestees testing positive for 
opiates remained relatively stable, at approximately 8 
percent in the first three quarters of 2002. 
 
The NOPD reported 108 heroin possession arrests in 
the first half of 2002, compared with 165 in 2001, and 
102 distribution arrests, compared with 75 in the same 
period in 2001. Of the 108 people arrested for posses-
sion in the first half of 2002, 12 percent (n=13) were 
White males, 70 percent (76) were Black males, 8 per-
cent (9) were White females, and 9 percent (10) were 
Black females. 
 
Preliminary DMP data for 2001 showed heroin purity 
at 36.2 percent. The average price per milligram pure 
was $3.74. The DEA reported that the price of heroin 
remained stable in the first half of 2002 compared with 
2001. In the first half of 2002, a gram cost $300– $600, 
an ounce cost $4,000– $9,000, and a kilogram cost 
$80,000– $100,000. 
 
Marijuana 
 
Marijuana continues as a major problem among youth 
in the city of New Orleans, but indicators were mixed. 
 
While there was no significant change in the rate of 
marijuana ED mentions from 1994 to 2001, the rate 
decreased significantly from 87 to 71 per 100,000 
population from 2000 to 2001 (exhibit 1). The rate for 
males continued to be higher than that for females (102 
vs. 41 per 100,000 in 2001), but it did decline 22 per-
cent from 2000. Rates by age group were highest 
among those age 26– 29 (278) and those age 18– 19 
(225 per 100,000 population). 
 
Primary marijuana treatment admissions increased 
slightly from 29.2 in 2000 to 30.5 in 2001 (exhibit 2). 
 
ADAM data show that 45 percent of male arrestees 
tested positive for marijuana in the first three quarters 
of 2002, as did 35 percent of females. In 2001, 46.2 
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percent of males and 28.5 percent of females tested 
marijuana-positive. 
 
According to the NOPD, marijuana possession arrests 
increased from 2,695 in the first half of 2001 to 3,474 
in the first half of 2002. Of the 3,474 possession arrests 
in 2002, White males accounted for 18.4 percent 
(n=641), Black males for 71.8 percent (2,495), White 
females for 3.2 percent (112), and Black females for 
6.3 percent (217). Distribution arrests for marijuana 
increased from 402 in the first half of 2001 to 611 in 
the first half of 2002. The 2002 distribution arrests 
decreased among White males but increased among 
White females and among Black males and females. 
Black males accounted for nearly 83 percent of the 
marijuana distribution arrests, followed by Black 
females (11 percent). 
 
Marijuana prices showed no change between 2001 
and 2002, averaging $2– $5 a joint, $700 per gram, 
$125– $160 per ounce, $800– $1,000 per pound, and 
$2,000 per kilogram. Hashish remained at $150 per 
ounce and tetrahydrocannabinol (TCH) liquid at $200 
per mililiter. 
 
Other Drugs 
 
There were few significant numbers or changes to 
report in drugs other than cocaine/crack, heroin, and 
marijuana; however, narcotic analgesics/combinations 
ED rates per 100,000 population increased signifi-
cantly from 35 in 1994 to 74 in 2001 (exhibit 1). The 
2001 ED rate for narcotic analgesics/combinations was 
higher than that for marijuana and heroin. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
Through November 1, 2002, 6,655 adult cases of 
AIDS were reported in Louisiana. Of these, 18 percent 
were injection drug users (IDUs) and 9 percent were 
male IDUs who had sex with other men. 
 
Through November 1, 2002, 6,429 new HIV cases 
were reported; 17 percent were IDUs and 7 percent 
were male IDUs who had sex with other men. 
 
 
For inquiries concerning this report, please contact Gail Thornton-Collins, New Orleans Health Department, 2025 Canal Street, Suite 200, New 
Orleans, LA 70112, Phone: (504) 528-1912, E-mail: <gaily47@hotmail.com>.  
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Exhibit 1. Rates of ED Mentions Per 100,000 Population in New Orleans:  1994, 1999–2001 
 
Percent Change 
Drug 1994 1999 2000 2001 1994, 
2001 
1999, 
2001 
2000, 
2001 
Cocaine 164 176 162 123 -24.6 -30.0 -23.8 
Heroin 17 53 80 46 177.0 -14.0 -42.2 
Marijuana 77 86 87 71   -18.4 
Narcotic Analgesics/ 
Combinations 35 49 55 74 112.3   
 
SOURCE: DAWN, OAS, SAMHSA 
 
 
 
Exhibit 2. Percentages of Admissions in Orleans Parish by Drug and Year:  1991–2001 
SOURCE:  Louisiana State Office of Alcohol and Drug Abuse 
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ABSTRACT 
Drug use trends were mixed for this reporting period. 
Cocaine indicators in New York City, which had 
declined at the end of the last decade, continued to 
show some signs of increasing. While treatment 
admissions for cocaine in the first half of 2002 
showed increases, and the Street Studies Unit reported 
signs of a rebound in cocaine use, emergency 
department (ED) mentions were stable. Heroin trends 
again appeared to be mixed, with ED mentions 
remaining stable and treatment admissions decreasing 
slightly. Heroin remains available at very high purity 
levels. Even marijuana indicators, which had been 
reaching new peaks, seem to have stabilized, with only 
slight increases in treatment admissions. Prescription 
drugs continue to be available on the street. Ecstasy is 
widely available throughout New York City, especially 
at dance clubs and large social events. For AIDS 
cases in New York City, injection drug use remains 
the modal risk factor. The effects of September 11, 
2001, on the New York City drug scene continue to be 
closely monitored. 
 
INTRODUCTION 
 
Area Description 
 
New York City, with 8 million people, is by far the 
largest city in the United States. It is situated in the 
southeastern corner of the State on the Atlantic coast 
and encompasses an area of 320 square miles. It has 
nearly 600 miles of waterfront and one of the world’s 
largest harbors. 
 
Historically, New York City has been home to a large 
multiracial, multiethnic population. Findings from the 
2000 census show that the population diversity 
continues: 45 percent are White; 27 percent are Black; 
27 percent are Hispanic of any race; 10 percent are 
Asian and Pacific Islander; and less than 1 percent are 
Native American, Eskimo, and Aleut. Nearly 2 million 
New York City residents are foreign born, and nearly 
700,000 legal immigrants became New York City 
residents between 1990 and 1998. The Dominican 
Republic is currently the city’s largest source of 
immigrants. 
 
The city remains the economic hub of the Northeast. Its 
main industries include services and wholesale and 
retail trade. Of the more than 3.5 million people 
employed in the city, 20 percent commute from 
surrounding areas. Overall, the unemployment rate in 
New York City for October 2002 was 7.8 percent, 
compared with 5.7 percent in New York State and 5.7 
percent in the Nation. According to the Bureau of 
Labor Statistics, the New York City rate is dramatically 
higher than in October 2001, when the rate was 6.8, and 
October 2000, when the rate was 5.4. New York City is 
still feeling the economic effects of the September 11, 
2001, attacks on the World Trade Center and their 
aftermath. Many jobs in New York City were lost as a 
result of decreased business activity and the relocation 
of business firms. 
 
Data Sources 
 
This report describes current drug abuse trends in New 
York City from about 1991 to 2001, using the data 
sources summarized below. 
 
• Emergency department (ED) drug mentions 
data were derived from the Drug Abuse Warning 
Network (DAWN), Office of Applied Studies 
(OAS), Substance Abuse and Mental Health 
Services Administration (SAMHSA), for 1991 
through 2001. The comparable 1994– 2001 
weighted data are based on a representative sample 
of hospitals in New York City and Westchester, 
Rockland, and Putnam Counties.  
 
• Drug abuse-related death data are from the 
DAWN mortality system. Data from 1991 through 
1995 covered New York City, Long Island, and 
Putnam County and included heroin/morphine and 
unspecified types of opiates. Beginning in 1996, 
DAWN covered only New York City, and the 
category for heroin/morphine no longer included 
other opiates. The DAWN system covered 75 
percent of the metropolitan statistical area (MSA) 
jurisdictions and 87 percent of the MSA popula-
tion in 2000. 
 
• Drug treatment admissions data were provided 
by the New York State Office of Alcoholism and 
Substance Abuse Services (OASAS) for 1991–
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2002 and included both State-funded and 
nonfunded admissions. Demographic data are for 
the first half of 2002. 
 
• Arrestee drug testing data were provided by the 
Arrestee Drug Abuse Monitoring (ADAM) pro-
gram, National Institute of Justice (NIJ), for 2001. 
The adult male sample data are weighted, based on 
probability sampling. Adult female data are 
unweighted and based on different sampling and 
data collection methods. 
 
• Drug-related arrest data were provided by the 
New York City Police Department (NYPD) for 
1991 through the first half of 2001. 
 
• Drug price, purity, and trafficking data were 
provided by the Drug Enforcement Administration 
(DEA) and the DEA’s Domestic Monitor Program 
(DMP) for heroin. These data are supplemented by 
information from the OASAS Street Studies Unit 
(SSU) reports. 
 
• Cocaine use during pregnancy data were 
provided by the New York City Department of 
Health for 1991– 2000. 
 
• Acquired immunodeficiency syndrome (AIDS) 
data were provided by the New York City Depart-
ment of Health for 1984– 2001. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
In general, cocaine indicators, which had been 
declining, are beginning to show increases, and the 
drug still accounts for major problems in New York 
City (exhibit 1). 
 
For the New York City metropolitan area, DAWN 
estimates for ED mentions remained relatively stable 
between 1994 and 1998 (from 20,145 to 19,549), but 
declined significantly from 1998 to 2000. The estimate 
for 2001 (13,898) shows a significant decrease of 31 
percent from 1994. The rate of cocaine emergencies per 
100,000 population in the New York City metropolitan 
area for 2001 was 166, the same as the previous year, 
and a decline of almost 34 percent since 1994. The 
comparable national rate for 2001 was 76. While the 
national rate had been relatively stable, there was a 22-
percent increase in this rate from 1994. 
 
While primary cocaine treatment admissions to State-
funded and nonfunded programs in New York City 
declined from 17,572 in 1998 to 14,059 in 2000, they 
increased slightly in 2001 to 14,375, and showed 
continuing increases, with 7,453 in the first half of 
2002 (exhibit 1). In the first half of 2002, cocaine 
admissions constituted 22 percent of all New York 
City’s 33,437 drug and alcohol treatment admissions 
(excluding alcohol-only). 
 
Exhibit 2 shows demographic characteristics of cocaine 
treatment admissions for the first half of 2002 by the 
two primary modes of use: smoking crack (representing 
63 percent of cocaine admissions) and using cocaine 
intranasally (representing 34 percent). Those who smoke 
crack are more likely than those who use intranasally to 
be female (37 vs. 24 percent), Black (66 vs. 43 percent), 
readmissions to treatment (78 vs. 70 percent), and 
without income (39 vs. 27 percent). The two groups are 
similar in secondary drugs of abuse, primarily alcohol 
and marijuana. All admissions for primary cocaine abuse 
represent an aging population.  The increase in Hispanics 
among treatment admissions who use cocaine 
intranasally, which had stabilized recently, has risen 
again to 38 percent in the first half of  2002. 
 
ADAM urinalysis data for 2001 show drug positives 
remaining the highest for cocaine. The 2000 weighted 
data for adult males show that 45 percent tested 
cocaine-positive. In the unweighted adult female 
sample, 57 percent tested positive for cocaine. 
 
The SSU finds powder cocaine quality to be relatively 
stable and buying and use to be rebounding. Powder 
cocaine has typically been a drug sold from indoor 
locations, but observers report that there has been a 
steady increase in the number of street peddlers 
offering powder cocaine. Cocaine is sold in $10, $20, 
$30, and $60 amounts. The most common price is the 
$20-packet, which contains about one-fourth ounce. 
The $25 and $30 prices usually represent variation in 
quality, but not in the amount of product.  
 
There is a great variety of packaging methods used in 
the marketing of cocaine in New York City. These 
materials include aluminum foil, light plastic wrap 
knotted at both ends, cellophane, vials, nail-sized 
plastic bags, folded paper, magazine pages, and 
balloons. Of these, the traditional material, aluminum 
foil, continues to be the most frequently used, followed 
by plastic wrap and cellophane. Users tend to prefer the 
malleability of the aluminum, but dislike that the 
cocaine can “ cook up”  (melt) in the foil from body 
heat. Plastic wrap has recently increased in use, while 
vials have declined.  
 
The use of brand names is becoming less common, 
since they attract attention from law enforcement and 
are too easy to duplicate by competitors. Currently, 
brand names tend to be the color of the package, e.g. 
“ blue bag.”  “ Perico”  is a common Spanish slang term 
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for cocaine; “ powder”  and “ fishscale”  are also common 
slang terms. Dominican drug gangs dominate the 
distribution of cocaine in New York City. At the street 
level, sellers frequently match the predominant racial 
composition of the surrounding community.  
 
The selling of powder cocaine involves three basic 
methods. The method gaining popularity is the techno 
method or virtual connection method. A buyer makes a 
connection with a seller through the use of a beeper, 
cell phone, or the Internet. An order is made and a 
meeting or delivery is scheduled. The most common 
method of selling cocaine is from an apartment. 
Cocaine sellers typically work out of their own 
apartments or ones belonging to relatives. Another 
method, which is also becoming increasingly common, 
is the selling of cocaine from the street. Typically this 
form of street selling is done in connection with an 
apartment operation. In order to reduce the amount of 
buyer traffic in and out of an apartment, street sellers 
work outside. The individual who wants to buy a $10 or 
$20 amount of cocaine obtains the product from the 
street vendor, while individuals interested in buying 
larger quantities are directed upstairs. Like most other 
street sellers, those who sell cocaine usually sell only 
one type of drug offered in one standard package size. 
Virtual sellers and dealers working out of an apartment 
are able to sell other drugs. There is some indication 
that some cocaine sellers are also offering club drugs.  
 
The majority of powder cocaine users are Hispanic and 
Black, but there is a sizeable number of White users, 
including an influx of young white-collar professionals 
who use cocaine recreationally. According to 
observations by field staff, buyers appear to be almost 
evenly split in terms of gender. Field staff also report 
large clusters of young buyers in the 18– 25-year-old 
range, suggesting a new generation of users.  
 
According to street interviews, most powder cocaine 
users report that they only “ snort”  the drug. However, 
an increasing number report that they know people who 
have started to inject cocaine. 
 
Crack users report that the drug is highly available, 
despite a reduction in “ open-air”  markets and less 
aggressive selling because of concerns over security. 
The reduction in “ open-air”  markets is attributed to 
police department efforts aimed at suppressing street 
drug selling. Researchers found that the quality of crack 
since the last study period remains unchanged.  
 
Crack is associated with three basic prices: $5, $10, and 
$20. During the present study period, field researchers 
were unable to find any location offering crack in $3-
bags. The most common price continues to be $10 for 
one-tenth gram. Interviews with several street sellers, 
however, indicated that they want to make the $20 for 
two-tenths gram amount the standard price to reduce 
the risk of exposure, since sellers are most vulnerable at 
the time of drug exchange. 
 
There are three basic packaging materials used for 
crack: thumbnail sized plastic bags, plastic vials, and 
glassine bags. Of these, the thumbnail-sized bag seems 
to be the most popular, followed by the plastic vial. As 
with powder cocaine, brand names are usually the color 
of the package. Old slang terms such as “ rock,”  and, in 
Spanish, “ roca,”  continue to be used.  
 
Street crack sellers are typically Black or Hispanic 
males. According to street contacts, the middle-level 
dealing operation that supplies the street sellers is 
dominated by Dominican drug gangs. Crack sellers are 
typically older than other street sellers; most are age 26–
35. Most crack sellers operate within a partnership or 
small localized crew (two to five people), and they tend 
to obtain their supply of crack “ up-front”  (on credit) with 
no money down. The entire outstanding balance is due 
the next time they need to replenish their inventory. 
Typically, the dealer starts the street seller with a $100 
supply of crack, or 10 packets. Before the seller can 
obtain a new supply, he needs to pay the dealer $80. The 
seller is making approximately $2 on each packet sold. 
Many of the heavy crack-selling locations around the 
city are found in or around public housing developments, 
followed by apartments. Usually these apartments are 
not the sellers’ homes, but are specifically established as 
selling locations that can be abandoned if necessary. 
Although there are still open-air street locations, fewer 
crack sellers are operating from the street because of law 
enforcement efforts. As a rule, street crack sellers do not 
sell other drugs. If they do offer another drug, it is likely 
to be marijuana, which many users smoke to reduce the 
“ crash-effect”  resulting from the prolonged use of crack. 
 
The majority of crack users are Black and Hispanic 
males. Originally, crack had a strong appeal among 
young adults, but it appears that crack users are getting 
older. Field researchers report very few young users, 
and most buyers appear to be veteran users. Crack users 
interviewed by the SSU reported that they smoked 
crack, often using an old broken glass stem. There was 
some talk about injecting crack, but the field 
researchers could not find anyone using this method, or 
knowing anyone who had used this method.  
 
The DEA reports that prices for powder cocaine are 
$22,000– $30,000 per kilogram and $900– $950 per 
ounce. To minimize conspicuous traffic, transactions 
are few but prices are high. According to the DEA, 
crack sells for about $1,000– $1,500 per ounce and 
$27– $45 per gram. 
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DAWN figures for cocaine-involved deaths, which 
declined steadily from 1995 to 1999, showed a 26-
percent increase in 2000 (to 492 from 392 in 1999) 
(exhibit 1). 
 
The NYPD reports a decline in cocaine arrests since 
1995, when they totaled 40,846 (exhibit 1). The number 
of cocaine arrests in 2000 was 31,919, essentially the 
same as in 1999, but a 22-percent decrease since 1995. 
Of the 13,956 cocaine arrests in the first half of 2001, 
83 percent involved crack. 
 
Another important indirect indicator of cocaine use is 
the number of births in New York City to women who 
admit using cocaine during pregnancy. This not only 
indicates use among women, but it underscores a 
serious aspect of the cocaine problem. For several 
years, the number of women using cocaine during 
pregnancy increased. In 1989, the number of births to 
women who used cocaine peaked at 3,168. After 1989, 
the number steadily declined to 490 in 2000— an 85-
percent decline over 11 years (exhibit 1). 
 
Heroin 
 
Heroin trends, which had appeared to stabilize, are 
mixed for this CEWG reporting period (exhibit 3). The 
number of heroin ED mentions remained relatively 
stable from 11,129 to 10,644 between 1994 and 2001. 
Estimates for 2001 showed a nonsignificant increase 
from the year before. The rate in the New York 
metropolitan area was 127 heroin mentions per 100,000 
population for 2001, almost the same as the rate for the 
year 2000, 128. The estimated national rate was 37 
heroin mentions per 100,000 population.  
 
Primary heroin treatment admissions to all treatment 
programs in New York City have been gradually 
increasing. Between 1991 and 2001, admissions rose 
from 15,085 to 22,779, a 51-percent increase over the 
10-year period (exhibit 3). The number for the first half 
of 2002— 10,838— was less than in either half of 2001. 
In the first half of 2002, primary heroin admissions 
constituted 32 percent of New York City’s 33,437 drug 
and alcohol treatment admissions (excluding alcohol 
only). 
 
Intranasal heroin use may have peaked in the second 
half of 1998, when 62 percent of heroin admissions to 
all New York City drug treatment programs reported 
this as their primary route of administration. Since then, 
the proportions reporting intranasal use declined 
slightly, to approximately 60 percent in 1999, 2000, 
2001, and the first half of 2002. Meanwhile, heroin 
injection increased among heroin admissions, from 32 
percent in the second half of 1998 to 37 percent in the 
second half of 2002. 
Exhibit 4 highlights general demographic characteris-
tics of heroin abusers admitted to all New York City 
treatment programs in the first half of 2002 by mode of 
use. In general, primary heroin admissions are 
overwhelmingly male (74 percent), older than 35 (67 
percent), more likely to be Hispanic (54 percent) than 
Black (25 percent) or White (19 percent), usually 
readmissions to treatment (87 percent), and likely to 
report cocaine as a secondary drug of abuse (35 
percent). Compared with heroin injectors, intranasal 
users are more likely to be Hispanic (58 vs. 48 percent), 
and first admissions to treatment (15 vs. 9 percent). In 
contrast, primary heroin injectors are more likely than 
intranasal users to be White (32 vs. 11 percent), to 
report cocaine as a secondary drug of abuse (43 vs. 31 
percent), and to have started use before reaching age 20 
(58 vs. 42 percent). 
 
In addition to heroin admissions to traditional treatment 
programs, heroin admissions for detoxification or crisis 
services in New York City have become a sizable 
number. These special services are usually short term, 
provided in a hospital or community-based setting, and 
medically supervised. In 1995, 4,503 such admissions 
were reported for heroin abuse; by 2000, 15,040 
comparable admissions were reported; and by 2001 that 
figure increased to 15,913. In the first half of 2002, the 
number of admissions to crisis services for heroin 
abuse was 7,250. 
 
DAWN medical examiner (ME) figures for heroin-
involved deaths in the New York City metropolitan 
area present an inconsistent picture over the last few 
years, with both increases and decreases. In 2000, there 
were 193 heroin-involved deaths (exhibit 1). 
 
ADAM urinalysis data for 2001 show that 14 percent of 
females tested opiate-positive, as did 19 percent of 
males. 
 
From 1992 to 2000, the DMP found average heroin 
purities to be generally above 60 percent. Preliminary 
findings for the first half of 2001 show an average 
purity of 55.7 percent, down from 62.9 percent in 2000. 
The associated price was $0.61, an increase from $0.42 
per milligram pure in 2000. Kilogram prices are 
$65,000– $80,000 for South American heroin, $65,000–
$140,000 for Southwest Asian heroin, and $40,000–
$80,000 for Southeast Asian heroin. 
 
According to the SSU field staff, heroin in New York 
City is moderately to highly available. As one 
informant’s comment demonstrates, “ Heroin is all over 
the place. I can be anywhere [in the city], I know I’m 
only 15 minutes away from a connection.”  By 
comparison, crack is still considered more readily 
available, with the number of crack street sellers and 
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buyers continuing to exceed the number of heroin 
sellers and buyers. Compared with crack sellers, heroin 
sellers tend to be less overt and less aggressive, and 
they usually do not operate on the street. The SSU, 
however, reports an increasing trend of heroin sellers 
working from the street or semi-public locations, such 
as hallways, restaurants, and cars. The areas in which 
heroin is most readily available are primarily low-
income, Hispanic and Black communities with 
extensive public housing developments.  
 
The word on the street is that Colombians, working 
through a distribution network controlled by Dominican 
gangs, dominate the heroin trade in the city. Heroin 
distribution in New York City functions according to a 
three-tier system, primarily controlled by Hispanic 
groups. The first tier is occupied by Colombians, who 
are the principal providers of heroin. The second tier is 
occupied by Dominican drug gangs, who dominate mid-
level and local distribution. Below them are the street 
sellers. Most operate from indoor locations, affording 
them better security and cover. When the sellers operate 
out of an apartment, it is usually a location specifically 
for the purpose of dealing heroin, and not the seller’s 
living quarters. The street sellers tend to be independent 
sellers working by themselves, or in concert with a 
partner or small crew (two to five individuals).  
 
Although heroin is most often sold from indoor 
locations, one common street location is near drug 
treatment centers. Other locations are public housing 
developments, playgrounds, and parks. While heroin 
sellers do not tend to sell other drugs, the most common 
other drug they sell is cocaine, since many heroin users 
like to speedball.  
 
While the majority of heroin users are Black and 
Hispanic males age 35– 50, there appear to be many more 
young new buyers than were observed a year ago. The 
majority of buyers report that they are sniffers and only 
snort. Field researchers, however, report an apparent 
increase in the number of individuals offering needles for 
sale at or near heroin selling locations. In addition, 
needle exchange programs and other harm reduction 
efforts continue to distribute large numbers of needles.  
 
There is no indication that Mexican or Asian heroin is 
available or being sold in the city. The most common 
form of heroin in the city appears to be a white powder 
associated with the Colombians. The purity is reported 
to be of good “ snortable”  quality. Heroin has far less 
price variation than some of the other street drugs. The 
predominant price is $10 per packet, and each contains 
approximately one-tenth gram of powder. There are 
five principal packaging materials: glassine bags, 
cellophane, light plastic wrap knotted at both ends, 
folded paper, and balloons. Of these, the glassine bag is 
by far the most popular, followed by cellophane and 
plastic wrap. During this study period, observers 
reported a strong decline in the use of thumbnail-sized 
bags and aluminum foil.  
 
The use of brand names is becoming less common. 
“ Two-on-Two,”  “ Passion,”  “ Sleep Walker,”  “ Not 
Quitely,”  “ XXL,”  “ Special,”  “ Cash Money,”  “ Blue-
bay,”  and “ Badboy”  are all current brand names. As 
with the other drugs discussed, brand names often 
reflect the color of the package. “ Manteca,”  Spanish for 
lard, is a common slang term for heroin. 
 
Much like cocaine arrests, heroin arrests reached a high 
of 28,083 in 1989, declined for a few years, and then 
peaked in 1995 at 38,131 (exhibit 3). Heroin arrests 
increased slightly between 1999 and 2000 (from 32,949 
to 33,665), a decline of approximately 12 percent from 
1995. The number of heroin arrests for the first half of 
2001 appears to be roughly at the same level as in the 
first half of 2000. 
 
Other Opiates/Narcotics 
 
Although the numbers are small, ED mentions of 
hydrocodone and oxycodone combinations have shown 
increases. According to DAWN data, hydrocodone/ 
combinations mentions increased from 42 in 1994 to 98 
in 2001, an increase of 133 percent. Moreover, the 
change between 2000 and 2001, from 62 to 98 
mentions, represented a significant increase of 58 
percent. Mentions of oxycodone/combinations also 
showed an increase, rising from 56 mentions in 2000 to 
88 in 2001, an increase of 57 percent. Oxycodone 
mentions increased from 3 in 1999 to 38 in 2001, an 
increase of more than 1,000 percent.  
 
Among ME deaths reported by DAWN, the category of 
narcotic analgesics, which includes all legal and illegal 
narcotic analgesics and combinations (excluding 
heroin/morphine), showed a large increase in New 
York City from 252 in 1998 and 271 in 1999, to 590 in 
2000. It should be noted, however, that in 1996 there 
were 511 such deaths. 
 
Users have told the SSU that injecting liquid morphine 
from patches of fentanyl (a synthetic opiate) produces 
an intense high. Street contacts report that users have 
searched the garbage of senior citizen housing and 
hospices for fentanyl patches that were not disposed of 
properly.  
 
Marijuana 
 
In New York City, marijuana treatment admissions 
continued to increase steadily, while ED mentions 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— New York City 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 154 
were stable (exhibit 5). The total number of 
marijuana ED mentions— estimated from the current 
sample of hospitals— rose from 2,578 in 1994 to 
3,501 in 2001. This increase, however, was not 
significant. The rate of marijuana ED mentions for 
2001 for the New York City metropolitan area was 42 
per 100,000 population, suggesting stability in the 
rates since 1994. The comparable national estimate in 
2001 was 44 per 100,000 population. 
 
Primary marijuana admissions to all treatment 
programs have been increasing steadily over the past 
several years. The number increased more than 
eightfold between 1991 and 2001, from 1,374 to 
13,270, the highest annual number (exhibit1). That 
figure rose again in the first half of 2002 to 7,232, the 
highest half-year total for marijuana admissions ever 
recorded. In 1991, primary marijuana admissions 
represented less than 5 percent of all treatment 
admissions; by the first half of 2002, these admissions 
represented 22 percent of admissions (excluding 
alcohol-only) to all New York City treatment 
programs. 
 
Exhibit 6 shows demographic characteristics of 
primary marijuana admissions to all New York City 
treatment programs in the first half of 2002. The vast 
majority were male (82 percent); and 37 percent were 
younger than 21. More than one-half (53 percent) were 
Black, 34 percent were Hispanic, and 10 percent were 
White. Alcohol was the secondary drug of abuse for 44 
percent of the marijuana admissions, and most (72 
percent) had some criminal justice status. 
 
According to the SSU, marijuana continues to be the 
most widely available illicit drug in New York City. It 
continues to be of very good quality and potency. 
Street-level marijuana is available in three prices: $10, 
$20– $25 (per one-half ounce), and $50– $60 (per 
ounce). During the study period, field researchers were 
unable to find any location offering marijuana in $5 
amounts or loose joints. The most common street price 
continues to be the $10 amount. Typically, buyers 
interested in the $20 and $50 amounts have to obtain 
them through house connections.  
 
There are several packaging materials used for 
marijuana street selling: nail-sized plastic bags, glassine 
bags, aluminum foil, and manila envelopes. Manila 
envelopes are rare and unpopular because the customer 
cannot see the product.  Common slang terms for 
marijuana are “ tree,”  “ weed,”  and “ bluwee.”  
 
The majority of marijuana sellers are adolescents and 
young adults. The sellers tend to reflect the ethnic 
makeup of their community. As mentioned earlier, the 
techno method, in which a connection is made through 
beeper, cell phone, or the Internet, has gained in 
popularity. The most common sales method is from a 
private residence. Marijuana sellers usually work out of 
their own apartments. This may constitute a part-time 
avocation that helps supplement their income and habit. 
Many of them develop a client list and require an 
introduction before selling to a stranger. The method 
associated with the highest risk is street selling, which 
is still quite common in certain communities. 
 
The use of marijuana is evident across all social groups. 
However, the drug seems to be most popular among 
adolescents and young adults. Many of the buyers are 
in college or high school. While the majority of 
observed buyers were male, there were a substantial 
number of lone female buyers. One aspect about 
marijuana users, particularly young White males, is that 
they become fascinated with information about the 
various types and qualities of marijuana. It is similar to 
some people’s knowledge about wine; they in essence 
become “ pot”  connoisseurs.  
 
Traditionally, marijuana was smoked in a joint.  This 
method is now less common, and many stores do not 
even carry rolling paper. Currently, the most popular 
route of marijuana administration involves blunts, 
hollowed out cigars. Alternatively, the marijuana is 
wrapped in cigar leaves and smoked. Very often, the 
leaves are dipped in brandy or some other aromatic 
liquor. A popular cigar company is marketing two 
additional variations on the original Corona cigar— a 
green leaf cigar and a vanilla version. To facilitate 
smoking, a number of companies are marketing 
individually rolled cigar leaves ($1 each), which come 
in various flavors, including brandy, honey, cognac, 
and vanilla.  
 
Adult arrestees in the ADAM samples for 2001 were 
much more likely to test positive for marijuana than for 
opiates. Approximately 40 percent of male arrestees 
tested positive for marijuana, as did 32 percent of the 
females. For male arrestees, the number of marijuana-
positive urinalyses approached that for cocaine-positive 
urinalyses. 
 
According to the DEA, marijuana prices range from 
$200 to $2,000 per pound wholesale and from $1,000 
to $5,000 per pound for hydroponic marijuana. 
 
In spite of decriminalizing possession of small amounts 
of marijuana, the NYPD continues to make a record 
number of marijuana-related arrests in New York City 
(exhibit 5). Cannabis-involved arrests had reached a 
low of 4,762 in 1991, but they increased more than 12 
times in the following 9 years to 60,455 in 2000. Data 
from the first half of 2001 show arrestees at about the 
same level as in 2000. About 98 percent of these arrests 
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were for misdemeanors, and 32 percent involved 
persons age 20 or younger. Moreover, cannabis arrests 
accounted for 45 percent of all drug arrests in New 
York City in the first half of 2001, a dramatic change 
from earlier years. 
 
Stimulants 
 
Although methamphetamine is popular in other parts of 
the Nation, there were relatively few arrests, ED 
mentions, deaths, and treatment admissions related to 
the drug in New York City. In fact, there have been no 
ED mentions for methamphetamine, and in 2000, only 
three methamphetamine deaths were reported in the 
five boroughs of New York City. Use of metham-
phetamine, and perhaps ketamine as well, appears to be 
especially on the rise among young males in the gay 
community. Recently, the Gay Men’s Health Crisis felt 
the need to double the number of methamphetamine 
anonymous meetings that their organization offers. 
Methamphetamine is available in powder, pill, or liquid 
form, with pill form being the most popular.  
 
Depressants 
 
While some indicators of the nonmedical use of 
psychoactive prescription drugs have not been 
increasing, the SSU continues to report a variety of drugs 
readily available on the street for $1 or more per pill. 
 
Alprazolam (Xanax) and clonazepam (Klonopin) ED 
mentions have been increasing since the mid-1990s, 
while diazepam (Valium) mentions have been 
declining. Alprazolam mentions increased 95 percent, 
from 323 in 1994 to 704 in 2001. Clonazepam 
mentions increased from 123 in 1994 to 328 in 2001, an 
increase of 167 percent. Conversely, diazepam 
mentions decreased from 459 in 1994 to 280 in 2001, a 
decrease of 39 percent. There continue to be few (about 
1 percent) treatment admissions with a psychoactive 
prescription drug as a primary drug of abuse.  
 
According to the SSU, the three most popular pills on 
the street are alprazolam (Xanax or “ footballs” ), selling 
for $5 per pill; clonidine (Catapres), selling for $1 per 
pill; and the antidepressant amitriptyline (Elavil or 
“ sticks” ), selling for $1 per pill.  
 
Many pill sellers obtain their inventory of pills by 
getting prescriptions (typically three per visit) from 
unscrupulous doctors. The doctor gets paid by 
Medicaid, and the pill seller may pay additional cash 
(usually $100) for the prescriptions. The prescriptions 
are then taken to a pharmacy to be filled. The majority 
of pill selling locations are found within a two-block 
radius of treatment programs. 
 
Hallucinogens 
 
The number of phencyclidine (PCP) ED mentions 
declined significantly, from 852 in 1994 to 203 in 2001, 
a decrease of 76 percent. ED mentions for lysergic acid 
diethylamide (LSD) also decreased, from 150 in 1994 
to 62 in 2001, a change of nearly 59 percent. In the past 
few years, PCP-involved deaths have averaged about 6 
per year, except for 1995, when 16 such deaths were 
reported by DAWN. Between 1998 and 1999, PCP-
involved deaths increased from 2 to 11. 
 
In Harlem, PCP sells for $10 per bag and is packaged in 
small plastic bags. Although it is available as a bottled 
liquid, PCP is primarily sold in packets of marijuana, 
parsley, or mint leaves that have been soaked in the drug. 
 
Club Drugs 
 
The SSU continues to report the availability of 
methylenedioxymethamphetamine (MDMA), a stim-
ulant with hallucinogenic properties, in many areas of 
the city. MDMA is often called “ ecstasy”  or “ XTC,”  
although other substances are often sold as ecstasy.  
 
MDMA ED mentions may be stabilizing. Although ED 
mentions increased significantly from 7 in 1994 to 172 
in 2001, an increase of more than 2,000 percent, the 
number of mentions dropped (insignificantly) from 200 
in 2000 to 172 in 2001. 
 
The price for a single pill of ecstasy ranges from $5 to 
$30. Generally, the prices tend to run higher if these 
substances are purchased inside a club or rave. The 
most common sales unit for ecstasy is the single pill or 
tablet. The club drugs sellers are usually White, young, 
and male, and many are middle or upper class. This 
profile is beginning to expand across racial, ethnic, and 
social class boundaries, because ecstasy is also sold by 
sellers of other types of drugs.  
 
Club drug users tend to be White and young males, 
although according to SSU, club drugs are also quite 
popular among females. Many of the users are older 
high school students, college students, or young 
working professionals. These drugs are particularly 
popular among suburban White youth who regularly 
venture into the city for entertainment and fun. There 
are, however, indications that club drugs, particularly 
ecstasy, are making greater inroads among New York 
residents, especially non-White users. There are reports 
that some Hispanic groups are becoming involved in 
the distribution of ecstasy, which may suggest that 
more Hispanic and inner city residents are beginning to 
use this drug. Club drug users typically ingest multiple 
substances, such as alcohol, marijuana, cocaine, or 
other club drugs. 
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Also available as a club drug in New York City, the 
veterinary anesthetic ketamine produces effects similar 
to PCP and visual effects similar to LSD. On the street, 
the drug is called “ Special K”  and sells for 
approximately $20 per dosage unit. It may be 
administered intranasally or injected. While ketamine is 
not currently a controlled substance under Federal law, it 
is listed as a controlled substance in New York State. 
The number of ketamine ED mentions has remained 
relatively stable for the last few years, numbering 24 in 
2001. 
 
Another club drug of concern is gamma hydroxy-
butyrate (GHB). While GHB ED mentions in New York 
City are very low and changes have not been significant, 
they increased to 31 in 2000, up from 16 in 1999 and 5 
in 1998. In 2001, however, the number of GHB ED 
mentions dropped to 15, similar to the 1999 level. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
The AIDS epidemic, with its impact on injection drug 
users (IDUs), has played a crucial role in shaping the 
New York City drug scene over the last 2 decades. 
 
The cumulative total of 128,141 adult and pediatric 
AIDS cases reported in New York City through 
December 2001 represents a rate of more than 1,600 
cases per 100,000 New Yorkers. Of New York City’s 
cumulative 126,130 adult AIDS cases, 55,161 (44 
percent) involved heterosexual IDUs. Homosexual 
males accounted for 38,236 cases (30 percent). 
Among heterosexual IDUs who have contracted AIDS 
in New York City, 74 percent are male and 26 percent 
are female. About 43 percent of these individuals are 
age 30– 39. Blacks continue to be the modal group, 
accounting for 42 percent, followed by Hispanics (37 
percent) and Whites (25 percent). Among female IDUs, 
Blacks remain the majority (53 percent), followed by 
Hispanics (34 percent) and Whites (13 percent). Female 
IDUs are also younger than their male counterparts: 63 
percent are age 39 or younger, compared with 54 
percent of the males. 
 
Of the 2,011 pediatric AIDS cases (children age 12 or 
younger at time of diagnosis), 47 percent involve 
mothers who have injected drugs. An additional 16 
percent involve mothers who were sex partners of 
IDUs. Thus, at least 63 percent of the children with 
AIDS have parents who are in some way involved with 
injection drug use. 
 
Overall, reports show that 77,992 New Yorkers have 
died of AIDS, representing 61 percent of all those who 
have contracted the disease. 
 
It should be noted that in June 2000, the New York 
State Department of Health implemented a law that 
mandates health care providers to report all cases of 
diagnosed HIV infection and HIV illness in addition to 
AIDS cases. This will ultimately result in improved 
data, providing information on the people more 
recently infected and those for whom prevention and 
planning are particularly important. However, it has 
resulted in a tremendous increase in the number of lab 
reports received by the New York City Health 
Department, and there is currently a backlog of 
information that the department is processing, leading 
to delays in reporting. 
 
For inquiries concerning this report, please contact Rozanne Marel, Ph.D., Director of Data Analysis, Applied Studies, New York State Office of 
Alcoholism and Substance Abuse Services, 501 7th Avenue, 9th Floor, New York, New York 10018, Phone: 646-728-4605, Fax: 646-728-4685, or 
E-mail: <RozanneMarel@oasas.state.ny.us>. 
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Exhibit 1. Semiannual Cocaine Trends for Selected Indicator Data in New York City by Number:  
   1991–First Half 2002 
 
Year 
Semiannual/ 
Annual 
Periods 
Deaths 
Involving 
Cocaine1 
Cocaine 
Emergency 
Department 
Mentions2 
Treatment 
Admissions: 
Cocaine as 
Primary 
Drug of 
Abuse3 
Cocaine 
Arrests4 
Births to 
Women 
Using 
Cocaine5 
1991 
1H 
2H 
Total 
 
 
804 
  7,769 
  8,330 
16,099 
  5,314 
  7,232 
12,546 
 
 
37,769 
 
 
2,239 
1992 
1H 
2H 
Total 
 
 
733 
  9,180 
11,233 
20,413 
  7,753 
  7,224 
14,977 
 
 
33,708 
 
 
1,786 
1993 
1H 
2H 
Total 
 
 
818 
10,499 
10,586 
21,085 
6,978 
7,219 
14,197 
 
 
31,296 
 
 
1,611 
1994 
1H 
2H 
Total 
 
 
755 
10,084 
10,130 
20,1456 
  7,794 
  7,613 
15,407 
 
 
38,200 
 
 
1,288 
1995 
1H 
2H 
Total 
 
 
908 
  9,915 
  9,808 
19,7156 
  8,371 
  7,836 
16,207 
 
 
40,846 
 
 
1,059 
1996 
1H 
2H 
Total 
 
 
659 
11,070 
10,522 
21,592 
  8,561 
  8,817 
17,378 
 
 
38,813 
 
 
1,005 
1997 
1H 
2H 
Total 
 
 
501 
10,233 
  9,969 
20,202 
  9,048 
  8,401 
17,449 
 
 
35,431 
 
 
   864 
1998 
1H 
2H 
Total 
 
 
437 
  9,989 
  9,560 
19,549 
  8,999 
  8,573 
17,572 
 
 
35,577 
 
 
   742 
1999 
1H 
2H 
Total 
 
 
392 
7,386 
7,413 
14,799 
8,346 
7,567 
15,913 
 
 
31,781 
 
 
626 
2000 
1H 
2H 
Total 
492 
6,883 
7,367 
14,250 
7,337 
6,722 
14,059 
 
 
31,919 
 
 
490 
2001 
1H 
2H 
Total 
 
7,449 
6,450 
13,898 
7,343 
7,032 
14,375 
13,956 
 
 
 
 
2002 
1H 
2H 
Total 
  
7,453 
 
  
 
SOURCES:  1DAWN, OAS, SAMHSA, including New York City, Long Island, and Putnam County  
  through 1995.  Starting with 1996 the data include New York City only. 
 
2DAWN, OAS, SAMHSA, weighted data, based on a representative sample of hospitals for New York City and  
  Westchester, Rockland, and Putnam Counties.  
 3New York State Office of Alcoholism and Substance Abuse Services (OASAS)-funded and nonfunded treatment  
  admissions. 
 4New York City Police Department. 
 5New York City Department of Health. 
 
6The total has been adjusted according to revised data, but the half-year totals have not been revised. 
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Exhibit 2. Characteristics of Primary Cocaine Admissions1 to State-Funded2 and Nonfunded3  
    Treatment Programs in New York City by Mode Of Administration:  First Half of 2002 
 
Demographic  
Characteristic 
Total 
(N =7,453) 
Smoking Crack 
(n = 4,681) 
Using 
Cocaine Intranasally 
(n =2,541) 
Gender 
     Male 
     Female 
 
68 
32 
 
63 
37 
 
76 
24 
Age at Admission 
     25 and younger 
     26–35 
     36 and older 
     (Average age) 
 
7 
30 
63 
(37.9 years) 
 
  5 
28 
67 
(38.4 years) 
 
12 
33 
56 
(36.7 years) 
Race/Ethnicity 
     Black 
     Hispanic 
     White 
 
57 
28 
13 
 
66 
23 
10 
 
43 
38 
18 
No Source of Income4 35 39 27 
Some Criminal Justice Status 45 42 51 
Readmissions 75 78 70 
Age of First Use 
     14 and younger 
     15–19 
     20–29 
     30 and older 
 
7 
28 
44 
21 
 
  5 
23 
48 
24 
 
  8 
37 
38 
17 
Secondary Drug of Abuse 
     Alcohol 
     Marijuana 
     Heroin 
 
48 
21 
  6 
 
48 
21 
  6 
 
49 
23 
  4 
 
1Figures on this table may differ somewhat from figures cited on other tables because computer runs may have been executed at   
 different times and files are being updated continuously. 
2State-funded programs receive some or all funding through the New York State Office of Alcoholism and Substance Abuse  
 Services (OASAS). 
3Nonfunded programs receive funding through sources other than OASAS. 
4Defined as not earning income, not receiving support from family or significant others, and not receiving any public assistance. 
 
SOURCE: OASAS 
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Exhibit 3. Semiannual Heroin Trends for Selected Indicator Data in New York City: 
  1991–First Half 2002 
 
Year 
Semiannual/ 
Annual 
Period 
Deaths 
Involving 
Heroin1 
Heroin/Morphine 
Emergency 
Department 
Mentions2 
Treatment 
Admissions: 
Heroin as 
Primary Drug of 
Abuse3 
Heroin 
Arrests4 
Average 
Purity of 
Street 
Heroin 
(%)5 
1991 
1H 
2H 
Total 
 
 
582 
2,684 
3,335 
6,019 
  7,180 
  7,905 
15,085 
 
 
23,622 
 
 
(50.6) 
1992 
1H 
2H 
Total 
 
 
681 
3,879 
4,503 
8,382 
  8,219 
  8,004 
16,223 
 
 
23,509 
 
 
(62.3) 
1993 
1H 
2H 
Total 
 
 
796 
5,131 
6,220 
11,351 
  8,369 
  8,620 
16,989 
 
 
24,595 
 
 
(66.1) 
1994 
1H 
2H 
Total 
 
 
612 
5,561 
5,624 
11,1296 
9,070 
9,117 
18,187 
 
 
33,206 
 
 
(63.9) 
1995 
1H 
2H 
Total 
 
 
751 
5,288 
5,440 
10,7066 
  9,286 
  9,001 
18,287 
 
 
38,131 
 
 
(69.4) 
1996 
1H 
2H 
Total 
 
 
192 
5,654 
5,478 
11,132 
  9,161 
  9,617 
18,778 
 
 
37,901 
 
 
(56.3) 
1997 
1H 
2H 
Total 
 
 
269 
4,900 
4,581 
9,481 
10,276 
10,431 
20,707 
 
 
35,325 
 
 
(62.5) 
1998 
1H 
2H 
Total 
 
 
230 
4,613 
4,605 
9,218 
10,793 
10,203 
20,996 
 
 
37,483 
 
 
(63.6) 
1999 
1H 
2H 
Total 
 
 
171 
4,153 
5,150 
9,302 
10,690 
10,189 
20,879 
 
 
32,949 
 
 
(61.8) 
2000 
1H 
2H 
Total 
193 
5,378 
5,630 
11,009 
10,944 
10,672 
21,616 
 
 
33,665 
 
 
(62.9)   
2001 
1H 
2H 
Total 
 
5,428 
5,216 
10,644 
11,324 
11,455 
22,779 
  
2002 
1H 
2H 
Total 
 
 
 
 
10,838 
 
 
  
 
SOURCES:  1 DAWN, OAS, SAMHSA, including New York City, Long Island, and Putnam County through 1995.  Starting with  
       1996, the data include New York City only.  
       Prior to 1996, the data include heroin/morphine deaths as well as opiates not specified by type.  Beginning with  
       1996, the data include only heroin/morphine deaths. 
  
2 DAWN, OAS, SAMHSA, weighted data, based on a representative sample of hospitals for New York City and  
    Westchester, Rockland, and Putnam Counties. 
    3 New York State Office of Alcoholism and Substance Abuse Services (OASAS)-funded and nonfunded treatment  
         admissions. 
     4 New York City Police Department. 
     5 U.S. Drug Enforcement Administration.  
     
6 The total has been adjusted according to revised data, but the half-year totals have not been revised. 
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Exhibit 4. Characteristics of Primary Heroin Admissions1 to State-Funded2 And Nonfunded3  
   Treatment Programs in New York City by Mode Of Administration: First Half of 2002 
 
Demographic  
Characteristic 
Total 
(N = 10,838) 
Using Heroin 
Intranasally 
(n = 6,487) 
Injecting Heroin 
(n = 3,990) 
Gender 
     Male 
     Female 
 
74 
26 
 
74 
26 
 
75 
25 
Age at Admission 
25 and younger 
26–35 
36 and older 
(Average age) 
 
  8 
26 
67 
(39.0 years) 
 
  6 
26 
68 
(39.1 years) 
 
  10 
25 
65 
(39.0 years) 
Race 
Black 
Hispanic 
White 
 
25 
54 
19 
 
30 
58 
11 
 
17 
48 
32 
No source of income4 24 25 22 
Some Criminal Justice Status 35 40 27 
Readmissions 87 85 91 
Age of First Use 
14 and younger 
15–19 
20–29 
30 and older 
 
13 
35 
34 
18 
 
11 
31 
36 
22 
 
16 
42 
31 
11 
Secondary Drug of Abuse 
Alcohol 
Marijuana 
Cocaine 
 
12 
8 
35 
 
12 
  9 
31 
 
11 
  5 
43 
 
1  Figures on this table may differ somewhat from figures cited on other tables because computer runs may have been executed at  
  different times and files are being updated continuously. 
2  State-funded programs receive some or all funding through the New York State Office of Alcoholism and Substance Abuse   
  Services  (OASAS). 
3  Nonfunded programs receive funding through sources other than OASAS. 
4  Defined as not earning income, not receiving support from family or significant others, and not receiving any public assistance. 
 
SOURCE:  OASAS 
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Exhibit 5. Semiannual Marijuana Trends for Selected Indicator Data in New York City by Number:  
   1991–First Half 2002 
 
Year 
Semiannual/ 
Annual 
Period 
Marijuana 
Emergency 
Department 
Mentions1 
Treatment Admissions: 
Marijuana as Primary 
Drug of Abuse2 
Cannabis 
Arrests3 
1991 
1H 
2H 
Total 
   605 
   591 
1,196 
      687 
      687 
  1,374 
 
 
  4,762 
1992 
1H 
2H 
Total 
   896 
1,134 
2,003 
     953 
  1,003 
  1,956 
 
 
  5,078 
1993 
1H 
2H 
Total 
1,011 
1,081 
2,092 
  1,207 
  1,497 
  2,704 
 
 
  6,145 
1994 
1H 
2H 
Total 
1,181 
1,408 
2,5784 
  2,031 
  1,793 
  3,824 
 
 
  8,815 
1995 
1H 
2H 
Total 
1,516 
1,460 
2,9744 
  2,171 
  2,159 
  4,330 
 
 
12,357 
1996 
1H 
2H 
Total 
1,723 
1,848 
3,571 
  2,845 
  3,185 
  6,030 
 
 
18,991 
1997 
1H 
2H 
Total 
1,939 
1,900 
3,839 
  3,794 
  3,657 
  7,451 
 
 
27,531 
1998 
1H 
2H 
Total 
1,986 
1,696 
3,682 
  4,554 
  4,473 
  9,027 
 
 
42,030 
1999 
1H 
2H 
Total 
1,799 
1,692 
3,491 
  5,119 
  5,100 
10,219 
 
 
43,122 
2000 
1H 
2H 
Total 
1,856 
1,688 
3,544 
  5,664 
  5,487 
11,151 
 
 
60,455 
2001 
1H 
2H 
Total 
1,904 
1,598 
3,501 
6,677 
6,593 
13,270 
 
 
27,693 
2002 
1H 
2H 
Total 
 
7,232 
 
 
 
 
SOURCES:  1 DAWN, OAS, SAMHSA, weighted data, based on a representative sample of hospitals for New York City and  
       Westchester, Rockland, and Putnam Counties (2000 data are preliminary). 
    2  New York State Office of Alcoholism and Substance Abuse Services (OASAS)-funded and nonfunded treatment  
      admissions. 
    3 New York City Police Department. 
    
4 The total has been adjusted according to revised data, but the half-year totals have not been revised. 
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Exhibit 6. Characteristics of Primary Marijuana Admissions1 to State-Funded2 and Nonfunded3   
    Treatment Programs in New York City: First Half of 2002   
 
Demographic Characteristic Percent of All Treatment Programs (N = 7,232) 
Gender 
     Male 
     Female 
 
82 
18 
Age at Admission 
     20 and younger 
     21–25 
     26–35 
     36 and older 
     (Average Age) 
 
37 
27 
23 
13 
(24.9 years) 
Race 
     Black 
     Hispanic 
     White 
 
53 
34 
10 
No Source of Income4 21 
Some Criminal Justice Status 72 
Readmissions 49 
Age of First Use 
     14 and younger 
     15–19 
     20–29 
     30 and older 
 
48 
41 
9 
2 
Secondary Drug of Abuse 
     Alcohol 
     Cocaine 
 
44 
10 
 
1 Figures on this table may differ somewhat from figures cited on other tables because computer runs may have been executed at  
  different times and files are being updated continuously. 
2 State-funded programs receive some or all funding through the New York State Office of Alcoholism and Substance Abuse  
  Services (OASAS). 
3 Nonfunded programs receive funding through sources other than OASAS. 
4 Defined as not earning income, not receiving support from family or significant others, and not receiving any public assistance. 
 
SOURCE: OASAS 
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ABSTRACT 
 
According to estimated rates of emergency depart-
ment (ED) mentions per 100,000 population, 
cocaine was the most mentioned drug in Philadel-
phia EDs (n=252 in 2001). In the first half of 2002, 
78 percent of male cocaine treatment admissions 
and 85 percent of female cocaine treatment admis-
sions were crack smokers. In 2001, the rate of 
heroin ED mentions per 100,000 population (119) 
was the highest DAWN rate reported in Philadel-
phia in at least 12 years. The average number of 
drugs mentioned in ED cases did not continue to 
increase after doing so from 1998 through 2000. 
The average number of drugs detected in decedents 
by the medical examiner increased each half-year 
from the first half of 1998 through the second half 
of 2001, but it declined in the first half of 2002. 
Heroin/morphine detections in decedents exceeded 
cocaine detections from the second half of 1999 
through the second half of 2001, but cocaine detec-
tions exceeded heroin/morphine detections in the 
first half of 2002. The preliminary rate of mari-
juana ED mentions in 2001 rose significantly from 
1994 and was estimated at 122 per 100,000 popula-
tion. Focus groups reported the increased 
availability and use of commercial blunt wrappers 
made of cigar tobacco leaves as an alternative to 
buying cigars for wrapping marijuana and other 
additives. Participants also reported increased use 
of oxycodone products and alprazolam. 
 
INTRODUCTION 
 
Area Description 
 
Philadelphia, the largest city in the State, is located in 
the extreme southeastern corner of Pennsylvania. The 
2000 U.S. census count of 1,517,550 Philadelphia 
residents represents a 7-percent increase from the 1990 
census count, despite interim estimates of population 
decline. The 2000 Philadelphia population was 45.0 
percent White, 43.2 percent African-American, 0.3 
percent American Indian and Alaska Native, 4.5 percent 
Asian, 4.8 percent other race, and 2.2 percent two or 
more races. Hispanics (of various races) accounted for 
an estimated 8.5 percent of the population, and persons 
age 18 and older accounted for 74.7 percent. 
 
Data Sources 
 
This report focuses primarily on the city/county of 
Philadelphia and includes data from the sources 
shown below. For the purposes of this report, fiscal 
year (FY) refers to a year starting July 1 and ending 
the following June 30. 
 
• Emergency department (ED) drug mentions data 
were derived from the Drug Abuse Warning Network 
(DAWN), Office of Applied Studies (OAS), 
Substance Abuse and Mental Health Services 
Administration (SAMHSA), for 1994– 2001.  
 
• Drug treatment admissions data for programs 
in Philadelphia County were provided by the 
Pennsylvania Department of Health, Client 
Information System, for July 1, 1995, through 
June 30, 2002. Data for FY 2002 are preliminary 
and subject to revision because of the treatment 
reporting schedule, which results in frequent 
delays of up to 1 year between a treatment 
admission and the reporting of that event. 
 
• Drug-related mortality data were provided by 
the Philadelphia Medical Examiner’s (ME) 
Office. These data cover mortality cases with 
toxicology reports indicating the detection of 
drugs in decedents in Philadelphia. The time 
period is January 1, 1995, through June 30, 2002. 
(The cases include persons who died from the 
adverse affects of one or multiple drugs, as well 
as persons who exhibited some substance 
presence but died from other causes. The 
Philadelphia ME also distinguishes between 
persons who appeared to have a lethal reaction to 
what might be considered a light or moderate 
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amount of drugs and persons whose toxicology 
reports showed a high level of drugs in their 
systems.) 
 
• Arrestee urinalysis data on booked adult male 
arrestees were derived from reports from the 
Arrestee Drug Abuse Monitoring (ADAM) pro-
gram of the National Institute of Justice (NIJ) for 
2001. Provisional unweighted data for the first 
three quarters of 2002 are also included. 
 
• Heroin purity and price data were provided by 
the Drug Enforcement Administration (DEA), 
Domestic Monitor Program (DMP), through 
2001. 
 
• Acquired immunodeficiency syndrome (AIDS) 
data were provided by the Philadelphia Depart-
ment of Public Health’s AIDS Activities Coor-
dinating Office on AIDS cases from November 1, 
1981, to June 30, 2002.  
 
In addition to these sources, this report draws on 
focus group discussions with former drug users 
currently enrolled in treatment programs, as well as 
outreach workers assigned to homeless populations, 
substance abusers, and persons with the human 
immunodeficiency virus (HIV) infection. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Preliminary DAWN ED data for 2001 show the 
average number of drug abuse mentions per hospital 
episode remained relatively stable, at 1.87 drugs per 
episode (exhibit 1). The estimated growth of drug 
mentions from 1994 to 2001 (52 percent) has exceeded 
the estimated growth of ED episodes (45.5 percent). 
 
The average number of drugs detected in decedents 
by the ME increased in the second half of 2001 for 
the eighth consecutive half-year, to 2.91, then 
declined to 2.60 in the first half of 2002 (exhibit 2). 
Mortality cases with positive toxicology reports 
decreased 13 percent, from 717 in FY 2001 to 623 in 
FY 2002. Of the 623 deaths in FY 2002, adverse 
reactions to drugs accounted for 57 percent, overdose 
for 3 percent, and violence for 18 percent; 22 percent 
of the deaths were attributed to other causes.  
 
White males accounted for the largest proportion of 
drug-positive decedents in 11 consecutive half-year 
periods through December 2001, accounting for 34−44 
percent of all cases. However, African-American 
males exceeded White males in the first half of 2002. 
Whites, as a group, constituted the plurality of ME 
drug-related cases from 1995 through June 2002, 
ranging from 45 to 54 percent. Males accounted for 77 
percent of all deaths with positive toxicology reports 
in FY 1999, 73 percent in FY 2000, 75 percent in FY 
2001, and 77 percent in FY 2002. In FY 2002, males 
accounted for 77 percent of drug-positive deaths 
among Whites, 77 percent among African-Americans, 
and 83 percent among Hispanics. Among females, 
Whites accounted for the largest number of drug 
deaths from 1996 through 2001 (45– 55 percent), 
followed by African-Americans (34– 55 percent). 
Hispanics accounted for 3– 9 percent, and Asians for 
0– 2 percent, of all female deaths. 
 
In the 2001 ADAM study, adult male booked arrestees 
in Philadelphia ranked fifth highest in the 33-city 
panel in positive urinalysis results for multiple drugs 
and fourth highest with respect to the NIDA-5 drugs 
(cocaine, opiates, marijuana, methamphetamine, and 
phencyclidine [PCP]). The latter ranking is particularly 
remarkable, considering the lack of methamphetamine 
cases in this city. In the ADAM measurement of heavy 
use of a NIDA-5 drug, Philadelphia males were tied 
for fifth (45.1 percent within the past 30 days) among 
33 cities (median=39.6 percent). In the measurement 
of risk for dependence, Philadelphia males were tied 
for fourth (45.7 percent) among 33 cities 
(median=38.6 percent). For the first three quarters of 
2002, the provisional unweighted data for males 
indicated a range of 72.7 to 76.7 percent positive for 
the NIDA-5 drugs. 
 
The Pennsylvania Client Information System is 
limited to the identification of a maximum of three 
substances as drugs of abuse at treatment intake. The 
highest average number of drugs of abuse identified 
at admission to treatment occurred in the first half of 
1999 (n=2.06). In the second half of 2001, the 
average was 1.96 drugs of abuse, and in the first half 
of 2002, the average was 1.85 drugs of abuse.  
 
In autumn 2002, focus groups consisting of drug users 
who were new to treatment estimated that of the regular 
drug-using population, 9 percent use just one drug per 
day, 20 percent use two, 31 percent use three, and 40 
percent use four or more different drugs per day.  
 
Cocaine and Crack 
 
Cocaine/crack remains the major drug of abuse in 
Philadelphia. The estimated rate of cocaine/crack ED 
mentions in the Philadelphia primary metropolitan 
statistical area (PMSA) was 252 per 100,000 popu-
lation in 2001 (exhibit 1). From 1994 to 2001, the rate 
of cocaine ED mentions among females increased 
significantly (50.3 percent), from 111 in 1994 to 166 
per 100,000 population in 2001. Rates continued to be 
higher among males than females and, by age group, 
were highest among persons age 26– 44.  
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ME data show that cocaine was present in 14 percent 
fewer cases in FY 2002 than in FY 2001 (exhibit 2). 
Despite this decrease, the presence of cocaine in total 
drug-positive toxicology reports remained stable 
between 44 and 47 percent from FY 1998 through FY 
2002. 
 
Another drug(s) was found in 84 percent of all ME 
cocaine-positive cases in the second half of 2001 and 
84 percent in the first half of 2002. Heroin/morphine 
was present in 37 percent of cocaine-positive 
toxicology reports in both the second half of 2001 
and the first half of 2002. Cocaine in combination 
with alcohol remains a significant finding in cocaine-
positive toxicology reports. In FY 2000, FY 2001, 
and FY 2002, alcohol was present in 44, 23, and 32 
percent of cases in which cocaine was also detected. 
ME toxicology unit staff view alcohol as particularly 
dangerous when it is used in combination with sub-
stances that normally do not produce death. 
 
Preliminary treatment data for FY 2002 show that 
cocaine, as a primary drug, accounted for 28 percent 
of all admissions, down from 31 percent in FY 2001 
(exhibit 3). Cocaine treatment admissions peaked in 
1991, at 63 percent.  
 
In FY 2002, males accounted for 61 percent of 
primary cocaine treatment admissions (exhibit 4). 
This percentage has been increasing since FY 1999 
(55 percent). In FY 2002, African-Americans 
accounted for 79 percent of primary cocaine 
treatment admissions, followed by Whites (14 per-
cent), Hispanics (5 percent), and Asians and others (2 
percent). 
 
Since FY 1998, an average of 83 percent of primary 
cocaine admissions reported smoking the drug, 13 
percent reported intranasal use, only 2 percent 
reported injecting, and 1 percent through 
other/unknown routes (exhibit 4). Since the first half 
of 1990, at least 80 percent of cocaine treatment 
admissions have reported smoking the drug. Of all 
male cocaine admissions in FY 2002, nearly 78 
percent reported smoking the drug; the comparable 
figure for females was 85 percent. 
 
In the Philadelphia ADAM site in 2001, 21.9 percent 
of adult male arrestees reported using crack during 
the past 30 days, the fourth highest percentage among 
CEWG sites included in ADAM. In the same time 
period, 11.4 percent of the adult male arrestees 
reported using powder cocaine during the past 30 
days, the fifth highest level among CEWG sites in the 
ADAM study. The provisional unweighted urinalysis 
data for males in the first three quarters of 2002 
showed that a range of 37.3 to 41.7 percent were 
cocaine-positive; the urinalysis did not distinguish 
crack cocaine from cocaine powder. 
 
During autumn 2002 focus group sessions, former 
drug users new to formal treatment indicated that 
they perceived the potency of crack to have 
diminished since the implementation of Safe Streets 
began on May 1, 2002. Safe Streets is a strategy of 
the Philadelphia Police Department that involves the 
stationing of 200– 300 officers on corners where drug 
sales are known to be very active. The initiative is 
credited with disrupting sales and driving sales 
indoors, thereby reducing the flow of suburbanites 
into Philadelphia to buy drugs.  
 
The predominant form of crack sold in Philadelphia 
is “ ready rock,”  which costs $5. The $5-rock ranged 
in size from 6 to 9 millimeters from 1996 until this 
year. After the disruption in the market caused by 
Safe Streets, the size of the $5-rock was reduced to 
4– 7 millimeters. Treys ($3-rocks) ranged in size from 
3 to 5 millimeters since 1996, but were reduced to 3 
to 4 millimeters this year. Shapes of crack range from 
circular to bumpy circular to parallelogram. Powder 
cocaine is not as readily available in small ($5) 
quantities, but $10 and especially $20 bags are quite 
common. Spring 2002 participants estimated that 
about 68 percent of powder cocaine buys are for 
intranasal use, 17 percent are injected straight, and 15 
percent are injected in a “ speedball.”  The autumn 
2002 participants made remarkably consistent 
estimates for the uses of cocaine in powder form: 65 
percent for intranasal use, 21 percent for injection 
straight, and 14 percent for speedball injection. 
 
Crack users continue to report frequent use in 
combination with 40-ounce bottles of malt liquor, 
beer, or other drugs, including alprazolam (Xanax), 
diazepam (Valium), marijuana, or cigarettes. Powder 
cocaine, oxycodone (Percocet or OxyContin), and 
methadone were less frequently mentioned as drugs 
used with crack. The autumn 2002 focus groups 
continued to report an aging crack-using population, 
mostly in their late twenties through thirties; the 
groups estimated the crack-using population as 54 
percent African-American, 24 percent White, 20 
percent Hispanic, and 2 percent Asian.  
 
Heroin and Morphine 
 
According to preliminary DMP data, the street-level 
purity of heroin in Philadelphia was 73 percent in 
2001, the highest of all cities in the program for the 
past 5 years. The national average for heroin purity 
ranged from 36 to 42 percent from 1997 through 2000  
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and was 34 percent in 2001. The average price per 
milligram pure in Philadelphia was 40 cents in 2001—
the fourth least costly in the study— compared with the 
national average of $1.30 per milligram pure. 
 
From 1994 to 2001, the rate of heroin ED mentions 
per 100,000 population increased significantly, from 
53 to 119 (exhibit 1). Significant increases occurred 
in all age groups (since 1994), except among those 
age 30– 34 and 35– 44. The largest significant increase 
from 1994 to 2001 occurred in the 12– 17-year-old 
group (597.2 percent). The smallest significant 
increase from 1994 to 2001 occurred in the 35-and-
older age group (80.0 percent).  
 
For the 6 half-years ending in June 2002, positive 
heroin/morphine toxicology reports occurred in 46 to 
51 percent of all deaths with the presence of drugs 
(exhibit 2). White males accounted for 54 percent of 
all positive heroin/morphine toxicology reports in the 
second half of 1999, 45 percent in each half of 2000 
and in the first half of 2001, 50 percent in the second 
half of 2001, and 59 percent in the first half of 2002. 
 
Toxicology reports detecting the presence of heroin/ 
morphine do not indicate a disproportionate number 
of deaths among younger persons. Since the mid-
1990s, fewer than 16 percent of the heroin-positive 
decedents have been age 25 or younger. In FY 2000, 
FY 2001, and FY 2002, 13 percent, 15 percent, and 
12 percent of decedents, respectively, were in this 
young age group. 
 
During the 5 half-years from January 2000 through 
June 2002, heroin/morphine alone was identified in 
16, 12, 11, 11, and 10 percent of the respective heroin/ 
morphine toxicology reports. Cocaine in addition to 
heroin/morphine accounted for 36, 45, 68, 35, and 38 
percent, respectively, during these periods.  
 
In FY 2002, heroin primary treatment admissions 
continued to rank third behind cocaine and alcohol 
(exhibit 3). Heroin admissions accounted for 24 
percent of all admissions in FY 2001 and 25 percent 
in FY 2002. During FY 2002, 66 percent of all heroin 
treatment admissions were males (exhibit 5); 50 
percent were White, 36 percent were African-
American, 12 percent were Hispanic, and 2 percent 
were Asian/others. 
 
As depicted in exhibit 5, the preferred routes of 
administration for heroin, illegal methadone, and 
other opiates have been relatively stable among 
heroin/other opiate treatment admissions. Within the 
“ swallowed”  route, the increasing numbers through 
FY 2001 could suggest that users of pharmaceutically 
produced synthetic opiates have been entering 
treatment. (The preliminary data for FY 2002 does 
not bear out this hypothesis, but these data will be 
revised in the June 2003 CEWG report.) 
 
In 2001, 12 percent of adult male arrestees in the 
Philadelphia ADAM study tested positive for opiates. 
This was the fourth highest percentage among 
CEWG sites included in ADAM. The provisional 
unweighted urinalysis data for males in the first three 
quarters of 2002 showed a range of 11.7 to 15.1 
percent positive for opiates. 
 
The autumn 2002 focus group participants continued 
to report that the $10-bag remained the standard unit 
of purchase. The $10-bag usually yields one hit; $5- 
and $20-bags reportedly remained available. Focus 
groups in autumn 2000 and spring 2001 indicated that 
new heroin users begin use in their midteens; the 
autumn 2001, spring 2002, and autumn 2002 groups 
stated that new users begin in their late teens. All 
groups since autumn 2000 have reported that the 
average heroin user injects the drug five times per day. 
 
The autumn 2002 groups estimated that 33 percent of 
heroin users use heroin only, 59 percent also use 
crack, and 8 percent use heroin and cocaine powder 
in speedball injections. These groups also indicated 
that more than one-half of new users are female and 
White. 
 
Other Opiates 
 
The nonmedical use of oxycodone products, in-
cluding OxyContin, Percocet/Percodan, Roxicet, and 
Tylox, continued to be reported by individuals in 
treatment. Preliminary rates of DAWN ED mentions 
of narcotic analgesics/combinations increased signifi-
cantly (147.7 percent) from 27 per 100,000 
population in 1994 to 67 per 100,000 population in 
2001 (exhibit 1). Oxycodone ED mentions in Phila-
delphia increased significantly from 3 in 1994 to 494 
in 2001. 
 
There were 10 positive toxicology ME reports 
involving oxycodone for the 2½ years from January 
1995 through June 1997 (exhibit 2). In the 
subsequent 2½ years, ending December 31, 1999, 
there were 58 positive toxicology reports for oxy-
codone, followed by 135 positive toxicology reports 
for oxycodone in the subsequent 2½ years ending 
June 30, 2002. Spring and autumn 2002 focus groups 
reported the spread of oxycodone use to all 
racial/ethnic groups.   
 
Hydrocodone mentions in mortality cases have also 
increased (exhibit 2). There were 13 positive toxicol-
ogy ME reports for hydrocodone for the 2½ years 
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from January 1995 through June 1997. In the subse-
quent 2½ years ending December 31, 1999, there 
were 32 positive toxicology reports for hydrocodone, 
followed by 81 positive toxicology reports for the 
drug in the subsequent 2½ years ending June 30, 
2002. 
 
Marijuana 
 
The rate of marijuana ED DAWN mentions per 
100,000 population in Philadelphia increased signifi-
cantly (165.2 percent) from 46 in 1994 to 122 in 2001 
(exhibit 1). The most dramatic (and significant) 
change within age groups was among 45– 54-year-
olds; the rate for this group in 1994 was 13 per 
100,000 population, compared with 57 in 2001. The 
18– 19-year-old group, at 459 per 100,000 population, 
had the highest rate in 2001.  
 
The proportion of those citing marijuana as the pri-
mary drug of abuse among clients entering treatment 
has increased, from 13 percent in FY 2000, to 15 
percent in FY 2001, to 17 percent in FY 2002 (ex-
hibit 3). Among all FY 2002 admissions, marijuana 
was mentioned by an additional 13 percent as a sec-
ondary drug and by 8 percent as a tertiary drug. 
Among primary marijuana admissions, males 
accounted for 78 percent and African-Americans for 
63 percent. When marijuana was identified as the 
primary drug of abuse in FY 2002, the average num-
ber of drugs noted as problematic was 1.82. 
 
The ADAM data on adult male arrestees for 2001 
indicated that 49.8 percent reported marijuana use 
within the past 30 days. This was the third highest 
percentage among ADAM/CEWG sites. The provi-
sional unweighted urinalysis data for males in the 
first three quarters of 2002 showed a range of 44.1 to 
50 percent testing positive for marijuana. 
 
Focus group participants and outreach workers con-
tinued to report that marijuana use is widespread 
throughout Philadelphia. Since 1992, focus groups 
have referred to marijuana use in the form of blunts, 
which are nicknamed “ phillies”  (after the most 
popular cigar brand used in making blunts) or “ Ls”  
(more commonly used than phillies in the last year).  
 
In autumn 2001 focus group sessions, participants 
mentioned for the first time the availability and use of 
commercially marketed cigar tobacco leaves, known 
as “ blunt wraps,”  for wrapping marijuana (and other 
additives) into a blunt. This product is attractive to 
users because it is available in several different 
flavors; is less costly than cigars; and eliminates the 
effort of cutting off the ends of a cigar, splitting it 
open lengthwise, and emptying the contents. 
Participants in the spring 2002 focus groups indicated 
that blunt wraps were far more available than they 
were in the previous autumn. Businesses that are 
open into the late evening have become increasingly 
popular as outlets for blunt wraps. The spring 2002 
focus groups estimated that 40 percent of marijuana 
users smoke blunts made from cigars, 39 percent use 
blunt wraps, and 21 percent use cigarette-rolling 
papers and smoke joints. The autumn 2002 focus 
group participants estimated that 63 percent of 
marijuana users smoke blunts made from cigars, 27 
percent use blunt wraps, and 10 percent use cigarette-
rolling papers and smoke joints. 
 
The combination of marijuana and PCP, frequently 
mixed in blunts, is commonly called a “ love boat”  or 
“ wet”  (which is also a term for PCP). Users who 
were new to treatment in autumn 2002 estimated that 
37 percent of blunts are laced with PCP and 15 
percent with crack (called “ Turbos” ). Blunt users 
commonly ingest beer, wine coolers, whiskey, 
alprazolam, or diazepam along with the blunt. Less 
commonly, blunt smokers use powder cocaine, 
vodka, barbiturates, clonazepam, oxycodone, and/or 
cough syrup.  
 
Other Drugs  
 
PCP began gaining popularity as an additive to blunts 
in 1994. Users describe its effects as making them 
hallucinate and feel “ invincible,”  “ crazy,”  “ numb,”  or 
“ violent.”  The DAWN ED rate for PCP was 17 per 
100,000 population in 2001 (exhibit 1). This is a 
significant increase (83.3 percent) from the rate of 10 
per 100,000 in 1994. Between 1994 and 2001, the 
rate of PCP ED mentions per 100,000 increased 
significantly (76 percent) among males (from 15 to 
26) and among females (a 96.4 percent increase from 
5 to 9). The 18– 19-year-old age group had the 
highest ED rates by far in 2001, at 106 per 100,000 
population. For this age group, there was a statis-
tically significant increase of 140.1 percent from 
1994 (with a rate of 44) to 2001 (with a rate of 106).  
 
There were 56 PCP detections by the ME in 
decedents in FY 2001 and 59 in FY 2002 (exhibit 2). 
These totals constituted the highest annual totals for 
this drug on record. The ADAM data for 2001 
indicated that 6.9 percent of adult male arrestees 
tested positive for PCP, the third highest percentage 
among ADAM/CEWG sites. The provisional un-
weighted urinalysis data for males in the first three 
quarters of 2002 indicated a range of 9.1 to 11.2 
percent positive. 
 
In FY 2002, PCP was mentioned as the primary, 
secondary, or tertiary drug by 2.5 percent of all 
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treatment admissions. When PCP was identified as 
the primary drug of abuse in FY 2002, the average 
number of drugs noted as problematic was 2.11. PCP 
has become easier to obtain than ever and is more 
commonly available on mint leaves for use in lacing 
blunts. Less commonly, PCP in liquid form is 
available and is used by having cigarettes dipped into 
the liquid. This method is referred to as “ sherms”  or 
“ dip sticks.”  
 
Methamphetamine/amphetamine abuse remains a 
relatively minor problem in Philadelphia. The 
DAWN ED rates per 100,000 population for meth-
amphetamine in Philadelphia were 1 each in 1998, 
1999, 2000, and 2001. DAWN ED amphetamine 
rates rose (significantly) from 3 mentions per 
100,000 population in 1994 to 9 mentions in 2001. 
Methamphetamine or an amphetamine was present in 
a low of 4 decedents in FY 2000. The high of 19 
decedents in FY 2002 is the highest total since 14 in 
FY 1999 (exhibit 2). Treatment admissions for 
methamphetamine/amphetamines as the primary drug 
of abuse from FY 1998 to FY 2002 were 25, 40, 26, 
24, and 35, respectively (exhibit 3). Methamphet-
amine/amphetamines are rarely identified as a 
secondary or tertiary drug of choice. Focus group 
members indicated that methamphetamine is still 
difficult to obtain, is not sold outdoors, requires a 
connection, and is not very popular. 
 
Prescription drugs are most frequently detected 
among decedents in combination with other drugs of 
the same type and/or in combination with cocaine, 
heroin, or alcohol. Nearly all of the mentions for the 
most frequently detected prescription drugs among 
decedents declined from FY 2001 to FY 2002 
(exhibit 2). Only oxazepam (Serax) mentions 
increased in this time period. However, since the 
spring of 2000, all focus groups have reported that 
alprazolam has overtaken diazepam as the “ most 
popular pill”  on the street. 
 
DAWN ED mentions for methylenedioxymetham-
phetamine (MDMA) numbered 19, 27, 89, 141, and 
203 for the 5 years beginning with 1997, with 
statistically significant increases between 1999 and 
2001 (by 128.1 percent) and 2000– 2001 (by 44.0 
percent). MDMA was present in 2 mortality cases in 
FY 1999 (the first year this drug was detected by the 
ME), then in 7 cases in FY 2000, 13 cases in FY 
2001, and 13 cases in FY 2002. Focus groups in the 
spring and autumn of 2000 described MDMA as 
highly potent and used in combination with heroin, 
alcohol, and/or cough syrup. Focus groups held since 
spring 2001 have reported that MDMA is used in 
combination with marijuana and lysergic acid 
diethylamide (LSD), which better describes use in 
clubs or raves. The autumn 2002 focus groups 
described the users as evenly split by gender and as 
teenagers to people in their early twenties. MDMA 
usually sells for $25 per dose in Philadelphia. 
 
Hospital ED mentions of ketamine were extremely 
rare in the Philadelphia area from 1994 to 2001. 
Ketamine was detected in three decedents in the first 
half of 2000, the first time it appeared in Philadelphia 
mortality cases. No deaths with the presence of 
ketamine occurred in the second half of 2000, but 
there were two positive toxicology reports for the 
drug in the first half of 2001, one in the second half, 
and none in the first half of 2002. Autumn 2002 focus 
group participants reported that ketamine is used in 
nightclubs and is not widely available; the drug 
usually sells for $10 per tablet.  
 
Gamma hydroxybutyrate (GHB) was mentioned in 
53 DAWN ED cases in 1999, 79 cases in 2000, and 
90 in 2001. Autumn 2002 focus group participants 
were unaware of this drug.  
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
As of June 30, 2002, Philadelphia recorded 15,120 
cumulative AIDS cases among adults (exhibit 6). 
Among those cases, 5,518 involved injection drug 
users (IDUs). Another 829 were in the dual exposure 
category of IDUs who were also men who had sex 
with other men (MSM). 
 
The Philadelphia AIDS Activities Coordinating 
Office reported a drop from the early 1990s through 
June 2002 in the percentage of AIDS cases involving 
the MSM category. From the early 1990s through 
June 30, 2002, there was a continual increase in the 
percentage of new cases among IDUs (with the only 
exception occurring in the second half of 2001). New 
cases with heterosexual contact as a risk factor 
continued to exceed the historical average. Hetero-
sexual contact is the identified exposure category in 
almost one-sixth of all AIDS cases through June 
2002, and it accounted for a little more than 37 
percent of cases identified in FY 2002. 
 
For inquiries concerning this report, please contact Samuel Cutler, City of Philadelphia, Coordinating Office for Drug and Alcohol Abuse 
Programs, Philadelphia Behavioral Health System, 1101 Market Street, Suite 800, Philadelphia, Pennsylvania 19107-2908, Phone: (215) 685-
5414, Fax: (215) 685-5427, E-mail: <sam.cutler@phila.gov>. 
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Exhibit 1. Rates of ED Mentions Per 100,000 Population in Philadelphia for Selected Drugs:  
    1994 to 20011 
 
Percent Change 
Major Drugs of Abuse 1994 1995 1996 1997 1998 1999 2000 20011 1994, 
2001 
2000, 
2001 
Total—Major Substances 
of Abuse 441 536 549 602 666 675 617 736 67.1  
Alcohol-in-Combination 137 150 147 160 181 184 171 205 50.0  
Cocaine 187 208 224 239 275 260 216 252   
Heroin 53 84 83 79 73 85 96 119 126.3  
Marijuana 46 67 74 97 112 114 101 122 165.2  
Narcotic Analgesics/ 
Combinations 27 31 33 48 49 47 55 67 147.7  
PCP/Combinations 10 13 8 10 12 12 12 17 83.3  
Benzodiazepines 58 69 71 90 88 82 84 95 63.3 40.5 
Average Number of 
Drug Mentions per 
Episode  
1.79 1.80 1.79 1.84 1.83 1.87 1.89 1.87   
 
1
 Estimates for 2001 are preliminary. 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
Exhibit 2. Semiannual Mortality Data in Philadelphia with the Presence of Selected Drugs as  
    Detected by the Medical Examiner:  January 1, 1995–June 30, 2002 
 
1995 1996 1997 1998 1999 2000 2001 2002 
ME Identified Drugs 
1H 2H 1H 2H 1H 2H 1H 2H 1H 2H 1H 2H 1H 2H 1H 
Cocaine 189 147 133 144 152 132 130 115 130 108 146 165 169 131 157 
Heroin/Morphine 162 156 125 165 178 175 152 119 119 117 151 181 179 137 154 
Phencyclidine (PCP) 21 23 20 9 23 23 9 10 26 9 14 34  22 23 36 
Oxycodone 0 2 0 1 7 12 14 15 9 8 23 26 33 20 33 
Propoxyphene 21 8 14 13 16 26 9 12 12 10 21 18 27 16 21 
Hydrocodone 0 1 2 6 4 4 6 9 8 5 11 16 22 16 16 
Amphetamine/Methamphetamine 6 4 7 4 5 7 1 5 9 3 1 4 8 4 15 
Diazepam 15 18 18 13 21 28 22 17 24 17 18 16 28 28 13 
Oxazepam 0 3 3 6 12 12 9 10 9 2 8 4 8 9 8 
Alprazolam 5 3 11 6 9 8 9 10 3 5 9 7 18 13 7 
Temazepam 4 1 11 10 14 11 10 9 15 3 13 5 13 10 7 
Sertraline 2 0 2 2 5 6 3 4 9 7 7 11 7 11 6 
Fluoxetine 4 3 6 3 5 10 12 12 6 8 8 13 9 8 6 
MDMA 0 0 0 0 0 0 0 0 2 4 3 5 8 11 2 
Total Deaths with the Presence of 
Drugs (Toxicology Reports) 340 292 261 304 296 311 275 259 289 244 326 354 363 298 325 
Total Drugs Mentioned 694 560 522 609 641 635 573 555 641 562 781 864 985 867 844 
Average Number of Drugs per Death 2.04 1.92 2.00 2.00 2.17 2.04 2.08 2.14 2.22 2.30 2.40 2.44 2.71 2.91 2.60 
 
SOURCE:  Philadelphia Medical Examiner’s Office 
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Exhibit 3. Treatment Admissions by Primary Drug of Abuse:  FY 1996–FY 2002 
 
Primary Drug FY 1996 FY 1997 FY 1998 FY 1999 FY 2000 FY 2001 FY 20021 
Cocaine 4,741 3,172 2,264 1,973 2,065 2,258 1,776 
Alcohol 3,944 2,597 1,734 1,671 1,708 1,853 1,622 
Heroin 2,584 2,026 1,486 1,041 1,077 1,779 1,573 
Other Opiates 60 46 52 49 46 101 86 
Marijuana 1,033 789 607 960 773 1,103 1,060 
PCP 153 109 33 44 35 46 75 
Other Hallucinogens 27 16 9 9 8 8 4 
Methamphetamine/ 
  Amphetamine 44 38 25 40 26 24 35 
Benzodiazepines 35 33 29 49 28 34 30 
Other Tranquilizers 16 20 8 6 2 5 1 
Barbiturates 20 21 8 10 9 15 15 
Other Sedatives/ 
  Hypnotics 24 19 12 15 19 19 17 
Inhalants 4 2 1 1 0 4 0 
Over-the-Counter 1 4 3 8 25 3 3 
Other (Not Listed) 197 105 28 8 26 92 92 
Total 12,892 8,997 6,299 5,884 5,847 7,344 6,389 
Average Number of Drugs per Admission:   1.90 
 
1Subject to revision. 
 
SOURCE:  Pennsylvania Department of Health, Client Information System 
 
 
Exhibit 4. Cocaine Treatment Admissions by Route of Administration and Gender:   
   FY 1998–FY 2002 
  
Route of Administration and Gender FY 1998 FY 1999 FY 2000 FY 2001 FY 20021 
Smoked    Male 
 
n 
(%) 
1,018 
(45.0) 
882 
(43.0) 
1,162 
(46.5) 
1,171 
(46.1) 
844 
(47.5) 
     Female n 
(%) 
877 
(38.7) 
793 
(38.7) 
963 
(38.5) 
969 
(38.1) 
586 
(33.0) 
Intranasal   Male n 
(%) 
186 
(8.2) 
177 
(8.6) 
178 
(7.1) 
233 
(9.2) 
212 
(11.9) 
     Female n 
(%) 
74 
(3.3) 
111 
(5.4) 
115 
(4.6) 
99 
(3.9) 
88 
(5.0) 
Injected    Male n 
(%) 
56 
(2.5) 
55 
(2.7) 
40 
(1.6) 
36 
(1.4) 
12 
(0.7) 
     Female n 
(%) 
18 
(0.8) 
15 
(0.7) 
11 
(0.4) 
11 
(0.4) 
9 
(0.5) 
Other/Unknown  Male n 
(%) 
21 
(0.9) 
10 
(0.5) 
13 
(0.5) 
12 
(0.5) 
16 
(0.9) 
     Female n 
(%) 
14 
(0.6) 
7 
(0.3) 
18 
(0.7) 
11 
(0.4) 
9 
(0.5) 
Total    Male N 
(%) 
1,281 
(56.6) 
1,124 
(54.8) 
1,393 
(55.7) 
1,452 
(57.1) 
1,084 
(61.0) 
     Female N 
(%) 
983 
(43.4) 
926 
(45.2) 
1,107 
(44.3) 
1,090 
(42.9) 
692 
(39.0) 
Total 2,264 2,050 2,500 2,542 1,776 
 
1
 Subject to revision. 
 
SOURCE:  Pennsylvania Department of Health, Client Information System 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Philadelphia 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 171
Exhibit 5. Heroin, Illegal Methadone, and Other Opiate Treatment Admissions by Route of   
   Administration and Gender:  FY 1998–FY 2002  
 
Route of Administration and Gender FY 1998 FY 1999 FY 2000 FY 2001 FY 20021 
Injected    Male 
 
n 
(%) 
655 
(43.2) 
761 
(46.6) 
966 
(41.3) 
953 
(40.3) 
672 
(40.5) 
     Female n 
(%) 
276 
(18.2) 
378 
(23.2) 
611 
(26.1) 
485 
(20.5) 
305 
(18.4) 
Intranasal   Male n 
(%) 
375 
(24.7) 
275 
(16.9) 
382 
(16.3) 
434 
(18.4) 
342 
(20.6) 
     Female n 
(%) 
166 
(10.9) 
165 
(10.1) 
247 
(10.6) 
274 
(11.6) 
191 
(11.5) 
Swallowed   Male n 
(%) 
9 
(0.6) 
17 
(1.0) 
30 
(1.3) 
76 
(3.2) 
49 
(3.0) 
     Female n 
(%) 
4 
(0.3) 
4 
(0.2) 
40 
(1.7) 
39 
(1.6) 
38 
(2.3) 
Smoked    Male n 
(%) 
19 
(1.3) 
15 
(0.9) 
33 
(1.4) 
46 
(1.9) 
23 
(1.4) 
     Female n 
(%) 
5 
(0.3) 
6 
(0.4) 
16 
(0.7) 
10 
(0.4) 
8 
(0.5) 
Other/Unknown  Male n 
(%) 
6 
(0.4) 
7 
(0.4) 
10 
(0.4) 
30 
(1.3) 
20 
(1.2) 
     Female n 
(%) 
1 
(<0.1) 
4 
(0.2) 
6 
(0.3) 
18 
(0.8) 
12 
(0.7) 
Total    Male N 
(%) 
1,064 
(70.2) 
1,075 
(65.9) 
1,421 
(60.7) 
1,539 
(65.1) 
1,106 
(66.6) 
     Female N 
(%) 
452 
(29.8) 
557 
(34.1) 
920 
(39.3) 
826 
(34.9) 
554 
(33.4) 
Total 1,516 1,632 2,341 2,365 1,660 
 
1
 Subject to revision. 
 
SOURCE:  Pennsylvania Department of Health, Client Information System 
 
 
 
Exhibit 6. Adult AIDS Cases in Philadelphia by Exposure Category:  July 1, 2001–June 30, 2002,   
    and Cumulative Totals Through June 30, 2002 
 
July 1, 2001–June 30, 2002 November 1, 1981–June 30, 2002 
Exposure Category 
Number Percent Number Percent 
IDU 378 (32.8) 5,518 (36.5) 
MSM and IDU 26 (2.3) 829 (5.5) 
MSM 312 (27.0) 5,949 (39.3) 
Heterosexual Contact 429 (37.2) 2,511 (16.6) 
Blood Products 0 (0.0) 89 (0.6) 
No Identified Risk 
Factor 9 (0.8) 224 (1.5) 
Total Adult Cases 1,154 (100.0) 15,120 (100.0) 
 
SOURCE:  Philadelphia Department of Public Health, AIDS Activities Coordinating Office 
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Drug Abuse Trends in Phoenix and Arizona 
 
Ilene L. Dode, Ph.D.1 
 
ABSTRACT 
 
After a dramatic rise in the number of drug-related 
deaths in Maricopa County through 2000, deaths 
related to all of the major drugs, except meth-
amphetamine, decreased 16 percent for 2001. 
Trends in methamphetamine use are among the 
most striking. The percentage of arrestees testing 
positive for methamphetamine increased by 5 per-
cent from 2000 to 2001 for both males and females. 
Additionally, methamphetamine-related deaths have 
increased steadily since 1997. The indicators for 
cocaine/crack, heroin, marijuana, and other nar-
cotic drugs remained unchanged or decreased 
slightly, except for hydrocodone, oxycodone, and 
the anxiolytics, sedatives, and hypnotics. Emergency 
department (ED) mentions for amphetamine and 
methamphetamine revealed significant change. In 
addition to methamphetamine, drugs of greatest 
concern in Arizona currently are MDMA, PCP, 
GHB, and various hallucinogens, including mush-
rooms. Prior to 1990, 6 percent of reported AIDS 
cases were female, compared with 11 percent of 
cases from 1990 through 2000. Prior to 1990, 10 
percent of the AIDS cases were among Hispanics; 
from 1990 to the present, the percentage rose to 18 
percent. Proposition 203, an initiative to decriminal-
ize possession of small amounts of marijuana, failed 
in the November election. 
 
INTRODUCTION 
 
Area Description 
 
There is no place on earth quite like the Grand 
Canyon State. Central Arizona, comprised of Ari-
zona’s capital city of Phoenix and the 20 surrounding 
cities such as Chandler, Glendale, Mesa, Paradise 
Valley, Scottsdale, and Tempe, is a place of super-
latives. With slightly more than 3 million residents, it 
is one of the country’s largest metropolitan areas, 
encompassing more than 2,000 square miles. 
 
In the past decade, Arizona’s population increased 
three times faster than that of the rest of the Nation, 
becoming home to more than 5.1 million people. The 
official population count, 5,130,632 according to the 
U.S. Bureau of the Census, is nearly 1.5 million more 
than in 1990. Racial and ethnic minorities were 
responsible for more than one-half of the State’s total 
growth. Minorities now constitute 36 percent of the 
State’s total population, a gain from 28 percent a 
decade ago. 
  
The population of the State is 64 percent White, 25 
percent Hispanic, 5 percent Native American, 3 per-
cent African-American, 2 percent Asian American, 
and 2 percent other groups. Since 1990, the State’s 
Hispanic population has increased by 88 percent. 
Latinos now total 1.3 million, or the equivalent of the 
population within the city limits of Phoenix. 
 
The population of Maricopa County (Phoenix) is 72 
percent White, 21 percent Hispanic, 4 percent 
African-American, 2 percent Asian American, and 1 
percent other groups. 
  
Data Sources 
 
This report is based on the most recent available data 
obtained from the following sources: 
 
• Emergency department (ED) drug mentions 
data were derived from the Drug Abuse Warn-
ing Network (DAWN), Office of Applied 
Studies, Substance Abuse and Mental Health 
Services Administration (SAMHSA), for 1994 
through 2001. 
 
• Drug-related death data were provided by the 
Maricopa County Medical Examiner (ME) Of-
fice for 1989 through 2001. 
 
• Treatment data were provided by three sources: 
the Treatment and Assessment Screening Center 
(TASC) Juvenile Standard and Intensive Pro-
bation Program Report (April– October 2002); 
TASC Adult Deferred Prosecution Program 
cumulative report (March 1989– October 2002); 
Terros, Inc.’s data on admissions to outpatient 
detoxification treatment (May– October 2002); 
and the Arizona Department of Health Services 
(ADHS), Division of Behavioral Health Ser-
vices, Bureau of Substance Abuse Treatment and 
Prevention, Statewide Treatment Profile, No-
vember 2002. 
1
 The author is affiliated with EMPACT Suicide Prevention Center, Phoenix, Arizona. 
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• Arrestee drug testing data for Phoenix were 
derived from the Arrestee Drug Abuse Monitoring 
(ADAM) program, National Institute of Justice 
(NIJ), for 2000, 2001, and the third quarter of 
2002; ADAM data for Tucson are also presented. 
 
• Drug price and purity data were provided by 
the Phoenix Police Department Drug Enforce-
ment Bureau and the Drug Enforcement Admin-
istration (DEA) for 2002.  
 
• Acquired immunodeficiency syndrome (AIDS) 
and human immunodeficiency virus (HIV) data 
for Arizona were provided by ADHS, Division of 
Disease Prevention, Office of Chronic Infectious 
Disease, for January 1990 through June 2002. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
Cocaine-related deaths (n=136) for 2001 reflect a 
decline of 18 percent in cocaine deaths compared 
with 2000, but cocaine/morphine deaths combined 
appear to have essentially stabilized for the third 
consecutive year, totaling 52 in 2001 (exhibit 1). 
 
Cocaine ED mentions gradually rose from 1,057 in 
1994 to a peak of 1,877 in 1999; however, estimates 
of rates of ED mentions per 100,000 population 
decreased from 2000 to 2001 (exhibit 2). The recent 
decline was not significant, but the increase of 65.8 
percent between 1994 and 2001 was significant. The 
rate per 100,000 population for females in 2001 was 
40, compared with 25 in 1994, a significant increase 
of 57.9 percent. Cocaine ED mentions also increased 
significantly for Hispanics, rising from 260 mentions 
in 1994 to 402 in 2001.  
 
Cocaine treatment admissions to the TASC Adult 
Deferred Prosecution Program remain unchanged at 
29.5 percent of cumulative treatment admissions 
since March 1989 (3,349 of 7,442), similar to the 3 
previous reporting periods (exhibit 3). The Terros 
outpatient detoxification program reported that 13 
percent of treatment admissions were for cocaine in 
2000; the proportion declined slightly to 11 percent 
in 2002. As shown in exhibit 4, 6 percent of the 
juvenile admissions to the TASC Probation Program 
in the second quarter of 2002 were for cocaine abuse. 
 
ADHS, Division of Behavioral Health Services 
(BHS), data revealed that 14 percent of all treatment 
admissions statewide for fiscal year (FY) 2002 were 
for cocaine abuse (exhibit 5). 
The Phoenix ADAM data reveal that 32.5 percent of 
adult male arrestees in 2000 and 27.2 percent in 2001 
tested positive for cocaine (exhibit 6). Also, 28 
percent of adult female arrestees in Maricopa County 
in 2000 and 24.1 percent in 2001 tested cocaine-
positive. Tucson ADAM data show that 38.5 and 
39.8 percent of adult male arrestees and 48.4 and 
36.3 percent of female arrestees tested positive for 
cocaine during the respective time periods. The 
proportion of Phoenix male arrestees testing positive 
for cocaine declined to 21.3 percent in the second 
quarter of 2002; however, by the third quarter, 28.3 
percent tested cocaine-positive. A smaller proportion 
of female arrestees tested positive for cocaine in the 
second quarter of 2002. 
 
Powder cocaine is consistently available throughout 
the Phoenix, Tucson, and Nogales areas of Arizona, 
according to the DEA. Wholesale cocaine is primarily 
sold in powder form in kilogram and half-kilogram 
pressed bricks, wrapped in cellophane and packaging 
tape. Recently, wrappings have included Mylar 
material and black carbon paper. A kilogram of 
powder cocaine sells for $14,500– $17,500 in Phoenix 
and for $10,000– $15,000 in Yuma, a border city. 
 
In the Phoenix area, an eightball of cocaine sells for 
$120– $150, and an ounce sells for $400– $800. In 
Tucson, an eightball of powder cocaine sells for $80–
$130. An ounce of crack sells for $500– $600 in 
Phoenix, compared with $400– $800 for an ounce of 
powder cocaine. 
 
The Arizona Department of Public Safety (DPS) 
reported 1,814 arrests in 1991 for the manufacture 
and sale of opiates/cocaine. Ten years later, in 2001, 
there were 1,602 arrests. Arrests for possession of 
cocaine (3,056) decreased in the past 3 years from a 
peak of 4,088 in 1998. 
 
It has been reported that smugglers of illegal immi-
grants into Arizona are forcing the immigrants to take 
cocaine before they begin the journey through the 
desert. The traffickers tell the immigrants that the 
cocaine will help the body retain water needed for 
desert travel. 
 
In August 2002, a highly publicized case involved the 
death of a 10-day-old baby who had been exposed to 
daily crack smoke while in vitro and after being taken 
home from the hospital. The death has been ruled a 
homicide. The County Prosecutor’s office is pursuing 
prosecution of the mother and grandmother in the 
death. 
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Heroin/Morphine 
 
The Maricopa County ME reported 137 morphine-
related deaths in 2000, compared with 44 in 1989 
(exhibit 1). It appears that morphine deaths peaked 
during 1999 and 2000. Deaths for 2001 totaled 103, a 
24.8-percent decrease from 2000. Deaths related to 
the combination of methamphetamine with heroin or 
cocaine decreased 27.1 percent. 
 
The number of heroin ED mentions increased from 
472 in 1994 to 777 in 2001, a significant change of 
64.6 percent, but episodes remained stable for the 
past few years. The rate of heroin ED mentions per 
100,000 population declined insignificantly from 40 
in 2000 to 27 in 2001 (exhibit 2). Of the CEWG 
cities, only Minneapolis (13) and Dallas (14) have a 
lower rate per 100,000 population. 
 
For the second half-year, the Terros, Inc., outpatient 
detoxification program presented an unusual data 
mix. Historically, detoxification for heroin represents 
60– 70 percent of the clients, but for the past year, 46 
percent of those seeking services did so for heroin 
detoxification. Opiate admissions to the TASC Adult 
Deferred Prosecution Program remained stable at 5.6 
percent of the cumulative total (635 of 7,442) from 
March 1989 to September 2002 (exhibit 3). TASC 
juvenile testing data showed that 1.3 percent tested 
positive for opiates. No juveniles admitted to the 
TASC Probation Program in the second quarter of 
2002 reported opiate use (exhibit 4). 
 
The ADAM data suggest that opiates are one of the 
least used drugs in Maricopa and Pima Counties. In 
Maricopa County, positive tests for opiates were 
nearly identical for males and females at 6 percent for 
2000 and 2001 (exhibit 6). Third-quarter 2002 data 
reflect an 8.2-percent decrease for females, but the 
number tested was minuscule. 
 
Black tar heroin remains the most frequently 
encountered form of heroin used by the well-estab-
lished “ traditional”  community of heroin abusers in 
the Phoenix and Tucson metropolitan areas. Current 
street prices for heroin in the metropolitan areas are 
relatively unchanged from previous CEWG reporting 
periods. The price for a “ paper”  in Yuma dropped 
from $25– $40 to $10, while the price for an ounce 
increased from $700 to $1,500– $2,000. In 2001, the 
average price per milligram pure was $0.36, with a 
purity of 40.6 percent. It has been reported that 
Mexican traffickers are increasing the purity in order 
to compete with Colombian heroin. Colombia and 
Mexico are the two major sources of heroin that 
enters Arizona. Mexico suffered from a severe 
drought for an extended time, which significantly 
impacted heroin production. Rainfall has returned to 
normal, and opium poppy cultivation has also 
returned to normal. 
 
Other Opiates 
 
The Phoenix DEA Diversion Group reports that the 
most commonly abused pharmaceutical controlled 
substances include Vicodin, Lortab, and other hydro-
codone products; Percocet, OxyContin, and other 
oxycodone products; benzodiazepines; and codeine 
products. Carisoprodol (Soma) in combination with 
other analgesic controlled substances, tramadol 
(Ultram), and nalbuphine (Nubain) continue to be 
highly abused prescription-only substances. 
 
ED mentions for hydrocodone/combinations increased 
395.9 percent from 1994 (74) to 2001 (367) (exhibit 
7). Acetaminophen-hydrocodone mentions increased 
582.6 percent between 1994 (46) and 2001 (314). ED 
mentions for oxycodone/combinations increased 262.9 
percent, from 89 mentions in 1994 to 323 in 2001, 
while oxycodone mentions increased 1,450 percent, 
from 8 in 1994 to 124 in 2001. Narcotic analgesics/ 
combinations showed a significant increase for the past 
3 reporting years. ED mentions for narcotic analgesics 
increased 269.9 percent from 492 in 1994 to 1,820 in 
2001, and also between 1999 and 2001, and 2000 and 
2001. 
 
Staff of methadone clinics reported a significant 
diversion of methadone tablets outside of the clinics. 
Reportedly, clients are selling methadone in 10-
milligram tablets. Prices for the diverted phar-
maceutical drugs are $20– $25 per 40-milligram Oxy-
Contin tablet; $5 per tablet for Percocet; $5 per tablet 
for Vicodin-ES; $4 per 10-milligram Valium tablet; 
$5– $6 per tablet for 10 milligrams of Lortab; and $2 
per tablet for Soma. 
 
Marijuana 
 
The number of marijuana ED mentions increased 
significantly between 1994 (451 mentions) and 2001 
(1,284), up 184.7 percent. The rate per 100,000 
population in 1994 was 23, compared with 45 in 
2001, an increase of 95.8 percent (exhibit 2). The rate 
for 2001 (45) represented a decrease of 9.6 percent 
from the rate in 1999 (50). 
 
Marijuana was reported as the primary drug of choice 
by 21.2 percent of clients in the TASC Adult Deferred 
Prosecution Program (exhibit 3). ADHS/BHS treat-
ment data indicated that 19 percent of clients admitted 
to treatment statewide presented with marijuana as the 
primary drug of choice (exhibit 5). 
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The TASC Juvenile Probation Program quarterly 
reports reveal that marijuana is consistently the drug 
of choice for about 40 percent of juveniles (exhibit 
3b). The Client Drug Test Results Summary for 
Juvenile Services through TASC states that 1,780 
(43.2 percent) of 4,122 individual juveniles tested 
between July 1, 2002, and September 30, 2002, were 
positive for one or more drugs. Seventy-three percent 
of juveniles tested positive for marijuana. 
Amphetamine was identified in 17.5 percent of 
juveniles, cocaine in 7.9 percent, and opiates in 1.3 
percent. 
 
Estimates for marijuana ED mentions by patient 
demographic characteristics reveal two separate, but 
noteworthy, significant increases. The number of 
mentions for youth age 12– 17 indicated a continuing 
upward trend. In 1994, there were 105 mentions for 
youth age 12– 17, compared with 295 in 2001, a 181-
percent increase. The percentage of Hispanic ED 
marijuana mentions steadily increased from 74 in 
1994 to 206 in 2001, a 178-percent increase.  
 
The ADAM report reflects trends in marijuana use 
that differed between Maricopa and Pima Counties 
for 2000 and 2001. In Maricopa County, the propor-
tion of arrestees testing positive for marijuana 
increased by approximately 5 percent among both 
males and females. In Pima County, the proportion of 
arrestees testing positive for marijuana decreased by 
approximately 3 percent. In Phoenix, 39.7 percent of 
males tested marijuana-positive in 2001 (exhibit 5). 
The proportion for females was 26.5 percent. 
 
The price fluctuation of wholesale and retail 
quantities of marijuana is minimal because of the 
steady availability. Price depends on location in 
Arizona, the number of middlepersons, and the size 
of the purchase. There were no reported price 
changes during this past-6-month period, with the 
exception of the pound price in Phoenix, which was 
reported to range from $500 to $750, and the ounce 
price in Tucson, which was from $40 to $100. 
 
The DPS reported that arrests for marijuana 
possession were stable for 2000 (14,947) and 2001 
(15,097). Arrests for marijuana possession rep-
resented 59 percent of total arrests for possession. 
 
Marijuana is readily available throughout the year, 
although there is a greater influx of marijuana along 
the border of Mexico and Arizona between July and 
September following the June– August harvest. 
 
The Yuma DEA reports encountering a form of 
marijuana known as “ chronic or purple kush.”  The 
leaves and stalk of the plant have a purple-tinge 
color. It is reported to sell for $20 per gram and $125 
per quarter-ounce, compared with $20– $25 per 
quarter-ounce for traditional marijuana. It is believed 
that chronic or purple kush may be a type of 
marijuana grown hydroponically in the San Francisco 
Bay area where cooler weather might be a factor. The 
smoke is reported to be thick, musky, and spicy, and 
the high reportedly is immediate, almost opiate-like. 
 
Stimulants 
 
Methamphetamine trends are the most prominent of 
all drug categories addressed in this report. Many of 
the indicators continue to increase and reflect an 
increase in female and juvenile involvement with this 
drug. The coordinator of the largest outpatient 
adolescent substance abuse treatment program reports 
anecdotally that the current reported drug of choice 
among clients is methamphetamine, followed by 
marijuana. 
 
Methamphetamine-related deaths have steadily 
increased in Maricopa County for the past 4 years 
(51, 75, 105, and 159, respectively). These deaths 
increased 51.4 percent in 2001 compared to 2000 
(exhibit 1).  
 
The number of methamphetamine ED mentions 
increased 77.1 percent from 1999 (341) to 2001 
(604), while the number of amphetamine ED men-
tions increased 120.9 percent from 1994 (402) to 
2001 (888). The Phoenix rate of methamphetamine 
ED mentions per 100,000 population decreased from 
29 in 2000 to 21 for 2001, or 28.2 percent (exhibit 
2a). Of the CEWG cities, only San Francisco (39) 
and San Diego (27) continued to have higher meth-
amphetamine ED rates per 100,000 population in 
2001 than Phoenix. In 2001, amphetamine rates per 
100,000 population for the same three cities, plus 
Seattle, were San Francisco (50), San Diego (37), 
Seattle (33), and Phoenix (31)— all representing the 
highest rates of amphetamine ED mentions in the 
DAWN system. 
 
The number of amphetamine ED mentions increased 
significantly from 1994 to 2000, 1999 to 2000, and 
2000 to 2001 among males and females; Whites, 
Blacks, and Hispanics; and in groups age 20– 25, 26–
34, and 35 and older. 
 
A statistical summary of the TASC Adult Deferred 
Prosecution Program revealed that 26.7 percent 
(n=3,029) of the March 1989 through September 
2002 treatment admissions (7,442) were for meth-
amphetamine abuse (exhibit 3a). Ten percent of 
admissions to the TASC Juvenile Standard and 
Intensive Program in the second quarter of 2002 were 
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for methamphetamine (exhibit 3b). The TASC Client 
Drug Test Results Quarterly Summary revealed that 
17.5 percent of juveniles (4,127) tested positive for 
amphetamine and methamphetamine. Eight percent 
of clients admitted to the Terros Outpatient Detox-
ification Program were for methamphetamine treat-
ment. ADHS statewide treatment admissions data 
indicate that 11 percent of clients reported meth-
amphetamine as their primary drug (exhibit 4). 
 
ADAM data for 2000, 2001, and two quarters of 
2002 revealed a greater percentage of arrestees 
testing positive for methamphetamine in Maricopa 
County than in Pima County. Pima County showed 
little difference between 2000 and 200l. In Pima 
County, 7 percent of male arrestees tested positive in 
both years. The proportion of females testing meth-
amphetamine-positive increased slightly from 8.4 
percent in 2000 to 11.4 percent in 2001. In 2000 and 
2001 in Maricopa County, 18.7 percent and 22 
percent of males tested methamphetamine-positive; 
the respective figures for females were 24.5 and 29 
percent. Second and third quarter data for 2002 
reflect an even greater increase for females in 
Maricopa County. In the second quarter, 43.3 percent 
tested methamphetamine-positive, as did 50.6 percent 
in the third quarter. 
 
Ongoing DEA investigations show no decrease in 
availability of methamphetamine in Arizona. Meth-
amphetamine continues to be widely available 
throughout most of the State in the crude brownish 
Mexican form and the more pure crystallized form 
referred to as “ ice”  or “ glass”  that has a much higher 
purity level, 95– 99. The crude methamphetamine has 
a purity range of 20 to 40 percent. The DEA 
estimates that approximately 30– 40 percent of the 
methamphetamine purchased was ice, with the 
remainder being Mexican methamphetmaine. 
 
The DEA and Phoenix Police Department report the 
following methamphetamine prices, which vary 
depending on location in the State: a pound sells for 
$5,000– $6,000 in Phoenix and $4,000– $7,000 in 
Tucson. In Phoenix, ice sells for $9,000 per pound 
and $600 per ounce, and an ounce of methamphet-
amine sells for $425. An ounce of methamphetamine 
sells for $300– $600, and an ounce of ice sells for 
$900 in Tucson. Prices differ from the previous 
CEWG reporting period. 
 
The DEA reports 145 clandestine methamphetamine 
labs were seized during the third and fourth quarters 
of 2002. The pseudoephedrine/red phosphorous/ 
iodine method was the manufacturing process 
reported in all seized labs. The cost of iodine crystals 
is $40 per 2-ounce jar. It has been reported that it 
takes approximately 300 pseudoephedrine cold tab-
lets to make an ounce of methamphetamine. It 
reportedly takes 2– 4 pounds of iodine to make 1 
pound of methamphetamine. Each pound of 
methamphetamine results in 5 pounds of toxic waste 
and costs approximately $6,000 per lab to clean up. 
 
Other Drugs 
 
Club drugs were reported to be readily available at 
raves, bars, and clubs that cater to the college-age 
population. According to a confidential source, there 
is a rumor in the rave community in Maricopa 
County that some of the ecstasy at raves is being 
laced with heroin and methamphetamine. The DEA 
reported that field drug tests on seized ecstasy might 
be valid. The seized ecstasy tablets have been 
embedded with logos of “ flying white doves”  and 
“ HP,”  for “ Harry Potter.”  
 
Ecstasy prices have increased from the previous 
report. One tablet sells for $20– $25. If 1,000 ecstasy 
tablets are purchased, the price is $7– $10 per tablet; 
if 10,000 or more are purchased, the price is $5 per 
tablet. 
 
The number of ED mentions for different types of 
club drugs in Phoenix varies widely. Despite being 
readily available, the number of lysergic acid 
diethylamide (LSD) ED mentions decreased 54.1 
percent from 135 mentions in 2000 to 62 in 2001 
(exhibit 8). MDMA mentions (20) in 1999 rose to 96 
in 2001, a 380-percent increase. There were 16 ED 
mentions for phencyclidine (PCP) in 1994, compared 
with 61 in 2001, a 281-percent increase. 
 
Several sources reported that various drugs with 
hallucinogenic properties are readily available 
throughout the State, including peyote, Psilocybin 
mushrooms, LSD, PCP, and ketamine. LSD hits 
reportedly sell for $4 each if 1 blotter hit is 
purchased, $3 each for 3 hits or more, and $140– $150 
for 1 bottle (90 dosage units). 
 
Reported prices for gamma hydroxybutyrate (GHB) 
were unchanged at $5– $10 for one dose (1 teaspoon); 
$425 for 25 pounds; $3,200 for a 55-gallon drum 
wholesale; and $4,300 for a 55-gallon drum retail.  
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE2 
 
Since 1981, there has been a total of 8,086 AIDS 
cases and 5,320 HIV, non-AIDS, cases reported to 
2
 This section of the report represents an “ Executive Summary,”  prepared by Rick DeStephens, Arizona Department of Health Services, Office of  
  HIV/AIDS, derived from the HIV/AIDS Semiannual Report, July 1, 2002. 
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the Arizona Department of Health Services. Of these 
AIDS cases, 4,333 (54 percent) are known to be 
deceased.  
 
HIV disease is disproportionately distributed in 
Arizona. While Maricopa County has 60 percent of 
the State’s population, it has 70 percent of the 
reported AIDS cases and 72 percent of reported HIV 
cases. Likewise, Pima County, the next most pop-
ulous county, has 16 percent of the population, but 21 
percent of AIDS cases and 19 percent of HIV cases. 
 
Ninety-one percent of the total reported AIDS cases 
are male, but an increasing percentage of recently 
reported cases are female (6 percent of cases reported 
prior to 1990 were female, compared with 11 percent 
of cases from 1990 through 2000). Fourteen percent 
of the total reported HIV cases are female. 
 
Seventy-one percent of all AIDS cases have been in 
the White population, but recent trends show 
increasing numbers of AIDS and HIV cases within 
minority communities. For example, African-Amer-
icans represent 3 percent of the Arizona population, 
and, prior to 1990, 5 percent of the reported AIDS 
cases were in this group. From 1990 to the present, 
the percentage of African-American AIDS cases 
increased to 8 percent, with 13 percent of the 
reported AIDS cases being African-Americans in 
1999 and 2000. For HIV only, African-Americans 
represent 11 percent of the total cases. The same 
pattern holds true for the Hispanic AIDS cases. Prior 
to 1990, 10 percent of the AIDS cases were Hispanic, 
while from 1990 to the present, the percentage rose to 
18 percent. For the last 2 complete years (2000 and 
2001), Hispanics accounted for 25 percent of the 
AIDS cases. Eighteen percent of the HIV cases are 
among Hispanics. While the percentage of Native 
Americans reported with AIDS has remained fairly 
constant (2– 3 percent of reported cases), there has 
been an increase to 6 percent of reported cases in the 
past 2 years. Native Americans account for 3 percent 
of the HIV cases. 
 
The predominant mode of transmission of AIDS and 
HIV reported throughout the course of the epidemic in 
Arizona has been male-to-male sexual contact, 
accounting for 61 percent of the AIDS cases and 50 
percent of the HIV cases. Twelve percent of the AIDS 
cases and 14 percent of the HIV cases have been 
linked to injection drug use. Additionally, another 11 
percent of AIDS cases and 8 percent of HIV cases 
have been shown in men who engage in male-to-male 
sexual contact while also engaging in injection drug 
use. Heterosexual contact with an HIV-positive person 
or person known to have a risk factor for HIV (6 
percent of AIDS cases and 8 percent of HIV cases) is a 
small but increasing proportion of Arizona’s cases, 
particularly among females. 
 
The majority of AIDS cases are diagnosed between 
the ages of 30 and 39 (45 percent). However, HIV 
cases are more evenly split between the age groups of 
30– 39 and 20– 29 (40 percent and 34 percent, respec-
tively). Arizona has been very fortunate in that there 
has consistently been a very low rate of pediatric HIV 
and AIDS cases. 
 
ELECTION FOOTNOTE 
 
The 2002 Arizona ballot included an initiative to de-
criminalize possession of small amounts of mari-
juana. Proposition 203 would have made possession 
of 2 ounces or less of marijuana a civil violation 
punishable by a fine of no more than $250. The fine 
could be waived by taking a drug education class. 
Besides reducing penalties for marijuana possession 
from a low-level felony, the law would have allowed 
doctors to recommend, rather than prescribe, mari-
juana for qualifying patients. The Arizona DPS 
would have been required to distribute confiscated 
marijuana for free to those who receive doctors’  
recommendations. The initiative would have expand-
ed existing laws that generally bar prison or jail 
sentences for nonviolent drug offenders. It would 
have barred judges from including jail time as a pro-
bation condition.  
 
It would have also amended the State’s existing 
medicinal marijuana law to allow State-registered 
patients or their caregivers to legally possess up to 2 
ounces of medical “ pot”  and grow two marijuana 
plants. Nonregistered patients or those who possess 
greater quantities of medical pot would have been 
permitted to raise an affirmative defense of medical 
necessity in court. 
 
Medical marijuana laws have twice been voted for in 
the affirmative, but this initiative was not supported 
by the Arizona voters in November 2002. 
 
For inquiries concerning this report, please contact Ilene L. Dode, Ph.D., EMPACT Suicide Prevention Center, Inc., 1232 East Broadway, Suite 
120, Tempe, Arizona 85282, Phone: 480-784-1514, Fax: 480-967-3528, E-mail: <idode@aol.com>. 
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Exhibit 5: Characteristics of Treatment Admissions in Arizona by Percent:  2002 
 
Characteristic Percent 
Substance of Abuse at Admission 
 Alcohol 
 Marijuana 
 Cocaine 
 Methamphetamine 
 Heroin 
 All other 
 
35 
19 
14 
11 
9 
12 
Age Group 
 20–25 
 26–35 
 36–45 
 46 and older 
 
17 
31 
33 
19 
Chronic Medical Disorder at Admission 
 HIV/other disability 
 Headaches 
 Head injury 
 Arthritis 
 Asthma 
 Hypertension 
 Any medical disorder 
 
18 
8 
6 
6 
6 
5 
57 
Other Presenting Problem at Admission 
 Suicidal 
 Victim of abuse 
 Co-occurring MH/SA 
 
19 
7 
35 
Criminal Justice Status at Admission 
 Criminal 
 Driving under the influence (DUI) 
 Civil order 
 Any court order 
 
24 
8 
5 
37 
Income Sources at Admission 
 No income 
 Employed 
 TANF1/food stamps 
 SSI/SSDI2 
 
50 
35 
5 
10 
 
1
 TANF=Temporary Assistance for Needy Families. 
2
 SSI/SSDI=Supplemental Security Income and Social Security Disability Insurance. 
 
SOURCE:  Arizona Department of Health Services, Division of Behavioral Health Services, Bureau of Substance Abuse and  
 Prevention Services 
 
 
 
Exhibit 6. Percentages of Adult Male and Female Arrestees Testing Positive for Drugs in Phoenix:   
2001 
 
Drug Males Females 
Cocaine/Crack 27.2 31.6 
Opiates 6.0 6.3 
Marijuana 39.7 26.5 
Methamphetamine 25.3 32.3 
 
SOURCE:  ADAM, NIJ 
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Patterns and Trends in Drug Abuse in St. Louis 
 
Heidi Israel Adams, Ph.D., R.N., L.C.S.W.,1 and Jim Topolski, Ph.D.2  
 
ABSTRACT 
 
Heroin indicators have increased slightly, while 
cocaine retains a strong presence in all urban 
indicators. Methamphetamine is increasingly prom-
inent in St. Louis indicators. St. Louis and St. 
Charles County law enforcement personnel are 
concerned about methamphetamine use, and meth-
amphetamine labs in rural areas continue to be a 
problem. Club drugs, such as MDMA and GHB, 
reportedly have an increasing presence in St. Louis 
and are the new prevention and law enforcement 
concern. Indicator data concerning club drug 
use/abuse are sparse. Marijuana indicators have 
been trending up in St. Louis for some time. 
Primary marijuana treatment admissions more than 
doubled between 1997 and 2002. PCP is again noted 
in ED admissions data. In the St. Louis area, 6,002 
cases of HIV and AIDS have been identified 
through November 2001. 
 
INTRODUCTION 
 
Area Description 
 
The St. Louis metropolitan statistical area (MSA) 
includes approximately 3 million people living in the 
city of St. Louis; St. Louis County; the surrounding 
rural Missouri counties of Franklin, Jefferson, Lin-
coln, St. Charles, and Warren; in Illinois, East St. 
Louis; and St. Clair County. St. Louis’s population 
has continued to decrease to approximately 350,000, 
many of whom are indigent and minorities. Although 
violent crime has generally decreased, it remains high 
in drug-trafficking areas. St. Louis County, which 
surrounds St. Louis City, has more than 1 million 
residents, many of whom fled the inner city. The 
county is a mix of established affluent neighborhoods 
and middle and lower class housing areas on the 
north and south sides of the city. The most rapidly 
expanding population areas are in St. Charles and 
Jefferson Counties, which have a mixture of classes 
and both small towns and farming areas. The living 
conditions and cultural differences have resulted in 
contrasting drug use patterns. 
 
Much of the information included in this report is 
specific to St. Louis City and County and not to the 
total MSA. Anecdotal information and some treat-
ment data are provided for the rural area and for the 
State. Limited data are also available for other parts 
of Missouri and offer a contrast to the St. Louis drug 
use picture. 
 
Data Sources 
 
The sources used in this report are indicated below:  
 
 Emergency department (ED) drug mentions 
data were provided by the Drug Abuse Warning 
Network (DAWN), Office of Applied Studies, 
Substance Abuse and Mental Health Services 
Administration (SAMHSA), for 1994– 2001. 
 
 Drug treatment data were derived from the 
Treatment Episode Data Set (TEDS) database. 
Private treatment programs in St. Louis County 
provided anecdotal information. 
 
 Heroin price and purity information was 
provided by the Drug Enforcement Admin-
istration (DEA)’s Domestic Monitor Program 
(DMP). 
 
 Drug-related mortality data were provided by 
the St. Louis City Medical Examiner’s Office. 
 
 Intelligence data were provided by the Missouri 
Highway Patrol and the DEA. 
 
 Human immunodeficiency virus (HIV) and 
acquired immunodeficiency syndrome (AIDS) 
data were derived from the HIV Vaccine Trials 
Unit at St. Louis University and the St. Louis 
Metropolitan AIDS Program. 
 
Linda Cottler, Ph.D., of Washington University, who 
has multiple behavioral research grants, provided 
additional data. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine indicators are stable in St. Louis. While 
methamphetamine has become a prominent drug of 
abuse in other cities and in the rural areas of 
Missouri, cocaine has retained its dominance in the 
St. Louis urban area. Possible reasons for this 
situation are that methamphetamine is used primarily 
1
 Dr. Israel Adams is affiliated with the Division of Infectious Diseases, Saint Louis University Medical School, St. Louis, Missouri. 
1
 Dr. Topolski is affiliated with the Division of Evaluation, Policy, and Ethics, Missouri Institute of Mental Health, St. Louis, Missouri. 
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by Whites, while cocaine is used primarily by 
African-Americans; also St. Louis City drug dealers 
are primarily African-American, and city traffickers 
deal cocaine and heroin. Consequently, methamphet-
amine is not as regularly available in St. Louis City, 
but it is more readily available outside the city.  
 
Heroin of reasonable purity has continued to be 
available but is also quite expensive compared with 
other cities. This midwestern city is a destination 
market, with small entrepreneurial groups marketing 
the drug.  
 
Drug education and prevention activities have con-
tinued at the community level through programs such 
as Drug Abuse Resistance Education (DARE) and 
collaborative arrangements between communities and 
the police. These groups are particularly active in the 
surrounding counties of St. Louis. The poor city 
economy continues to foster drug abuse and distri-
bution. Marijuana continues to be a very popular drug 
of abuse among younger adults and may be a 
reflection of a high number of court referrals. Gangs 
continue to be involved in drug trade and related 
violence, with large numbers of African-American 
and Asian youth and young adults involved in these 
groups. Interdiction programs include Operation 
Jetway and Operation Pipeline.  
 
Cocaine and Crack 
 
According to DAWN, the rate of cocaine ED men-
tions per 100,000 population increased dramatically 
in 1994, declined for several years, and recently 
peaked again in 2001 at 134 (exhibit 1a). 
 
The St. Louis City/County medical examiner (ME) 
reported that cocaine-related deaths trended down-
ward from 128 in 1994 to 66 in 2000. Many of the 
deaths in the late 1990s were overdoses. DAWN ME 
data corroborate a decreasing trend since 1994.  
 
Cocaine treatment admissions and law enforcement 
data have stabilized over the past few years. How-
ever, treatment admissions decreased almost 20 
percent between the first halves of 2001 and 2002. 
Cocaine no longer drives the efforts of St. Louis law 
enforcement and treatment programs. The DEA’s 
emphasis has shifted from cocaine to methamphet-
amine, club drugs, and heroin. 
 
Law enforcement sources, the DEA, and street 
informants continued to report high quality, wide 
availability, and low prices for cocaine. Cocaine is 
used and most available in the urban areas. Powder 
cocaine grams sold for $100– $125; purity averaged 
77 percent (exhibit 1b). Crack prices have dropped to 
between $100 and $250 per gram and $20 per rock 
on the street corner. All cocaine in St. Louis is 
initially in the powder form and is converted to crack 
for distribution. Cocaine was readily available on the 
street corner in rocks or grams. The price of a gram 
in Kansas City was stable at $250. The “ rock”  price 
is the same in smaller cities outside St. Louis, but the 
gram price is higher. 
 
The continued use of cocaine, particularly crack by 
urban women, has potentially severe long-term 
consequences by contributing to the spread of sex-
ually transmitted diseases (STDs) through multiple 
partners. Numerous small behavioral studies of 
crack-abusing women have found that crack use is 
predictive of multiple partners and HIV risk ex-
posure. The STD rate in St. Louis has decreased for 
men, but it remains high for women.  
 
Most cocaine users smoke crack cocaine, though 
some use powder cocaine. Only injection drug users 
(IDUs) who combine cocaine and heroin (“ speed-
ball” ) use cocaine intravenously. Younger users 
smoke cocaine exclusively. Polydrug use is also 
evident in the treatment data. The reported use of 
marijuana, heroin, and methamphetamine in addition 
to cocaine suggests this trend will likely continue. 
 
Cocaine use varies by area, and the drug is primarily 
used in urban areas.  
 
Heroin 
 
Heroin consistently appears in all indicators. Heroin 
ED mentions rose steadily through 2000 and 
increased more than 20 percent from 2000 to 2001. 
ED mentions for the 18– 25 and 26– 34 age groups 
had significantly increased in the recent reporting 
periods, while mentions dropped for 12– 17-year-olds 
between 2000 and 2001, although not significantly. 
The increase in heroin mentions among all age 
groups indicates the wide availability of this drug in 
this MSA. The three top reasons for seeking medical 
intervention were overdose, withdrawal, and 
unexpected reaction.  
 
Heroin-related deaths reported by the St. Louis 
City/County ME peaked in 1997 and leveled off in 
recent years. In 2000, there were 55 heroin-related 
deaths (exhibit 1a). Statewide heroin deaths due to 
overdose alone were not much higher, because heroin 
purity is higher in the St. Louis area than in other 
cities in Missouri. Many of these heroin deaths may 
have resulted from increased purity levels, although 
DMP data show a peak of 24 percent purity in 1998 
and a drop to 13.4 percent in 2001. For the first time, 
more heroin deaths occurred in St. Louis County than 
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in the inner city; these deaths are interpreted to 
support the trend that heroin use is increasing in the 
suburbs. 
 
While heroin treatment admissions increased 
dramatically between 1996 and 2000, admissions 
leveled off in 2001 and in the first half of 2002. 
Limited slots for admissions to State-funded meth-
adone or modified medical detoxification programs 
exist in Missouri, which may influence this data. 
When queried, private treatment programs stated that 
10−25 percent of their admission screens were for 
heroin abuse, but admission depended on “ ability to 
pay.”  Thus, many heroin abusers in need of treatment 
were referred to State-supported programs or “ private 
pay”  methadone programs. Rapid detoxification, 
using naltrexone (Depade, ReVia), is still a treatment 
option at private hospitals, but it is expensive. About 
36 percent of heroin admissions were younger than 
25. Of all heroin admissions, 42 percent reported 
smoking or intranasal use as the primary method of 
administration. Young users reported a fear of need-
les as a reason for alternative methods of admin-
istration. The increased availability of consistent, 
higher purity heroin has led to a wider acceptance of 
the drug in social circles. One of the reasons for its 
acceptance is that it does not have to be injected to 
get the desired effects. If the purity decreases 
significantly, many users will have to snort or inject 
heroin to get high. 
 
A steady supply of Mexican heroin remains 
available. The DEA’s DMP purchased equal 
quantities of heroin on both the north and south sides 
of the city, indicating wider market availability. 
Historically, heroin purity has fluctuated by area and 
over time, with varying availability. In the past 2 
years, purchase purities ranged from 4 to 70 percent, 
with an average of 15 percent (exhibit 1b). 
 
Most heroin is purchased in aluminum foil. In 
addition, it is sold in bundles (one-tenth-gram 
packages of heroin in plastic wrap and aluminum foil 
known as “ bindles” ) for $40 (exhibit 1b). The 
number-5 gel capsule is also available. Most 
available heroin is dark brown or black tar and of 
consistent quality and availability. Mexican heroin is 
generally the only type available.  
 
Heroin cost $3.53 per milligram in the most recent 
DMP analysis, making heroin in St. Louis some of 
the most expensive in the country. The city is an end-
user market and is dependent on transportation of the 
heroin from points of entry into the Midwest. The 
wholesale price remains at $250– $600 per gram. On 
street corners, heroin sells for $250 per gram. Most 
business is handled by cellular phone, which has 
decreased the seller’s need to have a regular location, 
thus reducing the risk of being arrested. In St. Louis 
and other smaller urban areas, heroin is sold by small 
distribution networks, as well as by many small 
entrepreneurs. Wide sampling of the available drug 
quality can be difficult because identification is more 
difficult in this compact, free enterprise distribution 
pattern.  
 
Kansas City’s heroin supply differs from that of St. 
Louis. Most heroin in Kansas City is black tar and is 
consistently of poor quality (less than 10 percent 
pure). The gram price for this poorer quality heroin is 
about the same as the gram price for higher purity 
heroin in St. Louis. The supply has been consistent 
during the last 6 months, and a $10-bag of heroin is 
available. Heroin has also become available in the 
smaller, more rural cities of Springfield and Joplin, 
each of which has a small IDU population using 
heroin and methamphetamine. 
 
Other Opiates/Narcotics 
 
OxyContin (a long-lasting, time-release version of 
oxycodone) abuse remains a concern for treatment 
providers and for law enforcement. Prescription 
practices are closely monitored for abuse and isolated 
deaths have been reported, but no consistent reports 
are available on the magnitude of this potential 
problem. It is the most frequently stolen drug in 
pharmacy robberies and costs $40 for an 80-
milligram tablet on the street (exhibit 1b). Although a 
small number of treatment admissions reflect other 
opiates, they continue to represent less than 1 percent 
of all treatment admissions. Oxycodone ED mentions 
have increased significantly between 2000 and 2001, 
as have methadone and morphine ED mentions.  
 
The use of hydromorphone (Dilaudid) remains 
common among a small population of White chronic 
addicts. The drug costs $45– $75 per 4-milligram pill. 
Abuse of oxycodone (Percocet and Percodan) by 
prescription is growing in popularity.   
 
Marijuana 
 
The rate of ED marijuana mentions per 100,000 
population increased steadily from 37 in 1995 to 101 
in 2001. ED marijuana mentions rose from 1,640 in 
1999 to 2,311 in 2001 (exhibit 1a). St. Louis ranks 
third in ED visits among the 21 CEWG cities. 
 
Treatment admissions more than doubled from 1997 
(1,573 admissions) to 2001 (3,210 admissions) and 
appear to be holding stable for 2002. Marijuana, 
viewed by young adults as acceptable to use, is often 
combined with alcohol. The younger-than-26 age 
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group accounted for 66 percent of primary marijuana 
treatment admissions in the first half of 2002. 
 
Because of the heroin, cocaine, and methamphet-
amine abuse problems and the recent “ club drug”  
scare in St. Louis, law enforcement officials have 
focused less attention on marijuana abuse. Limited 
resources require establishing enforcement priorities. 
Often, probation requires participation in treatment 
for younger users who do not identify themselves as 
drug dependent. As a potential gateway drug to more 
serious drug abuse, marijuana is being seriously 
targeted in local prevention efforts and in the 
educational system.  
 
Marijuana is available from Mexico or domestic 
indoor growing operations. Indoor production makes 
it possible to produce marijuana throughout the year. 
Therefore, law enforcement officials have been 
focusing more attention on indoor growing 
operations. In addition to the Highway Patrol 
Pipeline program, which monitors the transportation 
of all types of drugs on interstate highways, 
Operations Green Merchant and Cash Crop identify 
and eradicate crops. Much of the marijuana grown in 
Missouri is shipped out of the State. 
 
Stimulants 
 
Methamphetamine, along with alcohol, remains a 
primary drug of abuse in both the outlying rural areas 
and statewide (because most of Missouri, outside of 
St. Louis and Kansas City, is rural). The rate of ED 
methamphetamine mentions was 5 per 100,000 
population in St. Louis in 2001 (exhibit 1a). The 
number of ED methamphetamine mentions increased 
56 percent, from 104 in 1999 to 162 in 2000, but 
dropped 29 percent to 115 in 2001. Most of the 
mentions in 2001 involved males (73 percent), and all 
were White.  
 
Methamphetamine (“ crystal”  or “ speed” ) was found 
at very low levels in city indicators in 1995, but 
reported use increased in the last 4 years. In rural 
areas, methamphetamine appears regularly in the 
treatment data, but there are a limited number of 
admissions in St. Louis. Methamphetamine has been 
identified as a problem in all parts of the State. The 
urban, street-level distributors in St. Louis deal in 
cocaine, so amphetamine use is not as widespread in 
the St. Louis area. Cocaine and methamphetamine 
use are split along racial lines in the State. While the 
number of methamphetamine treatment admissions 
was still relatively low in St. Louis (177 for 2000 and 
430 in 2001), in rural treatment programs meth-
amphetamine was the drug of choice after alcohol. To 
further support this difference between St. Louis and 
the rest of the State, a Drug and Alcohol Services 
Information System (DASIS) report showed a state-
wide admissions rate change from 7.0 per 100,000 
population in 1993 to 69.0 in 1999, an 873-percent 
increase. 
 
In 2000, methamphetamine was also detected in a 
few ME cases in the St. Louis metropolitan area.  
 
The Midwest Field Division of the DEA increased its 
cleanup of clandestine methamphetamine labs to 
about 200 in 1999 and 250 in 2000. The intensity of 
these law enforcement efforts is based on the 
availability of funds for local police departments to 
clean up box labs under Community Oriented Pol-
icing Service (COPS) funding. Thefts of anhydrous 
ammonia are being monitored in rural areas. In 2001, 
the Missouri Highway Patrol reported 2,137 seizures 
of methamphetamine labs, dumpsites, and locations 
of inactive labs occurred in Missouri, ranking it 
ahead of California, Washington, and Kansas. 
 
Locally produced methamphetamine purity fluctuated 
between 70 and 80 percent, while methamphetamine 
from Mexico was only 20 to 30 percent pure (exhibit 
1b). In the new methamphetamine scene, Hispanic 
traffickers, rather than the old network of motorcycle 
gangs, are the predominant distributors, although 
individual entrepreneurs are also involved. Shipments 
from super labs in the Southwest are trucked in via 
the interstate highway system. Methamphetamine 
shipments have been seized in the interstate Highway 
Patrol Pipeline program, with purity ranging from 20 
to 30 percent. Methamphetamine sells for $700–
$1,300 per ounce in St. Louis and for as little as $37–
$100 per gram in some areas. 
 
Use of methamphetamine and its derivatives has 
become more widespread among high school and 
college students, who do not consider these drugs as 
dangerous as others. Because methamphetamine is so 
inexpensive and easy to produce, it is likely that its 
use will continue to spread. Competition between 
those who import methamphetamine from Mexico 
and those who locally produce it is likely to affect 
both price and purity. 
 
Depressants  
 
DAWN ED data reflect few mentions in this category 
in 2001, except for diazepam (n=202), lorazepam 
(119), and alprazolam (418). These rates are not 
significantly different from in prior years.  
 
Private treatment programs often provide treatment 
for benzodiazepine, antidepressant, and alcohol 
abusers. Day hospital programs and 3-day detox-
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ification have become the treatments of choice for 
individuals who abuse these substances. Since many 
of the private treatment admissions are polysubstance 
abusers, particular drug problems are not clearly 
identified.  
 
Hallucinogens 
 
Over the years, lysergic acid diethylamide (LSD) has 
sporadically reappeared in local high schools and 
rural areas. Blotters sell for $2– $4 per 35-microgram 
dose (exhibit 1b). Much of this LSD is imported from 
the Pacific coast. DAWN data show a steady increase 
of LSD ED mentions from 1997 (19) to 2000 (74), 
but a drop to 52 in 2001. 
 
PCP has been available in limited quantities in the 
inner city and has generally been used as a dip on 
marijuana joints. While PCP is not seen in quantity, it 
remains in most indicator data, including ED men-
tions, police exhibits, and as a secondary drug in ME 
data. Most of the users of this drug in the inner city 
are African-American. PCP ED mentions increased 
significantly from 2000 to 2001 for females and for 
those age 18– 25 and 35– 44. However, the total num-
ber of mentions remains relatively low at 110. 
 
Club Drugs 
 
DAWN ED data show few mentions of methylene-
dioxymethamphetamine (MDMA) (55 in 2001). Of 
these mentions, 55 percent were female and 78 
percent were White. No mentions of ketamine or 
GHB were noted, although younger users report these 
drugs are available. Stimulants noted in the city have 
included methylenedioxyamphetamine (MDA) and 
MDMA (“ ecstasy,”  “ XTC” ). MDMA is readily 
available at raves and other dance parties and sells for 
$20– $30 per tablet. The rave scene has become quite 
popular in St. Louis. Most ecstasy users are teenagers 
or young adults. While reported use of MDMA or 
“ X”  in high school students is frequent, no indicator 
quantifies use in this age group.  
 
Toxicology reports showing high levels of ecstasy are 
rare. Most of the reports about high levels of MDMA 
abuse are anecdotal or are part of a polydrug user’s 
history. Public treatment programs report no admis-
sions for MDMA. The private treatment programs 
that were queried report MDMA as part of a polydrug 
abuser’s history or in less than 2 percent of their 
treatment admissions.  
 
A local researcher reports that hepatitis C is at high 
levels among a cohort of known MDMA users. This 
hepatitis rate may be due to the polydrug use history 
of these participants. 
Dr. Linda Cottler has conducted key informant inter-
views with several high school and college students 
to gather data on club drugs in St. Louis. A survey of 
1,250 students from one suburban St. Louis high 
school showed that 30 percent of the students stated 
someone had approached them offering ecstasy. Dr. 
Cottler’s research group is investigating use further 
and is using focus group interviews with users and 
professionals to gather data. 
 
Gamma hydroxybutyrate (GHB) use has increased in 
the St. Louis area. Because it is a depressant, its use 
with alcohol and its unpredictable purity present 
users with major health risks. No recent deaths have 
been reported from this “ date-rape”  drug. GHB is 
often sold in nightclubs for $5 per capful or $40 per 
ounce. GHB education efforts are directed towards 
ED personnel, who often see the users initially. Ket-
amine (“ Special K” ), a veterinary anesthetic, is 
known for its hallucinogenic effects. An increase in 
ketamine robberies from veterinary offices has been 
reported. Use of ketamine has been acknowledged 
anecdotally. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
Seropositivity among IDUs remained low in St. 
Louis. However, it increased among sexual partners 
of individuals practicing high-risk modes of ex-
posure. The largest increase was found among young 
African-American females, who were infected 
through heterosexual contact, and young African-
American males. As a result, increased specialized 
minority prevention efforts have been initiated.  
 
Of the total 2,028 HIV-positive cases identified 
through November 2001, 7 percent were IDUs and 4 
percent involved men who have sex with men 
(MSM) and are also IDUs (exhibit 2).  
 
Cumulative acquired immunodeficiency syndrome 
(AIDS) cases totaled 3,974 through November 2001 
(exhibit 3). Of these cases, 2 percent were IDUs and 
2 percent were MSM/IDUs. The reported AIDS and 
HIV-positive cases continued to be represented 
primarily by MSMs. The number of infected African-
Americans was increasing disproportionately among 
males and females.  
 
SPECIAL PROJECTS AND RELATED HEALTH ISSUES 
 
STD Rate 
 
St. Louis had a syphilis epidemic in 1993 and 1994. 
In 2000, St. Louis ranked eighth in the Nation for 
syphilis cases. In 2001, the city dropped to 51st in the 
number of identified syphilis cases. St. Louis ranks 
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third for gonorrhea, with cases remaining at 
approximately 1,000 per year, and second for 
chlamydia. Risk-reduction activities have traditionally 
had limited effects on the recidivism rates with STD 
cases, leading to the evaluation of harm-reduction 
models. Recent research has also focused on the 
attributes of the risk taker rather than the method of 
risk reduction delivery. The increase in heterosexual 
transmission is a concern for public health officials. 
Further research is needed on ways to effect sustained 
behavior change. 
 
HIV Research 
 
Saint Louis University has continued research on 
HIV prevention vaccines. Most of the prevention 
vaccine trials have been Phase I trials in low-risk 
individuals. Two Phase II trials using a mixture of 
HIV risk groups and one Phase III trial have been 
undertaken to date. Plans for another Phase III trial 
were scuttled after poor laboratory assay results made 
progression with the current vaccine not feasible.  
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Exhibit 1a. Combined Indicators for Cocaine, Heroin, Marijuana, and Methamphetamine in 
St. Louis:  19961H2002 
 
Indicator Cocaine Heroin Marijuana Methamphetamine 
Deaths (N)     
 1996 93 51 NA 9 
 1997 43 67 NA 11 
 1998 47 56 NA 9 
 1999 51 44 NA 4 
 2000 66 55 NA 4 
DAWN ED Data     
 Number of mentions (2001) 3,080 1,309 2,311 115 
 Percent change (2000−2001) +281 +211 +311 -291 
 Rate per 100,000 pop. (2001) 134 57 101 5 
 5-year trend  Doubled Tripled Doubled Almost doubled 
 
 Gender of mentions (%) (2001) 
• Male 
• Female 
 
 
62.2 
37.2 
 
 
54.8 
41.2 
 
 
61.7 
37.6 
 
 
73.0 
27.0 
 
 Age (%) (2001) 
•  12–17 
•  18–34 
• 35 and older 
 
 
1.3 
41.1 
57.6 
 
 
1.5 
54.9 
43.5 
 
 
8.6 
56.7 
34.7 
 
 
7.8 
60.9 
30.4 
 
Route of Administration (%) (2000) 
• Smoking 
• Intranasal 
• Injection 
• Unknown/other 
 
 
62.3 
25.9 
7.0 
4.8 
 
 
6.4 
22.2 
71.5 
– 
 
NA 
 
 
18.8 
15.6 
46.9 
18.8 
Treatment Admissions Data     
 Illicit drug admissions (%) (2001) 36.5 12.4 27.7 7.5 
 Illicit drug admissions (%) (1H 2002) 33.6 10.8 29.6 4.2 
 
 Gender (%) (1H 2002) 
• Male 
• Female 
 
 
55.8 
44.2 
 
 
63.7 
36.3 
 
 
75.5 
24.5 
 
 
54.3 
45.7 
 
 Age (%) (1H 2002) 
•  12–17 
•  18–25 
•  26–34 
•  35 and older 
 
 
0.3 
6.3 
27.3 
66.1 
 
 
0.8 
34.9 
25.6 
38.6 
 
 
25.5 
40.1 
20.3 
14.1 
 
 
4.4 
32.6 
36.5 
26.5 
 
 Race/Ethnicity (%) (1H 2002) 
• White 
• African-American 
• Hispanic 
 
 
25.1 
74.1 
0.6 
 
 
39.0 
59.9 
0.8 
 
 
43.1 
56.0 
0.9 
 
 
99.2 
0.4 
0.4 
 
 Route of Administration (%) 
 (1H 2002) 
• Smoking 
• Intranasal 
• Injecting 
 
 
 
89.8 
5.6 
1.6 
 
 
 
3.2 
37.4 
54.8 
 
 
 
95.6 
0.3 
0.1 
 
 
 
45.2 
18.7 
30.0 
 
1
 Not significant 
 
SOURCES:  SAMHSA Website, TEDS database, DEA, client ethnographic information
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Exhibit 1b. Combined Indicators for Cocaine, Heroin, Marijuana, and Methamphetamine in 
St. Louis: 19961H2002 
 
Indicator Cocaine Heroin Marijuana Methamphetamine 
and Other Drugs 
Multisubstance Combinations Older users combine 
with heroin, alcohol 
Older users combine 
with cocaine, alcohol 
Joints dipped in PCP Marijuana commonly 
used in combination 
Market Data (1H2002) HCL $100–$125/g, 
77% pure; Crack 
$20/rock, 50–90% 
pure 
$10/cap, $40/bindle, 
$3.53/mg, $250–
$600/g, 15% pure, 
Mexican heroin 
Sinsemilla $500–
$1,200/Ib, 20% THC; 
Imported 
$2,000−$4,000/Ib 
Meth $37-$100/g, 
Mexican (20-30%) 
and local (70-80% 
purity); 
hydromorphone $40–
$70/4-mg pill; LSD 
blotters $2–$4/35 
microgram, oxycontin 
$40/80 mg 
Qualitative Data Readily available, 
urban choice 
Younger users, 1/3 
<25 
Readily available, 2/3 
in Tx < 25 
Club drug gaining 
presence, 
rural/suburban 
users–amphet. 
Other Data of Note NR NR NR Meth lab seizures 
plateaued 
 
SOURCE:  SAMHSA Website, TEDS database, DEA, client ethnographic information 
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Exhibit 2. HIV-Positive Test Results in the St. Louis Metropolitan Area by Exposure Category,  
  Gender, Race/Ethnicity, and Age: Year-to-Date and Cumulative Totals Reported  
  Through November 2001 
 
HIV-Positive Test Results 
Jan 2001–November 2001 Cumulative Through November 2001 Category 
Number (Percent) Number (Percent) 
Exposure category     
Men/sex/men (MSM) 56 (30.0) 1,272 (63.0) 
Injection drug user (IDU) 6 (3.0) 137 (7.0) 
IDU and MSM 1 (1.0) 74 (4.0) 
Hemophilia 0 (0.0) 11 (1.0) 
Heterosexual 28 (15.0) 320 (15.0) 
Blood transfusion 1 (1.0) 5 (0.0) 
Perinatal 0 (0.0) 12 (1.0) 
Unknown 96 (50.0) 197 (9.0) 
Gender and race/ethnicity     
Male     
• White 55 (29.0) 756 (38.0) 
• African-American 77 (41.0) 880 (43.0) 
• Hispanic 2 (1.0) 17 (1.0) 
• Other 0 (0.0) 19 (1.0) 
• Unknown 7 (4.0) 13 (1.0) 
Female     
• White 7 (4.0) 65 (3.0) 
• African-American 37 (19.0) 271 (13.0) 
• Hispanic 0 (0.0) 2 (0.0) 
• Other 3 (2.0) 5 (0.0) 
Age     
<13 1 (1.0) 14 (1.0) 
13−19 2 (1.0) 108 (5.0) 
20−29 14 (7.0) 676 (33.0) 
30−39 20 (11.0) 733 (36.0) 
40−49 14 (7.0) 277 (14.0) 
50+ 2 (1.0) 71 (4.0) 
Unknown 135 (72.0) 149 (7.0) 
Total 188  2,028  
 
SOURCE: St. Louis Metropolitan AIDS Program
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Exhibit 3. AIDS Cases in the St. Louis Metropolitan Area by Exposure Category, Gender,  
  Race/Ethnicity, and Age:  Year-to-Date and Cumulative Totals Reported Through  
  November 2001 
 
AIDS Cases 
Jan. 2001Nov. 2001 Cumulative Through November 2001 Category 
Number (Percent) Number (Percent) 
Exposure category     
Men/sex/men (MSM) 65 (38.0) 1,040 (26.0) 
Injection drug user (IDU) 12 (7.0)  85 (2.0) 
IDU/MSM 4 (2.0)  61 (2.0) 
Hemophilia 0 (0.0) 29 (1.0) 
Heterosexual 27 (16.0) 151 (4.0) 
Blood transfusion 0 (0.0) 20 (1.0) 
Perinatal 0 (0.0) 0 (0.0) 
Unknown 61 (37.0) 2,588  (65.0)  
Gender and race/ethnicity     
Male     
• White 47 (28.0) 1,984 (50.0) 
• African-American 88 (52.0) 1,531 (39.0) 
• Hispanic 0 (0.0) 39 (1.0) 
• Other 2 (1.0) 12 (0.0) 
• Unknown 0 (0.0) 0 (0.0) 
Female     
• White 7 (4.0) 95 (2.0) 
• African-American 24 (14.0) 306 (8.0) 
• Hispanic 0 (0.0) 4 (0.0) 
• Other 1 (1.0) 3 (0.0) 
Age     
<13 1  (1.0) 17 (0.0) 
13−19 3 (2.0) 28 (1.0) 
20−29 26 (15.0) 539 (14.0) 
30−39 71 (42.0) 1,220 (31.0) 
40−49 50 (30.0) 567 (14.0) 
50+ 17 (9.0) 200 (5.0) 
Unknown 1 (1.0) 1,403 (35.0) 
Total 169  3,974  
 
SOURCE:  St. Louis Metropolitan AIDS Program 
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Indicators of Drug Abuse in San Diego County 
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ABSTRACT 
 
From 2000 to 2001, indicators of drug abuse were 
mixed. Total accidental overdose deaths declined 
slightly, from 237 to 220 during that period, and that 
decline was reflected in a decline in such deaths for 
cocaine, heroin, and methamphetamine. Total emer-
gency department (ED) mentions also declined (from 
1,002 in 2000 to 812 in 2001), and most of the 
individual drug mentions decreased as well. Mari-
juana ED mentions, however, increased significantly 
during that time period. Total treatment admissions 
increased by 17 percent between 2000 and 2001, and 
increased admissions were found among all major 
drug categories. Black tar continued to be the dom-
inant form of heroin available in the county and it 
was widely available. Between 2000 and 2001, 
methamphetamine prices declined, while purity in-
creased slightly. The use of club drugs, such as GHB, 
MDMA, and ketamine, continued to be reported by 
the media.  
 
INTRODUCTION 
 
Area Description 
 
San Diego County is located in the southwestern corner 
of California and is bordered by the Pacific Ocean to 
the west, Mexico to the south, desert to the east, and a 
mountain range and a major military base to the north. 
Within San Diego County, there are many sparsely 
populated rural areas used for cultivating marijuana and 
manufacturing methamphetamine. Geographic con-
ditions also contribute to illegal drug smuggling. 
 
In 2001, there were an estimated 2.9 million inhab-
itants. At 60 percent, Whites still constitute the 
majority of the population, with Hispanics accounting 
for 25 percent, African-Americans 6 percent, and Asian 
minority groups 10 percent. The median age is 33.6 
years, and the overall population is aging. Whites, with 
a median age of 38.1, are the oldest group. Hispanics 
have the lowest median age at 25.3 years, with African-
Americans following closely at 27.3 years. 
 
Data Sources 
 
This report presents available data from 1994 through 
2001, unless otherwise noted.  
 
Data compiled for this report are from the following 
sources: 
 
• Accidental overdose death data were provided by 
the San Diego County Medical Examiner (ME) for 
1994– 2001. Limitation: Marijuana is not included. 
 
• Emergency department (ED) drug mentions data 
were derived from the Drug Abuse Warning Net-
work (DAWN), Office of Applied Studies, Sub-
stance Abuse and Mental Health Services Admin-
istration (SAMHSA), for 1994– 2001.  
 
• Treatment admissions data were provided by the 
San Diego County Alcohol and Drug Data System 
(SDCADDS), 1994– 2001. Limitations: The system 
is an admission-based data set; individuals can 
account for multiple admissions; and local meth-
adone programs under private administration are not 
included, deflating total opiate admissions.  
 
• Arrestee drug testing data were derived from the 
Arrestee Drug Abuse Monitoring (ADAM) pro-
gram, Criminal Justice Research Unit, San Diego 
Association of Governments (SANDAG), 1994–
2001. Limitations: Alcohol is not included. Also, 
the adult male sample from 2000 onward was based 
on probability sampling and is not comparable to 
adult female or juvenile data, which are based on 
other sampling and data collection procedures. 
 
• Drug price and purity data were provided by the 
Narcotics Information Network, March 2002. 
 
• Acquired immunodeficiency syndrome (AIDS) 
data were derived from the San Diego County 
Health and Human Services Agency, “ Definitive 
and Presumptive AIDS Cases Surveillance Survey,”  
October 30, 2002. 
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DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
From 2000 to 2001, three indicators of cocaine use 
decreased or remained relatively stable, and one 
treatment admission increased. Over the 8-year span, 
1994– 2001, cocaine indicators tended to decrease. The 
exceptions were primary cocaine treatment admissions, 
which were unchanged, and ED mentions, which 
increased, but not significantly (exhibit 1).  
 
In 2001, cocaine was detected in 28 of the 220 
accidental overdose deaths, compared with 58 in 2000 
and 54 in 1994. The 28 deaths in 2001 represented 13 
percent of total accidental overdoses and a 52-percent 
decrease from 2000. Cocaine was rarely the only drug 
found in the decedent; common combinations were 
heroin and/or alcohol. The typical cocaine overdose 
case was male (86 percent), White (71 percent), and 
between the ages of 36 and 45 (82 percent). Although 
African-Americans represented only 18 percent of all 
cocaine overdose deaths, that proportion was much 
higher than African-American representation in the 
general population (6 percent). African-Americans 
continued to be overrepresented in all indicators for 
cocaine. 
 
There were 812 cocaine ED mentions in 2001, 
compared with 1,002 in 2000, a 19-percent decrease. 
The 667 cocaine mentions in 1994 did not represent a 
significant difference from the 2001 figure. Cocaine 
mentions accounted for nearly 7 percent of total 2001 
ED mentions, decreasing from 9 percent in 2000. Over 
the entire 8-year period under discussion, cocaine 
ranged from 7 to 9 percent of all ED mentions. In 2001, 
males accounted for 62 percent of cocaine mentions; 
Whites accounted for 52 percent, African-Americans 
for 27 percent, and Hispanics for 5 percent. When 
asked about motive for use, 43 percent cited 
dependence; 44 percent reported that the reason for the 
ED visit was chronic effects of cocaine. As with 
overdose deaths, cocaine ED mentions were seldom 
single-drug episodes: nearly three-quarters (72 percent) 
of these mentions were multiple drug episodes.  
 
Within the treatment population, individuals reporting 
cocaine as the primary drug used increased from 1,300 
in 2000 to 1,469 in 2001, a 13-percent increase. From 
1994 to 2001, however, the number of admissions was 
unchanged. As a percentage of total admissions, 
cocaine was static at 9 percent in 2000 and 2001. A 
typical cocaine admission in 2001 was African-
American (62 percent) and male (60 percent) with a 
mean age of 37.2. Eighty-five percent of the primary 
cocaine admissions in 2001 reported smoking as the 
preferred mode of use. Sixty-six percent used drugs 
other than cocaine, primarily alcohol. Forty-four 
percent were referred by the criminal justice system, 
and 92 percent reported one or more past arrests.  
 
Cocaine-positive adult arrestees in the ADAM program 
continued to decline in 2001. The proportion of males 
positive for cocaine use fell from 15 percent in 2000 to 
13 percent in 2001. The proportion of adult females 
who showed recent use of cocaine fell from 26 percent 
in 2000 to 17 percent in 2001. One percent of juvenile 
arrestees tested positive for cocaine in 2001. In the first 
half of 2002, 11 percent of adult males, 23 percent of 
adult females and 3 percent of juveniles tested positive 
for cocaine. The 2002 data should be considered 
provisional. 
 
Cocaine’s price and availability remained unchanged 
from the June CEWG reporting period. Rock cocaine 
could be purchased for $10 for one-tenth of a gram. 
The gram price ranged from $40 to $80, with purity 
levels ranging from 68 to 72 percent. 
 
Seizures at the southwest border increased.  
 
Heroin 
 
Heroin indicators appeared to be mixed. From 2000 to 
2001, there were minor increases in treatment 
admissions and opiate-positive tests among adult 
arrestees but decreases in deaths and ED mentions 
(exhibit 3).  
 
In 2001, heroin was detected in less than one-half (47 
percent) of accidental overdose deaths, the lowest level 
of any period since 1994. From 2000 to 2001, heroin’s 
presence in accidental overdoses decreased 17 percent, 
and from 1994 to 2001, there was a 13-percent 
decrease. The majority of decedents in whom heroin 
was detected were White (63 percent), male (83 
percent), and age 35 or older (77 percent). 
 
There were 733 ED mentions of heroin in 2001, 
representing a 29-percent decrease from 2000. The 2001 
mentions represented 6 percent of total ED mentions for 
that year, compared with 9 percent in 2000. The majority 
of ED patients who reported heroin were male (68 
percent) and White (60 percent). Nearly one-third (31 
percent) were age 45 or older. When asked the motive 
for using heroin, 80 percent cited dependence; 59 percent 
reported chronic effects as the reason for the visit to the 
ED. Surprisingly, 76 percent of the 2001 heroin ED 
mentions represented single-drug episodes. 
 
Treatment admissions for heroin as the primary drug 
increased 3 percent from 2000 to 2001, when there 
were 1,493 such admissions. As a percent of total 2001 
admissions, heroin accounted for 9 percent, 2 percent 
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less than in 2000. When total numbers for 1994 and 
2001 are compared, heroin admissions decreased 17.5 
percent, perhaps as the result of the closure of the only 
county-funded methadone program. In 2001, the typical 
heroin admission was White (54 percent) or Hispanic 
(34 percent), male (66 percent), had a median age of 
35, and had been using heroin for 15 years. The 
majority of heroin users in treatment reported injection 
as the major means of use (88 percent). Another 8 
percent reported smoking, and 2 percent reported 
snorting the drug. Two-thirds reported secondary drug 
use: 26 percent cited a preference for cocaine, 19 
percent for methamphetamine, and 13 percent for 
alcohol. More than one-half were referred to treatment 
by the criminal justice system, and 67 percent entered 
treatment under some type of legal sanction. Ninety-
four percent had at least one prior arrest; 41 percent 
reported having nine or more arrests.  
  
Eight percent of adult male and 9 percent of adult female 
arrestees tested positive for opiates in 2001. Despite 
ongoing accounts of increased juvenile heroin use, few 
juvenile arrestees tested opiate-positive in the San Diego 
ADAM study. In 2001, opiates were detected in only 1 
percent of the juvenile arrestees tested. 
 
There was no new information on heroin price and 
purity. In March 2002, the Narcotics Information 
Network reported that black tar continued to be the 
dominant form of heroin in the county and was widely 
available. Purity levels ranged from 12 to 60 percent in 
gram quantities and were as high as 70 percent in larger 
quantities. Quantities as small as .02 to .05 grams could 
be purchased for $5 to $16. 
 
Marijuana 
 
Most marijuana indicators increased in 2001. The only 
decrease was in marijuana-positive tests among adult 
males participating in the ADAM program (exhibit 3). 
 
The ME does not routinely test for marijuana, so there 
are no data for that measure. However, there has been 
some discussion about the feasibility of including 
marijuana in the panel of tests. 
 
In 2001, there were 1,107 marijuana ED mentions, 
compared with 955 in 2000, a 16-percent increase. 
From 1994 to 2001, marijuana mentions increased 116 
percent, rising from 512 to 1,107. Since 1997, 
marijuana has accounted for 8 or 9 percent of total 
mentions in all time periods so, in that respect, there 
was remarkable stability. In 2001, the typical marijuana 
ED mention was White (62 percent), male (68 percent), 
and was likely to be between the ages of 18 and 34 (49 
percent). Nearly one-half of the 2001 mentions 
involved psychic effects as the motive for using mari-
juana; one-third came to the ED because of unexpected 
reaction to the drug. Another 30 percent reported 
chronic effects as the reason for coming to the hospital. 
 
Treatment admissions for primary marijuana use con-
tinued to increase within the county’s treatment system. 
In 2001, there were 3,143 marijuana admissions, more 
than for heroin and cocaine combined. This number 
represented 19 percent of total admissions. From 1994 
to 2001, primary marijuana admissions increased a 
remarkable 442 percent. As was reported earlier, most 
of the increase can be accounted for by the county’s 
continued emphasis on treatment-on-demand for 
adolescents. Consequently, the majority of 2001 
marijuana admissions were young. The majority of 
marijuana admissions in 2001 were male (68 percent), 
with Whites representing 43 percent of these admis-
sions, African-Americans 16 percent, and Hispanics 32 
percent. Slightly more than two-thirds were younger 
than 18 at admission. Another 10 percent were between 
the ages of 18 and 21. Sixty-eight percent of these 
clients reported secondary drug use; 43 percent cited 
secondary alcohol use, and 16 percent cited meth-
amphetamine use. Nearly 75 percent were referred to 
treatment by the criminal justice system; only 13 
percent reported no prior arrests. Marijuana use was a 
relatively recent activity for these admissions; the mean 
years of use reported was 6.9. 
 
Within the arrestee population, marijuana was the most 
frequently detected drug among adult males and 
juveniles and was second only to methamphetamine for 
adult females. In 2001, 36 percent of adult males, 45 
percent of juveniles, and 28 percent of adult females 
were positive for marijuana. Marijuana continued to be 
the drug most often detected among San Diego juveniles.  
  
Marijuana pound prices decreased from 2000 to 2001, 
falling from a range of $400 to $310.  
 
Stimulants 
 
Methamphetamine overdose deaths and ED mentions 
declined between 2000 and 2001, but treatment 
admissions increased during that period (exhibit 4). In 
2001, methamphetamine was detected in only 48 (22 
percent) accidental overdose deaths. The majority of 
these decedents in 2001 were White (65 percent) and 
male (78 percent). More than three-quarters (79 
percent) were between the ages of 36 and 45.  
 
ED mentions for methamphetamine and amphetamines 
combined were estimated at 1,641 in 2000 and 1,615 in 
2001. Mentions for methamphetamine (and ampheta-
mines) represented 14 percent of total ED mentions in 
2001, as in 2000. The number of amphetamine ED 
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mentions increased significantly from 1994 to 2001 (from 
381 to 942), while methamphetamine mentions increased 
significantly from 1999 to 2001 (from 584 to 673).  
 
Treatment admissions for methamphetamine increased 
from 4,251 in 1999 to 4,507 in 2000, to 5,725 in 2001. 
Methamphetamine continued to be the most frequently 
reported primary drug among treatment admissions, 
with alcohol a close second. From 1994 to 2001, 
methamphetamine admissions increased 59 percent. In 
2001, the typical primary methamphetamine admission 
was White (59 percent) and male (51 percent). 
Hispanics, at 25 percent, were overrepresented. Forty 
percent were between the ages of 26 and 35. More than 
one-half (57 percent) smoked the drug, 22 percent 
snorted, and 19 percent reported injection as the 
primary route of administration. Sixty-one percent 
reported secondary drug use, and the most common 
secondary drug was marijuana. More than one-half 
were referred by the criminal justice system, and 90 
percent had been arrested at least one time. A majority 
(63 percent) reported prior experience with treatment. 
 
Within the arrestee population, 32 percent of adult 
males, 37 percent of adult females, and 11 percent of 
juveniles tested positive for methamphetamine in 2001.  
 
Methamphetamine prices rose slightly from March 
2001 to March 2002. The price of an “ eightball”  (one-
eighth ounce) increased from $100 to $110– $130 
during that period, while the price for one-quarter 
ounce increased from $150– $200 to $150– $400. Pound 
prices showed more variability, with the range 
changing from $4,500– $9,500 to $3,500– $11,500. 
Purity levels showed a wide variance, from 30– 40 
percent average purity at the gram level to as high as 
93– 97 percent for high-grade methamphetamine in 
pound quantities. 
 
Alcohol and Other Drugs 
 
Alcohol 
 
Indicators of alcohol problems were mixed in 2001. 
Alcohol was present in 96 of the 220 accidental overdose 
deaths, a 12-percent increase from 2000. ED mentions of 
alcohol combined with other drugs, however, did not 
change significantly from 2000 (1,622) to 2001 (1,660). 
As a proportion of total mentions, alcohol combinations 
were remarkably stable between 1997 and 2001, 
accounting for 15 percent in 1997, 1998, and 1999, and 
14 percent in 2000 and 2001. 
 
Primary alcohol treatment admissions were essentially 
stable from 1999 to 2001, rising from 3,915 to 4,013. 
From 1994 to 2001, primary alcohol admissions 
increased nearly 33 percent, from 3,028 to 4,013. In 
2001, the typical alcohol admission was White (66 
percent), male (69 percent), and was 35 or older (63 
percent). Nearly one-half (49 percent) reported no 
secondary drug use. Of those who did report secondary 
use, 18 percent reported marijuana and 17 percent 
reported methamphetamine. Slightly more than one-
quarter were referred by the criminal justice system, 
and 19 percent reported nine or more arrests. Two 
thirds reported a prior treatment episode, and 59 
percent had been drinking longer than 20 years. Most 
(83 percent) were unemployed. 
 
Other Drugs 
 
There continued to be media reports of the use of rave 
drugs, including gamma hydroxybutyrate (GHB), 
methylenedioxymethamphetamine (MDMA), and 
ketamine (“ K,”  “ Special K” ) in San Diego County. This 
was especially true for MDMA. Information from local 
members of the Narcotics Task Force supported the 
reports. Conversely, there was little hard evidence of 
the use of these drugs in data reports from the ME, 
ADAM, or the treatment centers, although MDMA ED 
mentions, while small in number, did increase 
significantly from 1994 to 2001 (from 6 to 52, a 767-
percent increase). There were several arrests for 
MDMA possession and use in a Del Mar nightclub, but 
there has been little additional coverage of actual 
events since then. There can be little doubt that these 
drugs are widely available in San Diego, but infor-
mation on who uses the drugs and where and how they 
are used will not be available until ethnographic studies 
are conducted. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
There were 10,612 adult, adolescent, and pediatric 
AIDS cases reported through November 30, 2000, in 
San Diego County. Of these, 54 were pediatric cases. 
Of the adult and adolescent cases, 76 percent occurred 
among men having sex with men (MSM), 9 percent 
occurred among injection drug users (IDUs), 9 percent 
occurred among the dual risk category of MSM/IDU, 4 
percent were attributable to heterosexual contact, and 2 
percent were attributable to all other causes. Transmis-
sion modes among women were very different from 
men. Most women (50 percent) acquired the disease 
through heterosexual contact, while 39 percent were 
IDUs and 11 percent acquired AIDS through other 
means. The majority of all cases were White (66 
percent), followed by Hispanics (20 percent) and 
African-Americans (12 percent).  
 
For inquiries concerning this report, please contact Michael Ann Haight, E-mail: <michaelhaight@cox.net>. 
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Exhibit 1. Cocaine Indicators for San Diego County:  1994–2001 
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Exhibit 2. Heroin Indicators for San Diego County:  1994–2001 
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Exhibit 3. Marijuana Indicators for San Diego County:  1994–2001 
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Exhibit 4. Methamphetamine Indicators for San Diego County:  1994–2001 
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Patterns and Trends of Drug Use in the San Francisco Bay Area 
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ABSTRACT 
 
Cocaine use prevalence appears to be rising again, 
after a significant decline in the late 1990s. The 
shift away from smoking crack and toward snorting 
powder persists. The former predominance of 
Blacks among users continues to ebb. Heroin use 
indicators showed a peak in 1999, followed by a 
significant decline. The average age of users con-
tinues to increase. Local street prices of heroin have 
risen considerably since 2001. Marijuana indicators 
suggest a continued increase in prevalence. Meth-
amphetamine indicators are mixed. Usage is still 
widespread, and risky injection practices among 
gay/bisexual men remain a major factor for HIV 
incidence. Incidence of new HIV infection declined 
between 1997 and 2001 for heterosexual drug 
injectors, but increased for gay male and transsex-
ual injectors. 
 
INTRODUCTION 
 
Area Description 
 
The San Francisco Bay area consists of the following 
counties: San Francisco, San Mateo, Alameda, Con-
tra Costa, and Marin. The population was 4,123,000 
as of the 2000 census. 
 
The bay area experienced its initial growth during the 
California gold rush. In the succeeding century and a 
half, it expanded greatly as a center for shipping, 
manufacturing, finance, and tourism. In recent years, 
Pacific Basin trade and high technology industries, 
such as software and biotechnology, have led to fur-
ther expansion and to a highly diversified economy. 
The population is among the most multicultural of 
any urban region of the United States, with a par-
ticularly large, varied, and long-established Asian-
American representation (19 percent of the total). 
The Hispanic population— one resident in five— rep-
resents a wide cross-section of persons of Latin 
American origin. Blacks account for some 11 percent 
of bay area residents. San Francisco County has long 
been a mecca for gays: gay men constitute more than 
15 percent of the adult male population. 
 
Since 1994, there has been a steep rise in the cost of 
rental housing in the bay area, especially in San 
Francisco, Marin, and San Mateo Counties. This has 
caused significant out-migration of lower income 
people, which may be exerting downward pressure 
on local drug-use prevalence. However, partly as a 
result of reverses in high-technology industries, San 
Francisco County suffered an increase in its unem-
ployment rate from 2 to 6 percent in the last year and 
a half. 
 
Data Sources 
 
The sources of data for the drug abuse indicators used 
in this report are described below: 
 
• Emergency department (ED) drug mentions 
data were obtained from the Drug Abuse Warn-
ing Network (DAWN), Office of Applied Studies, 
Substance Abuse and Mental Health Services 
Administration (SAMHSA), for three counties of 
the San Francisco Bay area (San Francisco, 
Marin, and San Mateo) from 1996 through 2001.  
 
• Treatment admissions data were available for 
all five bay area counties for calendar years 
(CYs) 1999– 2001 and the first 8 months of CY 
2002. These data were compiled by the Califor-
nia Department of Alcohol and Drug Programs 
(DADP). Treatment admissions data were also 
provided by the San Francisco Department of 
Public Health (SFDPH) for that county for fiscal 
years (FYs) 2001 and 2002. 
 
• Medical Examiner (ME) data on drug mentions 
in decedents in three counties (San Francisco, 
Marin, and San Mateo) were provided by the 
DAWN mortality system for CY 2000, along with 
comparable data for 1996– 1999. Demographic 
data on decedents were available for San 
Francisco County for FY 2000. The DAWN 
system covered 100 percent of the metropolitan 
statistical area (MSA) jurisdiction and 100 percent 
of the MSA population in 2000. 
 
• Reports of arrests for drug-law violations and 
counts of reported burglaries were provided by 
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the San Francisco Police Department (SFPD) for 
2001 and the first 10 months of 2002. 
 
• Arrestee drug testing data on adult males are 
from the Arrestee Drug Abuse Monitoring 
(ADAM) program, National Institute of Justice 
(NIJ), for San Jose and Sacramento for the first 
three quarters of 2001. 
 
• Price and purity data were obtained from the 
Drug Enforcement Administration (DEA), Dom-
estic Monitor Program (DMP), and referenced 
heroin “ buys,”  mostly were made in San Fran-
cisco County. Data for 2001 were compared with 
those for 1994– 2000. Data on trafficking in heroin 
and other drugs for the first quarter of 2002 were 
available from the National Drug Intelligence 
Center’s report, “ California, Drug Threat Assess-
ment Update.”  
 
• Ethnographic information was obtained through 
interviews with treatment program staff and out-
reach workers in November 2002. Their observa-
tions were compared with those they made in 
November 2001 and May 2002 and pertained 
mostly to San Francisco County. 
 
• The Party and Play Study data were derived 
from a study conducted in autumn 2000 and 
winter 2001 by the SFDPH, Acquired Immuno-
deficiency Syndrome (AIDS) Office. The sample 
consisted of 356 gay/bisexual men at “ late night”  
venues. 
 
• Hepatitis B and C data for San Francisco 
County were available for 1996 through 2001 
and for the first 46 weeks of 2002. Hepatitis C 
virus (HCV) prevalence estimates were provided 
by the SFDPH. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
Cocaine use prevalence appears to be rising again, 
after a significant decline in the late 1990s. The shift 
away from smoking crack and toward snorting pow-
der continues. The former predominance of Blacks 
among users continues to ebb. 
 
ED mentions for cocaine declined from 1996 to 1998, 
but rose back above their 1996 level by 2001 (exhibit 
1). The rate of cocaine/crack ED mentions for 2001 
was 158 per 100,000 population, 36 percent higher 
than the rate for 1998. 
 
In the five-county bay area, the overall number of 
admissions for drug treatment, other than alcohol, 
declined steadily between 1999 and 2002 (exhibit 2). 
However, the proportion of cocaine/crack among 
these admissions held steady at 24 percent. 
 
In San Francisco County during FY 2002, 2,503 per-
sons were in treatment for primary cocaine problems. 
This total was 19 percent higher than in FY 2001, but 
still 8 percent lower than that for FY 1999. 
 
According to DAWN data, ME death mentions 
involving cocaine in three bay area counties fluctuated 
within a narrow range, with no particular trend, 
between 1996 and 2000 (exhibit 3). Of the cocaine-
related death mentions in 2000 in San Francisco, males 
accounted for 81 percent; the median age was just over 
40. 
 
San Jose, a nearby metropolis which is an ADAM 
site, may give some indication of cocaine use prev-
alence in San Francisco. During January– September 
2001, 12 percent of adult male arrestees in San Jose 
tested positive for cocaine. This was the third lowest 
figure for cocaine among all 31 ADAM sites. The 
median cocaine-positive proportion for those sites 
was 30 percent. 
 
According to the DEA, local kilogram prices for co-
caine ranged from $13,000 to $21,000. 
 
Heroin 
 
According to ethnographic observers, there has been 
an increase in heroin use among younger Whites, 
most of whom do not inject. Older users still prefer 
the injection route. Prices increased in 2002, with 
half-grams of “ street”  heroin quoted at $20, twice the 
price in 2001. 
 
ED mentions of heroin reached a peak in 1999 and 
then dropped by 10 percent in 2000, remaining at that 
level in 2001 (exhibit 1). 
 
The count of treatment admissions for primary heroin 
problems in the five-county bay area fell significantly 
between 1999 and 2002 (exhibit 2). As a proportion 
of all primary drug admissions excluding alcohol, 
heroin accounted for 64 percent in 1994, 55 percent 
in 1999, and only 41 percent in the first 8 months of 
2002. 
 
In San Francisco County, 4,164 persons were in public 
treatment for primary heroin abuse in FY 2002. This is 
down 20 percent from the count in FY 2001.  
 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— San Francisco Bay Area 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 205
In the three-county bay area reporting to DAWN, ME 
death mentions involving heroin in 2000 were at their 
lowest level in 5 years (exhibit 3). The count for 2000 
was 19 percent lower than the average for 1996–
1999. Males accounted for 87 percent of the heroin-
related death mentions in 2000. The median age of 
the decedents was 40. 
 
Arrests for heroin-related offenses totaled 5,311 in 
2001, a drop of 13 percent from the 5,981 recorded in 
2000. However, the rate of arrests during the first 10 
months of 2002 was 16 percent higher than during a 
similar period in 2001. 
 
Because many heroin users support their habits 
through property crimes, reported burglaries may be 
a good indicator of use. The number of such reports 
in San Francisco fell by 49 percent between 1993 and 
1999 (11,164 to 5,704). The count for 2001 was 18 
percent above the 1999 level, but that for the first 10 
months of 2002 was only 7 percent above a similar 
period for 1999. These changes may reflect the price 
of heroin more than the prevalence of users: it is 
noteworthy that reported burglaries and the local 
price of heroin are both barely one-quarter of what 
they were 20 years ago. 
 
The DEA’s DMP tested heroin street buys in the San 
Francisco area during the first half of 2001. Of the 15 
buys, 14 were of Mexican origin. The 2001 samples 
averaged 15 percent pure and cost $2.11 per pure 
milligram, compared with 16 percent and $0.71 in 
2000, 20 percent and $0.47 in 1999, 26 percent and 
$0.33 in 1998, 26 percent and $0.63 in 1997, 24 per-
cent and $0.83 in 1996, 35 percent and $0.83 in 1995, 
and 29 percent and $0.95 in 1994. Local samples of 
heroin were thus generally “ Mexican”  and showed a 
very sharp increase in average price between 1998 
and 2001. 
 
Prices for kilograms of heroin ranged from $15,000 
(Mexican black tar) to $75,000 (South American) in 
the first quarter of 2002. Purity ranged from 10 per-
cent to 68 percent. 
 
In a “ late night”  sample of gay/bisexual men sampled 
by the Party and Play Study, 14 percent reported 
injecting heroin in the prior 3 months, and 8 percent 
reported noninjection heroin use. 
 
Indicators showed a peak in heroin use in 1999, 
followed by a significant decline. The average age of 
users continues to increase. Local street prices of her-
oin have risen considerably since 2001. 
Other Opiates 
 
Ethnographic observers note a strong increase in the 
presence of oxycodone in the street scene. This is 
confirmed by ED data (exhibit 1). ME death men-
tions in the overall narcotic analgesics category 
fluctuated within a narrow range in 1996– 2000, with 
no discernible trend (exhibit 3). 
 
Marijuana 
 
Ethnographic observers note an increase in marijuana 
use among young people. The number of ED mari-
juana mentions nearly doubled between 1998 and 
2001 (exhibit 1). The proportion of females among 
these mentions increased significantly between 2000 
and 2001, although males accounted for more than 
two-thirds of the marijuana ED mentions. 
 
In San Francisco County, the proportion of primary 
marijuana abusers among all persons in treatment 
increased from 6 percent in FY 2001 to 9 percent in 
FY 2002. 
 
Arrests for marijuana-related offenses in San Francisco 
County were 1,364 in 2001, a decline of more than 
one-fifth from the 1,736 recorded in 2000. However, 
the rate of arrests in the first 10 months of 2002 was 5 
percent higher than for a similar period in 2001. 
 
In Northern California, California-produced mari-
juana sold for $1,500 to $4,000 per pound, while 
Mexico-produced marijuana sold for $380 to $1,400 
per pound. 
 
The indicators point to a continued increase in mari-
juana use prevalence.  
 
Stimulants 
 
Ethnographic observers note that the speed scene in 
San Francisco remained active in 2002, but less so 
than during the peak years of activity around 1997. 
Gay men no longer predominate the user population. 
 
The number of methamphetamine/speed ED mentions 
dropped sharply from 1997 to 1998, and then remained 
roughly the same through 2001 (exhibit 1). Between 
1994 and 2001, methamphetamine ED mentions 
significantly decreased by 53 percent. 
 
Treatment admissions for primary amphetamine 
problems in the five-county bay area increased 
somewhat between 2000 and 2002 (exhibit 2). The 
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proportion of primary amphetamine users among all 
nonalcohol drug admissions rose from 13 percent in 
1999 to 20 percent in 2002. In San Francisco County, 
primary speed users increased among persons in 
treatment from 6 percent to 8 percent between FY 
2001 and FY 2002. 
 
In the three-county bay area, ME death mentions 
involving methamphetamine rose from 44 in 1996 to 
58 in 1999, then fell back to 45 in 2000 (exhibit 3). In 
San Francisco County during the 1990s, the highest 
annual count of deaths ascribed to amphetamines 
(alone or in combination) was 40 in 1995. The count 
in 2000 was down by 65 percent, to 14. Of the meth-
amphetamine-related death mentions in 2000, males 
accounted for 93 percent, and the median age was 40. 
 
Two nearby metropolises that are ADAM sites may 
give some indication of the situation in San Fran-
cisco. In Sacramento and San Jose, respectively, 29 
percent and 28 percent of male adult arrestees tested 
positive for methamphetamine in January– September 
2001. These were two of the three highest figures for 
methamphetamine-positive findings among adult 
males in all 31 ADAM sites. Methamphetamine-
positive results among males were 20 percent or 
higher in only eight sites, all in Pacific or Mountain 
States. 
 
In California, the DEA reports that a pound of meth-
amphetamine costs $3,000– $7,000 for “ low-grade”  
and $13,500– $18,000 for “ high-grade.”  
 
Gay/bisexual men in the Party and Play Study sample 
reported a high rate of methamphetamine abuse. Fully 
64 percent of these men cited noninjection use in the 
prior 3 months, while 33 percent cited injection use. 
Fifteen percent of the men reported “ having used a 
needle after someone else”  during the prior 3 months. 
This is a high rate of HIV-risky parenteral behavior, 
albeit among a “ fast lane”  subset of homosexually 
active men. 
 
Methamphetamine indicators are mixed. Usage con-
tinues to be widespread, and risky injection practices 
among gay/bisexual men continue to be a major 
factor in HIV incidence. 
 
Depressants 
 
The annual rate of ED mentions for the overall cate-
gory of benzodiazepines varied in a narrow range 
between 1996 and 2000, then rose significantly 
between 2000 and 2001 (exhibit 1). However, ME 
death mentions of benzodiazepines decreased by 22 
percent between 1997 and 2000 (exhibit 3). 
 
Hallucinogens 
 
Lysergic acid diethylamide (LSD) ED mentions in-
creased from 1998 to 2000, then returned nearly to 
the 1998 level in 2001. PCP mentions increased by a 
significant 23 percent between 1999 and 2001 (ex-
hibit 1). 
 
Club Drugs 
 
Ethnographic observers concur that methylenedioxy-
methamphetamine (MDMA or “ X” ) is widely avail-
able, with a street price of $20 and sometimes $15 
per pill. The annual count of ED mentions for this 
drug quadrupled in 4 years, from 38 in 1998 to 152 in 
2001 (exhibit 1). Two other club drugs, gamma 
hydroxybutyrate (GHB) and ketamine, remained at 
elevated levels in 2001. Males accounted for about 
four-fifths of GHB mentions in 2001; the median age 
was about 31. Among the Party and Play sample, 36 
percent reported MDMA use in the prior 3 months, 
while 18 percent reported GHB use and 17 percent 
reported ketamine use. The actual number of club 
drug mentions remains small, though, compared with 
mentions for cocaine or methamphetamine.  
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
AIDS 
 
San Francisco County had a cumulative total of 
28,159 AIDS cases through September 30, 2002, an 
increase of 389 (1.4 percent) from the total reported 
through September 30, 2001. Of these cases, 1,946 
(6.9 percent) were heterosexual IDUs, an increase of 
47 (2.5 percent) in a year. Another 3,557 AIDS cases 
(12.6 percent) were men who had sex with other men 
(MSM) and also injected drugs; this number 
increased by 120 (3.5 percent) in a year. The rate of 
cases reported has been decelerating for some time 
among heterosexual IDUs and lately has also been 
decelerating among MSM/IDUs. AIDS data among 
transgender San Franciscans have been collected only 
since 1996, but the cumulative total of cases— 281—
is a surprisingly large proportion of an overall trans-
gender population, estimated at 3,000. 
 
Among San Franciscans diagnosed in 2000 through 
2002, heterosexual IDUs accounted for 15 percent, 
up from 10 percent among those diagnosed in 1994 
through 1996, and 14 percent in 1997 through 1999. 
However, the overall case numbers in 2000– 2002 
were far lower than those of the late 1980s and early 
1990s. As a result, the percentage of heterosexual 
IDUs among the cumulative AIDS caseload will 
probably not increase significantly from the current 
level of 7 percent. 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— San Francisco Bay Area 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 207
The demography of the cumulative heterosexual IDU 
caseload with AIDS has changed very little in the past 
11 years. This caseload is 69 percent male, 50 percent 
Black, 35 percent White, 12 percent Hispanic, and 1 
percent Asian/Pacific Islander. By contrast, the 
gay/bisexual IDU caseload is 72 percent White, 16 
percent Black, 9 percent Hispanic, and 2 percent 
Asian/Pacific Islander. The heterosexual IDU dem-
ography is like that of heroin users except for over-
representation of Blacks, while the gay male IDU 
demography is similar to that for male speed users. 
 
Semiannual surveys by the Urban Health Study 
(UHS) point to a decline in HIV-positive prevalence 
of heterosexual IDUs not in treatment. Prevalence 
figures were generally in the 9 to 10 percent range 
between 1997 and 2002 for San Francisco IDUs. 
Prevalence of IDUs in Richmond (Contra Costa 
County) ranged between 20 and 25 percent in the 
early 1990s, then between 15 and 18 percent in 
1997– 99; prevalence was only 10 percent in 2001. 
Prevalence in West Oakland samples (Alameda 
County) ranged around 15 or 16 percent in the middle 
1990s, then ranged around 10 percent in 1997– 99; 
prevalence was only 6 percent in 2001. 
By means of a consensus of experts, San Francisco 
County estimated that there would be 220 new HIV 
infections among IDUs during 2001. This amounts to a 
low HIV annual incidence among heterosexuals (0.6 
percent for men, 1.1 percent for women), a high inci-
dence among MSMs (4.6 percent), and an extremely 
high incidence among transsexuals (13.2 percent). 
 
Hepatitis B 
 
From 1996 through 2001, reported cases of hepatitis 
B in San Francisco County rarely deviated from a 
pace of about one per week. The pace dropped sig-
nificantly during 2002, to about one case every 11 
days. 
 
Hepatitis C 
 
The prevalence of hepatitis C virus (HCV) is alarm-
ingly high among IDUs in San Francisco. The 
SFDPH estimates that HCV infection is at least 72 
percent, and perhaps as high as 86 percent, among the 
county’s overall IDU population of about 18,700. 
 
For inquiries concerning this report, please contact John A. Newmeyer, Ph.D., Haight-Ashbury Free Clinics, Inc., 612 Clayton Street, 2nd Floor, 
San Francisco, California 94117, Phone: (415) 931-5420, Fax: (415) 864-6162, <E-mail: jnewmeyer@aol.com>. 
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Exhibit 1. Number of ED Mentions in San Francisco for Selected Drugs:  1996–2001 
 
Drug Mentioned 1996 1997 1998 1999 2000 2001 
Percent 
Change 
2000–2001 
Cocaine 2,310 1,979 1,843 1,935 2,054 2,482 20.8 
Heroin 3,132 2,719 2,360 3,050 2,756 2,790 1.2 
Marijuana 424 388 391 469 627 704 12.3 
Methamphetamine 934 1,012 616 554 591 611 3.4 
Oxycodone/ 
Combinations 20 20 26 17 31 54 74.2 
PCP/Combinations 158 122 67 62 70 76 8.6 
LSD 104 73 43 55 67 46 -31.3 
MDMA 32 35 38 47 107 152 42.1 
GHB 78 83 102 138 151 158 4.6 
Ketamine 4 1 2 4 14 11 -21.4 
Benzodiazepines 730 727 619 665 664 825 24.2 
Total Mentions 14,213 13,491 12,525 12,702 12,171 13,743 12.9 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
Exhibit 2. Admissions to Drug Treatment Programs in the San Francisco Bay Area by Primary  
 Drug of Abuse:  1999–2001 and January–August 2002 
 
Drug 1999 2000 2001 Jan–Aug 2002 
Cocaine 8,727 7,718 7,428 4,547 
Heroin 19,763 17,416 14,673 7,679 
Amphetamine 4,595 4,469 5,073 3,679 
All drugs 
(excluding alcohol) 36,069 32,034 30,920 18,855 
 
SOURCE:  California Department of Alcohol and Drug Programs (DADP) 
 
 
 
Exhibit 3. Medical Examiner Drug Mentions in Three Counties (Including San Francisco): 
 1996–2000 
 
Drug 1996 1997 1998 1999 2000 
Cocaine 155 127 158 158 146 
Heroin/Morphine 212 159 164 192 148 
Methamphetamine 44 49 45 58 45 
Narcotic Analgesics 175 156 185 198 164 
Benzodiazepines 66 71 62 50 55 
 
SOURCE:  DAWN, OAS, SAMHSA 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Seattle-King County Area 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 209
Recent Drug Abuse Trends in the Seattle-King County Area 
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ABSTRACT 
 
Cocaine-related deaths increased to previous high 
levels in 2002, following a decline in 2001, while 
cocaine emergency department (ED) mentions 
remained flat from 2000 to 2001. The number of 
heroin-related deaths also increased, following sharp 
declines observed from mid-2000 through 2001, 
while ED mentions were significantly lower in 2001. 
Overall, drug-related deaths and ED mentions for 
most other opiates/narcotics were at their highest 
levels, with ED mentions for narcotic analgesics/ 
combinations surpassing those for heroin for the first 
time. Marijuana use was widespread, with recent 
increases in ED mentions and treatment admissions. 
Indicators of methamphetamine use plateaued, 
including treatment admissions and manufacturing 
site seizures. PCP ED mentions remained at new 
higher levels; MDMA and GHB indicators remained 
elevated, and LSD use continued its long downward 
trend. All of these ED mentions for club drugs 
accounted for only about 5 percent of ED mentions. 
Treatment admissions for hallucinogens and club 
drugs remained at very low levels. Indicators of 
depressant use remained fairly steady, with relatively 
high levels of ED mentions and low levels of 
treatment admissions. Among men who have sex with 
men who were recently treated at the county sexually 
transmitted disease (STD) clinic, the use of either 
MDMA or methamphetamine was significantly 
associated with risky sexual behaviors and contract-
ing STDs. Injection drug users (IDUs), including 
those who also engage in male-to-male sex, have 
constituted 14 percent of newly diagnosed HIV 
infections in recent years. Hepatitis C may infect up 
to 85 percent of IDUs in King County. 
 
INTRODUCTION 
 
Area Description 
 
Located on Puget Sound in western Washington, 
King County spans 2,130 square miles, of which the 
city of Seattle occupies 84 square miles. The 
combined ports of Seattle and nearby Tacoma make 
Puget Sound the second largest combined loading 
center in the United States. Seattle-Tacoma interna-
tional airport, located in King County, is the largest 
airport in the Pacific Northwest. The Interstate 5 
corridor runs from Tijuana, Mexico, to the south, 
passes through King County, and continues north-
ward to Canada. Interstate 90’s western terminus is in 
Seattle; it runs east over the Cascade Mountain range, 
through Spokane and across Idaho and Montana. 
 
According to the 2000 census, the population of King 
County is 1,737,034, an increase of 15.2 percent 
since 1990. King County is the 12th largest county in 
the United States. Of Washington’s 5.9 million resi-
dents, 29 percent live in King County. The city of 
Seattle’s population is 563,374; the suburban popula-
tion of King County is growing at a faster rate than 
Seattle itself. 
 
The county’s population is 75.7 percent White, 10.8 
percent Asian/Pacific Islander, 5.5 percent Hispanic, 
5.4 percent African-American, 0.9 percent Native 
American or Alaska Native, 0.5 percent Native 
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Hawaiian and Other Pacific Islander, and 2.6 “ some 
other race.”  Those reporting two or more races con-
stitute 4.1 percent of the population. Income statistics 
show that 8.0 percent of adults and 12.3 percent of 
children live below the Federal poverty level, lower 
than the State averages of 10.2 percent and 15.2 per-
cent, respectively. 
 
Data Sources 
 
• Emergency department (ED) drug mentions 
data were derived from Drug Abuse Warning 
Network (DAWN), Office of Applied Studies, 
Substance Abuse and Mental Health Services 
Administration (SAMHSA), for 1994 through 
2001. A drug “ mention”  indicates that the patient 
identified the substance as something he or she 
had recently taken; it may or may not have been 
the reason for the ED visit. Available data are for 
King and neighboring Snohomish Counties 
combined. 
 
• Treatment admissions data were extracted 
from the Washington State Department of Social 
and Health Services’  Treatment and Assessment 
Report Generation Tool (TARGET). TARGET is 
the department’s statewide alcohol/drug treat-
ment activity database system and report-gener-
ating software. Data were compiled for King 
County from January 1, 1999, through June 30, 
2002. Data for all substance abuse-related treat-
ment admissions are included; this contrasts with 
previous CEWG reports, when admissions for 
alcohol-only were excluded. Only the primary 
drug at the time of treatment admission is avail-
able. Data on private pay and Department of 
Corrections clients, as well as those receiving 
detoxification services, are excluded. 
 
• Drug-related mortality data were provided by 
the King County Medical Examiner (ME). In-
formation about drug-caused deaths in King 
County is presented by half-year from January 1, 
1994, through June 30, 2002. The data include 
deaths directly caused by licit or illicit drug 
overdose and exclude deaths caused by poisons. 
Therefore, totals may differ slightly from drug 
death reports published by the King County 
ME’s office, which include fatal poisonings. 
Testing is not done for marijuana. Because more 
than one drug is often identified per individual 
drug overdose death, the total number of drugs 
identified exceeds the number of actual deaths.  
 
• Arrestee drug testing data were obtained from 
the Arrestee Drug Abuse Monitoring (ADAM) 
program. As part of the National Institute of Jus-
tice’s ADAM program, King County’s urinalysis 
results for January through December 2001 are 
included in the narratives for cocaine, heroin, 
marijuana, stimulants (methamphetamine), and 
phencyclidine (PCP). Provisional, unweighted 
data for males in the first half of 2002 are pro-
vided as well; note that this data will change 
some when sampling weights are applied. All 
data are for adult, male arrestees only. 
 
• Illegal drug price, purity, production, traf-
ficking, distribution, and availability data were 
provided by four sources. Heroin price and 
purity data for the United States and Seattle are 
from the Drug Enforcement Administration’s 
(DEA) Domestic Monitor Program (DMP). Data 
presented are from the first half of 2001, the 
most current data available. Qualitative data for 
the first half of 2002 were provided by local 
DEA intelligence staff. DEA Diversion Control 
provided data on prescription drug sales to 
hospitals and pharmacies in 2001. Data from the 
U.S. Customs Service relating to the seizures for 
all illegal drugs are included for January 1, 2001, 
to June 30, 2002. The majority of customs 
seizures are at the Blaine, Washington, border 
crossing, where Interstate 5 crosses the northern 
border of the State and into Canada near 
Vancouver. This is the third busiest Canadian 
border crossing for passengers and the fourth 
busiest for commercial traffic nationally. Other 
relevant data are from the Northwest High 
Intensity Drug Trafficking Area (NW HIDTA). 
Pursuant to its designation by the Office of 
National Drug Control Policy, the NW HIDTA 
produces a Threat Assessment for the region on 
an annual basis. Data for 1998 through 2001 are 
from all Federal, State, and local law 
enforcement agencies and narcotics task forces 
in the region, and the Western States Information 
System (WSIN). The most comprehensive and 
current source of methamphetamine production 
data is now the Washington State Department of 
Ecology (DOE), which is mandated to respond to 
and document all “ Methamphetamine Incidents,”  
including operating labs, dump sites, and other 
sites associated with the manufacture of 
methamphetamine.  
 
• Data on infectious diseases related to drug use, 
including the human immunodeficiency virus 
(HIV), acquired immunodeficiency syndrome 
(AIDS), and hepatitis, were provided by three 
sources. The Sexually Transmitted Disease (STD) 
Clinic, Public Health –  Seattle & King County 
(PHSKC) provided data on clients’ drug use, 
health status, and health behaviors for October 
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2001 to September 2002. The Epidemiology 
Research Unit, PHSKC, provided findings from 
two longitudinal cohort studies of Seattle-area 
drug injectors. Funded by the National Institute 
on Drug Abuse (NIDA) and conducted by 
PHSKC, the studies began in 1994 and continued 
through 2002. Another source is “ HIV/AIDS 
Epidemiology Report.”  Data on HIV and AIDS 
cases (including exposure related to injection 
drug use) in Seattle-King County, other Wash-
ington counties, Washington State (July 1999 
through June 2002), and the United States (Janu-
ary 1999 through December 2001) are provided 
by PHSKC, the Washington State Department of 
Health, and the Federal Centers for Disease 
Control and Prevention (CDC). HIV cases were 
reported to PHSKC or the Washington Depart-
ment of Health between September 1999 (when 
HIV reporting was first implemented in Wash-
ington State) and October 2002. 
 
• Washington State Alcohol/Drug Help Line 
(ADHL) provides confidential 24-hour telephone-
based treatment referral and assistance for 
Washington State. Data are presented for January 
2001 to June 2002 for calls originating within King 
County. Data presented are for drugs mentioned. A 
caller may refer to multiple drugs; therefore, there 
are more drug mentions than there are calls. The 
data exclude information on alcohol and nicotine, 
which account for more than one-half of the calls. 
In the first half of 2002, there were 2,724 calls, of 
which 86 percent concerned adults. 
 
• The Washington State Poison Center operates 
a 24-hour hotline. Data are presented for King 
County.  Multiple substances may be recorded 
for each call. Many of the calls are related to 
serious or unusual situations reported by health 
care facilities. Only a small amount of all 
poisonings or exposures are reported to the Poi-
son Center; these data do not approximate 
prevalence data. Calls requesting only general in-
formation are not included in these data.. 
 
• Key informant interview data are obtained from 
discussions with treatment center staff, street 
outreach workers, and drug users.  
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
There were an estimated 3,409 cocaine mentions in 
2001 (exhibit 1), a 35 percent increase from 1999. In 
2001, 62 percent of ED mentions were male. Nearly 
one-half of the mentions involved Whites, nearly 
one-third Blacks, and nearly 5 percent Hispanics, 
consistent with most previous years. The majority 
ranged in age from 26 to 44. From 1999 to 2001 
significant increases occurred in mentions across all 
age categories 18 and older. Over the 8-year period 
from 1994 to 2001, significant increases were seen 
for those age 45– 54 (168 percent) and among those 
age 55 and older (163 percent). This corresponds 
with anecdotal reports that cocaine users represent an 
aging cohort.  In 2001, dependence was cited most 
often by those whose reasons for using the drug were 
known. Only 30 percent of visits to the ED involving 
cocaine were for cocaine alone. Of these single drug 
episodes, the most common reasons for the visit 
included chronic effects (23 percent), unexpected 
reaction (16 percent), and accident/injury (16 
percent). 
 
In the first half of 2002, cocaine admissions 
represented 12 percent of total treatment admissions. 
The number of cocaine admissions in the first half of 
2002 was virtually identical to those in the preceding 
half-year period. Admissions to drug treatment for 
adults reporting cocaine as their primary drug have 
declined by approximately 1 percentage point each 
year since 1999 (exhibit 2).  
 
There were 49 mentions of cocaine in drug-involved 
deaths in the first half of 2002 (exhibit 3), accounting 
for 48 percent of all drug-related deaths. This is the 
second highest number of deaths since 1994; in the 
first half of 2000 there were 51 cocaine-related 
deaths. Thirteen of the 102 reported drug-related 
deaths were for cocaine alone. The drugs most com-
monly seen in combination with cocaine were heroin, 
other opiates, and alcohol, consistent with previous 
years. The average age of the decedents was 42, with 
a range of 25– 57 years of age. Seventy-one percent 
(n=35) of the decedents whose deaths were cocaine-
related were White, 18 percent (9) were African-
American, 6 percent (3) were Native American, and 
the remaining 2 deaths were coded as “ other.”  
Eighty-one percent of decedents with cocaine 
identified were male, similar to previous years.  
 
In the first half of 2002, there were 13 reports of co-
caine seizures by the U.S. Customs Service, totaling 
36.8 pounds (16.7 kilograms). The number of sei-
zures is down slightly, with many fewer pounds 
seized. A single seizure of more than two tons was 
made in the first half of 2001. 
 
In Seattle, as noted earlier, ADAM data are only 
available for adult, male arrestees. Provisional data are 
available for the first two quarters of 2002. For this 
time period, 36 percent of male arrestees tested positive 
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for cocaine, a possible increase in cocaine-positives 
from 2000 (31 percent) and 2001 (31 percent). 
 
The NW HIDTA reports that the street cost of 
cocaine is roughly $30 per gram, $500– $900 per 
ounce, and $14,000– $24,000 per kilogram. 
Intelligence reports indicate that powder cocaine is 
increasingly more available in King County and other 
areas of the State. 
 
Of the 535 exposures to street drugs reported to the 
Washington State Poison Center for King County in 
2001, 54 were exposures to cocaine. Trend data are 
not yet available. 
 
Cocaine continues to be the second most common ille-
gal drug mentioned by all callers to the ADHL. It is the 
most common drug cited by adults— 24 percent for the 
first half of 2002, the same as for all of 2001. For teen-
agers, cocaine is the fourth most common drug men-
tioned, with 37 calls, representing 10 percent of all 
calls, in the first half of 2002. 
 
Heroin 
 
The estimated number of heroin ED mentions 
decreased significantly from 2000 to 2001, dropping 
from 2,490 to 1,927 (exhibit 1). The ages of those 
reporting heroin have generally remained constant 
since 1994, with those under 18 representing less 
than 1 percent of ED visits, those 18– 25 representing 
11 percent, those 26– 34 representing 26 percent, and 
those over 35 constituting 62 percent. The only sig-
nificant long-term trend was an increase in mentions 
among those age 45– 54, up 92 percent since 1994. 
Heroin is the only major drug for which the majority 
of ED visits are related to use of a single drug. In 
2001, 61 percent of the heroin mentions involved use 
of only that drug. The main reasons for these single 
drug visits were chronic effects (53 percent), fol-
lowed by overdose (16 percent) and withdrawal (11 
percent). The vast majority reported dependence as 
their motivation for using. Heroin was the second 
most commonly cited illegal drug, following cocaine. 
 
The number and proportion of primary treatment ad-
missions for heroin increased in the first half of 2002 
to 661, 16 percent of all admissions in the county, up 
from 606 admissions (14 percent) in the previous 
half-year (exhibit 2). Admissions were down overall 
from a recent peak in the second half of 1999 through 
2000, which was related primarily to the utilization of 
public funding that had been underexpended. 
 
Forty-eight heroin-related deaths were reported in the 
first half of 2002, a substantial increase from the 27 
and 34 deaths in the second and first halves of 2001, 
respectively (exhibit 3). The age range of these dece-
dents was 21 to 73, with an average of 41, similar to 
previous years. The race/ethnicity of decedents were 
as follows: 37 Caucasians, 6 African-Americans, 3 
Native Americans, and 2 “ other.”  This racial distri-
bution has been relatively constant since 1999, with 
the exception of 2001, when only one African-
American died from heroin-related causes. The pro-
portion of heroin-only deaths declined from 1999 to 
2001 and remained steady into the first half of 2002. 
There were 49 deaths from heroin alone in 1999, ac-
counting for 42 percent of heroin-involved deaths. 
There were 41 heroin-alone deaths (41 percent) in 
2000, 16 (26 percent) in 2001, and 13 (of 48) in the 
first half of 2002 (27 percent). In 2001, the rate of 
heroin-involved deaths per 100,000 population in 
Seattle was 3.5, a sharp drop from the rate of 5.7 in 
2000 (exhibit 4). 
 
The primary form of heroin on the streets is Mexican 
black tar. China white, a common form in Vancouver, 
British Columbia, and on the east coast of the United 
States, is virtually nonexistent in the local area 
according to regional HIDTA and DEA information. 
 
Provisional ADAM data for the first half of 2002 
appear to show a slight decline in the proportion of 
new arrestees testing positive for heroin, 8 percent. 
The proportion was 10 percent in both 2001 and 2000. 
 
Calls to the ADHL in the first half of 2002 for heroin 
represented 9.6 percent of all drug-related calls, un-
changed from 2001. Teens were less likely to call 
about heroin: only 2 percent of calls by teens were 
related to heroin, compared with 11 percent for 
adults. These proportions have been consistent for the 
past 1½ years. 
 
Data for heroin seizures by the U.S. Customs Service 
were unavailable for the first half of 2002. In 2001, 
seizures of heroin by customs officials were infre-
quent, and the total volume was small compared to 
the level of use, with 12 seizures totaling 7 pounds. 
The major trafficking route is believed to involve the 
interstate highway system from the southwestern 
United States, once the product has crossed the 
Mexican border. It is believed there is not much 
heroin trafficking across the Washington-Canadian 
border in either direction. 
 
The DEA reports that declining heroin purity was first 
noted in 2000, and purity has remained at lower levels. 
The average purity of 14 samples collected by the DMP 
in Seattle was 10.3 percent during January– June 2001; 
this is similar to the 12.7 percent purity for the 23 
samples collected during all of 2000. This relative 
consistency in purity is supported by anecdotal 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Seattle-King County Area 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 213
information from HIDTA, although there are occa-
sional reports of high quality heroin at local needle 
exchanges. Of the samples tested, 11 were identified as 
Mexican; the origins of 2 samples were unidentifiable, 
and 1 sample was insufficient to test. According to the 
DMP, the average price per milligram pure was $2.69 
during the first half of 2001, compared with $1.15 for 
2000. Local informants noted that the DMP-reported 
prices appear higher and the purity lower than what 
they are seeing on the streets. 
 
The most current data from the Seattle DEA for the 
first half of 2001 are that a gram of black tar heroin 
sells for $50– $100, with one-tenth gram selling for 
$20– $50. Local informants report that heroin is sell-
ing for $20 for one-fifth of a gram in the downtown 
core. In the Capitol Hill neighborhood, a densely 
populated neighborhood adjacent to downtown, a 
gram sells for $50. Buying larger quantities has 
become less expensive over the last several years. In 
1998 an “ eightball”  (equivalent to one-eighth of an 
ounce or approximately 3.5 grams) sold for $175, 
whereas in 2001 it sold for between $100 and $125. 
 
Other Opiates/Narcotics 
 
For the purposes of this report, “ other opiates/ nar-
cotics”  include codeine, dihydrocodeine, fentanyl, 
hydrocodone, methadone, oxycodone, propoxyphene, 
and the narcotic analgesics/combinations reported in 
the DAWN ED data. 
 
In 2001, there were an estimated 2,560 ED mentions 
of narcotic analgesics/combinations (exhibit 1), 
ranking such mentions ahead of those for heroin for 
the first time. Oxycodone/combinations mentions 
increased significantly in recent years, more than 
doubling from 1999 to 2000 and increasing another 
52 percent from 2000 to 2001 (to 254 mentions). 
Methadone followed a similar trend, with a 
significant increase from 1999 to 2000 (77 percent), 
followed by a 92-percent increase the following year 
Mentions for hydrocodone and its combinations (e.g., 
Vicodin and Percocet) increased significantly 
between 1999 and 2000, with similar levels in 2001. 
However, mentions of codeine/ combinations 
decreased 74 percent from 1994 to 2001, with steady 
levels from 1999 through 2001. (Data note: The 
“ narcotic analgesic not otherwise specified”  sub-
category includes more than one-half of the 
mentions, limiting the accuracy of this data.) 
 
The category of “ narcotic analgesics, not otherwise 
specified”  was the fifth most common single-drug-
only ED visit type, with 354 such visits estimated for 
2001. The most common reasons for visiting the 
emergency department among these single drug users 
included chronic effects (22 percent), accident/injury 
(15 percent), withdrawal (13 percent), unexpected 
reaction (11 percent), and overdose (10 percent). The 
primary reasons for using were dependence (58 per-
cent) and suicide (7 percent). 
 
Treatment data point to low levels of treatment 
demand for other opiates, with such admissions 
representing approximately 1 percent of all primary 
treatment admissions (exhibit 2). There was a 
decrease from 54 to 29 clients admitted to treatment 
for other opiates from the second half of 2001 to the 
first half of 2002.  
 
Deaths involving other opiates reached their highest 
level in at least the past 9 years, with a total of 31 
mentions of other opiates associated with 29 deaths 
in the first half of 2002 (exhibit 3). Decedents ranged 
in age from 19 to 75, with an average age of 41. 
Oxycodone and methadone were the two most com-
monly identified drugs in deaths related to other 
opiate use during the last several years, constituting 
75 percent of other opiates identified from 1999 to 
2001. In the first half of 2002, oxycodone was 
identified 13 times, and methadone was identified 14 
times; combined, these represented 87 percent of all 
other opiates identified. Two deaths involved both 
oxycodone and methadone. The 2002 data reflect a 
continued increase of oxycodone-associated deaths, 
from 4 in 1999 to 18 in 2001. Deaths in which 
methadone is identified continued at a relatively 
constant rate. What constitutes a methadone-related 
death is unclear, however, particularly among 
methadone-tolerant individuals. Efforts are underway 
to better understand the role of methadone in deaths. 
It is unknown how many deaths are among those 
receiving methadone for opiate substitution treat-
ment, compared with those who have obtained either 
a legal prescription or have illegally obtained the 
drug. Of the four other cases involving prescription 
opiates, two involved codeine, one fentanyl, and one 
hydrocodone (e.g., Vicodin). 
 
The ADHL reported 38 calls related to methadone for 
the first half of 2002, representing less than 2 percent 
of the calls. The proportion of calls was similar to the 
previous year. In 2002, all of the calls were from 
adults; in the prior year, six calls were from teens. 
 
According to the local DEA, hydrocodone is the most 
commonly diverted narcotic. This is related in large 
part to its status as a Schedule III drug under the 
Controlled Substances Act, as opposed to oxycodone, 
which is a more tightly restricted Schedule II nar-
cotic. Note that hydrocodone in its pure form is 
Schedule II, but in combination with other medi-
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Seattle-King County Area 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 214
cations, for example when combined with acetamino-
phen (Vicodin), it is Schedule III.  
 
Washington State was well above the national aver-
age in hospital purchases of hydrocodone, oxyco-
done, OxyContin, methadone, codeine, morphine, 
and hydromorphone during 2001, according to the 
DEA.  Pharmacy purchases were well above average 
for morphine, oxycodone, and OxyContin. King 
County is above the State average in hospital pur-
chases for oxycodone, OxyContin, morphine, and 
hyrdromorphone, not surprising since King County is 
also the location of the Pacific Northwest’s regional 
trauma center and most major hospitals, where these 
drugs are likely to be administered and prescribed. 
The drug with the highest rate of purchases was 
oxycodone. Hospital purchases averaged 455 grams 
per 100,000 residents in Washington, compared with 
217 grams per 100,000 residents nationally. Phar-
macy purchases were 473 grams per 100,000 in the 
State, compared with 333 per 100,000 nationally. 
Data are available from the DEA on the amount of 
OxyContin distributed in Washington State, primarily 
to hospitals and pharmacies, from January 1997 
through March 2001. These data point to a roughly 
1,600-percent increase in Washington and a 1,300-
percent increase in the Nation during this timeframe. 
 
Methadone was also dispensed at higher levels in the 
State than in the Nation, with an average of 118 
grams per 100,000 residents for Washington hospi-
tals, compared with 49 grams per 100,000 population 
nationally in 2001. Methadone dispensed through 
opiate substitution clinics is not included in this DEA 
data, indicating that virtually all of this methadone is 
being prescribed for pain management. Almost all 
methadone dispensed for “ take home”  dosing by 
opiate substitution treatment centers is in liquid form, 
as opposed to the tablet form prescribed for pain 
management.  
 
Informants report that most methadone sold on the 
street in the Seattle area is in tablet form, suggesting 
that its source may be prescriptions for pain man-
agement. The street cost of methadone in this form is 
approximately $0.50 per milligram. 
 
An issue that will continue to be explored is to what 
degree recent indicator data point to abuse of other 
opiate medications versus an increase in their legiti-
mate prescription by physicians in an attempt to bet-
ter manage pain, a condition that has historically been 
undermedicated.  
 
Marijuana 
 
Marijuana continues to be one of the most widely 
used illicit substances in the area. Provisional ADAM 
data for the first half of 2002 show that 43 percent of 
the male arrestees tested positive for marijuana. This 
compares with 35 percent for 2001 and 38 percent 
during 2000. Marijuana remains the drug most com-
monly identified in urinalysis tests of arrestees in 
King County. This points to its popularity as well as 
the fact that marijuana can be detected in urine tests 
far longer than other drugs. 
 
Marijuana remained the third most common single 
illegal substance mentioned in DAWN data (exhibit 
1). A surge in  marijuana mentions that has been 
evident since the first half of 2000 was maintained 
through 2001. The number of marijuana ED mentions 
significantly increased by 98 percent from 1999 to 
2001 when there were 1,596 mentions (exhibit 1). 
Seventy-one percent of the marijuana mentions were 
part of multidrug episodes. Reasons for using cited 
by those who had used only marijuana included 
psychic effects (33 percent) and dependence (20 
percent). Reasons for visiting the ED included 
chronic effects (29 percent) and unexpected reaction 
(21 percent). 
 
Between 1994 and 2001 and 1999 and 2001, mari-
juana mentions increased significantly for all major 
age categories, except for mentions by 26– 34-year-
olds from 1994 to 2001. In the short term, during 
2001, ED mentions declined by 42 percent for those 
age 12– 17; for ages 18– 25 the decline was 21 
percent; and for ages 26– 29 years, the decline was 31 
percent. For the first time since at least 1994, the 35–
and-older age group was the most likely to mention 
marijuana during an ED visit, accounting for 34 per-
cent of the ED mentions during this period. Young 
adults were no longer the age group most likely to 
mention marijuana use, with approximately 32 per-
cent of marijuana mentions occurring among those 
age 18– 25. Teenagers constituted approximately 12 
percent of marijuana ED mentions.  
 
Treatment admissions for marijuana increased from 
819 (19.5 percent) in the second half of 2001 to 845 
(20.5 percent) in the first half of 2002 (exhibit 2). 
This continues a trend that began in 1996. Marijuana 
continued to be the second most common reason for 
drug treatment in the first half of 2002, with alcohol 
representing nearly 40 percent of admissions. Ap-
proximately two-thirds of youth treatment admissions 
have been for marijuana in recent years.  
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Marijuana continued to be the drug most commonly 
cited among those who called the ADHL, 
representing one-quarter of the calls. A substantial 
difference between adults and teens is evident; 49 
percent of teen calls concerned marijuana, compared 
with 21 percent of adult calls.  
 
HIDTA data collected from local, State, and Federal 
law enforcement sources show the following prices 
for various types and sources of marijuana: 1 pound 
of Mexican sells for $500– $700; 1 pound of domestic 
sells for $2,400– $3,200; 1 pound of “ BC Bud”  from 
British Columbia, Canada, sells for $2,800– $3,000; 
and 100 starter plants sell for $1,500. Cultivation 
seizures reported to HIDTA for Washington State 
totaled 317 in 2000 and 401 in 2001; in King County 
there were 24 seizures in 2000 and 12 in 2001. 
 
The U.S. Customs Service reported continued large 
increases in marijuana seizures, principally at the 
U.S.-Canadian border crossing at Blaine, where 
Interstate 5 crosses into Canada near Vancouver. In 
the first half of 2002 there were 408 seizures, 
compared with 301 and 268 for the second and first 
halves of 2001, respectively. A substantial increase in 
the quantity seized occurred between the first and 
second halves of 2001, from 3,432 to 7,519 pounds, 
largely because of the increased border security 
following the terrorist attacks of September 2001. 
This increase continued in the first half of 2002, 
when 9,811 pounds was seized as the heightened 
border security continued. The number of large 
seizures increased substantially following the terrorist 
attacks and continued into 2002, with 19 seizures of 
more than 100 pounds from January to June. The 
largest seizure, 1,475 pounds, was identified in 
January 2002 from a commercial truck. 
 
Stimulants  
 
DAWN ED mentions for amphetamines in Seattle-
King County increased significantly from 1999 to 
2001, while ED methamphetamine mentions decreased 
significantly from 2000 to 2001. Methamphetamine 
ED mentions in 2001 totaled 395 (exhibit 1). Overall, 
amphetamines and methamphetamine rank fifth and 
sixth, respectively, among all illegal drugs in the 
DAWN ED system. (Note: A categorization problem 
is suspected because of the high levels of amphetamine 
mentions that do not correspond to other indicator data 
or anecdotal reports. Miscategorization of metham-
phetamine as amphetamine is suspected in other data 
sources as well, as noted in DAWN reports.) 
 
Almost one-half (47 percent) of the 395 methamphet-
amine-related ED mentions in 2001 involved meth-
amphetamine alone. The primary reasons for using 
among this group included dependence (40 percent) 
and psychic effects (38 percent). Reasons for the ED 
visit included unexpected reactions (32 percent) and 
chronic effects (24 percent). 
 
The numbers of King County treatment admissions 
for primary amphetamine and methamphetamine 
abuse remained stable during the first half of 2002, 
continuing at levels similar to those in 2001. Meth-
amphetamine admissions accounted for 8.9 percent of 
the total King County treatment admissions in the 
first half of 2002, compared with 8.7 percent in 2001, 
6.8 percent in 2000, and 4.9 percent in 1999 (exhibit 
2). They continued to be surpassed by admissions for 
primary alcohol, cocaine, heroin, and marijuana 
abuse. During 2001, the rate of methamphetamine 
treatment admissions per capita was three times 
lower in King County than throughout the rest of the 
State. Persons reporting amphetamine as their pri-
mary substance have consistently accounted for 0.7–
1.0 percent of the total King County treatment 
admissions. 
 
The majority of calls to the poison center related to 
street drugs were for amphetamines and methamphet-
amine (59 percent). A specific category for metham-
phetamine was added 2 years ago, but it is rarely used. 
 
Data from PHSKC’s STD clinic indicate that among 
men who have sex with men (MSM), methamphet-
amine use is significantly associated with increased 
numbers of sexual partners, contracting gonorrhea, 
having a new HIV diagnosis, having preexisting HIV, 
transmitting HIV, and acquiring HIV. Overall, life-
time methamphetamine use among those seen at the 
clinic was reported by 8.7 percent of MSMs, com-
pared with 1.7 percent of heterosexual men 
(p<0.0001). Use of methamphetamine by MSM 
injection drug users (IDUs) has been noted for over a 
decade in the Seattle area. 
 
The proportion of calls to the ADHL that originated in 
King County regarding methamphetamine decreased 
from 18.9 percent for the first half of 2001 to 14.9 
percent in the first half of 2002. Methamphetamine 
was the third most common illegal drug mentioned by 
those calling about both teenagers and adults. 
 
The percentage of male arrestees in the Seattle-King 
County ADAM program who tested positive for 
methamphetamine continued to increase, according 
to provisional data available for 2002. Data for the 
first half of 2002 showed that 14.4 percent of the 
arrestees tested positive for methamphetamine (60 of 
the 416 tested). This compares to 11 percent in 2001 
and 9 percent in 2000. 
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Four deaths involving methamphetamine and one 
involving amphetamine were recorded in King 
County for the first half of 2002, equaling the number 
reported for all of 2001. This may represent a return 
to the levels reported for 2000 (11) and 1999 (14), 
although the total remains relatively small and has 
not changed much since 1995. In 2002, the dece-
dents’  ages ranged from 26 to 40, with an average 
age of 34. This is similar to the average age of 36 
during 1999 to 2001 and lower than the average age 
of those who died of heroin- and cocaine-related 
causes, which was 41– 42 in recent years. 
 
Local street prices of methamphetamine in Seattle-
King County and throughout the State of Washington 
have remained stable in spite of increasing availabil-
ity. Methamphetamine sells for $20– $60 per gram, 
$350– $650 per ounce, and $4,250– $6,000 per pound 
in Seattle-King County.  
 
Similar to previous years, law enforcement sources 
estimate that 65– 75 percent of the methamphetamine 
available in Washington State is transported from 
Oregon, California, and Mexico. The quantities 
involved in this commerce are suggested by a recent 
investigation in Pierce County, directly south of King 
County, in which an organization that was trafficking 
approximately 100 kilograms of methamphetamine 
per month was dismantled. Further indication of the 
level of this activity is provided by the U.S. Customs 
Service, which reported the seizure of 8.45 pounds of 
methamphetamine at five land, maritime, and com-
mercial air ports of entry during the first half of 2002, 
compared with the seizure of approximately 1 pound 
of methamphetamine during the first half of 2001.  
 
Nonetheless, ease of access to precursor ingredients 
(increasingly imported from Canada); the availability 
of equipment, recipes, and locations; and the purity 
of methamphetamine produced by local clandestine 
labs continued to sustain methamphetamine’s preva-
lence in Washington State and King County. Because 
of State and national changes in reporting protocols, 
the source and scope of the data quantifying clandes-
tine labs changed in 2002. The most comprehensive 
and current source of this data is now the Washington 
State Department of Ecology, which is mandated to 
respond to and document all “ Methamphetamine 
Incidents,”  including operating labs, dump sites, and 
other sites associated with the manufacture of meth-
amphetamine. DOE data for the period of January 
through October 2002 suggests that the proliferation 
of clandestine labs in Washington State stabilized in 
2002 at a level that indicates a slight decrease from 
2001. A total of 1,567 methamphetamine incidents 
were reported during January through November 
2002, compared with 1,886 for all of 2001, 1,449 for 
2000, and 789 in 1999. Although 2002 would thus be 
the first period in 7 years to show a decrease in meth-
amphetamine incidents, it will likely exceed the 2000 
total and will continue to rank Washington State third 
in the Nation for methamphetamine manufacturing 
activity, as measured by the number of labs and 
dump sites seized. It is important to note that this 
measurement does not account for the amount of 
methamphetamine manufactured, a more difficult 
indicator to measure. 
 
Similarly, the number of methamphetamine incidents 
reported in King County appears to have stabilized in 
2002. DOE reported a total of 223 incidents for the 
period of January through November 2002 (14 per-
cent of the statewide total), compared with 271 in 
2001 (9 percent of the statewide total), 231 in 2000 
(16 percent of the statewide total), and 107 in 1999 
(13 percent of the statewide total), suggesting a return 
to the level reported in King County during 2000 and 
sustaining King County’s ranking second in the State 
for the number of activities associated with metham-
phetamine manufacturing. However, the rate of inci-
dents per capita in King County was half the State’s 
average in 2001. 
 
Informants report increasing use of “ ice”  and “ glass,”  
converted forms of methamphetamine that have 
higher purity. Anecdotal reports supported by treat-
ment data dating back to 1994 suggest that users are 
increasingly smoking methamphetamine as opposed 
to using it in other ways. 
 
Depressants  
 
Barbiturates, benzodiazepines, and other sedative/ 
depressant drugs in this analysis include alprazolam 
(Xanax), butalbital (Fioricet), chlordiazepoxide 
(Librium), cyclobenzaprine (Flexeril), diazepam 
(Valium), hydroxyzine pamoate (Vistaril), lorazepam 
(Ativan), meprobamate (Equanil), oxazepam (Serax), 
phenobarbital, promethazine (Phenergan), secobarbital 
(Seconal), temazepam (Restoril), triazolam (Halcion), 
and zolpidem (Ambien).  
 
ED mentions for “ anxiolytics, sedatives and hypnot-
ics”  were at a low point in 1999 and have since 
returned to previous higher levels. In 2001, the 1,845 
mentions placed these depressants below cocaine, 
heroin, and narcotic analgesics/combinations, and just 
above marijuana in terms of the rate of mentions 
(exhibit 1). The majority of mentions were for 
benzodiazepines (73 percent). 
 
In the first half of 2002, there were 20 deaths in 
which depressants were identified, with a total of 26 
depressants identified among these decedents. 
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Depressant-related deaths have varied greatly over 
time, with a gradual trend upward over the past 7 
years. All deaths in the first half of 2002 involved 
multiple substances, with other opiates, identified in 
11 of the 20 deaths, the most common. Sixty percent 
of the decedents were female and 80 percent were 
Caucasian; the average age was 45. This is similar to 
demographics over the past 3 years, when 57 percent 
were female, the average age was 43, and 87 percent 
were Caucasian. Depressants are the only drug for 
which the majority of decedents are female. 
 
The ADHL reported data on adult calls related to 
benzodiazepines, barbiturates, and tranquilizers, which 
combined represented less than 1 percent of drugs 
mentioned by callers. 
 
Treatment data point to relatively few admissions for 
tranquilizers, barbiturates, benzodiazepines, and other 
sedatives or hypnotics. Combined, these substances 
accounted for 24 admissions in the first half of 2002, 
37 admissions in 2001, 12 in 2000, and 24 in 1999, 
never constituting more than 0.5 percent of all admis-
sions. Of this group, tranquilizers have shown the 
only substantial change; there were 32 treatment 
admissions for tranquilizer use between July 2001 
and June 2002, compared to 9 for the prior 2½ years.  
 
Hallucinogens and Club Drugs 
 
Hallucinogens include lysergic acid diethylamide 
(LSD), mescaline, peyote, psilocybin (mushrooms), 
and PCP. “ Club drugs”  is a general term used for 
drugs that are popular at nightclubs and raves, 
including the hallucinogens, methylenedioxymetham-
phetamine (MDMA or ecstasy), gamma hydroxybu-
tyrate (GHB), gamma butyrolactone (GBL, a precur-
sor to GHB) ketamine, and nitrous oxide. 
 
Recent short-term trends point to a slight decline in 
ED mentions of MDMA, with a statistically 
significant decrease of 20 percent between the first 
and second halves of 2001. Longer-term trends reveal 
a significant increase in MDMA mentions from 1999 
to 2001, from 32 to 115 (exhibit 1). In 1994, there 
were only 2 mentions of MDMA across the two-
county reporting area, compared with 115 in 2001. In 
2001, 59 percent of MDMA mentions were among 
males, similar to 2000. Whites represented the 
majority of MDMA mentions, though missing data 
were substantial for race/ethnicity. The largest 
proportion of mentions involved those age 18– 25, 
followed by 12– 17-year-olds and 26– 34-year-olds. In 
2001, nearly two-thirds of the mentions involving 
MDMA also involved other drugs. The most 
common reason for visiting the ED among those who 
had used only MDMA was an unexpected reaction, 
with the most common reason mentioned for taking 
the drug being psychic effects. 
 
GHB mentions have shown a pattern similar to 
MDMA mentions, with a peak in 2000 and a signifi-
cantly lower number, 39 mentions, in 2001. The age 
distribution of GHB mentions is different than that 
for MDMA, with GHB mentions most common 
among those age 18– 24 and 26– 34, with no mentions 
among those younger than 18. The majority were 
White and male. A majority, 55 percent, of GHB-
related ED visits were single drug episodes. 
 
PCP mentions increased 78 percent from the first half 
to the second half of 2001, to 82 mentions. The 
number of PCP ED mentions ALSO INCREASED 
SIGNIFICANTLY FROM 1994 TO 2001 (exhibit 1). 
Slang terms for various combinations of PCP with 
other drugs, often combined with marijuana ciga-
rettes, include “ shermans,”  “ wet,”  “ fry,”  and 
“ embalming fluid”  (embalming fluid refers to the use 
of embalming fluid to dissolve the PCP; no 
psychoactive effects are known to be caused by the 
embalming fluid itself). During 2001, 25 percent of 
those who mentioned using PCP also mentioned 
using marijuana; this is lower than the 43 percent 
reported nationally. Twenty-three percent of 128 PCP 
ED mentions were for PCP used alone. 
 
DAWN ED data indicate a 71-percent decrease in the 
number of LSD mentions from 1994 to 2001, from 
212 to 62 (exhibit 1). Forty-five percent of the 67 
LSD mentions were single drug episodes. ED 
mentions of psychedelic mushrooms increased 50 
percent from 1999 to 2001, returning to levels not 
seen since 1996. (Note that psychedelic mushrooms 
constituted all of the “ miscellaneous hallucinogen”  
category in 2001 and the majority of such mentions for 
all available data.) In 2001, 42 percent of ED visits for 
psychedelic mushrooms involved no other drugs. 
There was only one mention of ketamine in 2001. 
 
While there have been some significant changes in 
the ED mentions for club drugs, it is important to 
remember that MDMA, GHB, PCP, ketamine, psy-
chedelic mushrooms, and LSD combined only con-
stitute 5 percent of all ED drug mentions for 2001.  
 
The King County ME reported one club drug death 
during the first half of 2002, that of a 29-year-old 
Caucasian male caused by acute GHB intoxication. 
GHB was the only substance identified, and it was 
the first time that GHB was identified in a death in 
King County. Between 1999 and 2001, there were 
five club drug-related deaths, all involving MDMA. 
Of these MDMA-related deaths, three involved only 
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MDMA; one also involved methamphetamine and 
the other cocaine. 
 
ADAM data for drugs in this category are limited to 
PCP. Provisional data for the first half of 2002 shows 
2 percent (n=9) of male arrestees tested positive for 
PCP. Two percent of adult male arrestees also tested 
positive in 2001 for PCP, similar to the 1 percent 
reported in 2000. 
 
Treatment admissions for hallucinogens, inhalants, 
and PCP during the first half of 2002 (n=15) 
remained consistent with previous 6-month periods 
according to TARGET data. Anecdotal reports from 
treatment professionals indicate increasing numbers 
of youth and adult clients who report histories of 
hallucinogen and club drug use at assessment, but 
they rarely characterize this use as problematic. 
 
Calls to the ADHL regarding club drugs made up 4 
percent of all calls regarding illegal drugs in the first 
half of 2002 (n=102), with 70 calls about MDMA 
specifically. A higher proportion of youth called 
about ecstasy; 7 percent of youth calls were about 
ecstasy, compared with 2 percent of adult calls. 
 
Other sources of information concerning patterns of 
club drug use are mostly anecdotal. Prices for ecstasy, 
GHB, PCP, and LSD have remained stable over the 
last year (e.g., a 150– 250-milligram tablet of MDMA 
sells for $20– $30). The injection of pure MDMA 
powder (as opposed to dissolved ecstasy tablets) is 
becoming more popular among methamphetamine and 
cocaine injectors, although product availability is 
inconsistent. In April 2002, managers of two gay sex 
clubs in Seattle reported an unusual spike in near-fatal 
drug interactions and overdoses among customers. Ten 
incidents involving combinations of GHB, alcohol, 
methamphetamine, and nitrous oxide were reported; 
normally, one incident per month is the average for 
both clubs combined. 
 
A number of massive raves are produced in Seattle 
every year. The Seattle Fire Department reported 6 
large raves in the last 2 years, with attendance rang-
ing from 5,400 to 12,500 people. According to the 
Seattle Police Department, 8,700 people attended a 
June 2002 rave at which 29 people were arrested and 
864 MDMA pills were seized. Other drugs seized at 
that rave included mushrooms, diazepam/Valium, 
and marijuana. 
 
The U.S. Customs Service made 11 MDMA seizures 
totaling 132 pounds, with 1 seizure of 110 pounds 
from a commercial flight. This is first year that data 
on MDMA seizures were available. 
  
The DEA reports no significant cases involving traf-
ficking or manufacturing in club drugs in Washington 
State. GHB manufacturing labs have been found in 
Oregon, often in combination with methamphetamine 
labs. In September 2002, arrests were made in a case 
involving Internet sales of GBL from Canada to the 
United States, including locations in Oregon and 
Seattle. GBL is metabolized by the body and con-
verted into GHB. 
 
A significant relationship between MDMA use and 
increased risk for STDs in MSMs was seen among 
clients at PHSKC’s STD clinic. MSMs reported 
using MDMA at almost double the rate of heterosex-
ual men (15.8 percent compared with 8.2 percent) 
during the period of October 2001 to September 2002 
(p<0.0001). Among MSMs, there are significant 
associations between MDMA use and a higher 
number of sexual partners, contracting gonorrhea, 
and engaging in behaviors that increase the risk of 
contracting HIV. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE  
 
There are an estimated 12,000– 15,000 injection drug 
users who live in Seattle and King County. While 
there are distinct differences among races, the overall 
prevalence of HIV among non-MSM/IDU cases in 
King County appears to have remained low and sta-
ble over the past 14 years. Various sero-surveys con-
ducted in methadone treatment centers, correctional 
facilities, and through street- and community-targeted 
sampling strategies over this period yield an HIV 
prevalence estimate of 1– 2 percent among King 
County’s non-MSM/IDU population. Treatment-
based surveys, conducted from 1988 through 1999, 
indicate significant variance in HIV-infection rates 
among IDUs of color compared to Whites. The 
infection rate among African-American and Hispanic 
IDUs was 2– 3 times higher, and the rate among 
American Indian and Alaska Native IDU was 5– 6 
times higher, than that observed among White IDUs. 
No positive cases were found among Asian or Pacific 
Islander IDUs who entered treatment. Treatment 
clients who did not have permanent housing were 
significantly more likely to be HIV positive than 
those who were stably housed (3.4 percent vs. 1.6 
percent; p<0.5). 
 
The rate of HIV infection among the roughly 3,000 
male IDUs in King County who have the dual risk of 
same sex encounters is estimated at 47 percent for 
those who primarily inject methamphetamine and 14 
percent for those who primarily inject other drugs. 
The infection rate among MSM/IDUs who do not 
inject methamphetamine is comparable to the HIV 
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prevalence estimate for all MSMs in the Seattle area. 
As noted in other sections of this report, PHSKC 
STD clinic data point to a significant increased risk 
among MSMs of contracting STDs, including HIV, 
among those who use methamphetamine or MDMA 
compared to those MSMs who report never having 
used these drugs. 
 
Although overall HIV prevalence among IDUs in 
King County is relatively low, a high proportion of 
this population shows evidence of previous exposure 
to other blood-borne viruses. Epidemiologic studies 
conducted among more than 4,000 IDUs by Public 
Health’s HIV/AIDS Epidemiology Research Unit 
since 1994 reveal that 85 percent of King County 
IDUs may be infected with hepatitis C (HCV), and 
70 percent show markers of prior infection with 
hepatitis B (HBV). Incidence studies indicate that 21 
percent of noninfected Seattle-area IDUs acquire 
HCV each year, and 10 percent of IDUs who have 
not had hepatitis B acquire HBV. The HIV incidence 
rate among IDUs in these studies was estimated to be 
less than 0.5 percent per year. High prevalence and 
alarming transmission rates for HBV and HCV sug-
gest that injection risk behaviors persist, creating 
potential for the future spread of HIV among IDUs in 
King County. 
 
More detailed information on HIV/AIDS in King 
County and other counties in the State is presented in 
exhibit 5. 
 
For inquiries concerning this report, please contact Caleb Banta-Green, MPH, MSW, Alcohol and Drug Abuse Institute, University of Washing-
ton, 1107 NE 45th St, Suite 120; Seattle, WA 98105, Phone: (206) 685-3919, Fax: (206) 543-5473, E-mail: <calebbg@u.washington.edu>, Web: 
<http://adai.washington.edu>.  
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Exhibit 1.  Estimated Number of DAWN ED Mentions in the Seattle Area:  1994–2001 
0
500
1,000
1,500
2,000
2,500
3,000
3,500
4,000
Alcohol-in-combination 2,900 2,272 2,149 2,988 2,221 2,228 3,173 3,145
Cocaine 3,029 2,158 2,143 2,850 2,399 2,519 3,338 3,409
Heroin 2,137 2,023 2,418 2,894 2,421 2,470 2,490 1,927
Marijuana 910 993 899 1,663 936 808 1,414 1,596
Amphetamines 186 233 178 462 293 345 640 699
Methaphetamine 309 258 195 479 266 353 540 395
Antidepressants 1,150 817 780 839 646 587 796 798
Depressants 1,912 1,421 1,360 1,634 1,275 1,092 1,611 1,845
Narcotic analgesics 1,215 954 943 1,422 1,104 1,237 1,699 2,560
1994 1995 1996 1997 1998 1999 2000 2001
0
50
100
150
200
250
300
MDMA (ecstasy) 2 10 12 20 19 32 128 115
LSD 212 245 182 163 94 121 107 62
PCP 20 36 50 49 47 47 116 128
Misc. hallucinogens 74 41 60 53 45 48 37 72
GHB 0 0 3 17 34 57 39
1994 1995 1996 1997 1998 1999 2000 2001
Most frequent 
drugs 
Hallucinogens 
and “club drugs” 
1 
1
 Barbiturates, benzodiazepines, misc. anxiolytics, sedatives, and hypnotics. 
1
 Dots (…) indicate that an estimate with a relative standard error greater than 50 percent has been suppressed. 
 
SOURCE:  DAWN, OAS, SAMHSA 
…
1
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1H 1999 2H 1999 1H 2000 2H 2000 1H 2001 2H 2001 1H 2002 
Description N % N % N % N % N % N % N % 
Alcohol2 1,910 44.2 2,331 43.3 2,130 38.9 1,935 38.8 1,951 41.2 1,745 41.5 1,635 39.7 
Amphetamines 28 0.7 39 0.7 52 1.0 30 0.6 46 1.0 28 0.7 28 0.7 
Heroin 732 216.9 956 17.8 1,032 18.9 929 18.6 636 13.4 606 14.4 661 16.0 
Marijuana 763 17.6 958 17.8 1,119 20.4 948 19.0 986 20.8 819 19.5 845 20.5 
Cocaine 583 13.5 752 14.0 731 13.4 666 13.4 649 13.7 501 11.9 495 12.0 
Methamphetamine 212 4.9 260 4.8 317 5.8 392 7.9 379 8.0 394 9.4 366 8.9 
Other Opiates 43 1.0 40 0.7 36 0.7 40 0.8 41 0.9 54 1.3 29 0.7 
Other Drugs 55 1.3 46 0.9 58 1.1 46 0.9 50 1.0 61 1.4 61 1.5 
Total 4,326 100 5,382 100 5,475 100 4,986 100 4,738 100 4,208 100 4,120 100 
 
1
 Primary substances include duplicated admissions to treatment. Counts for the first half of 2002 are preliminary because of delays in  
  data entry. 
2
 Alcohol includes alcohol alone and in combination with other drugs 
 
SOURCE:  Washington State TARGET data system— Structured Ad Hoc Reporting System
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1H 1999 2H 1999 1H 2000 2H 2000 1H 2001 2H 2001 1H 2002
Alcohol Amphetamines Heroin
Marijuana Cocaine Methamphetamine
Other Opiates Other Drugs
Exhibit 2.  Half-Yearly Trends in Primary1 Alcohol/Drug Treatment Admissions in Seattle-King  
                  County by Drug and Percent:  January 1999–June 2002 
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Exhibit 3. Drugs Identified in Drug-Caused Deaths in Seattle-King County by Number: January 
    1994–June 20021  
0
10
20
30
40
50
60
70
80
90
# 
of
 T
im
es
 
D
ru
g 
Id
en
tifi
ed
Heroin 40 49 52 79 74 61 60 51 56 87 61 56 66 36 34 27 48
Cocaine 24 41 37 32 38 36 37 29 27 42 42 34 51 38 29 20 49
Alcohol 35 27 36 49 51 36 48 33 51 52 31 36 42 34 19 13 28
Other Opiates 14 14 5 9 15 16 16 13 25 23 24 10 26 23 29 26 31
Depressants 12 11 6 14 20 17 15 23 25 26 16 14 21 16 32 16 26
Antidepressants 22 17 12 11 14 19 17 24 24 25 14 20 24 24 27 19 27
Amphetamines 1 0 4 2 2 2 1 5 1 2 2 12 7 4 3 2 5
Total Deaths 75 83 81 102 112 106 103 76 102 120 103 102 130 89 86 67 102
1994 
H1
1994 
H2
1995 
H1
1995 
H2
1996 
H1
1996 
H2
1997 
H1
1997 
H2
1998 
H1
1998 
H2
1999 
H1
1999 
H2
2000 
H1
2000 
H2
2001 
H1
2001 
H2
2002 
H1
 1
 More than one drug is often identified per individual drug overdose death; table excludes poison-related deaths. 
2
 The amphetamines identification category includes methamphetamine but does not include MDMA. 
 
SOURCE: Medical Examiner, PHSKC 
2 
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Exhibit 4: Rate of Heroin-Involved Deaths Per 100,000 Population in Seattle-King County:   
    1989–2001  
 
3.3 2.7
3.7
5.3 5.7
8.2 8.2
6.7
8.8
7
5.7
3.53.6
0
2
4
6
8
10
1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001
 
*Note that rates from 2000 onward are calculated using the 2000 census population, prior years are calculated using  the 1990 
census, except for 1989. 
 
SOURCE:  Medical Examiner, Public Health-Seattle & King County  
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Exhibit 5. Demographic Characteristics of HIV Diagnoses, Including AIDS, in Seattle-King  
 County, Other Washington Counties, Washington State, and the United States:   
 Cumulative Through June 30, 2002, Data Reported as of October 31, 2002  
 
Case Numbers & Deaths King County HIV Including AIDS 
Other WA Counties 
HIV Including AIDS 
Washington State 
HIV Including AIDS 
United States1 
AIDS Only 
Cumulative Diagnoses 
Cumulative Deaths 
Currently Living 
8,632 
3,774 
4,858 
4,599 
1,939 
2,660 
1,3231 
5,713 
7,518 
816,149 
467,910 
348,239 
King County2 Other WA Counties2 Washington State2 United States3 Case Demographics 
(Last 3 Years Number Percent Number Percent Number Percent Number Percent 
Gender 
 Male 
 Female 
 
934 
123 
 
88 
12 
 
516 
126 
 
80 
20 
 
1,450 
249 
 
85 
15 
 
92,041 
31,601 
 
74 
26 
Age 
 12 and younger 
 13–19 
 20–29 
 30–39 
 40–49 
 50–59 
 60 and older 
 
4 
12 
219 
496 
249 
65 
12 
 
0 
1 
21 
47 
24 
6 
1 
 
1 
12 
123 
270 
162 
52 
22 
 
0 
2 
19 
42 
25 
8 
3 
 
5 
24 
342 
766 
411 
117 
34 
 
0 
1 
20 
45 
24 
7 
2 
 
– 
– 
– 
– 
– 
– 
– 
 
Race/Ethnicity 
 White 
 Black 
 Hispanic 
 Asian 
 Native American 
 Unknown 
 
673 
234 
107 
29 
8 
6 
 
64 
22 
10 
3 
1 
1 
 
423 
85 
84 
18 
21 
11 
 
66 
13 
13 
3 
3 
2 
 
1,096 
319 
191 
47 
29 
17 
 
65 
19 
11 
3 
2 
1 
 
36,363 
60,980 
24,456 
1,197 
537 
109 
 
29 
49 
20 
1 
0 
0 
Exposure Category 
 Male-male sex 
 Injection drug user 
 IDU & male-male sex 
 Heterosexual contact 
 Hemophilia 
 Transfusion 
 Mother at risk/has AIDS 
 Undetermined/other 
 
672 
78 
74 
121 
2 
5 
3 
102 
 
64 
7 
7 
11 
0 
0 
0 
10 
 
285 
115 
38 
94 
– 
1 
1 
108 
 
44 
18 
6 
15 
0 
0 
0 
17 
 
957 
193 
112 
215 
2 
6 
4 
210 
 
56 
11 
7 
13 
0 
0 
0 
12 
 
48,835 
33,534 
5,789 
33,027 
481 
1,029 
400 
547 
 
39 
27 
5 
27 
0 
1 
0 
0 
Total HIV Cases Diagnosed 
in Last 3 Years 1,057  642  1699  123,642  
 
Technical Note: The US data do not show specific incidence estimates for hemophilia or transfusion cases for 2000 and 2001,  
     these numbers were interpolated from earlier incidence data.  Also, the U.S. data do not show specific incidence  
     estimates for subdivisions of pediatric cases.  Therefore, the pediatric cases were redistributed by sex and race,  
     and assumed to be perinatal.  
 
1
 U.S. data are limited to AIDS cases only, reported through 12/31/2001; age distribution by year is not available for U.S. AIDS cases. 
2
 Diagnosed between 7/1/1999 and 6/30/2002, reported through 10/31/2002. 
3
 AIDS cases only, diagnosed between 1/1/1999 and 12/31/2002, reported through 12/31/2002. 
 
SOURCES:  PHSKC, WA State Department of Health, Centers for Disease Control and Prevention 
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ABSTRACT 
 
Crack cocaine is the illicit drug for which 21 percent 
of adult clients enter treatment. The proportion of 
Anglo and Hispanic admissions for crack now totals 
48 percent as African-American crack admissions 
decline. Powder cocaine inhalers tend to be His-
panic, and injectors tend to be Anglo. The rate of 
emergency department (ED) mentions of cocaine in 
Dallas has declined. Cocaine is a significant prob-
lem on the border. Alcohol is the primary drug of 
abuse in Texas in terms of dependence, deaths, 
treatment admissions, and arrests. Alcohol use 
among Texas secondary school students between 
2000 and 2002 was stable. Heroin addicts entering 
treatment are primarily injectors and are most likely 
to be Hispanic or Anglo males. ED mentions of 
heroin in Dallas have declined. Mexican heroin is 
more available and purer, with several recent 
samples at 60–70 percent. There are reports of 
efforts to begin marketing South American heroin in 
the Dallas area. Hydrocodone is a much larger 
problem in Texas than oxycodone. Codeine cough 
syrup continues to be abused. Seventy-five percent of 
youths entering treatment report marijuana as their 
primary problem drug. Dallas ED mentions of 
marijuana have declined. The 2002 school survey 
found that student use in grades 7 and 8 continues 
to decline, but those in higher grades has increased 
since 2000. Methamphetamine and amphetamines 
are widely available and are a problem, particularly 
in the northern part of the State. Alprazolam 
(Xanax) mentions are increasing in ED and 
Department of Public Safety lab reports. Club drug 
use continues to spread, with those who began using 
these drugs several years ago now appearing in 
treatment. Ecstasy ED cases and treatment admis-
sions continue to rise, and the 2002 secondary 
school survey showed that student lifetime use rose 
from 4.5 percent in 2000 to 8.6 percent in 2002. 
GHB, GBL, and similar precursor drugs remain a 
problem, particularly in the Metroplex area, with a 
high rate of ED mentions. Rohypnol remains a 
problem along the border. Ketamine continues as a 
problem, with the Dallas ED rate above the national 
level. Use of marijuana joints dipped in embalming 
fluid that can contain PCP (‘fry’) continues, with  
 
cases seen in the poison control centers, emergency 
rooms, and treatment. DXM continues to be a 
problem with adolescents. The proportions of AIDS 
cases related to injection drug use and to the 
heterosexual route of transmission are increasing, 
as are the proportions of females and persons of 
color. The proportion of needle users entering 
treatment continues to decrease. 
 
INTRODUCTION 
 
Area Description 
 
The population of Texas in 2001 was 21,175,281, 
with 52 percent being Anglo, 11 percent African-
American, 32 percent Hispanic, and 3 percent “ other.”  
Illicit drugs continue to enter from Mexico through 
cities such as El Paso, Laredo, McAllen, and 
Brownsville, as well as smaller towns along the bor-
der. The drugs then move northward for distribution 
through Dallas/Fort Worth and Houston. In addition, 
drugs move eastward from San Diego through 
Lubbock and from El Paso to Amarillo and Dal-
las/Fort Worth. A major problem is that Mexican 
pharmacies sell many controlled substances to U.S. 
citizens, who can legally bring up to 50 dosage units 
into the United States. The use of private and express 
mail companies to traffic narcotics and smuggle 
money continues to increase. Seaports are used to 
import heroin and cocaine via commercial cargo ves-
sels. The international airports in Houston and 
Dallas/Fort Worth are major ports for the distribution 
of drugs in and out of the State. 
 
Data Sources 
 
Substance Abuse Trends in Texas is an ongoing series 
that is published every 6 months as a report to the 
Community Epidemiology Work Group meetings 
sponsored by the National Institute on Drug Abuse. 
To compare December 2002 data with earlier periods, 
please refer to previous editions that are available in 
hard copy from the Texas Commission on Alcohol 
and Drug Abuse (TCADA) or on the TCADA Web 
page at <http://www.tcada.state.tx.us/research/sub 
abusetrends.html> and at the Web page of the Gulf  
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Coast Addiction Technology Transfer Center at 
<http://www.utattc.net>. 
 
Data for this report were obtained from the following 
sources: 
 
• Price, purity, trafficking, distribution, and 
supply information was provided by quarterly 
2002 reports on trends in trafficking from the 
Dallas, El Paso, and Houston Field Divisions of 
the Drug Enforcement Administration (DEA). 
 
• Treatment data are from the Texas Commission 
on Alcohol and Drug Abuse (TCADA) Client 
Oriented Data Acquisition Process (CODAP). 
The data cover clients at admission to treatment 
in TCADA-funded facilities from the first quarter 
of 1983 through December 31, 2002; however, 
only partial data have been available for Dallas 
County since July 1999. For most drugs, the 
characteristics of clients entering with a primary 
problem with the drug are discussed, but in the 
case of emerging club drugs, information is 
provided on any client with a primary, secondary, 
or tertiary problem with that drug. 
 
• Overdose death data on drug overdose deaths 
statewide through 2001 came from death 
certificates from the Bureau of Vital Statistics of 
the Texas Department of Health. Data on the 
Dallas and San Antonio metropolitan areas came 
from the mortality data from the Drug Abuse 
Warning Network (DAWN), 2000, published by 
the Substance Abuse and Mental Health Services 
Administration (SAMHSA). 
 
• Emergency department drug mentions data in 
the Dallas area emergency departments (EDs) 
through 2001 came from DAWN, Office of 
Applied Studies, SAMHSA.  
 
• Drug use by arrestees data are from the 
Arrestee Drug Abuse Monitoring Program 
(ADAM) of the National Institute of Justice (NIJ) 
through the third quarter of 2002 for Laredo and 
San Antonio. Note that, because of changes in 
methodology, data prior to 2000 are not 
comparable to data after 2000, and that data on 
male and female arrestees are not comparable. 
The 2000 and 2001 data on adult male arrestees 
represent weighted data; all other data are 
unweighted or provisional. 
 
• Arrest data are from the Uniform Crime Report 
(UCR) collected by the Texas Department of 
Public Safety (DPS). 
 
• Student substance use data came from 
TCADA’s Texas School Survey of Substance 
Abuse: Grades 7-12 2002 and Texas School 
Survey of Substance Abuse: Grades 4-6 2002. 
 
• Adult substance use data came from TCADA’s 
2000 Texas Survey of Substance Use Among 
Adults. 
 
• Poison control center data are from the Texas 
Poison Control Centers for 1998, 1999, 2000, 
2001, and 2002. 
 
• Drugs identified by laboratory tests are from 
the National Forensic Laboratory Information 
System (NFLIS), which reported data collected 
by all of the Texas Department of Public Safety 
(DPS) laboratories for 1998 through August 
2002.  
 
• Acquired immunodeficiency syndrome (AIDS) 
data are from the Texas Department of Health 
(TDH), which provided annual and year-to-date 
AIDS data for the period ending September 30, 
2002. 
 
• Street outreach reports provided drug trends for 
June– August 2002 and were reported to TCADA 
by the human immunodeficiency virus (HIV) 
street outreach workers. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Cocaine and Crack 
 
The TCADA Texas School Survey of Substance 
Abuse: Grades 7-12 2002 found that 7.2 percent of 
students in nonborder counties had ever used powder 
cocaine, and 2.5 percent had used cocaine in the past 
month. In comparison, students in schools on the 
Texas border reported higher levels of powder 
cocaine use: 13.3 percent lifetime and 6.0 percent 
past-month use. Use of crack was lower, with non-
border students reporting 2.7 percent lifetime and 0.6 
percent past-month use; border students reported 4.0 
percent lifetime and 1.5 percent past-month use. 
Lifetime use by grade is shown in exhibit 1.  
 
TCADA’s 2000 Texas Survey of Substance Use 
Among Adults reported 12 percent of Texas adults had 
ever used powder cocaine and 1 percent had used it in 
the past month, up from 10 percent lifetime and 0.4 
percent past-month use in 1996. The increase in past-
year use (1.4 percent to 1.9 percent) was statistically 
significant. The levels of crack cocaine use did not 
change between 1996 and 2000 (2 percent lifetime 
and 0.1 percent past month). 
 
Texas Poison Control Centers reported 497 confirmed 
cocaine exposure cases in 1998, 498 misuse or abuse  
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cases involving cocaine in 1999, 874 in 2000, 1,024 
in 2001, and 1,195 in 2002. 
 
Exhibit 2 shows that the rate of cocaine ED mentions 
per 100,000 population in the Dallas DAWN data 
continued to decrease from the peak period in 1998. 
The decreases in rates between 2000 and 2001 were 
statistically significant for both genders and for all 
age groups except those under age 18. 
 
Cocaine (crack and powder) accounted for 29 percent 
of all adult admissions to TCADA-funded treatment 
programs in 2002. Crack cocaine is the primary illicit 
drug abused by adult clients admitted to publicly 
funded treatment programs throughout Texas, al-
though it dropped from 28 percent of all adult 
admissions in 1993 to 21 percent in 2002.  
 
Abusers of powder cocaine constitute 8 percent of all 
admissions to treatment. Cocaine inhalers are the 
youngest and the most likely to be Hispanic and 
involved in the criminal justice or legal system. 
Cocaine injectors are older than inhalers but younger 
than crack smokers and are more likely to be Anglo 
(exhibit 3). 
 
The term “ lag”  refers to the period from first con-
sistent or regular use of a drug to date of admission to 
treatment. Powder cocaine inhalers average 9 years 
between first regular use and entrance to treatment, 
while injectors average 13 years of use before they 
enter treatment. 
 
Between 1987 and 2002, the percentage of treatment 
admissions using powder cocaine who are Hispanic 
increased from 23 percent to 45 percent, while for 
Anglos, the proportion dropped from 48 percent to 44 
percent. The proportion of African-Americans also 
dropped, from 28 percent to 10 percent. Exhibit 4 not 
only shows this increase by Anglos and Hispanics in 
the use of powder cocaine, but it also shows that the 
proportion of crack cocaine admissions who are 
African-American dropped from 75 percent in 1993 to 
51 percent in 2002, while the proportion of Anglos 
increased from 20 percent in 1993 to 33 percent in 
2002. The percentage of Hispanic admissions in-
creased from 5 to 14 percent in the same time period.  
 
Powder cocaine was the primary drug of abuse for 6 
percent of youths entering treatment during 2002. 
Crack cocaine accounted for 1 percent of all youth 
admissions. Of the powder cocaine admissions, 73 
percent were Hispanic and 21 percent were Anglo. Of 
the crack cocaine admissions, 55 percent were His-
panic and 35 percent were Anglo. 
 
The number of deaths in which cocaine was 
mentioned increased to a high of 491 in 2001 (exhibit 
5). The average age of the decedents continued to  
 
increase to 38.7 years in 2001. Of these decedents, 42 
percent were Anglo, 28 percent were Hispanic, and 28 
percent were African-American. Seventy-six percent 
were male. 
 
The DAWN medical examiner system reported that 
the number of deaths in the Dallas area involving a 
mention of cocaine increased from 134 in 1996 to 157 
in 2000, while in San Antonio, the number of deaths 
with a mention of cocaine increased from 63 in 1996 
to 126 in 2000. 
 
The proportion of arrestees testing positive for 
cocaine has decreased from the peak periods in the 
early 1990s. The high percentage of male and female 
arrestees in Laredo testing positive for cocaine shows 
the extent of the cocaine problem on the border 
(exhibit 6).  
 
Exhibit 7 shows the proportion of substances 
identified by the DPS labs which were cocaine. In 
2002, cocaine accounted for 35 percent of all items 
examined by the labs. 
 
In the second half of 2002, powder cocaine was 
reported by the DEA as being abundant, especially at 
the retail level in ounce and gram quantities. 
Intelligence suggests that kilogram quantities of 
cocaine are available and that the major trafficking 
organizations in Houston, El Paso, and Laredo have 
multiple sources of supply from Mexico. Intelligence 
also indicates that drug trafficking organizations on 
the east coast are interested in obtaining supplies of 
cocaine through Dallas, where prices are lower than 
on the east coast. 
 
The DEA also reports that crack cocaine is readily 
available. Normally, powder cocaine is transported to 
Dallas and then cooked locally for sale. However, 
since the penalties for crack are more severe, some 
dealers are opting not to convert powder to crack. 
Crack is the most common illicit drug in the Tyler 
area, and runners from Northeast Texas travel to 
Dallas and Houston to obtain pound and kilogram 
amounts of crack for sale.  
 
A rock of crack costs between $10 and $100, with $10 
being the most common price. An ounce of crack 
cocaine costs $375– $900 in Houston, $500– $800 in 
Dallas, $550– $750 in Tyler, $500– $800 in Beaumont, 
$650– $850 in Amarillo and Lubbock, $400– $650 in 
San Antonio, $830 in El Paso, $600– $850 in 
McAllen, and $700– $750 in Fort Worth. 
 
Depending on location in the State, a gram of powder 
cocaine sells for $40– $100. A gram costs $50– $100 
in Dallas, $50– $60 in El Paso, $70– $90 in Midland, 
$80– $100 in Houston, and $100 in Alpine, Amarillo,  
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and Lubbock. An ounce ranges between $400 and 
$1,200. An ounce costs $400– $500 in Laredo, $450–
$800 in Houston, $500– $1,200 in Dallas, $600 in 
Alpine, $600– $800 in McAllen, $400– $600 in San 
Antonio, $650– $850 in Amarillo and Lubbock, $700–
$1,000 in Tyler, and $750 in Fort Worth. A kilogram 
sells for $11,000– $23,000 (exhibit 8).  
 
In Austin, according to street outreach workers, crack 
cocaine is plentiful but the quality is poor. The prices 
on the street range from $5 to $20; three $20 rocks 
can be purchased for $40. Crack users who want to 
inject crack are now using citric acid, rather than 
lemon juice, since it is less harmful to the veins. In El 
Paso, the number of crack users is reportedly in-
creasing, particularly among the older adolescent and 
young adult populations on the west side of the city. 
 
Alcohol 
 
Alcohol is the primary drug of abuse in Texas. The 
1998 secondary school survey found that 72 percent 
of the students had ever drunk alcohol and 38 percent 
had drunk in the past month; in 2000, 71 percent had 
ever drunk alcohol and 36 percent used it in the past 
month; in 2002, 71 percent had ever used alcohol and 
35 percent had used in the past month.  
 
Among students in grades 4– 6 in 2002, 25 percent 
had ever drunk alcohol and 16 percent had drunk in 
the past school year. 
 
The 2000 Texas adult survey found that 66 percent of 
Texas adults reported having drunk alcohol in the past 
year. In 1996, 65 percent reported past-year drinking. 
In 2000, 17 percent reported binge drinking, and 6 
percent reported heavy drinking in the past month. 
Some 15.7 percent of all adults reported problems 
with alcohol use in the past year in 2000; 16.8 percent 
reported past-year problems in 1996. In comparison, 
5.2 percent of adults in 2000 and 4.1 percent of adults 
in 1996 reported past-year problems with the use of 
drugs. 
 
The number of mentions per 100,000 population of 
alcohol in combination with other drugs in Dallas 
EDs peaked in 1998 (exhibit 9).  
 
In 2002, 35 percent of adult clients admitted to 
publicly funded programs had a primary problem with 
alcohol. They were the oldest of the clients (average 
age of 38); 57 percent were Anglo, 23 percent were 
Hispanic, and 18 percent were African-American. The 
majority (71 percent) were male.  
 
Among adolescents, alcohol constituted 9 percent of 
all treatment admissions. Some 65 percent were male; 
64 percent were Hispanic, 28 percent were Anglo, 
and 6 percent were African-American. Eighty percent 
were involved with the juvenile justice or legal 
systems. 
 
Far more persons die as an indirect result of alcohol 
than from the direct result of alcohol, as exhibit 10 
shows. Direct deaths are those in which the substance, 
alcohol or drugs caused the death, while indirect 
deaths are those in which the actual cause of death 
was due to another reason, such as a car wreck or a 
violent crime, but alcohol or drugs were involved.  
 
More Texans are arrested for public intoxication (PI) 
than for any other substance abuse offense, although 
the arrest rate for PI per 100,000 is decreasing; the 
rates for the other substance abuse offenses are fairly 
level (exhibit 11).  
 
Heroin 
 
The proportion of Texas secondary students reporting 
lifetime use of heroin dropped from 2.4 percent in 
1998, to 1.6 percent in 2000, to 1.7 percent in 2002. 
Past-month use dropped from 0.7 percent in 1998 to 
0.5 percent in 2000 and 2002. 
 
The 2000 Texas adult survey found that 1.2 percent of 
adults reported lifetime use of heroin and 0.1 percent 
reported past-month use. 
 
Calls to Texas Poison Control Centers involving 
confirmed exposures to heroin rose from 181 in 1998, 
to 218 in 1999, to 295 in 2000, to 241 in 2001, to 221 
in 2002. 
 
The rate of Dallas ED mentions of heroin per 100,000 
population has dropped since the peaks in 1997 and 
1998 (exhibit 12). 
 
Heroin ranks third after alcohol and cocaine as the 
primary drug for which adult clients are admitted to 
treatment. It accounted for 12 percent of admissions 
in 2002, compared with 9 percent in 1993. The char-
acteristics of these addicts vary depending on the 
route of administration, as exhibit 13 shows. 
 
Most heroin addicts entering treatment inject heroin. 
While the number of individuals who inhale heroin is 
small, it is significant to note that the lag period from 
first use to seeking treatment is 10 rather than 15 
years for injectors. This shorter lag period means that 
contrary to street rumors that “ sniffing or inhaling is 
not addictive,”  inhalers will need treatment much 
more quickly than needle users.  
 
Exhibit 14 shows that over time, African-Americans 
have been much less likely to enter treatment for 
heroin abuse than Anglos or Hispanics. 
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Only 1.4 percent of all adolescents admitted to 
TCADA-funded treatment programs reported a pri-
mary problem of heroin. Of these youths, 92 percent 
were Hispanic. 
 
The number of deaths with a mention of heroin or 
narcotics statewide decreased from a high of 374 in 
1998 to 339 in 2001 (exhibit 15). Of the 2001 
decedents, 54 percent were Anglo, 36 percent were 
Hispanic, and 8 percent were African-American; 81 
percent were male and the average age was 39.1 
years. 
 
The DAWN ME reporting system, which collects 
more detailed reports from medical examiners in the 
Dallas and San Antonio areas, reported that the 
number of deaths involving a mention of heroin or 
morphine in the Dallas area increased from 66 in 1996 
to 94 in 2000, while in the San Antonio area, the 
number of deaths involving a mention of heroin or 
morphine increased from 51 in 1996 to 90 in 2000. 
 
The results for arrestees testing positive for opiates 
between 1991 and 2002 have remained mixed, except 
for the increase by Laredo females (exhibit 16). 
 
Exhibit 7 shows that the proportion of items identified 
as heroin by DPS labs remained consistent at 1 to 2 
percent over the years. 
 
According to the DEA, heroin is more available, and 
heroin from Mexico is increasing in purity. The 
decline in availability in 2000 was caused by a 
drought in Mexico in 1999– 2000. Heroin is reported 
as readily available in El Paso. In the Houston DEA 
Division, the availability and purity fluctuates from 
stable to increasing, even though the division 
experienced an unprecedented number of high volume 
heroin seizures, which reflects increasing availability 
and purity along the border. While purity in Houston 
was lower in 2000 and 2001, the purity for the first 
half of 2002 averaged 28 percent. Large seizures are 
being made. A seizure of 33.5 kilograms of Mexican 
heroin at a purity of 70 percent was made in April 
2002 near San Antonio. In Laredo, a free sample of 
white heroin at 95 percent pure was obtained in the 
summer of 2002. In mid-August 2002, four 
individuals died from heroin overdoses in Laredo, and 
another 25 nonfatal overdoses have been reported. 
Street-level samples obtained in Laredo during this 
period showed purities of 60 percent, 63 percent, and 
67.7 percent. In the Dallas Field Division, purity for 
2002 averaged 30 percent, with a range of 4.6 to 67 
percent. In the Houston Field Division, the average 
purity was 28 percent. 
 
At the same time, intelligence indicates that South 
American heroin is more available in the Dallas area, 
and that this heroin is intended not only for  
 
distribution and transshipment but also for con-
sumption by local users. Heroin traffickers are 
reportedly interested in expanding operations in and 
around Dallas for greater distribution of heroin in the 
Metroplex. In addition, reports have been received of 
white heroin now being produced in Mexico. 
 
The predominant form of heroin in Texas is black tar, 
which has a dark gummy, oily texture. In the Austin 
area, a hit is referred to as a “ balloon.”  The piece of 
black tar is placed in a small piece of plastic and then 
placed in a small balloon. The cost of an ounce of 
black tar heroin has decreased (exhibit 17). 
Depending on the location, black tar heroin sells on 
the street for $10– $20 per capsule, $50– $350 per 
gram, $500– $4,500 per ounce, and $35,000– $60,000 
per kilogram. In the Dallas area, heroin costs $10– $20 
per capsule, $1,600– $2,800 per ounce, and $35,000–
$60,000 per kilogram. In Fort Worth, an ounce costs 
$1,200– $1,900, and a kilogram sells for $50,000. In 
El Paso, heroin costs $100 per gram, $1,000– $1,500 
per ounce, and $31,300 per kilogram. In Alpine, 
heroin costs $20 per bag, $125 per gram, and $2,100–
$2,200 per ounce; in Midland, an ounce costs between 
$2,300 and $4,800. An ounce costs $1,000– $2,000 in 
Houston, $1,200– $1,400 in Laredo, $2,500– $3,000 in 
McAllen, and $1,800– $3,100 in San Antonio. 
 
Mexican brown heroin, which is black tar that has 
been cut with lactose, manitol, baby laxative, coffee 
creamer, Benadryl, vitamin B, or another substance 
and then turned into a powder, costs $10 per capsule, 
$110– $300 per gram, and $700– $3,000 per ounce. In 
Fort Worth, it is packaged in a gel capsule and 
referred to as “ a pill,”  with 10– 15 pills in a gram.  
 
Brown heroin can be injected or inhaled. Black tar 
can be diluted with water and either injected or 
inhaled (“ shebang,”  “ waterloo,”  “ monkey water,”  
“ aqua de chango” ) by squirting the liquefied heroin 
solution up the nose using a syringe with the needle 
broken off, with a nasal sprayer, medicine dropper, or 
cotton swab that has been soaked in the solution. 
 
Colombian heroin sells for $2,000 per ounce and 
$60,000– $70,000 per kilogram in the Dallas area. 
Southwest Asian heroin costs $70,000 per kilogram in 
Dallas. 
 
The Domestic Monitor Program (DMP) of the DEA is 
a heroin purchase program that provides data on the 
purity, price, and origin of retail-level heroin 
available in the major metropolitan areas of the 
nation. As exhibit 18 shows, over time, the purity and 
price varies, although it is purer and cheaper in El 
Paso as compared to farther from the border. The 
DMP also reports that heroin from sources other than 
Mexico was found in 2001. Of the street “ buys”  in  
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Dallas, 32 were Mexican, 5 were Southeast Asian, 
and 1 was unknown. In El Paso, 15 were Mexican and 
1 was unknown. In Houston, 38 were Mexican, 1 was 
South American, and 1 was unknown.  
 
AIDS outreach workers in Austin report that the 
quality of heroin is very good and availability is 
plentiful. In June, it was reported that “ pure”  heroin 
was being brought to Austin straight from Mexico, 
but no specifics were given about what was 
considered “ pure.”  Heroin drug dealers were report-
edly giving out “ hot shots”— a mix of heroin and rat 
poison— to people on a hit list whom they wanted to 
kill. Some eight deaths were reported within the 
community within about three months, but they were 
not publicized. One veteran heroin addict who has 
been consistently using over a 20-year period reported 
that he injected one $20 hit of heroin and nodded out 
in the bathroom for over 4 hours because of the high 
quality of the heroin. Also, there have been reports 
that heroin is being cut with an unknown substance 
that causes boils and/or big lumps on the site of 
injection. Some of the Hispanic males in their fifties 
and older who had not been using heroin in years 
began to use again because of the high quality of the 
drug. 
 
Outreach workers in El Paso report that purity of 
black tar is up, and there were eight fatal overdoses in 
a period of 2 weeks. 
 
In the Lower Rio Grande Valley, outreach workers 
reported seeing an increase of young persons age 16–
21 injecting heroin. For several years there was an 
increase in cocaine use among young persons in this 
area. However, outreach workers are now reporting 
increases in heroin injection. This trend is happening 
in the smaller Valley communities such as Donna, 
Weslaco, and Mercedes, as opposed to the larger 
Valley cities such as McAllen and Brownsville. 
 
Other Opiates  
 
This group excludes heroin but includes opiates such 
as methadone, codeine, hydrocodone (Vicodin, Tus-
sionex), oxycodone (OxyContin, Percodan, Percocet-
5, Tylox), d-propoxyphene (Darvon), hydromorphone 
(Dilaudid), morphine, meperidine (Demerol), and 
opium.  
 
The 2000 Texas adult survey found that in 2000, 
lifetime use of other opiates was 4.4 percent and past-
month use was 0.5 percent; in comparison, in 1996, 
lifetime use was 3 percent and past-month use was 0.2 
percent. Some 2.3 percent of Texas adults in 2000 
reported ever having used codeine, and 0.7 percent 
used in the past year. Lifetime use of hydrocodone 
was 0.7 percent, and past-year use was 0.4 percent. 
 
Hydrocodone is a larger problem in Texas than is 
oxycodone. The poison control centers reported there 
were 429 abuse or misuse calls concerning hydro-
codone in 2002. In comparison, there were 68 calls 
about misuse or abuse of OxyContin or oxycodone 
reported in same period. There were also 19 cases 
involving methadone in 1999, 32 cases in 2000, 28 in 
2001, and 54 in 2002.  
 
Dallas area ED mentions of hydrocodone and hydro-
codone in combination with other substances have 
increased over the years; the increase between 1994 
and 2001 was statistically significant, as was the 
increase in mentions of oxycodone and oxycodone in 
combination (exhibit 19).  
 
Some 4.2 percent of all adults who entered treatment 
during 2002 used opiates other than heroin. Of these, 
61 used illegal methadone and 1,762 used other 
opiates. Those who reported a primary problem with 
illicit methadone were equally likely to be male or 
female (50 percent each), 36 years old, Anglo (80 
percent) or Hispanic (18 percent). Twelve percent 
were homeless, 13 percent were employed, 41 percent 
were referred by the criminal justice system, and 41 
percent had never been in treatment before. Of those 
with problems with other opiates, 57 percent were 
female; the average age was 36; 83 percent were 
Anglo; 32 percent had never been in treatment; 9 
percent were homeless; 14 percent were employed; 
and 29 percent were referred by the criminal justice 
system. 
 
In 1999, there were 8 deaths with a mention of oxy-
codone, compared with 20 in 2000 and 40 in 2001. In 
1999, there were 25 deaths involving hydrocodone; in 
2000, there were 52, and in 2001, 107. There were 
also 36 deaths involving methadone in 1999, com-
pared with 62 in 2000 and 93 in 2001. There were 
nine deaths in 2001 involving fentanyl. 
 
In the Dallas-Fort Worth DEA Field Division, 
Dilaudid sells for $20– $80 per tablet, Soma sells for 
$2– $5 per tablet, and hydrocodone sells for $3– $10 
per tablet. OxyContin sells for $15– $30 per tablet. 
Methadone sells for $10 per tablet. In Houston, 
promethazine or phenergan with codeine sells for 
$100– $125 for 8 ounces, and hydrocodone sells for 
$3– $5 per pill. 
 
DPS labs reported examining 479 hydrocodone 
exhibits in 1999, 629 in 2000, 771 in 2001, and 262 
through August 2002. In comparison, the number of 
exhibits involving oxycodone was 36 in 1999, 72 in 
2000, 115 in 2001, and 35 through August 2002.  
 
In Tyler, OxyContin is reported to be more popular 
than hydrocodone as a drug of choice for narcotic 
addicts. 
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In Austin, “ Lean”  or “ Drank”  is promethazine 
(phenergan) with codeine. It is usually sold in baby 
bottles and measured out in ounces and is readily 
available. Texas rappers are singing about it, and 
older adolescents and younger adults (16– 25-year-
olds) are using it. One pint costs $200– $250, but it 
can sometimes cost as much as $350. People 
sometimes mix about 6 to 8 ounces in a 3-liter bottle 
of soft drink. A very small bottle of Robitussin or 
“ Lean”  is sold on the street for $30– $60. It is usually 
cut or mixed with Karo syrup and put in soda water to 
drink. T-shirts that advertise “ Lean”  are sold in 
Austin, and drinking Lean has spread from the 
African-American community to Hispanics and 
Anglos. 
 
OxyContin is reported as selling for $35– $60 per 
tablet in Austin, and Vicodin costs $1– $2 per tablet; 
20 tablets sell for $15 in some areas. 
 
Marijuana 
 
The number of students in grades 4– 6 who had ever 
used marijuana dropped from 2.8 percent in 2000 to 
2.6 percent in 2002, and use in the past school year 
dropped from 2.1 percent to 1.7 percent. Among 
Texas secondary students, 32 percent had ever tried 
marijuana, and 14 percent had used in the past month, 
levels identical to 2000. While past-month use by 
students in grades 7 and 8 continued to drop, use by 
students in grades 9 and 10 increased from 2000; use 
by 11th and 12th students remained stable (exhibit 
20). 
 
In comparison, 37 percent of adults reported lifetime 
and 4 percent reported past-month marijuana use in 
2000, compared with 34 percent lifetime and 3 
percent past-month use in 1996. Prevalence was much 
higher among younger adults. Thirteen percent of 
those age 18– 24 in 2000 reported past-month use, 
compared with 6 percent of those age 25– 34 and 2 
percent of those age 35 and over. The increase in past-
year use between 1996 and 2000 (6 to 7 percent) was 
statistically significant. 
 
There were 360 marijuana cases reported to the Texas 
Poison Control Centers in 2000, 358 in 2001, and 412 
in 2002. The average age of the cases in 2002 was 
23.6. There were another 201 cases in 2000, 206 in 
2001, and 263 in 2002 in which terms such as 
“ formaldehyde,”  “ fry,”  “ amp,”  or “ PCP”  were also 
mentioned.  
 
Mentions of marijuana per 100,000 population in EDs 
in Dallas have declined since the peak levels in 1998 
(exhibit 21). The decline in the rate for those age 12–
17 between 2000 and 2001 was statistically 
significant.  
 
Marijuana was the primary problem for 10 percent of 
adult admissions to treatment programs in 2002. The 
average age of adult marijuana clients continues to 
increase: in 1985, the average age was 24; in 2002, it 
was 27. 
 
Seventy-five percent of all adolescent admissions in 
2002 had a primary problem with marijuana, com-
pared with 35 percent in 1987. In 2002, 57 percent of 
these adolescents were Hispanic, 24 percent were 
Anglo, and 17 percent were African-American (in 
1987, 7 percent were African-American). 
 
The percentage of arrestees testing positive for mari-
juana continues to vary by city (exhibit 22). It has 
dropped from its peak levels in Dallas and Laredo, but 
the percentage remains high in San Antonio. 
 
Cannabis was identified in 35 to 36 percent of all the 
exhibits analyzed by DPS laboratories in 1999 and 
2000, but the proportion dropped to 31 percent in 
2001 and 32 percent in 2002 (exhibit 7). 
 
The Houston DEA Field Division reports that 
marijuana is readily available. The Dallas DEA Field 
Division likewise reports that it readily available. 
Much of the marijuana is smuggled in from Mexico. 
However, marijuana grown outdoors locally is 
available, and there is significant indoor hydroponic 
growing, with tetrahydrocannabinol (THC) contents 
up to 15 percent. Sinsemilla sells for $750– $1,200 a 
pound in the Dallas-Fort Worth area. The average 
price for a pound of commercial grade marijuana is 
$200– $250 in Laredo, $180– $250 in McAllen, $400–
$700 in San Antonio, $300– $600 in Houston, $250–
$500 in El Paso, $500– $700 north of the Border 
Patrol checkpoints in the Alpine area, $500– $600 in 
Midland, $450– $700 in the Dallas and Fort Worth 
areas, and $500 in Lubbock. Exhibit 23 shows the 
range of prices across the State since 1992. 
 
Exhibit 24 plots the trends in lifetime use of mari-
juana as reported in the secondary school surveys, 
adolescent admissions to treatment for a primary 
problem of marijuana, the proportion of adolescent 
drug arrests for marijuana, and adolescent marijuana 
ED mentions in Dallas. As this exhibit shows, all the 
indicators have risen since 1992, although there was a 
slight decline in lifetime use as reported in the state-
wide school surveys since 1998. 
 
Stimulants 
 
Uppers in this report include stimulants such as 
amphetamines, methamphetamines, speed, over-the-
counter medicines containing ephedrine, and prescrip-
tion drugs such as Ritalin (methylphenidate) when 
taken for nonmedical reasons.  
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The 2002 secondary school survey reported the 
lifetime use of uppers among students was 8.1 percent 
in 1998, 6.7 percent in 2000, and 7.3 percent in 2002. 
Past-month use was 3.1 percent in 1998, 2.7 percent 
in 2000, and 3.3 percent in 2002. 
 
Among Texas adults in 2000, 12 percent reported 
lifetime use and 1 percent reported past-month use of 
uppers. In comparison, in 1996, lifetime use was 10 
percent and past-month use was 1 percent. The 
difference in past-year use from 1996 to 2000 (1.1 
percent to 1.9 percent) was statistically significant. 
 
In 2000, there were 393 cases of abuse or misuse of 
amphetamines, methamphetamines, speed, etc., 
reported to Texas Poison Control Centers. There were 
451 in 2001 and 392 in 2002. 
 
Exhibit 25 shows the number of mentions of 
methamphetamine and amphetamines in Dallas EDs. 
The decrease in the number of mentions for meth-
amphetamine between 1994 and 2001 was statistically 
significant, as was the increase in mentions for am-
phetamines. The rate of mentions for amphetamines 
in the Dallas emergency rooms in 2001 was higher 
than the national rate (12.2 per 100,000 in Dallas vs. 
7.3 per 100,000 nationally), while the rate for 
methamphetamines was 3.6 per 100,000 in Dallas and 
5.9 per 100,000 in the Nation.  
 
Methamphetamines and amphetamines accounted for 
8 percent of adult admissions in 2002; this is an 
increase from 5 percent in 2000. There were 1,672 
admissions in 1998 and 3,183 in 2002. The average 
client admitted for a primary problem with stimulants 
is aging. In 1985, the average age was 26; in 2002, it 
was 31. The proportion of Anglo clients rose from 80 
percent in 1985 to 92 percent in 2002, while the 
proportion of Hispanics dropped from 11 to 6 percent 
and the proportion of African-Americans dropped 
from 9 to 1 percent. Unlike the other drug categories, 
more than one-half of these clients entering treatment 
were women (54 percent) in 2002. Most stimulant 
users were injectors, with differences seen among the 
clients based on route of administration (exhibit 26). 
Only 2 percent of adolescent admissions were for 
stimulants. 
 
Methamphetamine and amphetamine injectors were 
more likely to have been in treatment before (54 
percent readmissions) than smokers (39 percent 
readmissions), oral users (50 percent readmissions), 
or inhalers (45 percent readmissions). 
 
There were 17 deaths in which amphetamines or 
methamphetamines were mentioned in 1997, 20 in 
1998, 21 in 1999, 39 in 2000, and 51 in 2001. Of the 
2001 decedents, 82 percent were male; the average  
 
 
age was 36.2; 76 percent were Anglo, 18 percent were 
Hispanic, and 6 percent were African-American. 
 
The proportion of arrestees testing positive for 
amphetamines in the ADAM program is low, as 
exhibit 27 shows. 
 
Local labs are using the “ Nazi method,”  which 
includes ephedrine or pseudoephedrine, lithium, and 
anhydrous ammonia, or the “ cold method,”  which 
uses ephedrine, red phosphorus, and iodine crystals. 
The “ Nazi method”  is the most common method used 
in North Texas. Before these methods became 
common, most illicit labs used the “ P2P method,”  
which is based on 1-phenyl-2-propanone. The most 
commonly diverted chemicals are 60-milligram 
pseudoephedrine tablets, such as Xtreme Relief, Mini-
Thins, Zolzina, Two-Way, and Ephedrine Release. 
 
Methamphetamine and amphetamine together 
constituted between 12 and 18 percent of all items 
examined by DPS laboratories between 1998 and 
2002 (exhibit 7), and they continue to increase. In 
2002, 17.2 percent were methamphetamine and 0.59 
percent were amphetamines.  
 
Notice that while the Dallas DAWN mentions in 
exhibit 27 are more likely to be amphetamines, the 
DPS laboratory report for the Dallas area indicated 
that 32.0 percent of the exhibits were metham-
phetamine and 0.68 percent were amphetamine. There 
is no explanation for these differences. 
 
Stimulants are more of a problem in the northern half 
of the State, as exhibit 28 shows. In Amarillo in the 
Texas panhandle, 41 percent of all the drug items 
examined by the DPS laboratory were either meth-
amphetamine or amphetamines, while in McAllen, 
less than 1 percent were these substances. Labs in the 
northern part of the State are also more likely to 
report analyzing substances that turned out to be 
ammonia or pseudoephedrine, which are chemicals 
used in the manufacture of methamphetamine. 
  
According to DEA, both Mexican and locally 
produced methamphetamine are available. “ Ice”  is 
being sold in Houston by Mexican traffickers. 
Mexican methamphetamine is the primary type in 
Texas, while domestically produced metham-
phetamine is manufactured by motorcycle gangs and 
independent producers in small batches. Most of these 
labs are small and mobile and produce for local 
distribution. Because of difficulties in obtaining 
precursor chemicals in Texas, lab operators travel to 
Louisiana and Oklahoma to obtain needed supplies. 
 
The price for a pound of methamphetamine is  
$10,600 in El Paso, $8,000– $10,000 in Midland,  
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$6,000– $11,000 in the Houston area, $4,500– $5,500 
in Laredo, $1,200– $1,300 in McAllen, $5,000– $8,000 
in Fort Worth, $6,000– $7,000 in Tyler, and $8,000–
$9,000 in Lubbock. In Dallas, a pound of domestic 
methamphetamine sells for $4,500– $10,000, an ounce 
sells for $700– $1,100, and a gram costs $70– $100. 
Mexican methamphetamine sells for $5,800– $9,000 
per pound and $400 per ounce in Dallas. In San 
Antonio, an ounce costs $700– $1,000. 
 
According to street outreach workers in Austin, 
methamphetamine is $60– $90 per gram and readily 
available; one-half ounce costs $300. Many younger 
adults (age 25– 30) are smoking methamphetamine; 
most of the older adults are injecting. Street outreach 
workers in Fort Worth report “ ice”  is on the streets. 
 
Depressants 
 
This “ downer”  category includes three groups of 
drugs: barbiturates, such as phenobarbital and 
secobarbital (Seconal); nonbarbiturate sedatives, such 
as methaqualone, over-the-counter sleeping aids, and 
chloral hydrate; and tranquilizers and benzo-
diazepines, such as diazepam (Valium), alprazolam 
(Xanax), flunitrazepam (Rohypnol), clonazepam 
(Klonopin or Rivotril), flurazepam (Dalmane), 
lorazepam (Ativan), and chlordiazepoxide (Librium 
and Librax). Rohypnol is discussed separately in the 
Club Drugs section of this report. 
 
The 2002 secondary school survey showed that 
reported lifetime use of downers increased from 5.8 
percent among students in 2000 to 7.1 percent in 
2002. Past-year use increased from 2.6 percent in 
2000 to 3.4 percent in 2002. 
 
The 2000 adult survey reported lifetime use at 6.9 
percent and past-month use at 0.6 percent; in 1996, 
lifetime use was 6.2 percent and past-month use was 
0.3 percent. The difference in past-year use between 
1996 and 2000 (1 to 1.8 percent) was statistically 
significant. 
 
The number of mentions of alprazolam (Xanax), 
diazepam (Valium), and clonazepam (Klonopin) in 
the Dallas EDs is rising (exhibit 29).  
 
About 1.2 percent (545 clients) of the adults entering 
treatment in 2002 had a primary problem with 
barbiturates, sedatives, or tranquilizers. Only 37 
percent were male; 81 percent were Anglo, 8 percent 
were African-American, and 9 percent were Hispanic. 
Forty-two percent were involved in the criminal 
justice or legal systems, and 20 percent were 
employed. 
 
Alprazolam, clonazepam, and diazepam are among 
the 10 most commonly identified substances  
 
according to DPS lab reports, although none of these 
drugs accounted for more than 2 percent of all items 
examined in a year. The proportion of Xanax exhibits 
is increasing (exhibit 30). 
 
Both Houston and Dallas DEA Field Divisions report 
Xanax to be one of the most commonly abused 
diverted drugs. Xanax sells for $3– $10 per tablet, and 
Valium sells for $1– $10 per tablet. In Austin, street 
outreach workers report Klonopin costs $2– $3 each. 
Valium 10-milligram or 20-milligram pills can be 
purchased for $1– $2, and the blue 1-milligram 
football-shaped Xanax pills cost $2 each. The 2-
milligram “ white bars”  or “ handle bars”  Xanax pills 
are scored and can be broken into four small pieces; 
they sell for $4– $5 a pill and are very popular and 
readily available. In Houston, there appears to be an 
increase in the use of Xanax (“ Xandies” ) on the 
streets. In Dallas, Xanax and Soma are used to 
heighten and prolong the effects of heroin. 
 
Club Drugs and Hallucinogens 
 
Methylenedioxymethamphetamine (MDMA or 
Ecstasy) 
 
The 2002 secondary school survey reported that 
lifetime ecstasy use among students was 8.6 percent, 
up from 4.5 percent in 2000. Student past-month use 
in 2002 was 3.1 percent, compared with 1.9 percent in 
2000.  
 
The 2000 adult survey reported that 3.1 percent had 
ever used ecstasy and 1.0 percent had used in the past 
year. 
 
Texas Poison Control Centers reported 24 cases of 
ecstasy in 1998, 45 in 1999, 116 in 2000, 155 in 2001, 
and 172 in 2002. 
 
The rate of mentions of ecstasy per 100,000 in Dallas 
EDs in 2001 was 2.5; the national rate was 2.2. The 
change in the rates in Dallas between 1994 and 2001 
was statistically significant. Exhibit 31 shows the 
number of ED mentions of ecstasy. Notice that while 
ecstasy users were among the youngest, there was a 
larger racial/ethnic diversity than seen with other club 
drugs (exhibit 32). MDMA patients were not likely to 
just use MDMA: only 6 percent of the episodes 
mentioned MDMA alone. Some 41 percent mentioned 
alcohol and MDMA; 26 percent mentioned cocaine 
and MDMA; 21 percent mentioned marijuana and 
MDMA; 14 percent mentioned amphetamines or 
methamphetamine and MDMA; 9 percent mentioned 
LSD and MDMA; and 4 percent mentioned heroin 
and MDMA. 
 
Adult admissions for a primary, secondary, or tertiary 
problem with ecstasy increased from 63 in 1998, to 97  
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in 1999, to 141 in 2000, to 252 in 2001, and to 329 in 
2002. Of the 2002 admissions, the average age was 
24; 70 percent were Anglo, 14 percent were African-
American, and 13 percent were Hispanic. Sixty-one 
percent were male; 44 percent were referred by the 
criminal justice or legal system; and 21 percent were 
employed. While 23 percent of these clients in 2002 
listed ecstasy as their primary drug of abuse, another 
20 percent reported marijuana as their primary drug, 
16 percent reported amphetamines or methamphet-
amine as their primary drug, 13 percent reported 
powder cocaine, and 12 percent reported alcohol as 
their primary problem drug. 
 
Among adolescents, there were 18 admissions in 
1998, 17 admissions in 1999, 58 in 2000, 97 in 2001, 
and 189 in 2002 who had a primary, secondary, or 
tertiary problem with ecstasy. The average age of the 
2002 admissions was 15.9; 68 percent were male; 81 
percent were referred from the juvenile justice 
system; 46 percent were Anglo, 39 percent were 
Hispanic, and 13 percent were African-American. Of 
these 2002 admissions, 54 percent reported a primary 
problem with marijuana and 25 percent reported a 
primary problem with ecstasy. 
 
In 1999, there were two deaths in Texas that involved 
MDMA. There was one death in 2000 and five in 
2001. Of those in 2001, the average age was 24.6; 80 
percent were Anglo and 60 percent were male. 
 
Exhibit 33 shows the increases in “ club drug”  
substances identified by DPS labs. The labs identified 
MDMA as the substance in 102 exhibits in 1999, 373 
in 2000, 675 in 2001, and 222 through August 2002. 
Methylenedioxyamphetamine (MDA) was identified 
in 31 exhibits in 1999, 27 in 2000, 48 in 2001, and 52 
in 2002.  
 
According to the DEA, MDMA is becoming even 
more available. Single-dosage units of MDMA sell 
for $7.50–$15 in Dallas, $10-$30 in Houston, $7–$20 
in McAllen, and $15–$25 in San Antonio. The num-
ber of raves is reportedly increasing in the Houston 
area. In Dallas, MDMA is increasing in popularity at 
nightclubs that have a predominantly young African-
American clientele, and Hispanic organizations are 
now distributing ecstasy. Most MDMA in Texas 
comes from Europe, although some may be 
originating in Mexico. 
 
In Austin, ecstasy sells for $20– $30 per pill; the cost 
to the dealers is reportedly $15– $19 per pill. Ecstasy 
is increasing in availability and popularity in El Paso, 
according to street outreach workers. 
 
Viagra is being sold on the streets in Tyler in com-
bination with ecstasy, and the pills are referred to as 
“ Blue Boys.”  
Gamma Hydroxybutyrate (GHB), Gamma Butyrate 
Lactone (GBL), 1,4 Butanediol (1,4 BD) 
 
The 2000 Texas adult survey reported that 0.4 percent 
of respondents had ever used GHB and 0.1 percent 
had used in the past year. 
 
Texas Poison Control Centers reported 110 cases of 
exposure to GHB in 1998, 153 in 1999, 108 in 2000, 
113 in 2001, and 100 in 2002. 
 
Exhibit 31 shows the overall increases in the mentions 
of GHB in the EDs in the Dallas area. In 2001, the 
rate of mentions per 100,000 for GHB was 4.1; only 
San Francisco had a higher rate at 10.1 per 100,000. 
The national average was 1.3 per 100,000. As shown 
in exhibit 32, patients mentioning GHB were more 
likely to be older than patients mentioning other club 
drugs. In addition, only 15 percent of the patients 
mentioned only having used GHB during the episode; 
60 percent had also used alcohol, 14 percent 
mentioned cocaine, 10 percent mentioned metham-
phetamine or amphetamines, and 7 percent mentioned 
MDMA. In some instances they had used three or 
four drugs in combination. 
 
Clients with a primary, secondary, or tertiary problem 
with GHB, GBL, or 1,4 BD are continuing to be seen 
in treatment. In 1998, 2 adults were admitted, com-
pared with 17 in 1999, 12 in 2000, 19 in 2001, and 34 
in 2002. In 2002, the average age was 32; 53 percent 
were male and 91 percent were Anglo. Twenty-nine 
percent were employed, and 59 percent were involved 
with the criminal justice or legal system. Fifty-six 
percent had a history of injection drug use. GHB 
clients seem to have problems with the so-called 
“ harder drugs.”  While 35 percent had a primary 
problem with GHB, 21 percent had a problem with 
amphetamines or methamphetamine, 18 percent had a 
primary problem with crack cocaine, and 9 percent 
had a primary problem with heroin. One adolescent 
was admitted to treatment in 2002 for a problem with 
GHB. 
 
In 1999, there were three deaths that involved GHB, 
in 2000 there were five deaths, and in 2001 there were 
three. 
 
In 1999, 133 items were identified by DPS labs as 
being GHB or GBL and 4 were 1,4 BD; in 2000, 52 
were GHB or GBL and 4 were 1,4 BD; in 2001, 34 
were GHB or GBL and 17 were 1,4 BD. Through 
August 2002, 26 were GHB or GBL and 4 were 1,4 
BD. Eighty-eight percent of the GHB, GBL, and 1,4 
BD items were identified in the DPS lab in the Dallas 
area, which shows use of GHB seems to be centered 
in this area of the State. 
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In Dallas, GHB trafficking is reportedly on the rise, 
and the price of a gallon of GHB has dropped. In the 
third quarter of 2002, a gallon sold for $1,600; in the 
fourth quarter of 2002, it sold for $100– $200. In 
Houston, a dose of GHB costs $5– $10 and a gallon 
costs $725– $1,000. 
 
Ketamine 
 
The 2000 adult survey reported that 0.3 percent of 
respondents had ever used ketamine and 0.1 percent 
had used in the last year. 
 
Seven cases of misuse of ketamine were reported to 
Texas Poison Control Centers in 1999, 15 were 
reported in 2000, 14 in 2001, and 10 in 2002. The 
average age of these cases in 2002 was 19.8. 
 
In the Dallas EDs in 2001, the rate of ketamine men-
tions per 100,000 population was 0.35, above the 
national average of 0.27. There were 11 mentions in 
2001 (exhibit 31). Forty-five percent of the patients 
mentioning ketamine also mentioned alcohol, while 
27 percent also mentioned GHB, and 9 percent also 
mentioned amphetamine, marijuana, or cocaine, 
respectively. None of the patients in 2001 only took 
ketamine. 
 
One client was admitted to TCADA treatment 
programs in 2002 with a secondary or tertiary 
problem with ketamine. The client was a 17-year-old 
Anglo female with a primary problem with cocaine. 
 
There were also two deaths in 1999 that involved the 
use of ketamine, none in 2000, and one in 2001.  
 
In 1999, 25 substances were identified as ketamine by 
DPS labs, compared with 29 in 2000, 31 in 2001, and 
38 in 2002, to date.  
 
Two significant seizures of ketamine in the third 
quarter and the seizure of 120 vials of ketamine in the 
fourth quarter with local destinations were made at 
Dallas-Fort Worth in 2002, which indicates the 
demand in the area. GHB sells in Fort Worth for 
$2,200– $2,500 per liter. 
 
LSD 
 
The secondary school survey shows that use of 
hallucinogens (defined as lysergic acid diethylamide 
[LSD], phencyclidine [PCP], etc.) is continuing to 
decrease. Lifetime use peaked at 7.4 percent in 1996 
and had dropped to 4.5 percent by 2002. Past-month 
use dropped from 2.5 percent in 1996 to 1.2 percent in 
2002.  
 
 
 
 
The 2000 adult survey reported that 8.8 percent of 
Texas adults had ever used LSD and 0.9 percent had 
used in the past year. 
 
Texas Poison Control Centers reported 64 mentions 
of LSD in 1998, 101 in 1999, 82 in 2000, 43 in 2001, 
and 9 in 2002. The average age of cases in 2002 was 
19.8 years. There were also 110 cases of intentional 
misuse or abuse of hallucinogenic mushrooms 
reported in 2000, compared with 94 in 2001 and 151 
in 2002; the average age in 2002 was 21.7. 
 
There were 43 mentions of LSD in the Dallas DAWN 
ED data in 2001 (exhibit 31). The rate of mentions per 
100,000 in Dallas in 2001 was 1.4, which was above 
the national average of 1.1. The decline in the rate per 
100,000 population in Dallas between 1994 and 2001 
was statistically significant. As exhibit 33 shows, 
patients mentioning LSD tended to be younger than 
users of GHB or MDMA. In addition, 28 percent 
mentioned no other drug during this episode— a 
proportion higher than users of other club drugs. 
Some 33 percent also mentioned marijuana, 13 
percent mentioned alcohol, 8 percent mentioned 
MDMA, and 7 percent mentioned cocaine. 
 
In 2002, there were 250 adults with a primary, 
secondary, or tertiary problem with hallucinogens, 
compared with 303 in 2001 and 316 in 2000. The 
average age of these individuals in 2002 was 27; 64 
percent were male; 64 percent were Anglo, 19 percent 
were African-American, and 17 percent were His-
panic. Twenty percent were employed, and 54 percent 
were in the criminal justice or legal system. Twenty-
five percent of these adult clients had a primary 
problem with a hallucinogen; another 23 percent had 
a primary problem with marijuana, 12 percent had a 
problem with either amphetamines/methamphetamine 
or alcohol or crack, respectively. 
 
There were 320 youths with a primary, secondary, or 
tertiary problem with hallucinogens admitted to 
treatment in 2000, compared with 183 in 2001 and 
185 in 2002. The average age was 15.9; 84 percent 
were male; 50 percent were Anglo, 34 percent were 
Hispanic, and 12 percent were African-American. 
Eighty-six percent were involved in the juvenile 
justice system, and marijuana was the primary drug 
used by 64 percent, followed by hallucinogens at 14 
percent. 
 
There were two deaths in 1999 that involved LSD. 
There were no deaths with a mention of LSD reported 
in 2000 or 2001. 
 
In 1999, DPS labs identified 405 substances as LSD; 
they identified 234 as LSD in 2000 and 119 in 2001.  
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LSD data for 2002 to date have not been reported 
(exhibit 33).  
 
A dosage unit of LSD is selling for $1– $10 in Dallas, 
$5– $10 in Tyler, $6– $10 in Fort Worth, and $7 in 
Lubbock. In McAllen, it sells for $8, and an ounce 
sells for $450. 
 
Phencyclidine (PCP) 
 
The 2000 Texas adult survey reported that 0.9 percent 
of adults had ever used PCP or “ angel dust”  and 0.1 
percent had used in the past year. 
 
Texas Poison Control Centers cases in which terms 
such as “ fry,”  “ amp,”  or “ PCP”  were mentioned, or 
abuse of formaldehyde was mentioned, increased 
from 175 in 2000 to 195 in 2001 and to 237 in 2002. 
The average age in 2002 was 21.8. 
 
The rate of ED mentions of PCP in the Dallas was 3.1 
per 100,000 in 2001, above the national rate of 2.4 per 
100,000. As exhibit 31 shows, the number of 
mentions of PCP in Dallas peaked in 2000. However, 
the increase between 1994 and 2001 was statistically 
significant. 
 
Because of the tendency of some users to strip off 
their clothes while under its influence, PCP has a 
nickname of “ buck naked.”  
 
Adult admissions to treatment with a primary, second-
dary, or tertiary problem with PCP are increasing. In 
1998, 102 were admitted, compared with 125 in 1999, 
174 in 2000, 178 in 2001, and 269 in 2002. Of these 
clients in 2002, 83 percent were African-American 
and 69 percent were male. The average age was 25, 
41 percent were involved in the criminal justice 
system; 16 percent were employed; and 20 percent 
were homeless. While 49 percent reported a primary 
problem with PCP, another 22 percent reported a 
primary problem with marijuana, which demonstrates 
the link between these two drugs and the use of “ fry,”  
which is a marijuana joint or cigar dipped in 
embalming fluid that can contain PCP. 
 
Among adolescent clients, there were 62 admissions 
for a primary, secondary, or tertiary problem with 
PCP in 1998, 118 in 1999, 76 in 2000, 67 in 2001, 
and 52 in 2002. Of the 2002 admissions, 87 percent 
were male; 48 percent were African-American, 37 
percent were Hispanic, and 12 percent were Anglo; 
the average age was 15.6 years. Ninety-six percent 
had been referred to treatment or were involved in the 
juvenile justice system. Marijuana was the primary 
drug of abuse for 64 percent of the clients, and PCP 
was the primary drug for 21 percent. 
 
 
 
There were three deaths in 1999, three in 2000, and 
five in 2001 in Texas which involved PCP. In 2001, 
all were African-American males, and the average age 
was 23.6. 
 
PCP use in past years was most likely to be found 
among Dallas and Houston male arrestees; however, 
data for these cities were not reported in 2001 (exhibit 
34).  
 DPS labs identified 77 substances as PCP in 1999, 
100 in 2000, 144 in 2001, and 39 through August 
2002. Exhibit 33 shows an increase in the proportion 
of all exhibits which were identified as PCP by DPS. 
Until the complete 2002 data are received, it will be 
impossible to determine if the previous increase in the 
number of PCP exhibits will continue. 
 
DEA reports that PCP sells for $100 per gram in 
McAllen; in Dallas it sells for $10– $25 per “ Sherm”  
stick or cigarette, $350– $500 per ounce, and $3,800 
for a pint bottle.  
 
According to the HIV intervention workers in 
Houston, use of “ Water,”  which is a cigarette or mari-
juana joint dipped in embalming fluid, is growing. 
 
Rohypnol (Flunitrazepam) 
 
Rohypnol use in Texas first began along the Texas-
Mexico border and then spread northward. The 2002 
secondary school survey found that students from the 
border area were about three times more likely to 
report Rohypnol use than those living elsewhere in 
the State (10.9 vs. 3.8 percent lifetime, and 4.4 vs. 1.3 
percent current). Use by grade is shown in exhibit 35. 
 
The 2000 Texas adult survey found that 0.8 percent of 
adults reported lifetime use and 0.1 percent reported 
past-year use of Rohypnol. 
 
The number of confirmed exposures to Rohypnol 
reported to the Texas Poison Control Centers was 101 
in 1998, 77 in 1999, 88 in 2000, 65 in 2001, and 73 in 
2002. Of the 2002 cases, the average age was 17.1; 61 
percent of the cases were reported in counties that 
border Mexico. 
 
In 2001, the rate of ED mentions for Rohypnol in 
Dallas was 0.26 per 100,000; only Miami had a higher 
rate at 0.29. As exhibit 32 shows, the number of 
mentions of Rohypnol increased between 2000 and 
2001; the increase between 1994 and 2001 was 
statistically significant. 
 
Of all the adult and youth Rohypnol treatment admis-
sions, 82 percent in 2002 were primarily located on 
the Texas border. In 1998, 87 adults were admitted 
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into treatment with a primary, secondary, or tertiary 
problem with Rohypnol. In 1999, 130 were admitted, 
compared with 74 in 2000, 78 in 2001, and 90 in 
2002. Of the adult clients in 2002, 90 percent were 
Hispanic and 7 percent were Anglo; 74 percent were 
male. The average age was 26, which is much 
younger than most adult clients entering treatment 
(overall average age is 35 years). Only 14 percent 
were employed, and 48 percent were involved with 
the criminal justice or legal system. While 16 percent 
of these clients said that Rohypnol was their primary 
problem drug, 28 percent reported marijuana, 17 
percent reported heroin, 14 percent reported crack, 
and 12 percent reported alcohol. 
 
In 1998, there were 160 youths admitted to treatment 
with a primary, secondary, or tertiary problem with 
Rohypnol. In 1999, 234 were admitted; in 2000, 250 
were; in 2001, 319 were; and in 2002, 275 were. Of 
the 2002 admissions, 74 percent were male; the 
average age was 15.5 years and 96 percent were 
Hispanic. Some 76 percent were involved in the 
juvenile justice system. Fourteen percent of these 
youth listed Rohypnol as their primary drug; 
marijuana was the primary drug for 56 percent and 
cocaine for 15 percent. 
 
DPS lab exhibits for Rohypnol numbered 54 in 1999, 
32 in 2000, 31 in 2001, and 7 through August 2002. 
 
Although Roche is reported to no longer be making 
the 2-milligram Rohypnol tablet, which was a favorite 
with abusers, generic versions are reportedly still 
being produced, and the blue dye added to the 
Rohypnol tablet is not in the generic version. The dye 
is not proving effective: people intent on committing 
sexual assault are now serving blue tropical drinks 
and blue punches into which Rohypnol can be 
slipped. 
 
Dextromethorphan (DXM) 
 
School personnel in Texas have been reporting 
problems with the abuse of DXM, especially the use 
of Robitussin-DM, Tussin, and Coricidin Cough and 
Cold Tablets HBP. These substances can be 
purchased over the counter and, if taken in large 
quantities, can product hallucinogenic effects. 
Coriciden HBP pills are known as “ Triple C’s”  or 
“ Skittles.”  
 
Poison control centers reported 145 intentional abuse 
or misuse cases of Coricidin in 2000, 236 in 2001, 
and 266 in 2002. The average age of the cases in 2002 
was 17.6 years. 
 
DPS labs examined 12 substances in 1999 that were 
DXM, 35 in 2000, 12 in 2001, and 26 through August 
2002. 
Outreach workers in El Paso report use of “ Skittles”  is 
increasing in popularity. 
 
Inhalants 
 
The 2002 elementary school survey found that 9.3 
percent of students in grades 4– 6 had ever used 
inhalants, and 6.5 percent had used in the school year. 
The 2002 secondary school survey found that 18 
percent of students had ever used inhalants and 6.8 
percent had used in the past month. Some 18.5 
percent of secondary school males had ever used 
inhalants, compared with 17.4 percent of females. 
Some 20.7 percent of Hispanic, 17.9 percent of 
Anglo, and 11.8 percent of African-American 
students had ever used inhalants. 
 
Inhalant use exhibits a peculiar age pattern not 
observed with any other substance. The prevalence of 
lifetime and past-month inhalant use was higher in the 
lower grades and lower in the upper grades (exhibit 
36). This decrease in inhalant use as students age may 
be partially due to the fact that inhalant users drop out 
of school early and hence are not in school in later 
grades to respond to school-based surveys. 
 
Texas Poison Control Centers in the first three 
quarters of 2002 reported 12 cases of intentional 
misuse or abuse of Freon (average age 19.2 years). 
There were three cases of misuse of whiteout. 
Products used with automobiles are also misused, 
with 41 cases of intentional misuse or abuse of 
gasoline (average age of 22.1) and 21 cases of misuse 
of carburetor cleaner, starter, or transmission fluid, 
etc. (average age of 20.8). There were 38 cases of 
intentional misuse or abuse of paint (average age 
22.2), 14 cases of intentional misuse or abuse of 
aerosols (average age 26.6), 8 cases of misuse or 
abuse of glue (average age 27.2), 9 cases of misuse or 
abuse of propane or lighter fluid (average age 23.8), 
and 4 cases of intentional abuse of nitrous oxide 
(average age 31.3). 
 
Exhibit 37 summaries the Dallas ED DAWN 
mentions for the major inhalant categories for 1994–
2001. As shown, volatile agents accounted for most 
mentions each year. 
 
Exhibit 38 shows the characteristics of patients who 
enter the EDs in the Dallas area with a mention of 
inhalants. Just as the number entering for different 
substances changes over the years, so do the char-
acteristics of the patients. However, in 2000 and 2001, 
more of the patients were older than 17, and more 
were Hispanic. 
 
Inhalant abusers represented 1.7 percent of the 
admissions to adolescent treatment programs in 2002. 
The youths entering treatment tended to be male (72 
percent) and Hispanic (77 percent). The over-
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representation of Hispanic youths is related to the fact 
that TCADA has developed and funded programs that 
were targeted specifically to this group. Only 0.2 
percent (64 clients) of adult admissions were for a 
primary problem with inhalants; the average age was 
29, 64 percent were male, and 70 percent were 
Hispanic.  
 
In 2000, there were 12 deaths involving misuse of 
inhalants and in 2001, 15. Six deaths involved Freon 
and two involved nitrous oxide (exhibit 39). The 
average age was 38.4; 93 percent were male; 73 
percent were Anglo and 13 percent were Hispanic or 
African-American, respectively. 
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE 
 
The proportion of adult and adolescent AIDS cases 
related to injection drug use has gone from 16 percent 
in 1987 to 27 percent through September 2002. In 
1987, 4 percent of the cases were injection drug users 
(IDUs), and 12 percent were exposed through male-
to-male sex and injection drug use. In 2002, of the 
cases where mode of exposure was known, 21 percent 
of the cases were IDUs, and 6 percent were men who 
have sex with men (MSM) and also were IDUs 
(exhibit 40). The proportion of cases resulting from 
heterosexual contact has risen from 1 percent in 1987 
to 19 percent in 2002.  
 
In 1987, 3 percent of the AIDS cases were females 
older than 12; in 2002, 21 percent were female. In 
1987, 12 percent of the adult and adolescent cases 
were African-American; in 2002, 40 percent were 
African-American. As exhibit 41 shows, the pro-
portion of Anglo males has dropped, while the 
proportion of African-Americans and Hispanics has 
increased. 
 
In Austin, AIDS intervention clients report that water 
and bleach kits are selling for $2 when syringes are 
not available; new syringes can be purchased in the 
late evenings for $2 on the streets in certain areas. 
Some sex industry workers report that the quality of 
crack cocaine has not been good and they have 
resorted to shooting heroin after many years of not 
using needles. There has been about a 10– 20 percent 
increase in the number of male sex industry workers; 
many who had been incarcerated have been released 
and they have returned to active addiction. The 
program also reports that as the drugs become more 
available, the sex industry business increases. Sex 
industry workers reported they were offered about 
twice the amount of money for unprotected sex than 
for protected sex 
 
Hepatitis C is rampant in all communities and people 
have little or no education about the disease. In the 
African-American community, many people are not 
willing to get medical help because of a distrust of the 
system and also a lack of services available.  
For inquiries concerning this report, please contact Jane Maxwell, Ph.D., Center for Social Work Research, The University of Texas at Austin, 
1717 West 6th Street, Suite 335, Austin, TX 78703, Phone: 512-232-0610, Fax: 512-232-0613, E-mail: <jcmaxwell@sbcglobal.net>. 
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Exhibit 1. Percentage of Border and Nonborder Secondary Students Who Had Ever Used Powder  
 Cocaine and Crack, by Grade:  2002 
8.5
13.8
17.3
18.5
20.5
5.1
4.03.0
8.0 9.0
11.011.0
0.0
5.0
10.0
15.0
20.0
25.0
Grade 7 Grade 8 Grade 9 Grade 10 Grade 11 Grade 12
Cocaine-Border Cocaine-Nonborder
Crack-Border Crack-Nonborder
SOURCE:  TCADA 
 
 
 
Exhibit 2. Dallas DAWN Mentions of Cocaine Per 100,000 Population by Age and Gender: 
 1989–2001 
 
 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Total 59.1  45.4  56.9  52.9  57.7  61.5  61.6  58.3  73.6  106.0  85.6  87.3  57.1  
Age Group              
 12–17 33.3  20.9  20.2  16.0  21.2  18.8  20.6  35.0  33.7  65.8  45.3  36.4  23.2  
 18–25 140.9  102.5  116.9  106.3  109.1  100.5  105.5  92.0  155.5  192.3  139.9  130.4  67.9  
 26–34 115.1  94.9  119.7  106.2  112.2  141.6  121.9  117.1  132.8  192.4  152.9  171.7  109.7  
 35 and older 24.7  19.4  30.3  32.9  39.3  39.3  46.9  43.2  54.7  83.7  74.7  75.8  56.2  
Gender              
 Male 76.6  58.0  69.0  69.1  72.4  75.2  79.3  77.8  97.1  142.2  112.0  114.9  73.8  
 Female 42.3 32.8 45.3 37.3 43.1 48.4 44.0 38.8 51.1 70.9 60.5 60.5 39.6 
 
SOURCE:  DAWN, OAS, SAMHSA 
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Exhibit 3. Characteristics of Adult Clients Admitted to TCADA-Funded Treatment with a Primary  
 Problem with Cocaine by Route of Administration:  2002 
 
Characteristic Crack Cocaine Smoke 
Powder 
Cocaine Inject 
Powder 
Cocaine Inhale Cocaine All
1
 
Admissions (N) 9,073 1,062 2,075 12,666 
Percent of Cocaine Admissions 72 8 16 100 
Lag-First Use to Treatment 
(Years) 11 13 9 11 
Average Age 37 34 31 35 
Percent Male 56 66 62 58 
Percent African-American 51 5 11 39 
Percent Anglo 33 68 32 36 
Percent Hispanic 14 25 55 24 
Percent CJ Involved 35 40 51 39 
Percent Employed 14 16 29 18 
Percent Homeless 19 15 6 16 
 
1
 Total includes clients with “other” routes of administration. 
 
SOURCE:  TCADA 
 
 
 
Exhibit 4. Routes of Administration of Cocaine by Race/Ethnicity of Treatment Admissions:   
 1993–2002 
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SOURCE:  TCADA 
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Exhibit 5. Age and Race/Ethnicity of Persons Who Died with a Mention of Cocaine:  1992–2001 
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Exhibit 6. Percentages of Arrestees Testing Positive for Cocaine:  1991–2002 
 
Arrestees 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Males 
 Dallas 
 Houston 
 Laredo 
 San Antonio 
 
43 
56 
NR1 
29 
 
41 
41 
NR 
31 
 
45 
41 
NR 
31 
 
35 
28 
NR 
31 
 
31 
40 
NR 
24 
 
32 
39 
NR 
28 
 
32 
39 
NR 
26 
 
29 
36 
37 
27 
 
34 
36 
42 
23 
 
28 
32 
45 
20 
 
30 
NR 
35 
30 
 
NR 
NR 
38 
33 
Females 
 Dallas 
 Houston 
 Laredo 
 San Antonio 
 
46 
51 
NR 
24 
 
48 
44 
NR 
25 
 
43 
43 
NR 
24 
 
46 
36 
NR 
23 
 
44 
32 
NR 
23 
 
36 
34 
NR 
23 
 
34 
29 
NR 
18 
 
30 
37 
33 
20 
 
40 
23 
21 
19 
 
24 
32 
22 
NR 
 
NR 
NR 
27 
NR 
 
NR 
NR 
NR 
NR 
 
1
 NR=Not reported. 
 
SOURCE:  ADAM, NIJ 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Texas 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 242
Exhibit 7. Percent of Substances Identified by DPS Labs: 1998–August 2002 
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SOURCE:  NFLIS 
 
 
 
Exhibit 8. Price of a Kilogram of Cocaine in Texas:  1987–2002 
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Exhibit 9. Rate of ED Mentions in Dallas of Alcohol-in-Combination with Other Drugs Per 100,000  
 Population:  1992–2001 
 
 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Total Rate 50.4 60.6 57.9 57.6 57.9 65.7 83.0 68.0 74.8 57.6 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
Exhibit 10. Direct and Indirect Alcohol and Drug Deaths Per 100,000 Population:  1994–2001 
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SOURCE:  TDH, Analyses by TCADA 
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Exhibit 11. Substance Abuse Arrests Per 100,000 Population:  1994–2001 
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Exhibit 12. Dallas ED Mentions of Heroin Per 100,000 Population by Age and Gender:  1989–2001 
 
 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Total 14.1 14.0 10.2 11.9 12.7 10.3 11.2 13.8 20.9 20.5 17.4 19.1 14.3 
Age Group              
 12–17 – – – 1.0 2.0 2.7 – 9.9 – 6.8 7.1 5.8 5.2 
 18–25 18.6 15.8 12.8 11.9 13.1 14.3 16.2 30.8 60.4 55.0 45.3 49.1 23.0 
 26–34 27.2 26.1 16.8 22.9 15.9 13.2 15.8 17.3 24.7 24.0 19.4 22.9 20.3 
 35 and older 11.6 13.0 10.4 11.8 16.0 11.9 12.2 11.8 15.0 18.0 15.6 17.2 14.4 
Gender              
 Male 19.4 19.0 12.4 18.1 16.9 14.7 15.1 19.0 33.3 27.4 22.4 27.1 19.3 
 Female 8.9 9.2 8.2 5.8 8.8 5.7 7.4 8.9 9.0 13.9 12.4 11.4 9.0 
 
SOURCE:  DAWN, OAS, SAMHSA 
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Exhibit 13. Characteristics of Adult Clients Admitted to TCADA-Funded Treatment with a Primary  
 Problem With Heroin by Route of Administration:  2002 
 
Characteristic Inject Inhale All1 
Admissions (N) 4,645    313    5,149    
Percent of Heroin Admits 90%    6%    100%    
Lag-1st Use to Treatment-Years 15    10    15    
Average Age 37    32    36    
Percent Male 71%    67%    70%    
Percent African American 6%    47%    9%    
Percent Anglo 36%    20%    36%    
Percent Hispanic 56%    31%    54%    
Percent CJ Involved 33%    36%    33%    
Percent Employed 12%    17%    13%    
Percent Homeless 14%    11%    14%    
 
1
 Total includes clients with other routes of administration. 
 
SOURCE:  TCADA 
 
 
 
Exhxibit 14. Percent of Heroin Admissions to Treatment by Race/Ethnicity:  1986–2002 
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SOURCE:  TCADA 
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Exhibit 15. Age and Race/Ethnicity of Persons Who Died with a Mention of Heroin:  1992–2001 
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SOURCE:  TDH, Analyses by Jane Maxwell 
 
 
 
Exhibit 16. Percentages of Arrestees Testing Positive for Opiates:  1991–2002 
 
Arrestees 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Males             
 Dallas 4% 4% 5% 3% 5% 5% 4% 2% 5% 3% 5% NR 
 Houston 3% 3% 2% 3% 5% 8% 10% 8% 6% 7% NR NR 
 Laredo NR1 NR NR NR NR NR NR 11% 11% 10% 11% 7% 
 San Antonio 15% 14% 14% 13% 10% 10% 10% 10% 10% 10% 9% 11% 
Females             
 Dallas 9% 9% 11% 8% 5% 10% 4% 5% 7% 5% NR NR 
 Houston 4% 4% 5% 6% 3% 4% 5% 7% 7% 3% NR NR 
 Laredo NR NR NR NR NR NR NR 0% 2% 7% 10% NR 
 San Antonio 20% 13% 15% 14% 13% 13% 9% 9% 10% NR NR NR 
 
1  NR=Not reported. 
 
SOURCE:  ADAM, NIJ 
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Exhibit 17. Price of an Ounce of Mexican Black Tar Heroin in Texas:  1987–2002 
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Exhibit 18. Price and Purity of Heroin Purchased in Dallas, El Paso, and Houston by DEA: 
 1995–2001 
 
 Site/Price/Purity 1995 1996 1997 1998 1999 2000 2001 
 Dallas Purity 6.8% 3.5% 7.0% 11.8% 14.0% 16.0% 13.4% 
   Price/Milligram Pure $2.34 $6.66 $4.16 $1.06 $1.01 $0.69 $1.36 
 Houston Purity 16.0% 26.1% 16.3% 34.8% 17.4% 18.2% 11.3% 
   Price/Milligram Pure $1.36 $2.15 $2.20 $2.43 $1.24 $1.14 $1.51 
 El Paso Purity1     56.7% 50.8% 41.8% 
   Price/Milligram Pure     $0.49 $0.34 $0.44 
 
1 El Paso began reporting in mid-1999. 
 
SOURCE:  DMP, DEA 
 
 
 
Exhibit 19. Dallas ED Mentions of Hydrocodone and Oxycodone Combinations:  1994–2001 
 
Mentions 1994 1995 1996 1997 1998 1999 2000 2001 
Hydrocodone/Combinations 214 189 211 310 276 245 303 375 
Oxycodone/Combinations 8 4 15 6 13 8 27 42 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
$0 
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Exhibit 20. Percentage of Texas Secondary Students Who Had Used Marijuana in the Past  
 Month, By Grade:  1988–2002 
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Exhibit 21. ED Mentions in Dallas of Marijuana Per 100,000 Population by Age and Gender: 
 1989–2001 
 
Mentions 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 
Total 23.8 15.6 11.1 14.8 15.7 20.0 23.2 23.1 37.9 61.9 47.6 49.0 33.8 
Age Group              
 12–17 38.7 23.8 13.0 24.9 34.5 38.0 45.6 56.1 70.0 123.6 94.3 117.4 70.0 
 18–25 69.5 44.5 30.9 40.6 46.1 54.2 69.4 58.1 118.4 170.4 140.6 127.8 72.1 
 26–34 35.2 26.1 18.8 24.5 19.9 31.5 32.9 29.4 44.7 85.2 65.7 66.0 53.2 
 35 and older 6.5 4.0 3.9 4.4 5.3 6.8 7.5 10.2 17.3 28.3 19.9 20.9 15.8 
Gender              
 Male 32.7 21.6 14.8 20.0 20.1 24.7 32.7 33.3 51.7 84.8 64.0 65.2 43.5 
 Female 15.2 9.9 7.4 9.6 11.1 15.3 13.9 13.3 24.7 39.8 32.1 33.0 23.7 
 
SOURCE:  DAWN, OAS, SAMHSA 
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Exhibit 22. Percentage of Arrestees Testing Positive for Marijuana:  1991–2002 
 
Arrestees 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
 Males             
 Dallas  19% 28% 27% 33% 39% 43% 44% 43% 39% 36% 33% NR 
 Houston  17% 24% 24% 23% 30% 28% 23% 36% 38% 36% NR NR 
 Laredo  NR1 NR NR NR NR NR NR 39% 33% 29% 26% 28% 
 San Antonio  19% 28% 32% 30% 34% 38% 34% 41% 36% 41% 41% 39% 
 Females             
 Dallas 11% 24% 20% 23% 23% 26% 27% 24% 27% 21% NR NR 
 Houston 8% 12% 15% 13% 20% 24% 17% 20% 23% 27% NR NR 
 Laredo NR NR NR NR NR NR NR 13% 9% 17% 14% NR 
 San Antonio 8% 16% 17% 15% 16% 18% 17% 18% 16% NR NR NR 
 
1 NR=Not reported. 
 
SOURCE:  ADAM, NIJ 
 
 
 
Exhibit 23. Price of a Pound of Commercial Grade Marijuana in Texas:  1992–2002 
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Exhibit 24. Indicators of Adolescent Marijuana Use:  1987–2002 
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Exhibit 25. ED Mentions in Dallas of Stimulants:  1994–2001 
 
Stimulant 1994 1995 1996 1997 1998 1999 2000 2001 
Methamphetamines 152 203 115 159 186 100 135 111 
Amphetamines 92 133 120 263 336 307 351 378 
 
SOURCE:  DAWN, OAS, SAMHSA 
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Exhibit 26. Characteristics of Adult Clients to TCADA-Funded Treatment with a Primary Problem  
 of Amphetamines or Methamphetamine by Route of Administration:  2002 
 
Characteristic Smoke Inject Inhale Oral All 
Admissions (N) 752    1,771    382    232    3,183    
Percent of Stimulant 
Admits 37%    23%    19%    11%    100%    
Lag-1st Use to Tmt-Yrs. 9    13    10    11    11    
Average Age-Yrs. 29    31    30    32    31    
Percent Male 47%    46%    53%    37%    46%    
Percent African American 1%    1%    1%    3%    1%    
Percent Anglo 90%    95%    87%    88%    92%    
Percent Hispanic 7%    4%    9%    8%    6%    
Percent CJ Involved 47%    49%    52%    43%    48%    
Percent Employed 25%    48%    29%    19%    19%    
Percent Homeless 7%    11%    5%    10%    9%    
 
SOURCE:  TCADA 
 
 
 
Exhibit 27. Percentages of Arrestees Testing Positive for Amphetamines:  1991–2002 
 
Arrestees 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 
Males             
 Dallas 1% 1% 4% 2% 2% 1% 4% 3% 3% 2% 2% NR 
 Houston 0% 0% 0% 0% 0% 0% 0% 0% 0% 1% NR NR 
 Laredo NR1 NR NR NR NR NR NR 0% 0% 0% 0% 0% 
 San Antonio 1% 0% 0% 0% 1% 1% 2% 0% 0% 0% 3% 2% 
Females             
 Dallas 3% 3% 6% 4% 4% 2% 4% 4% 4% 3% NR NR 
 Houston 0% 0% 1% 0% 1% 1% 2% 0% 0% 2% NR NR 
 Laredo NR NR NR NR NR NR NR 0% 0% 0% 0% 0% 
 San Antonio 2% 1% 2% 0% 3% 2% 4% 2% 2% NR NR NR 
 
1
 NR=Not reported. 
 
SOURCE:  ADAM, NIJ 
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Exhibit 28. Percent of Items Analyzed by DPS Labs in January–August 2002 That Were  
 Methamphetamine or Amphetamines 
 
Lab Site Percent 
El Paso (El Paso) 0 
Hidalgo (McAllen) 0.34 
Webb (Laredo) 0.72 
El Paso (El Paso) 3.74 
Nueces (Corpus Christi) 7.94 
Harris (Houston) 6.73 
Travis (Austin) 18.73 
McLennan (Waco) 18.67 
Smith (Tyler) 10.13 
Dallas (Dallas) 33.03 
Midland (Odessa) 16.29 
Taylor (Abilene) 45.99 
Lubbock (Lubbock) 25.95 
Potter (Amarillo) 41.48 
 
SOURCE:  NFLIS 
 
 
 
Exhibit 29. Number of ED Mentions of Selected Benzodiazepines in the Dallas Area:  1994–2001 
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SOURCE:  DAWN, OAS, SAMHSA 
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Exhibit 30. Benzodiazepines Identified by DPS Labs:  1998–2002 
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
1998 1999 2000 2001 2002
Xanax Valium Klonopin
SOURCE:  NFLIS 
 
 
 
Exhibit 31. Number of ED Mentions of Selected “ Club Drugs”  and Hallucinogens in Dallas:   
 1994–2001 
 
Club Drug 1994 1995 1996 1997 1998 1999 2000 2001 
GHB 11 37 60 72 160 156 169 128 
Ketamine 2 1 4 3 0 3 10 11 
LSD 107 133 84 77 93 105 64 43 
Ecstasy 21 57 20 17 15 24 71 77 
PCP 27 65 26 36 62 95 120 96 
Rohypnol 1 14  ...  13 7 5 4 8 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
Exhibit 32. Characteristics of Patients Entering Dallas EDs With Mentions of Club Drugs by  
 Percent:  2001 
 
Characteristic GHB LSD MDMA PCP Ketamine 
% Male 66% 79% 62% 86% 91% 
% Anglo 77% 79% 60% 9% 64% 
% Hispanic 9% …  9% …  18% 
% African-American 0% 0% 13% 80% 0% 
12–17 2% 33% 25% 8% 27% 
18–25 56% 63% 55% 57% 45% 
26–34 35% 2% 14% 30% 18% 
35 and older 7% 2% 6% 2% 9% 
 
SOURCE:  DAWN, OAS, SAMHSA 
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Exhibit 33. Club Drugs Identified by DPS Labs by Percentage of All Drugs Identified:  1998–2002 
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Exhibit 34. Percentage of Arrestees Testing Positive for PCP:  1991–2001 
 
Arrestees 1991  1992  1993  1994  1995  1996  1997  1998  1999  2000  2000  2001  
Males             
 Dallas 0% 3% 3% 5% 8% 4% 3% 4% 5% 4% 2% NR 
 Houston 0% 0% 1% 3% 4% 3% 3% 6% 7% 5% NR NR 
 Laredo NR1 NR NR NR NR NR NR 0% 0% 0% 0% 0% 
 San Antonio 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 
Females             
 Dallas 0% 0% 1% 2% 2% 1% 1% 0% 1% 2% NR NR 
 Houston 0% 0% 0% 1% 2% 1% 1% 2% 1% 2% NR NR 
 Laredo NR NR NR NR NR NR NR 0% 0% 0% 0% 0% 
 San Antonio 0% 0% 0% 0% 0% 0% 0% 0% 0% NR NR 0% 
 
1
 NR=Not reported 
 
SOURCE:  ADAM, NIJ 
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Exhibit 35. Percentage of Border and Nonborder Secondary Students Who Had Ever Used  
 Rohypnol by Grade:  2002 
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SOURCE:  TCADA 
 
 
Exhibit 36. Percentage of Texas Secondary Students Who Had Used Inhalants Ever or in the Past  
 Month by Grade 
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Exhibit 37. Dallas ED Mentions of Various Inhalants:  1994–2001 
 
Inhalant 1994 1995 1996 1997 1998 1999 2000 2001 
Volatile Agent 65 29 52 59 41 51 44 40 
   Paint 7  3 1 3 13 8 6 
   Toluene Glue 28 4 17 19 10 5 13 9 
   Other Volatile Agents 30 24 32 39 28 33 23 25 
Nitrites 0 0 0 0 0 0 1 0 
Chloro-fluoro-hydrocarbons 1 8 0  3  1   
General Anesthetics 0 1  0 1 0  0 
 
SOURCE:  DAWN, OAS< SAMHSA 
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Exhibit 38. ED Mentions in Dallas of Inhalants by Patient Demographic Characteristics and  
 Percent:  1994–2001 
 
Characteristic 1994 1995 1996 1997 1998 1999 2000 2001 
Age 12–17 56% 33% 46% 37% 48% 30% 20% 29% 
Age 18–25 27% 28% 37% 30% 27% 34% 35% 27% 
Age 26–34 8% 5% 9% 22% 11% 21% 27% 27% 
Age 35 and older 9% 13% 5% 11% 14% 13% 14% …  
Male 70% 54% 60% 84% 70% 68% 67% 64% 
Anglo 50% 59% 19% 40% 41% 23% 24% 38% 
Hispanic 41% 26% 68% 44% 36% 36% 45% 49% 
Total (N) 66 39 57 63 44 53 49 45 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
Exhibit 39. Texas Deaths With Mention of Inhalants:  1988–2001 
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Exhibit 40. AIDS Cases in Texas by Route of Transmission1 and Percent:  1987–3Q 2002 
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Exhibit 41. Percentage of Male and Female AIDS Cases by Race/Ethnicity:  1987–3Q 2002 
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Patterns and Trends of Drug Abuse in Washington, DC 
  
 Susanna Nemes, Anna Carin Johansson, Lauren Hess, Jennifer Weil,1 and Alfred Pach2 
  
ABSTRACT 
 
This report documents drug abuse patterns and 
trends for Washington, DC. It mainly focuses on 
changes between 2000 and 2001 and includes some 
2002 data. Cocaine indicators were mostly steady, 
while a number of marijuana indicators showed 
signs of decline. Heroin emergency department (ED) 
mentions decreased slightly, whereas treatment ad-
missions increased. Heroin purity levels remained 
steady, prices decreased, and ethnographic sources 
reported that the drug is readily available throughout 
the city. Cocaine and heroin continued to account for 
the greatest proportion of treatment admissions. 
OxyContin use increased. Indicators of PCP use 
showed increases, with a major increase in ED men-
tions between 2000 and 2001. The use of MDMA 
continued to grow. Although most methamphetamine 
indicators were low, there was a nonsignificant de-
crease in ED mentions between 2000 and 2001, while 
treatment admissions increased. The proportion of 
HIV/AIDS cases attributable to injection drug use 
continued to increase, disproportionately affecting 
African-American males. Immediately following the 
terrorist attacks of September 11, 2001, heroin and 
cocaine, as well as marijuana and MDMA became 
less available in certain markets in the District. How-
ever, the diversion of police to other areas for sur-
veillance in the initial weeks following the attacks led 
to heightened activity in drug markets, while some 
drug trafficking processes were disrupted.  
 
INTRODUCTION 
 
Area Description 
 
The Nation’s Capital is divided into eight wards 
distinguishable by race and economic status. A 
majority of Washington=s White and wealthier res-
idents live in the northwest part of the city, while 
most of the poorer African-American populations 
reside in the eastern quadrants of the city. The 
District retained its majority African-American pop-
ulation in 2002. African-American residents account-
ed for 60 percent of the total population and Whites 
for 31 percent; the remainder were primarily His-
panic and/or Pacific Islanders (U.S. Bureau of the 
Census, 2002). In the first half of 2001, the District 
remained a city divided by race and geography. How-
ever, data from the 2000 census indicate significant 
demographic changes in the last decade. The Dist-
rict’s population fell by 5.7 percent during the 1990s, 
to 572,059 in 2000. The number of African-Amer-
icans decreased by 14.1 percent. Conversely, the 
number of Asians grew by 38.6 percent, and the 
number of Hispanic residents grew by 37.4 percent. 
The White population also grew by a modest 2 per-
cent during this time period.  
 
The population of the District continues to reflect an 
older demographic profile than the general U.S. pop-
ulation. In 2000, of the eight age categories reported 
by the DC Office of Planning, residents age 65 and 
older represented the fifth largest segment of the 
population, at 12.2 percent.  
 
Despite a nationwide economic recession, wealth 
distributions became more polarized during 2002. 
Buoyed by the draw of potential income from service 
employment, Government spending, and an estab-
lished technology industry, measures of wealth such 
as median household income increased in the DC 
metropolitan region, while the percentage of persons 
in poverty increased in many localities in and around 
Washington.  
 
Mostly fueled by decreasing incidents of theft, 
overall index crimes declined by 3.2 percent between 
2000 and 2001 in the District. While the aggregate of 
index crimes declined, the number of homicides 
increased 14.6 percent. 
 
Washington, DC, plays an important role in the drug 
transportation network along the eastern seaboard of 
the United States. Information from the Department 
of Justice’s National Drug Intelligence Center 
(NDIC) suggests that the District has a wide variety 
of drug transportation options, including an extensive 
highway system, three major airports, and rail and 
bus systems. While both NDIC and ethnographic 
information suggest that traffickers extensively 
utilize all of these options, Washington appears to be 
a secondary drug distribution center, with most drugs 
intended for distribution in DC being distributed first 
to larger cities such as New York and Miami.  
1
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Although this overall pattern has remained consistent 
in recent months, ethnographic data and news reports 
suggest that higher security at airports has shifted 
smuggling activities to rail, bus, and commercial 
package delivery networks. Availability of marijuana, 
methamphetamine, methylenedioxymethamphetamine 
(MDMA), heroin, and crack decreased after September 
11, 2001, perhaps because of transporting difficulties 
related to increased airport security. Information from 
the NDIC suggests that Colombian drug trafficking 
organizations (DTOs) continue to play a major role in 
supplying opiates and cocaine to DC criminal groups 
of Colombian and Dominican descent. In addition, 
increasing involvement among Hispanic gangs and 
Asian traffickers has been noted, as has decreasing 
violence by Jamaican organized criminal groups.  
 
Data Sources 
 
A number of sources were used to obtain compre-
hensive information regarding the drug use patterns 
and trends in Washington, DC. Data for this report 
were obtained from the sources shown below. 
 
• Emergency department (ED) drug mentions 
data were derived through 2001 from the Drug 
Abuse Warning Network (DAWN), Office of 
Applied Studies (OAS), Substance Abuse and 
Mental Health Services Administration 
(SAMHSA).  
 
• Drug-related death data were derived from the 
Drug Abuse Warning Network (DAWN) annual 
medical examiner (ME) data for 2000.  
 
• Drug treatment data were obtained through 2001 
on characteristics of admissions to publicly funded 
treatment programs in Washington, DC, and from 
the Office of Applied Studies, SAMHSA, 
Treatment Episode Data Set (TEDS), based on 
administrative data reported to TEDS through 
September 30, 2002. The 2000 and 2001 TEDS 
data used in this report are not comparable to prior-
year data that were derived from local sources. 
 
• Arrest, crime, and law enforcement action data 
were derived from the Metropolitan Police 
Department (MPD) crime statistics and press 
releases pertaining to law enforcement action 
through June 2001, <www.mpdc.dc.gov>, and 
from the MPD Central Crime Analysis Unit’s 
tables on Arrests by Sex for Adults and Juveniles 
through 2001. 
 
• Arrestee urinalysis data were provided by the 
District of Columbia Pretrial Services Agency and 
included data on adult and juvenile arrestee 
urinalysis results through April 2002. For the third 
quarter of 2002, data were derived from the 2002 
provisional unweighted ADAM urine data in 
Washington, DC, and represent small numbers of 
adult male and female arrestees. 
 
• Drug prices and trafficking trends data were 
obtained from the Drug Enforcement Admin-
istration (DEA), Washington Field Division, and 
the DEA’s Domestic Monitor Program (DMP) 
“ Quarterly Trends in the Traffic,”  Washington 
Division, FY 2001; “ Quarterly Price List,”  Fourth 
Quarter Fiscal Year 2001; drug seizure data 
through August 2001; and DMP data through the 
first quarter of 2002. Other information was 
provided by the Federal Bureau of Investigation 
(FBI) and District narcotics officers. Still other 
trafficking data were derived from the Washing-
ton-Baltimore High Intensity Drug Trafficking 
Area (HIDTA) “ District of Columbia Threat 
Assessment,”  available at <http://www.white 
housedrugpolicy.gov>; “ Washington, DC, Threat 
Assessment,”  January 2002. Other trafficking data 
were derived from NDIC, “ District of Columbia 
Drug Threat Assessment,”  January 2002 at <http: 
//usdoj.gov/ndic/pubs>. 
 
• General information on drug use was derived 
from the Office of National Drug Control Policy 
(ONDCP) reports “ Pulse Check: Trends in Drug 
Abuse Mid-Year 2001,”  and “ Washington, D.C., 
Profile of Drug Indicators,”  <http://www.white 
housedrugpolicy.gov>; the District of Columbia, 
Department of Health, Addiction, Prevention and 
Recovery Administration (APRA), “ A 2000 
Household Survey on Substance Abuse: Summary 
of Findings,”  September 2001; and the Center for 
Substance Abuse Research, University of Mary-
land, Drug Early Warning System, “ Ecstasy in 
Maryland,”  August 2001. 
 
• Acquired immunodeficiency syndrome (AIDS) 
data were provided by the District of Columbia 
Department of Health, Administration for 
HIV/AIDS, “ District of Columbia AIDS Surveil-
lance Report,”  Volume 21, No. 1, September 30, 
2002, the “ District of Columbia HIV/AIDS 
Epidemiological Profile 2001,”  available at 
<http://dchealth.dc.gov/services/administration_of
fices/hiv_aids/pdf/epiprofile2001.pdf>, and by 
the HIV/AIDS Surveillance Report, September 25, 
2002, available at <http://www.cdc.gov/hiv/stats/ 
hasrlink.htm>. 
 
• Census data for the District of Columbia were 
derived from the “ Council of the District of 
Columbia; Subcommittee on Labor, Voting Rights 
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and Redistricting; Testimony of the Office of 
Planning/State Data Center on Bill 14-137, The 
Ward Redistricting Amendment Act of 2002,”  
<http/www.planning.dc.gov/documents/single_rac
e.shtm>.  
 
Ethnographic research provided qualitative data on 
price, purity, and social aspects of drug use through 
interviews with law enforcement officers, DC city 
administration officials, and local experts. 
 
Media reports used included those from the 
Washington Post, <http://www.washingtonpost. 
com>, and press releases from the District of 
Columbia Mayor’s Office News Web site 
<http://dc.gov/mayor/index.shtm>. 
 
DRUG ABUSE PATTERNS AND TRENDS  
 
This section presents data from drug-related 
incidents, such as ED episodes, arrests, and other data 
sources described above. 
 
For 2000 and 2001, the number of DAWN ED 
episodes and mentions combined for the major 
substances of abuse increased slightly in the District. 
The number of combined drug episodes rose slightly 
but insignificantly, from 10,303 to 10,566. ED 
mentions per 100,000 population decreased from 262 
to 254.  
 
The rates of DAWN ED mentions per 100,000 
population for 2001 in the District are as follows: 69 
for cocaine, 45 for heroin, and 51 for marijuana. 
Several other metropolitan areas in the northeastern, 
southeastern, and mid-Atlantic States had higher ED 
rates of cocaine and heroin mentions than the 
District. Among the 20 CEWG cities reporting 
DAWN ED rates in 2001, DC ranked 15th for 
cocaine, 13th for heroin, and 12th for marijuana.  
 
Between 2000 and 2001, the number of admissions to 
publicly funded drug treatment providers in the 
District of Columbia decreased, from 6,025 to 5,736. 
There were small increases in the number of 
admissions for primary abuse of heroin, cocaine, 
amphetamines, and phencyclidine (PCP). The 
number of primary marijuana admissions declined 
from 484 in 2000 to 367 in 2001, accounting for 6 
percent of the 5,736 admissions in 2001. Primary 
cocaine admissions for smoking crack also declined, 
from 1,626 to 1,450; nevertheless, crack still 
accounted for 25 percent of all admissions in 2001. 
Heroin admissions, however, increased slightly, from 
2,121 to 2,181, accounting for 37.9 percent of all 
2001 admissions. Primary admissions for intranasal 
use of cocaine rose from 448 to 474, a 6-percent 
increase. Likewise, admissions for amphetamines 
increased from 14 to 33, and PCP admissions 
increased from 43 to 105. 
 
According to DAWN ME data, total drug abuse-
related deaths in the Washington, DC, metropolitan 
statistical area (MSA) rose from 215 to 235 between 
1996 and 2000, a 9-percent increase. Within the 
District in 2000, there were 100 drug-related deaths. 
The number of cocaine-related death mentions in the 
MSA increased slightly, from 101 in 1996 to 107 in 
2000. However, during this same time period, the 
number of heroin-related death mentions decreased 8 
percent, from 91 to 84. In 2000, 69 percent of the 
cocaine mentions involved more than one drug, as 
did 75 percent of the heroin mentions. Sixty-eight 
percent of the decedents in 2000 were male, 52 
percent were African-American, and 76 percent were 
age 35 and older. However, as the demographic 
makeup of the District continues to change, the 
number of White decedents associated with drug 
abuse is beginning to show a slight increase. 
 
Threat assessment data gleaned from ethnographers 
and law enforcement agencies show stability in prices 
for illicit drugs and an increase in drug purity.  
 
District of Columbia arrest data indicate a 16-percent 
increase in the number of drug-related arrests among 
adults between the first halves of 2000 and 2001. 
However, the District of Columbia Pretrial Services 
Agency, which tests adult arrestees for cocaine, 
opiates, and PCP, reported little change through these 
reporting periods and the first quarter of 2002, when 
the proportion of adult arrestees testing positive for 
any drug typically fell between 43 and 46 percent.  
 
The following sections will present data on specific 
drugs of abuse in the District. 
 
Cocaine and Crack 
 
Cocaine remains the most widely abused drug in the 
District of Columbia, based on a number of 
indicators. ME data from DAWN suggest that the 
number of deaths associated with cocaine in 
Washington, DC, remained steady between 1996 and 
2000. In 1996, a total of 57 cocaine-related deaths 
were reported; in 2000, the figure remained nearly 
level, at 54.  
 
Although ME numbers remained relatively stable 
throughout the 1990s and 2000, DAWN ED mentions 
for cocaine for 2000 and 2001 were at a 4– 5-year 
low. From 1996 onward, ED mentions peaked at 
3,718 in 1998. The number dropped to 2,894 in 2001, 
an insignificant increase from 2000 (n=2,830). 
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Between 1998 and 2001, rates per 100,000 popula-
tion declined from 97 to 69, and no significant rate 
change occurred from 2000 to 2001 (exhibit 1). 
Earlier tests on annual ED cocaine rates per 100,000 
from 1998 (97) to 2000 (72) do show a significant 
decrease (a 23.9- percent change). 
 
Treatment admissions data suggest that abuse of 
powder cocaine remained at high levels between 2000 
and 2001. The number of persons entering treatment 
for smoked cocaine (i.e., crack) decreased by approx-
imately 11 percent, from 1,626 in 2000 to 1,450 in 
2001. Crack admissions accounted for 75.4 percent of 
all cocaine admissions in 2001. Reports of intranasal 
cocaine use remained at similarly high levels between 
2000 and 2001. For intranasal cocaine administration, 
District treatment facilities reported 448 admissions in 
2000 and 474 in 2001. Excluding alcohol, primary 
cocaine admissions accounted for more than 41 
percent of admissions for abuse of an illicit drug in 
2001, down slightly from 2000 (exhibit 2). 
 
Information from the District of Columbia Pretrial 
Services Agency shows that cocaine-positive ur-
inalysis results among juvenile arrestees remained 
steady between the first quarters of 2001 and 2002, at 
less than 10 percent (exhibit 3). The percentage of 
adult arrestees testing cocaine-positive also remained 
stable between April 2001 and March 2002, at 
approximately 34 percent (exhibit 4). 
 
Among the small samples of adult arrestees tested in 
the third quarter of 2002, provisional unweighted 
ADAM urine data for Washington, DC, showed that 
27.3 percent of the men were cocaine-positive. More 
than one-half (52.9 percent) of the women also tested 
cocaine-positive.  
 
Prices for crack cocaine began at a low of $10– $20 
for a “ bag”  or loose “ rock”  of crack cocaine. In the 
second quarter of 2002, grams of crack sold for $80–
$100. An ounce of crack sold for $900– $1,750, and a 
“ 31”  (grams) and a “ 62”  (grams) sold for $1,000–
$1,300 and $1,500– $2,600, respectively. Kilograms 
of crack sold for $30,000 during this reporting 
period.  
 
Prices for powder cocaine varied greatly according to 
the level of purity. Grams of powder cocaine during 
the second quarter of 2002 sold for $50– $100, which 
was the same price as in fiscal year (FY) 2001; this 
price was cheaper than for grams of crack. An ounce 
of powder cocaine sold for $600– $2,000, depending 
on purity. A “ 31”  and a “ 62”  sold for $1,100– $1,200 
and $1,450– $3,500, respectively. Kilograms of 
powder cocaine likewise ranged widely in price, from 
$17,500 to $35,000.  
Trafficking patterns remained steady between 2001 
and 2002. Often, a courier will travel to the source 
city, obtain a quantity of cocaine, and then return to 
Washington. Alternatively, a supplier will travel to 
Washington and set up a temporary shop for distribu-
tion. Traffickers utilize a variety of methods to 
transport powder cocaine, including rail, bus, and 
commercial package delivery. A common method of 
transporting drugs is the use of motor vehicles 
equipped with sophisticated secret compartments. At 
least two major seizures of multikilogram amounts of 
powder cocaine were made in 2001. In each of the 
two seizures, more than 30 kilograms of powder 
cocaine were found in a private motor vehicle 
equipped with false compartments. Law enforcement 
sources report that members of Dominican criminal 
groups are the most prominent distributors of 
wholesale powder cocaine in the District of Colum-
bia. Mexican criminal organizations have also begun 
to distribute wholesale quantities of powder cocaine. 
 
Trafficking patterns of powder cocaine and crack 
differ in the DC area, because penalties are greater 
for the possession and distribution of large amounts 
of crack than for powder cocaine. Thus, the bulk of 
crack cocaine consumed in the metropolitan area is 
brought in from Philadelphia or New York City as 
powder cocaine and is converted into crack. In DC, 
crack cocaine is most commonly distributed by 
“ crews,”  or loosely affiliated individuals from 
particular neighborhoods who organize themselves 
for the purposes of selling cocaine or other drugs. 
Crews are often known by the neighborhood in which 
they operate (e.g., “ Hobart Stars”  or “ 6200 Crew” ), 
and they tend to control small areas of the District 
and sell crack on street corners and in various 
neighborhoods and public housing projects. The 
crews are also known for their violence.  
 
Law enforcement sources suggest that involvement 
of senior citizens in the cocaine trade is increasing in 
the District. Individuals age 60 and older are 
reportedly being recruited as cocaine couriers, and a 
small minority began selling crack cocaine from their 
residences in public housing projects.  
 
Heroin 
 
In Washington, DC, and 16 other major U.S. cities, 
heroin has surpassed crack as the drug associated 
with the most serious consequences— medically, 
legally, and socially (Pulse Check: Trends in Drug 
Abuse, April 2002).  
 
DAWN data show 1,888 heroin ED mentions in 
Washington, DC, in 2001. This represents an 
insignificant decrease from 2000 (n=1,946). Annual 
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rates per 100,000 population were steady between 
2000 (49) and 2001 (45). In 2001, men continued to 
outnumber women by nearly twofold in the rate of 
ED heroin mentions per 100,000 population for the 
District. The increase in the rate of heroin ED 
mentions among those age 18– 25 from 2000 (40 per 
100,000) to 2001 (45) was statistically insignificant. 
The 35– 44 age group continues to have the highest 
rate of heroin ED mentions, at 87 in 2001, compared 
with 102 in the first half of 2000.  
 
The District reported 2,181 primary heroin admis-
sions to publicly funded treatment programs during 
2001, up from 2,121 for 2000. Heroin admissions for 
2001 represented 37.9 percent of all treatment admis-
sions and, as shown in exhibit 2, for 47.0 percent of 
all admissions for illicit drug abuse. As in 2000, 
heroin treatment admissions continued to outnumber 
those for cocaine. The vast majority of the heroin 
admissions in 2001 were African-American, male, 
and age 35 or older.  
 
DAWN ME data for Washington, DC, heroin-related 
mentions increased between 1996 (n=35) and 1998 
(53), and decreased from 1998 to 2000 (36). 
 
Urinalysis results from the District of Columbia 
Pretrial Services Agency indicate that the percentage 
of adult arrestees testing positive for opiates through 
2001 has remained relatively steady since 1992. In 
the first halves of 2000 and 2001, respectively, 13 
and 15 percent of adult arrestees tested opiate-
positive. However, in the first quarter of 2002, 
opiate-positive tests hovered at 11 percent of all adult 
arrestees testing positive for any drug (exhibit 4). 
Possession with intent to distribute was the most 
commonly reported charge.  
 
Data from the DMP indicate that the average purity 
level of heroin in the city remained steady at around 
24 percent in 2000 and 2001. The 2001 figure is 
substantially lower than the national average of 34 
percent. The national DMP price per milligram of 
pure heroin in 2001 averaged $1.30, which is slightly 
higher than the $1.05 per milligram of pure heroin 
price in Washington, DC. Across the District, street-
level heroin is packaged in small, plastic, zip-lock 
bags; paper packets; or capsules (a recent trend) and 
sold for $8, $10, or $20 per bag. The price of heroin 
depends on its purity, the number of bags purchased, 
and the amount of heroin in each bag. Also available 
are grams at $120– $150 (40– 90 percent purity). 
Heroin that is reputedly unaltered with quinine and 
called “ bone,”  typically favored by intranasal users, 
can be purchased for $30– $70 per bag; purity levels 
of these bags fluctuate from 40 to 70 percent. Finally, 
there were 771 heroin seizures (totaling 1,227 grams) 
in the first 11 months of 2000.  
 
Data from the Washington/Baltimore HIDTA and 
ethnographic sources continue to suggest that overall 
use of heroin in the region has increased in the past 
several years. Alarming trends have developed 
among younger addicts, especially the use of heroin 
in combination with other drugs (polydrug use). A 
growing heroin addict population has led to a 
massive increase in methylenedioxymethamphet-
amine (MDMA or “ ecstasy” ) use. 
 
Heroin remains readily available throughout the city, 
even as purity fluctuates from week to week. As in 
2000, the scope and characteristics of individual 
users continue to broaden. Health educators and 
outreach workers report an increase in use among 
suburban and inner-city adults between the ages of 22 
and 27. Among these young users, inhaling remains 
the primary route of administration.  
 
Despite the booming real estate market and gentrifica-
tion currently impacting the whole city, street-level 
heroin continues to be marketed and distributed in 
open-air drug markets. According to District narcotics 
officers, the traditional heroin markets still operate in 
the city, but recently younger persons (age 16– 18) 
have begun selling the drug and establishing new 
locations throughout the city. An estimated 25– 30 of 
these markets exist in the District, with some located 
along the Maryland/DC border to make heroin more 
accessible to suburban users. However, the great 
majority of the city’s heroin distribution groups are 
crews of young men ranging in age from their early 
twenties to midthirties. Because of competition for 
buyers, dealers continue to label their packages in 
order to distinguish their products (e.g., “ Bin Laden,”  
“ Holy Terror,”  and “ No Limit” ). According to the 
DEA, most of the heroin sold in the District originates 
in South America. Also, HIDTA reports a relatively 
new and significant phenomenon in the District of 
Columbia— the emergence of Asian groups operating 
in the heroin market. 
 
Other Opiates/Narcotics 
 
Opiates such as oxycodone (Percocet, Percodan), 
Tylenol with codeine, and occasionally hydro-
morphone (Dilaudid) can be purchased near metha-
done clinics throughout the city. Addicts misuse 
these and other pharmaceuticals to ease the symp-
toms of opiate withdrawal and to heighten the effects 
of heroin. There were no arrests related to Dilaudid in 
the first half of 2001; in the first half of 2000, two 
arrests for possession with intent to distribute this 
drug were reported. 
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The illegal use of OxyContin, the time-release 
version of the painkiller oxycodone, has emerged as a 
substantial threat to the residents of the 
Washington/Baltimore region. According to the 
HIDTA 2001 OxyContin Report, the illegal use of 
this drug is both a “ substantial threat”  to Washington, 
DC, residents and a “ major concern to law 
enforcement and health care professionals.”  An 
official of the DEA’s regional drug diversion 
program notes that OxyContin abuse has increased 
dramatically and the drug continues to be very 
accessible. According to HIDTA, OxyContin has no 
common user demographics. DC and Maryland 
authorities reported users as young as 15. In the 
District, police officials have observed OxyContin 
(“ OC” ) sales conducted outside heroin addiction 
treatment facilities in the northeast area of the 
District. It can also be found where heroin is sold or 
where heroin addicts congregate, especially at the 
street level. Since 1998, this synthetic opiate has been 
linked to at least 43 deaths in southwest Virginia. 
Within the Baltimore/DC region, two confirmed 
deaths have been related to OxyContin since 2000.  
 
According to HIDTA, after the OxyContin pill is 
crushed, the powder can be snorted, chewed, or 
dissolved and injected. The drug has also been 
reported to mix well in alcohol. The Prince William 
County, Virginia, Police Department reported addicts 
using a rare liquid form of the drug called Oxyfast.  
 
HIDTA reports indicate that the majority of dealers 
distributing OxyContin in the region are independent, 
street-level pushers. The FBI has identified the 
District as the only area where many of the distribu-
tors are older African-American males in their fifties. 
According to District narcotics officers, 40-milligram 
tablets of OxyContin sell for $20, and 20-milligram 
tablets cost $10. While 80- and 160-milligram tablets 
are available, they are much harder to obtain in the 
District. Current OxyContin prices represent a 50-
percent reduction from the previous price of $1 per 
milligram. The 40-milligram tablet, which is 
affordable at $20, is considered the most popular 
dosage unit sold in the region. 
 
DAWN data show a total of 1,098 ED mentions of 
narcotic analgesics/combinations for 2001. This is a 
significant increase from the 672 mentions reported 
in 2000. ED mentions for the overall category of 
analgesics in 2001 totaled 2,596, a nonsignificant 
change from the 2,094 mentions in 2000. 
 
The rate of analgesics ED mentions per 100,000 
population remained relatively stable between 2000 
(at 53) and 2001 (at 62); however, the rate for 
narcotic analgesics/combinations increased signifi-
cantly, from 17 in 2000 to 26 in 2001, a 54-percent 
change (exhibit 1). 
 
Marijuana 
 
In 2001, marijuana ED mentions in the District totaled 
2,135, compared with 2,510 in 2000. This decrease 
was not significant. The rate of ED marijuana 
mentions per 100,000 population for 2001 was 51 
(exhibit 1). As in previous years, African-Americans 
continued to predominate among marijuana ED 
mentions. Rates of ED marijuana mentions per 
100,000 population by age group were highest for 
persons age 18– 19 in 2000 (204) and 2001 (223). 
 
According to DAWN ME data, one marijuana-related 
drug abuse death occurred in 2000. In 2001, the ME 
reported no marijuana-related deaths. 
 
Between 2000 and 2001, the total number of 
marijuana admissions to publicly funded treatment 
facilities declined 24 percent, from 484 to 367. For 
this time period, primary marijuana as a percentage 
of admissions for illicit drug abuse decreased, from 
10.2 to 7.9 percent (exhibit 2). A growing concern in 
the District is the increasing number of Hispanic 
residents who cite marijuana as their drug of choice. 
In 2000, Hispanics accounted for only 6 percent of 
the admissions for marijuana abuse; this figure rose 
to 12 percent by 2001. Cocaine remains the most 
frequently mentioned secondary drug among primary 
marijuana treatment admissions. One-fifth of the 
marijuana admissions reported cocaine/crack as their 
secondary drug in the first half of 2001, up from 11 
percent in 2000. 
 
Data from the District of Columbia Pretrial Services 
Agency Urinalysis Division show a 16.4-percent 
decrease in marijuana-positive tests among juvenile 
arrestees from the first quarter of 2001 to the first 
quarter of 2002, when 51 percent of the juveniles 
tested marijuana-positive (exhibit 3). The data in-
dicate that marijuana is the most common drug for 
which juvenile arrestees test positive; rarely is the 
presence of cocaine or phencyclidine (PCP) detected 
without a positive result for tetrahydrocannabinol 
(THC). 
 
For the third quarter of 2002, provisional unweighted 
ADAM urine data for Washington, DC, showed that 
28.2 percent of the men tested marijuana positive, as 
did 17.6 percent of the women. 
 
According to ethnographic data, HIDTA, District of 
Columbia police officials, and DEA sources, 
marijuana continues to be abundant and easily 
obtained throughout the Washington, DC, metropoli-
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tan region. There are reports that hydroponic 
marijuana is now prevalent in the District and is 
“ extremely potent.”  According to District narcotics 
officers, “ blunts (marijuana rolled in cigar paper) are 
not as common”  in the District as they once were. 
Flavored cigar papers are now the favorite for 
younger marijuana smokers in their early teens 
through midtwenties. Since 1992, adolescents and 
young adults in the District have been lacing 
marijuana cigarettes with PCP and small rocks of 
crack cocaine. Law enforcement sources report that 
clubgoers favor the more potent types of marijuana 
for use, together with drugs such as MDMA, lysergic 
acid diethylamide (LSD), and methamphetamine. 
Preventive efforts to reduce marijuana abuse among 
youth have been particularly difficult, primarily 
because the drug is celebrated in a manner far less 
frequently demonstrated in the adult world. In fact, 
data from a number of Federal law enforcement 
agencies indicate that on any given day, T-shirts, 
hats, and even bumper stickers adorned with 
marijuana leaves, and/or words such as “ blunt”  or 
“ chronic”  (popular street slang across the country for 
high-grade marijuana) can be purchased at a variety 
of locations in the District. 
 
District law enforcement sources indicate that 
marijuana users tend to be young, African-American, 
male, and from lower socioeconomic groups. Of 
note, the District’s local child welfare and juvenile 
justice agencies report an increase in young female 
marijuana users over the past 7 years. As is the case 
in most metropolitan areas, marijuana use among 
young females is often underrepresented and/or 
underdiagnosed, primarily because youth courts, 
lockup facilities, detention centers, and the like are 
often ill equipped to address the needs of adolescent 
females. National data show that many of these 
females are not accorded an opportunity to participate 
in age-appropriate drug treatment interventions until 
well into their late twenties and thirties. 
 
According to the Washington DEA Field Division, 
the pound price of commercial grade marijuana 
ranged from $700 to $1,400 in the first and second 
quarters of 2001; these prices were higher than the 
$600– $1,300 per pound reported in the third quarter 
of 2000. Currently, a pound of “ hydro”  or “ kind bud”  
(the most potent form) sells for $1,200– $6,000. 
Smaller bags, called “ dimes,”  of kind bud and hydro 
sell for $10– $20 per gram, and commercial grade 
marijuana sells for $5– $10 per bag. An ounce of 
commercial grade sells for $100, and an ounce of 
hydro or kind bud sells for approximately $480. 
Marijuana prices in the District are generally thought 
to be the highest in the metropolitan region. This may 
reflect the fact that about 12 or more branches of 
Federal and local law enforcement agencies patrol the 
District independently and in tandem. 
 
Marijuana appears to pose a lower threat of violent 
crimes than other illicit drugs (e.g., cocaine and 
heroin). However, as local traditional dealers of 
cocaine and heroin continue to augment their distri-
bution stock and pile of illicit drugs, the association 
of marijuana with violent crimes is increasing.  
 
Reports indicate that much of the marijuana in 
Washington, DC, is grown locally (e.g., on Mary-
land’s Eastern Shore). However, the majority of 
marijuana found in the District results from com-
mercial and Postal Service trafficking. Commonly 
referred to as “ drip trafficking,”  Postal Service 
conveying involves mass mailing of small amounts of 
marijuana in numerous packages. “ Drip trafficking”  
offers the distinct benefit of avoiding stiff penalties 
and significantly reducing financial liability in the 
wake of aggressive legislation passed in 2000 and 
2001 in the District that made distribution, intent to 
distribute, and possession of more than one-half 
pound of marijuana a felony carrying a 5-year 
sentence. DEA data show that Jamaican drug 
trafficking groups represent one of the largest sub-
groups involved in the importation and distribution of 
marijuana to the area. The two most common types 
of indoor-grown marijuana are hydro, which refers to 
plants grown in water (hydroponically), and kind bud 
(“ bud,”  or “ KB” ), which is grown with enhanced soil 
and lighting. Both hydro and kind bud are considered 
high-potency types of marijuana. Although they are 
not new types of marijuana, they have only recently 
become visible in the District. These types of 
marijuana are frequently grown in, and imported 
from, Canada and transported to the District via New 
York for wholesale distribution. 
 
Marijuana seizure data from FY 1999 to FY 2000 
show a substantial decline in the amount of the drug 
seized. According to the Washington Field Division 
of the DEA, preliminary data for December 2000 
through March 2001 indicate that 19.5 kilograms of 
marijuana and 4.5 grams of hashish were seized 
during these months.  
 
Stimulants 
 
The use of amphetamine-type substances, such as 
methamphetamine, does not appear to be a serious 
problem in Washington, DC, according to most data 
sources. However, institutional and surveillance 
reports from 1999 to 2002 suggest the growing use 
and availability of these substances. Ethnographic 
reports indicate that methamphetamine is used alone 
or in combination with alcohol, marijuana, powder 
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cocaine, and MDMA. User groups include homo-
sexual men, club attendees, white-collar profes-
sionals, business owners, teenagers, and young 
adults. Ethnographic reports indicate that metham-
phetamine is used at dance and music venues that are 
part of the rave/club subculture. There are a few users 
among some lower socioeconomic groups and outlaw 
motorcycle groups, although most motorcycle groups 
in the region have been disbanded. An ethnographic 
respondent observed that greater numbers of users in 
the club scene are injecting methamphetamine, a 
phenomenon known locally as “ pointing.”  Indicator 
data support this claim.  
 
For a number of years, most methamphetamine 
indicators have shown few problems associated with 
this drug in the District. ED methamphetamine men-
tions are so low as to often lack standard precision. 
There were only 24 ED methamphetamine mentions 
in 2001, an insignificant decrease compared with 62 
in 2000. The rates per 100,000 population were as 
low as 2 for 2000 and 1 for 2001. The ME data show 
one methamphetamine-related death in 1998 and one 
in 2000.  
 
There were 33 primary methamphetamine treatment 
admissions during 2001, compared with only 14 in 
2000, more than a twofold increase over the 1-year 
period. In 2001, 79 percent of methamphetamine 
admissions were White, 14 percent were Hispanic, 
and 7 percent were African-American, suggesting an 
expanding ethnoracial context of users. Nearly three-
quarters (71 percent) were male. One-half of the 
methamphetamine admissions were age 35 and older. 
Another 28 percent were age 25– 34, an increase in 
treatment cases for this age group. While it is too 
early to tell whether this shift is an artifact of small 
numbers, the ethnographic data suggest an increase in 
methamphetamine use in the younger rave/club 
subculture. Nevertheless, those entering treatment are 
still dominated by an older cohort of users. 
Corroborating ethnographic reports, more than one-
quarter (28.6 percent) of methamphetamine treatment 
admissions reported injecting as their main route of 
administration, although intranasal use remained the 
main mode of ingesting methamphetamine.  
 
DEA reports for the second quarter of 2002 indicate 
that prices for methamphetamine have varied over the 
past few years. During the recent reporting period, 
methamphetamine continued to be sold for $100 per 
gram, which is similar to gram prices in 2001, but 
lower than the gram price in 2000 ($150). Ounce 
prices in the second quarter of 2002 in the District 
ranged from $1,100 to $2,900, which is a much wider 
range and is less expensive than the ounce prices of 
$2,700 in 2001 and $2,400– $2,800 in 2000. Pounds 
of methamphetamine sold for $13,000 in the District. 
In Virginia, pounds sold for $10,000– $12,500 in 
Richmond and $11,500– $17,000 in Roanoke, 
approximately one-half of the cost (i.e., $25,000–
$28,000, respectively) in these areas during 2001. 
This may be a troublesome development. However, 
most methamphetamine is sold in DC in smaller 
quantities and at higher retail prices for users: one-
half gram may cost $60– $140, and one-half ounce 
may cost $1,000.  
 
There are a number of gradations in the quality of 
methamphetamine, largely related to the substances 
and techniques used in the manufacturing process. 
The DEA reports that most methamphetamine avail-
able in DC is of 70-percent purity and is produced 
through the hydriodic acid/red phosphorus method 
that yields high-quality methamphetamine. This type 
of methamphetamine is sent from the Southwest and 
California through Mexican drug trafficking organ-
izations. Methamphetamine of lower quality pro-
duced by the phenyl-2-propanone (p2p) method can 
be found, though in lesser quantities, and it is 
associated with distribution by motorcycle gangs.  
 
The DEA reports that Washington, DC, is a trans-
shipment center for trafficking methamphetamine by 
Mexican drug trafficking organizations. It arrives by 
automobile; with couriers who body-carry the drug 
on planes, trains, and buses; and through express mail 
services. During the first quarter of 2001, police 
seized 70 grams in a package mailed from California, 
and couriers have been identified by the DEA as 
carrying several pounds on commercial airlines from 
California to the DC metropolitan area.  
 
Hallucinogens 
 
LSD continues to be used in the District of Columbia, 
although its use appears to be decreasing. Ethno-
graphic reports suggest that its popularity has not 
waned as much as its availability. According to the 
DEA, LSD is sold in the form of blotter sheets of 
paper soaked in the drug, as a liquid placed on sugar 
cubes or candy or dropped directly on the tongue 
from breath-drop and eye-drop bottles, and in larger 
multigram quantities as crystal LSD. When diluted or 
dissolved, 1 gram of crystal LSD yields 10,000 
dosage units. Blotter sheets, which are perforated into 
one-quarter inch-square individual doses, are the 
most common form of LSD available. They are sold 
by the tab, in “ sheets”  (100 tabs), and in “ cubes”  (10 
sheets).  
 
LSD is used largely by high school- and college-age 
individuals at area raves, concerts, and nightclubs. 
LSD is commonly sold and used alongside various 
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club drugs. DEA investigations also cite accounts of 
young adults and clubgoers practicing “ candy flip-
ping,”  or mixing ecstasy and LSD. 
 
The total number of LSD-related ED mentions in the 
District decreased significantly between 2001 (45 
mentions) and 2000 (25). There has been a general 
drop in ED mentions since 1995 (176). The reported 
LSD-related mentions per 100,000 population were 1 
for both 2000 and 2001. 
 
The DEA quotes LSD prices during the second 
quarter of FY 2002 at approximately $2– $5 per dose, 
which is $2– $3 less than the cost of individual doses 
in FY 2000. A sheet of 100 blotter doses sold for 
$200– $300, as opposed to $800 in 2001. A book of 
LSD, which is 1,000 dosage units, sold for $1,300–
$1,750. Three LSD seizures were reported in the 
District during 1999, and four were reported during 
the first 10 months of 2000. The DEA has identified 
California-based suppliers of the drug who ship it to 
the DC area in private automobiles and through 
express mail services. 
 
PCP ED mentions increased significantly from 2000 
(317) to 2001, when there were 525 mentions. In 
2000, the annual rate increased significantly from 
1999, rising from 5 to 8 mentions per 100,000 
population. In 2001, the number increased signifi-
cantly to 13 mentions per 100,000 population. Much 
of this increase is associated with an increase in 
younger users age 18– 25. 
 
Treatment admissions to publicly funded programs 
for primary abuse of PCP increased from 43 
admissions in 2000 to 105 in 2001, a 144-percent 
increase. The proportion of PCP admissions to total 
admissions also increased, from 0.7 percent in 2000 
to 1.8 percent in 2001. These admissions showed a 
strong demographic pattern: the majority were male 
(84 percent), age 25– 34 (91 percent), and African-
American (100 percent). PCP and PCP-combination 
ME mentions have varied from 1 to 2 between 1996 
and 2000. There was only one 1 mention in 2000. 
 
The District of Columbia Pretrial Services Agency 
data for juveniles reveal PCP trends similar to those 
for adults. Between 1998 and 2000, PCP-positive 
tests increased from 3 to 10 percent, a decrease from 
18 percent in 1995 (exhibit 3). However, the data by 
quarter for 2001 may reveal an alarming trend. 
During the first quarter of 2001, 11 percent of 
juveniles tested PCP-positive, nearly double the 6 
percent level in the first quarter of 2000. During the 
second and third quarters of 2001, 15 percent of 
juveniles tested PCP-positive. From February to 
April 2002, the rate of juveniles testing positive was 
more volatile, fluctuating from 12 to 9 to 15 percent. 
 
According to District of Columbia Pretrial Services 
urinalysis data, the percentage of adult arrestees 
testing PCP-positive increased markedly during the 
first half of the 1990s, peaking at 14 percent in 1995. 
The percentage then declined until 1998, dipping to 
only 2 percent (exhibit 4). More recently, the 
percentage of adult arrestees testing PCP-positive has 
been steadily increasing. During 2000, the percentage 
of adult arrestees testing PCP-positive (9 percent) 
was nearly back to the 1994 level. For more recent 
time periods, the percentage of positive arrestees 
increased from 9 percent in the first half of 2000 to 
13 percent in the first quarter of 2002. 
 
For the third quarter of 2002, provisional unweighted 
ADAM urine data for Washington, DC, showed that 
29.4 percent of the men tested PCP-positive, as did 
12.7 percent of the women. 
 
DEA investigations corroborated ethnographic reports 
that users generally combine PCP with marijuana. 
Within the District, PCP is used primarily by young 
African-American males and lower income to lower 
middle-income Whites, some of whom have ties to 
motorcycle gangs. However, recent DEA intelligence 
indicates an expanding interest in the drug among 
participants in the city’s club/rave scene. Club/rave 
attendees have shown a growing interest in PCP 
because its effects are similar to, though stronger than, 
those of ketamine, which is also a popular drug in the 
club/rave scene. It should be noted, however, that 
many manufacturers of ecstasy will use PCP as a 
cheap adulterant or even substitute it in their tablets, 
which the user unknowingly ingests. 
 
According to the DEA, PCP prices dropped markedly 
to $300– $600 per ounce during the second quarter of 
2002, compared with $700– $950 per ounce during the 
second and third quarters of FY 2001. These current 
prices are a return to the prices of the past few years: 
during 1998, 1999, and the fourth quarter of FY 2000, 
PCP was available for approximately $350 per ounce. 
Government reports indicate that PCP is being sold in 
gallons for $18,000– $22,000. Ethnographic data 
indicate that PCP is often marketed on the street as a 
marijuana-PCP combination, which is sold in 
aluminum foil packages for $15– $25. “ Dippers,”  or 
tobacco cigarettes dipped in liquid PCP, sell on the 
street for $25 each. Dippers are so potent that more 
than one person can get high from one cigarette. They 
are used primarily by persons in their late teens and 
early twenties and use is most prevalent in the 
southeast quadrant of the District. The MPD Narcotics 
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Unit reports that some dealers are putting ether on 
marijuana to make it smell like PCP. 
 
DEA data indicate that the number of PCP seizures 
rose from 39 in 1999 to 74 in the first 10 months of 
2000. PCP is imported to the District from 
surrounding suburbs, as well as from Cleveland, 
Newark, Philadelphia, and New York. Sources of 
supply differ somewhat by user group. Young 
African-American males continue to have connec-
tions to southern California-based manufacturers, 
while other user groups (motorcycle gangs, rave/club 
attendees) tend to have more local sources of supply. 
 
Club Drugs 
 
MDMA (ecstasy) continues to be the most prom-
inently abused club drug in the Washington, DC, 
metropolitan area. Although MDMA indicators are 
very low, ED mentions have been increasing. There 
were 110 mentions in 2001, an insignificant increase 
from 78 mentions in 2000. The rate of ED mentions 
per 100,000 population for 2001 was 3, compared 
with 2 in 2000. 
 
Ethnographic reports suggest that MDMA remained 
prevalent in the District’s gay and nightclub scenes in 
2002. Law enforcement reports show that MDMA 
trafficking increased dangerously in 2002. Interview 
and official information from the NDIC suggests that 
wholesale trafficking in MDMA increased among 
organized criminal groups, Asian groups in partic-
ular. At the same time, retail trafficking remained 
steady among middle- and upper middle-class 
college-age Whites who are not part of an organized 
criminal group. However, law enforcement officials 
have noted that crews who sell drugs in street drug 
markets have started distributing MDMA and have 
introduced a new level of violence associated with it. 
Involvement of military personnel in shipping 
MDMA from overseas and from bases in the United 
States became apparent in 2002.  
 
Law enforcement data also suggest that in 2002, use 
of MDMA spread beyond the rave scene into more 
established drug markets and was adopted by users of 
other drugs such as powder cocaine. MDMA-related 
crimes are increasing at festive nightclub and rave 
venues as drug trafficking organizations become 
increasingly involved in the MDMA trade. In 2000 
and 2001, a number of large MDMA seizures 
occurred in the DC area. In one instance, a suburban 
ring that had sold 200,000 tablets of MDMA was 
dismantled.  
 
Often, what is sold as MDMA or ecstasy is adulterated 
with PCP, methamphetamine, and other drugs, or it 
may contain only these other drugs. The price remains 
at $25– $30 per tablet, and the tablets often contain 1 of 
nearly 100 different logos (e.g., “ smiley faces,”  the 
“ Mitsubishi”  label, “ four-leaf clover,”  and others). 
 
While not as common as use of MDMA, use of the 
surgical anesthetic ketamine remained common in 
nightclub and dance scenes in DC during 2002. 
Ketamine ED mentions remained low, but increased 
from one in 1995 to seven in 2000. Ketamine ED 
mentions for 2001 were too low for precision 
estimates. Ketamine ED mentions per 100,000 
population were zero for 2000. 
 
Law enforcement officials claim that ketamine is 
smuggled into the District from Miami by Israeli and 
Russian distributors, or it may be obtained from break-
ins at veterinary clinics. It is sold at nightclubs and 
dances. The price of a bottle of liquid ketamine 
declined from $100 in FY 2000 to $60– $89 in FY 
2001.  
 
Gamma hydroxybutyrate (GHB) remained a drug of 
abuse in the District in 2002, although its use appears 
limited. GHB ED mentions increased steadily from 
1998 to 2000, but decreased insignificantly between 
2000 and 2001 (from 24 to 15 mentions). ED 
mentions per 100,000 remained low, at 1 in 2000 and 
zero in 2001. At least one fatality in the DC 
metropolitan area directly involved GHB in 2001. 
GHB retailed at $10– $25 per dosage unit (a capful) in 
2002.  
 
INFECTIOUS DISEASES RELATED TO DRUG ABUSE  
 
Washington, DC, remains a major AIDS epicenter. 
As of December 2001, 13,796 AIDS cases had been 
reported in the District of Columbia and 24,549 cases 
of AIDS had been reported in the greater 
metropolitan region. Washington, DC, reported the 
highest rates in the Nation of AIDS per 100,000 
people among adults and adolescents, at 275.7 and 
92.0, respectively. 
 
In DC, AIDS disproportionately affects Black males. 
The percentage of both reported and diagnosed cases 
in this group is considerable higher than those 
reported for Whites, Hispanics, and Asian/Pacific 
Islanders and Native Americans. AIDS cases are on 
the rise among women in DC. The annual AIDS rate 
for women in the District of Columbia is 92.0 per 
100,000 population, compared with 9.1 per 100,000 
the United States.  
 
The individuals who are at risk for contracting 
HIV/AIDS are those who participate in risky 
behaviors in communities where there is a high 
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prevalence of HIV infection. Risky behaviors include 
having unprotected sex, having sex with multiple 
partners, and injection drug use. When an 
individual’s judgment is impaired by injection drug 
use, or the use of any drug for that matter, he or she is 
at risk for HIV infection. That risk is then 
compounded by the prevalence of infection in the 
community.  
 
The proportion of cases attributable to injection drug 
use continues to grow. Among cases reported as of 
December 31, 2001, 26.6 percent were attributed to 
injection drug use. Data for 2001 indicate that while 
only 9 percent of White males with AIDS reported 
injection drug use as their primary exposure mode, 
more than 30 percent of Black and Hispanic males 
reported this mode of exposure. Diagnosed AIDS cases 
among Black injection drug users (IDUs) have also 
been increasing faster among men than among women.  
 
Between 1998 and 2001, injection drug use among 
males and females accounted for 17 percent and 10 
percent, respectively, of total diagnosed AIDS cases 
in the District of Columbia (exhibit 5). Furthermore, 
the shift in the epidemic toward non-White people 
and IDUs is reflected in cases from 1998 through 
2000, in which Blacks constituted nearly 100 percent 
of male and female cases involving injection drug 
use. Additional information on reported and 
diagnosed AIDS cases from 1998 to 2001 is 
presented in exhibit 5. As shown, one-third of the 
diagnosed cases are attributable to men who have sex 
with men (MSM), with another 2 percent involving 
MSM/IDUs. 
 
For inquiries concerning this report, please contact Susanna Nemes, Ph.D., c/o Danya International Inc., 8737 Colesville Road, Suite 1200, 
Silver Spring,  Maryland 20910, Phone: 240-645-1137, Fax: 301-565-3710, E-mail: <snemes@danya.com>. 
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Exhibit 1. Rate of DAWN ED Mentions Per 100,000 Population for Selected Drugs in  
 Washington, DC:  1996–2001 
 
Drug 1996 1997 1998 1999  2000  2001 
Cocaine/Crack 104 85 97 81 72 69 
Heroin 41 45 55 46 49 45 
Marijuana/Hashish 58 63 62 65 64 51 
PCP/PCP Combinations 9 6 4 5 8 13 
Benzodiazepines 32 29 28 23 21 22 
Narcotic Analgesics/ 
Combinations 20 21 19 18 17 26 
 
SOURCE:  DAWN, OAS, SAMHSA 
 
 
 
Exhibit 2. Percentage of Primary Treatment Admissions for Major Illicit Drugs (Excluding  
 Alcohol) in Washington, DC:  1997–2001 
 
Drug 1997 1998 1999 2000 2001 
Cocaine/Crack 37.0 46.0 47.0 43.6 41.4 
Heroin 32.0 35.0 37.0 44.6 47.0 
Marijuana 12.0 18.0 16.0 10.2 7.9 
Stimulants 0.0 0.0 0.0 0.3 0.7 
 
SOURCES:  Publicly funded treatment centers and, for 2000 and 2001, TEDS, SAMHSA  
 
 
 
Exhibit 3. Percentage of Juvenile Arrestees Testing Positive for Selected Drugs in  
 Washington, DC:  1995–1st Quarter 2002 
 
Drug 1995 1996 1997 1998 1999 2000 
1st 
Quarter 
2001 
1st 
Quarter 
2002 
Marijuana 58 62 63 63 64 61 61 51 
PCP 18 7 7 3 7 10 11 12 
Cocaine 4 6 6 8 7 6 4 7 
 
SOURCE:  District of Columbia Pretrial Services Agency 
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Exhibit 4: Percentage of Adult Arrestees Testing Positive for Selected Drugs in  
 Washington, DC:  1996–1st Quarter 2002 
 
Drug 1996 1997 1998 1999 2000 
1st 
Half 
2001 
1st 
Quarter 
2002 
Cocaine 41 39 43 39 34 34 33 
Opiates 11 11 11 12 10 15 11 
PCP 5 4 2 6 9 13 13 
 
SOURCE:  District of Columbia Pretrial Services Agency 
 
 
 
Exhibit 5. District of Columbia Reported and Diagnosed AIDS Cases by Gender, Race/Ethnicity, 
 Age, and Exposure:  1998–2001 
 
Reported Diagnosed Characteristic Number Percent Number Percent 
Gender     
 Adult male 1,954 73 1,590 71 
 Adult female 735 27 624 28 
 Pediatric 16 1 13 1 
 Total 2,705 100 2,227 100 
Race/Ethnicity     
 White 353 13 242 11 
 Black 2,231 82 1,880 84 
 Hispanic 103 4 90 4 
 Asian/Pacific Islander 14 1 11 1 
 Undisclosed/Unknown 4 0 4 0 
 Total 2,705 100 2,227 100 
Age Group     
 0–12 15 1 12 1 
 13–19 15 1 15 1 
 20–29 370 14 274 12 
 30–39 1,050 39 846 38 
 40–49 898 33 767 34 
 50 and older 357 13 313 14 
 Total 2,705 100 2,227 100 
Mode of Exposure     
 MSM 983 36 740 33 
 IDU/MSM 54 2 40 2 
 Male IDU 478 18 389 17 
 Female IDU 290 11 228 10 
 Male/heterosexual contact 219 8 201 9 
 Female/heterosexual contact 335 12 287 13 
 Perinatal 15 1 12 1 
 Unknown/other 331 12 330 15 
 Total 2,705 100 2,227 100 
 
SOURCE:  District of Columbia Department of Health, Division of Epidemiology, Administration for HIV/AIDS 
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Drug Abuse Warning Network Update 
 
Judy Ball, Ph.D., M.P.A.,1 and Lori Ducharme, Ph.D.2 
 
                                                           
1
 Judy Ball is affiliated with the Office of Applied Studies (OAS), Substance Abuse and Mental Health  
  Services Administration (SAMHSA), Rockville, Maryland. 
2
 Lori Ducharme is affiliated with the DAWN Facility Relations team, Westat, Rockville, Maryland. 
CEWG members were provided with an overview of 
the redesign of DAWN emergency department and 
mortality systems, inviting support of CEWG mem-
bers in the effort. The process has begun through 
recruitment of communities and building on com-
munity leadership. The initiatives will be launched on 
January 1, 2003, and phased in through 2006. The 
new DAWN emergency department (ED) system will 
cover the entire Nation by 2006, adding at least 27 
metropolitan statistical areas (MSAs) to the current 
21. Proposed areas are listed in exhibit 1. The 
stratified probability sample will include about 900 
short-term, general, non-Federal hospitals that 
operate 24-hour emergency departments. New data 
collection forms have been approved, the definition 
of a “ case”  has been expanded, all ages will be 
covered, and mentions will be expanded to include 
six drugs and alcohol. Health information currently 
lacking in DAWN will be gathered. New cases will 
include, for example, presenting complaint, 
diagnoses, case narrative, underage drinking, drug 
misuse, malicious poisoning, and adverse effects 
associated with prescription and over-the-counter 
drugs. Data will continue to be collected from retro-
spective review of medical charts. Trained reporters 
will submit data electronically; the system will alert 
them if any entries represent inconsistent data. 
Electronic reporting is expected to be fully 
implemented by February 2004. These and other 
changes will improve the quality of DAWN data. 
Improvements in precision of the ED estimates are 
expected, based on the expanded sample. ED data 
prior to 2002 will not be comparable to the new data; 
thus, new trends will begin in 2003. 
 
The DAWN mortality system will also be revised. 
All jurisdictions— approximately 300— in the 48 tar-
get areas will be recruited, rather than a nonrandom 
subset (as is currently the case). New mortality data 
items will include cause of death and place of death. 
Selected statewide systems may also be added.  
 
More timely and complete reporting of more descrip-
tive data— by more facilities in more metropolitan 
areas— will improve the utility of DAWN for the 
CEWG and other audiences. Of additional note, for the 
first time, the DAWN mortality and morbidity systems 
will be able to be linked, through special analyses of 
data collected in metropolitan areas with full ED and 
ME participation.  
 
For inquiries concerning this report, please contact Judy K. Ball, Ph.D., M.P.A., Office of Applied Studies, Substance Abuse and Mental Health 
Services Administration, 5600 Fishers Lane, Room 16-105, Rockville, MD 20857, Phone: 301-443-1437, Fax: 301-443-9847, E-mail: 
<jball@samhsa.gov>. 
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Exhibit 1. DAWN ED Sites in the Proposed Design1 
 
 
Northeast South 
 
Boston 
Buffalo 
Hartford 
Nassau-Suffolk 
New Haven 
New York 
Newark 
Philadelphia 
Pittsburgh 
Providence 
Springfield (MA) 
 
Atlanta 
Baltimore 
Birmingham 
Dallas 
Forth Worth 
Houston 
Knoxville 
Louisville 
Miami 
Mobile 
Nashville 
New Orleans 
San Antonio 
Tampa 
Washington, DC 
 
 
 
Midwest West 
 
Chicago 
Cincinnati 
Cleveland 
Detroit 
Indianapolis 
Kansas City 
Minneapolis/St. Paul 
Omaha 
St. Louis 
Wichita 
 
Denver 
Honolulu 
Las Vegas 
Los Angeles 
Orange County 
Phoenix 
Riverside/San Bernardino 
Salt Lake City 
San Diego 
San Francisco 
Seattle 
Tucson 
 
1
 Sites in boldface type are proposed new sites. 
 
SOURCE:  DAWN, presentation at the December 2002 CEWG meeting 
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American-Canadian Differences in Illicit Drug Use Among 
College Students:  Some Preliminary Findings 
 
Edward M. Adlaf,1 Meichun Kuo,2 Louis Gliksman,1 Andree Demers,3 Henry Wechsler 2 
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2
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3
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ABSTRACT 
 
Comparisons between the American 1999 College 
Alcohol Survey and the 1998 Canadian Campus 
Survey show that use of methamphetamine, 
cocaine, crack, and MDMA is higher in the United 
States than in Canada, while cannabis use is similar 
in the two countries. These differences are generally 
true, regardless of age, gender, or residential status 
of student, although some cross-national inter-
actions require further investigation. 
 
INTRODUCTION 
 
Although the United States conducts several surveys to 
estimate illicit drug use among college students 
(Gledhill-Hoyt et al. 2000; O’Malley and Johnston 
2002), such national data were not available in Canada 
until the 1998 Canadian Campus Survey (Gliksman et 
al. 2000). Thus, for the first time, there is the 
opportunity to compare directly the extent and nature 
of cross-national differences in illicit drug use. To this 
end, beginning in 2000, an informal program of 
collaborative work was begun by Henry Wechsler and 
his colleagues at the Harvard School of Public Health, 
colleagues at the Centre for Addiction and Mental 
Health, and those at the University of Montreal. 
 
Although both samples represent similarly aged 
undergraduates in each country, there are some 
important differences in the two post-secondary 
educational systems. First, although participation in 
higher education has historically been higher in the 
United States than in Canada, higher education 
graduation rates, based on the proportion of 22-year-
olds graduating with a university degree, are similar 
between the two countries, with 26 percent of 
Americans and 25 percent of Canadians graduating. 
Second, in contrast to the United States, where there 
are many well-known, large private universities, in 
Canada, universities are publicly funded and 
regulated by provincial governments. Thus, while 
Canadian universities share many political and 
economic attributes with State universities in the 
United States, they also have characteristics in 
common with the large private institutions. This 
paper presents preliminary data comparing illicit drug 
use between the 1998 Canadian Campus Survey 
(CCS) and the 1999 College Alcohol Study (CAS) in 
the United States. 
 
HIGHLIGHTS OF THE STUDY 
 
Data 
 
To fully evaluate cross-national differences, the two 
surveys were pooled into a single data file containing 
19,078 students under age 25 (12,344 U.S. and 6,734 
Canadian) from 135 universities (119 U.S. and 16 
Canadian). The two samples did not differ sig-
nificantly regarding gender or age group. However, 
the samples did differ significantly regarding the 
three categories of residence status. American under-
graduates were significantly more likely than 
Canadian undergraduates to reside on campus (41.3 
percent vs. 16.5 percent) and, consequently, were less 
likely to reside with parents off campus (11.9 percent 
vs. 51.0 percent). American students were also more 
likely to reside off campus without family than were 
Canadian students (46.8 percent vs. 32.5 percent) 
(see Kuo et al., 2002, for further details). Specific 
details of the two surveys are as follows. 
 
College Alcohol Study 
 
For this analysis, the 1999 CAS data are based on a 
nationally representative sample of 119 4-year 
colleges located in 40 States and the District of 
Columbia. Two-thirds of the colleges sampled are 
public institutions, while one-third are private. Forty-
four percent of the schools have an enrollment of 
over 10,000 students, while 23 percent enroll 5,001–
10,000 students and 34 percent have fewer than 5,000 
students. About two-thirds are located in an urban or 
suburban setting, and one-third are situated in small 
towns or rural settings. Fifteen percent have a 
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religious affiliation. Five percent enroll only females. 
Between February and April 1999, 26,775 question-
naires were mailed, of which 23,751 were deemed 
eligible. A total of 14,138 students returned question-
naires (a 60-percent response rate). The response rate 
varied between 40 and 83 percent among the 119 
colleges.  
 
Canadian Campus Survey 
 
The Canadian university system, which represents 
approximately 474,000 students, comprises about 50 
institutions. Universities are generally publicly 
funded and have no restrictions based on gender or 
religious affiliation; Greek organizations are rare 
(less than 2 percent of students reside in fraternities 
or sororities). The postsecondary education system in 
Canada includes universities, typically degree-
granting institutions, and colleges or community 
colleges, typically nondegree-granting institutions. 
With the exception of Ontario and Quebec, 
Canadians typically matriculate into a university after 
12 years of schooling, at about age 18. In Ontario and 
Quebec, students typically enter a university after an 
additional year of secondary school, at age 19. 
 
The 1998 CCS employed a stratified two-stage 
cluster selection of students enrolled in full-time, 
undergraduate studies at accredited universities 
during the 1998– 99 academic year. The sample was 
stratified according to five regions: British Columbia; 
the prairie provinces (Manitoba, Saskatchewan, and 
Alberta); Ontario; Quebec; and the Atlantic provinces 
(Newfoundland, Prince Edward Island, Nova Scotia, 
and New Brunswick). Four universities per region 
were initially selected, with probability proportional 
to size. In total, 23 universities were approached to 
participate (including 3 replacements), of which 16 
participated. Within each university, 1,000 students 
were randomly selected with equal probability, 
regardless of year and field of study. The sample of 
16 universities represents a national sample of all 
Canadian universities offering undergraduate 
degrees. Eight of the 16 universities have enrollments 
of 10,000 or more students, 6 have enrollments of 
between 5,000 and 10,000, and 2 have enrollments of 
less than 5,000 students. Eleven are English 
institutions, 3 are Francophone, and 2 are bilingual. 
As is the case for Canadian universities, none restrict 
attendance according to religion or gender (the 
proportion of males at the campus level varies 
between 30 percent and 45 percent). Sixteen 
thousand questionnaires were mailed, of which 
15,188 were deemed eligible mailings. Four mailings 
were employed during a 5-week period, beginning 
October 30, 1998. A total of 7,800 eligible and usable 
completions were returned, for a 51-percent student 
completion rate.  
 
Measures 
 
Assessed were the lifetime and past-12-month 
prevalence of several drug-use measures: cannabis 
(CAS: “ marijuana [or hashish]” ; CCS “ cannabis 
[marijuana, grass, pot, hash, hash oil, etc.]” ), 
methamphetamine (CAS: “ amphetamines [prescrip-
tion-type stimulant like speed, uppers, ups]” ; CCS: 
“ methamphetamines [speed, etc.]” ), cocaine (CAS: 
“ other forms of cocaine [other than crack]” ; CCS: 
“ powder cocaine [coke, snow, blow, etc.]” ), LSD 
(CAS: “ LSD” ; CCS: “ LSD [acid, barrels, blotters, 
etc.]” ), other hallucinogens (CAS: “ other psychedel-
ics or hallucinogens like mushrooms, mescaline or 
PCP” ; CCS “ hallucinogens [mescaline, magic 
mushrooms, mesc, etc.]” ), and ecstasy (CAS: 
“ Ecstasy [MDMA]” ; CAS “ Ecstasy” ). In the CAS 
sample, original responses were as follows: (1) never 
used, (2) used, but not in past 12 months, (3) used, 
but not in past 30 days, (4) used in past 30 days. 
Lifetime use was coded as values 2 to 4 to represent 
“ yes,”  and past-12-month use was coded as values 3 
and 4 to represent “ yes.”  In the CAS sample, original 
responses were as follows: (1) never used, (2) used in 
life, but not in past 12 months, (3) used in past 12 
months, but not since September, (4) used since 
September. Lifetime use was coded as values 2 to 4 
to represent “ yes”  and past-12-month use was coded 
as values 3 and 4 to represent “ yes.”  
 
Results 
 
Exhibit 1 shows lifetime and past-year prevalence of 
the six drug use measures. Ignoring other factors, 
lifetime prevalence is significantly higher in the 
United States than in Canada for methamphetamine 
(8.1 vs. 5.2 percent), cocaine (6.7 vs. 3.8 percent), 
crack (2.2 vs. 0.7 percent), and ecstasy (8.9 vs. 4.2 
percent), while use is higher in Canada for 
hallucinogens (18.4 vs. 13.3 percent). Lifetime use 
does not vary between the two samples for cannabis. 
A similar pattern emerges for past-year use: rates are 
higher in the United States than in Canada for 
methamphetamine (3.9 vs. 1.8 percent), cocaine (3.8 
vs. 1.6 percent), crack (0.9 vs. 0.2 percent), LSD (4.0 
vs. 2.0 percent), and ecstasy (5.6 vs. 2.5 percent), and 
lower for hallucinogens (6.2 vs. 8.7 percent). Again, 
past-year use of cannabis was similar between the 
two samples. 
 
Briefly, the univariate subgroup estimates in exhibit 2 
show the following. Generally, there are similar 
gender differences between the two countries, al-
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though the U.S. differences are more significant (for 
5 of 6 drugs), largely because of the larger sample 
size. Still, the Canadian gender differences appear 
weaker. Age differences are stronger in the United 
States than in Canada (for 5 of 6 drugs). Notably, 
hallucinogen use is higher in Canada than in the 
United States for both age groups. The residence 
effect is similar in significance for both countries, 
with all six drugs varying by residence status. The 
association here becomes more involved. Most 
notably, although use of cannabis does not differ 
substantially between countries, gender, or age, 
residence differences emerged. For cannabis use, 
Canadian students living on campus appear to report 
greater use than their American counterparts (36.2 vs. 
29.6 percent), and this difference holds for those 
living with parents as well (24.8 vs. 16.1 percent). 
Those living off-campus with family show no 
difference in use between the two countries. 
 
CONCLUSIONS 
 
Many of the cross-national differences noted among 
college students have also been observed among 
younger students. Most notably, rates of cannabis use 
have been shown to be similar between American and 
Canadian 10th- and 12th-graders, while rates of 
hallucinogen use were higher among Canadian 
students (Adlaf 2002). Still, unlike the college com-
parison, lifetime differences in the use of 
methamphetamine, cocaine, crack, and ecstasy were 
not evident among 10th- and 12th-graders in 2001. 
Possibilities for cross-national differences varying 
across populations may be related to methodological 
differences (e.g., mail vs. classroom administration, 
reporting differences) or to cohort differences (e.g., the 
college samples were born between 1978 and 1981, 
whereas the school sample was born between 1984 and 
1986). Future research needs to further evaluate the 
nature of cross-national differences in the association 
between residence and illicit drug use and assess 
whether cross-national differences in drug-related 
attitudes and beliefs and availability of drugs explain 
some of these differences.  
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Exhibit 1. Lifetime and Past-Year Prevalence of Illicit Drug Use Among United States and  
 Canadian Undergraduates 
 
U.S. (N=12,344) Canada (N=6,734) Drug Percent CI Percent CI Wald p 
       
Cannabis Lifetime 45.6 42.5–48.7 45.6 40.9–50.4 .995 
 Past 12 months 29.5 26.8–32.3 29.9 26.5–33.6 .835 
       
Methamphetamine Lifetime 8.1 7.1–9.2 5.2 4.3–6.2 <.001 
 Past 12 months 3.9 3.2–4.7 1.8 1.5–2.3 <.001 
       
Cocaine HCl Lifetime 6.7 5.8–7.6 3.8 2.9–5.0 <.001 
 Past 12 months 3.8 3.2–4.5 1.6 1.3–2.0 <.001 
       
Crack Lifetime 2.2 1.8–2.6 0.7 0.5–1.0 <.001 
 Past 12 months 0.9 0.7–1.1 0.2 0.2–0.3 <.001 
       
LSD Lifetime 10.6 9.3–12.1 11.4 9.2–14.2 .574 
 Past 12 months 4.0 3.3–4.8 2.0 1.4–2.8 <.001 
       
Hallucinogens Lifetime 13.3 11.7–15.0 18.4 15.7–21.5 .002 
 Past 12 months 6.2 5.3–7.3 8.7 7.2–10.4 .009 
       
Ecstasy Lifetime 8.9 7.6–10.4 4.2 3.3–5.4 <.001 
 Past 12 months 5.6 4.5–6.9 2.5 1.8–3.6 <.001 
 
SOURCE:  1999 College Alcohol Survey and 1998 Canadian Campus Survey 
 
 
 
Exhibit 2. Past-Year Prevalence of Illicit Drug by Gender, Age, and Residence Among United 
States and  Canadian Undergraduates 
 
Cannabis Meth Cocaine LSD Hallucino-gens MDMA Variable 
U.S. Can. U.S. Can. U.S. Can. U.S. Can. U.S. Can. U.S. Can. 
Gender *** ns *** ns *** ns *** ns *** ns ns ns 
  Male 31.8 31.3 4.5 2.3 4.8 1.6 5.2 2.5 8.3 9.7 6.0 2.8 
  Female 27.7 28.8 3.4 1.5 3.1 1.6 3.1 1.5 4.8 7.9 5.3 2.3 
Age ** ns ns ns *** ns *** ns * ns *** ns 
  Age <21 31.2 29.4 4.1 1.8 3.1 1.4 4.7 2.4 6.9 9.1 6.3 2.4 
  Age 21+ 27.1 30.4 3.6 1.9 4.8 1.8 3.0 1.6 5.3 8.3 4.5 2.6 
Residence *** *** ** *** *** *** *** *** *** *** *** ** 
  On-campus 29.6 36.2 3.8 2.4 2.4 1.9 4.2 3.8 6.2 11.8 5.2 2.4 
  Parents 16.1 24.8 2.0 1.0 2.7 0.6 1.8 1.0 3.1 5.6 3.2 1.5 
  Off-campus 34.2 35.2 4.7 3.0 5.6 3.1 4.6 2.6 7.4 12.1 6.8 4.3 
 
Notes: * p<.05; ** p<.01; *** p<.001; ns=not significant at p<.05 
 
SOURCE:  1999 College Alcohol Survey and 1998 Canadian Campus Survey 
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Drug Use and Abuse in Canada:  Review of National Data and 
Update on the Canadian Community Epidemiology Network on 
Drug Use (CCENDU) 
 
Colleen Anne Dell, Ph.D.1 
 
ABSTRACT 
 
Chaired by the Canadian Centre on Substance 
Abuse, Canada’s national addictions agency, the 
CCENDU is a multilevel collaborative drug surveil-
lance project. CCENDU collects, analyzes, and 
disseminates quantitative and qualitative infor-
mation on drug abuse. One of the data sources, the 
2001 Uniform Crime Report Survey, showed relative 
stability in the rate of total drug offenses, from 19.8 
per 10,000 population in 2000 to 19.7 in 2001. In 
2001, cannabis charges represented the majority of 
drug offenses for adult males (71 percent) and adult 
females (62 percent). More than one-quarter (27 
percent) of the female offenders and 21 percent of 
the male offenders involved (or were associated 
with) cocaine. Indicators showed that drug abuse 
patterns differed by area. For example, based on 
indicators, crack (injection and smoking) was the 
illicit drug of choice on the street in Toronto. An 
increase in methamphetamine indicators in 
Vancouver may be related to the methamphetamine 
problem in the United States in Washington and 
California. In Halifax, 80 percent of the treatment 
clients in a 2001 survey reported using cocaine, 
benzodiazepines, and/or opiates. It was reported that 
there was a strong presence of rave drugs in St. 
John’s, compared with 3 years ago. 
 
INTRODUCTION 
 
Area Description 
 
The Canadian Community Epidemiology Network on 
Drug Use (CCENDU) was established in response to a 
1995 feasibility study that identified the need for a 
Canada-wide surveillance system on substance use. 
Spearheaded by the Canadian Centre on Substance 
Abuse (CCSA) and guided by a steering committee, 
CCENDU is a collaborative project involving federal, 
provincial, and community agencies, with intersecting 
interests in drug use, health and legal consequences of 
use, treatment, and law enforcement. The strategic 
vision of CCENDU is “a partnership to monitor 
emerging drug trends and associated factors.”  
Twelve urban centers currently participate in 
CCENDU to varying degrees, and additional sites are 
under development. Despite ongoing funding 
concerns, site reports were prepared in 2002 for 
Ottawa, Winnipeg, Fredericton, Vancouver, Toronto, 
and Regina (interim report). (The reports are available 
at <http://www.ccsa.ca/ccendu/index.htm>.) The ob-
jective of this report is twofold: to provide an update 
on the CCENDU network and to provide the most 
current national data and select site-level data 
available. The report concludes with a description of 
plans being undertaken to improve the network’s 
monitoring capabilities. 
 
Data Sources 
 
Each CCENDU site collects, collates, and interprets 
data and information in eight major drug use areas 
(alcohol, cocaine, cannabis, heroin, sedative-
hypnotics and tranquilizers, hallucinogens other than 
cannabis, stimulants other than cocaine, and licit 
drugs) and in six indicator areas (prevalence; 
enforcement; treatment; morbidity; mortality; and the 
human immunodeficiency virus [HIV] and acquired 
immunodeficiency syndrome [AIDS] and hepatitis C, 
which includes injection drug use and needle 
exchange information). National data, including 
survey data, is accessed and disaggregated in the six 
indicator areas to the local sites when possible.  
 
National Surveys 
 
Nationally, the past quarter century in Canada has 
been characterized by inconsistent survey data 
collection on substance use and abuse. Although 
national data collection has been sporadic, there are 
several substance-use specific and related national 
surveys that can be utilized. These include the 1994 
Canada’s Alcohol and Other Drugs Survey (Statistics 
Canada); 1994–95 National Longitudinal Survey of 
Children and Youth (Statistics Canada); 1994–
95/1996–97/1998–99 National Population Health 
Survey; 1998 Canadian Campus Survey; and 2000 
Canadian Community Health Survey. 
1
 The author is affiliated with the Canadian Centre on Substance Abuse and the Department of Sociology and Anthropology, Carleton University. 
The CCENDU’s Research Officer, Karan Garabedian, assisted with the data collection and analysis in this report. 
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Other National Data Sources 
 
Following CCENDU’s data categorization system by 
indicator type, several key national data sources are 
used in this report. They are prevalence sources 
(national surveys identified above); treatment sources 
(Residential Care Facilities Survey, Statistics 
Canada); law enforcement sources (Uniform Crime 
Report Survey, Statistics Canada; Adult Criminal 
Court Survey, Statistics Canada; Drug Seizures, 
Canada Customs and Revenue Agency); mortality 
sources (Health Statistics Division, Statistics 
Canada); morbidity sources (Canadian Institute for 
Health Information); and HIV/AIDS and hepatitis C 
sources (Health Canada Surveillance Reports). 
 
NETWORK UPDATE  
 
Several advancements in the CCENDU network have 
occurred since the 2000 national report. CCENDU 
has continued to establish its national framework. 
This includes the creation of a strategic vision, 
expansion of the steering committee, design and 
distribution of a network pamphlet, and continued 
communication with the well established Community 
Epidemiology Work Group in the United States. 
CCENDU has also continued to facilitate data 
analysis. Two key efforts have been capitalizing on 
the CCSA’s “ Memorandum of Understanding”  with 
Carleton University, which allows access to data sets, 
and CCSA’s undertaking of a systematic review of 
national data sources and their disaggregation to the 
local site level.  
 
Through CCSA’s systematic review of available 
national data sources, existing data limitations have 
also been addressed. In addition, licit drugs have 
been included as a major data collection area; solvent 
data from the national Youth Solvent Abuse 
Committee will be included soon; hepatitis C has 
been included as an indicator; and the feasibility of 
on-reserve data collection is being explored. 
Methodological inconsistencies have similarly been 
addressed (i.e., standardization of the International 
Classification of Disease, Ninth Edition [ICD-9] 
codes). This will assist with data comparisons across 
the sites and in the establishment of new sites. 
Because timeliness of reporting has been a 
continuous obstacle, a Web-based format for regular 
report updates is in the development phase. Finally, 
linkages between researchers and program planners is 
being attained through such activities as the 
development of a joint quarterly newsletter with the 
Health, Education and Enforcement in Partnership 
(HEP) network (available on the Web at 
<http://www.ccsa.ca/HEP/index.htm>) and the de-
sign of a joint funding proposal that was submitted to 
and funded by the National Crime Prevention 
Strategy.  
 
The project, entitled “ Establishing a Proactive Model 
for Identifying and Developing Community Specific 
Responses to Substance Abuse”  has been funded in 
the amount of $200,000 per year for the next 3 years. 
The vision of the project is “ a venue to establish, 
strengthen and maintain collaboration at the local 
level within the substance abuse field by establishing 
a proactive model for identifying and developing 
community specific responses.”  Existing CCENDU 
sites will be expanded, and new ones will be 
established. The specific goals of the project are as 
follows:  
 
• To develop an innovative and sustainable means 
of addressing a root cause of crime and substance 
abuse at the community level by establishing a 
model for identifying, developing, and 
implementing community specific responses 
 
• To establish community partnerships in the crime 
and substance abuse fields that build on existing 
local, national, and international governmental 
and nongovernmental collaborations rooted in the 
CCENDU and HEP networks, which are locally 
driven and action oriented 
 
• To document and evaluate the established 
community response model so that it may be 
applied to other communities across Canada, both 
within and outside the realm of substance abuse 
 
DRUG ABUSE TRENDS— NATIONAL LEVEL 
 
The section draws on Canadian surveys, data sources, 
and select research reports that outline prevalence, 
treatment, law enforcement, morbidity, mortality, and 
HIV/AIDS/hepatitis C and associated factors related 
to substance use. When beneficial, comparisons are 
made between females and males. To provide 
consistency with other published reports, the data is 
weighted. Although this report focuses almost 
exclusively on national data sources, when possible, 
the data have been disaggregated to the local and/or 
provincial levels and distributed to the sites for 
inclusion in their reports. These reports can be 
accessed at <http:// www.ccsa.ca/ccendu/index.htm>.  
 
Prevalence 
 
Alcohol 
 
According to the 1998– 99 National Population 
Health Survey, 78.0 percent of Canadians age 15 and 
older used alcohol at least once in the past year (82.2 
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percent of males and 74.0 percent of females), 12.6 
percent used during their lifetime but not in the past 
year, and 9.5 percent had never used. These findings 
are similar although slightly higher to those from the 
1996 and 1994 surveys. The more recent 2000– 01 
Canadian Community Health Survey reported that 
among those who drank 5 or more drinks on 1 
occasion less than 12 times per year, there was 
similarity between the sexes, with females at 21.3 
percent and males at 25.9 percent. By age, the 
smallest variation occurred in the 20– 34 age category 
(30.7 percent male and 32.8 percent female), and the 
greatest variation occurred in the 45– 64 age category 
(13.6 percent female and 23.1 percent male). For 
those who drank 5 or more drinks on 1 occasion in 
excess of 12 times in the past year, there was great 
variation between the sexes, with 29.0 percent of 
males and 11.4 percent of females reporting such 
drinking 12 or more times in the past year. 
  
According to the 1998 Canadian Campus Survey, 
85.4 percent of undergraduate males and 87.5 percent 
of females reported alcohol use in the past 12 
months. There was a slightly higher finding with 
regard to lifetime use, averaging 92 percent for both 
sexes (90.6 percent for males and 92.4 percent for 
females). Women’s alcohol intake per week was 
nearly one-half that of men’s (females averaged 3.9 
drinks and males averaged 7.5). Some 41.1 percent of 
females reported harmful drinking (i.e., missed a 
class), and 29.3 percent reported hazardous drinking 
(i.e., drinking and driving) in the past 12 months. 
Slightly higher, 45.2 percent of males reported 
harmful drinking, and 31.8 percent reported 
hazardous drinking.  
Illicit Drugs 
 
Canada’s Alcohol and Other Drugs Survey (1994) 
revealed that the percentages of females age 15 and 
older who reported use of selected illicit drugs in the 
past year were as follows: 5.1 percent for cannabis; 
0.7 percent for lysergic acid diethylamide (LSD), 
speed or heroin; and 0.5 percent for cocaine. Figures 
for males were as follows: 10.1 percent for cannabis; 
1.5 percent for LSD, speed or heroin; and 0.8 percent 
for cocaine. The 1998 Canadian Campus Survey 
reported that 8.9 percent of female and 11.7 percent 
of male undergraduate students had used illicit drugs 
(not including cannabis) in the past 12 months, and 
28.0 percent of females and 29.6 percent of males 
had used cannabis. 
Licit Drugs 
 
The 2000– 01 Canadian Community Health Survey 
found that females reported higher use within the past 
month of all licit drugs compared with males: 
 
Drug Females Males 
Opiate analgesics 2.1 1.7 
Anti-depressants 2.1 0.9 
Sleeping pills 1.7 1.2 
Tranquilizers 1.1 0.6 
Diet pills 0.4 0.1 
Pain relievers 23.7 19.8 
 
The most recent national data on solvent use collected 
through Canada’s Alcohol and Other Drugs Survey 
(1994) revealed that 0.3 percent of females and 1.2 
percent of males age 15 and older had used a 
solvent(s) in their lifetime. The 1998– 99 National 
Longitudinal Survey of Children and Youth found that 
89.7 percent of 12 and 13 year old youth claimed that 
none of their friends had tried glue or solvents, 9.5 
percent had a few friends who had tried them, 0.6 
percent reported most of their friends had tried them, 
and 0.2 percent indicated that all of their friends had 
tried solvents. Current rates of inhalant abuse among 
Canada’s aboriginal youth population are unknown, 
although the media regularly depicts the rates as higher 
in this group than in the general population. There was, 
however, a 1993 national survey entitled First Nations 
and Inuit Community Youth Solvent Abuse Survey and 
Study2 that surveyed all bands or reserves in Canada 
with the goal of identifying the treatment needs of First 
nations youth across the country, including 
information on the numbers and characteristics of 
youth abusing solvents.3 It was reported that more than 
one-half of all solvent-abusing youth respondents 
began to abuse solvents when they were age 11 or 
younger. The largest group of respondents were 
experimental users (43.3 percent), followed by social 
users (37.5 percent) and chronic (19.2 percent) users.  
 
Enforcement 
 
Alcohol 
 
In 2001, CCSA and the Correctional Service of 
Canada commissioned a study, entitled Proportion of 
Crimes Associated with Alcohol and Other Drugs in 
2
 Kaweionnehta Human Resource Group. First Nations and Inuit Community Youth Solvent Abuse Survey and Study. Ottawa: National Native   
  Alcohol and Drug Abuse Program/Addictions and Community Funded Programs, 1993. 
3
 Solvent abuse included in this study is confined to volatile solvents, which are the most common inhaled by First Nations and Inuit youth. These  
  include glues, adhesives and cements, nail polish remover, paint remover and thinner, correction fluid and thinner, fuel gas, lighter fluid, dry  
  cleaning agents and spot removers, and aerosol propellants, in addition to other products. 
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Canada, and concluded that there is a strong 
association between crime and alcohol and illicit drug 
use. The study found that 24 percent of females were 
thought to be under the influence of alcohol and 9 
percent were thought to be under the influence of 
alcohol and drugs combined at time of their arrest. 
More than one-third (35 percent) of males were 
thought to be under the influence of alcohol and 10 
percent were thought to be under the influence of 
drugs and alcohol at time of their arrest. The study 
can be accessed at <http://www.ccsa.ca/docs/ 
crime2002.pdf>.  In addition, 3 percent of males and 
1 percent of females reportedly had committed a 
crime to attain alcohol for personal use, and 1 percent 
of males and 2 percent of females had committed a 
crime to attain alcohol and drugs. 
 
Illicit Drugs 
 
The 2001 Uniform Crime Report Survey revealed 
relative stability in the rate of total drug offenses, 
from 19.8 per 10,000 in 2000 to 19.7 per 10,000 in 
2001. In 2001, cannabis charges represented the 
majority of drug offenses/charges among adult males 
(71 percent, n=28,906), followed by cocaine (21 
percent, n=8,375), other drugs (7 percent, n=2,911), 
and heroin (1 percent, n=553). In comparison, there 
were proportionally fewer adult females charged for 
cannabis (62 percent, n=3,948), and a greater 
proportion charged for cocaine (27 percent, 
n=1,689), other drugs (9 percent, n=562), and heroin 
(2 percent, n=131). In 2001, the greatest difference in 
charges between adult males and females was for 
cannabis, with 63 percent (18,267) of males charged 
with possession, 25 percent (7,114) for trafficking, 12 
percent (3,342) for production, and 1 percent (183) 
for importation. For females, 44 percent (1,724) were 
charged with possession, 33 percent (1,321) for 
trafficking, 22 percent (870) for production, and 1 
percent (33) for importation.  
 
In 2000 and 2001, the majority of youth charged 
were male (86 percent and 87 percent, respectively). 
In 2001, cannabis charges represented the vast 
majority of drug offenses for which male youth were 
charged (89 percent, n=6,436), followed by other 
drugs (6 percent, n=408), and cocaine (5 percent, 
n=398). Charges for female youth were similar to 
those for the adult population. Compared to male 
youth, there were proportionally fewer charges for 
cannabis (79 percent, n=863), and proportionately 
greater charges for other drugs (10 percent, n=114), 
cocaine (9 percent, n=101), and heroin (1 percent, 
n=8). For cannabis charges, 75 percent (4,785) of 
male youth were charged with possession, 24 percent 
(1,554) with trafficking, and 1 percent (91) with 
production. Similar to their male counterparts, 72 
percent (622) of female youth were charged with 
possession, 25 percent (215) with trafficking, and 3 
percent (26) with production.  
 
From April 1 to June 30, 2002, the Canada Customs 
and Revenue Agency made 240 significant drug 
seizures, with a total value more than $36.7 million. 
Steroids represented the majority of seizures (102) 
($374 thousand value), followed by khat (51) ($1.3 
million), and cocaine (41) ($17.8 million).  
 
According to the Canada Customs and Revenue 
Agency, the number of Canadian dug seizures has 
remained constant (242 significant drug seizures 
from April 1 to June 20, 2001), but the value of drugs 
seized has declined considerably. A contributing 
factor has been a decline in the quantities of cocaine, 
ecstasy, and heroin seized, as well as a decline in the 
street value of cocaine. Over 40 percent of all 
seizures took place in the postal mode, 37 percent in 
the air mode, 18 percent in the courier mode, and less 
than 2 percent in both land and marine modes. 
 
A Correctional Service of Canada study found that 
from 1994 to 2001, there was a continuous albeit 
nominal increase in the number of individuals 
incarcerated for a drug offense, from 5,117 to 5,761. 
The majority of incarcerated drug offenders in 2001 
were male (94.1 percent). While female involvement 
in drug offenses is limited (5.9 percent in 2001), it 
steadily increased over the 6-year period (from 3 
percent or 163 females in 1994 to 6 percent or 342 
females in 2001). 
 
Treatment 
 
According to the 1998– 99 Residential Care Facilities 
Survey,4 there were a total of 4,752 beds licensed or 
approved for people with alcohol/drug addiction 
problems in Canada; 4,361 beds were available for 
use in 183 facilities, with an 88.8-percent occupancy 
rate. A comparable 1993/94 survey revealed a total of 
6,185 beds available in 262 facilities. There was little 
change, and in fact a slight decrease, in the number of 
beds available and a greater decrease in the number 
of facilities, over the 6-year period (6,019 beds in 238 
facilities).  
 
Morbidity 
 
Morbidity is defined as the burden of disease related 
to alcohol and other drug-related selected (illicit and 
4
 There are 238 facilities and 6,019 beds in total, but only 183 facilities (4,752 beds) reported in the 1998– 99 survey. 
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licit) injuries based on diagnosis at the time of 
hospital separation.5 Based on data tabulated from the 
2000– 01 Hospital Morbidity Database (Canadian 
Institute for Health Information), it is estimated that 
58,542 hospital separations in Canada (alive or dead) 
for individuals 15 years of age and older were 
attributable to alcohol and drug use as the most 
responsible diagnosis. Just over one-half of the 
separations were for males (51.5 percent or 30,149 
vs. 48.5 percent or 28,393 for females).  
 
Alcoholic dependence syndrome accounted for the 
highest number of alcohol separations for females 
(2,378), followed by non-dependent alcohol abuse 
(854 separations), and other alcoholic psychoses (828 
separations). Among males, alcohol dependence 
syndrome also represented the leading cause of 
alcohol-related morbidity (5,742 separations), 
followed by other alcoholic psychoses (2,461 
separations) and alcoholic cirrhosis of the liver 
(1,972 separations). 
 
“ All other”  diagnoses refer to cases in which a 
selected cause of disease is not considered the 
primary cause of illness by a physician. It is 
estimated that 137,429 hospital separations (both 
alive and dead) were attributable to alcohol and drug 
use in Canada during 2000– 2001. Males accounted 
for over half of the separations (84,991 for males vs. 
52,438 for females). The leading cause of alcohol-
related morbidity for females was alcohol 
dependence syndrome, representing 11,212 hospital 
separations, followed by nondependent abuse of 
alcohol (5,158 separations) and mental disorders 
related to alcohol and pregnancy (3,208 separations). 
A large proportion of alcohol-related morbidity 
among males was similarly for alcohol dependence 
syndrome (with 29,285 hospital separations), fol-
lowed by nondependent abuse of alcohol (9,770 
separations) and alcoholic cirrhosis of the liver 
(4,199 separations).  
 
Mortality 
 
According to the 1999 Statistics Canada Causes of 
Death Shelf Tables, 4,723 deaths were attributable to 
selected alcohol and illicit and licit drug-related 
mortality for all ages.5 This is an approximate 2-
percent decrease from 1998 (4,820). Regarding 
alcohol, in 1999 the leading causes of death for women 
were cirrhosis of the liver without mention of alcohol 
(409), alcoholic cirrhosis of the liver (172), acute pan-
creatis (142), and alcohol dependence syndrome (125). 
For men, the leading causes were alcoholic cirrhosis of 
the liver (609), cirrhosis of the liver without mention 
of alcohol (597), alcoholic dependence syndrome 
(427), and acute pancreatic (145).  
 
The proportion of fatally injured drivers in Canada 
with positive blood-alcohol levels declined from 48 
percent in 1992 to 33 percent in 1999. In 1998, 
alcohol was involved in 38 percent (1,245 people) of 
all motor vehicle fatalities in Canada, compared with 
34 percent (1,134 people) in 1999. 
 
HIV/AIDS/Hepititis C 
 
According to 2002 Health Canada Laboratory Centre 
for Disease Control data, cumulative through 
December 31, 2001, there were a total of 1,123 
positive HIV cases in which injection drug use was 
identified as the risk factor among women and 2,768 
among men. For both females and males, there has 
been a decrease over time in absolute numbers of 
injection drug use as a risk factor for HIV. However, 
in examination of all risk factors for HIV, injection 
drug use is high for both females and males. From 
1985 to 2001, injection drug use accounted for an 
average of 41.5 percent of all female HIV cases and 
23.0 percent of all male HIV cases.  
 
DRUG ABUSE TRENDS— LOCAL SITE LEVEL 
 
Deaths from illicit drug use continue to be high in 
both the city of Vancouver and the province of 
British Columbia (BC). However, since reaching a 
peak in 1998, the number of deaths has decreased. In 
2001, there were 222 illicit drug deaths in the 
province of British Columbia, of which 90 were in 
Vancouver. Also of heightened importance in 
Vancouver is the increase in methamphetamine use, 
which may reflect the problem Washington State in 
the United States has been experiencing. The 
Vancouver CCENDU committee held discussions 
regarding the development of an action team to 
address the problem of methamphetamine use. 
Consequently, a crystal methamphetamine environ-
mental scan summit was held in November 2002. The 
report can be accessed at <http://www.ccsa.ca/ccendu/ 
Reports/20033Reports.asp>. 
 
Whitehorse, Yukon, has one of the highest alcohol 
consumption rates in Canada, with reports of the 
injection of alcohol. Also, there is a high rate of Fetal 
Alcohol Syndrome (FAS) and Fetal Alcohol Effects 
(FAE) reported by educational institutions in some 
Yukon communities. 
 
The Alberta Alcohol Survey reported that 78.1 
percent of respondents are current drinkers and 13.9  
5
 The ICD-9 classifications used in this report were identified based on commonality of codes used among CCENDU site coordinators and local 
experts. 
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percent consider themselves problem drinkers in 
Edmonton, Alberta. There are similar rates at the 
provincial level (78.2 percent current drinkers and 
15.2 percent problem drinkers). An ethnographic 
study of injection drug users (IDUs) in Edmonton 
found that the first drug injected was overwhelmingly 
cocaine (31 percent), followed by methadone/speed 
(27 percent). Current drugs injected were opiates (33 
percent) and Talwin and Ritalin (25 percent). Among 
IDUs in the study, 72 percent were infected with 
hepatitis C, and 53 percent were not currently seeking 
treatment. Reasons given for not seeking treatment 
included fear of being judged, long waiting lists, the 
bureaucratic system, and painful and stressful 
treatment.  
 
Alcohol was the substance most used among adults 
and youth in Winnipeg, Manitoba. In 2001, there was 
an increase in drinking and driving charges. Thirty 
percent of high school students reported using 
marijuana in the past year, and 40 percent have used 
it at some point in their life. 
 
Crack (injection and smoking) continues to be the 
illicit drug of choice in Toronto, Ontario. Harm 
reduction measures have been taken (e.g., distribution 
of crack pipes, implementation of needle exchange 
programs). Cannabis and designer drug use has 
remained high. There has been an increase in solvent 
and polydrug use. Crack users do not traditionally use 
needle exchange sites as readily as heroin users or 
other drug users. 
 
Alcohol was the licit substance most often used by 
both youth and adults in Ottawa, Ontario, whereas 
cannabis was the illicit substance most often used. 
According to a study on injection drug use, in 1996 
the median age of IDUs in the Ottawa region was 33 
for women and 36 for men. In the Outaouais region 
in 1997, the median age was 32 for women and 38 
for men.  
 
Alcohol was the substance most often used in 
Fredericton, New Brunswick. There has also been an 
increase in the injection of Dilaudid. Additionally, 
there has been an increase in alcohol and cannabis 
use among students.  
 
A 2001 client drug-use study in Halifax, Nova Scotia, 
conducted with 5,262 male and 2,590 female 
treatment clients, reported that 80 percent of 
respondents were using cocaine, benzodiazepines, 
and/or opiates. Cannabis use was just below 80 
percent. The 1998 Student Drug Use Survey 
examined trends between 1991 and 1998 and found 
that the use of alcohol, nicotine, and cannabis more 
than once a month increased by 30 percent, 40 
percent, and 9 percent, respectively. The rate of 
cannabis use tripled from 4.4 percent in 1991 to 13.5 
percent in 1998.  
 
In St. John’s, Newfoundland, there is a strong 
presence of rave drugs compared with 3 years ago. 
There is also an increase in pharmacy break and 
enters where OxyContin was sought.  
 
FUTURE ACTIVITIES 
 
Several other activities have been taken on by the 
network to contribute to strengthening the capacity of 
the national network and local sites. An online 
community is currently being established for the 
CCENDU site coordinators and committee members 
to facilitate information sharing. Additionally, the 
online discussion facilities of the Virtual Clearing 
House on Alcohol, Tobacco and Other Drugs are 
planned to be used to discuss and take action on 
timely issues among the network members. The first 
moderated online discussion is set to focus on 
prescription drug use. Lastly, contact with and pres-
entations to the Federation of Canadian Munici-
palities drug strategy pilot sites have been made to 
foster involvement in local CCENDU site activities. 
For inquiries concerning this report, please contact Colleen Anne Dell, Ph.D., National Research Advisor, CCENDU, Canadian Centre on 
Substance Abuse, 75 Albert Street, Suite 3000, Ottawa, Ontario, Canada K1P 5E7, Phone: (613) 235-4048 ext. 235, Fax: (613) 235-8101, E-
mail: <cdell@ccsa.ca>. 
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Extent and Nature of Illicit Drug Use in Central Asia 
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ABSTRACT 
 
Since the breakdown of the Soviet Union, the newly 
independent countries of Central Asia have expe-
rienced major economic, social, and political tran-
sitions to open societies. Also, with the increasing 
use of Central Asia as a transit point for trafficking 
of heroin from Afghanistan to European markets, 
these countries have also experienced an increasing 
local epidemic of drug use. All indicators of drug 
use in these countries—the number of people 
registered for drug use treatment admissions, the 
number of people arrested for drug-related crimes, 
drug seizures, and increased availability of drugs in 
local markets accompanied by falling prices—have 
shown dramatic increases, especially since the mid-
nineties. The main transition has been from tra-
ditional smoking of opium or cannabis to injecting 
heroin and other opiates among younger age 
groups. The practice of sharing injections between 
drug users has also contributed in a significant 
manner to the spread of HIV and other blood-borne 
infections in the countries. 
 
INTRODUCTION 
 
Central Asia comprises the former Soviet republics of 
Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, 
and Uzbekistan, all of which gained independence in 
1991 (exhibit 1). During the Soviet era, these former 
republics shared common systems of government, 
economics, and social setup, in addition to a common 
religion and history. Today, however, these countries 
exhibit diversity in culture, climate, and language, as 
well as different economic, political, and social 
development.  A comparison of some key demograph-
ic, health, and economic indictors for the countries is 
shown in exhibit 2.  
 
Since the breakup of the former Soviet Union, the 
Central Asian States have been undergoing difficult 
economic, social, and political transitions. Because 
they are no longer integrated within the Soviet 
economy and therefore have lost subsidies from 
Moscow, the young countries have been fighting with 
the severe consequences of budgetary deficits, high 
inflation, negative industrial growth, and rising un-
employment. Moreover, the nation-building process 
has been draining most of the resources, leaving little 
room for social services. 
 
Also, in the last decade, the Central Asian States have 
been affected by an increasing influx of drugs from 
neighboring Afghanistan on their way to the profitable 
Russian and Western European markets. Evidence 
from elsewhere in Asia has shown that when a country 
is on a trafficking route, a considerable potential exists 
for the development of local drug abuse problems. 
Until the middle of the 1990s, the drug issue was 
perceived by the Central Asian States as a problem 
affecting other countries, and the local authorities 
mainly relied on international assistance to address 
drug trafficking issues with law enforcement 
interceptions. Since 1995, when heroin started being 
processed within Afghanistan and shipped across 
Central Asia, the burgeoning local drug markets 
brought a considerable change in the perceptions of 
drug problems in the regional countries. The Central 
Asian countries have been prompted to address the 
issue of increasing drug problems among the local 
population and combat drug trafficking within and 
across their territories. 
 
National Assessments of Drug Problems in 
Central Asia 
 
During 2000 and 2001, the United Nations Inter-
national Drug Control Programme’s regional office 
in Central Asia, with technical support from the 
Global Assessment Programme on Drug Abuse, 
implemented a regional project to assist the Central 
Asian nations in assessing the nature and extent of 
drug problems in each country and in developing 
evidence-based policies and interventions to address
1
 Dr. Niaz is affiliated with the Global Assessment Programme on Drug Abuse, UNODCCP, Ankara, Turkey. 
2
 Janusz Sieroslawski is affiliated with the Institute of Psychiatry and Neurology, Warsaw, Poland. 
3
 Mirzakhid Sultanov is affiliated with the UNODC, Regional Office for Central Asian, Tashkent, Uzbekistan. 
4
 Sagat Altynbekov is affiliated with the Republican Scientific Centre on Medical and Social Problems of Drug Abuse under the Agency for  
  Health Issues of the Republic of Kazakhstan. 
5
 Altynai Kudaikulova is affiliated with the State Commission on Drug Control under the Government of Kyrgyz Republic. 
6
 Nazire Dodkhudoeva is affiliated with the Drug Control Agency under the President of the Republic of Tajikistan. 
7
 Oleg Mustafin is affiliated with the Tashkent City Narcological Dispensary, Tashkent, Uzbekistan. 
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growing illicit drug use in the region. The project 
also aimed to help develop a sustainable data collec-
tion and monitoring system at the national and 
regional levels.  
 
Methodology 
 
The extensive national assessment studies conducted 
under the project utilized many methods and data 
sources to build up a comprehensive picture of the 
nature and extent of problem drug use in each 
country. The data sources and methods are described 
below:  
 
• An initial information needs and resource 
analysis was conducted based on existing data 
from treatment, health, and law enforcement 
sources to assess existing databases and sources 
of information on drug abuse in the countries and 
to identify the needs for developing drug use 
information and monitoring systems. The 
secondary data were also used as proxy indictors 
for time series analyses of changing trends of 
drug use. 
 
• Interviews with more than 100 key informants 
(e.g., doctors, nongovernmental organization 
[NGO] workers, law enforcement officials, local 
community leaders, teachers, and former drug 
users) were held in 5 urban and rural 
geographical locations in each country. The 
informants were interviewed to present their 
perspective on the extent and nature of problem 
drug use in their area. These interviews with 
diverse occupational groups helped develop local 
and national profiles of problem drug use in each 
country. 
 
• Using snowball techniques, about 100 problem 
drug users were interviewed in community 
settings in at least 2 locations in each country. The 
problem drug users were defined as persons who 
took drugs regularly and suffered from health and 
social consequences of drug use, with drugs being 
the most significant element of their lifestyle.  
 
• Interviews with drug users helped define the 
current patterns and trends of drug use among 
active drug users and assess the health and social 
consequences of drug use from the respondents’  
perspective. 
 
• Additional indepth interviews were done with 
about 200 injection drug users in the same 
locations. They answered questions regarding 
their initiation of injection drug use, current 
patterns of use, needle sharing, and sexual risk 
behaviors.  
 
• Interviews were also held with approximately 60 
drug users in each country in prison settings with 
the objective of assessing the drug use situation 
in prisons and  to determine whether their 
patterns differed in any way from those in com-
munity settings. 
 
• As a final outcome of these studies, the prevalence 
of problem drug use in each country was 
estimated using multiplier techniques. During the 
interviews, drug users were asked questions to 
determine the proportion of them and their friends 
who had been in treatment or registered in the past 
12 months. Based on this information, propor-
tional multipliers were calculated and applied to 
treatment and registered data for the year 2000, 
initially for the two main cities where interviews 
with drug users were conducted. Later, a national-
level multiplier was developed, and national 
estimates of problem drug use were calculated. 
Prevalence estimates for each country are 
presented in exhibit 3.  
 
CURRENT PATTERNS AND TRENDS IN DRUG USE 
 
Using information from the different sources and 
methodologies used in the assessment studies, brief 
descriptions of the current patterns and trends of drug 
use in four of the five countries are presented in this 
section. 
  
Kazakhstan 
 
The prevalence estimate rate of problem drug users in 
Kazakhstan per 100,000 population ranges between 
1,110 and 1,255 (exhibit 3). Kazakhstan reportedly 
has the highest rate of new drug users registered 
among all countries in the region. Whereas the rate of 
newly registered drug users was 5 per 100,000 
population in 1992, this has consistently increased, 
with a sharp increase between 1996 and 1998 (exhibit 
4). In 2000, the rate was reported as 77 per 100,000 
population. The rate of drug users treated each year 
has been increasing in a similar fashion, from 8.9 per 
100,000 population in 1992 to 37.8 per 100,000 in 
2000 (exhibit 5). Heroin is ranked as the first drug of 
abuse, followed by cannabis and opium. Almost two-
thirds of the drug users registered in 2000 were 
registered for opiates. In terms of age and gender, 
more than 20 percent of drug users were estimated to 
be younger than 19, and about one-third were 
estimated to be female. According to information 
from the Joint United Nations Programme on HIV/
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AIDS, there has been a rapid and significant growth 
of human immunodeficiency virus (HIV)-infected 
persons in the country. About 95 percent of HIV-
infected persons are injection drug users. Exhibit 6 
shows HIV and acquired immunodeficiency syn-
drome (AIDS) data for Central Asian countries. 
According to sources, between 50 and 80 percent of 
all drug injectors are also infected with either the 
hepatitis B or C viruses. While opium seizures in the 
country have shown a decline, there has been a sharp 
increase in heroin seizures (262 kilograms in 2000) 
and a steady increase in cannabis seizures (15,465 
kilograms in 2000) since 1997 (exhibit 7). Similarly, 
the rate of drug-related crimes, the highest in the 
region, also increased more than threefold from 1993 
to 2000, from 45 to 145 per 100,000 population.   
 
Kyrgyzstan 
 
The estimated number of problem drug users in 
Kyrgyzstan ranges from 80,000 to 100,000, and the 
rate per 100,000 population (1,644– 2,054) is 
reportedly the highest of all the Central Asian 
countries (exhibit 3). The rate of drug users registered 
for the first time has shown a fivefold increase since 
1992, to 15 per 100,000 population in 2000, while the 
rate of drug users treated per 100,000 population 
increased from 2.6 in 1992 to 7.7 in 2000 (exhibits 4 
and 5). In 1992, opiate users accounted for 10 percent 
of the drug users registered, while in 2000, they 
accounted for more than 80 percent of newly 
registered drug users. In 2000, more than 80 percent 
of drug users were registered for heroin, and more 
than 65 percent were injecting drugs. The percentage 
of females among registered drug users is less than 5 
percent. More than one-half of the drug users were 
estimated to be younger than 35, and 15 percent were 
younger than 19. Among the reported HIV infection 
cases in the country, 60– 80 percent of the infection 
cases are among injection drug users (exhibit 6). 
According to court data, the number of drug-related 
crimes has increased by 3.5 times over the past 
decade. In addition to the increase in the absolute 
number of such crimes, their share of the total 
number of criminal cases in the country also 
increased. In 1990, the proportion of drug-related 
crimes among all crimes totaled 8 percent; in 2000 
the share had risen to 15 percent. Drug-related crimes 
have thus become a significant component of overall 
criminality and have brought an additional burden for 
law enforcement agencies and, indirectly, for the 
whole society. While the prices of heroin 
(U.S.$10,500 per kilogram) and opium (U.S.$2,000 
per kilogram) have remained steady in the past few 
years, there has been a sharp increase in the total 
number of opiates, especially heroin, seized in the 
country (exhibits 8 and 9). 
Tajikistan 
 
The prevalence rate per 100,000 population of 
problem drug users in Tajikistan is estimated to range 
from 734 to 897 (exhibit 3). The reported rate of 
newly registered drug users per 100,000 population 
increased from 2 in 1992 to 28 in 2000 (exhibit 4). 
This rate of increase in Tajikistan is the second 
highest in the region. The rate per 100,000 population 
of drug users treated in 2000 was 4 times the rate in 
1992 (exhibit 5). Heroin users accounted for two-
thirds of the registered drug users in 2000, with one-
third of them being injection drug users. The majority 
of drug users (more than 50 percent) are younger than 
30, and one-quarter of the drug users are younger 
than 24. Females accounted for only 6 percent of the 
total registered drug users; however, an alarming 
120-times increase was noted in the rate of newly 
registered female drug users in 2000. According to 
the statistical data provided by the Ministry of 
Justice, the number of drug-related crimes has 
increased by more than 2 times in 1996– 2000. In 
addition to increases in the absolute number of such 
crimes, their share of the total number of criminal 
cases in the country increased as well. In 1996, the 
proportion of drug-related crimes totaled 13 percent 
of all criminal cases; in 2000 the share rose to 21 
percent. Since 1998, opiate seizures (heroin and 
opium) have increased, while cannabis seizures have 
declined (exhibit 10). The street prices of heroin and 
opium have declined during the same period, with 
2000 prices reported of U.S.$4,000 per kilogram of 
heroin and U.S.$18 per kilogram of opium (exhibit 
11). The reported rate of drug-related offenses has 
remained stable since 1993. 
 
Uzbekistan 
 
The estimated prevalence rate of problem drug users 
in Uzbekistan ranges from 262 to 367 per 100,000 
population (exhibit 3). With a sevenfold increase 
since 1992, the rate of new drug users registered was 
reported at 22 per 100,000 population in 2000 (ex-
hibit 4). The rate of drug users treated per 100,000 
population has also shown a sharp increase since 
1998. From 1992 to 1998, this rate was less than 5 
per 100,000 population, but in 2000 the rate in-
creased to more than 24 per 100,000 population 
(exhibit 5). An increasing number of these drug users 
are using opiates, especially heroin, with injection 
drug use reported as the method of use for up 60 
percent of these drug users. Injection drug use is also 
reported as the predominant mode of transmission for 
HIV infection in the country (exhibit 6). More than 
one-half of drug users are reportedly younger than 
30, and one-quarter are younger than 25. Males 
constitute the majority (80 percent) of drug users.  
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While drug seizures for cannabis have been on the 
decline, the reported seizures of opiates, especially of 
heroin, have increased tremendously since 1997 
(exhibit 12). The wholesale prices of heroin and 
opium have decreased considerably since 1998 
(exhibit 13). The rate of drug-related crimes reported 
in the country has remained stable in the past 8 years. 
 
CONCLUSIONS 
 
All the Central Asian countries are experiencing a 
rapidly increasing drug use problem. The main 
transition has been from traditional use of cannabis 
and opium to increasing use of heroin and increasing 
cases of injection drug use, especially among the 
younger age groups. The majority of drug users are 
reported to be male, but a considerable proportion of 
drug users are female. The situation is compounded 
by the lack of resources available within the countries 
to address the healthcare and social needs of the 
population. Therefore, there is a strong need to build 
capacity among professionals to address the needs of 
both this younger age group and females for the 
treatment and prevention of drug use.  
While a system to report drug use in each of the 
countries exists, there are some methodological 
issues that need to be addressed. One issue is the 
anonymity of drug users, since all the information of 
registered drug users has to be reported to the police. 
Consequently, drug users feel hesitant to seek help 
from the State-run narcology centers. The second 
major issue is reporting of the aggregate data. 
Depending upon the country, aggregate data is not 
presented by gender, age, type of drug use, and/or 
preferred method of drug use. Having this useful 
information would no doubt enable policymakers and 
service providers to monitor the patterns and trends 
of illicit drug use in their areas and design 
interventions accordingly. Finally, there is the issue 
of data management (the entry, analysis, and sharing 
of information among stakeholders in each of the 
countries). The countries in the region have lacked 
the capabilities to address these issues, especially 
with regard to data analysis and its dissemination. 
The Global Assessment Programme on Drug Abuse 
aims to help the member countries in the region to 
adequately address these shortcomings.  
 
For inquiries concerning this report, please contact Dr. Kamran Niaz, Regional Epidemiology Advisor, Southwest and Central Asia, Global 
Assessment Programme on Drug Abuse, UNODCCP, UN House Birlik Mahalessi, 2 Cadd, No. 11, Cankaya, 06610 Ankara, Turkey, Phone: 90-
312-454-1086, Fax: 90-312-496-1463, E-mail: <kamran.niaz@un.org.tr>.
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Exhibit 1. The Countries of Central Asia 
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Exhibit 2.  Health and Social Indicators in Central Asian Countries: 2000 
 
Indicator Kazakhstan Kyrgyzstan Tajikistan Turkmenistan Uzbekistan 
Size (thousand square 
kilometers) 2,717 198.5 143.1 488.1 447.4 
Population (million) 15.4 4.7 6.2 4.8 24.4 
Population Density (per 
square kilometer) 5.9 24.2 42.8 9.9 57.1 
Rural Population (as 
percentage of total) 44 65 73 55 63 
Annual Population 
Growth Rate -1 1 1.7 1.3 1.8 
Life Expectancy at Birth 65 67 68 66 70 
GDP Per Capita (U.S.$) 
 1988 
 
2,310 
 
1,240 
 
910 
 
1,490 
 
1,000 
 1999 1,290 300 290 660 720 
UNDP HDI1 Rank 73 97 110 100 106 
 
1
 United Nations Development Programme Human Development Index. 
 
SOURCE: World Development Indicators Database, Washington: World Bank, 2000 
 
 
 
Exhibit 3. Prevalence Estimates of Problem Drug Users in Selected Central Asian  
 Countries:  2000 
 
Country General Population Estimated Number of Problem Drug Users 
Rate Per 
100,000 Population 
Kazakhstan 14,869,021 165,000–186,000  1,110–1,255 
Kyrgyzstan 4,867,481 80,000–100,000 1,644–2,054 
Tajikistan 6,131,000 45,000–55,000 734–897 
Uzbekistan 24,813,109 65,000–91,000 262–367 
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Exhibit 4. Rate of Drug Users Registered for the First Time Per 100,000 Population in  
 Selected Central Asian Countries: 1992–2000 
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Exhibit 5. Rate of Drug Users Treated Per 100,000 Population in Selected Central Asian  
 Countries: 1992–2000  
 
0
5
10
15
20
25
30
35
40
1992 1993 1994 1995 1996 1997 1998 1999 2000
Uzbekistan
Kyrgyzstan
Kazakhstan
Tajikistan
 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Central Asia 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 294
Exhibit 6.  HIV/AIDS Case Data for Central Asian Countries 
 
Country Year of First HIV Case 
Cumulative HIV 
Cases to Date 
Cumulative 
AIDS Cases to 
Date 
Predominant 
Mode of 
Transmission 
Kazakhstan 1989 1,300 34 IDU 
Kyrgyzstan 1987 53 1 IDU/Heterosexual 
Tajikistan 1991 11  Heterosexual 
Turkmenistan 1997 4  Heterosexual 
Uzbekistan 1992 228 10 IDU 
 
SOURCE:  Joint United Nations Programme on HIV/AIDS 
 
 
 
 
Exhibit 7.  Number of Drug Seizures in Kazakhstan in Kilograms: 1990–2000 
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Exhibit 8.  Drug Seizures in Kyrgyzstan in Kilograms:  1992–2000
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Exhibit 9.  Retail Drug Prices in Kyrgyzstan in U.S. Dollars:  1998–2000
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Exhibit 10.  Drug Seizures in Tajikistan in Kilograms:  1991–2000
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Exhibit 11.  Retail Drug Prices in Tajikistan in U.S. Dollars:  1998–2000
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Exhibit 12.  Drug Seizures in Uzbekistan in Kilograms:  1994–2000
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Exhibit 13.  Wholesale Drug Prices in Uzbekistan in U.S. Dollars:  1998–2000
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Study of Juvenile Offenders in Israel 
 
Richard Isralowitz 
 
ABSTRACT  
 
The Israeli representative presented information on 
the CEWG approach being developed to monitor 
youth who have a high risk for drug use. The focus 
is on youth who have been referred by the juvenile 
justice system for supervisory services provided by 
the national office of Youth Probation Services. 
Funding support for this initiative was obtained 
from the U.S. Agency for International Develop-
ment, Middle East Regional Cooperation Program. 
The monitoring approach includes efforts to gather 
prevalence data from youth workers and youth.  
 
The findings presented were based on information 
collected from 89 youth workers who work with more 
than 7,000 youth. Results show that 32 percent of the 
youth had no connection with school; for those who 
had a connection, 85 percent had school attendance 
problems. A majority of the youth (69 percent) spent 
their evenings hanging around in the streets, 
playgrounds, parks, and shopping malls. Approxi-
mately 37 percent were considered to be abusing 
alcohol, 56 percent experienced binge drinking, and 
47 percent used alcohol in a car either as a passenger 
or driver of the vehicle. On average, youth spent 
about $100 each month on cigarettes, alcohol, and 
illegal drugs. Among the substances considered to be 
most problematic and accessible to the youth were 
alcohol, marijuana, ecstasy, and inhalants. Those 
youth who used and abused harmful substances 
tended to engage in stealing, property damage, and 
violent behavior. Also, the youth were victims of 
property theft and/or damage and beatings. Correla-
tion analyses show that youth who use drugs have 
problem behaviors in terms of theft, vandalism, and 
causing fights; are the victims of theft, vandalism, 
and violence; and tend to have little or no positive 
experience with school.  
 
For inquiries concerning this report, please contact Richard Isralowitz, Ph.D., Spitzer Department of Social Work, Ben Gurion University, P.O. 
Box 653, Be’er Sheva 84105 Israel, Phone: 972-7-647-2328, Fax: 972-8-647-2933, E-mail: <Richard@bgumail.bgu.ac.il>. 
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Update of the Epidemiologic Surveillance System of Addictions 
(SISVEA) in Mexico:  January– June 2002  
 
Roberto Tapia-Conyer, Patricia Cravioto, Pablo Kuri, Fernando Galván, and Blanca de la 
Rosa1 
 
                                                           
1
  The authors are affiliated with the Ministry of Health of Mexico. 
ABSTRACT 
 
Mexico’s Epidemiologic Surveillance System of 
Addictions, operating in 31 Mexican cities, gathered 
data on 5,412 patients in government treatment 
centers (GTCs) and 13,488 patients in nongovern-
ment treatment centers (NGCs) during the first half 
of 2002. Information on drug use among 3,779 
juvenile arrestees was also collected, as was data on 
drug-involved deaths. The GTC data show that 
cocaine ranked first as the main drug abused by 
patients, followed by marijuana, alcohol, and 
inhalants. At NGCs, heroin ranked first as the 
current drug of abuse, followed by cocaine and 
alcohol. Most patients were polydrug users. Cocaine 
and heroin use increased among juvenile arrestees, 
although marijuana was the most frequently reported 
drug of use. Alcohol continued to be the substance 
most commonly involved in drug-related deaths. 
 
INTRODUCTION 
 
The Epidemiologic Surveillance System of 
Addictions of Mexico (SISVEA), established in 
1990, involves the collaboration of different 
government and nongovernment agencies. SISVEA 
has provided periodic and timely information on 
tobacco, alcohol, and medical and illegal drug use 
that identifies risk groups, emerging drugs, changes 
in consumption patterns, and risk factors associated 
with morbidity and mortality of use and abuse of 
alcohol, tobacco, marijuana, cocaine, heroin, and 
other drugs. SISVEA began 12 years ago with only 8 
cities, which were mainly at the northern border of 
Mexico. Currently, SISVEA gathers information 
from 51 cities; one-quarter are located in the 6 States 
at the border, and the rest are in the other 26 States of 
the country. The information represents direct and 
indirect indicator data from different sources.  
 
Data Sources 
 
This report updates the activities of SISVEA during 
first half of 2002. The sources of data that are used to 
construct different indicators are described below: 
• Drug treatment data cover the characteristics 
and consumption patterns related to the first drug 
of use and primary drug of use. The data are 
collected from government treatment centers 
(Centers of Juvenile Integration, referred to 
hereafter as GTCs) and nongovernment treat-
ment centers (NGCs) in the participating 
SISVEA cities. 
 
• Drug consumption data are gathered for the 
general population and specific target groups, 
such as juvenile arrestees.  
 
• Data on drug use among juvenile arrestees 
were gathered from Juvenile Detention Centers 
and are based on 3,779 youth arrested during the 
first half of 2002. Information collected includes 
demographic characteristics of the youth and the 
types of offenses committed. 
 
• Medical examiner (ME) data cover drug-
related deaths, including accidental or violent 
deaths (homicides or suicides) in cases where 
drug abuse may be the direct cause of death or a 
contributing factor. 
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Marijuana 
 
GTCs 
 
According to government treatment centers, mari-
juana-abusing patients in the first half of 2002 were 
mostly male (91.6 percent); 31.9 percent were 
between the ages of 15 and 19, 45.7 percent had only 
a middle school education, 62.1 percent were single, 
and 51.1 percent came from a middle-low socio-
economic background (exhibit 1). The age of onset 
for 92.2 percent of marijuana users was between 10 
and 19 years; 61.8 percent of GTC clients reported 
daily use.  
 
Marijuana was the second most common drug of first 
use (13.0 percent) and the second most common 
primary current drug (17.6 percent) (exhibit 2). 
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During the first half of 2002, natural history data on 
marijuana use among this patient group showed 10.3 
percent were monodrug users at treatment entry. The 
rest (89.7 percent) were already using a second drug, 
usually alcohol (27.9 percent), followed by cocaine 
(24.3 percent) (exhibit 3). Of the multiple-drug users, 
83.0 percent advanced to a third drug, usually 
cocaine (22.3 percent), alcohol (18.8 percent), 
tobacco (15.2 percent), or inhalants (11.8 percent). 
 
NGCs 
 
According to data gathered from nongovernment 
treatment centers, marijuana-abusing patients in the first 
half of 2002 were mostly male (95.6 percent); 25.5 
percent were age 35 and older; 41.4 percent had a middle 
school education; and more than one-half were single 
(55.4 percent) (exhibit 4). The age of onset for marijuana 
use among these patients was between 10 and 14 for 48.4 
percent of them; 79.9 percent reported daily use. 
 
Marijuana was the first drug of use for 28.7 percent 
of NGC treatment admissions in the first half of 
2002; as a primary current drug, it ranked fourth (9.8 
percent) (exhibit 5). 
 
Natural history data on marijuana use reported by 
NGCs during 2002 show that 11.3 percent used only 
marijuana at first admission of treatment (exhibit 3). 
The remaining 88.7 percent had progressed to using a 
second drug, which in order of prevalence were 
cocaine (23.6 percent) and alcohol (15.3 percent). Of 
this group, 77.0 percent were already using a third 
drug, mainly heroin (25.3 percent), cocaine (24.5 
percent), and alcohol (10.6 percent). 
 
Juvenile Arrestees 
 
The Juvenile Detention Centers reported that 39.5 
percent of the 3,779 juveniles arrested during the first 
half of 2002 used marijuana (exhibit 6). Most were 
male (95.4 percent); 58.1 percent had an elementary 
school education, 37.5 percent were subemployed, 
38.6 percent had a tattoo, and 30.0 percent were gang 
members. More than one-third (33.5 percent) of the 
offenses were committed under intoxication, and 46.3 
percent of the offenses were robberies.  
 
ME Data 
 
Medical examiner data indicated that 10.8 percent of 
deaths reported in the first half of 2002 were 
associated with marijuana (exhibit 7). All were male; 
19.7 percent were between the ages of 30 and 34, 
18.0 percent were age 25– 29, and 14.8 percent were 
age 40 and older. The main cause of death in these 
cases was a firearm (31.1 percent), followed by 
intoxication (21.3 percent). Most deaths occurred on 
the street (69.5 percent) or at home (23.7 percent). 
 
Inhalants 
 
GTCs 
 
Inhalant users attending government treatment centers in 
the first half of 2002 were mostly male (85.7 percent) 
and age 15– 19 (34.7 percent). More than one-half (51.9 
percent) had only a middle school education, 75.3 
percent were single, and 53.5 percent were from a 
middle-low socioeconomic background (exhibit 1). 
Most began using inhalants between the ages of 10 and 
14 (67.8 percent); 42.1 percent used inhalants daily, and 
38.6 percent used them once a week. 
 
During 2002, inhalants ranked third as drug of first 
use (10.3 percent) and fourth as primary current drug 
(11.2 percent) among GTC patients (exhibit 2). 
 
GTC data on the natural history of inhalant use show 
that 26.6 percent were still monodrug users when 
entering treatment, while 73.4 percent were already 
using a second drug, mainly marijuana (34.7 
percent), alcohol (21.5 percent), and tobacco (17.1 
percent) (exhibit 8). Of these multiple-drug users, 
79.9 percent used a third drug, mainly marijuana 
(26.0 percent), alcohol (21.1 percent), cocaine (13.7 
percent), or tobacco (12.9 percent) (exhibit 3). 
 
NGCs 
 
In the first half of 2002, NGCs reported that of the 
1,580 patients who used inhalants, most were male 
(93.8 percent); 28.3 percent were age 15– 19, 55.2 
percent had an elementary school education, and 69.6 
percent were single (exhibit 4). More than one-half 
started using inhalants at age 10– 14 (57.3 percent), 
and 81.8 percent reported daily use. 
 
Inhalants ranked third (11.7 percent) as a drug of first 
use and fifth (8.0 percent) as a primary current drug 
among NGC clients (exhibit 5). 
 
Data on the natural history of inhalant users at NGCs show 
that 65.0 percent of this patient group had progressed to 
using a second drug, mainly marijuana (52.4 percent), 
alcohol (17.7 percent), and tranquilizers (6.6 percent) 
(exhibit 8). Of the 73.6 percent who used a third drug, most 
used cocaine (27.3 percent), marijuana (17.0 percent), 
tranquilizers (15.6 percent), or heroin (13.7 percent). 
 
Juvenile Arrestees 
 
According to Juvenile Detention Centers, 19.4 per-
cent of the youth arrested in the first half of 2002 
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used inhalants (exhibit 6). Most were male (94.4 
percent), had an elementary school education (66.9 
percent), and were subemployed (41.1 percent). 
Sizable proportions had tattoos (42.8 percent) and 
belonged to a gang (34.6 percent). More than one-
third (38.4 percent) committed the offense while 
intoxicated. Robbery was the most common offense 
(46.9 percent). 
 
Alcohol 
 
GTCs 
 
According to government treatment centers during 
the first half of 2002, 1,662 (30.7 percent) of the 
5,412 patients were abusing alcohol (exhibit 1). Of 
these, 85.1 percent were male, 26.6 percent were age 
15– 19, and 20.2 percent were age 20– 24. Nearly 44.0 
percent had a middle school education, 58.5 percent 
were single, and more than one-half (57.3 percent) 
were from a middle-low socioeconomic background. 
More than 45 percent began using alcohol between 
the ages of 15 and 19. Nearly one-half (49.7 percent) 
reported weekly use, and 26.8 percent reported using 
1– 3 times per month. 
 
Alcohol was the first most commonly reported drug 
of first use (30.8 percent) among GTC patients, but it 
ranked third (13.1 percent) as primary current drug 
(exhibit 2). 
 
Among those for whom alcohol was the drug of first 
use, 92.6 percent progressed to a second drug, usually 
tobacco (47.0 percent), marijuana (22.6 percent), and 
cocaine (16.6 percent) (exhibit 9). Of this multiple-
drug user group, 77.2 percent reported using a third 
drug, usually cocaine (31.6 percent), marijuana (30.8 
percent), or inhalants (11.4 percent) (exhibit 3b). 
 
NGCs 
 
Nongovernment treatment centers reported that most 
of the 3,395 patients in the first half of 2002 who 
abused alcohol were male (93.3 percent) (exhibit 4). 
Forty-two percent were age 35 or older; 33.4 percent 
had only an elementary school education; 43.4 
percent were single, and nearly one-half (44.8 
percent) started using alcohol between the ages of 15 
and 19. Nearly one-half reported daily use, and 39.1 
percent used once a week. 
 
Alcohol ranked second as the drug of first use (25.2 
percent) among NGC patients and third as a current 
primary drug (15.2 percent) (exhibit 5). 
 
Natural history data on alcohol abuse among NGC 
patients in the first half of 2002 show that 25.1 
percent were monodrug users; the remaining 74.9 
percent progressed to a second drug, typically 
marijuana (36.3 percent), cocaine (23.8 percent), and 
tobacco (18.2 percent). Of the 66.2 percent who 
progressed to a third drug, most used cocaine (31.5 
percent), marijuana (20.8 percent), or inhalants (9.1 
percent) (exhibit 9). 
 
Juvenile Arrestees 
 
Among juvenile arrestees in the first half of 2002, 
11.1 percent reported alcohol abuse (exhibit 6). Most 
(92.9 percent) were male; 48.5 percent had an 
elementary school education, 33.0 percent were 
employed, 25.4 percent had tattoos, and 25.7 percent 
were gang members. More than one-third of the 
juveniles (36.8 percent) committed the offense while 
intoxicated. Robbery (44.4 percent) was the most 
common offense. 
 
ME Data 
 
According to medical examiners, the abuse of alcohol 
was associated with 78.1 percent of the deaths 
reported in the first half of 2002. Most decedents 
were male (95.0 percent), and 42.1 percent were age 
40 or older (exhibit 7). The main cause of death was 
asphyxia (17.8 percent), followed by traffic accident 
(16.2 percent). The most common place where these 
deaths occurred was on the street (33.8 percent) or at 
home (31.3 percent). 
 
Cocaine 
 
GTCs 
 
Government treatment centers report that cocaine 
users in the first half of 2002 were mostly male (88.5 
percent); 28.9 percent were age 20– 24, 47.6 percent 
were middle school graduates, 57.6 percent were 
single, and 23.6 percent were married (exhibit 1). 
More than one-half (51.2 percent) were from a 
middle-low socioeconomic level, 40.5 percent 
initiated cocaine use between the ages of 15 and 19, 
and more than 86 percent used cocaine once a week 
(47.6 percent) or daily (38.5 percent). 
 
Among GTC patients, cocaine ranked fourth as the 
first drug of use (6.4 percent) and first as primary 
current drug (31.1 percent) (exhibit 2). 
 
Natural history data on cocaine abuse show that 41.8 
percent of those whose first drug of use was cocaine 
were still monodrug users when entering treatment; 
the rest were already using a second drug, usually 
marijuana (28.8 percent), alcohol (24.2 percent), or 
tobacco (17.4 percent). Of these multiple-drug users, 
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57.5 percent had started using a third drug and 
changed or combined it with alcohol (34.1 percent), 
tobacco (23.0 percent), or marijuana (20.6 percent) 
(exhibit 10). 
 
NGCs 
 
Among the cocaine abusers who attended nongovern-
ment treatment centers in the first half of 2002, 88.9 
percent were male; 23.5 percent were age 25– 29; 
40.3 percent had a middle school education, and 50.3 
percent were single (exhibit 4). Data show that 38.4 
percent started using cocaine between the ages of 15 
and 19; 62.0 percent reported daily use, and 30.1 
percent reported weekly use. 
 
Cocaine ranked fourth as the drug of first use in 6.1 
percent of the NGC patients and second as current 
primary drug (19.9 percent) (exhibit 5). 
 
Natural history data on cocaine abuse show that 40.2 
percent of these NGC patients were monodrug users 
upon treatment entry (exhibit 10). Nearly 60 percent 
used a second drug, usually marijuana (26.8 percent), 
heroin (20.3 percent), alcohol (19.5 percent), or 
crystal methamphetamine (13.9 percent). Of the 
multiple-drug users, 43.4 percent used a third drug, 
usually marijuana or alcohol (17.1 percent each) or 
heroin (11.1 percent). 
 
Juvenile Arrestees 
 
Juvenile Detention Centers reported cocaine use 
among 24.1 percent of the juvenile arrestees in the 
first half of 2002 (exhibit 6). Most were male (95.0 
percent); more than one-half had an elementary 
school education (58.3 percent) and were sub-
employed (38.5 percent). Also, 39.1 percent had 
tattoos, but only 28.1 percent were gang members. 
One-third of the juvenile arrestees (32.4 percent) 
committed the offense under intoxication. Robbery 
was the most common offense (48.7 percent). 
  
Heroin 
 
GTCs 
 
Heroin users at GTCs in the first half of 2002 were 
mostly male (88.9 percent). Nearly 89 percent were 
age 30 or older, 77.8 percent had an elementary 
school education, 33.3 percent were single, and 
another 33.3 percent were living with someone. 
Nearly 56 percent came from a low socioeconomic 
background, and 44.4 were from a middle-low 
socioeconomic background (exhibit 1). The age of 
onset for 66.7 percent of heroin users was between 15 
and 19. All reported daily use.  
Of the 5,412 patients attending treatment during first 
half of 2002, only 0.2 percent-reported heroin as drug 
of first use; as primary current drug, heroin ranked 
fifth (4.5 percent) (exhibit 2). 
 
NGCs 
 
At the nongovernment treatment centers in the first 
half of 2002, most heroin-abusing patients were male 
(92.0 percent); 39.7 percent were age 35 and older, 
44.8 percent had only an elementary school 
education, and 49.1 percent were single (exhibit 4). 
The age of first use of heroin among these patients 
was between 15 and 19 (37.7 percent); 97.1 percent 
reported daily use. 
 
Since 1994, heroin as drug of first use has been 
increasing (4.3 percent) (exhibit 5). As the primary 
current drug, heroin patients ranked first as the cause 
of treatment demand (28.0 percent) among NGC 
clients, a substantial increase from the approximately 
24 percent in 2001. 
 
Juvenile Arrestees 
 
The Juvenile Detention Centers reported that 0.7 
percent of the 3,779 juveniles arrested during first 
half of 2002 used heroin (exhibit 6). Most were male 
(88.9 percent); 48.1 percent had an elementary school 
education, and the same percentage was 
subemployed. Nearly 52 percent were gang members, 
and the same percentage had tattoos. More than 44 
percent of the offenses were committed under 
intoxication. Robbery was the most common offense 
(70.4 percent). 
 
CONCLUSIONS 
 
The SISVEA system has been strengthened and 
expanded to include at least one city in each State; 
the cities now total 51. Also, the system is being 
evaluated each trimester as part of the National 
Systems of Surveillance of Mexico. 
 
The types of drugs mentioned have varied across the 
different information sources:  
 
• Cocaine and heroin mentions have increased in 
Juvenile Detention Centers.  
 
• The abuse of alcohol remains the drug most 
related to deaths. 
 
• In government treatment centers, marijuana and 
inhalants have decreased as drugs of onset, while 
alcohol as the first drug of use continues to 
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increase. The most prevalent current drug in the 
first half of 2002 was cocaine, although it showed 
a decrease compared with the previous year.  
 
• In nongovernment treatment centers, cocaine 
decreased slightly as drug of onset. As a current 
drug, cocaine ranked first, with 23.8 percent 
seeking treatment for cocaine abuse. On the 
other hand, there was an increase in heroin as the 
drug of first use and as the current drug of use. 
 
 
For inquiries concerning this report, please contact Roberto Tapia-Conyer, Ministry of Health of Mexico, Cerro de Macuiltepec #83, Col. 
Campestre Churubusco, 04200, Delegacion Coyoacan, D.F., Mexico City, Mexico 04200, Phone: 525-55-53-71-45, Fax: 525-55-53-72-92, E-
mail: <rtapia@mail.ssa.gob.mx>. 
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Exhibit 1. Demographic Characteristics of GTC Patients in Mexico by First Drug of Use and  
  Percent:  January–June 2002 
 
Characteristic Total (N=5,412) 
Marijuana 
(n=699) 
Inhalants 
(n=554) 
Alcohol 
(n=1,662) 
Cocaine 
(n=347) 
Heroin 
(n=9) 
Gender 
 Male 
 Female 
 
85.1 
14.9 
 
91.6 
8.4 
 
85.7 
14.3 
 
85.1 
14.9 
 
88.5 
11.5 
 
88.9 
11.1 
Age 
 5–14 
 15–19 
 20–24 
 25–29 
 30–34 
 35 and older 
 
9.6 
30.0 
19.6 
15.7 
10.6 
14.5 
 
5.6 
31.9 
19.9 
15.7 
11.4 
15.5 
 
26.9 
34.7 
14.1 
11.0 
6.0 
7.4 
 
7.3 
26.6 
20.2 
17.6 
13.1 
15.2 
 
5.8 
26.6 
28.9 
20.8 
11.6 
6.4 
 
0.0 
0.0 
11.1 
0.0 
44.4 
44.4 
Schooling 
 Elementary 
 Middle 
 High 
 College 
 No formal education 
 Other 
 
19.7 
45.7 
21.4 
6.9 
0.4 
5.8 
 
20.1 
45.7 
23.1 
6.1 
0.6 
4.4 
 
36.8 
51.9 
7.7 
0.7 
0.7 
2.2 
 
16.5 
43.9 
24.4 
8.0 
0.4 
6.9 
 
12.9 
47.6 
25.3 
8.8 
0.3 
5.0 
 
77.8 
11.1 
0.0 
0.0 
0.0 
11.1 
Marital Status 
 Single 
 Married 
 Living together 
 Divorced 
 Widowed 
 Other 
 
61.6 
21.7 
9.8 
1.9 
0.1 
4.9 
 
62.1 
18.9 
12.4 
1.9 
0.1 
4.6 
 
75.3 
11.2 
8.3 
1.1 
0.2 
4.0 
 
58.5 
23.9 
10.1 
2.2 
0.0 
5.2 
 
57.6 
23.6 
10.1 
2.6 
0.3 
5.7 
 
33.3 
11.1 
33.3 
0.0 
0.0 
22.2 
Socioeconomic Level 
 High, middle-high 
 Middle 
 Middle-low 
 Low 
 
12.9 
8.5 
56.5 
22.1 
 
12.6 
8.0 
51.1 
28.3 
 
6.0 
5.4 
53.5 
35.0 
 
14.3 
7.7 
57.3 
20.7 
 
7.5 
16.1 
51.2 
25.2 
 
0.0 
0.0 
44.4 
55.6 
Age of Onset 
 Younger than 10 
 10–14 
 15–19 
 20–24 
 25–29 
 30–34 
 35 and older 
 
4.1 
50.4 
38.3 
4.7 
1.6 
0.5 
0.4 
 
2.1 
48.7 
43.5 
4.6 
0.7 
0.4 
0.0 
 
4.6 
67.8 
25.1 
1.3 
0.9 
0.2 
0.2 
 
5.0 
43.2 
45.4 
5.0 
0.9 
0.4 
0.1 
 
0.6 
21.0 
40.5 
19.8 
11.9 
3.0 
3.0 
 
0.0 
22.2 
66.7 
0.0 
0.0 
0.0 
11.1 
Frequency of Use 
 Daily 
 Once a week 
 1–3 times per month 
 1–11 times per year 
 
53.8 
20.9 
14.1 
1.1 
 
61.8 
25.9 
11.4 
0.8 
 
42.1 
38.6 
17.0 
2.3 
 
21.6 
49.7 
26.8 
1.8 
 
38.5 
47.6 
13.4 
0.4 
 
100.0 
0.0 
0.0 
0.0 
 
SOURCE: SISVEA— Government treatment centers 
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Exhibit 2.   Comparison Between Drug of First Use and Current Drug of Use Among GTC Patients  
   in Mexico by Percent:  1991–June 2002 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOURCE:  SISVEA— Government treatment centers 
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Exhibit 3. Natural History of Marijuana Use Among Treatment Patients in Mexico: 
   January–June 2002 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOURCE:  SISVEA— Government and nongovernment treatment centers 
Government Treatment Centers 
Nongovernment Treatment Centers 
Marijuana Used a second drug Used a third drug 
Alcohol 
Cocaine 
Tobacco 
Inhalants 
Other drug 
27.9%
24.3%
14.0%
13.3%
20.5%
Cocaine 
Alcohol 
Tobacco 
Inhalants 
Other drug 
22.3%
18.8%
15.2%
11.8%
31.9%10.3% 
Monodrug users 
17.0% 
83.0% 89.7% 
Marijuana Used a second drug Used a third drug 
Cocaine 
Alcohol 
Inhalants 
Tranquilizers 
Other drug 
23.6%
15.3%
15.0%
12.3%
33.8%
Heroin 
Cocaine 
Alcohol 
Tranquilizers 
Other drug 
25.3%
24.5%
10.6%
9.5%
30.1%11.3% 
Monodrug users 
23.0% 
77.0% 88.7% 
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Exhibit 4. Demographic Characteristics of NGC Patients in Mexico by First Drug of Use and  
  Percent:  January–June 2002 
 
Characteristic Total (N=13,488) 
Marijuana 
(n=3,877) 
Inhalants 
(n=1,580) 
Alcohol 
(n=3,395) 
Cocaine 
(n=831) 
Heroin 
(n=585) 
Gender 
 Male 
 Female 
 
92.5 
7.5 
 
95.6 
4.4 
 
93.8 
6.2 
 
93.3 
6.7 
 
88.9 
11.1 
 
92.0 
8.0 
Age 
 5–14 
 15–19 
 20–24 
 25–29 
 30–34 
 35 and older 
 
2.0 
15.1 
20.3 
19.4 
15.2 
28.0 
 
1.2 
14.3 
22.6 
20.0 
16.4 
25.5 
 
5.4 
28.3 
24.8 
17.6 
10.4 
13.4 
 
1.2 
9.3 
14.4 
17.3 
15.8 
42.0 
 
1.3 
19.4 
22.6 
23.5 
16.2 
17.0 
 
0.4 
3.4 
19.7 
20.0 
16.9 
39.7 
Schooling 
 Elementary 
 Middle 
 High 
 College 
 No formal education 
 Other 
 
38.0 
36.0 
15.3 
4.0 
13.5 
3.1 
 
37.1 
41.4 
14.8 
2.1 
2.6 
2.0 
 
55.2 
27.8 
4.8 
0.4 
6.5 
5.4 
 
33.4 
31.1 
19.5 
8.7 
3.6 
3.8 
 
27.2 
40.3 
22.3 
4.5 
2.3 
3.3 
 
44.8 
37.5 
11.7 
0.6 
3.5 
1.9 
Marital Status 
 Single 
 Married 
 Living together 
 Divorced 
 Widowed 
 Other 
 
52.7 
22.7 
12.9 
4.4 
1.0 
6.4 
 
55.4 
17.7 
14.8 
3.9 
0.9 
7.3 
 
69.6 
12.1 
10.9 
2.1 
0.8 
4.5 
 
43.4 
30.8 
10.2 
6.6 
1.6 
7.3 
 
50.3 
30.0 
11.1 
3.3 
0.1 
5.2 
 
49.1 
24.1 
14.2 
5.9 
0.3 
6.3 
Age of Onset 
 Younger than 10 
 10–14 
 15–19 
 20–24 
 25–29 
 30–34 
 35 and older 
 
5.1 
43.2 
38.2 
7.4 
3.2 
1.5 
1.5 
 
4.6 
48.4 
40.1 
4.4 
1.7 
0.5 
0.3 
 
8.8 
57.3 
30.2 
2.5 
0.5 
0.3 
0.4 
 
4.5 
37.3 
44.8 
8.6 
2.7 
0.7 
1.2 
 
0.7 
20.7 
38.4 
19.6 
9.3 
6.1 
5.1 
 
0.7 
13.2 
37.7 
19.8 
13.5 
8.2 
6.9 
Frequency of Use 
 Daily 
 Once a week 
 1–3 times per month 
 1–11 times per year 
 
73.6 
20.9 
4.3 
1.3 
 
79.9 
15.6 
3.1 
1.3 
 
81.8 
15.1 
2.0 
1.1 
 
49.5 
39.1 
9.6 
1.7 
 
62.0 
30.1 
6.0 
1.8 
 
97.1 
2.6 
0.2 
0.2 
 
SOURCE:  Nongovernment treatment centers 
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Exhibit 5. Comparison Between First Drug of Use and Current Drug of Use Among NGC Patients  
   in Mexico by Percent:  1994–June 2002 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOURCE:  SISVEA— Nongovernment treatment centers 
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Exhibit 7. Types of Death Under Intoxication of Selected Drugs1 in Mexico by Percent:   
  January–June 2002 
 
Characteristic Total (N=567) 
Alcohol 
(n=443) 
Marijuana 
(n=61) 
Opioid2 
(n=42) 
Gender 
 Male 
 Female 
 
94.1 
5.9 
 
95.0 
5.0 
 
100.0 
0.0 
 
95.2 
4.8 
Age 
 10–14 
 15–19 
 20–24 
 25–29 
 30–34 
 35–39 
 40 and older 
 
0.9 
7.6 
12.5 
15.5 
12.4 
13.8 
37.3 
 
1.1 
5.9 
11.8 
15.2 
11.3 
12.7 
42.1 
 
1.6 
13.1 
14.8 
18.0 
19.7 
18.0 
14.8 
 
0.0 
4.8 
11.9 
16.7 
26.2 
23.8 
16.7 
Cause of Death 
 Run over 
 Traffic accident 
 Fall 
 Electrocuted 
 Burned 
 Beaten 
 Asphyxia 
 Crushed 
 Firearm 
 Steel knife 
 Intoxicated 
 Other 
 
12.0 
12.9 
3.9 
0.4 
0.5 
7.1 
17.0 
0.0 
15.7 
5.0 
11.4 
14.1 
 
15.1 
16.2 
5.0 
0.2 
0.7 
7.8 
17.8 
0.0 
11.4 
4.6 
5.9 
15.3 
 
1.6 
3.3 
0.0 
1.6 
0.0 
6.6 
11.5 
0.0 
31.1 
13.1 
21.3 
9.8 
 
0.0 
0.0 
0.0 
0.0 
0.0 
4.8 
7.1 
0.0 
9.5 
2.4 
73.8 
2.4 
Place of Death 
 Traffic 
 Home 
 Street 
 Public baths 
 Recreational areas 
 At work 
 Service areas 
 Other 
 
20.3 
28.9 
41.4 
0.5 
0.9 
1.1 
1.1 
5.8 
 
25.7 
31.3 
33.8 
0.5 
1.2 
1.2 
0.9 
5.6 
 
1.7 
23.7 
69.5 
0.0 
0.0 
0.0 
1.7 
3.4 
 
0.0 
14.3 
85.7 
0.0 
0.0 
0.0 
0.0 
0.0 
 
1
 Deaths from all causes totaled 3,869. 
2
 Includes opium, morphine, and heroin. 
 
SOURCE:  Medical examiners 
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Exhibit 8. Natural History of Inhalant Use Among Treatment Patients in Mexico: 
    January–June 2002 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOURCE:  SISVEA— Government and nongovernment treatment centers 
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Exhibit 9. Natural History of Alcohol Use Among Treatment Patients in Mexico: 
    January–June 2002 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOURCE:  SISVEA— Government and nongovernment treatment centers 
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Exhibit 10. Natural History of Cocaine Use Among Treatment Patients in Mexico: 
  January–June 2002 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SOURCE:  SISVEA— Government and nongovernment treatment centers 
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Prevalence of Risk Factors and Substance Abuse Among 
Adolescents Age 12– 17 in the Gaza Strip, Palestine 
 
M. Afifi, M.D., M.Sc.,1 S. Sousi, Ph.D.,2 and Z. Abu Rsas, M.P.H.1 
 
                                                           
1
 M. Afifi, M.D., M.Sc. and Z. Abu Rsas, M.P.H., are affiliated with the Substance Abuse and Addiction Research Center (SARC), Gaza. 
2
 S. Sousi, Ph.D., is affiliated with Al-Azhar University, Gaza. 
ABSTRACT 
 
The Palestinian representative presented prelimi-
nary data from the high school survey of students 
age 15–17. This survey is the first study based on 
the CEWG approach to establish a monitoring and 
information system for substance abuse in Pales-
tine. Funding support for this initiative was 
obtained from U.S. Agency for International Devel-
opment (USAID), Middle East Regional Coopera-
tion Program. The information system will use 
regular school and university surveys, data collected 
from informants (community experts) through focus 
groups, Ministry of Health (MOH) reports, and the 
Anti-Narcotics General Administration (P-ANGA) 
reports. The preliminary findings presented repre-
sent data collected from 26 of the 70 high schools in 
Gaza Strip (1,034 of 54,695 students). Results show 
that 4.6–13.9 percent of boys and 2.1–10.3 percent 
of girls believe that using substances (including 
tobacco, alcohol, psychoactive tablets, inhalants, 
marijuana, and heroin) have little harmful effects, 
and 15.2–46.5 percent of boys and 8.4–46.2 percent 
of girls would have little or no objection to a friend 
using such substances. Thirty-four percent of boys 
and 5.5 percent of girls had observed one or more 
friends smoking in the school; these figures 
increase to 46 and 37.5 percent, respectively, in dis-
tricts. Among groups, 0.6–3.6 percent of boys and 
0.0–3.9 percent of girls were frequently observed 
using alcohol or substances other than tobacco. 
Across districts, the figures were 3.5–5.2 percent of 
boys and 0.5–5.2 percent of girls. The prevalence of 
use of different substances varied: 17.2 percent of 
boys and 7.9 percent of girls smoked cigarettes 
daily; 2.5 percent of boys and 5.6 percent of girls 
used tranquilizers, hypnotics, and central nervous 
system (CNS) stimulants frequently; 6.4 percent of 
boys and 2.6 percent of girls used inhalants (use of 
nail polish was common among girls); 3.0 percent 
of boys and 1.1 percent of girls used marijuana; and 
1.7 percent of boys and 0.8 percent of girls used 
heroin mixtures. 
 
INTRODUCTION 
 
Area Description 
 
The Gaza Strip is located in the southern part of Pal-
estine. It is heavily populated (1.2 million inhabitants 
live in 362 square kilometers). Sixty-five percent of 
the population are refugees who live in nine camps. 
Approximately one-half of the population are be-
tween the ages of 10 and 25, and the population 
growth rate is 3.5 percent per year. Unemployment 
exceeds 60 percent, and 80 percent of families live 
below the poverty line. Security and economic situa-
tions have been very bad in the last 2 years (2000–
2002) because of the uprisings (Intifada) and Israeli 
military activities. 
 
Previously, there has been no reliable information 
system for monitoring and reporting on the use and 
abuse of the addicting substances in Palestine and in 
the Gaza Strip specifically. The major source of in-
formation has been the annual report of the Anti-
Drug General Administration (P-ANGA), which de-
scribes police activities related to reducing drug sup-
ply. There is an urgent need to create a solid and reli-
able information system that deals with the different 
aspects of addiction, including supply and demand, 
drug-related morbidity and deaths, the extent of 
spread and the types of drugs as they emerge, and the 
risk factors that can be used to monitor and predict 
the future of the addiction phenomena. Such a system 
will be very helpful for policymakers in planning 
activities to control drugs. 
 
The MERC Project 
 
During 1997– 2000, regional and international activi-
ties were conducted to increase the knowledge about 
the size of the drug problem in the Middle East re-
gion, including Palestine, and to shed light on pos-
sible approaches to controlling the drug problems. 
From those efforts, it was concluded that there was a 
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real need to develop an efficient information and 
monitoring system on substance misuse and the re-
lated phenomena. This conclusion was supported by 
a project financed by the Middle East Regional Co-
operation (MERC) program by the U.S. Agency for 
International Development. NIDA’s CEWG approach 
was adopted for the proposed project. 
 
The first stage of the project was to create the proper 
tools to collect the basic data for the planned data-
base. Two main tools were developed for the adoles-
cent survey and for the experts (informants). 
 
The main sources of data for building the database 
included the following: 
 
• Data from high school surveys 
 
• Data from university surveys 
 
• Data from experts (informants) 
 
• Data complied from the reports of the P-ANGA 
and the Ministry of Health (MOH) 
 
• Other data from cross-sectional studies carried 
locally 
 
This presentation is focused on preliminary data from 
the high school survey. 
 
THE HIGH SCHOOL SURVEY:  PRELIMINARY DATA 
 
By December 2002, investigators had developed sur-
vey methods and collected data from several schools. 
The study population included 54,695 students 
(27,015 boys and 27,680 girls) attending 70 schools 
(33 schools for boys and 37 schools for girls). The 
study sample reported on here includes 1,034 stu-
dents randomly selected from 26 classes in 26 high 
schools (14 boys’  schools, and 12 girls’  schools). 
 
The major themes of the survey and the preliminary 
results are as follows: 
 
• The survey measured the knowledge/beliefs 
about the effects of using tobacco, alcohol, psy-
choactive drugs, inhalants, marijuana, and her-
oin. Preliminary findings based on this theme 
include the following: 
 
− Between 5.7 and 11.2 percent of boys and 4.5 
to 9.3 percent of girls believe that smoking 
tobacco, taking psychoactive tablets, using 
inhalants, and drinking beer have little or no 
harmful effects. 
− Between 4.6 and 13.9 percent of boys and 
2.1 to 10.3 percent of girls considered fre-
quent use of marijuana and occasional use of 
heroin to have little or no risk of addiction. 
 
• The survey measured students’ attitudes toward a 
friend using the various substances. Preliminary 
findings based on this theme include the following: 
 
− Between 41.4 and 46.5 percent of boys and 
23.3 to 46.2 percent of girls had little or no 
objection to a friend smoking, taking tablets, 
or using inhalants. 
 
− Slightly more than 17 percent of boys and 
10.0 percent of girls had little or no objec-
tion to a friend drinking beer or other alco-
holic beverages. 
 
− Between 15.2 and 15.9 percent of boys and 
8.4 to 9.2 percent of girls had little or no 
objection to a friend using substances like 
marijuana or heroin.  
 
• The study measured daily observations by the 
students in the schools and districts. Preliminary 
findings include the following: 
 
− Thirty-four percent of boys and 5.5 percent 
of girls had observed one or more school-
mates smoking at school. By district, these 
figures increase to 46 and 37.5 percent, 
respectively, among boys and girls. 
 
− Daily observations of schoolmates using tab-
lets at school were reported by 3.2 percent of 
boys and 3.9 percent of girls; this increased to 
5.2 percent in districts. 
 
− Since alcoholic drinks in Gaza are generally 
not available in stores, use of alcohol in 
school was rarely observed (0.6 percent of 
boys and none of the girls); in districts, 4.5 
percent of boys and 1.9 percent of girls 
reported such observations. 
 
− Observation of substance use (marijuana and 
heroin) was reported by 1.1 percent of boys 
but none of the girls; in the districts, 3.5 per-
cent of boys and 0.5 percent of girls reported 
observing schoolmates using marijuana or 
heroin at school.  
 
• The survey measured ease of obtaining sub-
stances. Findings from this theme include the 
following: 
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− Most students— 96.6 percent of boys and 95.9 
percent of girls— believe that tobacco and 
cigarettes are easy to obtain. 
 
− Also, 43.3 percent of boys and 57.9 percent 
of girls believe that stimulants and tranquil-
izers are easy to obtain. 
 
− Fewer students— 13.8 percent of boys and 
6.1 percent of girls— believe that obtaining 
marijuana is easy; 9.1 percent of boys and 
5.2 percent of girls believe heroin is easy to 
obtain. 
 
• The survey measured personal experience in use 
of substances. Findings from this theme include 
the following: 
− Daily cigarette smoking was reported by 
17.2 percent of the boys and 7.9 percent of 
the girls. 
 
− Psychoactive tablets were used by 2.5 per-
cent of the boys and 5.6 percent of the girls. 
 
− Inhalant use was reported by 6.4 percent of 
the boys and 2.6 percent of the girls (for 
girls, the most common inhaled substance 
was nail polish). 
 
− Three percent of the boys and 1.1 percent of 
the girls used marijuana. 
 
− Heroin mixtures were used by 1.7 percent of 
the boys and 0.8 percent of the girls. 
 
For inquiries concerning this report, please contact Mohamed F. Al-Afifi, M.D., Substance Abuse and Addiction Research Center (SARC), P.O. 
Box 1137, Rimal, Gaza, Palestinian Authority, Phone: 972-59-410251, Fax: 972-82-860013, E-mail: <m_alafifi@hotmail.com>. 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Southern Africa 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 317
Southern African Development Community Epidemiology Network 
on Drug Use (SENDU):  Findings July 2001— June 2002 
 
Charles D.H. Parry, Ph.D., and Andreas Plüddemann, M.A.1 
 
                                                 
1
 The authors are affiliated with the Medical Research Council (Cape Town), Tygerberg, South Africa. 
ABSTRACT 
 
The Southern African Development Community 
(SADC) Regional Drug Control Program provides 
for the establishment of a regional drug surveil-
lance network (SADC Epidemiology Network on 
Drug Use—SENDU) in the 14 SADC member 
States. At the end of June 2002, data were available 
from six countries: Botswana (Phase 1), Lesotho 
(Phase 2), Mauritius (Phase 2), Namibia (Phase 1), 
the Seychelles (Phase 2), and South Africa (Phase 
12). The findings indicate that while cannabis and 
alcohol dominate treatment demand, arrests, and 
community concern, there is an increase in harder 
drug use in some countries, especially heroin. 
Indicators also point to an increase in drug use 
among younger persons. In addition, an emergence 
of intravenous drug use in some countries and the 
spread of drugs historically confined to one 
particular area has been noted. Among the policy 
implications raised in the country reports for 
January to June 2002 were the following: there is a 
need to increase interventions aimed at youth; 
multifaceted strategies are needed to decrease the 
tolerance of alcohol abuse in society; attention 
should be given to addressing the danger of 
substance use in HIV prevention messages; and 
health workers need to be trained to identify drug 
abuse. Across countries, various issues requiring 
further research were raised, and suggestions were 
made for how data collection could be strengthened. 
Next steps include forwarding a summary of the 
findings and recommendations to the SADC 
Council of Ministers and expanding the project to 
three more countries in 2003.  
 
INTRODUCTION 
 
Project Overview 
 
The South African Community Epidemiology Net-
work on Drug Use (SACENDU) is an alcohol and 
other drug (AOD) surveillance system comprising 
a network of researchers, practitioners, and policy-
makers from five sites in South Africa. The network, 
managed by the Medical Research Council (MRC) of 
South Africa, has been operational since July 1996. 
In 2000, with funding from the South African 
Development Community (SADC) via the European 
Commission, the MRC was contracted to establish 
surveillance systems in the 13 other SADC member 
States.  
 
The project forms part of the 5-year SADC Drug 
Control Program. The broader (regional) network has 
been named the SADC Epidemiology Network on 
Drug Use. This initiative has been driven by several 
factors: the view that the burden of harm from AOD 
use in Southern Africa is likely to increase with 
development; the realization that various global, 
regional, and local factors have highlighted the need 
for monitoring substance use in Southern Africa at 
this time; and the SADC Drug Protocol, signed in 
1996, which highlights the importance of information 
and research to develop interdiction and demand 
reduction activities. 
 
The overall goal of the SADC Epidemiology Net-
work on Drug Use (SENDU) is to improve the 
information base for policymakers in SADC member 
States in order to address the health and socio-
economic burden caused by misuse of AODs. 
SENDU’s immediate purpose is to develop, establish, 
and evaluate a substance abuse surveillance system in 
each of the SADC member States, building on the 
SACENDU model operational in three cities and two 
provinces in South Africa. The initiative is supported 
logistically by the SADC Drug Control Officer and 
technically by the United Nations Office for Drugs 
and Crime (Global Assessment Program on Drug 
Abuse) and the National Institute on Drug Abuse 
(Division of Epidemiology, Services and Prevention 
Research) in the United States.  
  
The SENDU initiative has the following core 
components: 
 
• Ongoing training and technical support. 
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• Establishment of site- or country-specific net-
works and the implementation of a “ basic”  
surveillance system in each site, and if possible, 
additional components in some sites. The basic 
system is comprised of treatment demand data 
from specialist substance abuse treatment 
facilities (if available) and psychiatric hospitals, 
as well as information from police on arrests, 
seizures, and drug prices. Additional components 
might include school studies and mortuary or 
trauma unit studies. 
 
• Validation and collation of data during and after 
6-month country and regional report-back 
meetings. 
 
• Dissemination of findings via newsletters and 
reports, press briefings, and a Web site. 
 
A budget of $390,000 over 5 years has been provided 
to “ kick-start”  the process. The funds are being used 
for training/consultation meetings, technical support 
visits, and transportation for country representatives 
to semiannual regional meetings, as well as to 
facilitate report writing and information dissem-
ination.  
 
During 2001 and 2002, technical support visits were 
undertaken to Botswana, Lesotho, Malawi, Mauritius, 
Mozambique, Namibia, the Seychelles, and Tanzania. 
The foci of these visits was to learn more about 
patterns of AOD use in the countries; inform 
government officials about the SENDU initiative; 
assist countries in developing instruments to collect 
and collate secondary data on AOD use and 
associated consequences; provide technical support in 
other areas related to establishing and maintaining an 
AOD surveillance system; support country co-
ordinators in running an initial meeting of potential 
members of an AOD surveillance network; conduct 
visits to agencies where data are to be collected; and 
identify other areas requiring technical or other forms 
of support. 
 
Area Description 
 
The Southern African Development Community was 
established in 1992 and comprises 14 member States 
(exhibit 1). These countries differ greatly in land 
area, population, income levels, and official lan-
guages. The region has a population of more than 200 
million persons, with a landmass equal to that of the 
United States. Poverty reduction, drought, the human 
immunodeficiency virus (HIV) and acquired im-
munodeficiency syndrome (AIDS), and political 
instability are among the key issues currently facing 
SADC.  
Lesotho has a population of 2.1 million, and the 
island States of Mauritius and the Seychelles have 
populations of 1.2 million and nearly 80,000, 
respectively. The populations of Botswana and 
Namibia are 1.5 and 1.8 million persons, 
respectively. SACENDU comprises five sentinel 
sites, three of which are large port cities (Cape Town, 
Durban, and Port Elizabeth [PE]) and the other two 
are provinces: Gauteng, a largely urban province that 
includes the cities of Pretoria and Johannesburg, and 
Mpumalanga, a largely rural province bordered by 
Swaziland and Mozambique. The South African sites 
include about 36 percent of the country’s population. 
In contrast to South Africa, the surveillance systems 
in the five other countries referred to above focus on 
country-level data. 
 
Data Sources 
 
The following data sources are accessed in most 
countries: 
 
• Primary and secondary drugs of abuse reported 
by clients at specialist AOD treatment centers 
 
• Substance abuse-related diagnoses at acute psy-
chiatric treatment facilities 
 
• Police arrests, seizures, and price data 
 
• Alcohol-related deaths reported by mortuaries 
 
In addition, in selected countries the following in-
formation is accessed: 
 
• AOD-related trauma unit/ER admissions 
 
• Case records (from nongovernment organ-
izations [NGOs], probation services) 
 
• Prison data (AOD-related offenses and AOD use 
prior to the crime for which individuals were 
incarcerated) 
 
• Alcohol-related traffic offense data 
 
• Household, school, and rave surveys 
 
• Key informant interviews (school counselors, 
youth) 
 
• Alcohol production and licensing information 
 
The focus of this report is on the findings of Phase 1 
(January– June 2002) for Botswana and Namibia, 
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Phases 1 (July– December 2001) and 2 (January– June 
2002) for Lesotho, Mauritius, and the Seychelles, and 
Phases 11 (July– December 2001) and 12 (January–
June 2002) of the SACENDU Project.  
 
DRUG ABUSE PATTERNS AND TRENDS 
 
Treatment Demand Data 
 
Information on the primary drug of abuse reported at 
specialist AOD treatment centers2 is provided in 
exhibits 2– 5. Unless otherwise stated, data relate to 
January to June 2002. To facilitate country com-
parisons, data for South Africa are averaged over the 
five sentinel sites in the country.  
 
In Botswana, Mauritius, Namibia, and South Africa, 
there appears to be demand for treatment for a greater 
range of substances of abuse than in Lesotho and the 
Seychelles, where alcohol and cannabis are the only 
primary drugs of abuse reported (exhibit 2a). Based 
on treatment demand data, South Africa appears to 
have a greater range of available substances than 
other SADC countries for which SENDU data are 
available. Mauritius has by far the greatest proportion 
of patients in treatment whose primary drug of abuse 
is heroin (nearly 50 percent). The only other country 
reporting patients with heroin as the primary drug 
was South Africa. Differences by country for the 
major primary or secondary drugs of abuse are 
graphically depicted in exhibit 2b. 
 
South Africa is the only country with treatment 
patients reporting ecstasy as the primary drug of 
abuse (exhibit 2a). Methaqualone (Mandrax) and 
cocaine were only reported as a primary substances 
of abuse in treatment centers in Botswana, Namibia, 
and South Africa. 
 
The major changes noted between July– December 
2001 and January– June 2002 were as follows: an 
increase in the proportion of patients seeking 
treatment for primary abuse of alcohol for all four 
sites for which comparative data were available; a 
decrease in the proportion of treatment patients 
whose primary drug of abuse was cannabis for all 
four sites for which comparative data were available; 
and a decrease in the proportion of patients in 
Mauritius whose primary drug of abuse was heroin. 
 
Across countries and sites, the proportion of patients 
in treatment who were younger than 20 ranged from 
just over 3 percent in Mauritius to nearly one-quarter 
in South Africa (exhibit 3). Except for Lesotho, 
where the number of patients in treatment for 
substance abuse is low and appears to have 
decreased, these percentages have remained fairly 
stable over the two data collection periods. 
 
Across sites, with the exception of Mauritius, the 
predominant mode of ingesting substances is by 
swallowing or smoking (exhibit 4). In Mauritius, 
however, more than one-half of persons in treatment 
in the first half of 2002 injected their primary drug of 
abuse. In Mauritius, heroin is primarily used 
intravenously. In contrast, in South Africa heroin is 
mostly smoked (“ chasing the dragon” ), but an 
increasing proportion of patients with heroin as their 
primary drug of abuse report some injection use 
(more than 40 percent in Gauteng and Cape Town). 
 
In all sites reporting age, patients in treatment whose 
primary drug of abuse was alcohol were older than 
those reporting other primary drugs of abuse (exhibit 
5). The mean age of patients whose primary drug of 
abuse was cannabis ranged from 19 in Cape Town to 
32 in Mauritius. Patients whose primary drug of 
abuse was cannabis or ecstasy in South Africa 
generally appeared to be younger than persons 
reporting other primary drugs of abuse. Between the 
second half of 2001 and the first half of 2002 in 
Mauritius, there was a dramatic decrease in the age of 
patients whose primary drug of abuse was heroin. 
 
The proportion of persons in psychiatric treatment 
centers with an alcohol- or drug-related 
admission/discharge diagnosis ranged from a low of 
19 percent in Port Elizabeth (South Africa) to nearly 
50 percent in Mauritius, with the predominant 
substance being alcohol. Of the drugs, by far the most 
common substance was cannabis (in Namibia, the 
Seychelles, and South Africa) and heroin (in 
Mauritius).  
 
Law Enforcement Data 
 
Information on the proportion of police arrests for 
dealing in different drugs is shown in exhibit 6. In 
Botswana, Lesotho, and the Seychelles in the first 
half of 2002, all arrests for drug dealing involved 
cannabis. In Mauritius, more than one-half of arrests 
for drug dealing involved heroin. Heroin arrests were 
substantially greater in Mauritius than in South 
Africa, the only other SADC country (in the SENDU 
project) where police arrests for dealing in heroin 
were reported. In contrast to Botswana, Lesotho, 
Mauritius, and the Seychelles, in the four South 
African sites for which arrest data were available and 
in Namibia, persons were arrested for dealing in a 
much greater spectrum of substances. 
2
 In the case of Lesotho, this also includes four psychiatric hospitals/clinics that also provide substance abuse treatment services.  For 
Botswana, information comes from nine psychiatric hospitals. 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Southern Africa 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 320
Police seizures are indicated in exhibit 7. In the first 
half of 2002, the highest seizures of cannabis were 
noted in Botswana and South Africa (147,067 and 
707,444 kilograms, respectively), while the greatest 
amount of heroin was seized in South Africa (6.1 
kilograms) and Mauritius (5.0 kilograms). In the first 
half of 2002, seizures of cocaine, lysergic acid 
diethylamide (LSD), and speed only occurred in 
South Africa. Methaqualone, crack and ecstasy 
seizures were only reported in Namibia and South 
Africa. 
 
Information on drug prices is provided in exhibit 8. 
Cannabis is clearly very inexpensive in South Africa, 
at about U.S.$0.10 per gram. One explanation for this 
is that cannabis is widely cultivated in certain parts of 
South Africa. Heroin is also significantly cheaper in 
South Africa than in Mauritius. One gram of heroin 
in Mauritius costs approximately U.S.$267, 
compared with only U.S.$12 in Cape Town, South 
Africa. Information on drug purity is generally not 
available. No major changes in drug prices were 
noted over the two periods for the countries where 
comparative data were available. 
 
CONCLUSION 
 
This report aims to summarize the situation with 
regard to the nature and extent of AOD abuse and 
associated consequences in the six SADC member 
States that are fully participating in the SENDU 
project. In 2003, data from Malawi are expected to be 
available for the period July to December 2002, and 
from Mozambique and Tanzania for the period 
January to June 2003.  
 
The findings to date indicate that while cannabis and 
alcohol dominate treatment demand, arrests, and 
community concern, there is an increase in harder 
drug use, especially heroin, in some countries. 
Indicators also point to an increase in drug use among 
younger persons. In addition, an emergence of 
intravenous drug use has been noted in some 
countries, as has the spread of drugs historically 
confined to particular areas (e.g., the spread of 
methaqualone use from South Africa to Botswana 
and Namibia). 
 
Among the policy implications raised in the country 
reports for January to June 2002 were the following: 
 
• There is a need to increase interventions aimed at 
youth, including early intervention programs 
designed to delay the onset of AOD use and 
sustained use of drugs among experimental 
users; access to quality school-based prevention 
programs; programs specifically focusing on 
reducing cannabis use among youth (in Lesotho 
and South Africa) and heroin use among youth in 
certain urban areas (Mauritius [Port Louis], 
South Africa [Cape Town, Gauteng]); and treat-
ment options for young people in general. 
 
• Multifaceted strategies to decrease the tolerance 
of alcohol abuse in society are required in most 
SADC member States. 
 
• Specific attention should be given to addressing 
the danger of AOD abuse in HIV prevention 
messages (Mauritius and South Africa), as well 
as in addressing the risk associated with intra-
venous drug use (Mauritius, Namibia, and South 
Africa). 
 
• Training should be conducted with nurses and 
other health workers in how to identify drug 
abuse problems that may be may be manifested 
as a physical problem (Botswana). 
 
Across the countries, various issues requiring further 
research were raised, including the following: 
 
• The extent of female use of cannabis. 
 
• The link between AOD use and traffic collisions. 
 
• The relationship between AOD use and psy-
chiatric problems.  
 
• Comparison of crimes committed under the 
influence of substances like alcohol, cocaine, and 
heroin. 
 
• The link between substance use and HIV/AIDS. 
 
• The incidence of HIV and hepatitis C and B 
among injection and non-injection drug users in 
Mauritius. 
 
• Reasons for the non-use of rehabilitation services 
by young girls and women. 
 
• The effect of a change in cannabis policy in 
Europe on cannabis trafficking and use in South-
ern Africa. 
 
At the SENDU regional meeting held in Luanda 
(Angola) in November 2002, various suggestions 
were put forward for how data collection could be 
strengthened. Among other things, the need for 
computerization of certain data sources was stressed, 
as was the need to increase access to other data 
sources. In particular, sources other than treatment 
settings and law enforcement agencies need to be 
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accessed, especially those that will be useful in 
determining whether there are other drugs that are 
being used (e.g., ecstasy). The following sources 
specifically were mentioned: private hospital casualty 
departments; military hospitals; surveys of youth in 
schools and universities; mine workers; primary 
health care clinic attendees; and prisoners. 
 
Next steps include analysis of the first phase of data 
collected in Malawi (July– December 2002); data 
collection in Mozambique and Tanzania beginning 
January 2003; technical support visits to Swaziland, 
Zambia, and Zimbabwe in 2003; continued support to 
and communication with member States; hosting the 
third SENDU Report Back Meeting in Johannesburg 
in the first half of 2003; ongoing advocacy for the 
project and dissemination of existing data; and 
working on a proposal to ensure continuation of the 
project after June 2004. The latest findings of 
SENDU, plus the policy recommendations, have 
been included in a short report that will be delivered 
to the next meeting of the SADC Council of 
Ministers.  
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Exhibit 1.  Description of SADC Member States on Selected Indicators 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SADC Member State 
Land Area 
(Square 
Kilometers) 
Population 
(2001 
Estimates) 
GDP per 
Capita1 ($) Official Language 
Angola 1,246,700 10,366,031 1,000 Portuguese 
Botswana 600,370 1,586,119 6,600 English 
Democratic Republic of  
  the Congo 2,345,410 53,624,718 600 French 
Lesotho 30,355 2,177,062 2,400 English 
Malawi 118,480 10,548,250 900 English, Chichewa 
Mauritius 1,860 1,189,825 10,400 English 
Mozambique 801,590 19,371,057 1,000 Portuguese 
Namibia 825,418 1,797,677 4,300 English 
Seychelles 455 79,715 7,700 English, French 
South Africa 1,219,919 43,586,097 8,500 11 official languages2 
Swaziland 17,363 1,104,343 4,000 English, siSwati 
Tanzania 945,087 36,232,074 710 English, Swahili 
Zambia 752,614 9,770,199 880 English 
Zimbabwe 390,580 11,365,366 2,500 English 
 9,296,201 202,789,533   
 
1
 Purchasing power parity (2000 estimate). 
2  English predominates. 
 
SOURCE:  World Factbook 2001. Washington, DC:  Central Intelligence Agency, 2001 
 
 
Mauritius 
Swaziland 
Lesotho 
South 
Africa 
Namibia 
Botswana 
Zimbabwe Mozambique 
Tanzania 
Dem. Rep. 
of the 
Congo 
Zambia 
Angola 
Seychelles 
Malawi 
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE—Southern Africa 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 323
 
Ex
hi
bi
t 2
a.
 
Tr
ea
tm
en
t D
em
an
d 
Da
ta
: P
rim
ar
y 
Dr
ug
 o
f A
bu
se
 b
y 
Pe
rc
en
t:1
   
Ju
ly
 2
00
1–
Ju
ne
 2
00
2 
 Co
un
try
 
Pe
rio
d 
A
lc
oh
ol
 
Ca
nn
ab
is
 
M
et
ha
-
qu
al
on
e 
(M
tq
) 
Co
ca
in
e 
H
er
oi
n 
Ec
st
as
y 
O
TC
/P
re
2  
O
th
er
 
Pa
tie
nt
s 
(N
) 
Tr
ea
tm
en
t 
Ce
nt
er
s 
(N
) 
Bo
ts
w
an
a 
Ja
n–
Ju
n 
‘0
2 
70
.3
 
23
.8
 
0.
5 
0.
5 
0.
0 
0.
0 
0.
0 
4.
9 
(18
8) 
(9)
 
Ju
l–
De
c 
‘0
1 
54
.3
 
45
.7
 
0.
0 
0.
0 
0.
0 
0.
0 
0.
0 
0.
0 
(45
) 
(6)
 
Le
so
th
o 
Ja
n–
Ju
n 
‘0
2 
85
.0
 
15
.0
 
0.
0 
0.
0 
0.
0 
0.
0 
0.
0 
0.
0 
(20
) 
(5)
 
Ju
l–
De
c 
‘0
1 
21
.8
 
14
.1
 
0.
0 
0.
0 
58
.7
 
0.
0 
1.
3 
4.
1 
(46
7) 
(8)
 
M
au
rit
iu
s 
Ja
n–
Ju
n 
‘0
2 
32
.7
 
6.
6 
0.
0 
0.
0 
48
.2
 
0.
0 
1.
1 
11
.3
 
(45
2) 
(8)
 
N
am
ib
ia
 
Ja
n–
Ju
n 
‘0
2 
74
.0
 
8.
0 
12
.0
 
6.
0 
0.
0 
0.
0 
0.
0 
0.
0 
(50
) 
(2)
 
Ju
l–
De
c 
‘0
1 
69
.8
 
30
.2
 
0.
0 
0.
0 
0.
0 
0.
0 
0.
0 
0.
0 
(53
) 
(1)
 
Se
yc
he
lle
s 
Ja
n–
Ju
n 
‘0
2 
81
.5
 
18
.5
 
0.
0 
0.
0 
0.
0 
0.
0 
0.
0 
0.
0 
(65
) 
(1)
 
Ju
l–
De
c 
‘0
1 
52
.2
 
21
.4
 
10
.1
 
5.
1 
5.
1 
1.
1 
3.
1 
1.
6 
(5,
66
7) 
(48
) 
So
ut
h 
Af
ric
a 
Ja
n–
Ju
n 
‘0
2 
54
.0
 
19
.3
 
10
.3
 
5.
7 
5.
3 
1.
0 
3.
1 
1.
2 
(6,
10
8) 
(50
) 
 1  
R
ow
 p
er
ce
nt
ag
es
 to
ta
l 1
00
. 
2  
In
cl
ud
es
 p
sy
ch
ot
ro
pi
c 
m
ed
ici
ne
s.
 
 SO
UR
CE
S:
  S
pe
cia
lis
t A
O
D 
Tr
ea
tm
en
t C
en
te
rs
 
  
EPIDEMIOLOGIC TRENDS IN DRUG ABUSE— Southern Africa 
 
 
Proceedings of the Community Epidemiology Work Group, Vol. II, December 2002 324
Exhibit 2b. Treatment Demand Data for Selected Substances:  Primary or Secondary Drugs of  
 Abuse:  January–June 2002 
0
10
20
30
40
50
60
70
80
90
Botswana Lesotho Mauritius Namibia Seychelles S. Africa
Alcohol Cannabis Methaqualone Cocaine Heroin
 
SOURCES:  Specialist AOD Treatment Centers 
 
 
 
Exhibit 3.  Percentage of the Treatment Population Younger Than 20:  July 2001–June 2002 
 
Country Period Percent 
Botswana Jan–Jun ‘02 11.8  
Jul–Dec ‘011 40.0 Lesotho 
Jan–Jun ‘02 15.0  
Jul–Dec ‘01 2.4 Mauritius 
Jan–Jun ‘02 3.1 
Namibia Jan–Jun ‘02 10.0 
Jul–Dec ‘01 13.2 Seychelles 
Jan–Jun ‘02 9.2 
Jul–Dec ‘01 22.7 South Africa 
Jan–Jun ‘02 22.6 
 
1
 Younger than 23.  
 
SOURCES:  Specialist AOD Treatment Centers 
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Exhibit 4.  Primary Mode of Drug Use by Primary Substance of Abuse and Percent:   
      July 2001–June 2002 
 
Country Period Swallow Smoke Inject Snort Other 
Botswana Jan–Jun ‘02 70.4 24.7 0.0 4.8 0.0 
Lesotho Jul–Dec ‘01 52.1 47.9 0.0 0.0 0.0 
 Jan–Jun ‘02 85.0 15.0 0.0 0.0 0.0 
Jul–Dec ‘01 22.7 24.6 51.2 1.5 0.0 Mauritius 
Jan–Jun ‘02 31.3 15.1 52.6 1.0 0.0 
Namibia Jan–Jun ‘02 84.0 16.0 0.0 0.0 0.0 
Jul–Dec ‘01 71.7 28.3 0.0 0.0 0.0 Seychelles 
Jan–Jun ‘02 81.5 18.5 0.0 0.0 0.0 
Jul–Dec ‘01 56.5 38.0 2.1 2.6 0.7 South Africa 
Jan–Jun ‘02 58.0 35.9 2.4 3.1 0.7 
 
SOURCES:  Specialist AOD Treatment Centers 
 
 
 
Exhibit 5.  Mean Age of Persons in Treatment by Primary Drug of Abuse:  July 2001–June 2002 
 
Primary Drug of Abuse 
Country Period 
Alcohol Cannabis Metha-qualone Cocaine Heroin Ecstasy OTC/Pre
1
 
Jul–Dec ‘01 38.2 31.4 – – 32.7 – 26–28 
Mauritius 
Jan–Jun ‘02 41.0 31.9 – – 24.9 – 24.6–31.2 
Jul–Dec ‘01 41.3 19.1 – – – – – 
Seychelles 
Jan–Jun ‘02 40.0 25.0 – – – – – 
Jul–Dec ‘01 37–41 19–23 20–30 29–30 23–24 17–22 30–37 
South Africa 
Jan–Jun ‘02 37–41 19–23 21–28 27–36 23–25 20–23 35–41 
 
1
 Includes psychotropic medicines. 
 
SOURCES:  Specialist AOD Treatment Centers 
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